PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tittensor, DP; Mora, C; Jetz, W; Lotze, HK; Ricard, D; Vanden Berghe, E; Worm, B				Tittensor, Derek P.; Mora, Camilo; Jetz, Walter; Lotze, Heike K.; Ricard, Daniel; Vanden Berghe, Edward; Worm, Boris			Global patterns and predictors of marine biodiversity across taxa	NATURE			English	Article							DIVERSITY; CLIMATE; ENERGY; HOTSPOTS; SCALE; SIZE	Global patterns of species richness and their structuring forces have fascinated biologists since Darwin(1,2) and provide critical context for contemporary studies in ecology, evolution and conservation. Anthropogenic impacts and the need for systematic conservation planning have further motivated the analysis of diversity patterns and processes at regional to global scales(3). Whereas land diversity patterns and their predictors are known for numerous taxa(4,5), our understanding of global marine diversity has been more limited, with recent findings revealing some striking contrasts to widely held terrestrial paradigms(6-8). Here we examine global patterns and predictors of species richness across 13 major species groups ranging from zooplankton to marine mammals. Two major patterns emerged: coastal species showed maximum diversity in the Western Pacific, whereas oceanic groups consistently peaked across broad mid-latitudinal bands in all oceans. Spatial regression analyses revealed sea surface temperature as the only environmental predictor highly related to diversity across all 13 taxa. Habitat availability and historical factors were also important for coastal species, whereas other predictors had less significance. Areas of high species richness were disproportionately concentrated in regions with medium or higher human impacts. Our findings indicate a fundamental role of temperature or kinetic energy in structuring cross-taxon marine biodiversity, and indicate that changes in ocean temperature, in conjunction with other human impacts, may ultimately rearrange the global distribution of life in the ocean.	[Tittensor, Derek P.; Mora, Camilo; Lotze, Heike K.; Ricard, Daniel; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Vanden Berghe, Edward] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	Dalhousie University; Yale University; Rutgers State University New Brunswick	Tittensor, DP (corresponding author), Dalhousie Univ, Dept Biol, 1355 Oxford St, Halifax, NS B3H 4J1, Canada.	derekt@mathstat.dal.ca	Ricard, Daniel/G-1814-2014; Tittensor, Derek P./AAV-1117-2021; Jetz, Walter/ABF-1517-2020	Tittensor, Derek P./0000-0002-9550-3123; Lotze, Heike/0000-0001-6258-1304; Worm, Boris/0000-0002-5742-8716; Jetz, Walter/0000-0002-1971-7277	Sloan Foundation; NSF [DBI-0960550, BCS-0648733]	Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF))	We acknowledge contributions and sharing of data from L. Lucifora, V. Garcia, M. Kulbicki and P. Hull. We thank all the sources in Supplementary Tables 1 and 2 for making their data available. We are grateful to all OBIS data providers for making this study possible; see www.iobis.org for a full list. A. Rollo, G. Britten and D. Boyce provided technical help; W. Blanchard offered statistical advice. This paper builds on the efforts of all Census of Marine Life contributors, and long-term support from the Sloan Foundation. W.J. acknowledges support from NSF grants DBI-0960550 and BCS-0648733.	ALLEN AP, 2007, SCALING BIODIVERSITY; [Anonymous], 2001, BEHAV RES METH INS C; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; BIVAND R, 1956, SPDEP SPATIAL DEPEND; Briggs J. C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Brinton E., 2000, EUPHAUSIIDS WORLD OC; Cairns DK, 2008, MAR ECOL PROG SER, V356, P239, DOI 10.3354/meps07286; CASEY KS, 2010, OCEANOGRAPHY SPACE R, pCH16; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Darwin C., 1877, ORIGIN SPECIES; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Etnoyer Peter, 2004, Oceanography, V17, P90; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fornwall Mark, 2000, Oceanography, V13, P31; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Froese R, 2014, FISHBASE; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Green E.P., 2003, WORLD ATLAS SEAGRASS; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; KULBICKI M, 2007, MACROCOSME MICROCOSM; KULBICKI M, 2004, CHALLENGING COASTS T; Kulbicki M, 2007, CYBIUM, V31, P275; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; LUCIFORA L, PLOS ONE IN PRESS; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mora C, 2005, J BIOGEOGR, V32, P277, DOI 10.1111/j.1365-2699.2004.01155.x; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Prell W., 1999, IGBP PAGES WORLD DAT; R Core Development Team, 2009, R LANG ENV STAT COMP; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson D.R., 2002, SHORE FISHES TROPICA; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Roper CFE, 1984, FAO SPECIES CATALOGU, V3; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Spalding M. D., 1997, WORLD MANGROVE ATLAS, DOI DOI 10.1017/S0266467498300528; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Veron J., 2000, CORALS WORLD, V1-3; Wagner H, 2009, VEGAN COMMUNITY ECOL; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, P263, DOI 10.1016/B978-0-444-53301-2.00014-2	62	858	898	31	777	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1098	U107		10.1038/nature09329	http://dx.doi.org/10.1038/nature09329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20668450				2022-12-28	WOS:000281203600038
J	Cates, W				Cates, Willard, Jr.			After CAPRISA 004: time to re-evaluate the HIV lexicon	LANCET			English	Editorial Material							PREVENT		FHI, Res Triangle Pk, NC 27709 USA		Cates, W (corresponding author), FHI, Res Triangle Pk, NC 27709 USA.	wcates@fhi.org						Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; *IAVI, 2010, E002 IAVI; *IAVI, 2010, E001 IAVI; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; *VOICE, 2010, MTN003 VOICE	7	24	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					495	496		10.1016/S0140-6736(10)61200-7	http://dx.doi.org/10.1016/S0140-6736(10)61200-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20709216				2022-12-28	WOS:000281266800008
J	Wisanto, E; D'Hondt, M; Aerts, R; Geboes, K; De Hertogh, G; Sagaert, X				Wisanto, Erika; D'Hondt, Mathieu; Aerts, Raymond; Geboes, Karel; De Hertogh, Gert; Sagaert, Xavier			A cheesy diagnosis	LANCET			English	Editorial Material									[Wisanto, Erika; Geboes, Karel; De Hertogh, Gert; Sagaert, Xavier] Univ Hosp Leuven, Dept Pathol, B-3000 Louvain, Belgium; [D'Hondt, Mathieu; Aerts, Raymond] Univ Hosp Leuven, Dept Abdominal Surg, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Sagaert, X (corresponding author), Univ Hosp Leuven, Dept Pathol, Minderbroederstr 12, B-3000 Louvain, Belgium.	xavier.sagaert@uz.kuleuven.ac.be						Cummings B, 2001, CAN J SURG, V44, P298; Davis JR, 1998, AM J CLIN PATHOL, V109, P320, DOI 10.1093/ajcp/109.3.320; MAHMOUD A, 1997, AM SURG MAY, V5, P382; Selo-Ojeme D, 2007, J OBSTET GYNAECOL, V27, P660, DOI 10.1080/01443610701582792; Stuart Olivia A, 2009, J Med Case Rep, V3, P60, DOI 10.1186/1752-1947-3-60	5	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					564	564		10.1016/S0140-6736(10)60875-6	http://dx.doi.org/10.1016/S0140-6736(10)60875-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20709234	Green Accepted			2022-12-28	WOS:000281266800035
J	Walton, MA; Chermack, ST; Shope, JT; Bingham, CR; Zimmerman, MA; Blow, FC; Cunningham, RM				Walton, Maureen A.; Chermack, Stephen T.; Shope, Jean T.; Bingham, C. Raymond; Zimmerman, Marc A.; Blow, Frederic C.; Cunningham, Rebecca M.			Effects of a Brief Intervention for Reducing Violence and Alcohol Misuse Among Adolescents A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISORDERS IDENTIFICATION TEST; EMERGENCY-DEPARTMENT; PROBLEM DRINKING; CLINICAL-TRIAL; SCREENING-TEST; SELF-REPORT; BEHAVIOR; RISK; CONSUMPTION; PROGRAM	Context Emergency department (ED) visits present an opportunity to deliver brief interventions to reduce violence and alcohol misuse among urban adolescents at risk of future injury. Objective To determine the efficacy of brief interventions addressing violence and alcohol use among adolescents presenting to an urban ED. Design, Setting, and Participants Between September 2006 and September 2009, 3338 patients aged 14 to 18 years presenting to a level I ED in Flint, Michigan, between 12 PM and 11 PM 7 days a week completed a computerized survey (43.5% male; 55.9% African American). Adolescents reporting past-year alcohol use and aggression were enrolled in a randomized controlled trial (SafERteens). Intervention All patients underwent a computerized baseline assessment and were randomized to a control group that received a brochure (n = 235) or a 35-minute brief intervention delivered by either a computer (n = 237) or therapist (n = 254) in the ED, with follow-up assessments at 3 and 6 months. Combining motivational interviewing with skills training, the brief intervention for violence and alcohol included review of goals, tailored feedback, decisional balance exercise, role plays, and referrals. Main Outcome Measures Self-report measures included peer aggression and violence, violence consequences, alcohol use, binge drinking, and alcohol consequences. Results About 25% (n = 829) of screened patients had positive results for both alcohol and violence; 726 were randomized. Compared with controls, participants in the therapist intervention showed self-reported reductions in the occurrence of peer aggression (therapist, -34.3%; control, -16.4%; relative risk [RR], 0.74; 95% confidence interval [CI], 0.61-0.90), experience of peer violence (therapist, -10.4%; control, +4.7%; RR, 0.70; 95% CI, 0.52-0.95), and violence consequences (therapist, -30.4%; control, -13.0%; RR, 0.76; 95% CI, 0.64-0.90) at 3 months. At 6 months, participants in the therapist intervention showed self-reported reductions in alcohol consequences (therapist, -32.2%; control, -17.7%; odds ratio, 0.56; 95% CI, 0.34-0.91) compared with controls; participants in the computer intervention also showed self-reported reductions in alcohol consequences (computer, -29.1%; control, -17.7%; odds ratio, 0.57; 95% CI, 0.34-0.95). Conclusion Among adolescents identified in the ED with self-reported alcohol use and aggression, a brief intervention resulted in a decrease in the prevalence of self-reported aggression and alcohol consequences.	[Walton, Maureen A.; Chermack, Stephen T.; Blow, Frederic C.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Shope, Jean T.; Bingham, C. Raymond; Zimmerman, Marc A.; Cunningham, Rebecca M.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Shope, Jean T.; Bingham, C. Raymond] Univ Michigan, Transportat Res Inst, Ann Arbor, MI 48109 USA; [Cunningham, Rebecca M.] Univ Michigan, Dept Emergency Med, Injury Prevent Ctr, Ann Arbor, MI 48109 USA; [Chermack, Stephen T.; Blow, Frederic C.] Dept Vet Affairs, Ann Arbor, MI USA; [Cunningham, Rebecca M.] Hurley Med Ctr, Flint, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Walton, MA (corresponding author), Univ Michigan, Dept Psychiat, Rachel Upjohn Bldg,4250 Plymouth Rd, Ann Arbor, MI 48109 USA.	waltonma@umich.edu			National Institute on Alcohol Abuse and Alcoholism (NIAAA) [014889]; Hurley Medical Center; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014889] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Hurley Medical Center; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was supported by National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant 014889.; We thank project staff for their work, as well as Pat Bergeron (not paid by the project) for administrative assistance and Linping Duan, MS, for statistical support (paid analyst for the project), both from the University of Michigan. Finally, we thank the patients and medical staff at Hurley Medical Center for their support of this project.	BAER JS, 2002, MOTIVATIONAL INTERVI, P320; Bernstein E, 2009, ACAD EMERG MED, V16, P1072, DOI 10.1111/j.1553-2712.2009.00549.x; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cheng TL, 2008, PEDIATR EMERG CARE, V24, P130, DOI 10.1097/PEC.0b013e3181666f72; Chermack ST, 2002, DRUG ALCOHOL DEPEN, V66, P29, DOI 10.1016/S0376-8716(01)00180-6; Chung T, 2002, ALCOHOL CLIN EXP RES, V26, P223, DOI 10.1097/00000374-200202000-00010; Cooper C, 2006, J TRAUMA, V61, P534, DOI 10.1097/01.ta.0000236576.81860.8c; Cunningham RM, 2009, ACAD EMERG MED, V16, P1193, DOI 10.1111/j.1553-2712.2009.00513.x; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Harris K.M., 2003, NATL LONGITUDINAL ST; HEDGES LV, 2003, PREV SCI, V4, P27; Johnston BD, 2002, PEDIATRICS, V110, P267, DOI 10.1542/peds.110.2.267; Knight JR, 2002, ARCH PEDIAT ADOL MED, V156, P607, DOI 10.1001/archpedi.156.6.607; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Maio RF, 2005, ANN EMERG MED, V45, P420, DOI 10.1016/j.annemergmed.2004.10.013; Maio RF, 2000, ANN EMERG MED, V35, P252, DOI 10.1016/S0196-0644(00)70076-X; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; Miller WR, 1994, ALCOHOL USE MISUSE Y; Monti PM, 2007, ADDICTION, V102, P1234, DOI 10.1111/j.1360-0443.2007.01878.x; Monti PM, 2001, ADOLESCENTS, ALCOHOL, AND SUBSTANCE ABUSE: REACHING TEENS THROUGH BRIEF INTERVENTIONS, P145; Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989; Murphy DA, 2000, AM J EPIDEMIOL, V152, P805, DOI 10.1093/aje/152.9.805; Pitts SR, 2008, NATL HOSP AMBULATORY; Posner JC, 2004, PEDIATRICS, V113, P1603, DOI 10.1542/peds.113.6.1603; Rahdert E. R., 1991, ADOLESCENT ASSESSMEN; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schappert SM, 2008, NATL HLTH STAT REPOR, P8; Sieving RE, 2001, J ADOLESCENT HEALTH, V28, P73, DOI 10.1016/S1054-139X(00)00155-5; Spirito A, 2004, J PEDIATR-US, V145, P396, DOI 10.1016/j.jpeds.2004.04.057; Straus M, 1999, PHYS VIOLENCE AM FAM, P529; STRAUS MA, 1979, J MARRIAGE FAM, V41, P633; Swahn MH, 2004, J ADOLESCENT HEALTH, V34, P480, DOI 10.1016/S1054-139X(03)00368-9; Swahn MH, 2006, ADDICT BEHAV, V31, P2014, DOI 10.1016/j.addbeh.2006.02.001; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Walton MA, 2009, J ADOLESCENT HEALTH, V45, P77, DOI 10.1016/j.jadohealth.2008.12.005; Wolfe DA, 2001, PSYCHOL ASSESSMENT, V13, P277, DOI 10.1037//1040-3590.13.2.277; Zun LS, 2006, AM J EMERG MED, V24, P8, DOI 10.1016/j.ajem.2005.05.009	39	267	268	2	39	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					527	535		10.1001/jama.2010.1066	http://dx.doi.org/10.1001/jama.2010.1066			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682932	Green Accepted			2022-12-28	WOS:000280525700020
J	Harvey, RP				Harvey, Ralph P.			Carbonates and Martian Climate	SCIENCE			English	Editorial Material							EARLY MARS; IDENTIFICATION; ASSEMBLAGES		Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA	Case Western Reserve University	Harvey, RP (corresponding author), Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA.	rph@case.edu						Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; BLANEY DL, 1989, J GEOPHYS RES-SOLID, V94, P10159, DOI 10.1029/JB094iB08p10159; BLANEY DL, 1990, 9006 LPI, P83; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; Carr M.H, 1996, WATER MARS; Corrigan CM, 2004, METEORIT PLANET SCI, V39, P17, DOI 10.1111/j.1945-5100.2004.tb00047.x; Ehlmann BL, 2008, SCIENCE, V322, P1828, DOI 10.1126/science.1164759; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Levy JS, 2005, TERRA NOVA, V17, P503, DOI 10.1111/j.1365-3121.2005.00642.x; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Morris RV, 2010, SCIENCE, V329, P421, DOI 10.1126/science.1189667; POLLACK JB, 1991, ICARUS, V91, P173, DOI 10.1016/0019-1035(91)90017-N; SPENCER JR, 1990, J GEOPHYS RES-SOLID, V95, P14301, DOI 10.1029/JB095iB09p14301; Tosca NJ, 2006, EARTH PLANET SC LETT, V241, P21, DOI 10.1016/j.epsl.2005.10.021	16	7	8	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					400	401		10.1126/science.1192828	http://dx.doi.org/10.1126/science.1192828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651142				2022-12-28	WOS:000280196500024
J	Gordon, CM				Gordon, Catherine M.			Functional Hypothalamic Amenorrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; ANOREXIA-NERVOSA; BONE-DENSITY; ADOLESCENT GIRLS; DOUBLE-BLIND; YOUNG-WOMEN; NEUROENDOCRINE; LEPTIN; ENERGY; PATHOPHYSIOLOGY	A 16-year-old girl presents for evaluation of secondary amenorrhea. Her menarche was at the age of 12 years. Since she started running for exercise and sport at the age of 14 years, her menstrual periods have become lighter and less frequent. Her last menstrual period was 6 months ago. She has lost 2.3 kg (5 lb) over the past 3 months and reports a 2-week history of right foot pain. She typically runs 10 km (6 mi) per day, at least five times per week. On physical examination, her body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) is 19. There is pain on palpation along the fourth and fifth metatarsals; otherwise, the physical examination is normal. How should her case be evaluated and managed?	Childrens Hosp, Div Adolescent Med & Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Gordon, CM (corresponding author), Childrens Hosp, Div Adolescent Med & Endocrinol, 300 Longwood Ave, Boston, MA 02115 USA.	catherine.gordon@childrens.harvard.edu	Gordon, Catherine M/GOH-1814-2022	Gordon, Catherine M/0000-0001-8988-7186	Harvard-MIT Division of Health Sciences and Technology; Pfizer; Merck	Harvard-MIT Division of Health Sciences and Technology; Pfizer(Pfizer); Merck(Merck & Company)	Dr. Gordon reports being a consultant for Gilead Sciences and serving as codirector (with partial salary support) of the Clinical Investigator Training Program sponsored by the Harvard-MIT Division of Health Sciences and Technology, Pfizer, and Merck. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1986, J Adolesc Health Care, V7, P236; Austin SB, 2008, J ADOLESCENT HEALTH, V42, P450, DOI 10.1016/j.jadohealth.2007.11.139; BACHRACH LK, 1991, J CLIN ENDOCR METAB, V72, P602, DOI 10.1210/jcem-72-3-602; BERGA SL, 1989, J CLIN ENDOCR METAB, V68, P301, DOI 10.1210/jcem-68-2-301; Berga SL, 2003, FERTIL STERIL, V80, P976, DOI 10.1016/S0015-0282(03)01124-5; Bishop N, 2008, J CLIN DENSITOM, V11, P29, DOI 10.1016/j.jocd.2007.12.004; Borges LE, 2007, GYNECOL ENDOCRINOL, V23, P343, DOI 10.1080/09513590701327620; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Ducher G, 2009, BONE, V45, P760, DOI 10.1016/j.bone.2009.06.021; Emans SJ, 2005, PEDIAT ADOLESCENT GY; FLUG D, 1984, ANN HUM BIOL, V11, P495, DOI 10.1080/03014468400007411; FRISCH RE, 1991, TRENDS ENDOCRIN MET, V2, P191, DOI 10.1016/1043-2760(91)90018-I; FRISCH RE, 1980, J CLIN ENDOCR METAB, V51, P394, DOI 10.1210/jcem-51-2-394; GAMBACCIANI M, 1986, NEUROENDOCRINOLOGY, V43, P533, DOI 10.1159/000124578; Golden NH, 2008, ANN NY ACAD SCI, V1135, P163, DOI 10.1196/annals.1429.014; Golden NH, 2008, INT J EAT DISORDER, V41, P301, DOI 10.1002/eat.20503; Golden Neville H, 2002, J Pediatr Adolesc Gynecol, V15, P135, DOI 10.1016/S1083-3188(02)00145-6; Golden NH, 2005, J CLIN ENDOCR METAB, V90, P3179, DOI 10.1210/jc.2004-1659; Golden NH, 1997, ARCH PEDIAT ADOL MED, V151, P16, DOI 10.1001/archpedi.1997.02170380020003; Gordon CM, 2008, J CLIN DENSITOM, V11, P43, DOI 10.1016/j.jocd.2007.12.005; Gordon CM, 2002, J CLIN ENDOCR METAB, V87, P4935, DOI 10.1210/jc.2002-020545; Grinspoon S, 2002, J CLIN ENDOCR METAB, V87, P2883, DOI 10.1210/jc.87.6.2883; Hillard PJA, 2008, ANN NY ACAD SCI, V1135, P29, DOI 10.1196/annals.1429.022; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; KLIBANSKI A, 1995, J CLIN ENDOCR METAB, V80, P898, DOI 10.1210/jc.80.3.898; Kopp-Woodroffe SA, 1999, INT J SPORT NUTR, V9, P70, DOI 10.1123/ijsn.9.1.70; KOSLOWSKY M, 1992, J PERS ASSESS, V58, P27, DOI 10.1207/s15327752jpa5801_3; Laughlin GA, 1998, J CLIN ENDOCR METAB, V83, P25, DOI 10.1210/jc.83.1.25; Legro RS, 2000, J CLIN ENDOCR METAB, V85, P1021, DOI 10.1210/jc.85.3.1021; LEYENDECKER G, 1993, HUM REPROD, V8, P184, DOI 10.1093/humrep/8.suppl_2.184; Liu JH, 2008, ANN NY ACAD SCI, V1135, P179, DOI 10.1196/annals.1429.027; LIU JH, 1990, AM J OBSTET GYNECOL, V163, P1732, DOI 10.1016/0002-9378(90)91437-H; MARTIN KA, 1993, J CLIN ENDOCR METAB, V77, P125, DOI 10.1210/jc.77.1.125; Meczekalski B, 2008, GYNECOL ENDOCRINOL, V24, P4, DOI 10.1080/09513590701807381; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P3903, DOI 10.1210/jc.2003-031885; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Perkins RB, 1999, J CLIN ENDOCR METAB, V84, P1905, DOI 10.1210/jc.84.6.1905; PETRAGLIA F, 1987, ENDOCRINOLOGY, V120, P1083, DOI 10.1210/endo-120-3-1083; RASMUSSEN DD, 1986, J ENDOCRINOL INVEST, V9, P427, DOI 10.1007/BF03346958; Strokosch GR, 2006, J ADOLESCENT HEALTH, V39, P819, DOI 10.1016/j.jadohealth.2006.09.010; Thangavelu K, 2006, EXP CLIN PSYCHOPHARM, V14, P459, DOI 10.1037/1064-1297.14.4.459; Tolle V, 2003, J CLIN ENDOCR METAB, V88, P109, DOI 10.1210/jc.2002-020645; Tschugguel W, 2003, FERTIL STERIL, V80, P982, DOI 10.1016/S0015-0282(03)01012-4; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wiksten-Almstromer M, 2007, ACTA OBSTET GYN SCAN, V86, P65, DOI 10.1080/00016340601034970; WILDT L, 1987, J CLIN ENDOCR METAB, V64, P1334, DOI 10.1210/jcem-64-6-1334; Wojcik-Gladysz Anna, 2006, Reprod Biol, V6 Suppl 2, P21	47	126	139	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					365	371		10.1056/NEJMcp0912024	http://dx.doi.org/10.1056/NEJMcp0912024			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660404				2022-12-28	WOS:000280139300009
J	Koocher, G; Keith-Spiegel, P				Koocher, Gerald; Keith-Spiegel, Patricia			Peers nip misconduct in the bud	NATURE			English	Editorial Material									[Koocher, Gerald] Simmons Coll, Boston, MA 02115 USA; [Keith-Spiegel, Patricia] Ball State Univ, Muncie, IN 47306 USA	Simmons University; Ball State University	Koocher, G (corresponding author), Simmons Coll, 300 Fenway, Boston, MA 02115 USA.	koocher@simmons.edu	Koocher, Gerald Paul/AAC-6026-2020	Koocher, Gerald Paul/0000-0002-2445-3202				Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; SWAZEY JP, 1993, AM SCI, V81, P542; Wenger NS, 1999, EVALUATION REV, V23, P553, DOI 10.1177/0193841X9902300504; Whitley B.E., 2002, ACAD DISHONESTY ED G, DOI 10.4324/9781410608277	4	29	31	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2010	466	7305					438	440		10.1038/466438a	http://dx.doi.org/10.1038/466438a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	628SJ	20651674				2022-12-28	WOS:000280141200018
J	Alperin, M; Hoehler, T				Alperin, Marc; Hoehler, Tori			BIOGEOCHEMISTRY The Ongoing Mystery of Sea-Floor Methane	SCIENCE			English	Editorial Material							ANAEROBIC OXIDATION; BACTERIA; CONSTRAINTS; SEDIMENTS; CONSORTIUM; ARCHAEA		[Alperin, Marc] Univ N Carolina, Chapel Hill, NC 27599 USA; [Hoehler, Tori] NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA	University of North Carolina; University of North Carolina Chapel Hill; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Alperin, M (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	alperin@email.unc.edu; tori.m.hoehler@nasa.gov						Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Alperin MJ, 2009, AM J SCI, V309, P958, DOI 10.2475/10.2009.02; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; House CH, 2009, ENVIRON MICROBIOL, V11, P2207, DOI 10.1111/j.1462-2920.2009.01934.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Londry KL, 2008, ORG GEOCHEM, V39, P608, DOI 10.1016/j.orggeochem.2008.03.002; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; REEBURGH WS, 1976, EARTH PLANET SC LETT, V28, P337, DOI 10.1016/0012-821X(76)90195-3; Sommer S, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002389; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979	16	29	33	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					288	289		10.1126/science.1189966	http://dx.doi.org/10.1126/science.1189966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647456				2022-12-28	WOS:000279925900028
J	Utz, AL; Schaefer, PW; Snuderl, M				Utz, Andrea L.; Schaefer, Pamela W.; Snuderl, Matija			Case 20-2010: A 32-Year-Old Woman with Oligomenorrhea and Infertility Differential Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYSTIC-OVARY-SYNDROME; PROLIFERATION; EXPRESSION; WOMEN		[Utz, Andrea L.] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Snuderl, Matija] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Utz, Andrea L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Schaefer, Pamela W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Snuderl, Matija] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Utz, Andrea L.] Vanderbilt Univ, Med Ctr, Pituitary Ctr, Nashville, TN USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vanderbilt University	Utz, AL (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA.		Schaefer, Pamela/AAA-1323-2019	Snuderl, Matija/0000-0003-0752-0917				Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS219, DOI 10.1016/j.fertnstert.2008.08.038; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Balen AH, 2003, HUM REPROD UPDATE, V9, P505, DOI 10.1093/humupd/dmg044; Brassard M, 2008, MED CLIN N AM, V92, P1163, DOI 10.1016/j.mcna.2008.04.008; Brugh VM, 2004, MED CLIN N AM, V88, P367, DOI 10.1016/S0025-7125(03)00150-0; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Gejman R, 2008, HUM PATHOL, V39, P758, DOI 10.1016/j.humpath.2007.10.004; Kaltsas GA, 1999, J CLIN ENDOCR METAB, V84, P2731, DOI 10.1210/jc.84.8.2731; Kaltsas GA, 2004, TRENDS ENDOCRIN MET, V15, P204, DOI 10.1016/j.tem.2004.05.009; Kaltsas GA, 2007, CLIN ENDOCRINOL, V67, P917, DOI 10.1111/j.1365-2265.2007.02987.x; Mazal PR, 2001, CLIN NEUROPATHOL, V20, P163; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Quaas Alexander, 2008, Rev Obstet Gynecol, V1, P69; RAJASOORYA C, 1994, CLIN ENDOCRINOL, V41, P95, DOI 10.1111/j.1365-2265.1994.tb03789.x; Sam S, 2005, REV ENDOCR METAB DIS, V6, P55, DOI 10.1007/s11154-005-5225-z	17	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					178	186		10.1056/NEJMcpc1004359	http://dx.doi.org/10.1056/NEJMcpc1004359			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20647214				2022-12-28	WOS:000279574100012
J	Cami, J; Bernard-Salas, J; Peeters, E; Malek, SE				Cami, Jan; Bernard-Salas, Jeronimo; Peeters, Els; Malek, Sarah Elizabeth			Detection of C-60 and C-70 in a Young Planetary Nebula	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SPITZER-SPACE-TELESCOPE; GIANT BRANCH STARS; CIRCUMSTELLAR ENVELOPES; DUST FORMATION; CARBON; EMISSION; FULLERENES; SPECTRUM; FEATURES	In recent decades, a number of molecules and diverse dust features have been identified by astronomical observations in various environments. Most of the dust that determines the physical and chemical characteristics of the interstellar medium is formed in the outflows of asymptotic giant branch stars and is further processed when these objects become planetary nebulae. We studied the environment of Tc 1, a peculiar planetary nebula whose infrared spectrum shows emission from cold and neutral C-60 and C-70. The two molecules amount to a few percent of the available cosmic carbon in this region. This finding indicates that if the conditions are right, fullerenes can and do form efficiently in space.	[Cami, Jan; Peeters, Els; Malek, Sarah Elizabeth] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Cami, Jan; Peeters, Els] SETI Inst, Mountain View, CA 94043 USA; [Bernard-Salas, Jeronimo] Cornell Univ, Ithaca, NY 14853 USA; [Bernard-Salas, Jeronimo] Univ Paris 11, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France	Western University (University of Western Ontario); Cornell University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Cami, J (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.	jcami@uwo.ca	Cami, Jan/AAK-9178-2020	Cami, Jan/0000-0002-2666-9234	National Science and Engineering Research Council of Canada; Spitzer Space Telescope General Observer Program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spitzer Space Telescope General Observer Program	We thank M. Houde and A. Tielens for commenting on earlier versions of the manuscript, G. Fanchini for stimulating discussions on various properties of fullerene materials, and G. C. Sloan for discussions on carbonaceous species in PNe. Supported by a Discovery grant from the National Science and Engineering Research Council of Canada (J.C., E. P., and S. E. M.) and by the Spitzer Space Telescope General Observer Program.	Acker A, 2002, ASTRON ASTROPHYS, V384, P620, DOI 10.1051/0004-6361:20020009; Bernard-Salas J, 2009, ASTROPHYS J, V699, P1541, DOI 10.1088/0004-637X/699/2/1541; Cernicharo J, 2001, ASTROPHYS J, V546, pL123, DOI 10.1086/318871; Cherchneff I, 2000, ASTRON ASTROPHYS, V357, P572; CLAYTON GC, 1995, ASTRON J, V109, P2096, DOI 10.1086/117435; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; Fabian J, 1996, PHYS REV B, V53, P13864, DOI 10.1103/PhysRevB.53.13864; FOING BH, 1994, NATURE, V369, P296, DOI 10.1038/369296a0; FRENKLACH M, 1989, ASTROPHYS J, V341, P372, DOI 10.1086/167501; FRUM CI, 1991, CHEM PHYS LETT, V176, P504, DOI 10.1016/0009-2614(91)90245-5; FULARA J, 1993, CHEM PHYS LETT, V211, P227, DOI 10.1016/0009-2614(93)85190-Y; Habing HJ, 1996, ASTRON ASTROPHYS REV, V7, P97, DOI 10.1007/PL00013287; Herbig GH, 2000, ASTROPHYS J, V542, P334, DOI 10.1086/309523; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Herwig F, 2005, ANNU REV ASTRON ASTR, V43, P435, DOI 10.1146/annurev.astro.43.072103.150600; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Kwok S, 2009, INT J ASTROBIOL, V8, P161, DOI 10.1017/S1473550409004492; MARTIN MC, 1993, PHYS REV B, V47, P14607, DOI 10.1103/PhysRevB.47.14607; Milanova YV, 2009, ASTRON LETT+, V35, P518, DOI 10.1134/S1063773709080027; Moutou C, 1999, ASTRON ASTROPHYS, V347, P949; NEMES L, 1994, CHEM PHYS LETT, V218, P295, DOI 10.1016/0009-2614(93)E1488-3; Pardo JR, 2007, ASTROPHYS J, V661, P250, DOI 10.1086/513734; Scott A, 1997, ASTROPHYS J, V489, pL193, DOI 10.1086/316789; Sogoshi N, 2000, J PHYS CHEM A, V104, P3733, DOI 10.1021/jp9938718; Speck AK, 2009, ASTROPHYS J, V691, P1202, DOI 10.1088/0004-637X/691/2/1202; Stratmann RE, 1998, J RAMAN SPECTROSC, V29, P483, DOI 10.1002/(SICI)1097-4555(199806)29:6<483::AID-JRS268>3.0.CO;2-Q; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056; VONCZARNOWSKI A, 1995, CHEM PHYS LETT, V246, P321, DOI 10.1016/0009-2614(95)01106-J; WANG XK, 1995, J MATER RES, V10, P1977, DOI 10.1557/JMR.1995.1977; Willson LA, 2000, ANNU REV ASTRON ASTR, V38, P573, DOI 10.1146/annurev.astro.38.1.573	34	532	536	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1180	1182		10.1126/science.1192035	http://dx.doi.org/10.1126/science.1192035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20651118				2022-12-28	WOS:000281485600028
J	Grimes, RW; Nuttall, WJ				Grimes, Robin W.; Nuttall, William J.			Generating the Option of a Two-Stage Nuclear Renaissance	SCIENCE			English	Review							TOLERANCE; DESIGN; FUSION; POWER	Concerns about climate change, security of supply, and depleting fossil fuel reserves have spurred a revival of interest in nuclear power generation in Europe and North America, while other regions continue or initiate an expansion. We suggest that the first stage of this process will include replacing or extending the life of existing nuclear power plants, with continued incremental improvements in efficiency and reliability. After 2030, a large-scale second period of construction would allow nuclear energy to contribute substantially to the decarbonization of electricity generation. For nuclear energy to be sustainable, new large-scale fuel cycles will be required that may include fuel reprocessing. Here, we explore the opportunities and constraints in both time periods and suggests ways in which measures taken today might, at modest cost, provide more options in the decades to come. Careful long-term planning, along with parallel efforts aimed at containing waste products and avoiding diversion of material into weapons production, can ensure that nuclear power generation remains a carbon-neutral option.	[Grimes, Robin W.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, Ctr Nucl Engn, London HA9 8DT, England; [Nuttall, William J.] Cambridge Judge Business Sch, Cambridge CB2 1AG, England; [Nuttall, William J.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	Imperial College London; University of Cambridge; University of Cambridge	Grimes, RW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Ctr Nucl Engn, London HA9 8DT, England.	rgrimes@imperial.ac.uk; wjn21@cam.ac.uk			ESRC [ES/H035613/1] Funding Source: UKRI; Economic and Social Research Council [RES-152-25-1002, ES/H035613/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Abram T, 2008, ENERG POLICY, V36, P4323, DOI 10.1016/j.enpol.2008.09.059; *AM SOC MECH ENG, 2009, P 4 INT TOP M HIGH T, V1; Arborelius J, 2006, J NUCL SCI TECHNOL, V43, P967, DOI 10.3327/jnst.43.967; *ASTM, 2009, ASTM SPEC TECHN PUBL, V1505; Bickerstaff K, 2008, PUBLIC UNDERST SCI, V17, P145, DOI 10.1177/0963662506066719; *CAB OFF, 2010, CM7675; Cai ZM, 2010, RESOUR POLICY, V35, P77, DOI 10.1016/j.resourpol.2009.10.002; *DOE OFF BAS EN ST, 2006, BAS EN SCI WORKSH; *DOE OFF NUCL EN, 2010, SMALL MOD REACT; FULWOOD RR, 1999, PROBABILISTIC SAFETY; Gorlinskii YE, 2009, ATOM ENERGY+, V107, P122, DOI 10.1007/s10512-009-9206-2; Grimes RW, 2008, NAT MATER, V7, P683, DOI 10.1038/nmat2266; *INT AT EN AG, 2001, STIPUB1104 INT AT EN, P64; *INT AT EN AG, 2009, STIPUB1421 INT AT EN; *INT AT EN AG, 2007, NUCL TECHN REV 2007, P101; Manheimer W, 2004, J FUSION ENERG, V23, P223, DOI 10.1007/s10894-005-5615-y; Manheimer W, 2001, J FUSION ENERG, V20, P131, DOI 10.1023/A:1023480817784; Misra A, 2009, MATER RES SOC SYMP P, V1188, P167; MOSEY D, 2006, NUCL ENG INT SPECIAL, P69; Nuttall WJ, 2005, INT J CRIT INFRASTRU, V1, P380, DOI 10.1504/IJCIS.2005.006682; Nuttall W.J., 2005, ENGINEER        1031, P16; Odette GR, 2008, ANNU REV MATER RES, V38, P471, DOI 10.1146/annurev.matsci.38.060407.130315; Pouret L., 2009, NUCL FUTURE, V5, P333; Sinha RK, 2006, NUCL ENG DES, V236, P683, DOI 10.1016/j.nucengdes.2005.09.026; U.S.DOE, 2002, TECHN ROADM GEN 4 NU; Vitart X, 2006, ENERG CONVERS MANAGE, V47, P2740, DOI 10.1016/j.enconman.2006.02.010; Wilson P.D, 1996, NUCL FUEL CYCLE ORE; *WORLD NUCL, WORLD NUCL POW REACT	28	93	95	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					799	803		10.1126/science.1188928	http://dx.doi.org/10.1126/science.1188928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705854				2022-12-28	WOS:000280809900040
J	Wijffels, RH; Barbosa, MJ				Wijffels, Rene H.; Barbosa, Maria J.			An Outlook on Microalgal Biofuels	SCIENCE			English	Editorial Material							GENOME REVEALS; BIODIESEL; EVOLUTION	Microalgae are considered one of the most promising feedstocks for biofuels. The productivity of these photosynthetic microorganisms in converting carbon dioxide into carbon-rich lipids, only a step or two away from biodiesel, greatly exceeds that of agricultural oleaginous crops, without competing for arable land. Worldwide, research and demonstration programs are being carried out to develop the technology needed to expand algal lipid production from a craft to a major industrial process. Although microalgae are not yet produced at large scale for bulk applications, recent advances-particularly in the methods of systems biology, genetic engineering, and biorefining-present opportunities to develop this process in a sustainable and economical way within the next 10 to 15 years.	[Wijffels, Rene H.] Wageningen Univ, NL-6700 EV Wageningen, Netherlands; [Barbosa, Maria J.] Univ Wageningen & Res Ctr, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Wijffels, RH (corresponding author), Wageningen Univ, POB 8129, NL-6700 EV Wageningen, Netherlands.	rene.wijffels@wur.nl; maria.barbosa@wur.nl	Barbosa, Maria/K-7574-2018	Barbosa, Maria/0000-0002-8246-0777; Wijffels, Rene/0000-0001-7630-4295				Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Benemann JR, 2000, J APPL PHYCOL, V12, P291, DOI 10.1023/A:1008175112704; Bosma R, 2010, INT SUGAR J, V112, P74; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; de Fraiture C, 2008, WATER POLICY, V10, P67, DOI 10.2166/wp.2008.054; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; *EUR ENV AG, 2008, 5 EEA; Hersbach G.J.M., 1984, BIOTECHNOLOGY IND AN, VVolume 22, P45; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; International Energy Agency (IEA), 2010, OIL MARK REP; Kliphuis AMJ, 2010, BIOTECHNOL PROGR, V26, P687, DOI 10.1002/btpr.379; Lardon L, 2009, ENVIRON SCI TECHNOL, V43, P6475, DOI 10.1021/es900705j; Lestari S, 2009, CHEMSUSCHEM, V2, P1109, DOI 10.1002/cssc.200900107; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; OSWALD WILLIAM J., 1960, ADVANCES APPL MICROBIOL, V2, P223, DOI 10.1016/S0065-2164(08)70127-8; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Qiang H, 1996, J APPL PHYCOL, V8, P139, DOI 10.1007/BF02186317; Reijnders L, 2008, TRENDS BIOTECHNOL, V26, P349, DOI 10.1016/j.tibtech.2008.04.001; Sheehan J., 1998, LOOK BACK US DEP ENE; Tredici MR, 2010, BIOFUELS-UK, V1, P143, DOI 10.4155/BFS.09.10; Usui N, 1997, ENERG CONVERS MANAGE, V38, pS487, DOI 10.1016/S0196-8904(96)00315-9; van Egmond K, 2002, AMBIO, V31, P72, DOI 10.1639/0044-7447(2002)031[0072:TENC]2.0.CO;2; Walker TL, 2005, J PHYCOL, V41, P1077, DOI 10.1111/j.1529-8817.2005.00133.x; Wijffels RH, 2010, BIOFUEL BIOPROD BIOR, V4, P287, DOI 10.1002/bbb.215; Zijffers JWF, 2010, MAR BIOTECHNOL, V12, P708, DOI 10.1007/s10126-010-9258-2	28	1324	1392	10	779	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					796	799		10.1126/science.1189003	http://dx.doi.org/10.1126/science.1189003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705853				2022-12-28	WOS:000280809900039
J	Beaudet, AL; Javitt, G				Beaudet, Arthur L.; Javitt, Gail			Which way for genetic-test regulation?	NATURE			English	Editorial Material									[Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	abeaudet@bcm.edu						American College of Medicine Genetics Board of Directors, 2004, Genet Med, V6, P60; HaH Services, 2008, US SYST OV GEN TEST	2	28	28	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					816	817		10.1038/466816a	http://dx.doi.org/10.1038/466816a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20703287				2022-12-28	WOS:000280766100016
J	Tang, N; Stein, J; Hsia, RY; Maselli, JH; Gonzales, R				Tang, Ning; Stein, John; Hsia, Renee Y.; Maselli, Judith H.; Gonzales, Ralph			Trends and Characteristics of US Emergency Department Visits, 1997-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; MEDICAID	Context The potential effects of increasing numbers of uninsured and underinsured persons on US emergency departments (EDs) is a concern for the health care safety net. Objective To describe the changes in ED visits that occurred from 1997 through 2007 in the adult and pediatric US populations by sociodemographic group, designation of safety-net ED, and trends in ambulatory care sensitive conditions. Design, Setting, and Participants Publicly available ED visit data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 1997 through 2007 were stratified by age, sex, race, ethnicity, insurance status, safety-net hospital classification, triage category, and disposition. Codes from the International Classification of Diseases, Ninth Revision (ICD-9), were used to extract visits related to ambulatory care sensitive conditions. Visit rates were calculated using annual US Census estimates. Main Outcome Measures Total annual visits to US EDs and ED visit rates for population subgroups. Results Between 1997 and 2007, ED visit rates increased from 35.8 to 390.5 per 1000 persons (rate difference, 37.7; 95% confidence interval [Cl], -51.1 to 126.5; P=.001 for trend); the increase in total annual ED visits was almost double of what would be expected from population growth. Adults with Medicaid accounted for most of the increase in ED visits; the visit rate increased from 693.9 to 947.2 visits per 1000 enrollees between 1999 and 2007 (rate difference, 253.3; 95% Cl, 41.1 to 465.5; P=.001 for trend). Although ED visit rates for adults with ambulatory care sensitive conditions remained stable, ED visit rates among adults with Medicaid increased from 66.4 in 1999 to 83.9 in 2007 (rate difference, 17.5; 95% Cl, -5.8 to 40.8; P=.007 for trend). The number of facilities qualifying as safety-net EDs increased from 1770 in 2000 to 2489 in 2007. Conclusion These findings indicate that ED visit rates have increased from 1997 to 2007 and that EDs are increasingly serving as the safety net for medically underserved patients, particularly adults with Medicaid. JAMA. 2010;304(6):664-670	[Tang, Ning; Maselli, Judith H.; Gonzales, Ralph] Univ Calif San Francisco, Div Gen Internal Med, Dept Med, San Francisco, CA 94143 USA; [Stein, John; Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tang, N (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, Dept Med, 400 Parnassus Ave,Box 0320, San Francisco, CA 94143 USA.	ntang@medicine.ucst.edu	Dalla Zuanna, Teresa/G-3133-2015		California HealthCare Foundation [08-1256]; NIH/NCRR/OD UCSF-CTSI [KL2 RR024130]; AHRQ [1K08HS015569]; Robert Wood Johnson Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	California HealthCare Foundation; NIH/NCRR/OD UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The primary sponsor of this study was the California HealthCare Foundation grant 08-1256. Additional support was provided by NIH/NCRR/OD UCSF-CTSI grant KL2 RR024130 (J.S., R.Y.H., R.G.), AHRQ grant 1K08HS015569 (J.S.), and the Robert Wood Johnson Foundation Physician Faculty Scholars Program (R.Y.H.).	Agency for Healthcare Research and Quality, PREV QUAL IND OV; American Hospital Association, AHA ANN SURV DAT FIS; Backus L, 2001, J GEN INTERN MED, V16, P815, DOI 10.1046/j.1525-1497.2001.01239.x; Baker DW, 1996, ANN EMERG MED, V28, P677, DOI 10.1016/S0196-0644(96)70093-8; Berman S, 2002, PEDIATRICS, V110, P239, DOI 10.1542/peds.110.2.239; Burt Catharine W, 2004, Vital Health Stat 13, P1; *CDCP, SAS COD PROD AGGR VI; Centers for Disease Control and Prevention, INT CLASS DIS 9 REV; Cunningham Peter, 2003, Issue Brief Cent Stud Health Syst Change, P1; DIAMOND D, SEEKING ANSWERS MEDI; Fields WW, 2001, ACAD EMERG MED, V8, P1064, DOI 10.1111/j.1553-2712.2001.tb01116.x; Garcia LDO, 2007, J WORLD AQUACULT SOC, V38, P1, DOI 10.1111/j.1749-7345.2006.00068.x; Gardner RL, 2007, AM J EMERG MED, V25, P643, DOI 10.1016/j.ajem.2006.11.037; Government Accountability Office, GAO09347; Institute of Medicine, 2006, HOSP BAS EM CAR BREA, P42; *KAIS COMM MED UN, MED BEN ACC CAR; *KAIS COMM MED UN, ANN CHANG EMD ENR 50; *KAIS COMM MED UN, POL BRIEF EM DEP GRO; Kellermann AL, 2006, NEW ENGL J MED, V355, P1300, DOI 10.1056/NEJMp068194; Lambe S, 2003, ANN EMERG MED, V41, P35, DOI 10.1067/mem.2003.2; LEATHERMAN S, QUALITY HLTH CARE ME; McConville S, EMERGENCY DEP CARE C; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002; Rowland D, 2009, NEW ENGL J MED, V360, P1273, DOI 10.1056/NEJMp0901072; Schappert SM, 2006, VITAL HLTH STAT, V13, P1; Taylor Jassamy, 2006, Issue Brief George Wash Univ Natl Health Policy Forum, P1; *US BUR CENS, TABL 2 ANN EST RES P; *US BUR CENS, HLTH INS; *US BUR CENS, RES POP EST US AG SE; *US BUR CENS, HLTH INS COV STAT TY; *US BUR CENS, TABL HIA 2 HLTH INS; *US BUR CENS, RES POP EST US SEX R; *US BUR CENS, TABL 3 ANN EST RES P; *US BUR LAB STAT, HOUS DAT HIST A 1 EM; Xu KT, 2009, ANN EMERG MED, V54, P805, DOI 10.1016/j.annemergmed.2009.08.004; ZUCKERMAN S, 2004, HLTH AFF MILLWOOD	36	548	552	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					664	670		10.1001/jama.2010.1112	http://dx.doi.org/10.1001/jama.2010.1112			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699458	Green Accepted			2022-12-28	WOS:000280829200022
J	Liu, T; Ghosal, G; Yuan, JS; Chen, JJ; Huang, J				Liu, Ting; Ghosal, Gargi; Yuan, Jingsong; Chen, Junjie; Huang, Jun			FAN1 Acts with FANCI-FANCD2 to Promote DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							FANCONI-ANEMIA PATHWAY; DAMAGE RESPONSE; PROTEIN; IDENTIFICATION; FANCD2; BREAKS; BRCA1	Fanconi anemia (FA) is caused by mutations in 13 Fanc genes and renders cells hypersensitive to DNA interstrand cross-linking (ICL) agents. A central event in the FA pathway is mono-ubiquitylation of the FANCI-FANCD2 (ID) protein complex. Here, we characterize a previously unrecognized nuclease, Fanconi anemia-associated nuclease 1 (FAN1), that promotes ICL repair in a manner strictly dependent on its ability to accumulate at or near sites of DNA damage and that relies on mono-ubiquitylation of the ID complex. Thus, the mono-ubiquitylated ID complex recruits the downstream repair protein FAN1 and facilitates the repair of DNA interstrand cross-links.	[Liu, Ting; Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ghosal, Gargi; Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org; jhuang@zju.edu.cn	Yuan, Jingsong/G-4527-2011	Ghosal, Gargi/0000-0001-8399-5354	Life Sciences Institute, Zhejiang University; Fundamental Research Funds for the Central Universities, China; NIH; U.S. Department of Defense	Life Sciences Institute, Zhejiang University; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense)	This work was supported in part by grants from Startup Fund (Life Sciences Institute, Zhejiang University to J.H.), the Fundamental Research Funds for the Central Universities, China (to J.H.), and the NIH (to J.C.). We thank L. Li, X. Shen, and Y. Zhang for reagents. J.H. would like to thank J.C. for his continuous support and mentoring. J.C. is a recipient of an Era of Hope Scholar award from the U.S. Department of Defense and is a member of M.D. Anderson Cancer Center.	Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	22	195	201	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					693	696		10.1126/science.1192656	http://dx.doi.org/10.1126/science.1192656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20671156				2022-12-28	WOS:000280602700042
J	Ton-Hoang, B; Pastemak, C; Siguier, P; Guynet, C; Hickman, AB; Dyda, F; Sommer, S; Chandler, M				Ton-Hoang, Bao; Pastemak, Cecile; Siguier, Patricia; Guynet, Catherine; Hickman, Alison Burgess; Dyda, Fred; Sommer, Suzanne; Chandler, Michael			Single-Stranded DNA Transposition Is Coupled to Host Replication	CELL			English	Article							ESCHERICHIA-COLI MUTANTS; YERSINIA-PESTIS; INSERTION-SEQUENCE; GENOME SEQUENCE; PROTEIN; ARREST; TRANSCRIPTION; RECONSTITUTION; TERMINATION; MECHANISM	DNA transposition has contributed significantly to evolution of eukaryotes and prokaryotes. Insertion sequences (ISs) are the simplest prokaryotic trans-posons and are divided into families on the basis of their organization and transposition mechanism. Here, we describe a link between transposition of IS608 and ISDra2, both members of the IS200/IS605 family, which uses obligatory single-stranded DNA intermediates, and the host replication fork. Replication direction through the IS plays a crucial role in excision: activity is maximal when the "top'' IS strand is located on the lagging-strand template. Excision is stimulated upon transient inactivation of replicative helicase function or inhibition of Okazaki fragment synthesis. IS608 insertions also exhibit an orientation preference for the lagging-strand template and insertion can be specifically directed to stalled replication forks. An in silico genomic approach provides evidence that dissemination of other IS200/IS605 family members is also linked to host replication.	[Ton-Hoang, Bao; Siguier, Patricia; Guynet, Catherine; Chandler, Michael] CNRS, Lab Microbiol & Genet Mol, UMR 5100, F-31062 Toulouse, France; [Pastemak, Cecile; Sommer, Suzanne] Univ Paris 11, CNRS, Inst Genet & Microbiol,UMR 8621, Lab Rech Correspondant Commissariat Energie Atom, F-91405 Orsay, France; [Hickman, Alison Burgess; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ton-Hoang, B (corresponding author), CNRS, Lab Microbiol & Genet Mol, UMR 5100, 118 Route Narbonne, F-31062 Toulouse, France.	bao.tonhoang@ibcg.biotoul.fr; michael.chandler@ibcg.biotoul.fr	Guynet, Catherine/A-4815-2011; Guynet, Catherine/GPX-0917-2022	Chandler, Michael/0000-0002-0292-6662; Pasternak, Cecile/0000-0002-7884-2422; Siguier, Patricia/0000-0003-1620-6495	Centre National de Recherche Scientifique (France); ANR; European contract [LSHM-CT-2005-019023]; Commissariat a l'Energie Atomique and Electricite de France (France); National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036154] Funding Source: NIH RePORTER	Centre National de Recherche Scientifique (France); ANR(French National Research Agency (ANR)); European contract; Commissariat a l'Energie Atomique and Electricite de France (France); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank members of the "Mobile Genetic Elements'' group, A. Bailone, P. Polard, and D. Lane for discussions, G. Coste and B. Marty for expert technical assistance, L. Lavatine for guiding us through the mysteries of statistics, A. Varani for identifying a representative oligonucleotide sequence used in the PCR mapping for the D. radiodurans genome, and the Institut Curie for the use of the <SUP>137</SUP>Cs irradiation system. This work was supported by: intramural funding from the Centre National de Recherche Scientifique (France), in its later stages by ANR grant Mobigen (M.C. and S.S.), European contract LSHM-CT-2005-019023 (M.C.), and the Commissariat a l'Energie Atomique and Electricite de France (France; S.S.). At the National Institutes of Health, this work was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Bao TH, 2005, EMBO J, V24, P3325, DOI 10.1038/sj.emboj.7600787; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Belle JJ, 2007, J BACTERIOL, V189, P5452, DOI 10.1128/JB.00408-07; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; BIERNE H, 1994, J BACTERIOL, V176, P4165, DOI 10.1128/JB.176.13.4165-4167.1994; BIERNE H, 1994, MOL MICROBIOL, V13, P17, DOI 10.1111/j.1365-2958.1994.tb00398.x; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chandler M, 2009, CELL, V138, P621, DOI 10.1016/j.cell.2009.08.003; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; DODSON KW, 1989, GENE, V76, P207, DOI 10.1016/0378-1119(89)90161-3; EliasArnanz M, 1997, EMBO J, V16, P5775, DOI 10.1093/emboj/16.18.5775; FOUSER L, 1983, J BACTERIOL, V154, P1174, DOI 10.1128/JB.154.3.1174-1183.1983; GALAS DJ, 1982, J MOL BIOL, V154, P245, DOI 10.1016/0022-2836(82)90063-8; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Guynet C, 2009, MOL CELL, V34, P612, DOI 10.1016/j.molcel.2009.05.017; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Hu WY, 1998, J BACTERIOL, V180, P3039, DOI 10.1128/JB.180.12.3039-3048.1998; Islam MS, 2003, GENES GENET SYST, V78, P319, DOI 10.1266/ggs.78.319; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaplan DL, 2009, MOL MICROBIOL, V72, P279, DOI 10.1111/j.1365-2958.2009.06656.x; Karpinets TV, 2010, FUNCT INTEGR GENOMIC, V10, P97, DOI 10.1007/s10142-009-0142-y; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Kornberg A., 1992, DNA REPLICATION; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; LOUARN JM, 1974, MOL GEN GENET, V133, P193, DOI 10.1007/BF00267668; Mennecier S, 2006, MOL MICROBIOL, V59, P317, DOI 10.1111/j.1365-2958.2005.04936.x; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mohanty BK, 1998, J BIOL CHEM, V273, P3051, DOI 10.1074/jbc.273.5.3051; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Parks AR, 2009, CELL, V138, P685, DOI 10.1016/j.cell.2009.06.011; Pasternak C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000799; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Sanders GM, 2010, MOL CELL, V37, P273, DOI 10.1016/j.molcel.2009.12.025; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Turlan C, 2000, TRENDS MICROBIOL, V8, P268, DOI 10.1016/S0966-842X(00)01757-1; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; YIN JCP, 1988, J MOL BIOL, V199, P35, DOI 10.1016/0022-2836(88)90377-4; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	52	46	49	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					398	408		10.1016/j.cell.2010.06.034	http://dx.doi.org/10.1016/j.cell.2010.06.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691900	Green Accepted, Bronze			2022-12-28	WOS:000280609100017
J	Walczak, CE; Shaw, SL				Walczak, Claire E.; Shaw, Sidney L.			A MAP for Bundling Microtubules	CELL			English	Review							SPINDLE MIDZONE; PRC1; ORGANIZATION; ARRAYS; MOTORS	Microtubules assemble into arrays of bundled filaments that are critical for multiple steps in cell division, including anaphase and cytokinesis. Recent structural and functional studies, including two papers in this issue of Cell (Bieling et al., 2010; Subramanian et al., 2010), demonstrate how the MAP65 protein PRC1 crosslinks microtubules and cooperates with kinesin motors to control the dynamics and size of bundled regions.	[Walczak, Claire E.; Shaw, Sidney L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Walczak, CE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	cwalczak@indiana.edu; sishaw@indiana.edu		Shaw, Sidney/0000-0001-9195-6128	National Institutes of Health [GM059618]; National Science Foundation [0920555]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Clive Lloyd, Yixian Zheng, and Stephanie Ems-McClung for helpful discussions. The authors are supported by National Institutes of Health grant GM059618 to C.E.W. and National Science Foundation grant 0920555 to S.L.S.	Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Fu CH, 2007, CELL RES, V17, P449, DOI 10.1038/cr.2007.32; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hornick JE, 2010, SEMIN CELL DEV BIOL, V21, P290, DOI 10.1016/j.semcdb.2010.01.017; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; JIANG CJ, 1993, J CELL SCI, V105, P891; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; PELLMAN D, 1995, J CELL BIOL, V130, P1373, DOI 10.1083/jcb.130.6.1373; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	17	46	46	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					364	367		10.1016/j.cell.2010.07.023	http://dx.doi.org/10.1016/j.cell.2010.07.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691897	Bronze			2022-12-28	WOS:000280609100013
J	Williamson, CE; Rose, KC				Williamson, Craig E.; Rose, Kevin C.			When UV Meets Fresh Water	SCIENCE			English	Editorial Material							ULTRAVIOLET-RADIATION; INFECTIVITY; MIGRATION; PATTERNS; LAKES		[Williamson, Craig E.; Rose, Kevin C.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	Williamson, CE (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	craig.williamson@muohio.edu; rosekc@muohio.edu						Andrady A, 2010, PHOTOCH PHOTOBIO SCI, V9, P275, DOI 10.1039/b923342n; Connelly SJ, 2007, ENVIRON SCI TECHNOL, V41, P7101, DOI 10.1021/es071324r; Cooke SL, 2008, CAN J FISH AQUAT SCI, V65, P1144, DOI 10.1139/F08-039; Jordan R, 2006, J FISH BIOL, V68, P1291, DOI 10.1111/j.0022-1112.2006.00992.x; King BJ, 2008, J APPL MICROBIOL, V104, P1311, DOI 10.1111/j.1365-2672.2007.03658.x; Kodric-Brown A, 2002, ANIM BEHAV, V63, P391, DOI 10.1006/anbe.2001.1917; Leech DM, 2009, LIMNOL OCEANOGR, V54, P1152, DOI 10.4319/lo.2009.54.4.1152; McKenzie RL, 2009, PHOTOCHEM PHOTOBIOL, V85, P88, DOI 10.1111/j.1751-1097.2008.00400.x; ROBERTS L, 1989, SCIENCE, V244, P288, DOI 10.1126/science.244.4902.288; Rose KC, 2009, PHOTOCH PHOTOBIO SCI, V8, P1244, DOI 10.1039/b905616e; Rose KC, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000816; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Siebeck UE, 2010, CURR BIOL, V20, P407, DOI 10.1016/j.cub.2009.12.047; Tucker AJ, 2010, ECOLOGY, V91, P882, DOI 10.1890/09-0554.1; Zhang J, 2010, LIMNOL OCEANOGR, V55, P30, DOI 10.4319/lo.2010.55.1.0030	15	49	51	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					637	639		10.1126/science.1191192	http://dx.doi.org/10.1126/science.1191192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689007				2022-12-28	WOS:000280602700025
J	Blumenthal, D; Tavenner, M				Blumenthal, David; Tavenner, Marilyn			The "Meaningful Use" Regulation for Electronic Health Records	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blumenthal, David] US Dept HHS, Washington, DC 20201 USA; [Tavenner, Marilyn] Ctr Medicare & Medicaid Serv, Washington, DC USA	Centers for Medicare & Medicaid Services	Blumenthal, D (corresponding author), US Dept HHS, Washington, DC 20201 USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285					0	1301	1311	1	146	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					501	504		10.1056/NEJMp1006114	http://dx.doi.org/10.1056/NEJMp1006114			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634BB	20647183				2022-12-28	WOS:000280552700001
J	Olszewski, KL; Mather, MW; Morrisey, JM; Garcia, BA; Vaidya, AB; Rabinowitz, JD; Llinas, M				Olszewski, Kellen L.; Mather, Michael W.; Morrisey, Joanne M.; Garcia, Benjamin A.; Vaidya, Akhil B.; Rabinowitz, Joshua D.; Llinas, Manuel			Branched tricarboxylic acid metabolism in Plasmodium falciparum	NATURE			English	Article							CELLULAR-METABOLISM; MALARIA PARASITES; DEHYDROGENASE; PURIFICATION; MITOCHONDRIA; EXPRESSION; PATHWAYS; HISTONES; FLUX	A central hub of carbon metabolism is the tricarboxylic acid cycle 1, which serves to connect the processes of glycolysis, gluconeogenesis, respiration, amino acid synthesis and other biosynthetic pathways. The protozoan intracellular malaria parasites (Plasmodium spp.), however, have long been suspected of possessing a significantly streamlined carbon metabolic network in which tricarboxylic acid metabolism plays a minor role(2). Blood-stage Plasmodium parasites rely almost entirely on glucose fermentation for energy and consume minimal amounts of oxygen(3), yet the parasite genome encodes all of the enzymes necessary for a complete tricarboxylic acid cycle(4). Here, by tracing C-13-labelled compounds using mass spectrometry(5), we show that tricarboxylic acid metabolism in the human malaria parasite Plasmodium falciparum is largely disconnected from glycolysis and is organized along a fundamentally different architecture from the canonical textbook pathway. We find that this pathway is not cyclic, but rather is a branched structure in which the major carbon sources are the amino acids glutamate and glutamine. As a consequence of this branched architecture, several reactions must run in the reverse of the standard direction, thereby generating two-carbon units in the form of acetyl-coenzyme A. We further show that glutamine-derived acetyl-coenzyme A is used for histone acetylation, whereas glucose-derived acetyl-coenzyme A is used to acetylate amino sugars. Thus, the parasite has evolved two independent production mechanisms for acetyl-coenzyme A with different biological functions. These results significantly clarify our understanding of the Plasmodium metabolic network and highlight the ability of altered variants of central carbon metabolism to arise in response to unique environments.	[Olszewski, Kellen L.; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Olszewski, Kellen L.; Rabinowitz, Joshua D.; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA; [Mather, Michael W.; Morrisey, Joanne M.; Vaidya, Akhil B.] Drexel Univ, Coll Med, Ctr Mol Parasitol, Philadelphia, PA 19129 USA; [Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Drexel University; Princeton University; Princeton University	Llinas, M (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	manuel@genomics.princeton.edu		Mather, Michael/0000-0002-1062-0137	Burroughs Wellcome Fund; NIH [1DP2OD001315-01, R01 AI078063]; Beckman Young Investigators award; NSF [CBET-0941143]; Center for Quantitative Biology [P50 GM071508]; NIAID, NIH [AI028398]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063, R01AI028398, R22AI028398, R56AI028398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001315] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Young Investigators award; NSF(National Science Foundation (NSF)); Center for Quantitative Biology; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. McFadden and I. Sherman for discussions and scrutiny of the manuscript; B. Bennett, T. Campbell, E. De Silva, J. O'Hara, and H. Painter for reading of the manuscript; I. Ying for assistance with histone extraction; T. Spurck and C. Tonkin for the modified erythrocyte immobilization procedure for microscopy; M. Clasquin and W. Lu for developing the LC-MS methodology; E. Melamud for LC-MS data extraction and analysis; and J. Groves and H. Cooper for GC-MS analysis. M. L. is funded by the Burroughs Wellcome Fund and an NIH Director's New Innovators award (1DP2OD001315-01). J. D. R. is funded by a Beckman Young Investigators award, an NSF CAREER award and NIH R01 AI078063. M. L and J. D. R. receive support from the Center for Quantitative Biology (P50 GM071508). B. A. G. receives support from NSF grant CBET-0941143. K.L.O. is funded by an NSF Graduate Research Fellowship. J. M. M., M. W. M. and A. B. V. are supported by grant AI028398 from NIAID, NIH.	Andrews KT, 2009, CURR TOP MED CHEM, V9, P292, DOI 10.2174/156802609788085313; BERGMEYER HU, 1974, METHOD ENZYMAT AN, V1, P443; BLUM JJ, 1984, J PROTOZOOL, V31, P167, DOI 10.1111/j.1550-7408.1984.tb04310.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; ELFORD BC, 1985, MOL BIOCHEM PARASIT, V16, P43, DOI 10.1016/0166-6851(85)90048-9; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Forer A, 1998, CHROMOSOME RES, V6, P533, DOI 10.1023/A:1009224322399; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Hodges M, 2005, MOL BIOCHEM PARASIT, V143, P29, DOI 10.1016/j.molbiopara.2005.05.004; Kadekoppala M, 2000, INFECT IMMUN, V68, P2328, DOI 10.1128/IAI.68.4.2328-2332.2000; Keller Andrew, 2005, Mol Syst Biol, V1; KORNBERG A, 1951, J BIOL CHEM, V189, P123; KREBS H. A., 1937, Enzymologia, V4, P148; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Ma ZP, 2009, J LIPID RES, V50, P2131, DOI 10.1194/jlr.D900008-JLR200; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mi-ichi F, 2006, PARASITOLOGY, V133, P399, DOI 10.1017/S0031182006000540; Miao J, 2006, GENE, V369, P53, DOI 10.1016/j.gene.2005.10.022; MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sherman Irwin W., 1998, P135; Suraveratum N, 2000, MOL BIOCHEM PARASIT, V105, P215, DOI 10.1016/S0166-6851(99)00180-2; Takashima E, 2001, PARASITOL INT, V50, P273, DOI 10.1016/S1383-5769(01)00085-X; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wrenger C, 2003, EUR J BIOCHEM, V270, P1775, DOI 10.1046/j.1432-1033.2003.03536.x; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	48	99	101	1	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					774	U16		10.1038/nature09301	http://dx.doi.org/10.1038/nature09301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686576	Green Accepted			2022-12-28	WOS:000280562500043
J	Teslovich, TM; Musunuru, K; Smith, AV; Edmondson, AC; Stylianou, IM; Koseki, M; Pirruccello, JP; Ripatti, S; Chasman, DI; Willer, CJ; Johansen, CT; Fouchier, SW; Isaacs, A; Peloso, GM; Barbalic, M; Ricketts, SL; Bis, JC; Aulchenko, YS; Thorleifsson, G; Feitosa, MF; Chambers, J; Orho-Melander, M; Melander, O; Johnson, T; Li, XH; Guo, XQ; Li, MY; Cho, YS; Go, MJ; Kim, YJ; Lee, JY; Park, T; Kim, K; Sim, X; Ong, RTH; Croteau-Chonka, DC; Lange, LA; Smith, JD; Song, K; Zhao, JH; Yuan, X; Luan, JA; Lamina, C; Ziegler, A; Zhang, W; Zee, RYL; Wright, AF; Witteman, JCM; Wilson, JF; Willemsen, G; Wichmann, HE; Whitfield, JB; Waterworth, DM; Wareham, NJ; Waeber, G; Vollenweider, P; Voight, BF; Vitart, V; Uitterlinden, AG; Uda, M; Tuomilehto, J; Thompson, JR; Tanaka, T; Surakka, I; Stringham, HM; Spector, TD; Soranzo, N; Smit, JH; Sinisalo, J; Silander, K; Sijbrands, EJG; Scuteri, A; Scott, J; Schlessinger, D; Sanna, S; Salomaa, V; Saharinen, J; Sabatti, C; Ruokonen, A; Rudan, I; Rose, LM; Roberts, R; Rieder, M; Psaty, BM; Pramstaller, PP; Pichler, I; Perola, M; Penninx, BWJH; Pedersen, NL; Pattaro, C; Parker, AN; Pare, G; Oostra, BA; O'Donnell, CJ; Nieminen, MS; Nickerson, DA; Montgomery, GW; Meitinger, T; McPherson, R; McCarthy, MI; McArdle, W; Masson, D; Martin, NG; Marroni, F; Mangino, M; Magnusson, PKE; Lucas, G; Luben, R; Loos, RJF; Lokki, ML; Lettre, G; Langenberg, C; Launer, LJ; Lakatta, EG; Laaksonen, R; Kyvik, KO; Kronenberg, F; Konig, IR; Khaw, KT; Kaprio, J; Kaplan, LM; Johansson, A; Jarvelin, MR; Janssens, ACJW; Ingelsson, E; Igi, W; Hovingh, GK; Hottenga, JJ; Hofman, A; Hicks, AA; Hengstenberg, C; Heid, IM; Hayward, C; Havulinna, AS; Hastie, ND; Harris, TB; Haritunians, T; Hall, AS; Gyllensten, U; Guiducci, C; Groop, LC; Gonzalez, E; Gieger, C; Freimer, NB; Ferrucci, L; Erdmann, J; Elliott, P; Ejebe, KG; Doering, A; Dominiczak, AF; Demissie, S; Deloukas, P; de Geus, EJC; de Faire, U; Crawford, G; Collins, FS; Chen, YDI; Caulfield, MJ; Campbell, H; Burtt, NP; Bonnycastle, LL; Boomsma, DI; Boekholdt, SM; Bergman, RN; Barroso, I; Bandinelli, S; Ballantyne, CM; Assimes, TL; Quertermous, T; Altshuler, D; Seielstad, M; Wong, TY; Tai, ES; Feranil, AB; Kuzawa, CW; Adair, LS; Taylor, HA; Borecki, IB; Gabriel, SB; Wilson, JG; Holm, H; Thorsteinsdottir, U; Gudnason, V; Krauss, RM; Mohlke, KL; Ordovas, JM; Munroe, PB; Kooner, JS; Tall, AR; Hegele, RA; Kastelein, JJP; Schadt, EE; Rotter, JI; Boerwinkle, E; Strachan, DP; Mooser, V; Stefansson, K; Reilly, MP; Samani, NJ; Schunkert, H; Cupples, LA; Sandhu, MS; Ridker, PM; Rader, DJ; van Duijn, CM; Peltonen, L; Abecasis, GR; Boehnke, M; Kathiresan, S				Teslovich, Tanya M.; Musunuru, Kiran; Smith, Albert V.; Edmondson, Andrew C.; Stylianou, Ioannis M.; Koseki, Masahiro; Pirruccello, James P.; Ripatti, Samuli; Chasman, Daniel I.; Willer, Cristen J.; Johansen, Christopher T.; Fouchier, Sigrid W.; Isaacs, Aaron; Peloso, Gina M.; Barbalic, Maja; Ricketts, Sally L.; Bis, Joshua C.; Aulchenko, Yurii S.; Thorleifsson, Gudmar; Feitosa, Mary F.; Chambers, John; Orho-Melander, Marju; Melander, Olle; Johnson, Toby; Li, Xiaohui; Guo, Xiuqing; Li, Mingyao; Cho, Yoon Shin; Go, Min Jin; Kim, Young Jin; Lee, Jong-Young; Park, Taesung; Kim, Kyunga; Sim, Xueling; Ong, Rick Twee-Hee; Croteau-Chonka, Damien C.; Lange, Leslie A.; Smith, Joshua D.; Song, Kijoung; Zhao, Jing Hua; Yuan, Xin; Luan, Jian'an; Lamina, Claudia; Ziegler, Andreas; Zhang, Weihua; Zee, Robert Y. L.; Wright, Alan F.; Witteman, Jacqueline C. M.; Wilson, James F.; Willemsen, Gonneke; Wichmann, H. -Erich; Whitfield, John B.; Waterworth, Dawn M.; Wareham, Nicholas J.; Waeber, Gerard; Vollenweider, Peter; Voight, Benjamin F.; Vitart, Veronique; Uitterlinden, Andre G.; Uda, Manuela; Tuomilehto, Jaakko; Thompson, John R.; Tanaka, Toshiko; Surakka, Ida; Stringham, Heather M.; Spector, Tim D.; Soranzo, Nicole; Smit, Johannes H.; Sinisalo, Juha; Silander, Kaisa; Sijbrands, Eric J. G.; Scuteri, Angelo; Scott, James; Schlessinger, David; Sanna, Serena; Salomaa, Veikko; Saharinen, Juha; Sabatti, Chiara; Ruokonen, Aimo; Rudan, Igor; Rose, Lynda M.; Roberts, Robert; Rieder, Mark; Psaty, Bruce M.; Pramstaller, Peter P.; Pichler, Irene; Perola, Markus; Penninx, Brenda W. J. H.; Pedersen, Nancy L.; Pattaro, Cristian; Parker, Alex N.; Pare, Guillaume; Oostra, Ben A.; O'Donnell, Christopher J.; Nieminen, Markku S.; Nickerson, Deborah A.; Montgomery, Grant W.; Meitinger, Thomas; McPherson, Ruth; McCarthy, Mark I.; McArdle, Wendy; Masson, David; Martin, Nicholas G.; Marroni, Fabio; Mangino, Massimo; Magnusson, Patrik K. E.; Lucas, Gavin; Luben, Robert; Loos, Ruth J. F.; Lokki, Marja-Liisa; Lettre, Guillaume; Langenberg, Claudia; Launer, Lenore J.; Lakatta, Edward G.; Laaksonen, Reijo; Kyvik, Kirsten O.; Kronenberg, Florian; Koenig, Inke R.; Khaw, Kay-Tee; Kaprio, Jaakko; Kaplan, Lee M.; Johansson, Asa; Jarvelin, Marjo-Riitta; Janssens, A. Cecile J. W.; Ingelsson, Erik; Igi, Wilmar; Hovingh, G. Kees; Hottenga, Jouke-Jan; Hofman, Albert; Hicks, Andrew A.; Hengstenberg, Christian; Heid, Iris M.; Hayward, Caroline; Havulinna, Aki S.; Hastie, Nicholas D.; Harris, Tamara B.; Haritunians, Talin; Hall, Alistair S.; Gyllensten, Ulf; Guiducci, Candace; Groop, Leif C.; Gonzalez, Elena; Gieger, Christian; Freimer, Nelson B.; Ferrucci, Luigi; Erdmann, Jeanette; Elliott, Paul; Ejebe, Kenechi G.; Doering, Angela; Dominiczak, Anna F.; Demissie, Serkalem; Deloukas, Panagiotis; de Geus, Eco J. C.; de Faire, Ulf; Crawford, Gabriel; Collins, Francis S.; Chen, Yii-der I.; Caulfield, Mark J.; Campbell, Harry; Burtt, Noel P.; Bonnycastle, Lori L.; Boomsma, Dorret I.; Boekholdt, S. Matthijs; Bergman, Richard N.; Barroso, Ines; Bandinelli, Stefania; Ballantyne, Christie M.; Assimes, Themistocles L.; Quertermous, Thomas; Altshuler, David; Seielstad, Mark; Wong, Tien Y.; Tai, E-Shyong; Feranil, Alan B.; Kuzawa, Christopher W.; Adair, Linda S.; Taylor, Herman A., Jr.; Borecki, Ingrid B.; Gabriel, Stacey B.; Wilson, James G.; Holm, Hilma; Thorsteinsdottir, Unnur; Gudnason, Vilmundur; Krauss, Ronald M.; Mohlke, Karen L.; Ordovas, Jose M.; Munroe, Patricia B.; Kooner, Jaspal S.; Tall, Alan R.; Hegele, Robert A.; Kastelein, John J. P.; Schadt, Eric E.; Rotter, Jerome I.; Boerwinkle, Eric; Strachan, David P.; Mooser, Vincent; Stefansson, Kari; Reilly, Muredach P.; Samani, Nilesh J.; Schunkert, Heribert; Cupples, L. Adrienne; Sandhu, Manjinder S.; Ridker, Paul M.; Rader, Daniel J.; van Duijn, Cornelia M.; Peltonen, Leena; Abecasis, Goncalo R.; Boehnke, Michael; Kathiresan, Sekar			Biological, clinical and population relevance of 95 loci for blood lipids	NATURE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE; RISK; TRAITS; TRIGLYCERIDES; CHOLESTEROL; HUMANS	Plasma concentrations of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides are among the most important risk factors for coronary artery disease (CAD) and are targets for therapeutic intervention. We screened the genome for common variants associated with plasma lipids in >100,000 individuals of European ancestry. Here we report 95 significantly associated loci (P<5 x 10(-8)), with 59 showing genome-wide significant association with lipid traits for the first time. The newly reported associations include single nucleotide polymorphisms (SNPs) near known lipid regulators (for example, CYP7A1, NPC1L1 and SCARB1) as well as in scores of loci not previously implicated in lipoprotein metabolism. The 95 loci contribute not only to normal variation in lipid traits but also to extreme lipid phenotypes and have an impact on lipid traits in three non-European populations (East Asians, South Asians and African Americans). Our results identify several novel loci associated with plasma lipids that are also associated with CAD. Finally, we validated three of the novel genes-GALNT2, PPP1R3B and TTC39B-with experiments in mouse models. Taken together, our findings provide the foundation to develop a broader biological understanding of lipoprotein metabolism and to identify new therapeutic opportunities for the prevention of CAD.	[Musunuru, Kiran; Pirruccello, James P.; Voight, Benjamin F.; Bandinelli, Stefania; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Teslovich, Tanya M.; Willer, Cristen J.; Stringham, Heather M.; Bergman, Richard N.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Musunuru, Kiran; Ballantyne, Christie M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Musunuru, Kiran; Pirruccello, James P.; Voight, Benjamin F.; Guiducci, Candace; Gonzalez, Elena; Ejebe, Kenechi G.; Crawford, Gabriel; Burtt, Noel P.; Altshuler, David; Wong, Tien Y.; Gabriel, Stacey B.; Kathiresan, Sekar] Broad Inst, Cambridge, MA 02142 USA; [Musunuru, Kiran; Chasman, Daniel I.; Zee, Robert Y. L.; O'Donnell, Christopher J.; Assimes, Themistocles L.; Quertermous, Thomas; Altshuler, David; Ridker, Paul M.; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Musunuru, Kiran; Pirruccello, James P.; Tai, E-Shyong] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; [Smith, Albert V.; Feranil, Alan B.; Gudnason, Vilmundur] Iceland Heart Assoc, Heart Prevent Clin & Res Inst, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Kuzawa, Christopher W.; Thorsteinsdottir, Unnur; Gudnason, Vilmundur; Stefansson, Kari] Univ Iceland, IS-101 Reykjavik, Iceland; [Edmondson, Andrew C.; Li, Mingyao; Adair, Linda S.; Reilly, Muredach P.; Rader, Daniel J.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Edmondson, Andrew C.; Stylianou, Ioannis M.; Li, Mingyao; Reilly, Muredach P.; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Koseki, Masahiro; Masson, David; Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA; [Ripatti, Samuli; Surakka, Ida; Silander, Kaisa; Saharinen, Juha; Perola, Markus; Kaprio, Jaakko] Univ Helsinki, FIMM, FI-00014 Helsinki, Finland; [Ripatti, Samuli; Surakka, Ida; Silander, Kaisa; Perola, Markus; Kaprio, Jaakko] Natl Inst Hlth & Welf, FI-00251 Helsinki, Finland; [Chasman, Daniel I.; Zee, Robert Y. L.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Johansen, Christopher T.; Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; [Fouchier, Sigrid W.; Hovingh, G. Kees; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Isaacs, Aaron; Aulchenko, Yurii S.; Witteman, Jacqueline C. M.; Uitterlinden, Andre G.; Sijbrands, Eric J. G.; Janssens, A. Cecile J. W.; Hofman, Albert; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Peloso, Gina M.; Demissie, Serkalem; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Peloso, Gina M.; O'Donnell, Christopher J.; Demissie, Serkalem; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Barbalic, Maja; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Ricketts, Sally L.; Luben, Robert; Khaw, Kay-Tee; Sandhu, Manjinder S.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Bis, Joshua C.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Bis, Joshua C.] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Thorleifsson, Gudmar; Holm, Hilma; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE, IS-101 Reykjavik, Iceland; [Feitosa, Mary F.; Borecki, Ingrid B.] Washington Univ, Sch Med, Div Stat Genom, Ctr Genome Sci, St Louis, MO 63108 USA; [Chambers, John; Zhang, Weihua] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Orho-Melander, Marju; Melander, Olle; Groop, Leif C.] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden; [Johnson, Toby; Caulfield, Mark J.] Queen Mary Univ London, Clin Pharmacol & Barts & London Genome Ctr, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England; [Li, Xiaohui; Guo, Xiuqing; Haritunians, Talin; Chen, Yii-der I.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Cho, Yoon Shin; Go, Min Jin; Kim, Young Jin; Lee, Jong-Young] Natl Inst Hlth, Ctr Genome Sci, Seoul 122701, South Korea; [Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Bioinformat, Seoul 151742, South Korea; [Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea; [Kim, Kyunga] Sookmyung Womens Univ, Dept Stat, Seoul 140742, South Korea; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117597, Singapore; [Croteau-Chonka, Damien C.; Lange, Leslie A.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Ong, Rick Twee-Hee; Seielstad, Mark] Genome Inst Singapore, Singapore 138672, Singapore; [Smith, Joshua D.; Rieder, Mark; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Song, Kijoung; Yuan, Xin; Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline R&D, Div Genet, King Of Prussia, PA 19406 USA; [Zhao, Jing Hua; Luan, Jian'an; Wareham, Nicholas J.; Loos, Ruth J. F.; Langenberg, Claudia; Sandhu, Manjinder S.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Lamina, Claudia; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Ziegler, Andreas; Koenig, Inke R.] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23562 Lubeck, Germany; [Wright, Alan F.; Vitart, Veronique; Hayward, Caroline; Hastie, Nicholas D.] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Witteman, Jacqueline C. M.; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.] NGI, NCHA, NL-2300 RC Leiden, Netherlands; [Witteman, Jacqueline C. M.; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.] CMSB, NL-2300 RC Leiden, Netherlands; [Wilson, James F.; Rudan, Igor; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Willemsen, Gonneke; Hottenga, Jouke-Jan; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Wichmann, H. -Erich; Heid, Iris M.; Gieger, Christian; Doering, Angela] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; [Whitfield, John B.; Montgomery, Grant W.; Martin, Nicholas G.] PO Royal Brisbane Hosp, Queensland Inst Med Res, Genet Epidemiol Unit, Brisbane, Qld 4029, Australia; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Uitterlinden, Andre G.; Sijbrands, Eric J. G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Uda, Manuela; Sanna, Serena] Cittadella Univ Monserrato, CNR, INN, I-09042 Cagliari, Italy; [Tuomilehto, Jaakko; Salomaa, Veikko; Havulinna, Aki S.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, FI-00271 Helsinki, Finland; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Tanaka, Toshiko] NIA, Clin Res Branch, NIH, Baltimore, MD 21225 USA; [Tanaka, Toshiko] Medstar Res Inst, Baltimore, MD 21218 USA; [Spector, Tim D.; Soranzo, Nicole; Mangino, Massimo] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Soranzo, Nicole; Deloukas, Panagiotis; Barroso, Ines; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Smit, Johannes H.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Dept Psychiat, NL-1007 MB Amsterdam, Netherlands; [Sinisalo, Juha; Nieminen, Markku S.] HUCH, Dept Med, Div Cardiol, FI-00029 Helsinki, Finland; [Scuteri, Angelo] IRCCS, INRCA, Unita Operat Geriatria, I-00189 Rome, Italy; [Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London W12 0NN, England; [Schlessinger, David; Lakatta, Edward G.] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Sabatti, Chiara] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, FI-90220 Oulu, Finland; [Tanaka, Toshiko] Univ Ottawa, John & Jennifer Ruddy Canadian Cardiovasc Gen Ctr, Ottawa, ON K1Y 4W7, Canada; [Psaty, Bruce M.] Univ Washington, Dept Med, Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98101 USA; [Pramstaller, Peter P.; Pichler, Irene; Pattaro, Cristian; Hicks, Andrew A.] Univ Lubeck, European Acad Bozen Bolzano EURAC, Inst Med Genet, Lubeck, Germany; [Pedersen, Nancy L.; Magnusson, Patrik K. E.; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Parker, Alex N.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Pare, Guillaume] McMaster Univ, Genet & Mol Epidemiol Lab, Hamilton, ON L8N 3Z5, Canada; [Oostra, Ben A.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Meitinger, Thomas] Deutsch Forsch Zentrum Umwelt & Gesundheit, Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [McArdle, Wendy] Univ Bristol, Avon Longitudinal Study Parents & Children, Bristol BS8 2BN, Avon, England; [Marroni, Fabio] Inst Appl Genom, I-33100 Udine, Italy; [Lucas, Gavin] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, FI-00014 Helsinki, Finland; [Lettre, Guillaume] Univ Montreal, Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Laaksonen, Reijo] Tampere Univ Hosp, Ctr Sci, FI-33521 Tampere, Finland; [Kyvik, Kirsten O.] Univ So Denmark, Inst Reg Hlth Res, DK-5000 Odense, Denmark; [Kyvik, Kirsten O.] Univ So Denmark, Danish Twin Registry, Inst Publ Hlth, DK-5000 Odense, Denmark; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Fac Med, FI-00014 Helsinki, Finland; [Kaplan, Lee M.] Massachusetts Gen Hosp, Weight Ctr, Boston, MA 02114 USA; [Johansson, Asa; Igi, Wilmar; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, FI-90220 Oulu, Finland; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Heid, Iris M.] Univ Regensburg, Med Ctr, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Havulinna, Aki S.] Aalto Univ, Sch Sci & Technol, Dept Biomed Engn & Computat Sci, FI-00076 Aalto, Finland; [Hall, Alistair S.] Univ Leeds, Fac Med & Hlth, LIGHT Res Inst, Leeds LS2 9JT, W Yorkshire, England; [Groop, Leif C.] Helsinki Univ Hosp, Dept Med, FI-00029 Helsinki, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat,Ctr Neurobehav Genet, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, NIH, Baltimore, MD 21225 USA; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Dominiczak, Anna F.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, SE-17177 Stockholm, Sweden; [Collins, Francis S.; Bonnycastle, Lori L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Boekholdt, S. Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Boekholdt, S. Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Bergman, Richard N.] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Bandinelli, Stefania] ASF, Geriatr Unit, I-50125 Florence, Italy; [Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Assimes, Themistocles L.; Quertermous, Thomas] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 168751, Singapore; [Tai, E-Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117597, Singapore; [Tai, E-Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol, Singapore 117597, Singapore; [Tai, E-Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Publ Hlth, Singapore 117597, Singapore; [Feranil, Alan B.] Univ San Carlos, Off Populat Studies Fdn, Cebu 6000, Philippines; [Kuzawa, Christopher W.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Adair, Linda S.] Univ N Carolina, Carolina Populat Ctr, Dept Nutr, Chapel Hill, NC 27516 USA; [Taylor, Herman A., Jr.; Wilson, James G.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39126 USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Ordovas, Jose M.] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Epidemiol & Populat Genet, Madrid 28029, Spain; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Munroe, Patricia B.] Queen Mary Univ London, Clin Pharmacol & Barts & London Genome Ctr, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA 98109 USA; [Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, NIHR Biomed Res Unit Cardiovasc Dis, Glenfield Hosp, Leicester LE3 9QP, Leics, England	Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Johns Hopkins University; Icelandic Heart Association; University of Iceland; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Columbia University; University of Helsinki; Finland National Institute for Health & Welfare; Harvard University; Brigham & Women's Hospital; Western University (University of Western Ontario); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; University of Cambridge; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Imperial College London; Lund University; University of London; Queen Mary University London; Cedars Sinai Medical Center; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Seoul National University (SNU); Seoul National University (SNU); Sookmyung Women's University; National University of Singapore; University of North Carolina; University of North Carolina Chapel Hill; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Washington; University of Washington Seattle; GlaxoSmithKline; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Medical University of Innsbruck; University of Lubeck; University of Edinburgh; University of Edinburgh; Vrije Universiteit Amsterdam; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Erasmus University Rotterdam; Erasmus MC; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; Finland National Institute for Health & Welfare; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; King's College London; Wellcome Trust Sanger Institute; Vrije Universiteit Amsterdam; IRCCS INRCA; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Stanford University; University of Oulu; University of Ottawa; Group Health Cooperative; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; European Academy of Bozen-Bolzano; University of Lubeck; Karolinska Institutet; Amgen; McMaster University; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Bristol; University of Helsinki; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tampere University; Tampere University Hospital; University of Southern Denmark; University of Southern Denmark; University of Helsinki; Harvard University; Massachusetts General Hospital; Uppsala University; Imperial College London; University of Oulu; University of Regensburg; University of Regensburg; Aalto University; University of Leeds; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Imperial College London; University of Glasgow; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Southern California; Baylor College of Medicine; Stanford University; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; University of San Carlos; Northwestern University; University of North Carolina; University of North Carolina Chapel Hill; University of Mississippi; University of Mississippi Medical Center; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Tufts University; United States Department of Agriculture (USDA); University of London; Queen Mary University London; St Georges University London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	skathiresan@partners.org	Pramstaller, Peter P/C-2357-2008; König, Inke R/A-4544-2009; sanna, serena/H-3009-2019; Ripatti, Samuli/H-9446-2014; MASSON, David/AAC-8896-2022; Kastelein, John/AAF-7950-2020; Wichmann, Heinz Erich/AAA-5695-2022; MASSON, David/R-4557-2017; Gudnason, Vilmundur/AAE-7126-2019; Penninx, Brenda WJH/S-7627-2017; Mangino, Massimo/F-5134-2011; Gudnason, Vilmundur/K-6885-2015; Pare, Guillaume/T-9631-2018; bandinelli, stefania/AAL-4570-2020; Erdmann, Jeanette/P-7513-2014; Lucas, Gavin/D-4346-2012; Hengstenberg, Christian/U-5485-2019; Sim, Xueling/AAZ-6652-2020; Boekholdt, Matthijs S.M./G-7562-2014; Kronenberg, Florian/B-1736-2008; Smith, Albert Vernon/K-5150-2015; Tai, E Shyong/J-9831-2013; Spector, Tim D/F-6533-2012; Colaus, PsyColaus/K-6607-2013; Luben, Robert N/H-5519-2015; Hayward, Caroline/M-8818-2016; de Geus, Eco J.C./M-9318-2015; Rudan, Igor/I-1467-2012; Wilson, James F/A-5704-2009; Kaprio, Jaakko/A-1820-2008; Loos, Ruth J F/Q-2862-2016; Campbell, Harry/E-2959-2010; Feitosa, Mary F/K-8044-2012; Adiels, Martin/C-9278-2011; Deloukas, Panos/B-2922-2013; Rotter, Jerome/AAY-6598-2021; Meitinger, Thomas/O-1318-2015; Dominiczak, Anna F/P-9390-2017; Hegele, Robert/G-3301-2011; Masson, David/R-6633-2019; Lee, Jong-Young/M-6319-2013; Uda, Manuela/AAC-2645-2019; Abecasis, Goncalo R/B-7840-2010; Montgomery, Grant W/B-7148-2008; Assimes, Themistocles Leonard/D-9696-2015; Seielstad, Mark/T-7841-2019; Lamina, Claudia/F-7608-2010; Altshuler, David M/A-4476-2009; Lakatta, Edward G/AAL-1447-2020; Stylianou, Ioannis/C-6061-2012; Ejebe, Kenechi/I-9238-2016; Erdmann, Jeanette/A-4417-2009; Laaksonen, Reijo/D-6323-2014; Hall, Alistair/K-1953-2019; Khaw, Kay-Tee/AAZ-3209-2021; Aulchenko, Yurii/M-8270-2013; Wong, Tien Yin/AAC-9724-2020; Tall, Alan/AAT-8528-2021; Havulinna, Aki/AAM-4769-2021; Hegele, Robert/AAF-6482-2020; Sijbrands, Eric/A-1065-2009; Barbalić, Maja/E-2161-2017; Fouchier, Sigrid/A-8310-2011; Stefansson, Kari/AAE-7187-2019; Johansson, Åsa/G-5270-2011; Kyvik, Kirsten O/K-5680-2016; Voight, Benjamin/F-1775-2011; Marroni, Fabio/R-1819-2017; Loos, Ruth/GON-5877-2022; Boomsma, Dorret I/AAX-4470-2020; Ballantyne, Christie/A-6599-2008; Johansson, Åsa/AAG-6799-2021; Hicks, Andrew Anthony/E-9518-2017; Magnusson, Patrik KE/C-4458-2017; Langenberg, Claudia/ABG-9067-2021; Ordovas, Jose/B-8727-2013; Ziegler, Andreas/G-4246-2012; McCarthy, Mark/M-3763-2015	König, Inke R/0000-0003-0504-6465; sanna, serena/0000-0002-3768-1749; Ripatti, Samuli/0000-0002-0504-1202; MASSON, David/0000-0003-1692-0699; MASSON, David/0000-0003-1692-0699; Gudnason, Vilmundur/0000-0001-5696-0084; Penninx, Brenda WJH/0000-0001-7779-9672; Mangino, Massimo/0000-0002-2167-7470; Gudnason, Vilmundur/0000-0001-5696-0084; Pare, Guillaume/0000-0002-6795-4760; Erdmann, Jeanette/0000-0002-4486-6231; Sim, Xueling/0000-0002-1233-7642; Kronenberg, Florian/0000-0003-2229-1120; Smith, Albert Vernon/0000-0003-1942-5845; Luben, Robert N/0000-0002-5088-6343; Hayward, Caroline/0000-0002-9405-9550; de Geus, Eco J.C./0000-0001-6022-2666; Rudan, Igor/0000-0001-6993-6884; Wilson, James F/0000-0001-5751-9178; Kaprio, Jaakko/0000-0002-3716-2455; Loos, Ruth J F/0000-0002-8532-5087; Campbell, Harry/0000-0002-6169-6262; Feitosa, Mary F/0000-0002-0933-2410; Deloukas, Panos/0000-0001-9251-070X; Dominiczak, Anna F/0000-0003-4913-3608; Lee, Jong-Young/0000-0002-0092-9958; Uda, Manuela/0000-0002-4890-6456; Montgomery, Grant W/0000-0002-4140-8139; Assimes, Themistocles Leonard/0000-0003-2349-0009; Lamina, Claudia/0000-0002-5398-5806; Altshuler, David M/0000-0002-7250-4107; Ejebe, Kenechi/0000-0002-6090-8657; Aulchenko, Yurii/0000-0002-7899-1575; Wong, Tien Yin/0000-0002-8448-1264; Hegele, Robert/0000-0003-2861-5325; Sijbrands, Eric/0000-0001-8857-7389; Barbalić, Maja/0000-0001-8914-1691; Johansson, Åsa/0000-0002-2915-4498; Kyvik, Kirsten O/0000-0003-2981-0245; Marroni, Fabio/0000-0002-1556-5907; Johansson, Åsa/0000-0002-2915-4498; Hicks, Andrew Anthony/0000-0001-6320-0411; Magnusson, Patrik KE/0000-0002-7315-7899; Langenberg, Claudia/0000-0002-5017-7344; Quertermous, Thomas/0000-0002-7645-9067; Abecasis, Goncalo/0000-0003-1509-1825; Gonzalez, Elena/0000-0003-4380-663X; Sinisalo, Juha/0000-0002-0169-5137; Munroe, Patricia/0000-0002-4176-2947; Pichler, Irene/0000-0001-8251-0757; Ricketts, Sally/0000-0002-5644-7958; Melander, Olle/0000-0002-2581-484X; Cupples, L. Adrienne/0000-0003-0273-7965; Elliott, Paul/0000-0002-7511-5684; Demissie, Serkalem/0000-0002-8009-0987; Ordovas, Jose/0000-0002-7581-5680; Boekholdt, Matthijs/0000-0002-0861-0765; Pramstaller, Peter P/0000-0002-9831-8302; Meitinger, Thomas/0000-0002-8838-8403; Lakatta, Edward/0000-0002-4772-0035; Gieger, Christian/0000-0001-6986-9554; Ballantyne, Christie/0000-0002-6432-1730; Surakka, Ida/0000-0002-6669-5541; Janssens, A Cecile/0000-0002-6153-4976; Reilly, Muredach/0000-0002-3035-9386; Bergman, Richard/0000-0003-1539-4471; Caulfield, Mark/0000-0001-9295-3594; Voight, Benjamin/0000-0002-6205-9994; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Lucas, Gavin/0000-0003-4166-9416; Willer, Cristen/0000-0001-5645-4966; Hall, Alistair/0000-0003-0306-7887; Martin, Nicholas/0000-0003-4069-8020; Pirruccello, James/0000-0001-6088-4037; Johnson, Toby/0000-0002-5998-3270; Tai, E Shyong/0000-0003-2929-8966; Edmondson, Andrew/0000-0003-0313-0743; Barroso, Ines/0000-0001-5800-4520; Willemsen, Gonneke/0000-0003-3755-0236; Seielstad, Mark/0000-0001-5783-1401; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Soranzo, Nicole/0000-0003-1095-3852; Whitfield, John/0000-0002-1103-0876; Ziegler, Andreas/0000-0002-8386-5397; Waeber, Gerard/0000-0003-4193-788X; Van Duijn, Cornelia/0000-0002-2374-9204; McCarthy, Mark/0000-0002-4393-0510; SCUTERI, ANGELO/0000-0003-4784-5441	MRC [G0801566, G0601966, G0801056, G0700931, G0000934, G9521010, MC_U106188470, MC_qA137934, MC_U127561128, G0701863] Funding Source: UKRI; British Heart Foundation [PG/08/094/26019, RG/07/005/23633, SP/08/005/25115, PG/08/094, PG/02/128] Funding Source: Medline; FIC NIH HHS [TW05596] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G0701863, G0000934, MC_U106179471, G0601966, G0801056, G9521010D, G0401527, G0801566, G9521010, MC_QA137934, MC_U127561128, G0700931, MC_U106188470] Funding Source: Medline; NCI NIH HHS [CA 047988] Funding Source: Medline; NCRR NIH HHS [U54 RR020278, M01-RR00425, RR20649, UL1RR025005] Funding Source: Medline; NHGRI NIH HHS [1Z01 HG000024, T32 HG000040, T32 HG00040, U01HG004402, N01-HG-65403] Funding Source: Medline; NHLBI NIH HHS [N01 HC-15103, U01 HL069757, 5R01HL08821502, HL 080467, R01 HL089650, K99 HL098364, R01HL087652, 5R01HL08770003, T32HL007208, N01-HC-55016, N01-HC-45133, K99 HL098364-01, N01-HC-85079, N01-HC-85081, N01-HC-55018, HL 04381, N01-HC-85084, N01-HC-55022, R01HL086694, RC2 HL102419, RC1 HL099793, R01 HL089309, R01HL59367, N01-HC-85085, K99HL094535, R01 HL087676, N01-HC-25195, N02-HL-6-4278, RC1 HL099634-02, 5R01HL087679-02, U01 HL080295, RC1 HL099634, N01-HC-55021, N01-HC-85086, RC2 HL101864,, HL-54776, N01-HC-85082, N01-HC-35129, N01 HC-55222, N01-HC-55019, HL085144, R01HL087641, N01-HC-55015, N01-HC-85083, N01-HC-75150, N01-HC-55020, N01-HC-85080] Funding Source: Medline; NIA NIH HHS [N01-AG-12100] Funding Source: Medline; NICHD NIH HHS [R24 HD050924] Funding Source: Medline; NIDDK NIH HHS [DK56350, 5R01DK06833603, DK072193, DK062370, U01 DK062418, U01 DK062370, DK078150, R01 DK072193, R01 DK078150, DK063491, 5R01DK07568102] Funding Source: Medline; NIEHS NIH HHS [ES10126] Funding Source: Medline; NIGMS NIH HHS [T32 GM007092] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline; Wellcome Trust [076113/B/04/Z, 079895, 068545/Z/02, 077016/Z/05/Z] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085082, N01HC055016, N01HC055022, N01HC055021, N01HC055018, N01HC085085, N01HC075150, N01HC035129, N01HC085086, N01HC085079, N01HC085081, N01HC085080, N01HC085083, N01HC045133, N01HC055015, N01HC085084, N01HC025195, N01HC055020, N01HC055222, N01HC055019] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005596] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, UL1RR025005, P20RR020649, M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL087647, T32HL007208, RC2HL102419, K99HL094535, R01HL087641, RC1HL099793, R01HL059367, R01HL089309, R01HL064278, RC2HL101864, R01HL087679, R01HL054776, K23HL004381, K99HL098364, RC1HL099634, R01HL089650, R01HL087652, U01HL069757, R01HL085144, R01HL080467, R01HL087676, R01HL086694] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, U01HG004402, T32HG000040, N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418, P30DK063491, R01DK078150, U01DK062370, P30DK056350, R01DK072193, R56DK062370, R01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000965, ZIAAG007380, ZIAAG000799, N01AG012100, ZIAAG000675] Funding Source: NIH RePORTER; Medical Research Council [MC_qA137934, G0801056B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; MUSUNURU K, 2010, NATURE, V30; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	20	2658	2713	5	390	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					707	713		10.1038/nature09270	http://dx.doi.org/10.1038/nature09270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686565	Green Submitted, Green Accepted			2022-12-28	WOS:000280562500029
J	Xiao, SM; Drachev, VP; Kildishev, AV; Ni, XJ; Chettiar, UK; Yuan, HK; Shalaev, VM				Xiao, Shumin; Drachev, Vladimir P.; Kildishev, Alexander V.; Ni, Xingjie; Chettiar, Uday K.; Yuan, Hsiao-Kuan; Shalaev, Vladimir M.			Loss-free and active optical negative-index metamaterials	NATURE			English	Article							REFRACTIVE-INDEX; LIGHT; GAIN	The recently emerged fields of metamaterials and transformation optics promise a family of exciting applications such as invisibility, optical imaging with deeply subwavelength resolution and nanophotonics with the potential for much faster information processing. The possibility of creating optical negative-index metamaterials (NIMs) using nanostructured metal-dielectric composites has triggered intense basic and applied research over the past several years(1-10). However, the performance of all NIM applications is significantly limited by the inherent and strong energy dissipation in metals, especially in the near-infrared and visible wavelength ranges(11,12). Generally the losses are orders of magnitude too large for the proposed applications, and the reduction of losses with optimized designs seems to be out of reach. One way of addressing this issue is to incorporate gain media into NIM designs(13-16). However, whether NIMs with low loss can be achieved has been the subject of theoretical debate(17,18). Here we experimentally demonstrate that the incorporation of gain material in the high-local-field areas of a metamaterial makes it possible to fabricate an extremely low-loss and active optical NIM. The original loss-limited negative refractive index and the figure of merit (FOM) of the device have been drastically improved with loss compensation in the visible wavelength range between 722 and 738 nm. In this range, the NIM becomes active such that the sum of the light intensities in transmission and reflection exceeds the intensity of the incident beam. At a wavelength of 737 nm, the negative refractive index improves from -0.66 to -1.017 and the FOM increases from 1 to 26. At 738 nm, the FOM is expected to become macroscopically large, of the order of 10(6). This study demonstrates the possibility of fabricating an optical negative-index metamaterial that is not limited by the inherent loss in its metal constituent.	[Xiao, Shumin; Drachev, Vladimir P.; Kildishev, Alexander V.; Ni, Xingjie; Chettiar, Uday K.; Yuan, Hsiao-Kuan; Shalaev, Vladimir M.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Xiao, Shumin; Drachev, Vladimir P.; Kildishev, Alexander V.; Ni, Xingjie; Chettiar, Uday K.; Yuan, Hsiao-Kuan; Shalaev, Vladimir M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shalaev, VM (corresponding author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.	shalaev@purdue.edu	Kildishev, Alexander V./L-5725-2019; Shalaev, Vladimir M./B-9331-2019; Drachev, Vladimir/J-5778-2013; Kildishev, Alexander V/GSN-3724-2022; Ni, Xingjie/I-2235-2012	Kildishev, Alexander V./0000-0002-8382-8422; Shalaev, Vladimir M./0000-0001-8976-1102; Kildishev, Alexander V/0000-0002-8382-8422; Ni, Xingjie/0000-0001-7405-5678	ARO-MURI [50342-PH-MUR, W911NF-09-1-0539]; NSF [DMR 0611430]	ARO-MURI(MURI); NSF(National Science Foundation (NSF))	This work was supported in part by ARO-MURI awards 50342-PH-MUR and W911NF-09-1-0539 and by NSF PREM grant no. DMR 0611430. The authors acknowledge valuable discussions with T. Klar. V. M. S. is grateful to Y. Sivan and Z. Jacob for their comments.	Cai WS, 2007, OPT EXPRESS, V15, P3333, DOI 10.1364/OE.15.003333; Cook JJH, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/11/114026; Drachev VP, 2008, OPT EXPRESS, V16, P1186, DOI 10.1364/OE.16.001186; Fang A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.241104; Fromm DP, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2167649; Jackson J., 1975, CLASSICAL ELECTRODYN; Kildishev AV, 2008, OPT LETT, V33, P43, DOI 10.1364/OL.33.000043; Kildishev AV, 2006, J OPT SOC AM B, V23, P423, DOI 10.1364/JOSAB.23.000423; Kinsler P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.167401; Klar TA, 2006, IEEE J SEL TOP QUANT, V12, P1106, DOI 10.1109/JSTQE.2006.880597; KLIMOV VI, 2000, SCIENCE, V314, P290; Kriegler CE, 2010, IEEE J SEL TOP QUANT, V16, P367, DOI 10.1109/JSTQE.2009.2020809; Ku ZY, 2009, J OPT SOC AM B, V26, pB34, DOI 10.1364/JOSAB.26.000B34; Lezec HJ, 2007, SCIENCE, V316, P430, DOI 10.1126/science.1139266; Noginov MA, 2008, OPT EXPRESS, V16, P1385, DOI 10.1364/OE.16.001385; Noginov MA, 2006, OPT LETT, V31, P3022, DOI 10.1364/OL.31.003022; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pinchuk A, 2004, SURF SCI, V557, P269, DOI 10.1016/j.susc.2004.03.056; Plum E, 2009, OPT EXPRESS, V17, P8548, DOI 10.1364/OE.17.008548; Ramakrishna SA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.201101; Sarychev AK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085436; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Sivan Y, 2009, OPT EXPRESS, V17, P24060, DOI 10.1364/OE.17.024060; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Stockman MI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.177404; Stockman MI, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/2/024004; Tsakmakidis KL, 2007, NATURE, V450, P397, DOI 10.1038/nature06285; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Wegener M, 2008, OPT EXPRESS, V16, P19785, DOI 10.1364/OE.16.019785; Xiao SM, 2009, OPT LETT, V34, P3478, DOI 10.1364/OL.34.003478; Zhang S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137404; Zheludev NI, 2008, NAT PHOTONICS, V2, P351, DOI 10.1038/nphoton.2008.82	35	636	650	12	411	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					735	U6		10.1038/nature09278	http://dx.doi.org/10.1038/nature09278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686570				2022-12-28	WOS:000280562500034
J	Bourgeois, FT; Murthy, S; Mandl, KD				Bourgeois, Florence T.; Murthy, Srinivas; Mandl, Kenneth D.			Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-TRIALS; INDUSTRY SPONSORSHIP; BIAS; REGISTRATION; PUBLICATION; ASSOCIATION; CONCLUSIONS; PROTOCOLS; DESIGN; ACCESS	Background: Clinical trial registries are in widespread use to promote transparency around trials and their results. Objective: To describe characteristics of drug trials listed in ClinicalTrials.gov and examine whether the funding source of these trials is associated with favorable published outcomes. Design: An observational study of safety and efficacy trials for anticholesteremics, antidepressants, antipsychotics, proton-pump inhibitors, and vasodilators conducted between 2000 and 2006. Setting: ClinicalTrials.gov, a Web-based registry of clinical trials launched in 1999. Measurements: Publications resulting from the trials for the 5 drug categories of interest were identified, and data were abstracted on the trial record and publication, including timing of registration, elements of the study design, funding source, publication date, and study outcomes. Assessments were based on the primary funding categories of industry, government agencies, and nonprofit or non-federal organizations. Results: Among 546 drug trials, 346 (63%) were primarily funded by industry, 74 (14%) by government sources, and 126 (23%) by nonprofit or nonfederal organizations. Trials funded by industry were more likely to be phase 3 or 4 trials (88.7%; P < 0.001 across groups), to use an active comparator in controlled trials (36.8%; P = 0.010 across groups), to be multicenter (89.0%; P < 0.001 across groups), and to enroll more participants (median sample size, 306 participants; P < 0.001 across groups). Overall, 362 (66.3%) trials had published results. Industry-funded trials reported positive outcomes in 85.4% of publications, compared with 50.0% for government-funded trials and 71.9% for nonprofit or nonfederal organization-funded trials (P < 0.001). Trials funded by nonprofit or nonfederal sources with industry contributions were also more likely to report positive outcomes than those without industry funding (85.0% vs. 61.2%; P = 0.013). Rates of trial publication within 24 months of study completion ranged from 32.4% among industry-funded trials to 56.2% among nonprofit or nonfederal organization-funded trials without industry contributions (P = 0.005 across groups). Limitations: The publication status of a trial could not always be confirmed, which could result in misclassification. Additional information on study protocols and comprehensive trial results were not available to further explore underlying factors for the association between funding source and outcome reporting. Conclusion: In this sample of registered drug trials, those funded by industry were less likely to be published within 2 years of study completion and were more likely to report positive outcomes than were trials funded by other sources.	[Bourgeois, Florence T.] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bourgeois, FT (corresponding author), Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu	Murthy, Srinivas/AAS-7243-2020; Bourgeois, Florence/H-6710-2016	Bourgeois, Florence/0000-0001-7798-4560; Murthy, Srinivas/0000-0002-9476-839X	National Library of Medicine [5G08LM009778]; National Institute of Child Health and Human Development, National Institutes of Health; National Institute of Child Health and Human Development [5T32HD040128]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM009778] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Library of Medicine and National Institute of Child Health and Human Development, National Institutes of Health.; By training grant 5T32HD040128 (Dr. Bourgeois) from the National Institute of Child Health and Human Development and grant 5G08LM009778 (Dr. Mandl) from the National Library of Medicine.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Avorn J, 2007, NEW ENGL J MED, V357, P633, DOI 10.1056/NEJMp078134; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; *BRIST MYERS SQUIB, BRIST MYERS SQUIBB C; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; *CLIN TRIALS GOV, CLIN TRIALS GOV GLOS; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lassere M, 2002, LANCET, V360, P1620, DOI 10.1016/S0140-6736(02)11652-7; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; Nkansah N, 2009, PUBLIC HEALTH NUTR, V12, P1931, DOI 10.1017/S136898000900487X; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; O'Connor AB, 2009, JAMA-J AM MED ASSOC, V302, P191, DOI 10.1001/jama.2009.973; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Tonks L, 1999, BMJ-BRIT MED J, V319, P1565, DOI 10.1136/bmj.319.7224.1565; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; US Food and Drug Administration, DRUGS FDA; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582; Yamey, 1999, BMJ, V319, p939A; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	42	228	232	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					158	U48		10.7326/0003-4819-153-3-201008030-00006	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679560	Green Accepted, Green Published			2022-12-28	WOS:000280557600004
J	Omenetto, FG; Kaplan, DL				Omenetto, Fiorenzo G.; Kaplan, David L.			New Opportunities for an Ancient Material	SCIENCE			English	Review							SPIDER DRAGLINE SILK; PROTEINS; FIBROIN; FIBER; POLYMERS; STRENGTH; SEQUENCE; GENES; FILMS	Spiders and silkworms generate silk protein fibers that embody strength and beauty. Orb webs are fascinating feats of bioengineering in nature, displaying magnificent architectures while providing essential survival utility for spiders. The unusual combination of high strength and extensibility is a characteristic unavailable to date in synthetic materials yet is attained in nature with a relatively simple protein processed from water. This biological template suggests new directions to emulate in the pursuit of new high-performance, multifunctional materials generated with a green chemistry and processing approach. These bio-inspired and high-technology materials can lead to multifunctional material platforms that integrate with living systems for medical materials and a host of other applications.	[Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604	NIH; NSF; Air Force Office of Science Research; NATIONAL EYE INSTITUTE [R01EY020856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Air Force Office of Science Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the NIH, NSF, and Air Force Office of Science Research for support of the research on silk.	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Calvert P, 1998, NATURE, V393, P309, DOI 10.1038/30610; CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207; Plaza GR, 2009, MACROMOLECULES, V42, P8977, DOI 10.1021/ma9017235; Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332; PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a; Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413; Zhu ZH, 2008, EXPRESS POLYM LETT, V2, P885, DOI 10.3144/expresspolymlett.2008.103	31	1021	1101	58	959	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					528	531		10.1126/science.1188936	http://dx.doi.org/10.1126/science.1188936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671180	Green Accepted			2022-12-28	WOS:000280483500025
J	Onodera, T; Sakai, T; Hsu, JC; Matsumoto, K; Chiorini, JA; Yamada, KM				Onodera, Tomohiro; Sakai, Takayoshi; Hsu, Jeff Chi-feng; Matsumoto, Kazue; Chiorini, John A.; Yamada, Kenneth M.			Btbd7 Regulates Epithelial Cell Dynamics and Branching Morphogenesis	SCIENCE			English	Article							FIBRONECTIN; TUBULOGENESIS; LUNG; POLARITY; DOMAIN; ROLES	During embryonic development, many organs form by extensive branching of epithelia through the formation of clefts and buds. In cleft formation, buds are delineated by the conversion of epithelial cell-cell adhesions to cell-matrix adhesions, but the mechanisms of cleft formation are not clear. We have identified Btbd7 as a dynamic regulator of branching morphogenesis. Btbd7 provides a mechanistic link between the extracellular matrix and cleft propagation through its highly focal expression leading to local regulation of Snail2 (Slug), E-cadherin, and epithelial cell motility. Inhibition experiments show that Btbd7 is required for branching of embryonic mammalian salivary glands and lungs. Hence, Btbd7 is a regulatory gene that promotes epithelial tissue remodeling and formation of branched organs.	[Onodera, Tomohiro; Sakai, Takayoshi; Hsu, Jeff Chi-feng; Matsumoto, Kazue; Yamada, Kenneth M.] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Sakai, Takayoshi] Osaka Univ, Grad Sch Dent, Dept Oral Facial Disorders, Suita, Osaka 5650871, Japan; [Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sakai, T (corresponding author), Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA.	sakai@dent.osaka-u.ac.jp; kyamada@mail.nih.gov	Sakai, Takayoshi/L-1456-2019; Onodera, Tomohiro/G-1686-2012	Sakai, Takayoshi/0000-0003-4348-4896; Yamada, Kenneth/0000-0003-1512-6805	Japan Society for the Promotion of Science (JSPS) [21390534]; NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695, ZIADE000525] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank M. Hoffman, M. Larsen, and K. Musselmann for advice. T.O. was supported by a fellowship from the Japan Society for the Promotion of Science (JSPS). This work was supported in part by the Intramural Research Program of the NIH, NIDCR, and by Grants-in-Aid for Scientific Research (B) (21390534) from the JSPS to T. S. The SAGE data sets are available at the Gene Expression Omnibus (GEO) database under accession number GSE22374.	Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Davies JA, 2002, BIOESSAYS, V24, P937, DOI 10.1002/bies.10161; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Gill SE, 2006, DEV BIOL, V298, P540, DOI 10.1016/j.ydbio.2006.07.004; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Roman J, 1997, EXP LUNG RES, V23, P147, DOI 10.3109/01902149709074027; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; Spooner B S, 1986, Dev Biol (N Y 1985), V3, P225; Walker JL, 2008, DEV DYNAM, V237, P3128, DOI 10.1002/dvdy.21717; Widelitz RB, 2007, SEMIN CELL DEV BIOL, V18, P255, DOI 10.1016/j.semcdb.2007.02.005; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	25	114	117	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					562	565		10.1126/science.1191880	http://dx.doi.org/10.1126/science.1191880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671187	Green Accepted			2022-12-28	WOS:000280483500036
J	Schliehe, C; Juarez, BH; Pelletier, M; Jander, S; Greshnykh, D; Nagel, M; Meyer, A; Foerster, S; Kornowski, A; Klinke, C; Weller, H				Schliehe, Constanze; Juarez, Beatriz H.; Pelletier, Marie; Jander, Sebastian; Greshnykh, Denis; Nagel, Mona; Meyer, Andreas; Foerster, Stephan; Kornowski, Andreas; Klinke, Christian; Weller, Horst			Ultrathin PbS Sheets by Two-Dimensional Oriented Attachment	SCIENCE			English	Article							NANOCRYSTALS; AGGREGATION; GROWTH; PHASE; SHAPE; SIZE	Controlling anisotropy is a key concept in the generation of complex functionality in advanced materials. For this concept, oriented attachment of nanocrystal building blocks, a self-assembly of particles into larger single-crystalline objects, is one of the most promising approaches in nanotechnology. We report here the two-dimensional oriented attachment of lead sulfide (PbS) nanocrystals into ultrathin single-crystal sheets with dimensions on the micrometer scale. We found that this process is initiated by cosolvents, which alter nucleation and growth rates during the primary nanocrystal formation, and is finally driven by dense packing of oleic acid ligands on {100} facets of PbS. The obtained nanosheets can be readily integrated in a photodetector device without further treatment.	[Schliehe, Constanze; Pelletier, Marie; Jander, Sebastian; Greshnykh, Denis; Nagel, Mona; Meyer, Andreas; Foerster, Stephan; Kornowski, Andreas; Klinke, Christian; Weller, Horst] Univ Hamburg, Inst Phys Chem, D-20146 Hamburg, Germany; [Juarez, Beatriz H.] IMDEA Nanosci, Madrid 28049, Spain	University of Hamburg; IMDEA Nanociencia	Weller, H (corresponding author), Univ Hamburg, Inst Phys Chem, Martinistr 52, D-20146 Hamburg, Germany.	weller@chemie.uni-hamburg.de	Juarez, Beatriz H./G-7066-2011; Juarez, Beatriz H./L-5896-2017; Meyer, Andreas/C-5980-2009; Klinke, Christian/A-2525-2014; Weller, Horst/B-5715-2014; Förster, Stephan/B-2180-2015; Klinke, Christian/AAA-5798-2019	Juarez, Beatriz H./0000-0003-1704-060X; Juarez, Beatriz H./0000-0003-1704-060X; Meyer, Andreas/0000-0003-1749-8020; Klinke, Christian/0000-0001-8558-7389	European Commission [ERG FP7-PEOPLE-ERG-2008]; Spanish Ministry of Science and Innovation [RYC-2007-01709]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	B.H.J. thanks the European Commission for grant ERG FP7-PEOPLE-ERG-2008 and the Spanish Ministry of Science and Innovation for grant RYC-2007-01709.	ABRAHAMSSON S, 1962, ACTA CRYSTALLOGR, V15, P1261, DOI 10.1107/S0365110X62003321; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; CAPEK E, 1987, MONATSH CHEM, V118, P419, DOI 10.1007/BF00809924; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; CRAIG SR, 1993, J CRYST GROWTH, V128, P1263, DOI 10.1016/S0022-0248(07)80133-3; Duan TP, 2007, COLLOID SURFACE A, V310, P86, DOI 10.1016/j.colsurfa.2007.06.006; Houtepen AJ, 2006, J AM CHEM SOC, V128, P6792, DOI 10.1021/ja061644v; Huo ZY, 2009, NANO LETT, V9, P1260, DOI 10.1021/nl900209w; Juarez BH, 2008, J AM CHEM SOC, V130, P15282, DOI 10.1021/ja805662h; Jun YW, 2006, ANGEW CHEM INT EDIT, V45, P3414, DOI 10.1002/anie.200503821; Kaneko F, 1997, J PHYS CHEM B, V101, P1803, DOI 10.1021/jp963400a; Konstantatos G, 2006, NATURE, V442, P180, DOI 10.1038/nature04855; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; Lifshitz E, 2003, NANO LETT, V3, P857, DOI 10.1021/nl0342085; Luther JM, 2008, ACS NANO, V2, P271, DOI 10.1021/nn7003348; Mentzel TS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075316; Mokari TL, 2007, J AM CHEM SOC, V129, P9864, DOI 10.1021/ja074145i; Nagel M, 2007, Z PHYS CHEM, V221, P427, DOI 10.1524/zpch.2007.221.3.427; Nikolic MS, 2009, ANGEW CHEM INT EDIT, V48, P2752, DOI 10.1002/anie.200805158; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Polleux J, 2004, ADV MATER, V16, P436, DOI 10.1002/adma.200306251; Son JS, 2009, ANGEW CHEM INT EDIT, V48, P6861, DOI 10.1002/anie.200902791; Steckel JS, 2006, J AM CHEM SOC, V128, P13032, DOI 10.1021/ja062626g; Szendrei K, 2009, ADV MATER, V21, P683, DOI 10.1002/adma.200801752; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Urban JJ, 2006, J AM CHEM SOC, V128, P3248, DOI 10.1021/ja058269b; Yang HG, 2004, ANGEW CHEM INT EDIT, V43, P5930, DOI 10.1002/anie.200461129; Yong KT, 2007, J PHYS CHEM C, V111, P2447, DOI 10.1021/jp066392z	29	673	680	11	689	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					550	553		10.1126/science.1188035	http://dx.doi.org/10.1126/science.1188035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671184	Green Submitted			2022-12-28	WOS:000280483500032
J	Wagner, WR; Griffith, BP				Wagner, William R.; Griffith, Bartley P.			MEDICINE Reconstructing the Lung	SCIENCE			English	Editorial Material									[Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Surg, Pittsburgh, PA 15219 USA; [Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Griffith, Bartley P.] Univ Maryland, Dept Surg, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Wagner, WR (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Surg, Pittsburgh, PA 15219 USA.	wagnerwr@upmc.edu		Wagner, William/0000-0003-0082-8089	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069368] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069368] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burgess KA, 2009, BIOMED MICRODEVICES, V11, P117, DOI 10.1007/s10544-008-9215-2; Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020; Fischer S, 2008, ASAIO J, V54, P3, DOI 10.1097/MAT.0b013e318161d6ec; Hoganson DM, 2010, J THORAC CARDIOV SUR, V140, P990, DOI 10.1016/j.jtcvs.2010.02.062; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Polk AA, 2010, BIOTECHNOL BIOENG, V106, P490, DOI 10.1002/bit.22675; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Stoney WS, 2009, CIRCULATION, V119, P2844, DOI 10.1161/CIRCULATIONAHA.108.830174; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Zhang T, 2009, ARTIF ORGANS, V33, P36, DOI 10.1111/j.1525-1594.2008.00672.x	12	21	21	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					520	522		10.1126/science.1194087	http://dx.doi.org/10.1126/science.1194087			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671176				2022-12-28	WOS:000280483500021
J	Reeves, GK; Travis, RC; Green, J; Bull, D; Tipper, S; Baker, K; Beral, V; Peto, R; Bell, J; Zelenika, D; Lathrop, M				Reeves, Gillian K.; Travis, Ruth C.; Green, Jane; Bull, Diana; Tipper, Sarah; Baker, Krys; Beral, Valerie; Peto, Richard; Bell, John; Zelenika, Diana; Lathrop, Mark		Million Women Study Collaborators	Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; COMMON VARIANTS; RISK; ALLELES; FGFR2; WOMEN	Context There is limited evidence on how the risk of breast cancer and its subtypes depend on low-penetrance susceptibility loci, individually or in combination. Objective To analyze breast cancer risk, overall and by tumor subtype, in relation to 14 individual single-nucleotide polymorphisms (SNPs) previously linked to the disease, and in relation to a polygenic risk score. Design, Setting, and Participants Study of 10 306 women with breast cancer (mean age at diagnosis, 58 years) and 10 393 women without breast cancer who in 2005-2008 provided blood samples for genotyping in a large prospective study of UK women; and meta-analysis of these results and of other published results. Main Outcome Measures Estimated per-allele odds ratio (OR) for individual SNPs, and cumulative incidence of breast cancer to age 70 years in relation to a polygenic risk score based on the 4, 7, or 10 SNPs most strongly associated with risk. Results Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2 SNPs, were significantly greater for estrogen receptor (ER)-positive than for ER-negative disease, both in our data and in meta-analyses of all published data (pooled per-allele ORs [95% confidence intervals] for ER-positive vs ER-negative disease: 1.30 [1.26-1.33] vs 1.05 [1.01-1.10] for FGFR2; interaction P<.001; and 1.24 [1.21-1.28] vs 1.12 [1.07-1.17] for TNRC9; interaction P<.001). The next strongest association was for 2q-rs13387042, for which the per-allele OR was significantly greater for bilateral than unilateral disease (1.39 [1.21-1.60] vs 1.15 [1.11-1.20]; interaction P=.008) and for lobular than ductal tumors (1.35 [1.23-1.49] vs 1.10 [1.05-1.15]; interaction P<.001). The estimated cumulative incidence (95% confidence interval) of breast cancer to age 70 years among women in the top and bottom fifths of a polygenic risk score based on 7 SNPs was 8.8% (8.3%-9.4%) and 4.4% (4.2%-4.8%), respectively. For ER-positive disease the corresponding risks were 7.4% (6.9%-8.0%) and 3.4% (3.1%-3.8%), respectively; while for ER-negative disease they were 1.4% (1.2%-1.6%) and 1.0% (0.8%-1.2%). The findings did not differ materially according to the number of SNPs included in the polygenic risk model. Conclusions The polygenic risk score was substantially more predictive of ER-positive than of ER-negative breast cancer, particularly for absolute risk. JAMA. 2010; 304(4): 426-434	[Reeves, Gillian K.; Travis, Ruth C.; Green, Jane; Bull, Diana; Tipper, Sarah; Baker, Krys; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England; [Bell, John] Univ Oxford, Dept Regius Prof Med, Oxford OX3 7LF, England; [Zelenika, Diana; Lathrop, Mark] CEA, Ctr Natl Genotypage 1G, Paris, France; [Zelenika, Diana; Lathrop, Mark] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France	University of Oxford; University of Oxford; University of Oxford; University of Oxford; CEA; Foundation Jean Dausset-CEPH	Reeves, GK (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	gill.reeves@ceu.ox.ac.uk		Balkwill, Angela/0000-0002-6327-6245	UK Medical Research Council; Cancer Research UK; MRC [MC_U137686850, G0700474] Funding Source: UKRI; Medical Research Council [G0700474, G1000800b, MC_U137686850] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Million Women Study is supported by the UK Medical Research Council and Cancer Research UK. Genotyping of blood samples was supported by the Institut National du Cancer, France.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CURADO MP, 2007, SCI PUBLICATION, V160; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; *NAT CANC INT NETW, ALL BREAST CANC REP; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Rebbeck TR, 2009, CARCINOGENESIS, V30, P269, DOI 10.1093/carcin/bgn247; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Townsend PP., 1988, HLTH DEPRIVATION INE; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; *WHO, 2000, INT CLSAS DIS ONC; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	23	87	92	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					426	434		10.1001/jama.2010.1042	http://dx.doi.org/10.1001/jama.2010.1042			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664043	Bronze			2022-12-28	WOS:000280350100026
J	Cepko, C				Cepko, Constance			Seeing the Light of Day	SCIENCE			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; MODEL; DEATH		[Cepko, Constance] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Cepko, Constance] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cepko, C (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Berson EL, 2007, EXP EYE RES, V85, P7, DOI 10.1016/j.exer.2007.03.001; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Degenaar P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035007; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rodieck R.W., 1998, 1 STEPS SEEING; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28	12	11	13	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					403	404		10.1126/science.1194086	http://dx.doi.org/10.1126/science.1194086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651144				2022-12-28	WOS:000280196500026
J	Hyppa, RW; Smith, GR				Hyppa, Randy W.; Smith, Gerald R.			Crossover Invariance Determined by Partner Choice for Meiotic DNA Break Repair	CELL			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SISTER CHROMATIDS; STRAND EXCHANGE; RECOMBINATION REPAIR; JOINT MOLECULES; PROTEIN COMPLEX; RAD52 HOMOLOGS; DMC1; MEIOSIS	Crossovers between meiotic homologs are crucial for their proper segregation, and crossover number and position are carefully controlled. Crossover homeostasis in budding yeast maintains crossovers at the expense of noncrossovers when double-strand DNA break (DSB) frequency is reduced. The mechanism of maintaining constant crossover levels in other species has been unknown. Here we investigate in fission yeast a different aspect of crossover control-the near invariance of crossover frequency per kb of DNA despite large variations in DSB intensity across the genome. Crossover invariance involves the choice of sister chromatid versus homolog for DSB repair. At strong DSB hotspots, intersister repair outnumbers interhomolog repair similar to 3:1, but our genetic and physical data indicate the converse in DSB-cold regions. This unanticipated mechanism of crossover control may operate in many species and explain, for example, the large excess of DSBs over crossovers and the repair of DSBs on unpaired chromosomes in diverse species.	[Hyppa, Randy W.; Smith, Gerald R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	gsmith@fhcrc.org		Smith, Gerald/0000-0002-8747-1352	National Institutes of Health [GM031693]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Hiroshi Iwasaki for strains; Chad Ellermeier, Joseph Farah, and Emily Higuchi for unpublished recombination data; Michael Lichten and Hiroshi Iwasaki for unpublished information; Gareth Cromie for critical discussions and unpublished DSB data from the mbs1-19 mutant; and Sue Amundsen, Michael Lichten, and Naina Phadnis for helpful comments on the manuscript. This work was supported by research grant GM031693 from the National Institutes of Health to G.R.S.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cromie GA, 2005, GENETICS, V169, P595, DOI 10.1534/genetics.104.037176; Cromie Gareth, 2008, V3, P195, DOI 10.1007/7050_2007_025; Cromie GA, 2007, PLOS GENET, V3, P1496, DOI 10.1371/journal.pgen.0030141; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; DEVEAUX LC, 1992, GENETICS, V130, P251; Egel R, 2008, RECOMBINATION MEIOSI; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Farah JA, 2009, P NATL ACAD SCI USA, V106, P9356, DOI 10.1073/pnas.0902793106; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Fukushima K, 2000, NUCLEIC ACIDS RES, V28, P2709, DOI 10.1093/nar/28.14.2709; Grishchuk AL, 2003, GENETICS, V165, P1031; GUTZ H, 1971, GENETICS, V69, P331; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hyppa RW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000267; Jaramillo-Lambert A, 2010, GENETICS, V184, P613, DOI 10.1534/genetics.109.110338; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; KADYK LC, 1992, GENETICS, V132, P387; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Khasanov FK, 1999, GENETICS, V152, P1557; Khasanov FK, 2008, CURR GENET, V54, P197, DOI 10.1007/s00294-008-0212-z; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mercier R, 2005, CURR BIOL, V15, P692, DOI 10.1016/j.cub.2005.02.056; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; MOENS PB, 1987, MEIOSIS; MUNZ P, 1994, GENETICS, V137, P701; Muris DFR, 1997, CURR GENET, V31, P248, DOI 10.1007/s002940050202; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Octobre G, 2008, GENETICS, V178, P2399, DOI 10.1534/genetics.107.085696; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Rothenberg M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000722; SCHMIDT H, 1987, CURR GENET, V11, P303, DOI 10.1007/BF00355404; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; TEASE C, 1979, CHROMOSOMA, V73, P75, DOI 10.1007/BF00294847; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tsutsui Y, 2001, GENETICS, V159, P91; Tsutsui Y, 2000, GENETICS, V154, P1451; van den Bosch M, 2001, MUTAT RES-DNA REPAIR, V461, P311, DOI 10.1016/S0921-8777(00)00060-4; Webber HA, 2004, J CELL BIOL, V164, P819, DOI 10.1083/jcb.200310077; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Young JA, 2002, MOL CELL, V9, P253, DOI 10.1016/S1097-2765(02)00452-5	65	59	60	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					243	255		10.1016/j.cell.2010.05.041	http://dx.doi.org/10.1016/j.cell.2010.05.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655467	Bronze, Green Accepted			2022-12-28	WOS:000280204300016
J	Hacein-Bey-Abina, S; Hauer, J; Lim, A; Picard, C; Wang, GP; Berry, CC; Martinache, C; Rieux-Laucat, F; Latour, S; Belohradsky, BH; Leiva, L; Sorensen, R; Debre, M; Casanova, JL; Blanche, S; Durandy, A; Bushman, FD; Fischer, A; Cavazzana-Calvo, M				Hacein-Bey-Abina, Salima; Hauer, Julia; Lim, Annick; Picard, Capucine; Wang, Gary P.; Berry, Charles C.; Martinache, Chantal; Rieux-Laucat, Frederic; Latour, Sylvain; Belohradsky, Bernd H.; Leiva, Lily; Sorensen, Ricardo; Debre, Marianne; Casanova, Jean Laurent; Blanche, Stephane; Durandy, Anne; Bushman, Frederic D.; Fischer, Alain; Cavazzana-Calvo, Marina			Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; INSERTIONAL MUTAGENESIS; B-CELLS; SCID-X1; RECEPTOR; DISEASE; HUMANS	BACKGROUND The outcomes of gene therapy to correct congenital immunodeficiencies are unknown. We reviewed long-term outcomes after gene therapy in nine patients with X-linked severe combined immunodeficiency (SCID-X1), which is characterized by the absence of the cytokine receptor common gamma chain. METHODS The nine patients, who lacked an HLA-identical donor, underwent ex vivo retrovirus-mediated transfer of gamma chain to autologous CD34+ bone marrow cells between 1999 and 2002. We assessed clinical events and immune function on long-term follow-up. RESULTS Eight patients were alive after a median follow-up period of 9 years (range, 8 to 11). Gene therapy was initially successful at correcting immune dysfunction in eight of the nine patients. However, acute leukemia developed in four patients, and one died. Transduced T cells were detected for up to 10.7 years after gene therapy. Seven patients, including the three survivors of leukemia, had sustained immune reconstitution; three patients required immunoglobulin-replacement therapy. Sustained thymopoiesis was established by the persistent presence of naive T cells, even after chemotherapy in three patients. The T-cell-receptor repertoire was diverse in all patients. Transduced B cells were not detected. Correction of the immunodeficiency improved the patients' health. CONCLUSIONS After nearly 10 years of follow-up, gene therapy was shown to have corrected the immunodeficiency associated with SCID-X1. Gene therapy may be an option for patients who do not have an HLA-identical donor for hematopoietic stem-cell transplantation and for whom the risks are deemed acceptable. This treatment is associated with a risk of acute leukemia.	[Hacein-Bey-Abina, Salima; Martinache, Chantal; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, Dept Biotherapy, F-75015 Paris, France; [Hacein-Bey-Abina, Salima; Hauer, Julia; Rieux-Laucat, Frederic; Latour, Sylvain; Durandy, Anne; Fischer, Alain; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; [Hacein-Bey-Abina, Salima; Martinache, Chantal; Cavazzana-Calvo, Marina] Grp Hosp Univ Ouest, AP HP, Clin Invest Ctr Biotherapy, Paris, France; [Hacein-Bey-Abina, Salima; Picard, Capucine; Casanova, Jean Laurent; Blanche, Stephane; Fischer, Alain; Cavazzana-Calvo, Marina] Paris Descartes Univ, Paris, France; [Lim, Annick] Inst Pasteur, Unite Dev Lymphocytes, Paris, France; [Lim, Annick] INSERM, U668, Paris, France; [Casanova, Jean Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, U550, Paris, France; [Wang, Gary P.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Berry, Charles C.] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Belohradsky, Bernd H.] Univ Childrens Hosp, Dept Immunol & Infect Dis, Munich, Germany; [Leiva, Lily; Sorensen, Ricardo] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Casanova, Jean Laurent] Rockefeller Univ, Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; University of California System; University of California San Diego; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Rockefeller University	Hacein-Bey-Abina, S (corresponding author), Hop Necker Enfants Malad, Dept Biotherapy, 149 Rue Sevres, F-75015 Paris, France.	salima.hacein-bey@nck.ap-hop-paris.fr	Casanova, Jean-Laurent/I-3418-2017; Rieux-Laucat, Frédéric/A-7916-2017; Durandy, Anne/H-7475-2017; Picard, Capucine/H-3914-2017; Latour, Sylvain/H-3652-2017	Rieux-Laucat, Frédéric/0000-0001-7858-7866; Durandy, Anne/0000-0001-7706-8466; Picard, Capucine/0000-0001-8788-5056; Bushman, Frederic/0000-0003-4740-4056; Cavazzana, Marina/0000-0002-0264-0891; Casanova, Jean-Laurent/0000-0002-7782-4169; Latour, Sylvain/0000-0001-8238-4391	INSERM; Association Francaise contre les Myopathies [AT0203]; European Commission [QLK3-CT-1999-00859]; Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases [005242]; Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases [QLK3-CT-2001-00427]; Agence Nationale de la Recherche [05-MRAR-004]; Programme Hospitalier de Recherche Clinique of the Health Ministry [PHRC AOM 08064-P071204]; Assistance Publique-Hopitaux de Paris; Fondation de l'Avenir; Institut Pasteur and College de France; National Institutes of Health [AI52845, AI082020]; Akademie der Naturforscher Leopoldina [BMBF-LPD 9901/8-149]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082020, R01AI052845] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Commission(European CommissionEuropean Commission Joint Research Centre); Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases; Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases; Agence Nationale de la Recherche(French National Research Agency (ANR)); Programme Hospitalier de Recherche Clinique of the Health Ministry; Assistance Publique-Hopitaux de Paris; Fondation de l'Avenir; Institut Pasteur and College de France; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Akademie der Naturforscher Leopoldina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from INSERM, Association Francaise contre les Myopathies (AT0203), the European Commission (QLK3-CT-1999-00859), the Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases (005242), Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases (QLK3-CT-2001-00427), Agence Nationale de la Recherche (05-MRAR-004), Programme Hospitalier de Recherche Clinique of the Health Ministry (PHRC AOM 08064-P071204), Assistance Publique-Hopitaux de Paris, Fondation de l'Avenir, Institut Pasteur and College de France, and the National Institutes of Health (AI52845 and AI082020, to Dr. Bushman). Dr. Hauer was supported by a scholarship from the Akademie der Naturforscher Leopoldina (BMBF-LPD 9901/8-149).	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Baum C, 2007, CURR OPIN HEMATOL, V14, P337, DOI 10.1097/MOH.0b013e3281900f01; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; GENNERY AR, J ALLERGY C IN PRESS; Ginn SL, 2005, MED J AUSTRALIA, V182, P458, DOI 10.5694/j.1326-5377.2005.tb06785.x; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Sarzotti-Kelsoe M, 2009, BLOOD, V114, P1445, DOI 10.1182/blood-2009-01-199323; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; TANNER JM, 1986, CLIN ENDOCRINOL META, V15, P411, DOI 10.1016/S0300-595X(86)80005-6; WANG GP, 2010, BLOOD           0312; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412	23	427	451	0	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					355	364		10.1056/NEJMoa1000164	http://dx.doi.org/10.1056/NEJMoa1000164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660403	Green Accepted			2022-12-28	WOS:000280139300008
J	Gneezy, A; Gneezy, U; Nelson, LD; Brown, A				Gneezy, Ayelet; Gneezy, Uri; Nelson, Leif D.; Brown, Amber			Shared Social Responsibility: A Field Experiment in Pay-What-You-Want Pricing and Charitable Giving	SCIENCE			English	Article								A field experiment (N = 113,047 participants) manipulated two factors in the sale of souvenir photos. First, some customers saw a traditional fixed price, whereas others could pay what they wanted (including $0). Second, approximately half of the customers saw a variation in which half of the revenue went to charity. At a standard fixed price, the charitable component only slightly increased demand, as similar studies have also found. However, when participants could pay what they wanted, the same charitable component created a treatment that was substantially more profitable. Switching from corporate social responsibility to what we term shared social responsibility works in part because customized contributions allow customers to directly express social welfare concerns through the purchasing of material goods.	[Gneezy, Ayelet; Gneezy, Uri; Brown, Amber] Univ Calif San Diego, Rady Sch Management, La Jolla, CA 92093 USA; [Nelson, Leif D.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Brown, Amber] Disney Res, Glendale, CA 91201 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley	Gneezy, A (corresponding author), Univ Calif San Diego, Rady Sch Management, 9500 Gilman Dr, La Jolla, CA 92093 USA.	agneezy@ucsd.edu						ANDREONI J, 2007, NEW PALGRAVE DICT EC, V1, P34; Benabou R, 2010, ECONOMICA, V77, P1, DOI 10.1111/j.1468-0335.2009.00843.x; Besley T, 2007, J PUBLIC ECON, V91, P1645, DOI 10.1016/j.jpubeco.2007.07.006; David P., 2005, J PUBLIC RELAT RES, V17, P291, DOI [10.1207/s1532754xjprr1703_4, DOI 10.1207/S1532754XJPRR1703_4]; FRIEDMAN M, 1970, NY TIMES MAG, V32, P22; FRIESTAD M, 1994, J CONSUM RES, V21, P1, DOI 10.1086/209380; Gautier PA, 2012, J APPL ECONOMET, V27, P63, DOI 10.1002/jae.1184; GNEEZY A, 2010, PAY WHAT YOU WANT FA; List JA, 2002, J POLIT ECON, V110, P215, DOI 10.1086/324392; List JA, 2008, SCIENCE, V321, P207, DOI 10.1126/science.1156716; Meier S, 2007, J EUR ECON ASSOC, V5, P1203, DOI 10.1162/JEEA.2007.5.6.1203; Regner T, 2009, J ECON BEHAV ORGAN, V71, P395, DOI 10.1016/j.jebo.2009.04.001; Sen S, 2001, J MARKETING RES, V38, P225, DOI 10.1509/jmkr.38.2.225.18838	13	168	168	5	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					325	327		10.1126/science.1186744	http://dx.doi.org/10.1126/science.1186744			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625VW	20647467				2022-12-28	WOS:000279925900042
J	Schroeder, SA; Warner, KE				Schroeder, Steven A.; Warner, Kenneth E.			Don't Forget Tobacco.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SMOKING		[Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA USA; [Warner, Kenneth E.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Schroeder, SA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.			Warner, Kenneth/0000-0002-8214-1776				Deyton L, 2010, NEW ENGL J MED, V362, P1753, DOI 10.1056/NEJMp1004152; Land T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009770; MENDEZ D, 2007, ENDING TOBACCO PROBL, P599; Schroeder SA, 2009, JAMA-J AM MED ASSOC, V301, P522, DOI 10.1001/jama.2008.982; Warner K. E., 2007, TOBACCO CONTROL POLI, P3	5	42	42	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					201	204		10.1056/NEJMp1003883	http://dx.doi.org/10.1056/NEJMp1003883			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625AR	20647196				2022-12-28	WOS:000279864200001
J	Hausenloy, DJ; Opie, L; Yellon, DM				Hausenloy, Derek J.; Opie, Lionel; Yellon, Derek M.			Dissociating HDL cholesterol from cardiovascular risk	LANCET			English	Editorial Material							HIGH-DENSITY-LIPOPROTEIN; ACUTE CORONARY SYNDROMES; DISEASE; THERAPY; STATINS; EVENTS; MEN		[Hausenloy, Derek J.; Yellon, Derek M.] Univ Coll London Hosp, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Opie, Lionel] Univ Cape Town, Dept Med, Hatter Cardiovasc Res Inst, ZA-7700 Rondebosch, South Africa	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Cape Town	Hausenloy, DJ (corresponding author), Univ Coll London Hosp, Hatter Cardiovasc Inst, London WC1E 6HX, England.		Yellon, Derek M/ABD-5110-2021	Yellon, Derek/0000-0001-7791-9320; Hausenloy, Derek/0000-0003-0729-4956				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Grover SA, 2009, ARCH INTERN MED, V169, P1775, DOI 10.1001/archinternmed.2009.328; Hausenloy DJ, 2009, CURR OPIN CARDIOL, V24, P473, DOI 10.1097/HCO.0b013e32832ebfe7; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008; Ray KK, 2009, ARTERIOSCL THROM VAS, V29, P424, DOI 10.1161/ATVBAHA.108.181735; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, LANCET, V376, P333, DOI 10.1016/S0140-6736(10)60713-1	13	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2010	376	9738					305	306		10.1016/S0140-6736(10)61021-5	http://dx.doi.org/10.1016/S0140-6736(10)61021-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20655104				2022-12-28	WOS:000280717900004
J	Ridker, PM; Genest, J; Boekholdt, SM; Libby, P; Gotto, AM; Nordestgaard, BG; Mora, S; MacFadyen, JG; Glynn, RJ; Kastelein, JJP				Ridker, Paul M.; Genest, Jacques; Boekholdt, S. Matthijs; Libby, Peter; Gotto, Antonio M.; Nordestgaard, Borge G.; Mora, Samia; MacFadyen, Jean G.; Glynn, Robert J.; Kastelein, John J. P.		JUPITER Trial Study Grp	HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial	LANCET			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; RANDOMIZED-TRIAL; A-I; ATHEROSCLEROSIS; TORCETRAPIB; PRAVASTATIN; PREVENTION; HYPERCHOLESTEROLEMIA; TRIGLYCERIDES	Background HDL-cholesterol concentrations are inversely associated with occurrence of cardiovascular events. We addressed, using the JUPITER trial cohort, whether this association remains when LDL-cholesterol concentrations are reduced to the very low ranges with high-dose statin treatment. Methods Participants in the randomised placebo-controlled JUPITER trial were adults without diabetes or previous cardiovascular disease, and had baseline concentrations of LDL cholesterol of less than 3.37 mmol/L and high-sensitivity C-reactive protein of 2 mg/L or more. Participants were randomly allocated by a computer-generated sequence to receive rosuvastatin 20 mg per day or placebo, with participants and adjudicators masked to treatment assignment. In the present analysis, we divided the participants into quartiles of HDL-cholesterol or apolipoprotein A1 and sought evidence of association between these quartiles and the JUPITER primary endpoint of first non-fatal myocardial infarction or stroke, hospitalisation for unstable angina, arterial revascularisation, or cardiovascular death. This trial is registered with ClinicalTrials.gov, number NCT00239681. Findings For 17802 patients in the JUPITER trial, rosuvastatin 20 mg per day reduced the incidence of the primary endpoint by 44% (p<0.0001). In 8901 (50%) patients given placebo (who had a median on-treatment LDL-cholesterol concentration of 2.80 mmol/L [IQR 2.43-3.24]), HDL-cholesterol concentrations were inversely related to vascular risk both at baseline (top quartile vs bottom quartile hazard ratio [HR] 0.54, 95% CI 0.35-0.83, p=0.0039) and on-treatment (0.55, 0.35-0.87, p=0.0047). By contrast, among the 8900 (50%) patients given rosuvastatin 20 mg (who had a median on-treatment LDL-cholesterol concentration of 1.42 mmol/L [IQR 861), no significant relationships were noted between quartiles of HDL-cholesterol concentration and vascular risk either at baseline (1.12, 0.62-2.03, p=0.82) or on-treatment (1.03, 0.57-1.87, p=0.97). Our analyses for apolipoprotein A1 showed an equivalent strong relation to frequency of primary outcomes in the placebo group but little association in the rosuvastatin group. Interpretation Although measurement of HDL-cholesterol concentration is useful as part of initial caldiovascular risk assessment, HDL-cholesterol concentrations are not predictive of residual vascular risk among patients treated with potent statin therapy who attain very low concentrations of LDL cholesterol.	[Ridker, Paul M.; Mora, Samia; MacFadyen, Jean G.; Glynn, Robert J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Ridker, Paul M.; Libby, Peter; Mora, Samia] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02215 USA; [Genest, Jacques] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Gotto, Antonio M.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, Copenhagen, Denmark; [Boekholdt, S. Matthijs; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Boekholdt, S. Matthijs; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; McGill University; Cornell University; University of Copenhagen; Herlev & Gentofte Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Ridker, PM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA.		Libby, Peter/AAY-6404-2021; Boekholdt, Matthijs S.M./G-7562-2014; Nordestgaard, Borge Gronne/ABF-1310-2020; Kastelein, John/AAF-7950-2020	Libby, Peter/0000-0002-1502-502X; Boekholdt, Matthijs/0000-0002-0861-0765; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Mora, Samia/0000-0001-6283-0980; Nordestgaard, Borge/0000-0002-1954-7220; da Silva Franco, Roberto Jorge/0000-0001-9787-4393	AstraZeneca; National Heart Lung and Blood Institute; National Cancer Institute; Donald W Reynolds Foundation; Leducq Foundation; Novartis; Merck; Abbott; Roche; Sanofi-Aventis; ISIS; Merck-Schering Plough; Siemens; Vascular Biogenics; Boehringer-Ingellnem; Pfizer; Genzyme; Glaxo Smith Kline; Bristol-Myers Squibb	AstraZeneca(AstraZeneca); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Leducq Foundation(Leducq Foundation); Novartis(Novartis); Merck(Merck & Company); Abbott(Abbott Laboratories); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); ISIS; Merck-Schering Plough(Merck & CompanySchering Plough Corporation); Siemens(Siemens AG); Vascular Biogenics; Boehringer-Ingellnem; Pfizer(Pfizer); Genzyme(Sanofi-AventisGenzyme Corporation); Glaxo Smith Kline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb)	JUPITER was supported by AstraZeneca During the period of this study, PM R reports having received investigator-initiated research grant support from the National Heart Lung and Blood Institute, the National Cancer Institute, the Donald W Reynolds Foundation, the Leducq Foundation, AstraZeneca. Novartis, Merck, Abbott, Roche, and Sanofi-Aventis, consulting fees and lecture fees from AstraZeneca, ISIS, Novartis, Merck-Schering Plough, Sanofi-Aventis. Siemens, and Vascular Biogenics, and is listed as a co-Inventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease These patents have been licensed to several entitles, including AstraZeneca JG reports having received lecture fees from AstraZeneca, Novartis, Pfizer. Sanofi-Aventis, and Schering Plough, and consulting fees from AstraZeneca. Merck, Novartis, Sanofi. Aventis, Pfizer, and Schering-Plough AMG reports having received consulting fees from Aegerion, Arisaph, Dupont, KOWA, Merck Schering Plough, Merck, Novartis, Pfizer, and Reliant BGN reports receiving lecture fees from AstraZeneca, Pfizer. Merck, Sanofi-Aventis and Boehringer-Ingellnem, and consulting fees from AstraZeneca, Abbott, and Karo Bio JJPK reports receiving research grant support from AstraZeneca, Pfizer, Roche, Novartis, Merck, Merck Schering Plough, ISIS, Genzyme, and Sanofi-Aventis, lecture fees from AstraZeneca, Glaxo Smith Kline, Pfizer, Novartis. and Boehringer-Ingelhiem, and consulting fees from AstraZeneca, Abbott, Pfizer, ISIS, Genzymc, Roche. Novartis, Merck, Merck Schering Plough, and Sanofi-Aventis PL reports receiving lecture fees from Pfizer and lecture or consulting fees from AstraZeneca, Bristol-Myers Squibb, Glaxo Smith Kline, Merck, Pfizer, Sanofi-Aventis, VIA Pharmaceutical, Interleukin Genetics, Kowa Research Institute, Novartis, and Merck Schering Plough SM reports receiving research grant support from AstraZerieca and Merk RIG reports receiving research grant support from AstraZeneca and Bristol-Myers Squibb All other authors report no conflicts of interest; JUPITER was supported by AstraZeneca, USA We thank the medical teams from AstraZeneca whose efforts made this trial possible, the JUPITER study participants, and the more than 1000 physicians worldwide for their personal time, effort, and commitment to the JUPITER trial	Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; DOWNS JR, 1998, JAMA-J AM MED ASSOC, V279, pS161; Frassetto LA, 2009, EUR J CLIN NUTR, V63, P947, DOI 10.1038/ejcn.2009.4; Frost PH, 1996, CIRCULATION, V94, P2381, DOI 10.1161/01.CIR.94.10.2381; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Lamarche B, 1996, ATHEROSCLEROSIS, V119, P235, DOI 10.1016/0021-9150(95)05653-X; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; PEDERSEN TR, 1994, LANCET, V344, P1383; Ray KK, 2009, ARTERIOSCL THROM VAS, V29, P424, DOI 10.1161/ATVBAHA.108.181735; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77	25	179	186	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					333	339		10.1016/S0140-6736(10)60713-1	http://dx.doi.org/10.1016/S0140-6736(10)60713-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636FW	20655105				2022-12-28	WOS:000280717900031
J	Sheppard, SS; Trujillo, CA				Sheppard, Scott S.; Trujillo, Chadwick A.			Detection of a Trailing (L5) Neptune Trojan	SCIENCE			English	Article							KUIPER-BELT; IRREGULAR SATELLITES; PLANETARY MIGRATION; CHAOTIC CAPTURE; ASTEROIDS; URANUS; COMPLETENESS; ORBITS; LIMITS; ORIGIN		[Sheppard, Scott S.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Trujillo, Chadwick A.] Gemini Observ, Hilo, HI 96720 USA	Carnegie Institution for Science	Sheppard, SS (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	sheppard@dtm.ciw.edu		Sheppard, Scott/0000-0003-3145-8682; Trujillo, Chadwick/0000-0001-9859-0894	NASA New Horizons mission; Gemini Observatory	NASA New Horizons mission; Gemini Observatory	This study has its basis in part on data collected at Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. This paper includes data gathered with the 6.5-m Magellan Telescope located at Las Campanas Observatory, Chile. S.S.S. was supported in part by the NASA New Horizons mission to Pluto. C.A.T. was supported by the Gemini Observatory.	Chiang EI, 2005, ASTROPHYS J, V628, P520, DOI 10.1086/430825; Chiang EI, 2003, ASTRON J, V126, P430, DOI 10.1086/375207; Fernandez YR, 2003, ASTRON J, V126, P1563, DOI 10.1086/377015; Hahn JM, 2005, ASTRON J, V130, P2392, DOI 10.1086/452638; Levison HF, 2008, ICARUS, V196, P258, DOI 10.1016/j.icarus.2007.11.035; Lykawka PS, 2010, MON NOT R ASTRON SOC, V405, P1375, DOI 10.1111/j.1365-2966.2010.16538.x; Lykawka PS, 2009, MON NOT R ASTRON SOC, V398, P1715, DOI 10.1111/j.1365-2966.2009.15243.x; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; MURRAY CD, 1994, ICARUS, V112, P465, DOI 10.1006/icar.1994.1198; Nesvorny D, 2002, ICARUS, V160, P271, DOI 10.1006/icar.2002.6961; Nesvorny D, 2009, ASTRON J, V137, P5003, DOI 10.1088/0004-6256/137/6/5003; Sheppard SS, 2006, ASTRON J, V132, P171, DOI 10.1086/504799; Sheppard SS, 2006, SCIENCE, V313, P511, DOI 10.1126/science.1127173; Sheppard SS, 2005, ASTRON J, V129, P518, DOI 10.1086/426329; Zhou LY, 2009, MON NOT R ASTRON SOC, V398, P1217, DOI 10.1111/j.1365-2966.2009.15203.x	15	26	29	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1304	1304		10.1126/science.1189666	http://dx.doi.org/10.1126/science.1189666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20705814	Bronze			2022-12-28	WOS:000281657300026
J	Boekholdt, SM; Peters, RJG				Boekholdt, S. Matthijs; Peters, Ron J. G.			Rimonabant: obituary for a wonder drug	LANCET			English	Editorial Material							CANNABINOID-1 RECEPTOR BLOCKER; RISK-FACTORS; OVERWEIGHT PATIENTS; WEIGHT		[Boekholdt, S. Matthijs; Peters, Ron J. G.] Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Boekholdt, SM (corresponding author), Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands.	s.m.boekholdt@amc.uva.nl	Boekholdt, Matthijs S.M./G-7562-2014	Boekholdt, Matthijs/0000-0002-0861-0765				Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; European Medicines Agency, 2008, PUBL STAT BEXTR VALD; European Medicines Agency, 2010, EUR MED AG REC SUSP; Iestra JA, 2005, CIRCULATION, V112, P924, DOI 10.1161/CIRCULATIONAHA.104.503995; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Topol EJ, 2010, LANCET, V376, P517, DOI 10.1016/S0140-6736(10)60935-X; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X	9	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					489	490		10.1016/S0140-6736(10)61080-X	http://dx.doi.org/10.1016/S0140-6736(10)61080-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20709215				2022-12-28	WOS:000281266800004
J	Lee, I; Obukhov, Y; Xiang, G; Hauser, A; Yang, FY; Banerjee, P; Pelekhov, DV; Hammel, PC				Lee, Inhee; Obukhov, Yuri; Xiang, Gang; Hauser, Adam; Yang, Fengyuan; Banerjee, Palash; Pelekhov, Denis V.; Hammel, P. Chris			Nanoscale scanning probe ferromagnetic resonance imaging using localized modes	NATURE			English	Article							MAGNETIC-RESONANCE; FORCE MICROSCOPY; SPIN WAVES; SPECTRUM; DISK	The discovery of new phenomena in layered and nanostructured magnetic devices is driving rapid growth in nanomagnetics research. Resulting applications such as giant magnetoresistive field sensors and spin torque devices are fuelling advances in information and communications technology, magnetoelectronic sensing and biomedicine(1,2). There is an urgent need for high-resolution magnetic-imaging tools capable of characterizing these complex, often buried, nanoscale structures. Conventional ferromagnetic resonance(3,4) (FMR) provides quantitative information about ferromagnetic materials and interacting multicomponent magnetic structures with spectroscopic precision and can distinguish components of complex bulk samples through their distinctive spectroscopic features. However, it lacks the sensitivity to probe nanoscale volumes and has no imaging capabilities. Here we demonstrate FMR imaging through spin-wave localization. Although the strong interactions in a ferromagnet favour the excitation of extended collective modes, we show that the intense, spatially confined magnetic field of the micromagnetic probe tip used in FMR force microscopy can be used to localize the FMR mode immediately beneath the probe. We demonstrate FMR modes localized within volumes having 200 nm lateral dimensions, and improvements of the approach may allow these dimensions to be decreased to tens of nanometres. Our study shows that this approach is capable of providing the microscopic detail required for the characterization of ferromagnets used in fields ranging from spintronics to biomagnetism. This method is applicable to buried and surface magnets, and, being a resonance technique, measures local internal fields and other magnetic properties with spectroscopic precision.	[Lee, Inhee; Obukhov, Yuri; Xiang, Gang; Hauser, Adam; Yang, Fengyuan; Banerjee, Palash; Pelekhov, Denis V.; Hammel, P. Chris] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Hammel, PC (corresponding author), Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA.	hammel@mps.ohio-state.edu	Hammel, P Chris/O-4845-2014; Xiang, Gang/J-3433-2015; Hauser, Adam/G-2530-2012	Hammel, P Chris/0000-0002-4138-4798; Xiang, Gang/0000-0002-5060-975X; Hauser, Adam/0000-0003-1752-0937; Banerjee, Palash/0000-0002-3269-8541; Hammel, Pascal/0000-0002-4630-4996	US Department of Energy [DE-FG02-03ER46054]	US Department of Energy(United States Department of Energy (DOE))	We acknowledge financial support from the US Department of Energy through grant no. DE-FG02-03ER46054.	DAMON RW, 1965, J APPL PHYS, V36, P3453, DOI 10.1063/1.1703018; de Loubens G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.127601; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Hammel P. C., 2007, HDB MAGNETISM ADV 4, V5; HERRING C, 1951, PHYS REV, V81, P869, DOI 10.1103/PhysRev.81.869; Jorzick J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047204; Kakazei GN, 2004, APPL PHYS LETT, V85, P443, DOI 10.1063/1.1772868; KALINIKOS BA, 1986, J PHYS C SOLID STATE, V19, P7013, DOI 10.1088/0022-3719/19/35/014; Klein O, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.144410; Mewes T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144424; Obukhov Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3123264; Obukhov Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.197601; RUGAR D, 1992, NATURE, V360, P563, DOI 10.1038/360563a0; SCHLOMANN E, 1964, J APPL PHYS, V35, P159, DOI 10.1063/1.1713058; SIDLES JA, 1992, PHYS REV LETT, V68, P1124, DOI 10.1103/PhysRevLett.68.1124; SIDLES JA, 1995, REV MOD PHYS, V67, P249, DOI 10.1103/RevModPhys.67.249; Slavin A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237201; Urban R, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.212410; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; YUKAWA T, 1974, J APPL PHYS, V45, P3146, DOI 10.1063/1.1663739; Zhang Z, 1996, APPL PHYS LETT, V68, P2005, DOI 10.1063/1.115619; ZUTIC I, 2004, REV MOD PHYS, V323, P410	24	84	85	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					845	848		10.1038/nature09279	http://dx.doi.org/10.1038/nature09279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703302				2022-12-28	WOS:000280766100031
J	Panakova, D; Werdich, AA; MacRae, CA				Panakova, Daniela; Werdich, Andreas A.; MacRae, Calum A.			Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca2+ channel	NATURE			English	Article							VOLTAGE-SENSITIVE DYES; CARDIAC TISSUE; CELL-CULTURES; CONDUCTION; GASTRULATION; ACTIVATION; MOVEMENTS; DIFFERENTIATION; MORPHOGENESIS; MECHANISMS	Electrical gradients are critical for many biological processes, including the normal function of excitable tissues, left-right patterning, organogenesis and wound healing(1-4). The fundamental mechanisms that regulate the establishment and maintenance of such electrical polarities are poorly understood. Here we identify a gradient of electrical coupling across the developing ventricular myocardium using high-speed optical mapping of transmembrane potentials and calcium concentrations in the zebrafish heart. We excluded a role for differences in cellular excitability, connexin localization, tissue geometry and mechanical inputs, but in contrast we were able to demonstrate that non-canonical Wnt11 signals are required for the genesis of this myocardial electrical gradient. Although the traditional planar cell polarity pathway is not involved, we obtained evidence that Wnt11 acts to set up this gradient of electrical coupling through effects on transmembrane Ca2+ conductance mediated by the L-type calcium channel. These data reveal a previously unrecognized role for Wnt/Ca2+ signalling in establishing an electrical gradient in the plane of the developing cardiac epithelium through modulation of ion-channel function. The regulation of cellular coupling through such mechanisms may be a general property of non-canonical Wnt signals.	[Panakova, Daniela; Werdich, Andreas A.; MacRae, Calum A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	MacRae, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, 75 Francis St,Thorn 11, Boston, MA 02115 USA.	camacrae@bics.bwh.harvard.edu		Panakova, Daniela/0000-0002-8739-6225; Werdich, Andreas/0000-0002-1222-1180	HFSP; NIH; March of Dimes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098938, K08HL068711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075946] Funding Source: NIH RePORTER	HFSP(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. P. Heisenberg, L. Solnica-Krezel and J. Mably for the gift of reagents. We thank R. Peterson and I. Drummond for comments on the manuscript. D. P. is supported by a fellowship from the HFSP. A. A. W. was supported by an NIH training award to the CVRC at MGH. C. A. M. is supported by the March of Dimes and the NIH.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Chung CY, 2007, J CARDIOVASC ELECTR, V18, P1323, DOI 10.1111/j.1540-8167.2007.00959.x; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; Eloff BC, 2001, CARDIOVASC RES, V51, P681, DOI 10.1016/S0008-6363(01)00341-8; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; FAST VG, 1993, CIRC RES, V73, P914, DOI 10.1161/01.RES.73.5.914; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Girouard SD, 1996, J CARDIOVASC ELECTR, V7, P1024, DOI 10.1111/j.1540-8167.1996.tb00478.x; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HOYT RH, 1989, CIRC RES, V64, P563, DOI 10.1161/01.RES.64.3.563; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; LOEW LM, 1992, J MEMBRANE BIOL, V130, P1, DOI 10.1007/bf00233734; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Mills RW, 2008, AM J PHYSIOL-HEART C, V295, pH1270, DOI 10.1152/ajpheart.00350.2008; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Rohr S, 1998, BIOPHYS J, V75, P1062, DOI 10.1016/S0006-3495(98)77596-4; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thisse C., 2005, ZDBPUB0510251; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WATANABE T, 1983, CIRC RES, V52, P280, DOI 10.1161/01.RES.52.3.280; Windisch H, 2001, OPTICAL MAPPING OF CARDIAC EXCITATION AND ARRHYTHMIAS, P97; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Yao L, 2009, HIPPOCAMPUS, V19, P855, DOI 10.1002/hipo.20569; Yao SH, 2008, FEBS LETT, V582, P2325, DOI 10.1016/j.febslet.2008.05.036; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112	42	101	102	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					874	U109		10.1038/nature09249	http://dx.doi.org/10.1038/nature09249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20657579	Green Accepted			2022-12-28	WOS:000280766100038
J	Anderson, T				Anderson, Tatum			Pain control The politics of pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OPIOIDS; INDIA					tatumnanderson@gmail.com						Adams Vanessa, 2008, J Pain Palliat Care Pharmacother, V22, P101; CLEARY JF, 2010, EUROPE PALLIAT MED, V24, P109; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Human Rights Watch, 2009, ACC PAIN TREATM HUM; *INT NARC CONTR BO, 1961, SINGL CONV NARC DRUG; International Narcotics Control Board, REP INT NARC CONTR B; Rajagopal MR, 2007, J PAIN SYMPTOM MANAG, V33, P615, DOI 10.1016/j.jpainsymman.2007.02.028; Rajagopal MR, 2001, LANCET, V358, P139, DOI 10.1016/S0140-6736(01)05322-3; *UN EC SOC COUNC, 2010, COMM NARC DRUGS; *WHO, NARC PSYCH DRUGS ACH; WHO, ACC CONTR MED PROGR	12	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2010	341								c3800	10.1136/bmj.c3800	http://dx.doi.org/10.1136/bmj.c3800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DR	20702554				2022-12-28	WOS:000281028900004
J	Streicker, DG; Turmelle, AS; Vonhof, MJ; Kuzmin, IV; McCracken, GF; Rupprecht, CE				Streicker, Daniel G.; Turmelle, Amy S.; Vonhof, Maarten J.; Kuzmin, Ivan V.; McCracken, Gary F.; Rupprecht, Charles E.			Host Phylogeny Constrains Cross-Species Emergence and Establishment of Rabies Virus in Bats	SCIENCE			English	Article							UNITED-STATES; EPIDEMIOLOGY; TRANSMISSION; DYNAMICS	For RNA viruses, rapid viral evolution and the biological similarity of closely related host species have been proposed as key determinants of the occurrence and long-term outcome of cross-species transmission. Using a data set of hundreds of rabies viruses sampled from 23 North American bat species, we present a general framework to quantify per capita rates of cross-species transmission and reconstruct historical patterns of viral establishment in new host species using molecular sequence data. These estimates demonstrate diminishing frequencies of both cross-species transmission and host shifts with increasing phylogenetic distance between bat species. Evolutionary constraints on viral host range indicate that host species barriers may trump the intrinsic mutability of RNA viruses in determining the fate of emerging host-virus interactions.	[Streicker, Daniel G.; Turmelle, Amy S.; Kuzmin, Ivan V.; Rupprecht, Charles E.] Ctr Dis Control & Prevent, Rabies Team, Atlanta, GA 30333 USA; [Streicker, Daniel G.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Turmelle, Amy S.; McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Vonhof, Maarten J.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Vonhof, Maarten J.] Western Michigan Univ, Environm Studies Program, Kalamazoo, MI 49008 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; Western Michigan University; Western Michigan University	Streicker, DG (corresponding author), Ctr Dis Control & Prevent, Rabies Team, Atlanta, GA 30333 USA.	dstrike@uga.edu	Rupprecht, Charles/AAI-1544-2020	McCracken, Gary/0000-0002-2493-8103; Streicker, Daniel/0000-0001-7475-2705; Gilbert, Amy T./0000-0002-8256-0081	Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases; NSF; NSF-NIH [0430418]; U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory; Western Michigan University	Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases; NSF(National Science Foundation (NSF)); NSF-NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory; Western Michigan University	For helpful discussion and comments, we thank P. Beerli, J. Davies, S. Altizer, A. Park, P. Rohani, J. Allgeier, B. Han, P. Stephens, and three anonymous reviewers. For contributing rabid bats, we thank the Arizona State Public Health Laboratory, the California Department of Public Health, the Georgia Department of Community Health, the Florida Department of Health, the Idaho Department of Health and Welfare, the Indiana State Department of Health, the University of Iowa's University Hygienic Laboratory, the Mississippi State Department of Health, the New Jersey Department of Health and Senior Services, the Tennessee Department of Health, the Texas Department of State Health Services, the Virginia Consolidated Laboratory, and the Washington State Department of Health. For providing museum-vouchered bat tissues, we thank the Angelo State Natural History Collection, the Carnegie Museum of Natural History, the Centro de Investigaciones Biologicas del Noroeste, the Louisiana State University Museum of Natural Science, the Museum of Vertebrate Zoology, the U. S. National Museum of Natural History, the Royal Ontario Museum, and the University of Alaska Museum. The sequences generated in this study can be found at GenBank under accession numbers GU644641 to GU645012 and GU722925 to GU723257 (table S1). This work was supported by Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases and NSF Graduate Research Fellowships to D. G. S., NSF-NIH Ecology of Infectious Disease grant 0430418 to G. F. M., and funding from the U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory and Western Michigan University to M.J.V.	Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; BAER GM, 1990, LANCET, V335, P664, DOI 10.1016/0140-6736(90)90454-D; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanton JD, 2009, JAVMA-J AM VET MED A, V235, P676, DOI 10.2460/javma.235.6.676; BRASS DA, 1994, RABIES BATS NATURAL, P151; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Hughes GJ, 2005, J GEN VIROL, V86, P1467, DOI 10.1099/vir.0.80710-0; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Smith JS, 1995, SEMIN VIROL, V6, P387, DOI 10.1016/S1044-5773(05)80016-2; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102	19	304	309	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					676	679		10.1126/science.1188836	http://dx.doi.org/10.1126/science.1188836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689015				2022-12-28	WOS:000280602700037
J	Stolfi, A; Gainous, TB; Young, JJ; Mori, A; Levine, M; Christiaen, L				Stolfi, Alberto; Gainous, T. Blair; Young, John J.; Mori, Alessandro; Levine, Michael; Christiaen, Lionel			Early Chordate Origins of the Vertebrate Second Heart Field	SCIENCE			English	Article							ASCIDIAN CIONA-INTESTINALIS; MUSCLE DEVELOPMENT; MYOCARDIAL-CELLS; GENE-EXPRESSION; SPECIFICATION; MIGRATION; MESODERM; MESP	The vertebrate heart is formed from diverse embryonic territories, including the first and second heart fields. The second heart field (SHF) gives rise to the right ventricle and outflow tract, yet its evolutionary origins are unclear. We found that heart progenitor cells of the simple chordate Ciona intestinalis also generate precursors of the atrial siphon muscles (ASMs). These precursors express Islet and Tbx1/10, evocative of the splanchnic mesoderm that produces the lower jaw muscles and SHF of vertebrates. Evidence is presented that the transcription factor COE is a critical determinant of ASM fate. We propose that the last common ancestor of tunicates and vertebrates possessed multipotent cardiopharyngeal muscle precursors, and that their reallocation might have contributed to the emergence of the SHF.	[Stolfi, Alberto; Gainous, T. Blair; Young, John J.; Mori, Alessandro; Levine, Michael; Christiaen, Lionel] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Christiaen, Lionel] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	University of California System; University of California Berkeley; New York University	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA.	mlevine@berkeley.edu; lc121@nyu.edu	Stolfi, Alberto/AAS-8031-2021	Gainous, T. Blair/0000-0002-8987-3195; Levine, Michael/0000-0001-7629-0081; Christiaen, Lionel/0000-0001-5930-5667	NSF [IOB 0445470]; NIH [0745322]; New York University Faculty of Arts and Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Faculty of Arts and Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Hendrix for computational analysis, A. Cooc for technical assistance, and R. Harland, I. Philipp, and T. J. Park for advice. Supported by NSF grant IOB 0445470 (M.L.), NIH training grant 0745322 (T.B.G.), and a New York University Faculty of Arts and Science start-up package (L.C.).	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; Christiaen L, 2009, DEV BIOL, V328, P552, DOI 10.1016/j.ydbio.2009.01.033; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2007, SEMIN CELL DEV BIOL, V18, P16, DOI 10.1016/j.semcdb.2006.12.007; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; Giuliano P, 1998, MECH DEVELOP, V78, P199, DOI 10.1016/S0925-4773(98)00143-9; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Kang J, 2009, DEV BIOL, V334, P513, DOI 10.1016/j.ydbio.2009.06.041; Kokubo N, 2010, EVOL DEV, V12, P34, DOI 10.1111/j.1525-142X.2009.00389.x; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; Ogasawara M, 2002, DEV GENES EVOL, V212, P173, DOI 10.1007/s00427-002-0230-7; Okkema PG, 1997, DEVELOPMENT, V124, P3965; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Takatori N, 2004, DEV DYNAM, V230, P743, DOI 10.1002/dvdy.20082; Tzahor E, 2009, DEV BIOL, V327, P273, DOI 10.1016/j.ydbio.2008.12.035	29	123	124	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					565	568		10.1126/science.1190181	http://dx.doi.org/10.1126/science.1190181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671188	Green Accepted			2022-12-28	WOS:000280483500037
J	Reuben, DB				Reuben, David B.			Miracles, Choices, and Justice Tragedy of the Future Commons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY		Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, 10945 Le Conte Ave,Ste 2339, Los Angeles, CA 90095 USA.	dreuben@mednet.ucla.edu						[Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; *EC SATFF, DEF MOR HAZ; Gladwell M., 2005, NEW YORKER 0829; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; PEARLMAN RA, 1993, J CLIN ETHIC, V4, P33; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96	9	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					467	468		10.1001/jama.2010.1048	http://dx.doi.org/10.1001/jama.2010.1048			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664050				2022-12-28	WOS:000280350100033
J	Ozgul, A; Childs, DZ; Oli, MK; Armitage, KB; Blumstein, DT; Olson, LE; Tuljapurkar, S; Coulson, T				Ozgul, Arpat; Childs, Dylan Z.; Oli, Madan K.; Armitage, Kenneth B.; Blumstein, Daniel T.; Olson, Lucretia E.; Tuljapurkar, Shripad; Coulson, Tim			Coupled dynamics of body mass and population growth in response to environmental change	NATURE			English	Article							YELLOW-BELLIED MARMOTS; RECENT CLIMATE-CHANGE; REPRODUCTIVE STRATEGIES; QUANTITATIVE TRAIT; NATURAL-SELECTION; LIFE-HISTORY; DEMOGRAPHY; EVOLUTION; FLAVIVENTRIS; SURVIVAL	Environmental change has altered the phenology, morphological traits and population dynamics of many species(1,2). However, the links underlying these joint responses remain largely unknown owing to a paucity of long-term data and the lack of an appropriate analytical framework(3). Here we investigate the link between phenotypic and demographic responses to environmental change using a new methodology and a long-term (1976-2008) data set from a hibernating mammal (the yellow-bellied marmot) inhabiting a dynamic subalpine habitat. We demonstrate how earlier emergence from hibernation and earlier weaning of young has led to a longer growing season and larger body masses before hibernation. The resulting shift in both the phenotype and the relationship between phenotype and fitness components led to a decline in adult mortality, which in turn triggered an abrupt increase in population size in recent years. Direct and trait-mediated effects of environmental change made comparable contributions to the observed marked increase in population growth. Our results help explain how a shift in phenology can cause simultaneous phenotypic and demographic changes, and highlight the need for a theory integrating ecological and evolutionary dynamics in stochastic environments(4,5).	[Ozgul, Arpat; Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Childs, Dylan Z.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Armitage, Kenneth B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Blumstein, Daniel T.; Olson, Lucretia E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Imperial College London; University of Sheffield; State University System of Florida; University of Florida; University of Kansas; University of California System; University of California Los Angeles; Stanford University	Ozgul, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England.	a.ozgul@imperial.ac.uk	Coulson, Tim/AAL-8148-2021; Ozgul, Arpat/K-2032-2012; Blumstein, Daniel T./B-6199-2012; Childs, Dylan/P-7388-2018	Coulson, Tim/0000-0001-9371-9003; Ozgul, Arpat/0000-0001-7477-2642; Blumstein, Daniel T./0000-0001-5793-9244; Tuljapurkar, Shripad/0000-0001-5549-4245; Olson, Lucretia/0000-0002-5703-3351; Childs, Dylan/0000-0002-0675-4933	NERC; Wellcome Trust; NSF; NIH; NIA; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; Natural Environment Research Council [NE/G004390/1, NE/E015921/1, NE/E013015/1] Funding Source: researchfish; NERC [NE/E013015/1, NE/E015921/1, NE/G004390/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the 'marmoteers' who participated in collecting the long-term data, Rocky Mountain Biological Laboratory for providing the field facilities, B. Barr and D. Inouye for providing additional information on climate and plant phenology, and L. M. Chevin, J. A. Hostetler, D. Inouye, N. J. Singh and I. M. Smallegange for comments. This work was funded by NERC, the Wellcome Trust, NSF, NIH and NIA.	ANDERSON DC, 1976, ECOLOGY, V57, P552, DOI 10.2307/1936439; [Anonymous], 2008, R LANG ENV STAT COMP; Armitage K. B., 1996, BIODIVERSITY MARMOTS, P223; ARMITAGE KB, 1990, J COMP PHYSIOL B, V160, P491; ARMITAGE KB, 1976, AM MIDL NAT, V96, P36, DOI 10.2307/2424566; ARMITAGE KB, 1981, OECOLOGIA, V48, P36, DOI 10.1007/BF00346986; Armitage KB, 1998, J MAMMAL, V79, P385, DOI 10.2307/1382969; ARMITAGE KB, 1991, ANNU REV ECOL SYST, V22, P379, DOI 10.1146/annurev.es.22.110191.002115; ARMITAGE KB, 1974, ECOLOGY, V55, P1233, DOI 10.2307/1935452; ARMITAGE KB, 2003, WILD MAMMALS N AM BI, P188; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Caswell, 2000, MATRIX POPULATION MO; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Childs DZ, 2003, P ROY SOC B-BIOL SCI, V270, P1829, DOI 10.1098/rspb.2003.2399; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2008, AM NAT, V172, P599, DOI 10.1086/591693; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Fisher, 1958, GENETICAL THEORY NAT; FRASE BA, 1989, ETHOL ECOL EVOL, V1, P353, DOI 10.1080/08927014.1989.9525505; FRASE BA, 1980, MAMMALIAN SPECIES, V135, P1; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Humphries MM, 2004, INTEGR COMP BIOL, V44, P152, DOI 10.1093/icb/44.2.152; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Intergovernmental Panel on Climate Change, 2007, PHYS SCI BAS CONTR W; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; KILGORE DL, 1978, ECOLOGY, V59, P78, DOI 10.2307/1936633; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Laake J., 2022, MARK, P109; LANDE R, 1976, EVOLUTION, V30, P314, DOI [10.1111/j.1558-5646.1976.tb00911.x, 10.2307/2407703]; MELCHER JC, 1989, PHYSIOL ZOOL, V62, P429, DOI 10.1086/physzool.62.2.30156178; Ozgul A, 2009, AM NAT, V173, P517, DOI 10.1086/597225; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Schwartz OA, 1998, J ZOOL, V246, P337, DOI 10.1111/j.1469-7998.1998.tb00163.x; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Tuljapurkar S., 1997, STRUCTURED POPULATIO; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Woods BC, 2003, J MAMMAL, V84, P903, DOI 10.1644/BRG-106	54	445	449	5	392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2010	466	7305					482	U5		10.1038/nature09210	http://dx.doi.org/10.1038/nature09210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651690	Green Accepted, Green Submitted			2022-12-28	WOS:000280141200034
J	Cooper, CJ; Metch, B; Dragavon, J; Coombs, RW; Baden, LR				Cooper, Cristine J.; Metch, Barbara; Dragavon, Joan; Coombs, Robert W.; Baden, Lindsey R.		NIAID HVTN VISP Task Force	Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECOMBINANT GLYCOPROTEIN-120 VACCINE; PHASE-I TRIAL; CANDIDATE VACCINE; EFFICACY TRIAL; DOUBLE-BLIND; SAFETY; IMMUNOGENICITY; INFECTION; HEALTHY	Context Induction of protective anti-human immunodeficiency virus (HIV) immune responses is the goal of an HIV vaccine. However, this may cause a reactive result in routine HIV testing in the absence of HIV infection. Objective To evaluate the frequency of vaccine-induced seropositivity/reactivity (VISP) in HIV vaccine trial participants. Design, Setting, and Participants Three common US Food and Drug Administration-approved enzyme immunoassay (EIA) HIV antibody kits were used to determine VISP, and a routine diagnostic HIV algorithm was used to evaluate VISP frequency in healthy, HIV-seronegative adults who completed phase 1 (n=25) and phase 2a (n=2) vaccine trials conducted from 2000-2010 in the United States, South America, Thailand, and Africa. Main Outcome Measure Vaccine-induced seropositivity/reactivity, defined as reactive on 1 or more EIA tests and either Western blot-negative or Western blot-indeterminate/atypical positive (profile consistent with vaccine product) and HIV-1-negative by nucleic acid testing. Results Among 2176 participants free of HIV infection who received a vaccine product, 908 (41.7%; 95% confidence interval [CI], 39.6%-43.8%) had VISP, but the occurrence of VISP varied substantially across different HIV vaccine product types: 399 of 460 (86.7%; 95% CI, 83.3%-89.7%) adenovirus 5 product recipients, 295 of 552 (53.4%; 95% CI, 49.2%-57.7%) recipients of poxvirus alone or as a boost, and 35 of 555 (6.3%; 95% CI, 4.4%-8.7%) of DNA-alone product recipients developed VISP. Overall, the highest proportion of VISP (891/2176 tested [40.9%]) occurred with the HIV 1/2 (rDNA) EIA kit compared with the rLAV EIA (150/700 tested [21.4%]), HIV-1 Plus O Microelisa System (193/1309 tested [14.7%]), and HIV 1/2 Peptide and HIV 1/2 Plus O (189/2150 tested [8.8%]) kits. Only 17 of the 908 participants (1.9%) with VISP tested nonreactive using the HIV 1/2 (rDNA) kit. All recipients of a glycoprotein 140 vaccine (n=70) had VISP, with 94.3% testing reactive with all 3 EIA kits tested. Among 901 participants with VISP and a Western blot result, 92 (10.2%) had a positive Western blot result (displaying an atypical pattern consistent with vaccine product), and 592 (65.7%) had an indeterminate result. Only 8 participants with VISP received a vaccine not containing an envelope insert. Conclusions The induction of VISP in HIV vaccine recipients is common, especially with vaccines containing both the HIV-1 envelope and group-specific core antigen gene proteins. Development and detection of VISP appear to be associated with the immunogenicity of the vaccine and the EIA assay used. JAMA. 2010;304(3):275-283 www.jama.com	[Baden, Lindsey R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Cooper, Cristine J.; Metch, Barbara] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Dragavon, Joan; Coombs, Robert W.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Baden, LR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, PBB-A4,75 Francis St, Boston, MA 02115 USA.	lbaden@partners.org		Allen, Mary/0000-0001-8163-0714	NIAID [U01 AI046747, AI068614, AI46725, AI068618, AI046703, AI068635, AI069412]; University of Washington Center for AIDS Research [AI27757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U01AI068614, UM1AI068618, U01AI046703, UM1AI068635, UM1AI068614, U01AI068635, UM1AI069412, U01AI069412, U01AI046747, U01AI046725, U01AI068618] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIAID grants U01 AI046747, AI068614, AI46725, AI068618, AI046703, AI068635, and AI069412 and by the University of Washington Center for AIDS Research grant AI27757.	Ackers ML, 2003, J INFECT DIS, V187, P879, DOI 10.1086/368169; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Cleghorn F, 2007, JAIDS-J ACQ IMM DEF, V46, P222, DOI 10.1097/QAI.0b013e318149297d; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Goepfert PA, 2005, J INFECT DIS, V192, P1249, DOI 10.1086/432915; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Gorse GJ, 2008, VACCINE, V26, P215, DOI 10.1016/j.vaccine.2007.10.061; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gust DA, 2009, JAIDS-J ACQ IMM DEF, V52, P294, DOI 10.1097/QAI.0b013e3181ab6e93; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Khurana S, 2006, JAIDS-J ACQ IMM DEF, V43, P304, DOI 10.1097/01.qai.0000242465.50947.5f; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mulligan MJ, 2006, AIDS RES HUM RETROV, V22, P678, DOI 10.1089/aid.2006.22.678; Pialoux G, 2008, VACCINE, V26, P2657, DOI 10.1016/j.vaccine.2007.11.002; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Quirk EK, 2008, CLIN INFECT DIS, V47, P1593, DOI 10.1086/593313; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; SCHWARTZ DH, 1995, CLIN DIAGN LAB IMMUN, V2, P268, DOI 10.1128/CDLI.2.3.268-271.1995; Silbermann B, 2008, AIDS RES HUM RETROV, V24, P1445, DOI 10.1089/aid.2008.0107; SIMONSEN L, 1995, AM J EPIDEMIOL, V141, P1089, DOI 10.1093/oxfordjournals.aje.a117374; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; *WHO, 2008, GLOB SUMM AIDS EP	30	32	33	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					275	283		10.1001/jama.2010.926	http://dx.doi.org/10.1001/jama.2010.926			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639561	Green Accepted, Bronze			2022-12-28	WOS:000280107500017
J	Ahmad, H; Heur, M				Ahmad, Habeeb; Heur, Martin			Schnyder's Crystalline Corneal Dystrophy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ahmad, Habeeb; Heur, Martin] Doheny Eye Inst, Los Angeles, CA 90033 USA	Doheny Eye Institute	Ahmad, H (corresponding author), Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA.	jmheur@doheny.org							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					275	275		10.1056/NEJMicm0911357	http://dx.doi.org/10.1056/NEJMicm0911357			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647202				2022-12-28	WOS:000279864200010
J	Stone, JH; Merkel, PA; Spiera, R; Seo, P; Langford, CA; Hoffman, GS; Kallenberg, CGM; Clair, EWS; Turkiewicz, A; Tchao, NK; Webber, L; Ding, L; Sejismundo, LP; Mieras, K; Weitzenkamp, D; Ikle, D; Seyfert-Margolis, V; Mueller, M; Brunetta, P; Allen, NB; Fervenza, FC; Geetha, D; Keogh, KA; Kissin, EY; Monach, PA; Peikert, T; Stegeman, C; Ytterberg, SR; Specks, U				Stone, John H.; Merkel, Peter A.; Spiera, Robert; Seo, Philip; Langford, Carol A.; Hoffman, Gary S.; Kallenberg, Cees G. M.; Clair, E. William St.; Turkiewicz, Anthony; Tchao, Nadia K.; Webber, Lisa; Ding, Linna; Sejismundo, Lourdes P.; Mieras, Kathleen; Weitzenkamp, David; Ikle, David; Seyfert-Margolis, Vicki; Mueller, Mark; Brunetta, Paul; Allen, Nancy B.; Fervenza, Fernando C.; Geetha, Duvuru; Keogh, Karina A.; Kissin, Eugene Y.; Monach, Paul A.; Peikert, Tobias; Stegeman, Coen; Ytterberg, Steven R.; Specks, Ulrich		RAVE-ITN Res Grp	Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; ACTIVATION; INDUCTION; REMISSION; THERAPY; METHOTREXATE; MAINTENANCE; DAMAGE; INDEX	Background: Cyclophosphamide and glucocorticoids have been the cornerstone of remission-induction therapy for severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis for 40 years. Uncontrolled studies suggest that rituximab is effective and may be safer than a cyclophosphamide-based regimen. Methods: We conducted a multicenter, randomized, double-blind, double-dummy, noninferiority trial of rituximab (375 mg per square meter of body-surface area per week for 4 weeks) as compared with cyclophosphamide (2 mg per kilogram of body weight per day) for remission induction. Glucocorticoids were tapered off; the primary end point was remission of disease without the use of prednisone at 6 months. Results: Nine centers enrolled 197 ANCA-positive patients with either Wegener's granulomatosis or microscopic polyangiitis. Baseline disease activity, organ involvement, and the proportion of patients with relapsing disease were similar in the two treatment groups. Sixty-three patients in the rituximab group (64%) reached the primary end point, as compared with 52 patients in the control group (53%), a result that met the criterion for noninferiority (P<0.001). The rituximab-based regimen was more efficacious than the cyclophosphamide-based regimen for inducing remission of relapsing disease; 34 of 51 patients in the rituximab group (67%) as compared with 21 of 50 patients in the control group (42%) reached the primary end point (P=0.01). Rituximab was also as effective as cyclophosphamide in the treatment of patients with major renal disease or alveolar hemorrhage. There were no significant differences between the treatment groups with respect to rates of adverse events. Conclusions: Rituximab therapy was not inferior to daily cyclophosphamide treatment for induction of remission in severe ANCA-associated vasculitis and may be superior in relapsing disease. (Funded by the National Institutes of Allergy and Infectious Diseases, Genentech, and Biogen; ClinicalTrials.gov number, NCT00104299.) N Engl J Med 2010;363:221-32.	[Specks, Ulrich] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Stone, John H.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Merkel, Peter A.; Kissin, Eugene Y.; Monach, Paul A.] Boston Univ, Med Ctr, Boston, MA USA; [Spiera, Robert] Hosp Special Surg, New York, NY 10021 USA; [Seo, Philip; Sejismundo, Lourdes P.; Geetha, Duvuru] Johns Hopkins Univ, Baltimore, MD USA; [Langford, Carol A.; Hoffman, Gary S.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Kallenberg, Cees G. M.; Stegeman, Coen] Univ Groningen, Groningen, Netherlands; [Clair, E. William St.; Allen, Nancy B.] Duke Univ, Durham, NC USA; [Turkiewicz, Anthony] Univ Alabama Birmingham, Birmingham, AL USA; [Tchao, Nadia K.; Seyfert-Margolis, Vicki; Mueller, Mark] Immune Tolerance Network, Bethesda, MD USA; [Webber, Lisa; Ding, Linna] NIAID, Bethesda, MD 20892 USA; [Seyfert-Margolis, Vicki] US FDA, Rockville, MD 20857 USA; [Brunetta, Paul] Genentech Inc, San Francisco, CA 94080 USA; [Weitzenkamp, David; Ikle, David] Rho, Raleigh, NC USA	Mayo Clinic; Harvard University; Massachusetts General Hospital; Boston University; Johns Hopkins University; Cleveland Clinic Foundation; University of Groningen; Duke University; University of Alabama System; University of Alabama Birmingham; Immune Tolerance Network; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); Roche Holding; Genentech; Rho	Specks, U (corresponding author), Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	specks.ulrich@mayo.edu	Farina, Giuseppina/B-1800-2019; Spiera, Robert/W-7479-2019; Fervenza, Fernando/AAK-2400-2020; Ikle, David/AAK-7541-2020	Farina, Giuseppina/0000-0002-3948-6920; Ikle, David/0000-0003-0091-5246; Kissin, Eugene/0000-0002-7748-3384; Stegeman, Coen/0000-0002-0224-0927; Seo, Philip/0000-0003-3435-6737; Monach, Paul/0000-0003-4937-0515; Carey, John/0000-0001-7292-2328	National Institute of Allergy and Infectious Diseases [N01-AI-15416, ITN021AI]; Mayo Clinic and Foundation; National Center for Research Resources (NCRR) [RR024150-01, RR025005, K24 AR049185, K23 AR052820]; Boston University; National Institutes of Health [RR 025771, M01 RR00533, K24 AR02224]; Arthritis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150, M01RR001066, UL1RR025005, M01RR000533, UL1RR025771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR052820, U01AR051874, K24AR002224, K24AR049185] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mayo Clinic and Foundation; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Boston University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by a grant from the National Institute of Allergy and Infectious Diseases to the Immune Tolerance Network (N01-AI-15416; protocol no. ITN021AI). Genentech and Biogen provided the study medications and partial funding. At the Mayo Clinic and Foundation, the trial was supported by a Clinical and Translational Science Award from the National Center for Research Resources (NCRR) (RR024150-01); at Johns Hopkins University, by grants from the NCRR (RR025005) and career development awards (K24 AR049185, to Dr. Stone, and K23 AR052820, to Dr. Seo); and at Boston University, by a Clinical and Translational Science Award (RR 025771), grants from the National Institutes of Health (M01 RR00533) and a career development award (K24 AR02224, to Dr. Merkel), and an Arthritis Foundation Investigator Award (to Dr. Monach). Enzyme-linked immunosorbent assay kits for antineutrophil cytoplasmic antibody were provided by Euroimmun (Lubeck, Germany).	CUPPS TR, 1982, J IMMUNOL, V128, P2453; Damoiseaux JGMC, 2005, J CLIN IMMUNOL, V25, P202, DOI 10.1007/s10875-005-3863-2; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Exley AR, 1997, ARTHRITIS RHEUM, V40, P371, DOI 10.1002/art.1780400222; FAUCI AS, 1973, MEDICINE, V52, P535, DOI 10.1097/00005792-197311000-00002; FAUCI AS, 1983, ANN INTERN MED, V98, P1027; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; Goek ON, 2005, CURR OPIN RHEUMATOL, V17, P257, DOI 10.1097/01.bor.0000160777.28259.c2; Guillevin L, 1999, ARTHRITIS RHEUM-US, V42, P421, DOI 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Johnson P, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50025; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Martin F, 2004, IMMUNITY, V20, P517, DOI 10.1016/S1074-7613(04)00112-8; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; NOVACK SN, 1971, NEW ENGL J MED, V284, P938, DOI 10.1056/NEJM197104292841703; Pagnoux C, 2008, ARTHRITIS RHEUM-US, V58, P2908, DOI 10.1002/art.23800; Pagnoux C, 2008, NEW ENGL J MED, V359, P2790, DOI 10.1056/NEJMoa0802311; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Reinhold-Keller E, 2000, ARTHRITIS RHEUM, V43, P1021, DOI 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J; Seo P, 2005, ARTHRITIS RHEUM-US, V52, P2168, DOI 10.1002/art.21117; Specks U, 2001, ARTHRITIS RHEUM, V44, P2836, DOI 10.1002/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W; STEVENSON HC, 1980, IMMUNOLOGY, V39, P391; Stone JH, 2005, NEW ENGL J MED, V352, P351; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Stone JH, 2006, ARTHRITIS RHEUM-US, V54, P1608, DOI 10.1002/art.21869; WALTON EW, 1958, BRIT MED J, V2, P265, DOI 10.1136/bmj.2.5091.265; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; ZHU LP, 1987, J CLIN INVEST, V79, P1082, DOI 10.1172/JCI112922	35	1643	1734	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					221	232		10.1056/NEJMoa0909905	http://dx.doi.org/10.1056/NEJMoa0909905			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647199	Green Accepted, Bronze			2022-12-28	WOS:000279864200005
J	Ahmed, M; Al-Nozha, O				Ahmed, Mohammed; Al-Nozha, Omar			Large Prolactinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ahmed, Mohammed; Al-Nozha, Omar] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center	Ahmed, M (corresponding author), King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia.		Ahmed, Mohammed/T-5898-2019	Al Nozha, Omar/0000-0002-9238-4683					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					177	177		10.1056/NEJMicm0906033	http://dx.doi.org/10.1056/NEJMicm0906033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20647213				2022-12-28	WOS:000279574100010
J	Matson, PA; Parton, WJ; Power, AG; Swift, MJ				Matson, PA; Parton, WJ; Power, AG; Swift, MJ			Agricultural intensification and ecosystem properties	SCIENCE			English	Article							SOIL ORGANIC-MATTER; VEGETATIONAL DIVERSITY; NITROGEN; CULTIVATION; MANAGEMENT; DYNAMICS; INSECTS; GROWTH	Expansion and intensification of cultivation are among the predominant global changes of this century. Intensification of agriculture by use of high-yielding crop varieties, fertilization, irrigation, and pesticides has contributed substantially to the tremendous increases in food production over the past 50 years. Land conversion and intensification, however, also alter the biotic interactions and patterns of resource availability in ecosystems and can have serious local, regional, and global environmental consequences. The use of ecologically based management strategies can increase the sustainability of agricultural production while reducing off-site consequences.	COLORADO STATE UNIV, NAT RESOURCE ECOL LAB, FT COLLINS, CO 80523 USA; CORNELL UNIV, ECOL & SYSTEMAT SECT, ITHACA, NY 14853 USA; UNESCO, ROSTA, TROP SOIL BIOL & FERTIL PROGRAMME, NAIROBI, KENYA	Colorado State University; Cornell University	Matson, PA (corresponding author), UNIV CALIF BERKELEY, DEPT ENVIRONM SCI POLICY & MANAGEMENT, ECOSYST SCI DIV, BERKELEY, CA 94720 USA.							ALTIERI MA, 1986, AGR ECOSYST ENVIRON, V16, P29, DOI 10.1016/0167-8809(86)90073-3; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Beare MH, 1997, APPL SOIL ECOL, V6, P87, DOI 10.1016/S0929-1393(96)00150-3; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; BECKER B, 1997, ISSUES AGR, V10, P63; BOATMAN N, 1994, FIELD MARGINS INTEGR; BOUDREAU MA, 1993, PLANT PATHOL, V42, P16, DOI 10.1111/j.1365-3059.1993.tb01467.x; BOUDREAU MA, 1992, PHYTOPATHOLOGY, V82, P1051, DOI 10.1094/Phyto-82-1051; BOUDREAU MA, 1994, ECOL APPL, V4, P729, DOI 10.2307/1942003; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Cassman K. G., 1995, Agricultural sustainability: economic, environmental and statistical considerations., P231; CASSMAN KG, 1995, ADV SOIL SCI, P181; CHAMEIDES WL, 1994, SCIENCE, V264, P74, DOI 10.1126/science.264.5155.74; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; CRITCHLEY BR, 1979, PEDOBIOLOGIA, V19, P425; CRITCHLEY BR, 1989, RES METHODS CEREAL L, P200; CROSSON P, 1995, SCIENCE, V269, P461, DOI 10.1126/science.269.5223.461; DELMAS R, NUTR CYCLING AGROECO; Donigian Jr. A.S., 1994, EPA600R94067; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; GREENBERG R, 1994, AUK, V111, P672; Greenberg Russell, 1996, P59; GRIGG D, 1993, WORLD FOOD PROBLEM 1; Hall SJ, 1996, ANNU REV ENERG ENV, V21, P311, DOI 10.1146/annurev.energy.21.1.311; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Huber D., 1981, CRC HDB PEST MANAGEM, P357; HUBER DM, 1974, ANNU REV PHYTOPATHOL, V12, P139, DOI 10.1146/annurev.py.12.090174.001035; IZAC AMN, 1994, ECOL ECON, V11, P105, DOI 10.1016/0921-8009(94)90022-1; JENKINSON DS, 1990, PHILOS T R SOC B, V329, P361, DOI DOI 10.1098/rstb.1990.0177; LAVELLE P, 1989, PEDOBIOLOGIA, V33, P283; LAVELLE P, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P291; LAVELLE P, COMMUNICATION; Lynam J. K., 1989, Agricultural Economics, V3, P381, DOI 10.1016/0169-5150(89)90010-8; Matson PA, 1996, J GEOPHYS RES-ATMOS, V101, P18533, DOI 10.1029/96JD01536; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Metherell AK, 1995, SOIL MANAGEMENT GREE, V6, P259; MEYER WB, 1992, ANNU REV ECOL SYST, V23, P39, DOI 10.1146/annurev.es.23.110192.000351; Nambiar K.K., 1994, SOIL FERTILITY CROP, P234; *NAT RES COUNC, 1993, MAN WAST COAST URB A; Naylor R, 1997, POPUL DEV REV, V23, P41, DOI 10.2307/2137460; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Naylor RL, 1996, ANNU REV ENERG ENV, V21, P99, DOI 10.1146/annurev.energy.21.1.99; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; PANKHURST CE, 1994, SOIL BIOTA MANAGEMEN; PARTON WJ, 1994, SOIL SCI SOC AM J, V58, P530, DOI 10.2136/sssaj1994.03615995005800020040x; Paul E.A., 1997, SOIL ORGANIC MATTER; PAUSTIAN K, 1992, SOIL SCI SOC AM J, V56, P476, DOI 10.2136/sssaj1992.03615995005600020023x; Paustian K, 1995, SOIL MANAGEMENT GREE, P69; PIMENTEL D, 1982, BIOSCIENCE, V32, P595, DOI 10.2307/1308603; Pimentel D, 1993, WORLD SOIL EROSION C; Postel S., 1997, Nature's services: societal dependence on natural ecosystems., P195; Postel Sandra, 1996, V1996, P40; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Power A.G., 1990, AGROECOL RES ECOL BA, V78, P47; POWER AG, 1991, ECOLOGY, V72, P232, DOI 10.2307/1938917; Power AG, 1996, ECOL STU AN, V122, P173; Power Alison G., 1996, P91; REISSIG WH, 1986, ILLUSTRATED GUIDE IN; RISCH SJ, 1986, ECOLOGY, V67, P505, DOI 10.2307/1938593; ROBBINS CS, 1992, COMP NEOTROPICAL MIG; Robertson G. Philip, 1993, V55, P95; ROBERTSON GP, AGR ECOLOGY; RUSSELL EP, 1989, ENVIRON ENTOMOL, V18, P590, DOI 10.1093/ee/18.4.590; Scriber J.M., 1984, NITROGEN CROP PRODUC; SWIFT MJ, 1997, APPL SOIL ECOL, V6; SWIFT MJ, 1996, 13 GCTE; SWIFT MJ, 1993, BIODIVERSITY ECOSYST, P29; SWIFT MJ, 1997, ADV AGROECOLOGY; Tian G., 1997, P125; TONHASCA A, 1994, ECOL ENTOMOL, V19, P239, DOI 10.1111/j.1365-2311.1994.tb00415.x; *TROP SOIL BIOL FE, 1997, TSBF REP 1997; *UN FAO, 1993, AGR TOW 2010; VITOUSEK PM, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P193; VITOUSEK PM, IN PRESS ECOL APPL; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124; Woomer P.L., 1994, BIOL MANAG TROP SOIL; WUNDERLE JM, 1993, CONDOR, V95, P904, DOI 10.2307/1369428	78	1866	2035	42	1229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	1997	277	5325					504	509		10.1126/science.277.5325.504	http://dx.doi.org/10.1126/science.277.5325.504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM867	20662149	Green Submitted			2022-12-28	WOS:A1997XM86700032
J	Burkle, FM; Hsu, EB				Burkle, Frederick M., Jr.; Hsu, Edbert B.			Ram Janki Temple: understanding human stampedes	LANCET			English	Editorial Material									[Burkle, Frederick M., Jr.] Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Hsu, Edbert B.] Johns Hopkins Univ, Inst Med, Dept Emergency Med, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University	Burkle, FM (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	fburkle@hsph.harvard.edu	Burkle, Frederick/AAE-5423-2020					Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Burkle FM, 2010, PREHOSPITAL DISASTER, V25, P34, DOI [10.1017/S1049023X00007639, 10.1017/S1049023X00007998]; EM-DAT, 2010, INT DIS DAT; Evans A, 2009, MANAGING SCARCITY I; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Hsieh YH, 2009, DISASTER MED PUBLIC, V3, P217, DOI 10.1097/DMP.0b013e3181c5b4ba; Ngai KM, 2009, DISASTER MED PUBLIC, V3, P191, DOI 10.1097/DMP.0b013e3181c5b494; Singh HS, 2010, CNN             0305	8	38	38	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					106	107		10.1016/S0140-6736(10)60442-4	http://dx.doi.org/10.1016/S0140-6736(10)60442-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707NH	20655584				2022-12-28	WOS:000286292800008
J	Mackenbach, JP				Mackenbach, Johan P.			New trends in health inequalities research: now it's personal	LANCET			English	Editorial Material							SOCIOECONOMIC POSITION; COHORT; MORTALITY; IQ; ADULTHOOD; GENETICS; ABILITY; TRAITS		Erasmus MC, Dept Publ Hlth, NL-30000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Mackenbach, JP (corresponding author), Erasmus MC, Dept Publ Hlth, NL-30000 CA Rotterdam, Netherlands.	j.mackenbach@erasmusmc.nl						Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Batty GD, 2006, BMJ-BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Holtzman NA, 2002, J EPIDEMIOL COMMUN H, V56, P529, DOI 10.1136/jech.56.7.529; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; MacIntyre S, 1997, SOC SCI MED, V44, P723, DOI 10.1016/S0277-9536(96)00183-9; Mackenbach JP, 2005, J EPIDEMIOL COMMUN H, V59, P268, DOI 10.1136/jech.2004.026807; Nabi H, 2008, INT J EPIDEMIOL, V37, P591, DOI 10.1093/ije/dyn021; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109	12	26	27	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 11	2010	376	9744					854	855		10.1016/S0140-6736(10)60313-3	http://dx.doi.org/10.1016/S0140-6736(10)60313-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20663547				2022-12-28	WOS:000282069100008
J	Moreno, JGB; Licea, JAI; Ajenjo, CR				Bustamante Moreno, Jose Guadalupe; Izazola Licea, Jose Antonio; Ajenjo, Carlos Rodriguez			Tackling HIV and drug addiction in Mexico	LANCET			English	Editorial Material							TIJUANA		[Bustamante Moreno, Jose Guadalupe] Ctr Civ, Mexicali 21000, Baja California, Mexico; [Izazola Licea, Jose Antonio] Ctr Nacl Prevenc & Control VIH SIDA, Mexico City, DF, Mexico; [Ajenjo, Carlos Rodriguez] Consejo Nacl Contras Adicc, Mexico City, DF, Mexico		Moreno, JGB (corresponding author), Ctr Civ, Mexicali 21000, Baja California, Mexico.	jbustamante@baja.gob.mx			NIDA NIH HHS [R21 DA024381-01, R21 DA024381, R01 DA019829-01A1, R01 DA019829] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024381, R01DA019829] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; *CENSIDA, 2009, ACT REDD US DROG INF; Iniguez-Stevens E, 2009, GAC MED MEX, V145, P189; MORENO JGB, 2008, INT C AIDS MEX CIT M; *NAT I PSYCH RAM F, 2009, 2008 NAT HOUS SURV A; Patterson TL, 2009, AIDS, V23, P1763, DOI 10.1097/QAD.0b013e32832f08a1; Philbin MM, 2009, INT J DRUG POLICY, V20, P329, DOI 10.1016/j.drugpo.2008.09.002; *SECR SAL, 2009, CAS SIDA MEX; Strathdee SA, 2008, JAMA-J AM MED ASSOC, V300, P571, DOI 10.1001/jama.300.5.571; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690	10	28	28	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					493	495		10.1016/S0140-6736(10)60883-5	http://dx.doi.org/10.1016/S0140-6736(10)60883-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20650521	Green Accepted			2022-12-28	WOS:000281266800007
J	Hobbs, RM; Seandel, M; Falciatori, I; Rafii, S; Pandolfi, PP				Hobbs, Robin M.; Seandel, Marco; Falciatori, Ilaria; Rafii, Shahin; Pandolfi, Pier Paolo			Plzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1	CELL			English	Article							SPERMATOGONIAL STEM-CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; UNDIFFERENTIATED SPERMATOGONIA; RETINOIC ACID; MOUSE TESTIS; ZINC-FINGER; BONE-MARROW; MAMMALIAN TARGET; INITIATING CELLS; LIFE-SPAN	Hyperactivity of mTORC1, a key mediator of cell growth, leads to stem cell depletion, although the underlying mechanisms are poorly defined. Using spermatogonial progenitor cells (SPCs) as a model system, we show that mTORC1 impairs stem cell maintenance by a negative feedback from mTORC1 to receptors required to transduce niche-derived signals. We find that SPCs lacking Plzf, a transcription factor essential for SPC maintenance, have enhanced mTORC1 activity. Aberrant mTORC1 activation in Plzf(-/-) SPCs inhibits their response to GDNF, a growth factor critical for SPC self-renewal, via negative feedback at the level of the GDNF receptor. Plzf opposes mTORC1 activity by inducing expression of the mTORC1 inhibitor Redd1. Thus, we identify the mTORC1-Plzf functional interaction as a critical rheostat for maintenance of the spermatogonial pool and propose a model whereby negative feedback from mTORC1 to the GDNF receptor balances SPC growth with self-renewal.	[Hobbs, Robin M.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02115 USA; [Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Falciatori, Ilaria; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, Howard Hughes Med Inst, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; Cornell University; Howard Hughes Medical Institute	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Hobbs, Robin/I-2577-2014	Hobbs, Robin/0000-0002-3853-2614	NIH; NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank current and past members of the Pandolfi lab and in particular Takahiro Maeda and Rosa Bernardi for helpful discussion and advice. We would also like to thank Antonella Papa for generating luciferase reporters, Sharmila Fagoonee for experimental help, Leif Ellisen for Redd1 promoter constructs, and the flow cytometry facilities of BIDMC and MSKCC for expert support. M.S. is a Stanley and Fiona Druckenmiller Fellow of the New York Stem Cell Foundation. This work was supported by NIH grants to P.P.P.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; De Rooij DG, 2000, J ANDROL, V21, P776; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fischer S, 2008, J MED GENET, V45, P731, DOI 10.1136/jmg.2008.059451; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Hennige AM, 2000, MOL CELL ENDOCRINOL, V167, P69, DOI 10.1016/S0303-7207(00)00283-5; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Hamra FK, 2007, J BIOL CHEM, V282, P721, DOI 10.1074/jbc.M608398200; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martelli AM, 2007, CURR MED CHEM, V14, P2009; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nishioka C, 2009, INT J CANCER, V125, P1710, DOI 10.1002/ijc.24472; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; VIRTANEN I, 1986, ANAT RECORD, V215, P10, DOI 10.1002/ar.1092150103; Wu X, 2010, BIOL REPROD, V82, P1103, DOI 10.1095/biolreprod.109.083097; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang XF, 2006, BIOL REPROD, V74, P119, DOI 10.1095/biolreprod.105.045591	76	184	197	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					468	479		10.1016/j.cell.2010.06.041	http://dx.doi.org/10.1016/j.cell.2010.06.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691905	Green Accepted, Bronze			2022-12-28	WOS:000280609100023
J	Pletcher, MJ; Bibbins-Domingo, K; Liu, KA; Sidney, S; Lin, F; Vittinghoff, E; Hulley, SB				Pletcher, Mark J.; Bibbins-Domingo, Kirsten; Liu, Kiang; Sidney, Steve; Lin, Feng; Vittinghoff, Eric; Hulley, Stephen B.			Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: The CARDIA (Coronary Artery Risk Development in Young Adults) Study	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; HEART-DISEASE; BLOOD-PRESSURE; COMPUTED-TOMOGRAPHY; SERUM-CHOLESTEROL; FOLLOW-UP; ATHEROSCLEROSIS; CHILDHOOD	Background: Dyslipidemia causes coronary heart disease in middle-aged and elderly adults, but the consequences of lipid exposure during young adulthood are unclear. Objective: To assess whether nonoptimal lipid levels during young adulthood cause atherosclerotic changes that persist into middle age. Design: Prospective cohort study. Setting: 4 cities in the United States. Participants: 3258 participants from the 5115 black and white men and women recruited at age 18 to 30 years in 1985 to 1986 for the CARDIA (Coronary Artery Risk Development in Young Adults) study. Measurements: Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides, and coronary calcium. Time-averaged cumulative exposures to lipids between age 20 and 35 years were estimated by using repeated serum lipid measurements over 20 years in the CARDIA study; these measurements were then related to coronary calcium scores assessed later in life (45 years [SD, 4]). Results: 2824 participants (87%) had nonoptimal levels of LDL cholesterol (>= 2.59 mmol/L [>= 100 mg/dL]), HDL cholesterol (<1.55 mmol/L [<60 mg/dL]), or triglycerides (>= 1.70 mmol/L [>= 150 mg/dL]) during young adulthood. Coronary calcium prevalence 2 decades later was 8% in participants who maintained optimal LDL levels (<1.81 mmol/L [<70 mg/dL]), and 44% in participants with LDL cholesterol levels of 4.14 mmol/L (160 mg/dL) or greater (P < 0.001). The association was similar across race and sex and strongly graded, with odds ratios for coronary calcium of 1.5 (95% CI, 0.7 to 3.3) for LDL cholesterol levels of 1.81 to 2.56 mmol/L (70 to 99 mg/dL), 2.4 (CI, 1.1 to 5.3) for levels of 2.59 to 3.34 mmol/L (100 to 129 mg/dL), 3.3 (CI, 1.3 to 7.8) for levels of 3.37 to 4.12 mmol/L (130 to 159 mg/dL), and 5.6 (CI, 2.0 to 16) for levels of 4.14 mmol/L (160 mg/dL) or greater, compared with levels less than 1.81 mmol/L (<70 mg/dL), after adjustment for lipid exposure after age 35 years and other coronary risk factors. Both LDL and HDL cholesterol levels were independently associated with coronary calcium after participants who were receiving lipid-lowering medications or had clinically abnormal lipid levels were excluded. Limitation: Coronary calcium, although a strong predictor of future coronary heart disease, is not a clinical outcome. Conclusion: Nonoptimal levels of LDL and HDL cholesterol during young adulthood are independently associated with coronary atherosclerosis 2 decades later.	[Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Kaiser Permanente; Northwestern University; Feinberg School of Medicine	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu			National Heart, Lung, and Blood Institute [N01-HC-45204]; University of Alabama at Birmingham Coordinating Center [N01-HC-95095]; University of Alabama at Birmingham Field Center [N01-HC-48047]; University of Minnesota Field Center and Diet Reading Center [N01-HC-48048]; Northwestern University Field Center [N01-HC-48049]; Kaiser Foundation Research Institute [N01-HC-48050]; University of California, Irvine, Echocardiography Reading Center [N01-HC-45134]; Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center [N01-HC-05187]; Wake Forest University [N01-HC-45205]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045134, N01HC048048, N01HC005187, N01HC048049, N01HC048047, N01HC048050, N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048050, R29HL048048, R01HL048049, R01HL048048] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham Coordinating Center; University of Alabama at Birmingham Field Center; University of Minnesota Field Center and Diet Reading Center(University of Minnesota System); Northwestern University Field Center; Kaiser Foundation Research Institute; University of California, Irvine, Echocardiography Reading Center(University of California System); Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center; Wake Forest University; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.; By the University of Alabama at Birmingham Coordinating Center (grant N01-HC-95095); University of Alabama at Birmingham Field Center (grant N01-HC-48047); University of Minnesota Field Center and Diet Reading Center (year 20 examination) (grant N01-HC-48048); Northwestern University Field Center (grant N01-HC-48049); Kaiser Foundation Research Institute (grant N01-HC-48050); University of California, Irvine, Echocardiography Reading Center (years 5 and 10) (grant N01-HC-45134); Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center (year 15 examination) (grant N01-HC-05187); Wake Forest University (year 20 examination) (grant N01-HC-45205); and New England Medical Center (year 20 examination) (grant N01-HC-45204 from the National Heart, Lung and Blood Institute).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bao WH, 1996, ARCH INTERN MED, V156, P1315, DOI 10.1001/archinte.156.12.1315; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI 10.1016/j.jcmg.2009.03.009; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Chhatriwalla AK, 2009, J AM COLL CARDIOL, V53, P1110, DOI 10.1016/j.jacc.2008.09.065; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503; HULLEY SB, 1992, BRIT MED J, V304, P394, DOI 10.1136/bmj.304.6824.394; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; *NAT CHOL ED PROGR, 2004, DET EV TREATM HIGH B; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Nieto FJ, 1999, J CLIN EPIDEMIOL, V52, P559, DOI 10.1016/S0895-4356(99)00030-X; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sanchez A, 2000, ATHEROSCLEROSIS, V152, P265, DOI 10.1016/S0021-9150(00)00532-3; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; *US PREV SERV TASK, 2008, SCREEN LIP DIS AD; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802	46	80	83	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					137	U18		10.7326/0003-4819-153-3-201008030-00004	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679558	Green Accepted			2022-12-28	WOS:000280557600001
J	Unroe, M; Kahn, JM; Carson, SS; Govert, JA; Martinu, T; Sathy, SJ; Clay, AS; Chia, J; Gray, A; Tulsky, JA; Cox, CE				Unroe, Mark; Kahn, Jeremy M.; Carson, Shannon S.; Govert, Joseph A.; Martinu, Tereza; Sathy, Shailaja J.; Clay, Alison S.; Chia, Jessica; Gray, Alice; Tulsky, James A.; Cox, Christopher E.			One-Year Trajectories of Care and Resource Utilization for Recipients of Prolonged Mechanical Ventilation A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LENGTH-OF-STAY; INTENSIVE-CARE; ECONOMIC-EVALUATION; TRACHEOSTOMY; OUTCOMES; ILLNESS; SURVIVORS; BURDEN; COST; ICU	Background: Growing numbers of critically ill patients receive prolonged mechanical ventilation. Little is known about the patterns of care as patients transition from acute care hospitals to postacute care facilities or about the associated resource utilization. Objective: To describe 1-year trajectories of care and resource utilization for patients receiving prolonged mechanical ventilation. Design: 1-year prospective cohort study. Setting: 5 intensive care units at Duke University Medical Center, Durham, North Carolina. Participants: 126 patients receiving prolonged mechanical ventilation (defined as ventilation for >= 4 days with tracheostomy placement or ventilation for >= 21 days without tracheostomy), as well as their 126 surrogates and 54 intensive care unit physicians, enrolled consecutively over 1 year. Measurements: Patients and surrogates were interviewed in the hospital, as well as 3 and 12 months after discharge, to determine patient survival, functional status, and facility type and duration of postdischarge care. Physicians were interviewed in the hospital to elicit prognoses. Institutional billing records were used to assign costs for acute care, outpatient care, and interfacility transportation. Medicare claims data were used to assign costs for postacute care. Results: 103 (82%) hospital survivors had 457 separate transitions in postdischarge care location (median, 4 transitions [interquartile range, 3 to 5 transitions]), including 68 patients (67%) who were readmitted at least once. Patients spent an average of 74% (95% CI, 68% to 80%) of all days alive in a hospital or postacute care facility or receiving home health care. At 1 year, 11 patients (9%) had a good outcome (alive with no functional dependency), 33 (26%) had a fair outcome (alive with moderate dependency), and 82 (65%) had a poor outcome (either alive with complete functional dependency [4 patients; 21%] or dead [56 patients; 44%]). Patients with poor outcomes were older, had more comorbid conditions, and were more frequently discharged to a postacute care facility than patients with either fair or good outcomes (P < 0.05 for all). The mean cost per patient was $306 135 (SD, $285 467), and total cohort cost was $38.1 million, for an estimated $3.5 million per independently functioning survivor at 1 year. Limitation: The results of this single-center study may not be applicable to other centers. Conclusion: Patients receiving prolonged mechanical ventilation have multiple transitions of care, resulting in substantial health care costs and persistent, profound disability. The optimism of surrogate decision makers should be balanced by discussions of these outcomes when considering a course of prolonged life support.	[Cox, Christopher E.] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27710 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania	Cox, CE (corresponding author), Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Box 102043, Durham, NC 27710 USA.	christopher.cox@duke.edu	Cox, Christopher/ABH-7957-2020	Cox, Christopher/0000-0002-4486-0681; Kahn, Jeremy/0000-0001-9688-5576	National Institutes of Health [K23 HL081048, K23 HL082650, K23 HL067068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL067068, K23HL081048, K23HL082650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the National Institutes of Health (grants K23 HL081048, K23 HL082650, and K23 HL067068).	Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Carson SS, 2001, CHEST, V120, P928, DOI 10.1378/chest.120.3.928; Centers for Medicare & Medicaid Services, OV PROSP PAYM SYST; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Chudgar SM, 2009, CRIT CARE MED, V37, P49, DOI 10.1097/CCM.0b013e31819265c8; Cooper LM, 2004, CRIT CARE MED, V32, P2247, DOI 10.1097/01.CCM.0000146301.47334.BD; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Cox CE, 2007, CRIT CARE MED, V35, P1918, DOI 10.1097/01.CCM.0000275391.35834.10; Cox CE, 2007, CRIT CARE, V11, DOI 10.1186/cc5667; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Davis K, 2007, NEW ENGL J MED, V356, P1166, DOI 10.1056/NEJMe078007; Dewar DM, 1999, CRIT CARE MED, V27, P2640, DOI 10.1097/00003246-199912000-00006; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; El-Jawahri A, 2010, J CLIN ONCOL, V28, P305, DOI 10.1200/JCO.2009.24.7502; ELLIS SG, 1995, CIRCULATION, V92, P741, DOI 10.1161/01.CIR.92.4.741; Engoren M, 2004, CHEST, V125, P220, DOI 10.1378/chest.125.1.220; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyland DK, 1998, CHEST, V114, P192, DOI 10.1378/chest.114.1.192; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kind P., 1999, 172 U YORK YORK HLTH; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Nasraway SA, 2000, CRIT CARE MED, V28, P19, DOI 10.1097/00003246-200001000-00004; Nathens AB, 2006, CRIT CARE MED, V34, P2919, DOI 10.1097/01.CCM.0000243800.28251.AE; Nelson JE, 2004, CRIT CARE MED, V32, P1527, DOI 10.1097/01.CCM.0000129485.08835.5A; Nelson JE, 2007, ARCH INTERN MED, V167, P2509, DOI 10.1001/archinte.167.22.2509; Nelson JE, 2006, ARCH INTERN MED, V166, P1993, DOI 10.1001/archinte.166.18.1993; Rapoport J, 2003, MED CARE, V41, P386, DOI 10.1097/00005650-200303000-00007; *RTI INT, POST CAR PAYM REF DE; Taira DA, 2003, AM HEART J, V145, P452, DOI 10.1067/mhj.2003.3; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; White DB, 2007, ARCH INTERN MED, V167, P461, DOI 10.1001/archinte.167.5.461; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Zilberberg MD, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-242	46	309	317	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					167	U62		10.7326/0003-4819-153-3-201008030-00007	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679561	Green Accepted			2022-12-28	WOS:000280557600005
J	Gourine, AV; Kasymov, V; Marina, N; Tang, FG; Figueiredo, MF; Lane, S; Teschemacher, AG; Spyer, KM; Deisseroth, K; Kasparov, S				Gourine, Alexander V.; Kasymov, Vitaliy; Marina, Nephtali; Tang, Feige; Figueiredo, Melina F.; Lane, Samantha; Teschemacher, Anja G.; Spyer, K. Michael; Deisseroth, Karl; Kasparov, Sergey			Astrocytes Control Breathing Through pH-Dependent Release of ATP	SCIENCE			English	Article							IN-VIVO; RETROTRAPEZOID NUCLEUS; SYNAPTIC-TRANSMISSION; NEURONS; POTENTIATION; RATS	Astrocytes provide structural and metabolic support for neuronal networks, but direct evidence demonstrating their active role in complex behaviors is limited. Central respiratory chemosensitivity is an essential mechanism that, via regulation of breathing, maintains constant levels of blood and brain pH and partial pressure of CO(2). We found that astrocytes of the brainstem chemoreceptor areas are highly chemosensitive. They responded to physiological decreases in pH with vigorous elevations in intracellular Ca(2+) and release of adenosine triphosphate (ATP). ATP propagated astrocytic Ca(2+) excitation, activated chemoreceptor neurons, and induced adaptive increases in breathing. Mimicking pH-evoked Ca(2+) responses by means of optogenetic stimulation of astrocytes expressing channelrhodopsin-2 activated chemoreceptor neurons via an ATP-dependent mechanism and triggered robust respiratory responses in vivo. This demonstrates a potentially crucial role for brain glial cells in mediating a fundamental physiological reflex.	[Gourine, Alexander V.; Kasymov, Vitaliy; Marina, Nephtali; Spyer, K. Michael] UCL, London WC1E 6BT, England; [Tang, Feige; Figueiredo, Melina F.; Lane, Samantha; Teschemacher, Anja G.; Kasparov, Sergey] Univ Bristol, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of London; University College London; University of Bristol; Stanford University	Gourine, AV (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	a.gourine@ucl.ac.uk; sergey.kasparov@bristol.ac.uk	Kasparov, Sergey/C-4932-2014; Kasparov, Sergey/AAH-5286-2019	Kasparov, Sergey/0000-0002-1824-1764; Kasparov, Sergey/0000-0002-1824-1764	British Heart Foundation [PG/09/064/27886] Funding Source: Medline; Wellcome Trust [079040] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)		Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; FUKUDA Y, 1978, PFLUG ARCH EUR J PHY, V376, P229, DOI 10.1007/BF00584955; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hwang DY, 2001, HUM GENE THER, V12, P1731, DOI 10.1089/104303401750476230; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Ritucci NA, 2005, AM J PHYSIOL-REG I, V289, pR851, DOI 10.1152/ajpregu.00132.2005; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	26	599	614	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					571	575		10.1126/science.1190721	http://dx.doi.org/10.1126/science.1190721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20647426	Green Accepted			2022-12-28	WOS:000280483500039
J	Gudasz, C; Bastviken, D; Steger, K; Premke, K; Sobek, S; Tranvik, LJ				Gudasz, Cristian; Bastviken, David; Steger, Kristin; Premke, Katrin; Sobek, Sebastian; Tranvik, Lars J.			Temperature-controlled organic carbon mineralization in lake sediments	NATURE			English	Article							TERRESTRIAL CARBON; CLIMATE-CHANGE; BOREAL FOREST; SOIL CARBON; BURIAL; CYCLE; ACCUMULATION; RESPIRATION; RESERVOIRS; DYNAMICS	Peatlands, soils and the ocean floor are well-recognized as sites of organic carbonaccumulation andrepresentimportant global carbon sinks(1,2). Although the annual burial of organic carbon in lakes and reservoirs exceeds that of ocean sediments(3), these inland waters are components of the global carbon cycle that receive only limited attention(4-6). Of the organic carbon that is being deposited onto the sediments, a certain proportion will be mineralized and the remainder will be buried over geological timescales. Here we assess the relationship between sediment organic carbon mineralization and temperature in a cross-system survey of boreal lakes in Sweden, and with input froma compilation of published data from awide range of lakes that differ with respect to climate, productivity and organic carbon source. We find that the mineralization of organic carbon in lake sediments exhibits a strongly positive relationship with temperature, which suggests that warmer water temperatures lead to more mineralization and less organic carbon burial. Assuming that future organic carbon delivery to the lake sediments will be similar to that under present-day conditions, we estimate that temperature increases following the latest scenarios presented by the Intergovernmental Panel on Climate Change(7) could result in a 4-27 per cent (0.9-6.4 Tg Cyr(-1)) decrease in annual organic carbon burial in boreal lakes.	[Gudasz, Cristian; Steger, Kristin; Premke, Katrin; Sobek, Sebastian; Tranvik, Lars J.] Uppsala Univ, Dept Ecol & Evolut, SE-75236 Uppsala, Sweden; [Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58662 Linkoping, Sweden	Uppsala University; Linkoping University	Gudasz, C (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	cristian.gudasz@ebc.uu.se	Steger, Kristin/F-3000-2014; Steger, Kristin/F-4187-2014; Tranvik, Lars J/H-2222-2011	Steger, Kristin/0000-0001-6446-8022; Steger, Kristin/0000-0002-7737-0697; Bastviken, David/0000-0003-0038-2152; Premke, Katrin/0000-0001-6216-5386; Tranvik, Lars J./0000-0003-3509-8266	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning); VR (the Swedish Research Council)	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); VR (the Swedish Research Council)(Swedish Research Council)	The study was part of the research environment LEREC (Lake Ecosystem Response to Environmental Change), financially supported by FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning). Additional funding from VR (the Swedish Research Council) to L.J.T. and to D.B., and from FORMAS to S.S., is acknowledged.	ANDERSEN JM, 1976, WATER RES, V10, P329, DOI 10.1016/0043-1354(76)90175-5; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; den Heyer C, 1998, LIMNOL OCEANOGR, V43, P695, DOI 10.4319/lo.1998.43.4.0695; DeStasio BT, 1996, LIMNOL OCEANOGR, V41, P1136, DOI 10.4319/lo.1996.41.5.1136; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Einsele G, 2001, GLOBAL PLANET CHANGE, V30, P167, DOI 10.1016/S0921-8181(01)00105-9; Emerson S, 1988, PALEOCEANOGRAPHY, V3, P621, DOI 10.1029/PA003i005p00621; Fang X, 1999, CLIMATIC CHANGE, V42, P377, DOI 10.1023/A:1005431523281; Girard R. E., 2007, HIST CHEM PHYS BIOL; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; GRANELI W, 1979, Holarctic Ecology, V2, P51; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Hoskuldsson A., 1988, J CHEMOM, V2, P211, DOI [https://doi.org/10.1002/cem.1180020306, DOI 10.1002/CEM.1180020306]; Jankowski T, 2006, LIMNOL OCEANOGR, V51, P815, DOI 10.4319/lo.2006.51.2.0815; Kortelainen P, 2006, GLOBAL CHANGE BIOL, V12, P1554, DOI 10.1111/j.1365-2486.2006.01167.x; Molot LA, 1996, GLOBAL BIOGEOCHEM CY, V10, P483, DOI 10.1029/96GB01666; MULHOLLAND PJ, 1982, TELLUS, V34, P490, DOI 10.1111/j.2153-3490.1982.tb01837.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; PACE ML, 2004, RESP AQUATIC SYSTEMS, P103; PERSSON G, 2009, 4552 NAT SWED EPA; Rapalee G, 1998, GLOBAL BIOGEOCHEM CY, V12, P687, DOI 10.1029/98GB02336; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Sobek S, 2009, LIMNOL OCEANOGR, V54, P2243, DOI 10.4319/lo.2009.54.6.2243; Solomon S., 2007, PHYS SCI BASIS WORKI; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Wetzel R. G, 1990, VERH INT VEREIN LIMN, V24, P6, DOI DOI 10.1080/03680770.1989.11898687; ZAR JH, 1984, BIOSTAT ANAL, P292	35	354	379	23	407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					478	U3		10.1038/nature09186	http://dx.doi.org/10.1038/nature09186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651689	Green Submitted			2022-12-28	WOS:000280141200033
J	Pujades-Rodriguez, M; Balkan, S; Arnould, L; Brinkhof, MAW; Calmy, A				Pujades-Rodriguez, Mar; Balkan, Suna; Arnould, Line; Brinkhof, Martin A. W.; Calmy, Alexandra		AIDS Working Grp MSF	Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIRETROVIRAL THERAPY; MULTIPLE IMPUTATION; MISSING VALUES; POOR SETTINGS; VIRAL LOAD; REGIMEN; ADHERENCE; SURVIVAL; RESISTANCE; PROGRAM	Context Long-term antiretroviral therapy (ART) use in resource-limited countries leads to increasing numbers of patients with HIV taking second-line therapy. Limited access to further therapeutic options makes essential the evaluation of second-line regimen efficacy in these settings. Objectives To investigate failure rates in patients receiving second-line therapy and factors associated with failure and death. Design, Setting, and Participants Multicohort study of 632 patients >14 years old receiving second-line therapy for more than 6 months in 27 ART programs in Africa and Asia between January 2001 and October 2008. Main Outcome Measures Clinical, immunological, virological, and immunovirological failure (first diagnosed episode of immunological or virological failure) rates, and mortality after 6 months of second-line therapy use. Sensitivity analyses were performed using alternative CD4 cell count thresholds for immunological and immunovirological definitions of failure and for cohort attrition instead of death. Results The 632 patients provided 740.7 person-years of follow-up; 119 (18.8%) met World Health Organization failure criteria after a median 11.9 months following the start of second-line therapy (interquartile range [IQR], 8.7-17.0 months), and 34 (5.4%) died after a median 15.1 months (IQR, 11.9-25.7 months). Failure rates were lower in those who changed 2 nucleoside reverse transcriptase inhibitors (NRTIs) instead of 1 (179.2 vs 251.6 per 1000 person-years; incidence rate ratio [IRR], 0.64; 95% confidence interval [CI], 0.42-0.96), and higher in those with lowest adherence index (383.5 vs 176.0 per 1000 person-years; IRR, 3.14; 95% CI, 1.67-5.90 for <80% vs >= 95% [percentage adherent, as represented by percentage of appointments attended with no delay]). Failure rates increased with lower CD4 cell counts when second-line therapy was started, from 156.3 vs 96.2 per 1000 person-years; IRR, 1.59 (95% CI, 0.78-3.25) for 100 to 199/mu L to 336.8 per 1000 person-years; IRR, 3.32 (95% CI, 1.81-6.08) for less than 50/mu L vs 200/mu L or higher; and decreased with time using second-line therapy, from 250.0 vs 123.2 per 1000 person-years; IRR, 1.90 (95% CI, 1.19-3.02) for 6 to 11 months to 212.0 per 1000 person-years; 1.71 (95% CI, 1.01-2.88) for 12 to 17 months vs 18 or more months. Mortality for those taking second-line therapy was lower in women (32.4 vs 68.3 per 1000 person-years; hazard ratio [HR], 0.45; 95% CI, 0.23-0.91); and higher in patients with treatment failure of any type (91.9 vs 28.1 per 1000 person-years; HR, 2.83; 95% CI, 1.38-5.80). Sensitivity analyses showed similar results. Conclusions Among patients in Africa and Asia receiving second-line therapy for HIV, treatment failure was associated with low CD4 cell counts at second-line therapy start, use of suboptimal second-line regimens, and poor adherence. Mortality was associated with diagnosed treatment failure. JAMA. 2010;304(3):303-312 www.jama.com	[Pujades-Rodriguez, Mar] Med Sans Frontieres, Epictr, F-75011 Paris, France; [Arnould, Line] Med Sans Frontieres, Brussels, Belgium; [Brinkhof, Martin A. W.] Inst Social & Prevent Med, Bern, Switzerland; [Calmy, Alexandra] Med Sans Frontieres Campaign Access Essential Med, Geneva, Switzerland	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Pujades-Rodriguez, M (corresponding author), Med Sans Frontieres, Epictr, 42 Bis,Bd,8 Rue St Sabin, F-75011 Paris, France.	mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/T-1129-2018; Pujades-Rodriguez, Mar/G-4388-2014	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Pujades-Rodriguez, Mar/0000-0002-7778-3520; Brinkhof, Martin/0000-0002-9319-665X	Swiss National Science Foundation [32473B-122116]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partly supported by grant 32473B-122116 from the Swiss National Science Foundation, from which external funds for this particular project were provided. Salaries of Drs Pujades-Rodriguez, Balkan, and Arnould are ensured by MSF (Drs Balkan and Arnould are employed by the Medical Department of MSF; Dr Pujades-Rodriguez is employed by Epicentre, a satellite nongovernmental organization closely linked to and funded by MSF). Role of the Sponsor: The sponsor did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. Online-Only Material: eTables 1 through 4 are available at http://www.jama.com.	Ananworanich J, 2007, FUTURE HIV THERAPY, V1, P81; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Calmy A, 2004, AIDS, V18, P2353; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Carlin JB, 2008, STATA J, V8, P49, DOI 10.1177/1536867X0800800104; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Crowley S, 2010, LANCET, V375, P874, DOI 10.1016/S0140-6736(09)62064-X; FEIVESON A, CALCULATING POWER SI; Feiveson AH, 2002, STATA J, V2, P107, DOI 10.1177/1536867X0200200201; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; *HIV AIDS DEP WHO, UN ACC SCAL PRIOR HI; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Keiding N, 1997, STAT MED, V16, P215; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; LEWDEN C, 2009, SURVIVAL LOSS TO FOL; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Mocroft A, 2001, AIDS, V15, P201, DOI 10.1097/00002030-200101260-00009; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; PUJADESRODRIGUE.M, 2010, 18 INT AIDS C JUL 18; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Willig JH, 2008, AIDS, V22, P1951, DOI 10.1097/QAD.0b013e32830efd79; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD; YAZDANPANAH Y, 2008, 17 INT AIDS C AUG 3; Zhou J, 2010, HIV MED, V11, P31, DOI 10.1111/j.1468-1293.2009.00738.x	39	75	79	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					303	312		10.1001/jama.2010.980	http://dx.doi.org/10.1001/jama.2010.980			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639564	Bronze			2022-12-28	WOS:000280107500020
J	Thompson, MA; Aberg, JA; Cahn, P; Montaner, JSG; Rizzardini, G; Telenti, A; Gatell, JM; Gunthard, HF; Hammer, SM; Hirsch, MS; Jacobsen, DM; Reiss, P; Richman, DD; Volberding, PA; Yeni, P; Schooley, RT				Thompson, Melanie A.; Aberg, Judith A.; Cahn, Pedro; Montaner, Julio S. G.; Rizzardini, Giuliano; Telenti, Amalio; Gatell, Jose M.; Guenthard, Huldrych F.; Hammer, Scott M.; Hirsch, Martin S.; Jacobsen, Donna M.; Reiss, Peter; Richman, Douglas D.; Volberding, Paul A.; Yeni, Patrick; Schooley, Robert T.			Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NAIVE HIV-1-INFECTED PATIENTS; HEPATITIS-B-VIRUS; TWICE-DAILY LOPINAVIR/RITONAVIR; ONCE-DAILY ATAZANAVIR/RITONAVIR; OPTIMIZED BACKGROUND THERAPY; EARLY VIROLOGICAL FAILURE; DRUG-RESISTANCE; MYOCARDIAL-INFARCTION; DAILY DARUNAVIR/RITONAVIR; OPPORTUNISTIC INFECTIONS	Context Recent data regarding the consequences of untreated human immunodeficiency virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and antiretroviral-experienced patients warrant an update of the International AIDS Society-USA guidelines for the use of antiretroviral therapy in adults with HIV infection. Objectives To provide updated recommendations for management of HIV-infected adults, using antiretroviral drugs and laboratory monitoring tools available in the international, developed-world setting. This report provides guidelines for when to initiate antiretroviral therapy, selection of appropriate initial regimens, patient monitoring, when to change therapy, and what regimens to use when changing. Data Sources and Study Selection A panel with expertise in HIV research and clinical care reviewed relevant data published or presented at selected scientific conferences since the last panel report through April 2010. Data were identified through a PubMed search, review of scientific conference abstracts, and requests to antiretroviral drug manufacturers for updated clinical trials and adverse event data. Data Extraction and Synthesis New evidence was reviewed by the panel. Recommendations were drafted by section writing committees and reviewed and edited by the entire panel. The quality and strength of the evidence were rated and recommendations were made by full panel consensus. Conclusions Patient readiness for treatment should be confirmed before initiation of antiretroviral treatment. Therapy is recommended for asymptomatic patients with a CD4 cell count <= 500/mu L, for all symptomatic patients, and those with specific conditions and comorbidities. Therapy should be considered for asymptomatic patients with CD4 cell count >500/mu L. Components of the initial and subsequent regimens must be individualized, particularly in the context of concurrent conditions. Patients receiving antiretroviral treatment should be monitored regularly; treatment failure should be detected and managed early, with the goal of therapy, even in heavily pretreated patients, being HIV-1 RNA suppression below commercially available assay quantification limits. JAMA. 2010;304(3):321-333 www.jama.com	[Thompson, Melanie A.] AIDS Res Consortium Atlanta, Atlanta, GA USA; [Richman, Douglas D.; Schooley, Robert T.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Aberg, Judith A.] NYU, Sch Med, New York, NY USA; [Cahn, Pedro] Univ Buenos Aires, Sch Med, Hosp Juan Fernandez, RA-1053 Buenos Aires, DF, Argentina; [Cahn, Pedro] Univ Buenos Aires, Fdn Huesped, RA-1053 Buenos Aires, DF, Argentina; [Gatell, Jose M.] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; [Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Hammer, Scott M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Hirsch, Martin S.] Harvard Univ, Sch Med, Boston, MA USA; [Jacobsen, Donna M.] Int AIDS Soc USA, San Francisco, CA USA; [Montaner, Julio S. G.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Montaner, Julio S. G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Rizzardini, Giuliano] Luigi Sacco Hosp, Milan, Italy; [Telenti, Amalio] Univ Lausanne Hosp, Lausanne, Switzerland; [Volberding, Paul A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Volberding, Paul A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Yeni, Patrick] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Yeni, Patrick] Xavier Bichat Med Sch, Paris, France	University of California System; University of California San Diego; New York University; University of Buenos Aires; University of Buenos Aires; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Zurich; University Zurich Hospital; Columbia University; Harvard University; Harvard Medical School; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of Amsterdam; Academic Medical Center Amsterdam; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Milan; Luigi Sacco Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Thompson, MA (corresponding author), 131 Ponce de Leon Ave NE,Ste 130, Atlanta, GA 30308 USA.	drmt@mindspring.com	Gatell, Jose M/ABC-3607-2020; Montaner, Julio/K-7621-2012; VALLET, Yannick/F-9979-2011; gunthard, huldrych f/F-1724-2011; Telenti, Amalio/AAY-1674-2021	gunthard, huldrych f/0000-0002-1142-6723; 	Abbott Laboratories; Avexa; Boehringer Ingelheim Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Gilead Sciences; GeoVax; Katketsuken; Koronis Pharmaceuticals; Merck Research Laboratories; Myriad; Ora-Sure; Pfizer; Progenics Pharmaceuticals; Roche Laboratories; Roche Molecular Systems; Serono; Theratechnologies Tibotec Therapeutics; Tobira Therapeutics; Trimeris; VaxGen; GlaxoSmithKline Italy; International AIDS Society-USA; ViiV Healthcare; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); Avexa; Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Gilead Sciences(Gilead Sciences); GeoVax; Katketsuken; Koronis Pharmaceuticals; Merck Research Laboratories(Merck & Company); Myriad; Ora-Sure; Pfizer(Pfizer); Progenics Pharmaceuticals; Roche Laboratories; Roche Molecular Systems; Serono; Theratechnologies Tibotec Therapeutics; Tobira Therapeutics; Trimeris; VaxGen; GlaxoSmithKline Italy(GlaxoSmithKline); International AIDS Society-USA; ViiV Healthcare; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr Thompson reported receiving research grants awarded to AIDS Research Consortium of Atlanta from Abbott Laboratories, Avexa, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, GeoVax, Katketsuken, Koronis Pharmaceuticals, Merck Research Laboratories, Myriad, Ora-Sure, Panacos Pharmaceuticals (now Myriad), Pfizer, Progenics Pharmaceuticals, Roche Laboratories, Roche Molecular Systems, Serono, Theratechnologies Tibotec Therapeutics, Tobira Therapeutics, Trimeris, and VaxGen; has served on the scientific advisory boards or as a clinical trial design consultant for Chimerix, GeoVax, GlaxoSmithKline, Panacos Pharmaceuticals, Progenics Pharmaceuticals, and Tibotec Therapeutics; has received honoraria for scientific lectures from GlaxoSmithKline and Serono; and has served on data and safety monitoring boards for Tibotec Therapeutics. Dr Aberg reported serving as a scientific advisor to Abbott Laboratories, Boehringer Ingelheim Pharmaceutical, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Theratechnologies, Tibotec Therapeutics, and ViiV Healthcare; has received grants and research support from Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Schering-Plough, Theratechnologies, Tibotec Therapeutics, Virco Lab, and Wyeth; and has received honoraria from Abbott Laboratories, Bristol-Myers Squibb, and Gilead Sciences. Dr Cahn reported serving on the advisory boards for Avexa, Gilead Sciences, GlaxoSmithKline, Myriad Genetics, Merck, Pfizer, Pharmasset, ScheringPlough, and Tibotec Therapeutics; has served as an investigator for Avexa, Boehringer Ingelheim Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Pharmasset, Roche Laboratories, ScheringPlough, and Tibotec Therapeutics; and has received honoraria for speaking engagements from Abbott Laboratories, Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Merck, Pfizer, and Tibotec Therapeutics. Dr Montaner reported receiving research grants from, and served as an ad hoc advisor or consultant to, Abbott Laboratories, Argos Therapeutics, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Cato Research Canada, ConjuChem Biotech, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Johnson& Johnson, Merck Canada, Merck Frosst Laboratories, Pfizer Canada, Serono, Theratechnologies, and Tibotec Pharmaceuticals and has served on an endpoint adjudication committee for Schering-Plough. Dr Rizzardini reported receiving research grants from Gilead Sciences and Merck Sharp& Dohme. Dr Telenti reported receiving research grants or honoraria for lectures from Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, and GlaxoSmithKline. Dr Gatell reported receiving research grants or honoraria for serving on advisory boards or for lectures from Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharpe & Dohme, Pfizer, GlaxoSmithKline, Roche Laboratories, Theratechnologies, Tibotec Therapeutics, Tobira Therapeutics, and Virco Lab. Dr Gunthard reported serving as a consultant and medical advisor for Abbott Laboratories, Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Pfizer, Tibotec Therapeutics, and ViiV Healthcare and has received unrestricted research and educational grants from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp& Dohme, and Pfizer.; Dr Hammer reported serving on a scientific or clinical advisory boards for Merck, Progenics Pharmaceuticals, TaiMed Biologics, TibotecTherapeutics, and Wyeth; has received clinical research contracts from Merck; and has served on data and safety monitoring boards and committees for Bristol-Myers Squibb and on the board of directors of SIGA Pharmaceuticals. Dr Hirsch reported serving on data and safety monitoring boards for Merck and TaiMed Biologics. Dr Reiss reported serving as a scientific advisor to Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Theratechnologies, Tibotec Therapeutics, and Tobira Therapeutics; has served on data and safety monitoring boards and endpoint adjudication committees for Tibotec Therapeutics; has received honoraria for speaking engagements at scientific conferences from Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, and Theratechnologies; and has received research support from Gilead Sciences, ViiV Healthcare, and Boehringer Ingelheim Pharmaceuticals. Dr Richman reported being a consultant to Anadys Pharmaceuticals, Biota, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Chimerix, GenProbe, Gilead Sciences, Idenix Pharmaceuticals, Koronis Pharmaceuticals, Merck, Monogram Biosciences, Myriad Genetics, Pfizer, Roche, Theraclone Sciences, and Tobira Therapeutics; has served on an endpoint adjudication committee for Schering-Plough; has been the recipient of a research grant from Merck; and has been a stock options holder of Chimerix and Idenix Pharmaceuticals. Dr Volberding reported serving on data and safety monitoring boards for Merck and TaiMed Biologics and on an endpoint adjudication committee for Schering-Plough; has provided paid expert testimony for commercial firms; has served on scientific or clinical advisory boards for Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Pfizer, and Tobira Therapeutics; and has been the recipient of service grants for, or held contracts from, GlaxoSmithKline Italy. Dr Yeni reported receiving scientific grants from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Pfizer, Merck, and Roche Laboratories. Dr Schooley reported serving as a consultant to Achillion Pharmaceuticals, Anadys Pharmaceuticals, Ardea Biosciences, Gilead Sciences, GlaxoSmithKline, Inhibitex, iTherX, Johnson & Johnson, LabCorp, Merck, Myriad Biosciences, Pfizer, TaiMed Biologics, Tanox, Tobira Therapeutics, Vertex Pharmaceuticals, and Vical; has received grants from Gilead Sciences and Pfizer; and has stock options for Achillion Pharmaceuticals.; This work was funded by the International AIDS Society-USA. Panel members serve in volunteer capacities (ie, are not compensated). No private sector or government funding was used to support the effort. The International AIDS Society-USA has received grants for selected CME activities (unrelated to guidelines development) from Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Roche Laboratories, Tibotec Therapeutics, and ViiV Healthcare. Grants are pooled such that no single company supports any single effort.	Aberg JA, 2010, J INFECT DIS, V201, P315, DOI 10.1086/649898; Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Anis AH, 2009, JAIDS-J ACQ IMM DEF, V51, P631, DOI 10.1097/QAI.0b013e3181a4f00d; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bellini C, 2009, HIV MED, V10, P12, DOI 10.1111/j.1468-1293.2008.00646.x; Bessesen M, 1999, CLIN INFECT DIS, V28, P1032, DOI 10.1086/514750; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; BOLTZ V, 2010, 17 C RETR OPP INF SA; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007387; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Buchacz K, 2010, 17 ANN CAN C HIV AID; CAHN P, 2010, 17 C RETR OPP INF SA; Canducci F, 2009, AIDS, V23, P455, DOI 10.1097/QAD.0b013e328323da60; Carosi G, 2009, HIV CLIN TRIALS, V10, P356, DOI 10.1310/hct1006-356; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; CASSETTI I, 2008, 17 ANN INT AIDS C ME; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; COOPER DA, 2009, 5 INT AIDS SOC C HIV; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; DAAR E, 2010, 17 C RETR OPP INF SA; Dabis F, 2010, LANCET, V375, P2056, DOI 10.1016/S0140-6736(10)60838-0; De Castro N, 2009, CLIN INFECT DIS, V49, P1259, DOI 10.1086/605674; Donnell D, 2010, AIDS BEHAV, V14, P1182, DOI 10.1007/s10461-010-9712-1; Dore GJ, 2010, AIDS, V24, P857, DOI 10.1097/QAD.0b013e328334bddb; *DRUG INT HIV, DRUG INT CHARTS; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; EUROPEAN AIDS CLINICAL SOCIETY, GUID PREV MAN NON CO; European AIDS Clinical Society, EUR GUID CLIN MAN TR; Ferry T, 2009, JAIDS-J ACQ IMM DEF, V51, P407, DOI 10.1097/QAI.0b013e3181acb65f; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Gardner LI, 2008, AIDS PATIENT CARE ST, V22, P627, DOI 10.1089/apc.2007.0210; Gatell J, 2007, CLIN INFECT DIS, V44, P1484, DOI 10.1086/517497; GATHE J, 2009, J ACQ IMMUN DEF SYND, V15, P474; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; GOTUZZO E, 2010, 17 C RETR OPP INF SA; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; GUTMANN C, 2009, 16 C RETR OPP INF MO; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hargrove JW, 2010, AIDS, V24, pF11, DOI 10.1097/QAD.0b013e328335749d; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; HEERA J, 2009, 5 INT AIDS SOC C HIV; Heneine W, 2010, J INFECT DIS, V201, P647, DOI 10.1086/650545; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; *HIV INSITE, DAT ANT DRUG INT; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; Kaplan JE, 2009, MMWR RECOMM REP, V58, pCE1; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Kesselring AM, 2009, AIDS, V23, P1689, DOI 10.1097/QAD.0b013e32832d3b54; KIM D, 2010, 17 C RETR OPP INF SA; KIRK O, 2010, 17 C RETR OPP INF SA; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Klein CE, 2008, J CLIN PHARMACOL, V48, P553, DOI 10.1177/0091270007313392; Kopp JB, 1997, ANN INTERN MED, V127, P119, DOI 10.7326/0003-4819-127-2-199707150-00004; Kredo T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007268.pub2; Labarga P, 2007, J INFECT DIS, V196, P670, DOI 10.1086/520092; Landman R, 2009, J ANTIMICROB CHEMOTH, V64, P118, DOI 10.1093/jac/dkp146; LANG S, 2009, 16 C RETR OPP INF MO; Lapadula G, 2008, CLIN INFECT DIS, V46, P1127, DOI 10.1086/529394; Laufer N, 2008, ANTIVIR THER, V13, P953; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Le Tiec C, 2005, CLIN PHARMACOKINET, V44, P1035, DOI 10.2165/00003088-200544100-00003; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mackie NE, 2010, J INFECT DIS, V201, P1303, DOI 10.1086/651618; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Markowitz M, 2010, J INFECT DIS, V201, P1298, DOI 10.1086/651664; McGovern RA, 2010, 17 C RETR OPP INF SA; McIntyre J, 2005, ANTIVIR THER, V10, pS4; McIntyre J, 2010, 17 C RETR OPP INF SA; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Misovich SJ, 1997, REV GEN PSYCHOL, V1, P72, DOI [DOI 10.1037/1089-2680.1.1.72, 10.1037=1089-2680.1.1.72]; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mueller NJ, 2010, AIDS, V24, P1127, DOI 10.1097/QAD.0b013e328337b161; *NAT OST FDN, REC ALG NAT US OST F; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Malan DR, 2008, JAIDS-J ACQ IMM DEF, V47, P161, DOI 10.1097/QAI.0b013e31815ace6a; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Pas S, 2010, J CLIN MICROBIOL, V48, P1195, DOI 10.1128/JCM.01832-09; *PER HIV GUID WORK, 2009, PUBL HLTH SERV TASK; Pessoa MG, 2008, AIDS, V22, P1779, DOI 10.1097/QAD.0b013e32830b3ab5; Phillips AN, 2008, ANTIVIR THER, V13, P177; Post FA, 2009, CURR OPIN INFECT DIS, V22, P43, DOI 10.1097/QCO.0b013e328320ffec; Pulido F, 2009, HIV CLIN TRIALS, V10, P76, DOI 10.1310/hct1002-76; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rebeiro PF, 2008, CLIN INFECT DIS, V47, P1354, DOI 10.1086/592693; Reekie J, 2010, HIV MED, V11, P469, DOI 10.1111/j.1468-1293.2009.00816.x; Reekie J, 2008, AIDS, V22, P2381, DOI 10.1097/QAD.0b013e328317a6eb; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Scherrer AU, 2010, JAIDS-J ACQ IMM DEF, V53, P464, DOI 10.1097/QAI.0b013e3181bca4ec; Seden K, 2010, J ANTIMICROB CHEMOTH, V65, P1079, DOI 10.1093/jac/dkq086; Sierra-Madero J, 2010, JAIDS-J ACQ IMM DEF, V53, P582, DOI 10.1097/QAI.0b013e3181cae4a1; SORIANO V, 2008, 5 INT AIDS SOC C HIV; Soriano V, 2008, AIDS, V22, P1, DOI 10.1097/QAD.0b013e3282f0e2fd; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Swenson LC, 2010, 17 C RETR OPP INF SA; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; United States Food and Drug Administration (FDA), FDA DRUG SAF COMM ON; van Vonderen MGA, 2009, AIDS, V23, P1367, DOI 10.1097/QAD.0b013e32832c4947; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; von Linstow ML, 2010, HIV MED, V11, P448, DOI 10.1111/j.1468-1293.2009.00811.x; von Wyl V, 2008, CLIN INFECT DIS, V46, P1299, DOI 10.1086/528863; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Walmsley S, 2009, JAIDS-J ACQ IMM DEF, V50, P367, DOI 10.1097/QAI.0b013e318198a815; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2009, J ANTIMICROB CHEMOTH, V63, P1251, DOI 10.1093/jac/dkp114; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organization Collaborating Centre for Metabolic Bone Diseases, WHO FRACT RISK ASS T; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Young J, 2009, ANTIVIR THER, V14, P771, DOI 10.3851/IMP1291; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	146	686	713	2	85	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					321	333		10.1001/jama.2010.1004	http://dx.doi.org/10.1001/jama.2010.1004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639566				2022-12-28	WOS:000280107500022
J	May, JP; Joseph, P; Pape, JW; Binswanger, IA				May, John P.; Joseph, Patrice; Pape, Jean William; Binswanger, Ingrid A.			Health Care for Prisoners in Haiti	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							JAIL	Prisoners have disproportionate health care needs. Meeting those needs in a prison environment is challenging, especially in such resource-poor countries as Haiti. Even so, before the January 2010 earthquake, local and international organizations, in collaboration with the Haitian government, had been making significant progress to provide for the health needs of prisoners. The effort screened and identified prisoners for infectious disease, initiated appropriate care and treatment, and prepared prisoners for release to the community. Not only is it possible to establish an adequate prison health care program in a resource-poor country, it is necessary. Without adequate management of prisoners' health needs, especially for such infectious diseases as HIV and tuberculosis, disease burden increases. Infectious disease can spread among prisoners and impact the public's health. Recovery for postearthquake Haiti, as any nation rebuilding following natural disaster or conflict, requires respect for rule of law. This includes humane detention and the delivery of justice and adequate health care for prisoners.	[May, John P.] Ctr GHESKIO, Port Au Prince, Haiti		May, JP (corresponding author), 4960 SW 72nd Ave,Suite 400, Miami, FL 33155 USA.	drjpmay@aol.com	Binswanger, Ingrid/X-4496-2019	Binswanger, Ingrid/0000-0001-8862-8078	Robert Wood Johnson Foundation; Fogarty International Center [TW006896]; USAID [521-G-00-09-00030-00]; FOGARTY INTERNATIONAL CENTER [U2RTW006896] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); USAID(United States Agency for International Development (USAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	By the Robert Wood Johnson Foundation Physician Faculty Scholars Program (Dr. Binswanger), Fogarty International Center (grant TW006896), and USAID (grant 521-G-00-09-00030-00; Dr. May).	Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; BINSWANGER IA, 2010, UPTODATE VER 17 2; Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591; Farmer P, 2005, PATHOLOGIES POWER HL; FULLER A, 2002, PROLONGED PRETRIAL D; Greifinger R, 2005, J PUBLIC HEALTH POL, V26, P60, DOI 10.1057/palgrave.jphp.3200003; *HIV, 2007, HIV PRIS SUBS AFR OP; *INT CTR PRIS STUD, ENT WORLD PRIS POP R; Larouze B, 2008, T ROY SOC TROP MED H, V102, P841, DOI 10.1016/j.trstmh.2008.04.020; Levy M, 2007, PUBLIC HLTH BARS PRI, P73; Levy MH, 2007, MED J AUSTRALIA, V186, P647, DOI 10.5694/j.1326-5377.2007.tb01085.x; MAY JP, 1995, J HEALTH CARE POOR U, V6, P162; Sabol WJ, 2009, BUREAU JUSTICE STAT; Shakarishvili A, 2005, LANCET, V366, P57, DOI 10.1016/S0140-6736(05)66828-6	14	6	6	1	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2010	153	6					407	410		10.7326/0003-4819-153-6-201009210-00270	http://dx.doi.org/10.7326/0003-4819-153-6-201009210-00270			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	652WY	20679542				2022-12-28	WOS:000282043100008
J	Wood, SN				Wood, Simon N.			Statistical inference for noisy nonlinear ecological dynamic systems	NATURE			English	Article							POPULATIONS; MODELS	Chaotic ecological dynamic systems defy conventional statistical analysis. Systems with near-chaotic dynamics are little better. Such systems are almost invariably driven by endogenous dynamic processes plus demographic and environmental process noise, and are only observable with error. Their sensitivity to history means that minute changes in the driving noise realization, or the system parameters, will cause drastic changes in the system trajectory(1). This sensitivity is inherited and amplified by the joint probability density of the observable data and the process noise, rendering it useless as the basis for obtaining measures of statistical fit. Because the joint density is the basis for the fit measures used by all conventional statistical methods(2), this is a major theoretical shortcoming. The inability to make well-founded statistical inferences about biological dynamic models in the chaotic and near-chaotic regimes, other than on an ad hoc basis, leaves dynamic theory without the methods of quantitative validation that are essential tools in the rest of biological science. Here I show that this impasse can be resolved in a simple and general manner, using a method that requires only the ability to simulate the observed data on a system from the dynamic model about which inferences are required. The raw data series are reduced to phase-insensitive summary statistics, quantifying local dynamic structure and the distribution of observations. Simulation is used to obtain the mean and the covariance matrix of the statistics, given model parameters, allowing the construction of a 'synthetic likelihood' that assesses model fit. This likelihood can be explored using a straightforward Markov chain Monte Carlo sampler, but one further post-processing step returns pure likelihood-based inference. I apply the method to establish the dynamic nature of the fluctuations in Nicholson's classic blowfly experiments(3-5).	Univ Bath, Bath BA2 7AY, Avon, England	University of Bath	Wood, SN (corresponding author), Univ Bath, Bath BA2 7AY, Avon, England.	s.wood@bath.ac.uk	Wood, Simon N/B-3058-2010	Wood, Simon N/0000-0002-2034-7453	EPSRC/NERC	EPSRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Engineering & Physical Sciences Research Council (EPSRC))	I am grateful to W. Gurney, R. Nisbet, S. Ellner, P. Turchin and B. Kendall for many discussions of the problem addressed here, and to the participants in the 2009 Statistical Methods for Dynamic Systems Models Workshop in Vancouver for discussion of this particular work. This work is part of the research programme of the EPSRC/NERC-funded UK National Centre for Statistical Ecology.	Beaumont MA, 2002, GENETICS, V162, P2025; Campbell N. A., 1980, Applied Statistics, V29, P231, DOI 10.2307/2346896; Cox DR, 2006, PRINCIPLES OF STATISTICAL INFERENCE, P133; COX DR, 1974, THEORETICAL STAT, P11; DAVISON AC, 2003, STAT MODELS, P94; Gamerman D, 2006, MARKOV CHAIN MONTE C; GURNEY WSC, 1980, NATURE, V287, P17, DOI 10.1038/287017a0; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; KRZANOWSKI WJ, 1988, PRINCIPLES MULTIVARI, P60; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCFADDEN D, 1989, ECONOMETRICA, V57, P995, DOI 10.2307/1913621; NICHOLSON AJ, 1957, COLD SPRING HARB SYM, V22, P153, DOI 10.1101/SQB.1957.022.01.017; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; NISBET RM, 1982, MODELLING FLUCTUATIN, P285; SILVEY SD, 1975, STAT INFERENCE, P68; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; WATKINS DS, 1991, FUNDAMENTALS MATRIX, P128	18	286	288	1	84	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1102	+		10.1038/nature09319	http://dx.doi.org/10.1038/nature09319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20703226	Green Accepted, Green Submitted			2022-12-28	WOS:000281203600039
J	Astrup, A				Astrup, Arne			Is cardiometabolic risk improved by weight-loss drugs?	LANCET			English	Editorial Material							BLOOD-PRESSURE; BUPROPION		Univ Copenhagen, Fac Life Sci, Dept Human Nutr, DK-1958 Frederiksberg, Denmark	University of Copenhagen	Astrup, A (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Human Nutr, DK-1958 Frederiksberg, Denmark.	ast@life.ku.dk	Astrup, Arne/B-1407-2015	Astrup, Arne/0000-0001-8968-8996				Beyens MN, 2008, DRUG SAFETY, V31, P1017, DOI 10.2165/00002018-200831110-00006; BRAY GA, 2003, HDB HLTH CARE; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; DAVIDSON J, 1989, J CLIN PSYCHIAT, V50, P256; European Medicines Agency, 2010, QUEST ANSW SUSP MED; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; McCubbin JA, 1998, PSYCHOSOM MED, V60, P227, DOI 10.1097/00006842-199803000-00020; Thase ME, 2008, J CLIN PSYCHOPHARM, V28, P302, DOI 10.1097/JCP.0b013e318172424e; U.S. Food and Drug Administration, 2009, INF HEALTHC PROF VAR; 2010, LOW DOSE NALTREXONE	10	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					567	568		10.1016/S0140-6736(10)60999-3	http://dx.doi.org/10.1016/S0140-6736(10)60999-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20673996				2022-12-28	WOS:000281309100004
J	Fratini, M; Poccia, N; Ricci, A; Campi, G; Burghammer, M; Aeppli, G; Bianconi, A				Fratini, Michela; Poccia, Nicola; Ricci, Alessandro; Campi, Gaetano; Burghammer, Manfred; Aeppli, Gabriel; Bianconi, Antonio			Scale-free structural organization of oxygen interstitials in La2CuO4+y	NATURE			English	Article							PHASE-SEPARATION; STRAIN	It is well known that the microstructures of the transition-metal oxides(1-3), including the high-transition-temperature (high-T-c) copper oxide superconductors(4-7), are complex. This is particularly so when there are oxygen interstitials or vacancies 8, which influence the bulk properties. For example, the oxygen interstitials in the spacer layers separating the superconducting CuO2 planes undergo ordering phenomena in Sr2O1+yCuO2 (ref.9), YBa2Cu3O6+y (ref.10) and La2CuO4+y (refs 11-15) that induce enhancements in the transition temperatures with no changes in hole concentrations. It is also known that complex systems often have a scale-invariant structural organization 16, but hitherto none had been found in high-T-c materials. Here we report that the ordering of oxygen interstitials in the La2O2+y spacer layers of La2CuO4+y high-T-c superconductors is characterized by a fractal distribution up to a maximum limiting size of 400 mu m. Intriguingly, these fractal distributions of dopants seem to enhance superconductivity at high temperature.	[Fratini, Michela; Poccia, Nicola; Ricci, Alessandro; Campi, Gaetano; Bianconi, Antonio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Campi, Gaetano] CNR, Inst Crystallog, I-00016 Monterotondo, Italy; [Burghammer, Manfred] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Aeppli, Gabriel] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Aeppli, Gabriel] UCL, Dept Phys & Astron, London WC1H 0AH, England	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); European Synchrotron Radiation Facility (ESRF); University of London; University College London; University of London; University College London	Bianconi, A (corresponding author), Univ Roma La Sapienza, Dept Phys, Piazzale Aldo Moro 2, I-00185 Rome, Italy.	antonio.bianconi@uniroma1.it	Poccia, Nicola/L-1130-2016; Bianconi, Ginestra/AAE-4114-2020; Bianconi, Antonio/J-3997-2013; Fratini, Michela/AAC-1048-2019; Bianconi, Ginestra/I-5742-2018; Campi, Gaetano/H-1981-2018	Poccia, Nicola/0000-0001-7982-0113; Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Antonio/0000-0001-9795-3913; Fratini, Michela/0000-0003-3118-4335; Bianconi, Ginestra/0000-0002-3380-887X; Campi, Gaetano/0000-0001-9845-9394	European STREP [517039]; Sapienza University of Rome	European STREP(European Commission); Sapienza University of Rome	We are grateful to the ID13 beamline staff at ESRF, R. Davies, S. Agrestini, V. Palmisano, E. J. Sarria, L. Simonelli and A. Vittorini Orgeas for help in the early stage of this research project. We thank J. Zaanen and G. Bianconi for suggestions, comments and help with the data analysis. This experimental work has been carried out with the financial support of the European STREP project 517039 "Controlling Mesoscopic Phase Separation'' (COMEPHS) (2005-2008) and Sapienza University of Rome, research project "Stripes and High-T<INF>c</INF> Superconductivity''.	Agrestini S, 2003, J PHYS A-MATH GEN, V36, P9133, DOI 10.1088/0305-4470/36/35/302; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; BEDNORZ JG, 1986, Z PHYS B, V64, P193; Bianconi A, 2005, J SUPERCOND, V18, P625, DOI 10.1007/s10948-005-0047-5; Bianconi A, 1998, PHYSICA C, V296, P269, DOI 10.1016/S0921-4534(97)01825-X; Bishop AR, 2008, J PHYS CONF SER, V108, DOI 10.1088/1742-6596/108/1/012027; Caivano R, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/1/014004; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cojoc D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2821245; Cubrovic M, 2009, SCIENCE, V325, P439, DOI 10.1126/science.1174962; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Daubechies I., 1992, SOC IND APPL MATH, DOI [DOI 10.1137/1.9781611970104, 10.1137/1.9781611970104]; Evans PG, 2002, SCIENCE, V295, P1042, DOI 10.1126/science.1066870; Frello T, 1997, PHYSICA C, V282, P1089, DOI 10.1016/S0921-4534(97)00649-7; Hammel PC, 1998, PHYS REV B, V57, pR712, DOI 10.1103/PhysRevB.57.R712; Kusmartsev FV, 2000, PHYS LETT A, V275, P118, DOI 10.1016/S0375-9601(00)00555-7; Lee YS, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.020502; Liu LH, 2005, PHYSICA C, V425, P37, DOI 10.1016/j.physc.2005.05.014; Liu QQ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.100506; Lorenz B, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144522; Mohottala HE, 2006, NAT MATER, V5, P377, DOI 10.1038/nmat1633; Muller KA, 2005, STRUCT BOND, V114, P1, DOI 10.1007/b101015; Phillips JC, 2010, P NATL ACAD SCI USA, V107, P1307, DOI 10.1073/pnas.0913002107; Poccia N, 2010, ADV COND MATTER PHYS, V2010, DOI 10.1155/2010/261849; Savici AT, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.014524; Skinner S. J., 2003, MATER TODAY, V6, P30, DOI 10.1016/S1369-7021(03)00332-8; Soh YA, 2002, J APPL PHYS, V91, P7742, DOI 10.1063/1.1455609; Tokura Y, 2006, REP PROG PHYS, V69, P797, DOI 10.1088/0034-4885/69/3/R06; WADHAWAN VK, 2007, MONOGR PHYS CHEM MAT, V65	29	207	209	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					841	844		10.1038/nature09260	http://dx.doi.org/10.1038/nature09260			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703301	Green Submitted			2022-12-28	WOS:000280766100030
J	McPherron, SP; Alemseged, Z; Marean, CW; Wynn, JG; Reed, D; Geraads, D; Bobe, R; Bearat, HA				McPherron, Shannon P.; Alemseged, Zeresenay; Marean, Curtis W.; Wynn, Jonathan G.; Reed, Denne; Geraads, Denis; Bobe, Rene; Bearat, Hamdallah A.			Evidence for stone-tool-assisted consumption of animal tissues before 3.39 million years ago at Dikika, Ethiopia	NATURE			English	Article							HAMMERSTONE PERCUSSION; HADAR FORMATION; BONE SURFACES; CUT MARKS; HOMININ; BEHAVIOR; PLEISTOCENE; HYPOTHESIS; DIAGNOSIS; TURKANA	The oldest direct evidence of stone tool manufacture comes from Gona (Ethiopia) and dates to between 2.6 and 2.5 million years (Myr) ago(1). At the nearby Bouri site several cut-marked bones also show stone tool use approximately 2.5 Myr ago(2). Here we report stone-tool-inflicted marks on bones found during recent survey work in Dikika, Ethiopia, a research area close to Gona and Bouri. On the basis of low-power microscopic and environmental scanning electron microscope observations, these bones show unambiguous stone-tool cut marks for flesh removal and percussion marks for marrow access. The bones derive from the Sidi Hakoma Member of the Hadar Formation. Established (40)Ar-(39)Ar dates on the tuffs that bracket this member constrain the finds to between 3.42 and 3.24 Myr ago, and stratigraphic scaling between these units and other geological evidence indicate that they are older than 3.39 Myr ago. Our discovery extends by approximately 800,000 years the antiquity of stone tools and of stone-tool-assisted consumption of ungulates by hominins; furthermore, this behaviour can now be attributed to Australopithecus afarensis.	[McPherron, Shannon P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Alemseged, Zeresenay] Calif Acad Sci, Dept Anthropol, San Francisco, CA 94118 USA; [Marean, Curtis W.] Arizona State Univ, Inst Human Origins, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Wynn, Jonathan G.] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Reed, Denne] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Geraads, Denis] CNRS, UPR 2147, F-75014 Paris, France; [Bobe, Rene] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Bearat, Hamdallah A.] Arizona State Univ, Sch Engn Matter Transport & Energy, Ira A Fulton Sch Engn, Tempe, AZ 85287 USA	Max Planck Society; California Academy of Sciences; Arizona State University; Arizona State University-Tempe; State University System of Florida; University of South Florida; University of Texas System; University of Texas Austin; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University System of Georgia; University of Georgia; Arizona State University; Arizona State University-Tempe	McPherron, SP (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, DeutscherPl 6, D-04103 Leipzig, Germany.	mcpherron@eva.mpg.de	Wynn, Jonathan/C-1646-2010; McPherron, Shannon/C-9958-2010; Bearat, Hamdallah/Z-1388-2019; Geraads, Denis/AAY-6051-2020; GERAADS, Denis/AAC-7241-2021	McPherron, Shannon/0000-0002-2063-468X; Bearat, Hamdallah/0000-0001-7350-0792; GERAADS, Denis/0000-0003-2475-8011; Bobe, Rene/0000-0001-9059-2203	Authority for Research and Conservation of Cultural Heritage; National Museum of Ethiopia; Ministry of Tourism and Culture; Afar regional government; California Academy of Sciences	Authority for Research and Conservation of Cultural Heritage; National Museum of Ethiopia; Ministry of Tourism and Culture; Afar regional government; California Academy of Sciences	We thank the Authority for Research and Conservation of Cultural Heritage, the National Museum of Ethiopia, the Ministry of Tourism and Culture and the Afar regional government for permits and support; C. Mesfin, Z. Bedaso, T. Gebreselassie, Mesfin Mekonnen, H. Defar, A. Zerihun, G. Senbeto, Mogues Mekonnen, W. Aberra, T. Yifru and the people of the Dikika area for field assistance. We also thank the administration of Adaytu town and members of the Ethiopian armed forces. Funds for the 2009 field season were provided by the California Academy of Sciences. Travel expenses for D. G., S. P. M., D. R. and J.G.W. were covered by their respective institutions. C. W. M. and H. A. B. acknowledge the assistance of the research professionals in the John M. Cowley Center for High Resolution Electron Microscopy, LE-CSSS, ASU in conducting the ESEM imaging, and J. Thompson and S. Lansing for participating in the blind test. Z. A. thanks P. Mollard and K. Berge for assistance during fieldwork preparations.	Alemseged Z, 2005, J HUM EVOL, V49, P499, DOI 10.1016/j.jhevol.2005.06.001; Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Campisano CJ, 2007, THESIS RUTGERS U; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Chavaillon J., 1976, EARLIEST MAN ENV LAK, P565; de Heinzelin J, 1999, SCIENCE, V284, P625; Dominguez-Rodrigo A, 2007, J HUM EVOL, V53, P427, DOI 10.1016/j.jhevol.2007.05.010; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dupont-Nivet G, 2008, GEOL SOC AM SPEC PAP, V446, P67, DOI 10.1130/2008.2446(03); Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; GIFFORDGONZALEZ D, 1991, J ANTHROPOL ARCHAEOL, V10, P215, DOI 10.1016/0278-4165(91)90014-O; KIBUNJIA M, 1994, J HUM EVOL, V27, P159, DOI 10.1006/jhev.1994.1040; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Lisiecki L, 2005, PALEOCEANOGRAPHY, V20, P522; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pickering TR, 2008, J ANTHROPOL ARCHAEOL, V27, P30, DOI 10.1016/j.jaa.2007.07.002; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; White T.D., 1992, PREHISTORIC CANNIBAL; Wynn JG, 2006, NATURE, V443, P332, DOI 10.1038/nature05048; Wynn JG, 2008, GEOL SOC AM SPEC PAP, V446, P87, DOI 10.1130/2008.2446(04)	30	378	391	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					857	860		10.1038/nature09248	http://dx.doi.org/10.1038/nature09248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20703305				2022-12-28	WOS:000280766100034
J	Leach, J; Jack, B; Romero, J; Jha, AK; Yao, AM; Franke-Arnold, S; Ireland, DG; Boyd, RW; Barnett, SM; Padgett, MJ				Leach, Jonathan; Jack, Barry; Romero, Jacqui; Jha, Anand K.; Yao, Alison M.; Franke-Arnold, Sonja; Ireland, David G.; Boyd, Robert W.; Barnett, Stephen M.; Padgett, Miles J.			Quantum Correlations in Optical Angle-Orbital Angular Momentum Variables	SCIENCE			English	Article							PODOLSKY-ROSEN PARADOX; PARAMETRIC DOWN-CONVERSION; LIGHT; POSITION; ENTANGLEMENT; REALIZATION; VIOLATION; ENTROPY; STATES; BEAMS	Entanglement of the properties of two separated particles constitutes a fundamental signature of quantum mechanics and is a key resource for quantum information science. We demonstrate strong Einstein, Podolsky, and Rosen correlations between the angular position and orbital angular momentum of two photons created by the nonlinear optical process of spontaneous parametric down-conversion. The discrete nature of orbital angular momentum and the continuous but periodic nature of angular position give rise to a special sort of entanglement between these two variables. The resulting correlations are found to be an order of magnitude stronger than those allowed by the uncertainty principle for independent (nonentangled) particles. Our results suggest that angular position and orbital angular momentum may find important applications in quantum information science.	[Leach, Jonathan; Jack, Barry; Romero, Jacqui; Franke-Arnold, Sonja; Ireland, David G.; Padgett, Miles J.] Univ Glasgow, Dept Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland; [Jha, Anand K.; Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Yao, Alison M.; Barnett, Stephen M.] Univ Strathclyde, Dept Phys, SUPA, Glasgow G4 0NG, Lanark, Scotland	University of Glasgow; University of Rochester; University of Strathclyde	Padgett, MJ (corresponding author), Univ Glasgow, Dept Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland.	m.padgett@physics.gla.ac.uk	Franke-Arnold, Sonja/C-6927-2009; Padgett, Miles J/B-7625-2008; Ireland, David/N-4957-2019; Romero, Mary Jacquiline/A-1249-2013; Ireland, David G/E-8618-2010	Franke-Arnold, Sonja/0000-0002-2375-4206; Padgett, Miles J/0000-0001-6643-0618; Ireland, David/0000-0001-7713-7011; Romero, Mary Jacquiline/0000-0002-5840-2606; Ireland, David G/0000-0001-7713-7011; Yao, Alison/0000-0002-6260-5852; Leach, Jonathan/0000-0003-3561-4953; Barnett, Stephen/0000-0003-0733-4524	UK Engineering and Physical Sciences Research Council; European Commission [FP7-ICT-221906]; U.S. Department of Defense Multidisciplinary University Research Initiative; Engineering and Physical Sciences Research Council [EP/G011656/1, EP/G011567/1] Funding Source: researchfish; EPSRC [EP/G011656/1, EP/G011567/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. Department of Defense Multidisciplinary University Research Initiative(MURI); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is supported by the UK Engineering and Physical Sciences Research Council. S. F. A. is a Research Councils UK Research Fellow. S. M. B. and M.J.P. thank the Royal Society and the Wolfson Foundation. We thank J. Gotte and D. Oi for useful discussions. We acknowledge the financial support of the Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission, under the FET Open grant agreement HIDEAS number FP7-ICT-221906. We would like to thank Hamamatsu for their support of this work. A.K.J. and R. W. B. were supported by a U.S. Department of Defense Multidisciplinary University Research Initiative award. The experiment was devised by J.L., M.J.P., and A.K.J. and performed by J.L., B.J., and J.R. D. I. designed the coincidence-counting electronics. S. M. B. and A.M.Y. formulated the inequalities. The results were interpreted and the manuscript drafted by M.J.P., S. M. B., A.M.Y., J.L., R. W. B., and S. F. A., with further inputs from all authors.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Arlt J, 1999, PHYS REV A, V59, P3950, DOI 10.1103/PhysRevA.59.3950; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; BARNETT SM, 1989, PHYS REV A, V40, P2404, DOI 10.1103/PhysRevA.40.2404; BARNETT SM, 1989, J MOD OPTIC, V36, P7, DOI 10.1080/09500348914550021; BARNETT SM, 1990, PHYS REV A, V42, P6713, DOI 10.1103/PhysRevA.42.6713; BAZHENOV VY, 1990, JETP LETT+, V52, P429; Bell J. S., 1987, SPEAKABLE UNSPEAKABL; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BIALYNICKIBIRULA I, 1975, COMMUN MATH PHYS, V44, P129, DOI 10.1007/BF01608825; Boyer V, 2008, SCIENCE, V321, P544, DOI 10.1126/science.1158275; Collins D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.040404; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; FORBES GM, 2003, J PHYS MATH GEN, V36, P1; Franke-Arnold S, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/103; Franke-Arnold S, 2008, LASER PHOTONICS REV, V2, P299, DOI 10.1002/lpor.200810007; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; GONZALEZ AR, 1995, PHYS LETT A, V205, P247, DOI 10.1016/0375-9601(95)00582-N; Gotte JB, 2006, J MOD OPTIC, V53, P627, DOI 10.1080/009500340500227075; Grosshans F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.047905; Howell JC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.210403; KWIAT PG, 1993, PHYS REV A, V47, pR2472, DOI 10.1103/PhysRevA.47.R2472; Langford NK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.053601; Lassen M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.163602; Leach J, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/055; Leach J, 2009, OPT EXPRESS, V17, P8287, DOI 10.1364/OE.17.008287; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Pegg DT, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/062; Pors JB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.120502; Reid MD, 2009, REV MOD PHYS, V81, P1727, DOI 10.1103/RevModPhys.81.1727; REID MD, 1989, PHYS REV A, V40, P913, DOI 10.1103/PhysRevA.40.913; Stutz M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2752728; Torres JP, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.050301; Vaziri A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.240401; Wagner K, 2008, SCIENCE, V321, P541, DOI 10.1126/science.1159663; Walborn SP, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.160505; WALBORN SP, 2009, ARXIV09074263V1; Yao E, 2006, OPT EXPRESS, V14, P13089, DOI 10.1364/OE.14.013089	38	418	429	11	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					662	665		10.1126/science.1190523	http://dx.doi.org/10.1126/science.1190523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689014				2022-12-28	WOS:000280602700033
J	Love, ER; Bhattacharya, S; Smith, NC; Bhattacharya, S				Love, Eleanor R.; Bhattacharya, Siladitya; Smith, Norman C.; Bhattacharya, Sohinee			Effect of interpregnancy interval on outcomes of pregnancy after miscarriage: retrospective analysis of hospital episode statistics in Scotland	BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; SPONTANEOUS-ABORTION; SUBSEQUENT PREGNANCY; PERINATAL OUTCOMES; PRETERM DELIVERY; WOMEN; RISK; HEALTH; GRIEF	Objective To determine the optimum interpregnancy interval after miscarriage in a first recorded pregnancy. Design Population based retrospective cohort study. Setting Scottish hospitals between 1981 and 2000. Participants 30 937 women who had a miscarriage in their first recorded pregnancy and subsequently became pregnant. Main outcome measures The primary end point was miscarriage, live birth, termination, stillbirth, or ectopic pregnancy in the second pregnancy. Secondary outcomes were rates of caesarean section and preterm delivery, low birthweight infants, pre-eclampsia, placenta praevia, placental abruption, and induced labour in the second pregnancy. Results Compared with women with an interpregnancy interval of 6-12 months, those who conceived again within six months were less likely to have another miscarriage (adjusted odds ratio 0.66, 95% confidence interval 0.57 to 0.77), termination (0.43, 0.33 to 0.57), or ectopic pregnancy (0.48, 0.34 to 0.69). Women with an interpregnancy interval of more than 24 months were more likely to have an ectopic second pregnancy (1.97, 1.42 to 2.72) or termination (2.40, 1.91 to 3.01). Compared with women with an interpregnancy interval of 6-12 months, women who conceived again within six months and went on to have a live birth in the second pregnancy were less likely to have a caesarean section (0.90, 0.83 to 0.98), preterm delivery (0.89, 0.81 to 0.98), or infant of low birth weight (0.84, 0.71 to 0.89) but were more likely to have an induced labour (1.08, 1.02 to 1.23). Conclusions Women who conceive within six months of an initial miscarriage have the best reproductive outcomes and lowest complication rates in a subsequent pregnancy.	[Bhattacharya, Sohinee] Aberdeen Matern Hosp, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZD, Scotland; [Love, Eleanor R.; Bhattacharya, Siladitya] Univ Aberdeen, Aberdeen, Scotland; [Smith, Norman C.] Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Bhattacharya, S (corresponding author), Aberdeen Matern Hosp, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZD, Scotland.	sohinee.bhattacharya@abdn.ac.uk		Bhattacharya, Sohinee/0000-0002-2358-5860	Chief Scientist's Office in Scotland [CZG_2_283]; Chief Scientist Office [CZG/2/283] Funding Source: researchfish	Chief Scientist's Office in Scotland; Chief Scientist Office	This research was partially funded by the Chief Scientist's Office in Scotland (project No CZG_2_283). SB and SohB were employed by the University of Aberdeen at the time of doing this research and are independent from the funders. ERL is a medical student and NCS is employed by NHS Grampian. The findings and their interpretation in this study are the authors' own, and neither the funders nor the sponsors played any part in arriving at the conclusions.	Aref-Adib M., 2008, OBSTET GYNAECOL REPR, V18, P43, DOI [10.1016/j.ogrm.2007.12.001, DOI 10.1016/J.OGRM.2007.12.001]; Basso O, 1998, INT J EPIDEMIOL, V27, P642, DOI 10.1093/ije/27.4.642; Bhattacharya S, 2008, BJOG-INT J OBSTET GY, V115, P1623, DOI 10.1111/j.1471-0528.2008.01943.x; COLE SK, 1980, PERINATAL AUDIT SURV, P39; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; CONDEAGUDELO A, 2005, INT J GYNECOL OBSTET, V89, P34; Cuisinier M, 1996, J PSYCHOSOM OBST GYN, V17, P168, DOI 10.3109/01674829609025678; DaVanzo J, 2007, BJOG-INT J OBSTET GY, V114, P1079, DOI 10.1111/j.1471-0528.2007.01338.x; Franche RL, 1999, INF MENTAL HLTH J, V20, P175, DOI 10.1002/(SICI)1097-0355(199922)20:2<175::AID-IMHJ5>3.3.CO;2-H; Fuentes-Afflick E, 2000, OBSTET GYNECOL, V95, P383, DOI 10.1016/S0029-7844(99)00583-9; Goldstein RRP, 2002, AM J OBSTET GYNECOL, V186, P1230, DOI 10.1067/mob.2002.123741; Hassan MAM, 2005, HUM REPROD, V20, P657, DOI 10.1093/humrep/deh670; HATHOUT H, 1982, INT J GYNECOL OBSTET, V20, P145, DOI 10.1016/0020-7292(82)90028-5; MILLER JE, 1991, FAM PLANN PERSPECT, V23, P62, DOI 10.2307/2135451; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Nabukera SK, 2009, ARCH GYNECOL OBSTET, V279, P677, DOI 10.1007/s00404-008-0793-2; RAWLINGS JS, 1995, NEW ENGL J MED, V332, P69, DOI 10.1056/NEJM199501123320201; Royal College of Obstetricians and Gynaecologists, 2010, MAN GEST TROPH DIS; RUD B, 1985, ACTA OBSTET GYN SCAN, V64, P277, DOI 10.3109/00016348509155129; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Smits LJM, 2001, LANCET, V358, P2074, DOI 10.1016/S0140-6736(01)07105-7; Thomson F, 2005, BJOG-INT J OBSTET GY, V112, P632, DOI 10.1111/j.1471-0528.2004.00489.x; WHO, 2005, REP WHO TECHN CONS B; WILCOX AJ, 1988, NEW ENGL J MED, V319, P89; WYSS P, 1994, J PERINAT MED, V22, P235, DOI 10.1515/jpme.1994.22.3.235; Zhu Bao-Ping, 2003, Matern Child Health J, V7, P169, DOI 10.1023/A:1025184304391; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	28	54	58	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 5	2010	341								c3967	10.1136/bmj.c3967	http://dx.doi.org/10.1136/bmj.c3967			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636WK	20688842	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000280774200005
J	Jain, S				Jain, Shaili			The Role of Paraprofessionals in Providing Treatment for Posttraumatic Stress Disorder in Low-Resource Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; TESTIMONY; PROGRAM		[Jain, Shaili] Natl Ctr PTSD, VA Palo Alto Hlth Care Syst, Menlo Pk Div, Menlo Pk, CA 94025 USA; [Jain, Shaili] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Menlo Pk, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Jain, S (corresponding author), Natl Ctr PTSD, VA Palo Alto Hlth Care Syst, Menlo Pk Div, 795 Willow Rd, Menlo Pk, CA 94025 USA.	shaili.jain@va.gov						Agger I., 1990, J TRAUMA STRESS, V3, P115, DOI DOI 10.1002/JTS.2490030109; CIENFUEGOS AJ, 1983, AM J ORTHOPSYCHIAT, V53, P43, DOI 10.1111/j.1939-0025.1983.tb03348.x; Dowling FG, 2006, AM J PSYCHIAT, V163, P151, DOI 10.1176/appi.ajp.163.1.151; FOA EB, 2009, PRACTICE GUIDELINES, P551; GOENJIAN A, 1993, BRIT J PSYCHIAT, V163, P230, DOI 10.1192/bjp.163.2.230; Neuner F, 2008, J CONSULT CLIN PSYCH, V76, P686, DOI 10.1037/0022-006X.76.4.686; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Weine SM, 1998, AM J PSYCHIAT, V155, P1720, DOI 10.1176/ajp.155.12.1720	9	19	19	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					571	572		10.1001/jama.2010.1096	http://dx.doi.org/10.1001/jama.2010.1096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682940				2022-12-28	WOS:000280525700028
J	DeMarco, B				DeMarco, Brian			PHYSICS An Atomic View of Quantum Phase Transitions	SCIENCE			English	Editorial Material							OPTICAL LATTICE; ULTRACOLD ATOMS; MOTT INSULATOR; SINGLE ATOMS; GASES		Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	DeMarco, B (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	bdemarco@illinois.edu		DeMarco, Brian/0000-0002-2791-0413				Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Bernier JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061601; Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; Bloch I, 2008, SCIENCE, V319, P1202, DOI 10.1126/science.1152501; Hung CL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160403; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Paiva T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066406; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Wurtz P, 2010, APPL PHYS B-LASERS O, V98, P641, DOI 10.1007/s00340-009-3861-9	15	2	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					523	524		10.1126/science.1193401	http://dx.doi.org/10.1126/science.1193401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671178				2022-12-28	WOS:000280483500023
J	Huisman, J				Huisman, Jef			Comment on "Patterns of Diversity in Marine Phytoplankton"	SCIENCE			English	Editorial Material							STABLE COEXISTENCE; COMPETITION; PLANKTON; TESTS; LIGHT		Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands	University of Amsterdam	Huisman, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, POB 94248, NL-1090 GE Amsterdam, Netherlands.	j.huisman@uva.nl	Huisman, Jef/A-1089-2013	Huisman, Jef/0000-0001-9598-3211				Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Beninca E, 2008, NATURE, V451, P822, DOI 10.1038/nature06512; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Descamps-Julien B, 2005, ECOLOGY, V86, P2815, DOI 10.1890/04-1700; Floder S, 1999, LIMNOL OCEANOGR, V44, P1114; Grover J. P., 1997, RESOURCE COMPETITION; Hubbell Stephen P., 2001, V32, pi; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; Stomp M, 2004, NATURE, V432, P104, DOI 10.1038/nature03044; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747; Tilman D., 1982, Monographs in Population Biology, pi	15	12	12	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991								10.1126/science.1189880	http://dx.doi.org/10.1126/science.1189880			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671171				2022-12-28	WOS:000280483500014
J	Bolland, MJ; Avenell, A; Baron, JA; Grey, A; MacLennan, GS; Gamble, GD; Reid, IR				Bolland, Mark J.; Avenell, Alison; Baron, John A.; Grey, Andrew; MacLennan, Graeme S.; Gamble, Greg D.; Reid, Ian R.			Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-D SUPPLEMENTATION; HEART-DISEASE MORTALITY; CORONARY-ARTERY CALCIFICATION; RANDOMIZED CONTROLLED-TRIAL; NORMAL OLDER WOMEN; BONE LOSS; BLOOD-PRESSURE; SERUM-CALCIUM; FRACTURES; PREVENTION	Objective To investigate whether calcium supplements increase the risk of cardiovascular events. Design Patient level and trial level meta-analyses. Data sources Medline, Embase, and Cochrane Central Register of Controlled Trials (1966-March 2010), reference lists of meta-analyses of calcium supplements, and two clinical trial registries. Initial searches were carried out in November 2007, with electronic database searches repeated in March 2010. Study selection Eligible studies were randomised, placebo controlled trials of calcium supplements (>= 500 mg/day), with 100 or more participants of mean age more than 40 years and study duration more than one year. The lead authors of eligible trials supplied data. Cardiovascular outcomes were obtained from self reports, hospital admissions, and death certificates. Results 15 trials were eligible for inclusion, five with patient level data (8151 participants, median follow-up 3.6 years, interquartile range 2.7-4.3 years) and 11 with trial level data (11 921 participants, mean duration 4.0 years). In the five studies contributing patient level data, 143 people allocated to calcium had a myocardial infarction compared with 111 allocated to placebo (hazard ratio 1.31, 95% confidence interval 1.02 to 1.67, P=0.035). Non-significant increases occurred in the incidence of stroke (1.20, 0.96 to 1.50, P=0.11), the composite end point of myocardial infarction, stroke, or sudden death (1.18, 1.00 to 1.39, P=0.057), and death (1.09, 0.96 to 1.23, P=0.18). The meta-analysis of trial level data showed similar results: 296 people had a myocardial infarction (166 allocated to calcium, 130 to placebo), with an increased incidence of myocardial infarction in those allocated to calcium (pooled relative risk 1.27, 95% confidence interval 1.01 to 1.59, P=0.038). Conclusions Calcium supplements (without coadministered vitamin D) are associated with an increased risk of myocardial infarction. As calcium supplements are widely used these modest increases in risk of cardiovascular disease might translate into a large burden of disease in the population. A reassessment of the role of calcium supplements in the management of osteoporosis is warranted.	[Bolland, Mark J.; Grey, Andrew; Gamble, Greg D.; Reid, Ian R.] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1142, New Zealand; [Avenell, Alison; MacLennan, Graeme S.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland; [Baron, John A.] Dartmouth Med Sch, Dept Med, Hanover, NH USA; [Baron, John A.] Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA	University of Auckland; University of Aberdeen; Dartmouth College; Dartmouth College	Reid, IR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Med, Private Bag 92 019, Auckland 1142, New Zealand.	i.reid@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Reid, Ian/0000-0001-6021-5458; Gamble, Greg/0000-0003-0412-3203; MacLennan, Graeme/0000-0002-1039-5646	Health Research Council of New Zealand; University of Auckland School of Medicine Foundation; Scottish government health directorates; NATIONAL CANCER INSTITUTE [R01CA098286] Funding Source: NIH RePORTER; Chief Scientist Office [HSRU1] Funding Source: researchfish	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland School of Medicine Foundation; Scottish government health directorates; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chief Scientist Office	This review was funded by the Health Research Council of New Zealand and the University of Auckland School of Medicine Foundation. AA is funded by a career scientist award of the chief scientist office of the Scottish government health directorates. The Health Services Research Unit is funded by the chief scientist office of the Scottish government health directorates. The sponsors of the study had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The authors are independent from the funders.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Al-Delaimy WK, 2003, AM J CLIN NUTR, V77, P814, DOI 10.1093/ajcn/77.4.814; *AM ASS CLIN END, 2003, ENDOCR PRACT, V9, P545; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell A, 2009, COCHRANE DB SYST REV, V2; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Bonnick S, 2007, CURR MED RES OPIN, V23, P1341, DOI 10.1185/030079907X188035; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; Chung M, 2009, 183 AG HEALTHC RES Q; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; DEMER LL, 1995, CIRCULATION, V92, P2029, DOI 10.1161/01.CIR.92.8.2029; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELDERS PJM, 1991, J CLIN ENDOCR METAB, V73, P533, DOI 10.1210/jcem-73-3-533; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Green JH, 2003, ASIA PAC J CLIN NUTR, V12, P109; Griffith LE, 1999, AM J HYPERTENS, V12, P84, DOI 10.1016/S0895-7061(98)00224-6; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Iso H, 1999, STROKE, V30, P1772, DOI 10.1161/01.STR.30.9.1772; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jorde R, 1999, HYPERTENSION, V34, P484, DOI 10.1161/01.HYP.34.3.484; KNOX EG, 1973, LANCET, V1, P1465; Lappe JM, 2008, BRIT MED J, V336, P403, DOI 10.1136/bmj.39493.476667.1F; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; *NAT OST FDN, 2008, PHYS GUID PREV TREAT; Nilsson IL, 2002, J BONE MINER RES, V17, pN68; Peacock M, 2000, J CLIN ENDOCR METAB, V85, P3011, DOI 10.1210/jc.85.9.3011; Pentti K, 2009, MATURITAS, V63, P73, DOI 10.1016/j.maturitas.2009.03.006; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Reid IR, 2005, J CLIN ENDOCR METAB, V90, P3824, DOI 10.1210/jc.2004-2205; REID IR, 1995, AM J MED, V98, P331, DOI 10.1016/S0002-9343(99)80310-6; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; REID IR, 1986, AUST NZ J MED, V16, P193, DOI 10.1111/j.1445-5994.1986.tb01147.x; Reid IR, 2002, AM J MED, V112, P343, DOI 10.1016/S0002-9343(01)01138-X; REID IR, 2010, CLIN ENDOCRINOL OXF; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; SMITH EL, 1989, AM J CLIN NUTR, V50, P833, DOI 10.1093/ajcn/50.4.833; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; VANDERVIJVER LPL, 1992, INT J EPIDEMIOL, V21, P36, DOI 10.1093/ije/21.1.36; Vestergaard P, 2003, WORLD J SURG, V27, P216, DOI 10.1007/s00268-002-6541-z; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Weingarten MA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003548.pub3	58	701	725	1	59	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2010	341								c3691	10.1136/bmj.c3691	http://dx.doi.org/10.1136/bmj.c3691			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634HA	20671013	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000280570200001
J	Worner, HJ; Bertrand, JB; Kartashov, DV; Corkum, PB; Villeneuve, DM				Woerner, H. J.; Bertrand, J. B.; Kartashov, D. V.; Corkum, P. B.; Villeneuve, D. M.			Following a chemical reaction using high-harmonic interferometry	NATURE			English	Article							MULTIPHOTON IONIZATION; MULTIELECTRON DYNAMICS; CROSS-SECTIONS; GENERATION; MOLECULES; SPECTROSCOPY; DIFFRACTION; CONTINUUM	The study of chemical reactions on the molecular (femtosecond) timescale typically uses pump laser pulses to excite molecules and subsequent probe pulses to interrogate them. The ultrashort pump pulse can excite only a small fraction of molecules, and the probe wavelength must be carefully chosen to discriminate between excited and unexcited molecules. The past decade has seen the emergence of new methods that are also aimed at imaging chemical reactions as they occur, based on X-ray diffraction(1), electron diffraction(2) or laser-induced recollision(3,4)-with spectral selection not available for any of these new methods. Here we show that in the case of high-harmonic spectroscopy based on recollision, this apparent limitation becomes a major advantage owing to the coherent nature of the attosecond high-harmonic pulse generation. The coherence allows the unexcited molecules to act as local oscillators against which the dynamics are observed, so a transient grating technique(5,6) can be used to reconstruct the amplitude and phase of emission from the excited molecules. We then extract structural information from the amplitude, which encodes the internuclear separation, by quantum interference at short times and by scattering of the recollision electron at longer times. The phase records the attosecond dynamics of the electrons, giving access to the evolving ionization potentials and the electronic structure of the transient molecule. In our experiment, we are able to document a temporal shift of the high-harmonic field of less than an attosecond (1 as = 10(-18) s) between the stretched and compressed geometry of weakly vibrationally excited Br-2 in the electronic ground state. The ability to probe structural and electronic features, combined with high time resolution, make high-harmonic spectroscopy ideally suited to measuring coupled electronic and nuclear dynamics occurring in photochemical reactions and to characterizing the electronic structure of transition states.	[Woerner, H. J.; Bertrand, J. B.; Kartashov, D. V.; Corkum, P. B.; Villeneuve, D. M.] Natl Res Council Canada, Joint Lab Attosecond Sci, Ottawa, ON K1A 0R6, Canada; [Woerner, H. J.; Bertrand, J. B.; Kartashov, D. V.; Corkum, P. B.; Villeneuve, D. M.] Univ Ottawa, Ottawa, ON K1A 0R6, Canada; [Kartashov, D. V.] Vienna Univ Technol, Inst Photon, A-1040 Vienna, Austria	National Research Council Canada; University of Ottawa; Technische Universitat Wien	Villeneuve, DM (corresponding author), Natl Res Council Canada, Joint Lab Attosecond Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	david.villeneuve@nrc.ca	Wörner, Hans Jakob/B-1802-2013; Villeneuve, David M/I-4140-2012	Villeneuve, David M/0000-0002-2810-3648; Corkum, Paul/0000-0003-3394-5572	Canadian Institute for Photonic Innovation; NSERC; AFOSR; Swiss National Science Foundation (SNF)	Canadian Institute for Photonic Innovation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Funding from Canadian Institute for Photonic Innovation, NSERC and AFOSR is acknowledged. H.J.W. thanks the Swiss National Science Foundation (SNF) for a fellowship.	Bisgaard CZ, 2009, SCIENCE, V323, P1464, DOI 10.1126/science.1169183; Bucksbaum PH, 2007, SCIENCE, V317, P766, DOI 10.1126/science.1142135; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Domcke, 2004, ADV SER PHYS CHEM, V15; EICHLER HJ, 1986, LASER INDUCED DYNAMI, pCH2; Gessner O, 2006, SCIENCE, V311, P219, DOI 10.1126/science.1120779; HUBER KP, 1979, MOL SPECTRA MOL STRU, V4, P106; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Itatani J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123902; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Kanai T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153904; Le VH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.013414; Lein M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.183903; Lezius M, 2001, PHYS REV LETT, V86, P51, DOI 10.1103/PhysRevLett.86.51; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; Litvinyuk IV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033003; Mairesse Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143903; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Nugent-Glandorf L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.193002; Nugent-Glandorf L, 2002, J CHEM PHYS, V117, P6108, DOI 10.1063/1.1504084; Park H, 1996, J CHEM PHYS, V104, P4568, DOI 10.1063/1.471205; Rakitzis TP, 2002, J CHEM PHYS, V116, P9228, DOI 10.1063/1.1473801; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Wagner NL, 2006, P NATL ACAD SCI USA, V103, P13279, DOI 10.1073/pnas.0605178103; Wang ZM, 2000, PHYS REV LETT, V84, P3795, DOI 10.1103/PhysRevLett.84.3795; Wernet P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.013001; Worner HJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.103901; Zimmermann B, 2008, NAT PHYS, V4, P649, DOI 10.1038/nphys993	30	352	358	8	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					604	607		10.1038/nature09185	http://dx.doi.org/10.1038/nature09185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671706	Green Published			2022-12-28	WOS:000280412100049
J	Green, DR; Wang, RN				Green, Douglas R.; Wang, Ruoning			Calcium and Energy: Making the Cake and Eating It too?	CELL			English	Editorial Material									[Green, Douglas R.; Wang, Ruoning] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; VINCENCIO JM, 2009, CELL DEATH DIFFER, V20, P1006	9	16	16	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					200	202		10.1016/j.cell.2010.07.007	http://dx.doi.org/10.1016/j.cell.2010.07.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655464	Bronze			2022-12-28	WOS:000280204300012
J	Rosen, CJ; Motyl, KJ				Rosen, Clifford J.; Motyl, Katherine J.			No Bones About It: Insulin Modulates Skeletal Remodeling	CELL			English	Editorial Material							METABOLISM; EXPRESSION; GLUCOSE; MICE		[Rosen, Clifford J.; Motyl, Katherine J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA	Maine Medical Center	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA.	rosenc@mmc.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045433] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR045433] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Clowes JA, 2003, J CLIN ENDOCR METAB, V88, P4867, DOI 10.1210/jc.2002-021447; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Kaji H, 2009, J BONE MINER METAB, V27, P76, DOI 10.1007/s00774-008-0005-y; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366	7	23	23	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					198	200		10.1016/j.cell.2010.07.001	http://dx.doi.org/10.1016/j.cell.2010.07.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655463	Bronze			2022-12-28	WOS:000280204300011
J	Cole-King, A; Leppina, P				Cole-King, Alys; Leppina, Peter			Personal View Will the new UK government change our approach to risk?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leppina, Peter] Glyndwr Univ, Wrexham, Wales	Glyndwr University		alys.cole-king@wales.nhs.uk	Cole-King, Alys/AAF-9890-2020					Cole-King A, 2010, BRIT J GEN PRACT, V60, P3, DOI 10.3399/bjgp10X482022	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2010	341								c3890	10.1136/bmj.c3890	http://dx.doi.org/10.1136/bmj.c3890			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GW	20659980				2022-12-28	WOS:000280411700020
J	Crandall, CJ				Crandall, Carolyn J.			Lasofoxifene reduced vertebral fractures in postmenopausal women with osteoporosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Los Angeles, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Crandall, CJ (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.							Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-11	10.7326/0003-4819-153-2-201007200-02011	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643977				2022-12-28	WOS:000280095400029
J	Song, J; Ratner, ER; Wall, MM; Bartels, DM; Ulvestad, N; Petroskas, D; West, M; Weber-Main, AM; Grengs, L; Gelberg, L				Song, John; Ratner, Edward R.; Wall, Melanie M.; Bartels, Dianne M.; Ulvestad, Nancy; Petroskas, Dawn; West, Melissa; Weber-Main, Anne Marie; Grengs, Leah; Gelberg, Lillian			Effect of an End-of-Life Planning Intervention on the Completion of Advance Directives in Homeless Persons A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							DECISION-MAKING; MEDICAL-CARE; PREFERENCES; PEOPLE; HEALTH; WOMEN; ATTITUDES; DISPARITIES; DOCUMENTS; MORTALITY	Background: Few interventions have focused on improving end-of-life care for underserved populations, such as homeless persons. Objective: To determine whether homeless persons will complete a counseling session on advance care planning and fill out a legal advance directive designed to assess care preferences and preserve the dignity of marginalized persons. Design: Prospective, single-blind, randomized trial comparing self-guided completion of an advance directive with professionally assisted advance care planning. (ClinicalTrials.gov registration number: NCT00546884) Setting: 8 sites serving homeless persons in Minneapolis, Minnesota. Participants: 262 homeless persons recruited between November 2007 and August 2008. Intervention: Minimal, self-guided intervention consisting of advance directive forms and written educational information versus a one-on-one advance planning intervention consisting of counseling and completing an advance directive with a social worker. Measurements: Rate of advance directive completion, assessed by inspection of completed documents. Results: The overall completion rate for advance directives was 26.7% (95% CI, 21.5% to 32.5%), with a higher rate in the counselor-guided group (37.9%) than in the self-guided group (12.8%) (CI of adjusted difference, 15.3 to 34.3 percentage points). This difference persisted across all sites and most subgroups. The advance directive's 4 clinical scenarios found a preference for surrogate decision making in 29% to 34% of written responses. Limitations: Sampling was limited to a more stable subset of the homeless population in Minneapolis and may have been subject to selection bias. Modest compensation to complete the preintervention survey could have influenced participants to complete advance directives. Conclusion: Both a simple and complex intervention successfully engaged a diverse sample of homeless persons in advance care planning. One-on-one assistance significantly increased the completion rate. Homeless persons can respond to an intervention to plan for end-of-life care and can express specific preferences for care or a surrogate decision maker, but additional studies are needed to assess the effect of these directives on subsequent care.	[Song, John] Univ Minnesota, Ctr Bioeth, Sch Med, Sch Publ Hlth, Minneapolis, MN 55455 USA; Vet Affairs Med Ctr, Minneapolis, MN USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Song, J (corresponding author), Univ Minnesota, Ctr Bioeth, Sch Med, Sch Publ Hlth, N504 Boynton Hall,410 Church St SE, Minneapolis, MN 55455 USA.	songx006@umn.edu	Wall, Melanie/AAE-7828-2019	Weber-Main, Anne/0000-0002-2059-4681	National Institute for Nursing Research; National Center on Minority Health and Health Disparities [RO1-NR009815]	National Institute for Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Grant Support: By the National Institute for Nursing Research and the National Center on Minority Health and Health Disparities (RO1-NR009815).	Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Bartels DM, 2008, J CLIN ETHIC, V19, P214; BREAKEY WR, 1989, JAMA-J AM MED ASSOC, V262, P1352, DOI 10.1001/jama.262.10.1352; Buchanan D, 2007, MED EDUC, V41, P346, DOI 10.1111/j.1365-2929.2007.02705.x; BURT MR, 1996, HOMELESSNESS AM, P15; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; Coppola KM, 1999, DEATH STUD, V23, P617, DOI 10.1080/074811899200803; Degenholtz HB, 2003, CRIT CARE MED, V31, pS373, DOI 10.1097/01.CCM.0000065121.62144.0D; Degenholtz HB, 2002, J AM GERIATR SOC, V50, P378, DOI 10.1046/j.1532-5415.2002.50073.x; Dobalian A, 2006, ARCH GERONTOL GERIAT, V43, P193, DOI 10.1016/j.archger.2005.10.007; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; GELBERG L, 1989, JAMA-J AM MED ASSOC, V262, P1973, DOI 10.1001/jama.262.14.1973; Gerald L B, 2000, J Cardiopulm Rehabil, V20, P340, DOI 10.1097/00008483-200011000-00002; GREENLAND S, 1991, BIOMETRICS, V47, P319, DOI 10.2307/2532517; Grimaldo DA, 2001, ANESTHESIOLOGY, V95, P43, DOI 10.1097/00000542-200107000-00012; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; Ho VWK, 2000, AIDS CARE, V12, P97, DOI 10.1080/09540120047512; Hopp FP, 2000, GERONTOLOGIST, V40, P449, DOI 10.1093/geront/40.4.449; Jezewski MA, 2007, J AGING HEALTH, V19, P519, DOI 10.1177/0898264307300198; Kiely DK, 2001, J AM GERIATR SOC, V49, P1346, DOI 10.1046/j.1532-5415.2001.49263.x; Kwak J, 2005, GERONTOLOGIST, V45, P634, DOI 10.1093/geront/45.5.634; Landry FJ, 1997, J GEN INTERN MED, V12, P412, DOI 10.1046/j.1525-1497.1997.00072.x; Lim YW, 2002, MED CARE, V40, P510; LINK BG, 1994, AM J PUBLIC HEALTH, V84, P1907, DOI 10.2105/AJPH.84.12.1907; LUPTAK MK, 1994, GERONTOLOGIST, V34, P409; McAuley WJ, 2006, GERONTOLOGIST, V46, P377, DOI 10.1093/geront/46.3.377; McKinley ED, 1996, J GEN INTERN MED, V11, P651, DOI 10.1007/BF02600155; Meier DE, 1996, ARCH INTERN MED, V156, P1227, DOI 10.1001/archinte.156.11.1227; *MN DEP HLTH, 1998, INF B MINN DEP HLTH, V984; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; Munoz M, 1999, J COMMUNITY PSYCHOL, V27, P73, DOI 10.1002/(SICI)1520-6629(199901)27:1<73::AID-JCOP5>3.0.CO;2-#; *NAT COAL HOM, 2009, HOW MAN PEOPL HOM; *NIH, 2004, NAT I HLTH STAT OF T; Nishimura A, 2007, MAYO CLIN PROC, V82, P1480, DOI 10.4065/82.12.1480; Norris WM, 2005, CHEST, V127, P2180, DOI 10.1378/chest.127.6.2180; Phipps E, 2003, J CLIN ONCOL, V21, P549, DOI 10.1200/JCO.2003.12.080; Prendergast TJ, 2001, CRIT CARE MED, V29, pN34, DOI 10.1097/00003246-200102001-00007; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; Resnick Barbara, 2002, J Am Acad Nurse Pract, V14, P517, DOI 10.1111/j.1745-7599.2002.tb00084.x; Richter K P, 1995, Arch Fam Med, V4, P609, DOI 10.1001/archfami.4.7.609; Schirm V, 1996, APPL NURS RES, V9, P93, DOI 10.1016/S0897-1897(96)80479-4; Schwartz Carolyn E, 2004, J Palliat Med, V7, P233, DOI 10.1089/109662104773709350; SILVERMAN HJ, 1995, ARCH INTERN MED, V155, P502, DOI 10.1001/archinte.155.5.502; Song J, 2005, J CLIN ETHIC, V16, P251; Song J, 2007, J GEN INTERN MED, V22, P427, DOI 10.1007/s11606-006-0045-8; Song J, 2007, J GEN INTERN MED, V22, P435, DOI 10.1007/s11606-006-0046-7; Song J, 2008, J GEN INTERN MED, V23, P2031, DOI 10.1007/s11606-008-0771-1; Stein JA, 2002, CHILD ABUSE NEGLECT, V26, P1011, DOI 10.1016/S0145-2134(02)00382-4; Tarzian Anita J, 2005, J Palliat Med, V8, P36, DOI 10.1089/jpm.2005.8.36; Teno JM, 2004, ANN INTERN MED, V141, P159, DOI 10.7326/0003-4819-141-2-200407200-00017; Teno JM, 1997, J AM GERIATR SOC, V45, P508, DOI 10.1111/j.1532-5415.1997.tb05179.x; Tulsky JA, 1997, J CLIN ETHIC, V8, P150; UGARRIZA DN, 1994, NURS OUTLOOK, V42, P26, DOI 10.1016/0029-6554(94)90068-X; United States Conference of Mayors, 2007, HUNG HOM SURV STAT R; Wen CK, 2007, J GEN INTERN MED, V22, P1011, DOI 10.1007/s11606-007-0183-7; *WILD RES CTR, 2006, KEY FACTS STAT SURV; Zakrison TL, 2004, J URBAN HEALTH, V81, P596, DOI 10.1093/jurban/jth143	59	38	38	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2					76	W30		10.7326/0003-4819-153-2-201007200-00003	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628DU	20643989				2022-12-28	WOS:000280095400002
J	Ganguli, I				Ganguli, Ishani			Becoming a Physician: The Case for Primary Care -- A Medical Student's Perspective.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Ganguli, I (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; *NAT RES MATCH PRO, 2009, NAT RES MATCH PROGR; Phillips RL, 2009, SPECIALTY GEOGRAPHIC; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Wilkinson JE, 2010, FAM MED, V42, P28	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					207	209		10.1056/NEJMp0912843	http://dx.doi.org/10.1056/NEJMp0912843			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625AR	20647197				2022-12-28	WOS:000279864200003
J	Matloff, ET; Brierley, KL				Matloff, Ellen T.; Brierley, Karina L.			The double-helix derailed: the story of the BRCA patent	LANCET			English	Editorial Material							CANCER; GENETICS; PHYSICIANS; KNOWLEDGE; HEALTH; BREAST; RISKS		[Matloff, Ellen T.; Brierley, Karina L.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Yale University	Matloff, ET (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA.							*AM CIV LIB UN, 2010, BRCA SUPPL DECL E MA; BRIERLEY KL, CONNECTICUT IN PRESS; Doksum T, 2003, GENET MED, V5, P99, DOI 10.1097/01.GIM.0000055198.63593.32; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Gollust SE, 2002, JAMA-J AM MED ASSOC, V288, P1762, DOI 10.1001/jama.288.14.1762; Greendale K, 2001, AM J MED GENET, V106, P223, DOI 10.1002/ajmg.10010; Kepler TB, 2010, GENOMICS, V95, P312, DOI 10.1016/j.ygeno.2010.03.003; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1855, DOI 10.1056/NEJMp1004026; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; KORITZ S, 2009, CARLSON CRUVE   0909; Lecrubier A, 2002, EMBO REP, V3, P1120, DOI 10.1093/embo-reports/kvf251; *MYR GEN, ACC EX DALL E; *MYR GEN LAB INC, 2010, MYR FIN ASS PROGR FI; *MYR GEN LAB INC, 2009, MYR GEN ANN REP; RAY T, 2010, PHARMACOGENOMIC 0210; Westphal SP, 2002, NEW SCI, V175, P29; Wideroff L, 2005, J MED GENET, V42, P749, DOI 10.1136/jmg.2004.030296; Williams-Jones B, 2006, NEW GENET SOC, V25, P89, DOI 10.1080/14636770600603527; 2009, PHARMACOGENOMIC 0107	20	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					314	315		10.1016/S0140-6736(10)61150-6	http://dx.doi.org/10.1016/S0140-6736(10)61150-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20674708				2022-12-28	WOS:000280717900009
J	Moretti, A; Bellin, M; Welling, A; Jung, CB; Lam, JT; Bott-Flugel, L; Dorn, T; Goedel, A; Hohnke, C; Hofmann, F; Seyfarth, M; Sinnecker, D; Schomig, A; Laugwitz, KL				Moretti, Alessandra; Bellin, Milena; Welling, Andrea; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Hoehnke, Christian; Hofmann, Franz; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig			Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOMYOCYTES; GENERATION; MUTATIONS; KVLQT1; PATHOGENESIS; PROGENITORS; CHANNELS; HEART	Background: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(sub Ks) current. Methods: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. Results: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a ``ventricular,'' ``atrial,'' or ``nodal'' phenotype, as evidenced by the expression of cell-type-specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in ``ventricular'' and ``atrial'' cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q-KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(sub Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. Conclusions: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.) N Engl J Med 2010;363:1397-1409.	[Moretti, Alessandra; Bellin, Milena; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, Div Cardiol, D-81675 Munich, Germany; [Hoehnke, Christian] Tech Univ Munich, Klinikum Rechts Isar, Dept Plast Surg, D-81675 Munich, Germany; [Moretti, Alessandra; Bellin, Milena; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig] Tech Univ Munich, German Heart Ctr Munich, Dept Cardiol, D-81675 Munich, Germany; [Welling, Andrea; Hofmann, Franz] Tech Univ Munich, Inst Pharmacol & Toxicol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; Technical University of Munich	Laugwitz, KL (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, Div Cardiol, Ismaninger Str 22, D-81675 Munich, Germany.	klaugwitz@med1.med.tum.de	Moretti, Alessandra/O-9271-2015; Bellin, Milena/M-2311-2014; Dorn, Tatjana/O-6817-2015; Goedel, Alexander/AAX-3900-2020; Welling, Andrea/K-6674-2017	Moretti, Alessandra/0000-0001-5782-7832; Bellin, Milena/0000-0001-5380-6743; Goedel, Alexander/0000-0002-5980-2257; Welling, Andrea/0000-0002-5364-4980; Bott-Flugel, Lorenz/0000-0003-0932-1241; Sinnecker, Daniel/0000-0002-8116-9750	European Research Council (Marie Curie Excellence Team) [MEXT-23208]; German Research Foundation [923, La 1238 3-1/4-1]; German Ministry for Education and Research [01 GN 0826]	European Research Council (Marie Curie Excellence Team)(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by grants from the European Research Council (Marie Curie Excellence Team Grant, MEXT-23208), the German Research Foundation (Research Unit 923 and La 1238 3-1/4-1), and the German Ministry for Education and Research (01 GN 0826).	Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Freund C, 2010, NETH HEART J, V18, P51; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Imredy JP, 2008, AM J PHYSIOL-HEART C, V295, pH1867, DOI 10.1152/ajpheart.433.2008; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Laugwitz KL, 2007, NATURE, V446, P934, DOI 10.1038/nature05790; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lerche C, 2007, MOL PHARMACOL, V72, P796; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Pan N, 2009, CELL SIGNAL, V21, P349, DOI 10.1016/j.cellsig.2008.11.006; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 2001, EUROPACE, V3, P16, DOI 10.1053/eupc.2000.0141; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Vyas H, 2006, CIRCULATION, V113, P1385, DOI 10.1161/CIRCULATIONAHA.105.600445; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	41	868	899	0	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1397	1409		10.1056/NEJMoa0908679	http://dx.doi.org/10.1056/NEJMoa0908679			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20660394	Green Published			2022-12-28	WOS:000282575100005
J	Kim, K; Doi, A; Wen, B; Ng, K; Zhao, R; Cahan, P; Kim, J; Aryee, MJ; Ji, H; Ehrlich, LIR; Yabuuchi, A; Takeuchi, A; Cunniff, KC; Hongguang, H; Mckinney-Freeman, S; Naveiras, O; Yoon, TJ; Irizarry, RA; Jung, N; Seita, J; Hanna, J; Murakami, P; Jaenisch, R; Weissleder, R; Orkin, SH; Weissman, IL; Feinberg, AP; Daley, GQ				Kim, K.; Doi, A.; Wen, B.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Aryee, M. J.; Ji, H.; Ehrlich, L. I. R.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Yoon, T. J.; Irizarry, R. A.; Jung, N.; Seita, J.; Hanna, J.; Murakami, P.; Jaenisch, R.; Weissleder, R.; Orkin, S. H.; Weissman, I. L.; Feinberg, A. P.; Daley, G. Q.			Epigenetic memory in induced pluripotent stem cells	NATURE			English	Article							MAMMALIAN-CELLS; DNA METHYLATION; IPS CELLS; DIFFERENTIATION; TISSUE; GENERATION; MICE; ACTIVATION; MICROARRAY; SYSTEM	Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an 'epigenetic memory' of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer more readily establishes the ground state of pluripotency than factor-based reprogramming, which can leave an epigenetic memory of the tissue of origin that may influence efforts at directed differentiation for applications in disease modelling or treatment.	[Doi, A.; Wen, B.; Ji, H.; Irizarry, R. A.; Jung, N.; Murakami, P.; Feinberg, A. P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Doi, A.; Wen, B.; Ji, H.; Irizarry, R. A.; Jung, N.; Murakami, P.; Feinberg, A. P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Orkin, S. H.; Daley, G. Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kim, J.; Orkin, S. H.] Childrens Hosp, Howard Hughes Med Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Aryee, M. J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Ehrlich, L. I. R.; Seita, J.; Weissman, I. L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Yoon, T. J.; Weissleder, R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA; [Hanna, J.; Jaenisch, R.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA.	afeinberg@jhu.edu; george.daley@childrens.harvard.edu	Wen, Bo/P-5332-2019; Aryee, Martin/AAC-8113-2020; McKinney-Freeman, Shannon/N-8161-2018; Kim, Jonghwan/AAR-2815-2021; Feinberg, Andrew/AAY-7666-2020; Hanna, Jacob/K-1339-2012; jia, xu/A-8386-2016; Seita, Jun/AAM-1478-2020	Wen, Bo/0000-0003-0394-7366; McKinney-Freeman, Shannon/0000-0001-8061-2557; Hanna, Jacob/0000-0003-2042-9974; Seita, Jun/0000-0002-3008-3615; Naveiras, Olaia/0000-0003-3434-0022; Feinberg, Andrew/0000-0002-8364-1991; Kim, Jonghwan/0000-0002-9919-9843; Cahan, Patrick/0000-0003-3652-2540; Ji, Hong/0000-0002-9558-0620; /0000-0003-0828-4143; Ehrlich, Lauren/0000-0002-1697-1755	NIH [RO1-DK70055, RO1-DK59279, K99HL093212-01, R37CA054358, P50HG003233, R01AI047457, R01AI047458, CA86065, HL099999]; American Recovery and Reinvestment Act [RC2-HL102815]; LLS [3567-07]; Cooley's Anemia Foundation; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine [T1-00001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA086065, R37CA054358] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, K99HL093212, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047458, R01AI047457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059279, R01DK070055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; LLS; Cooley's Anemia Foundation; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	G.Q.D is an investigator of the Howard Hughes Medical Institute and was supported by NIH grants RO1-DK70055 and RO1-DK59279, and special funds received under the American Recovery and Reinvestment Act (RC2-HL102815). K. K. was supported by NIH (K99HL093212-01), LLS (3567-07) and Cooley's Anemia Foundation. A.P.F was funded by NIH grants R37CA054358 and P50HG003233. I.L.W. was funded by NIH grants R01AI047457, R01AI047458, CA86065 and HL099999, and the Thomas and Stacey Siebel Foundation. L.I.R.E. was supported by a Special Fellow Career Development award from the Leukemia and Lymphoma Society. J.S. is supported by a fellowship from the California Institute for Regenerative Medicine (T1-00001). We acknowledge K. Hochedlinger for sharing his manuscript before publication.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Bourne S, 2004, TISSUE ENG, V10, P796, DOI 10.1089/1076327041348293; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HOOD RCWS, 1948, STAIN TECHNOL, V23, P209, DOI 10.3109/10520294809106251; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirov G, 2003, GENOMICS, V82, P433, DOI 10.1016/S0888-7543(03)00167-8; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nadin BM, 2003, BLOOD, V102, P2436, DOI 10.1182/blood-2003-01-0118; NOMIZU T, 1994, ANAL CHEM, V66, P3000, DOI 10.1021/ac00091a004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; WDZIEKONSKI B, 2007, CURR PROTOC CELL BIO, V23; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	54	1563	1625	1	500	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					285	U60		10.1038/nature09342	http://dx.doi.org/10.1038/nature09342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20644535	Green Accepted, Green Submitted			2022-12-28	WOS:000281824900030
J	Tooley, CES; Petkowski, JJ; Muratore-Schroeder, TL; Balsbaugh, JL; Shabanowitz, J; Sabat, M; Minor, W; Hunt, DF; Macara, IG				Tooley, Christine E. Schaner; Petkowski, Janusz J.; Muratore-Schroeder, Tara L.; Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Sabat, Michal; Minor, Wladek; Hunt, Donald F.; Macara, Ian G.			NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein	NATURE			English	Article							AMINO-ACID; RIBOSOME; DIMETHYLPROLINE; SUBUNIT; H2B	The post-translational methylation of alpha-amino groups was first discovered over 30 years ago on the bacterial ribosomal proteins L16 and L33 (refs 1, 2), but almost nothing is known about the function or enzymology of this modification. Several other bacterial and eukaryotic proteins have since been shown to be alpha-N-methylated(3-10). However, the Ran guanine nucleotide-exchange factor, RCC1, is the only protein for which any biological function of alpha-N-methylation has been identified(3,11). Methylation-defective mutants of RCC1 have reduced affinity for DNA and cause mitotic defects(3,11), but further characterization of this modification has been hindered by ignorance of the responsible methyltransferase. All fungal and animal N-terminally methylated proteins contain a unique N-terminal motif, Met-(Ala/Pro/Ser)Pro-Lys, indicating that they may be targets of the same, unknown enzyme(3,12). The initiating Met is cleaved, and the exposed alpha-amino group is mono-, di- or trimethylated. Here we report the discovery of the first alpha-N-methyltransferase, which we named N-terminal RCC1 methyltransferase (NRMT). Substrate docking and mutational analysis of RCC1 defined the NRMT recognition sequence and enabled the identification of numerous new methylation targets, including SET (also known as TAF-I or PHAPII) and the retinoblastoma protein, RB. Knockdown of NRMT recapitulates the multi-spindle phenotype seen with methylation-defective RCC1 mutants(3), demonstrating the importance of alpha-N-methylation for normal bipolar spindle formation and chromosome segregation.	[Tooley, Christine E. Schaner; Petkowski, Janusz J.; Macara, Ian G.] Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Petkowski, Janusz J.; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Muratore-Schroeder, Tara L.; Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Sabat, Michal; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Tooley, CES (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	ces5g@virginia.edu	Hunt, Donald F/I-6936-2012; Minor, Wladek/F-3096-2014; Petkowski, Janusz Jurand/GPT-0474-2022; Petkowski, Janusz Jurand/T-4792-2019	Hunt, Donald F/0000-0003-2815-6368; Minor, Wladek/0000-0001-7075-7090; Petkowski, Janusz Jurand/0000-0002-1921-4848; Petkowski, Janusz Jurand/0000-0002-1921-4848; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, R01GM050526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from the National Institutes of Health to I.G.M., D.F.H., and W.M.; C.E.S.T. was the recipient of a post-doctoral fellowship from the National Institutes of Health.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLOOM KS, 1978, J BIOL CHEM, V253, P4446; Boyer SN, 1996, CANCER RES, V56, P4620; BROSIUS J, 1976, FEBS LETT, V68, P105, DOI 10.1016/0014-5793(76)80415-2; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Grimm R, 1997, FEBS LETT, V408, P350, DOI 10.1016/S0014-5793(97)00462-6; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; HENRY GD, 1982, FEBS LETT, V144, P11, DOI 10.1016/0014-5793(82)80558-9; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; MARTINAGE A, 1985, EUR J BIOCHEM, V147, P351, DOI 10.1111/j.1432-1033.1985.tb08757.x; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; NOMOTO M, 1982, J BIOCHEM-TOKYO, V91, P897, DOI 10.1093/oxfordjournals.jbchem.a133778; PETTIGREW GW, 1977, NATURE, V265, P661, DOI 10.1038/265661a0; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; WITTMANNLIEBOLD B, 1976, FEBS LETT, V68, P115, DOI 10.1016/0014-5793(76)80417-6; Yamamoto H, 1999, CLIN CANCER RES, V5, P1805; Yu WS, 2008, MOL CELLS, V26, P443	23	81	94	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1125	1128		10.1038/nature09343	http://dx.doi.org/10.1038/nature09343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20668449	Green Accepted			2022-12-28	WOS:000281203600044
J	Burton, DR; Weiss, RA				Burton, Dennis R.; Weiss, Robin A.			A Boost for HIV Vaccine Design	SCIENCE			English	Editorial Material							ANTIBODIES; GP120; BROAD		[Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] MIT & Harvard, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA; [Weiss, Robin A.] UCL, Div Infect & Immun, London W1T 4JF, England	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of London; University College London	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu; r.weiss@ucl.ac.uk						Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Koh WWL, 2010, J BIOL CHEM, V285, P19116, DOI 10.1074/jbc.M110.116699; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	14	55	61	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					770	773		10.1126/science.1194693	http://dx.doi.org/10.1126/science.1194693			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705840				2022-12-28	WOS:000280809900026
J	Dunlop, BW				Dunlop, Boadie W.			Should Sensitive Information From Clinical Trials Be Included in Electronic Medical Records?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Dunlop, BW (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1256 Briarcliff Rd NE,Bldg A,3rd Floor, Atlanta, GA 30322 USA.	bdunlop@emory.edu	Dunlop, Boadie/N-3362-2017	Dunlop, Boadie/0000-0002-4653-0483	NCATS NIH HHS [KL2 TR000455, UL1 TR000454] Funding Source: Medline; NCRR NIH HHS [KL2 RR025009, 1KL2-RR025009, UL1 RR025008] Funding Source: Medline; NIMH NIH HHS [K23 MH086690] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000455, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, KL2RR025009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH086690] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AM PSYCH ASS, 1991, DISCL PSYCH TREATM R, P1; *DEP HLTH HUM SERV, 2009, GUID IND INV RESP PR, P7; Dolan B., 2004, PSYCHIATRIST, V28, P53, DOI DOI 10.1192/PB.28.2.53; Kim D, 2010, J CLIN ETHIC, V21, P30; *NAT PUBL RAD, 2009, PUBL HLTH CAR DEL SY; *NIH OFF EXTR RES, CERT CONF BACKGR INF; PEAR R, 2009, NY TIMES        0117; Salomon RM, 2010, J AM MED INFORM ASSN, V17, P54, DOI 10.1197/jamia.M3341; Singh Jerome Amir, 2009, Acta Trop, V112 Suppl 1, pS71, DOI 10.1016/j.actatropica.2009.07.032; STEFAN S, 2001, HOLLOW PROMISES EMPL, P19	10	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					685	686		10.1001/jama.2010.1117	http://dx.doi.org/10.1001/jama.2010.1117			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	637PA	20699463	Green Accepted			2022-12-28	WOS:000280829200027
J	Goulielmakis, E; Loh, ZH; Wirth, A; Santra, R; Rohringer, N; Yakovlev, VS; Zherebtsov, S; Pfeifer, T; Azzeer, AM; Kling, MF; Leone, SR; Krausz, F				Goulielmakis, Eleftherios; Loh, Zhi-Heng; Wirth, Adrian; Santra, Robin; Rohringer, Nina; Yakovlev, Vladislav S.; Zherebtsov, Sergey; Pfeifer, Thomas; Azzeer, Abdallah M.; Kling, Matthias F.; Leone, Stephen R.; Krausz, Ferenc			Real-time observation of valence electron motion	NATURE			English	Article							ATTOSECOND; DYNAMICS; IONIZATION	The superposition of quantum states drives motion on the atomic and subatomic scales, with the energy spacing of the states dictating the speed of the motion. In the case of electrons residing in the outer (valence) shells of atoms and molecules which are separated by electronvolt energies, this means that valence electron motion occurs on a subfemtosecond to few-femtosecond timescale (1 fs = 10(-15) s). In the absence of complete measurements, the motion can be characterized in terms of a complex quantity, the density matrix. Here we report an attosecond pump-probe measurement of the density matrix of valence electrons in atomic krypton ions(1). We generate the ions with a controlled few-cycle laser field(2) and then probe them through the spectrally resolved absorption of an attosecond extreme-ultraviolet pulse(3), which allows us to observe in real time the subfemtosecond motion of valence electrons over a multifemtosecond time span. We are able to completely characterize the quantum mechanical electron motion and determine its degree of coherence in the specimen of the ensemble. Although the present study uses a simple, prototypical open system, attosecond transient absorption spectroscopy should be applicable to molecules and solid-state materials to reveal the elementary electron motions that control physical, chemical and biological properties and processes.	[Goulielmakis, Eleftherios; Wirth, Adrian; Yakovlev, Vladislav S.; Zherebtsov, Sergey; Kling, Matthias F.; Krausz, Ferenc] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Loh, Zhi-Heng; Pfeifer, Thomas; Leone, Stephen R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Loh, Zhi-Heng; Pfeifer, Thomas; Leone, Stephen R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Loh, Zhi-Heng; Pfeifer, Thomas; Leone, Stephen R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Santra, Robin] Argonne Natl Lab, Argonne, IL 60439 USA; [Santra, Robin] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Rohringer, Nina] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Yakovlev, Vladislav S.; Krausz, Ferenc] Univ Munich, Dept Phys, D-85748 Garching, Germany; [Azzeer, Abdallah M.] King Saud Univ, Dept Phys & Astron, Riyadh 11451, Saudi Arabia	Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Munich; King Saud University	Goulielmakis, E (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	elgo@mpq.mpg.de; srl@berkeley.edu; krausz@lmu.de	Rohringer, Nina/B-8030-2012; Loh, Zhi-Heng/B-6952-2011; Yakovlev, Vladislav S/C-4091-2015; Goulielmakis, Eleftherios/AAZ-1052-2020; Rohringer, Nina/AAI-9477-2020; Kling, Matthias F/D-3742-2014; Hädrich, Steffen/B-4331-2008; Rohringer, Nina/N-3238-2014; Santra, Robin/E-8332-2014; Azzeer, Abdallah M/A-4542-2011; Goulielmakis, Eleftherios/F-1693-2011; Kling, Matthias Friedrich/AHH-0080-2022	Loh, Zhi-Heng/0000-0001-9729-9632; Yakovlev, Vladislav S/0000-0002-0648-9375; Rohringer, Nina/0000-0001-7905-3567; Rohringer, Nina/0000-0001-7905-3567; Santra, Robin/0000-0002-1442-9815; Azzeer, Abdallah M/0000-0001-8334-9256; Goulielmakis, Eleftherios/0000-0003-3386-0245; Kling, Matthias Friedrich/0000-0002-1710-0775	Max Planck Society; King Saud University; DFG Cluster of Excellence: Munich Centre for Advanced Photonics; Marie-Curie Reintegration grant [MERG-CT-2007-208643]; DFG; Air Force Office of Scientific Research [FA9550-04-1-0242]; National Science Foundation [CHE-0742662, EEC-0310717]; Office of Science, Office of Basic Energy Sciences, US Department of Energy [DE-AC02-05-CH11231, DE-AC02-06CH11357]; MPG; US Department of Energy, Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Max Planck Society(Max Planck SocietyFoundation CELLEX); King Saud University(King Saud University); DFG Cluster of Excellence: Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Marie-Curie Reintegration grant(European Commission); DFG(German Research Foundation (DFG)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE)); MPG(Max Planck Society); US Department of Energy, Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	We thank U. Kleineberg, M. Hofstetter and M. Fiess for invaluable contributions. This work was supported by the Max Planck Society, the Nobel Program of King Saud University and the DFG Cluster of Excellence: Munich Centre for Advanced Photonics (http://www.munich-photonics.de). E. G. acknowledges a Marie-Curie Reintegration grant (MERG-CT-2007-208643). A. W., S.Z. and M. F. K. acknowledge support by the Emmy Noether programme of the DFG. Z.-H.L., T. P. and S. R. L. acknowledge support from the Air Force Office of Scientific Research (FA9550-04-1-0242), the National Science Foundation (CHE-0742662 and EEC-0310717) and the Director, Office of Science, Office of Basic Energy Sciences, US Department of Energy (DE-AC02-05-CH11231). T. P. acknowledges support from the MPRG program of the MPG. R. S. is supported by the Office of Basic Energy Sciences, Office of Science, US Department of Energy (DE-AC02-06CH11357). Part of this work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory (DE-AC52-07NA27344). S. R. L. gratefully acknowledges appointment as a Miller Research Professor in the Miller Institute for Basic Research in Science.	Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bucksbaum PH, 2007, SCIENCE, V317, P766, DOI 10.1126/science.1142135; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Gubbini E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.053602; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Jones RR, 1997, ADV ATOM MOL OPT PHY, V38, P1; Jurvansuu M, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012502; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Loh ZH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.143601; Loh ZH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2925268; MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359; Niikura H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.083003; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; POLLARD WT, 1990, J CHEM PHYS, V92, P4012, DOI 10.1063/1.457815; Ramunno L, 2008, SPRINGER SER OPT SCI, V134, P225, DOI 10.1007/978-0-387-34755-4_10; Rohringer N, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053402; Rottke H, 1996, J PHYS B-AT MOL OPT, V29, P1479, DOI 10.1088/0953-4075/29/8/012; Saloman EB, 2007, J PHYS CHEM REF DATA, V36, P215, DOI 10.1063/1.2227036; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Santra R, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.043403; Schoffler MS, 2008, SCIENCE, V320, P920, DOI 10.1126/science.1154989; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Southworth SH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043421; Young L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083601; Yudin GL, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.051401; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h	30	868	881	10	495	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					739	U7		10.1038/nature09212	http://dx.doi.org/10.1038/nature09212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686571	Green Published			2022-12-28	WOS:000280562500035
J	Vinck, P; Pham, PN				Vinck, Patrick; Pham, Phuong N.			Association of Exposure to Violence and Potential Traumatic Events With Self-reported Physical and Mental Health Status in the Central African Republic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOPKINS SYMPTOM CHECKLIST-25; MORTALITY; DEPRESSION; RATES; WAR; QUESTIONNAIRE; PREVALENCE; ATTITUDES; VALIDITY; DARFUR	Context For decades, the Central African Republic (CAR) has experienced violence, economic stagnation, and institutional failure. The latest wave of violence erupted in 2001 and continues to this day in some areas. Yet there has been little attention to the conflict and even less research to document and quantify the conflict's human cost. Objective To study levels of violence in CAR, including mortality levels, and the association between exposure to violence and traumatic events with self-reported physical and mental health status. Design, Setting, and Participants Multistage stratified cluster random survey of 1879 adults 18 years or older in selected households conducted in 5 administrative units of CAR (3 in the south, which has been free from recent violence, and 2 in the north, in which violence continues) between October and December 2009. Main Outcome Measures Mortality, morbidity, exposure to potential traumatic events, sense of insecurity, and meeting of symptom criteria for depression and anxiety using the Hopkins Symptom Checklist-25 with a cut-off score of 1.75. Results The crude mortality rate (CMR) was 4.9 deaths (95% confidence interval [CI], 4.6-5.1) per 1000 population per month and self-reported CMR due to violence was 0.8 deaths(95% CI, 0.6-1.0) per 1000 population per month. Thirty-five percent reported their physical health status as being good or very good while 29% described it as bad or very bad. Respondents in northern prefectures reported higher rates of mortality, exposure to trauma, and insecurity and lower levels of physical health and access to health services compared with those in the south. The estimated prevalences of symptoms of depression and anxiety were 55.3% (95% CI, 51.6%-59.0%) and 52.5% (95% CI, 48.1%-56.8%), respectively. Exposure to violence and self-reported physical health were statistically associated with mental health outcomes (P<.001). Anxiety symptom scores were higher for respondents in the northern prefectures than those in the south (t=2.54, P=.01). Conclusion A high proportion of adult respondents in CAR reported witnessing or having personally experienced traumatic events over the course of the conflicts, and more than half met symptom criteria for depression and anxiety. JAMA. 2010;304(5):544-552 www.jama.com	[Vinck, Patrick; Pham, Phuong N.] Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA; [Pham, Phuong N.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Vinck, Patrick; Pham, Phuong N.] Tulane Univ, Payson Ctr Int Dev, New Orleans, LA 70118 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tulane University	Vinck, P (corresponding author), Univ Calif Berkeley, Human Rights Ctr, 460 Stephens Hall 2300, Berkeley, CA 94720 USA.	pvinck@berkeley.edu		Pham, Phuong/0000-0002-5696-2933	John D. and Catherine T. MacArthur Foundation, Chicago, Illinois; Humanity United, Redwood City, California; Vulnerable Populations Initiative at University of California, Berkeley	John D. and Catherine T. MacArthur Foundation, Chicago, Illinois; Humanity United, Redwood City, California; Vulnerable Populations Initiative at University of California, Berkeley	The work was supported by grants from the John D. and Catherine T. MacArthur Foundation, Chicago, Illinois, and Humanity United, Redwood City, California.; The study was part of the Vulnerable Populations Initiative at University of California, Berkeley. We thank the respondents, interviewers, and partners in the field for their support. Neil Hendrick, BA, contributed to field supervision. Roger Sherwin, MD, Tulane University; Jennie Sherwin, BA; and Alexander Truong, MD, MPH, Johns Hopkins University, provided invaluable comments on the manuscript. Mr Hendrick was paid to assist with field work. Dr Sherwin, Ms Sherwin, and Dr Truong did not receive compensation for their contributions.	ADLER RJ, 1994, STOCH PROC APPL, V49, P1, DOI 10.1016/0304-4149(94)90109-0; ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839; BERMAN EG, 2006, CENTRAL AFRICAN REPU; BOGUE DJ, 1950, J AM STAT ASSOC, V45, P149, DOI 10.2307/2280675; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Debos M, 2008, AFR AFFAIRS, V107, P225, DOI 10.1093/afraf/adn004; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; DEJONG J, 2004, TRAUMA WAR VIOLENCE; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Fergusson DM, 2002, PSYCHOL MED, V32, P991, DOI 10.1017/S0033291702005986; Iacopino V, 2001, AM J PUBLIC HEALTH, V91, P2013, DOI 10.2105/AJPH.91.12.2013; International Crisis Group, 2007, 136 INT CRIS GROUP; International Federation for Human Rights, 2003, WAR CRIM CENTR AFR R; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Lhewa D, 2007, ASSESSMENT, V14, P223, DOI 10.1177/1073191106298876; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Mollica RF, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P34; Oruc L., 2008, INT J CULTURE MENTAL, V1, P105, DOI [DOI 10.1080/17542860802456620, 10.1080/17542860802456620]; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; ROSENFIELD S, 1980, J HEALTH SOC BEHAV, V21, P33, DOI 10.2307/2136692; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Silove D, 2007, J NERV MENT DIS, V195, P152, DOI 10.1097/01.nmd.0000254747.03333.70; SPITTAELS S, MAPPING CONFLICT MOT; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Vinck P, 2008, INT J TRANSIT JUST, V2, P398, DOI 10.1093/ijtj/ijn033; Wakabi W, 2008, LANCET, V371, P15, DOI 10.1016/S0140-6736(08)60051-3	35	26	26	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					544	552		10.1001/jama.2010.1065	http://dx.doi.org/10.1001/jama.2010.1065			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682934				2022-12-28	WOS:000280525700022
J	Qaseem, A; Snow, V; Owens, DK; Shekelle, P				Qaseem, Amir; Snow, Vincenza; Owens, Douglas K.; Shekelle, Paul		Amer Coll Phys	The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE RESEARCH; PATIENT PREFERENCES; QUALITY; STRENGTH; AGENCY	The American College of Physicians (ACP) established its evidence-based clinical practice guidelines program in 1981. The ACP's Guidelines Committee and the staff of the Clinical Programs and Quality of Care Department develop the clinical recommendations. The ACP develops 2 different types of clinical recommendations: clinical practice guidelines and clinical guidance statements. The ACP clinical practice guidelines and guidance statements follow a multistep development process that includes a systematic review of the evidence, deliberation of the evidence by the committee, summary recommendations, and evidence and recommendation grading. All ACP clinical practice guidelines and clinical guidance statements, if not updated, are considered automatically withdrawn or invalid 5 years after publication or once an update has been issued.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Stanford Univ, Stanford, CA 94305 USA; RAND, Santa Monica, CA USA	American College of Physicians; Stanford University; RAND Corporation	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			American College of Physicians	American College of Physicians	Financial support for the development of this guideline comes exclusively from the American College of Physicians' operating budget.	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Institute of Medicine, 1990, CLIN PRACTICE GUIDEL; NEASE RF, 1994, MED DECIS MAKING, V14, P382, DOI 10.1177/0272989X9401400409; Owens DK, 1998, SPINE, V23, P1073, DOI 10.1097/00007632-199805010-00023; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179	10	170	192	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					194	U95		10.7326/0003-4819-153-3-201008030-00010	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679562				2022-12-28	WOS:000280557600008
J	Bid, A; Ofek, N; Inoue, H; Heiblum, M; Kane, CL; Umansky, V; Mahalu, D				Bid, Aveek; Ofek, N.; Inoue, H.; Heiblum, M.; Kane, C. L.; Umansky, V.; Mahalu, D.			Observation of neutral modes in the fractional quantum Hall regime	NATURE			English	Article							EDGE STATES; NOISE; TRANSPORT; EXCITATIONS; SCATTERING; CHARGE	The quantum Hall effect takes place in a two-dimensional electron gas under a strong magnetic field and involves current flow along the edges of the sample. For some particle-hole conjugate states of the fractional regime (for example, with fillings between 1/2 and 1 of the lowest Landau level), early predictions suggested the presence of counter-propagating edge currents in addition to the expected ones. When this did not agree with the measured conductance, it was suggested that disorder and interactions will lead to counter-propagating modes that carry only energy-the so called neutral modes. In addition, a neutral upstream mode (the Majorana mode) was expected for selected wavefunctions proposed for the even-denominator filling 5/2. Here we report the direct observation of counter-propagating neutral modes for fillings of 2/3, 3/5 and 5/2. The basis of our approach is that, if such modes impinge on a narrow constriction, the neutral quasiparticles will be partly reflected and fragmented into charge carriers, which can be detected through shot noise measurements. We find that the resultant shot noise is proportional to the injected current. Moreover, when we simultaneously inject a charge mode, the presence of the neutral mode was found to significantly affect the Fano factor and the temperature of the backscattered charge mode. In particular, such observations for filling 5/2 may single out the non-Abelian wavefunctions for the state.	[Bid, Aveek; Ofek, N.; Inoue, H.; Heiblum, M.; Umansky, V.; Mahalu, D.] Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel; [Kane, C. L.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	Weizmann Institute of Science; University of Pennsylvania	Heiblum, M (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel.	moty.heiblum@weizmann.ac.il	Umansky, Vladimir/P-1334-2019; Bid, Aveek/F-3076-2010; Kane, Charles L/A-1035-2007; heiblum, moty/Q-1193-2019	Umansky, Vladimir/0000-0001-5727-2064; Bid, Aveek/0000-0002-2378-7980; 	Israeli Science Foundation (ISF); Minerva Foundation; German Israeli Foundation (GIF); German Israeli Project Cooperation (DIP); European Research Council under the European Community [FP7/2007-2013, 227716]; US-Israel Bi-National Science Foundation; Israeli Ministry of Science and Technology; NSF [DMR 0906175]	Israeli Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation; German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); German Israeli Project Cooperation (DIP); European Research Council under the European Community(European Research Council (ERC)); US-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); NSF(National Science Foundation (NSF))	We thank D. Feldman, Y. Gefen, A. Stern and I. Neder for discussions and E. Alcobi for comments on the manuscript. The work received partial support from the Israeli Science Foundation (ISF), the Minerva Foundation, the German Israeli Foundation (GIF), the German Israeli Project Cooperation (DIP), the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement 227716, and the US-Israel Bi-National Science Foundation. N.O. acknowledges support from the Israeli Ministry of Science and Technology. C.L.K. acknowledges support from the NSF (DMR 0906175).	ASHOORI RC, 1992, PHYS REV B, V45, P3894, DOI 10.1103/PhysRevB.45.3894; Bid A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.236802; Chung YC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.216804; Das Sarma S., 1997, PERSPECTIVE QUANTUM; Dolev M, 2008, NATURE, V452, P829, DOI [10.1038/nature06855, 10.1038/natureO6855]; Dolev M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161303; Feldman DE, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.161304; Granger G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086803; Grosfeld E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.106403; Heiblum M, 2006, PHYS STATUS SOLIDI B, V243, P3604, DOI 10.1002/pssb.200642237; Johnson BL, 1997, REP PROG PHYS, V60, P889, DOI 10.1088/0034-4885/60/9/002; JOHNSON MD, 1991, PHYS REV LETT, V67, P2060, DOI 10.1103/PhysRevLett.67.2060; KANE CL, 1994, PHYS REV LETT, V72, P4129, DOI 10.1103/PhysRevLett.72.4129; KANE CL, 1995, PHYS REV B, V51, P13449, DOI 10.1103/PhysRevB.51.13449; KANE CL, 1994, PHYS REV LETT, V72, P724, DOI 10.1103/PhysRevLett.72.724; Kane CL, 1997, PHYS REV B, V55, P15832, DOI 10.1103/PhysRevB.55.15832; LEE DH, 1998, EDGE TUNNELING FRACT; Lee SS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236807; LESOVIK GB, 1989, JETP LETT+, V49, P592; Levin M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236806; Lopez A, 1999, PHYS REV B, V59, P15323, DOI 10.1103/PhysRevB.59.15323; MACDONALD AH, 1990, PHYS REV LETT, V64, P220, DOI 10.1103/PhysRevLett.64.220; MARTIN T, 1992, PHYS REV B, V45, P1742, DOI 10.1103/PhysRevB.45.1742; Milovanovic M, 1996, PHYS REV B, V53, P13559, DOI 10.1103/PhysRevB.53.13559; Overbosch BJ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.035319; OVERBOSCH BJ, 2008, PHASE TRANSITION EDG; Umansky V, 2009, J CRYST GROWTH, V311, P1658, DOI 10.1016/j.jcrysgro.2008.09.151; WEN XG, 1990, PHYS REV B, V41, P12838, DOI 10.1103/PhysRevB.41.12838	28	155	157	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					585	590		10.1038/nature09277	http://dx.doi.org/10.1038/nature09277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671702	Green Submitted			2022-12-28	WOS:000280412100045
J	Argos, M; Kalra, T; Rathouz, PJ; Chen, Y; Pierce, B; Parvez, F; Islam, T; Ahmed, A; Rakibuz-Zaman, M; Hasan, R; Sarwar, G; Slavkovich, V; van Geen, A; Graziano, J; Ahsan, H				Argos, Maria; Kalra, Tara; Rathouz, Paul J.; Chen, Yu; Pierce, Brandon; Parvez, Faruque; Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Slavkovich, Vesna; van Geen, Alexander; Graziano, Joseph; Ahsan, Habibul			Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study	LANCET			English	Article							BLADDER-CANCER MORTALITY; PERIPHERAL VASCULAR-DISEASE; ENDEMIC AREA; SUPPLY-SYSTEM; SOUTHWESTERN TAIWAN; SKIN-LESIONS; LUNG; REDUCTION; RISK; INSTALLATION	Background Millions of people worldwide are chronically exposed to arsenic through drinking water, including 35-77 million people in Bangladesh. The association between arsenic exposure and mortality rate has not been prospectively investigated by use of individual-level data. We therefore prospectively assessed whether chronic and recent changes in arsenic exposure are associated with all-cause and chronic-disease mortalities in a Bangladeshi population. Methods In the prospective cohort Health Effects of Arsenic Longitudinal Study (HEALS), trained physicians unaware of arsenic exposure interviewed in person and clinically assessed 11 746 population-based participants (aged 18-75 years) from Araihazar, Bangladesh. Participants were recruited from October, 2000, to May, 2002, and followed-up biennially. Data for mortality rates were available throughout February, 2009. We used Cox proportional hazards model to estimate hazard ratios (HRs) of mortality, with adjustment for potential confounders, at different doses of arsenic exposure. Findings 407 deaths were ascertained between October, 2000, and February, 2009. Multivariate adjusted HRs for all-cause mortality in a comparison of arsenic at concentrations of 10.1-50.0 mu g/L, 501-1500 mu g/L, and 150.1-864.0 mu g/L with at least 10.0 mu g/L in well water were 1.34 (95% CI 0.99-1.82), 1.09 (0.81-1.47), and 1.68 (1.26-2.23), respectively. Results were similar with daily arsenic dose and total arsenic concentration in urine. Recent change in exposure, measurement of total arsenic concentrations in urine repeated biennially, did not have much effect on the mortality rate. Interpretation Chronic arsenic exposure through drinking water was associated with an increase in the mortality rate. Follow-up data from this cohort will be used to assess the long-term effects of arsenic exposure and how they might be affected by changes in exposure. However, solutions and resources are urgently needed to mitigate the resulting health effects of arsenic exposure.	[Argos, Maria; Kalra, Tara; Rathouz, Paul J.; Pierce, Brandon; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Argos, Maria; Ahsan, Habibul] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Parvez, Faruque; Slavkovich, Vesna; Graziano, Joseph] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Chen, Yu] NYU, Dept Environm Med, New York, NY 10016 USA; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Columbia Univ, Dhaka, Bangladesh; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Univ Chicago, Res Off Bangladesh, Dhaka, Bangladesh; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Columbia University; Columbia University; New York University; Columbia University	Ahsan, H (corresponding author), Univ Chicago, Ctr Canc Epidemiol & Prevent, 5841 S Maryland Ave,Suite N102, Chicago, IL 60637 USA.	habib@uchicago.edu	Hug, Balthasar L./G-1568-2010	Pierce, Brandon/0000-0002-7829-952X; Chen, Yu/0000-0002-1519-4894	National Institute of Health, Bethesda, MD, USA [P42ES010349, R01CA102484, R01CA107431, P30ES009089, P30CA014599]; NATIONAL CANCER INSTITUTE [R01CA107431, R01CA102484, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institute of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research is supported by National Institute of Health, Bethesda, MD, USA (grants P42ES010349, R01CA102484, R01CA107431, P30ES009089, and P30CA014599).	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2000, J OCCUP ENVIRON MED, V42, P1195, DOI 10.1097/00043764-200012000-00016; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chang CC, 2004, J TOXICOL ENV HEAL A, V67, P1353, DOI 10.1080/15287390490471451; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Harbut MR, 2000, ARCH ENVIRON HEALTH, V55, P285; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Morales KH, 2000, ENVIRON HEALTH PERSP, V108, P655, DOI 10.2307/3434887; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; NIXON DE, 1991, CLIN CHEM, V37, P1575; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Taeger D, 2004, J OCCUP ENVIRON MED, V46, P1007, DOI 10.1097/01.jom.0000141655.00168.0d; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; Tseng CS, 2002, ANGIOLOGY, V53, P529, DOI 10.1177/000331970205300505; TSUDA T, 1995, AM J EPIDEMIOL, V141, P198, DOI 10.1093/oxfordjournals.aje.a117421; World Health Organization; Water Sanitation and Health Team, 2004, WATER SANITATION HYG; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yang CY, 2008, J TOXICOL ENV HEAL A, V71, P533, DOI 10.1080/15287390801907509; Yang CY, 2004, ARCH ENVIRON HEALTH, V59, P484, DOI 10.1080/00039890409603430; Yang CY, 2005, ENVIRON RES, V98, P127, DOI 10.1016/j.envres.2004.07.013; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	30	467	480	6	167	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					252	258		10.1016/S0140-6736(10)60481-3	http://dx.doi.org/10.1016/S0140-6736(10)60481-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20646756	Green Accepted			2022-12-28	WOS:000280457200034
J	Grabbe, KL; Bunnell, R				Grabbe, Kristina L.; Bunnell, Rebecca			Reframing HIV Prevention in Sub-Saharan Africa Using Couple-Centered Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANSMISSION		[Grabbe, Kristina L.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Bunnell, Rebecca] US Ctr Dis Control & Prevent, Div Adult & Community Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Grabbe, KL (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, 1600 Clifton Rd NE,MS E04, Atlanta, GA 30333 USA.	kgrabbe@cdc.gov						Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; *MEAS DHS MACRO IN, DEM HLTH SURV; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; UNAIDS, UN ACC SCAL PRIOR HI; UNAIDS, AIDS EP UPD DEC 2009; WASHERNA NU, 2010, REG M ARUSH TANZ MAY	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					346	347		10.1001/jama.2010.1011	http://dx.doi.org/10.1001/jama.2010.1011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639571				2022-12-28	WOS:000280107500027
J	White, RH				White, Richard H.			Review: Heparin and mechanical compression are similar in reducing postsurgical VTE risk, but heparin increases bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DEEP-VEIN THROMBOSIS; PROPHYLAXIS; REPLACEMENT		Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	White, RH (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.							Blanchard J, 1999, J BONE JOINT SURG BR, V81B, P654, DOI 10.1302/0301-620X.81B4.9464; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; SANTORI FS, 1994, J BONE JOINT SURG BR, V76B, P579, DOI 10.1302/0301-620X.76B4.8027144	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-7	10.7326/0003-4819-153-2-201007200-02007	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643985				2022-12-28	WOS:000280095400025
J	Broccoli, AJ; Klein, SA				Broccoli, Anthony J.; Klein, Stephen A.			Comment on "Observational and Model Evidence for Positive Low-Level Cloud Feedback"	SCIENCE			English	Editorial Material							COUPLED CLIMATE MODELS; PART I	Clement et al. (Reports, 24 July 2009, p. 460) provided observational evidence for systematic relationships between variations in marine low cloudiness and other climatic variables and found that most current-generation climate models were deficient in reproducing such relationships. Our analysis of one of these models (GFDL CM2.1), using more complete model output, indicates better agreement with observations, suggesting that more detailed analysis of climate model simulations is necessary.	[Broccoli, Anthony J.] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA; [Klein, Stephen A.] Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94551 USA	Rutgers State University New Brunswick; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Broccoli, AJ (corresponding author), Rutgers State Univ, Dept Environm Sci, 14 Coll Farm Rd, New Brunswick, NJ 08901 USA.	broccoli@envsci.rutgers.edu	Klein, Stephen A/H-4337-2016; Broccoli, Anthony J/D-9186-2014	Klein, Stephen A/0000-0002-5476-858X; Broccoli, Anthony J/0000-0003-2619-1434				Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Lock AP, 2000, MON WEATHER REV, V128, P3187, DOI 10.1175/1520-0493(2000)128<3187:ANBLMS>2.0.CO;2; Stott PA, 2006, J CLIMATE, V19, P2763, DOI 10.1175/JCLI3731.1; Stouffer RJ, 2006, J CLIMATE, V19, P723, DOI 10.1175/JCLI3632.1; Wittenberg AT, 2006, J CLIMATE, V19, P698, DOI 10.1175/JCLI3631.1	6	11	11	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989								10.1126/science.1186796	http://dx.doi.org/10.1126/science.1186796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647450	Green Submitted			2022-12-28	WOS:000279925900020
J	Nuesch, E; Trelle, S; Reichenbach, S; Rutjes, AWS; Tschannen, B; Altman, DG; Egger, M; Juni, P				Nueesch, Eveline; Trelle, Sven; Reichenbach, Stephan; Rutjes, Anne W. S.; Tschannen, Beatrice; Altman, Douglas G.; Egger, Matthias; Jueni, Peter			Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMPIRICAL-EVIDENCE; RANDOMIZED-TRIALS; FUNNEL PLOTS; ALLOCATION CONCEALMENT; ANTIDEPRESSANT TRIALS; SYSTEMATIC REVIEWS; PUBLICATION BIAS; HEALTH-CARE; QUALITY; KNEE	Objective To examine the presence and extent of small study effects in clinical osteoarthritis research. Design Meta-epidemiological study. Data sources 13 meta-analyses including 153 randomised trials (41 605 patients) that compared therapeutic interventions with placebo or nonintervention control in patients with osteoarthritis of the hip or knee and used patients' reported pain as an outcome. Methods We compared estimated benefits of treatment between large trials (at least 100 patients per arm) and small trials, explored funnel plots supplemented with lines of predicted effects and contours of significance, and used three approaches to estimate treatment effects: meta-analyses including all trials irrespective of sample size, meta-analyses restricted to large trials, and treatment effects predicted for large trials. Results On average, treatment effects were more beneficial in small than in large trials (difference in effect sizes -0.21, 95% confidence interval -0.34 to -0.08, P=0.001). Depending on criteria used, six to eight funnel plots indicated small study effects. In six of 13 meta-analyses, the overall pooled estimate suggested a clinically relevant, significant benefit of treatment, whereas analyses restricted to large trials and predicted effects in large trials yielded smaller non-significant estimates. Conclusions Small study effects can often distort results of meta-analyses. The influence of small trials on estimated treatment effects should be routinely assessed.	[Nueesch, Eveline; Trelle, Sven; Reichenbach, Stephan; Rutjes, Anne W. S.; Tschannen, Beatrice; Egger, Matthias; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Nueesch, Eveline; Trelle, Sven; Jueni, Peter] Univ Hosp Bern, CTU Bern, Bern, Switzerland; [Reichenbach, Stephan] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland; [Rutjes, Anne W. S.] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Lab Clin Epidemiol Cardiovasc Dis, I-66030 Santa Maria Imbaro, Italy; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Trelle, Sven/D-3760-2009; Juni, Peter/Q-8700-2016; Altman, Douglas G/A-9714-2012; Rutjes, Anne/L-8750-2017	Trelle, Sven/0000-0002-8162-8910; Juni, Peter/0000-0002-5985-0670; Rutjes, Anne/0000-0001-9782-779X; Reichenbach, Stephan/0000-0001-8098-6567; Egger, Matthias/0000-0001-7462-5132	Swiss National Science Foundation [4053-40-104762/3, 3200-066378, PBBEB-115067, 3233-066377]; Cancer Research UK	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research UK(Cancer Research UK)	The study was funded by the Swiss National Science Foundation (grant No 4053-40-104762/3 and 3200-066378) through grants to PJ and SR and was part of the Swiss National Science Foundation's National Research Programme 53 on musculoskeletal health. SR's research fellowship was funded by the Swiss National Science Foundation (grant No PBBEB-115067). DGA was supported by Cancer Research UK. PJ was a PROSPER (programme for social medicine, preventive and epidemiological research) fellow funded by the Swiss National Science Foundation (grant No 3233-066377). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data of the study and had final responsibility for the decision to submit for publication.	Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Angst F, 2002, J RHEUMATOL, V29, P131; Avouac J, 2007, OSTEOARTHR CARTILAGE, V15, P957, DOI 10.1016/j.joca.2007.02.006; Bartels EM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub2; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eberle E, 1999, OSTEOARTHR CARTILAGE, V7, P502, DOI 10.1053/joca.1999.0246; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fransen M, 2003, COCHRANE DB SYST REV, V3; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000010.pub3; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kjaergard LL, 2008, ANN INTERN MED, V149, P219, DOI 10.7326/0003-4819-149-3-200808050-00023; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Manheimer E, 2007, ANN INTERN MED, V146, P868, DOI 10.7326/0003-4819-146-12-200706190-00008; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Nuesch E, 2009, INT J EPIDEMIOL, V38, P298, DOI 10.1093/ije/dyn265; Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rintelen B, 2006, ARCH INTERN MED, V166, P1899, DOI 10.1001/archinte.166.17.1899; Rutjes AWS, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002823.pub2, 10.1002/14651858.CD007321.pub2]; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Tendal B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3128; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Verhagen AP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006864; Vlad SC, 2007, ARTHRITIS RHEUM-US, V56, P2267, DOI 10.1002/art.22728; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	52	312	314	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2010	341								c3515	10.1136/bmj.c3515	http://dx.doi.org/10.1136/bmj.c3515			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XF	20639294	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000280157000002
J	Scholl, A; Kilian, L; Zou, Y; Ziroff, J; Hame, S; Reinert, F; Umbach, E; Fink, RH				Schoell, A.; Kilian, L.; Zou, Y.; Ziroff, J.; Hame, S.; Reinert, F.; Umbach, E.; Fink, R. H.			Disordering of an Organic Overlayer on a Metal Surface Upon Cooling	SCIENCE			English	Article							NTCDA MONOLAYERS; PHOTOEMISSION; ADSORPTION; MOLECULES; AG(111); PTCDA	Inverse melting or disordering, in which the disordered phase forms upon cooling, is known for a few cases in bulk systems under high pressure. We show that inverse disordering also occurs in two dimensions: For a monolayer of 1,4,5,8-naphthalene-tetracarboxylic dianhydride on Ag(111), a completely reversible order-disorder transition appears upon cooling. The transition is driven by strongly anisotropic interactions within the layer versus with the metal substrate. Spectroscopic data reveal changes in the electronic structure of the system corresponding to a strengthening of the interface bonding at low temperatures. We demonstrate that the delicate, temperature-dependent balance between the vertical and lateral forces is the key to understanding this unconventional phase transition.	[Schoell, A.; Kilian, L.; Zou, Y.; Ziroff, J.; Hame, S.; Reinert, F.; Umbach, E.; Fink, R. H.] Univ Wurzburg, D-97074 Wurzburg, Germany; [Reinert, F.] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany	University of Wurzburg; Helmholtz Association; Karlsruhe Institute of Technology	Scholl, A (corresponding author), Univ Wurzburg, Expt Phys 7, D-97074 Wurzburg, Germany.	achim.schoell@physik.uni-wuerzburg.de	Reinert, Friedrich T/J-3005-2013; Schöll, Achim/G-7990-2016; Fink, Rainer H./F-8365-2010; Fink, Rainer H/C-5333-2008	Fink, Rainer H./0000-0002-6896-4266; Fink, Rainer H/0000-0002-6896-4266; Reinert, Friedrich/0000-0001-7993-1171	German Bundesministerium fur Bildung und Forschung [05 KS1WWA-5, 05 KS7WE1]; Deutsche Forschungsgemeinschaft [DFG Re 1469/3-2]; BESSY (Berlin Electron Storage Ring Society for Synchrotron Radiation)	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BESSY (Berlin Electron Storage Ring Society for Synchrotron Radiation)	Fruitful discussions with M. Sokolowski and Th. Schmidt are gratefully acknowledged. This work was funded by the German Bundesministerium fur Bildung und Forschung (contracts 05 KS1WWA-5 and 05 KS7WE1) and by the Deutsche Forschungsgemeinschaft (contract DFG Re 1469/3-2). Experimental support by the BESSY (Berlin Electron Storage Ring Society for Synchrotron Radiation) staff during beam time is gratefully acknowledged.	BAI HY, 1997, PHYS REV B, V56, pR1136; Bendounan A, 2007, SURF SCI, V601, P4013, DOI 10.1016/j.susc.2007.04.054; Feeney MR, 2003, J CHEM PHYS, V119, P4582, DOI 10.1063/1.1593018; Gador D, 1999, J ELECTRON SPECTROSC, V101, P523, DOI 10.1016/S0368-2048(98)00486-1; Greer AL, 2000, NATURE, V404, P134, DOI 10.1038/35004689; Kilian L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136103; KILIAN L, 2002, THESIS U WURZBURG WU; Scholl A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.146406; Scholl A, 2004, J PHYS CHEM B, V108, P14741, DOI 10.1021/jp049005z; Schupper N, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046107; Schupper N, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.037202; Sinkler W, 1997, PHYS REV B, V55, P2874, DOI 10.1103/PhysRevB.55.2874; Skibbe O, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3159736; Stadler C, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/3/050; Stahl U, 1998, SURF SCI, V414, P423, DOI 10.1016/S0039-6028(98)00536-6; Stohr J., 1992, SPINGER SERIES SURFA, V25; Tautz FS, 2007, PROG SURF SCI, V82, P479, DOI 10.1016/j.progsurf.2007.09.001; TEDROW PM, 1969, PHYS REV, V181, P399, DOI 10.1103/PhysRev.181.399; Ziroff J, 2009, SURF SCI, V603, P354, DOI 10.1016/j.susc.2008.11.019; Zou Y, 2006, SURF SCI, V600, P1240, DOI 10.1016/j.susc.2005.12.050	20	51	51	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					303	305		10.1126/science.1189106	http://dx.doi.org/10.1126/science.1189106			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647462				2022-12-28	WOS:000279925900035
J	Forrest, CB; Bartek, RJ; Rubinstein, Y; Groft, SC				Forrest, Christopher B.; Bartek, Ronald J.; Rubinstein, Yaffa; Groft, Stephen C.			The case for a global rare-diseases registry	LANCET			English	Editorial Material									[Forrest, Christopher B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Forrest, Christopher B.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bartek, Ronald J.] Friedreichs Ataxia Res Alliance, Springfield, VA USA; [Rubinstein, Yaffa; Groft, Stephen C.] NIH, Off Rare Dis Res, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Forrest, CB (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	forrestc@email.chop.edu	Forrest, Christopher/CAF-1379-2022	Forrest, Christopher/0000-0003-1252-068X				Butcher J, 2007, LANCET NEUROL, V6, P298, DOI 10.1016/S1474-4422(07)70067-4; Dator DP, 2010, J UROLOGY, V183, P1280, DOI 10.1016/j.juro.2010.01.049; European Commission, RAR DIS; GLIKLICH RE, 2007, REG EV PAT OUTC US G; Haffner ME, 2006, NEW ENGL J MED, V354, P445, DOI 10.1056/NEJMp058317; McCormick J, 2010, LANCET, V375, P1007, DOI 10.1016/S0140-6736(09)62161-9; National Institutes of Health Office of Rare Diseases Research, RAR DIS REL TERMS; *NIH OFF RAR DIS R, ADV RAR DIS RES INT; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Watson MS, 2008, GENET MED, V10, P325, DOI 10.1097/GIM.0b013e31817b80fd; Wrobel P, 2009, WORKSH PAT REG RAR D	11	65	66	2	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1057	1059		10.1016/S0140-6736(10)60680-0	http://dx.doi.org/10.1016/S0140-6736(10)60680-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	20674966				2022-12-28	WOS:000289035000009
J	Ludwig, DS; Currie, J				Ludwig, David S.; Currie, Janet			The association between pregnancy weight gain and birthweight: a within-family comparison	LANCET			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; RISK-FACTORS; SIZE; INSULIN; ADOLESCENCE; HORMONES; GROWTH; CANCER; WOMEN	Background Excessive weight gain during pregnancy seems to increase birthweight and the offspring's risk of obesity later in life. However, this association might be confounded by genetic and other shared effects. We aimed to examine the association between maternal weight gain and birthweight using state-based birth registry data that allowed us to compare several pregnancies in the same mother. Methods In this population-based cohort study, we used vital statistics natality records to examine all known births in Michigan and New Jersey, USA, between Jan 1,1989, and Dec 31,2003. From an initial sample of women with more than one singleton birth in the database, we made the following exclusions: gestation less than 37 weeks or 41 weeks or more; maternal diabetes; birthweight less than 500 g or more than 7000 g; and missing data for pregnancy weight gain. We examined how differences in weight gain that occurred during two or more pregnancies for each woman predicted the birthweight of her offspring, using a within-subject design to reduce confounding to a minimum. Findings Our analysis induded 513 501 women and their 1164 750 offspring. We noted a consistent association between pregnancy weight gain and birthweight (beta 7.35, 95% CI 7.10-7.59, p<0.0001). Infants of women who gained more than 24 kg during pregnancy were 148.9 g (141.7-156.0) heavier at birth than were infants of women who gained 8-10 kg. The odds ratio of giving birth to an infant weighing more than 4000 g was 2.26 (2.09-2.44) for women who gained more than 24 kg during pregnancy compared with women who gained 8-10 kg. Interpretation Maternal weight gain during pregnancy increases birthweight independently of genetic factors. In view of the apparent association between birthweight and adult weight, obesity prevention efforts targeted at women during pregnancy might be beneficial for offspring.	[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Currie, Janet] Columbia Univ, Dept Econ, New York, NY 10027 USA	Harvard University; Boston Children's Hospital; Columbia University	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	US National Institutes of Health [R21 HD055613-01]; National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK082730]; New Balance Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730, P30DK040561] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); New Balance Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Data collection for this project was supported under US National Institutes of Health grant R21 HD055613-01. DSL was supported in part by a career grant from the National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK082730) and a grant from the New Balance Foundation. Cecilia Machado provided assistance with research. We thank Cara Ebbeling, Matthew Gillman, Steven Gortmaker, Joseph Majzoub, and Eric Rimm for critical review of the report.	Allison P. D, 2009, FIXED EFFECTS REGRES, V160; Alwin D., 2007, MARGINS ERROR STUDY; Araujo CL, 2009, EUR J CLIN NUTR, V63, P634, DOI 10.1038/ejcn.2008.20; Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; BUESCHER PA, 1993, AM J PUBLIC HEALTH, V83, P1163, DOI 10.2105/AJPH.83.8.1163; CHAMBERLAIN G, 1980, REV ECON STUD, V47, P225, DOI 10.2307/2297110; DeVader SR, 2007, OBSTET GYNECOL, V110, P745, DOI 10.1097/01.AOG.0000284451.37882.85; Dietz PM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.051; Eastman N J, 1968, Obstet Gynecol Surv, V23, P1003, DOI 10.1097/00006254-196811000-00001; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Eriksson M, 2007, PROSTATE, V67, P1247, DOI 10.1002/pros.20428; Fleten C, 2010, OBSTET GYNECOL, V115, P331, DOI 10.1097/AOG.0b013e3181ca4414; Getahun D, 2007, AM J OBSTET GYNECOL, V196, P530, DOI 10.1016/j.ajog.2006.12.036; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; GUILLAUME M, 1995, INT J OBESITY, V19, pS5; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harder T, 2008, AM J EPIDEMIOL, V168, P366, DOI 10.1093/aje/kwn144; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hjalgrim LH, 2003, AM J EPIDEMIOL, V158, P724, DOI 10.1093/aje/kwg210; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Kaufman JS, 2008, INT J EPIDEMIOL, V37, P624, DOI 10.1093/ije/dyn035; KIELY JL, 1994, DATA ACTION CDCS PUB, P105; King H, 1998, DIABETES CARE, V21, pB9; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V302, P241, DOI 10.1001/jama.2009.964; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Nohr EA, 2009, AM J CLIN NUTR, V90, P1288, DOI 10.3945/ajcn.2009.27919; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Okun N, 1997, J Matern Fetal Med, V6, P285; Parretti E, 2001, DIABETES CARE, V24, P1319, DOI 10.2337/diacare.24.8.1319; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pettitt D J, 2001, Curr Diab Rep, V1, P78, DOI 10.1007/s11892-001-0014-x; Pietilainen KH, 2001, AM J EPIDEMIOL, V154, P21, DOI 10.1093/aje/154.1.21; Remes ST, 2008, PEDIAT ALLERG IMM-UK, V19, P541, DOI 10.1111/j.1399-3038.2007.00707.x; Ryan EA, 2003, LANCET, V362, P1777, DOI 10.1016/S0140-6736(03)14942-2; SIMPSON JW, 1975, OBSTET GYNECOL, V45, P481; Verhaeghe J, 2006, METABOLISM, V55, P339, DOI 10.1016/j.metabol.2005.09.007; Wei JN, 2007, OBESITY, V15, P1609, DOI 10.1038/oby.2007.190; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Wise LA, 2010, EPIDEMIOLOGY, V21, P243, DOI 10.1097/EDE.0b013e3181cb61a9; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x	46	199	209	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2010	376	9745					984	990		10.1016/S0140-6736(10)60751-9	http://dx.doi.org/10.1016/S0140-6736(10)60751-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JZ	20691469	Green Accepted			2022-12-28	WOS:000282247600030
J	Boitano, AE; Wang, JA; Romeo, R; Bouchez, LC; Parker, AE; Sutton, SE; Walker, JR; Flaveny, CA; Perdew, GH; Denison, MS; Schultz, PG; Cooke, MP				Boitano, Anthony E.; Wang, Jian; Romeo, Russell; Bouchez, Laure C.; Parker, Albert E.; Sutton, Sue E.; Walker, John R.; Flaveny, Colin A.; Perdew, Gary H.; Denison, Michael S.; Schultz, Peter G.; Cooke, Michael P.			Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells	SCIENCE			English	Article							UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; BONE-MARROW; TRANSPLANTATION; ENGRAFTMENT; MICE; BIOLOGY; BINDING	Although practiced clinically for more than 40 years, the use of hematopoietic stem cell (HSC) transplants remains limited by the ability to expand these cells ex vivo. An unbiased screen with primary human HSCs identified a purine derivative, StemRegenin 1 (SR1), that promotes the ex vivo expansion of CD34(+) cells. Culture of HSCs with SR1 led to a 50-fold increase in cells expressing CD34 and a 17-fold increase in cells that retain the ability to engraft immunodeficient mice. Mechanistic studies show that SR1 acts by antagonizing the aryl hydrocarbon receptor (AHR). The identification of SR1 and AHR modulation as a means to induce ex vivo HSC expansion should facilitate the clinical use of HSC therapy.	[Boitano, Anthony E.; Wang, Jian; Bouchez, Laure C.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Boitano, Anthony E.; Romeo, Russell; Parker, Albert E.; Sutton, Sue E.; Walker, John R.; Cooke, Michael P.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Flaveny, Colin A.; Perdew, Gary H.] Penn State Univ, University Pk, PA 16803 USA; [Denison, Michael S.] Univ Calif Davis, Davis, CA 95616 USA	Scripps Research Institute; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schultz@scripps.edu; mcooke@gnf.org	wang, jian/GVS-0711-2022	bouchez, laure/0000-0003-4583-6760	California Institute for Regenerative Medicine; Skaggs Institute for Chemical Biology; National Institutes of Environmental Health Sciences [ES007685, ES04699]; NIH [ES004869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES004869, R01ES004869, P42ES004699, R01ES007685] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Skaggs Institute for Chemical Biology; National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Trussell, D. Rines, and M. Hull for assistance with flow cytometry and screen development; J. E. Tellew, S. Pan, Y. Wan, and X. Wang for synthesis of LGC006; and J. Hogenesch for helpful discussions. A. E. B was funded by grants from the California Institute for Regenerative Medicine and the Skaggs Institute for Chemical Biology. M.S.D. was funded by grants from the National Institutes of Environmental Health Sciences (ES007685 and ES04699). G.H.P. was funded by a grant from the NIH (ES004869). A patent application has been filed on SR1 for applications related to HSC expansion.	Brunstein CG, 2007, BRIT J HAEMATOL, V137, P20, DOI 10.1111/j.1365-2141.2007.06521.x; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jang JY, 2007, REPROD TOXICOL, V24, P303, DOI 10.1016/j.reprotox.2007.08.002; Kelly SS, 2009, BONE MARROW TRANSPL, V44, P673, DOI 10.1038/bmt.2009.284; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Mogul MJ, 2000, BONE MARROW TRANSPL, V25, pS58, DOI 10.1038/sj.bmt.1702372; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Sakai R, 2003, TOXICOL SCI, V72, P84, DOI 10.1093/toxsci/kfg002; Singh KP, 2009, BIOCHEM PHARMACOL, V77, P577, DOI 10.1016/j.bcp.2008.10.001; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Smith BG, 1908, BIOL BULL-US, V15, P9, DOI 10.2307/1535560; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Xia LJ, 2004, BLOOD, V104, P3091, DOI 10.1182/blood-2004-02-0650	22	714	787	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1345	1348		10.1126/science.1191536	http://dx.doi.org/10.1126/science.1191536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20688981	Green Accepted			2022-12-28	WOS:000281657300039
J	Cui, JX; Yao, Q; Li, S; Ding, XJ; Lu, QH; Mao, HB; Liu, LP; Zheng, N; Chen, S; Shao, F				Cui, Jixin; Yao, Qing; Li, Shan; Ding, Xiaojun; Lu, Qiuhe; Mao, Haibin; Liu, Liping; Zheng, Ning; Chen, She; Shao, Feng			Glutamine Deamidation and Dysfunction of Ubiquitin/NEDD8 Induced by a Bacterial Effector Family	SCIENCE			English	Article							HOST-CELL CYCLE; ESCHERICHIA-COLI; CYCLOMODULIN CIF; PROTEIN; LIGASE; DEGRADATION; CONJUGATION; ACTIVATION; INSIGHTS; BLOCKS	A family of bacterial effectors including Cif homolog from Burkholderia pseudomallei (CHBP) and Cif from Enteropathogenic Escherichia coli (EPEC) adopt a functionally important papain-like hydrolytic fold. We show here that CHBP was a potent inhibitor of the eukaryotic ubiquitination pathway. CHBP acted as a deamidase that specifically and efficiently deamidated Gln(40) in ubiquitin and ubiquitin-like protein NEDD8 both in vitro and during Burkholderia infection. Deamidated ubiquitin was impaired in supporting ubiquitin-chain synthesis. Cif selectively deamidated NEDD8, which abolished the activity of neddylated Cullin-RING ubiquitin ligases (CRLs). Ubiquitination and ubiquitin-dependent degradation of multiple CRL substrates were impaired by Cif in EPEC-infected cells. Mutations of substrate-contacting residues in Cif abolished or attenuated EPEC-induced cytopathic phenotypes of cell cycle arrest and actin stress fiber formation.	[Cui, Jixin; Yao, Qing; Li, Shan; Ding, Xiaojun; Lu, Qiuhe; Liu, Liping; Chen, She; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Cui, Jixin] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Cui, Jixin] Beijing Union Med Coll, Beijing 100730, Peoples R China; [Mao, Haibin; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	liu, li/HGC-0900-2022; Yao, Qing/AAE-1680-2020; Mao, Haibin/B-7609-2011	Li, Shan/0000-0001-8646-3193; Lu, Qiuhe/0000-0002-0202-7448	Chinese Ministry of Science and Technology [2008AA022309]; National Basic Research Plan of China 973; National Institutes of Health [R01 CA107134]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022309] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Basic Research Plan of China 973(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Ye, C. Fathman, Z. Pan, D. Haas, V. Yu, E. Boedeker, and Z. Chen for providing reagents. We are grateful to F. Du and X. Wang for their assistance in obtaining reagents. We also thank members of the Shao laboratory for helpful discussions and technical assistance. This work was supported by Chinese Ministry of Science and Technology grant 2008AA022309 and National Basic Research Plan of China 973 grants to F. S. and National Institutes of Health grant R01 CA107134 to N.Z. and H. M. N.Z. is a Howard Hughes Medical Institute investigator.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fu NY, 2007, P NATL ACAD SCI USA, V104, P10051, DOI 10.1073/pnas.0700007104; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Hsu Y, 2008, J MOL BIOL, V384, P465, DOI 10.1016/j.jmb.2008.09.051; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	21	152	162	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1215	1218		10.1126/science.1193844	http://dx.doi.org/10.1126/science.1193844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20688984	Green Accepted			2022-12-28	WOS:000281485600038
J	Zaman, K; Anh, DD; Victor, JC; Shin, S; Yunus, M; Dallas, MJ; Podder, G; Thiem, VD; Mai, LTP; Luby, SP; Tho, LH; Coia, ML; Lewis, K; Rivers, SB; Sack, DA; Schodel, F; Steele, AD; Neuzil, KM; Ciarlet, M				Zaman, K.; Anh, Dang Duc; Victor, John C.; Shin, Sunheang; Yunus, Md; Dallas, Michael J.; Podder, Goutam; Thiem, Vu Dinh; Mai, Le Thi Phuong; Luby, Stephen P.; Tho, Le Huu; Coia, Michele L.; Lewis, Kristen; Rivers, Stephen B.; Sack, David A.; Schoedel, Florian; Steele, A. Duncan; Neuzil, Kathleen M.; Ciarlet, Max			Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							ORAL POLIOVIRUS; SAFETY; IMMUNOGENICITY; MORTALITY; CHILDREN; DISEASE	Background Rotavirus vaccine has proved effective for prevention of severe rotavirus gastroenteritis in infants in developed countries, but no efficacy studies have been done in developing countries in Asia. We assessed the clinical efficacy of live oral pentavalent rotavirus vaccine for prevention of severe rotavirus gastroenteritis in infants in Bangladesh and Vietnam. Methods In this multicentre, double-blind, placebo-controlled trial, undertaken in rural Matlab, Bangladesh, and urban and periurban Nha Trang, Vietnam, infants aged 4-12 weeks without symptoms of gastrointestinal disorders were randomly assigned (1:1) to receive three oral doses of pentavalent rotavirus vaccine 2 mL or placebo at around 6 weeks, 10 weeks, and 14 weeks of age, in conjunction with routine infant vaccines including oral poliovirus vaccine. Randomisation was done by computer-generated randomisation sequence in blocks of six. Episodes of gastroenteritis in infants who presented to study medical facilities were reported by clinical staff and from parent recollection. The primary endpoint was severe rotavirus gastroenteritis (Vesikari score >= 11) arising 14 days or more after the third dose of placebo or vaccine to end of study (March 31,2009; around 21 months of age). Analysis was per protocol; infants who received scheduled doses of vaccine or placebo without intervening laboratory-confirmed naturally occurring rotavirus disease earlier than 14 days after the third dose and had complete clinical and laboratory results were included in the analysis. This study is registered with ClinicalTrials.gov, number NCT00362648. Findings 2036 infants were randomly assigned to receive pentavalent rotavirus vaccine (n=1018) or placebo (n=1018). 991 infants assigned to pentavalent rotavirus vaccine and 978 assigned to placebo were included in the per-protocol analysis. Median follow up from 14 days after the third dose of placebo or vaccine until final disposition was 498 days (IQR 480-575). 38 cases of severe rotavirus gastroenteritis (Vesikari score >= 11) were reported during more than 1197 person-years of follow up in the vaccine group, compared with 71 cases in more than 1156 person years in the placebo group, resulting in a vaccine efficacy of 48.3% (95% Cl 22.3-66.1) against severe disease (p=0.0005 for efficacy >0%) during nearly 2 years of follow-up. 25 (2.5%) of 1017 infants assigned to receive vaccine and 20 (2.0%) of 1018 assigned to receive placebo had a serious adverse event within 14 days of any dose. The most frequent serious adverse event was pneumonia (vaccine 12 [1.2%]; placebo 15 [1.5%]). Interpretation In infants in developing countries in Asia, pentavalent rotavirus vaccine is safe and efficacious against severe rotavirus gastroenteritis, and our results support expanded WHO recommendations to promote its global use.	[Victor, John C.; Lewis, Kristen; Neuzil, Kathleen M.] PATH, Seattle, WA 98109 USA; [Zaman, K.; Yunus, Md; Podder, Goutam; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Anh, Dang Duc; Thiem, Vu Dinh; Mai, Le Thi Phuong] Minist Hlth, Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Shin, Sunheang] Int Vaccine Inst, Seoul, South Korea; [Dallas, Michael J.; Coia, Michele L.; Rivers, Stephen B.; Schoedel, Florian; Ciarlet, Max] Merck Res Labs, N Wales, PA USA; [Tho, Le Huu] Khanh Hoa Hlth Serv, Nha Trang, Vietnam; [Sack, David A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Steele, A. Duncan] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland	International Centre for Diarrhoeal Disease Research (ICDDR); National Institute of Hygiene & Epidemiology (NIHE); International Vaccine Institute; Merck & Company; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Victor, JC (corresponding author), PATH, POB 900922, Seattle, WA 98109 USA.	cvictor@path.org		Vu, Thiem/0000-0001-6168-4555; Le, Mai/0000-0001-7581-4058; Victor, John/0000-0002-7970-6588; Yunus, Mohammed/0000-0003-1116-4978; Steele, Andrew Duncan/0000-0002-4946-037X	PATH; ICDDR,B; NINE; PATH through a GAVI Alliance; GAVI Alliance	PATH; ICDDR,B; NINE; PATH through a GAVI Alliance; GAVI Alliance	MID, MLC, SBR, FS, and MC are employees of Merck and own shares in the company. DAS was Director of ICDDR,B at the time of initiation of the study; after his departure from ICDDR,B, he received consultancy fees as part of his ongoing participation in the site's conduct of the study. Consultancy fees were part of the ICDDR,B budget, which was funded by PATH, ICDDR,B, NINE, and IVI were funded by PATH's Rotavirus Vaccine Program through a GAVI Alliance Grant to PATH to conduct this trial. All other authors declare that they have no conflicts of interest.; The study, with protocol V260-015, was designed, managed, undertaken, and analysed by the co-sponsors in collaboration with the site investigators and under the supervision and advice of the data and safety monitoring board. Investigators and their institutions were funded by PATH's Rotavirus Vaccine Program, with a grant from the GAVI Alliance. We thank the volunteers and their families; the scientific advisers Shams El Arifeen and Tasnim Azim (International Centre for Diarrhoeal Disease Research, Bangladesh); participating investigators Abu Syed Golam Faruque, Al Fazal Khan, and [has Hossain (International Centre for Diarrhoeal Disease Research, Bangladesh); all other staff from the International Centre for Diarrhoeal Disease Research, Bangladesh; the scientific advisers John Clemens and Paul Kilgore (International Vaccine Institute in Korea) and Truong Tan Minh (Khanh Hoa Health Service), and participating investigators Nguyen Hien Anh (National Institute of Hygiene and Epidemiology) and Phu Quoc Viet (Khanh Hoa Health Service); staff from the Department of Pediatrics, Khanh Hoa General Hospital, from the Pasteur Institute in Nha Trang, and from the 16 participating Commune Health Centres in Nha Trang; the members of the data and safety monitoring board (King Holmes [Chairman], Wasif All Khan, Edward Tsiri Agbenyega, Grace Irimu, Mamadou Marouf Keita, Dinh Sy Hien, Nik Zarifah, Nik Hussain Reed, and Janet Wittes); Penny M Heaton and Michelle G Goveia for their contribution to the design of the study; Bradley Raybold for contributions to the initiation and implementation of the study; Fay DiCandilo and Margaret Nelson for contributing to careful review of the data; Donna Hyatt for data management; Laura Mallette and Vladimir Liska for laboratory data coordination; Richard Ward and Monica McNeal for overseeing laboratory assays; Tracy Burke for ensuring adequate vaccine and placebo supplies; Family Health International and PharmaLink, especially Carolyn Enloe, Vivian Bragg, Laura Niver, Jen Auerbach, Linda McNeil, and all the Family Health International field monitors and safety. reporting staff; Vu Minh Huong (PATH) for monitoring assistance; Joyce Erickson (PATH) for contracting and financial analysis; and Carolien Bakker and David Oxley (PATH) for administrative assistance.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Atherly D, 2009, J INFECT DIS, V200, pS28, DOI 10.1086/605033; Block SL, 2007, PEDIATRICS, V119, P11, DOI 10.1542/peds.2006-2058; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Ciarlet M, 2008, PEDIATR INFECT DIS J, V27, P874, DOI 10.1097/INF.0b013e3181782780; Ciarlet M, 2009, VACCINE, V27, pG72, DOI 10.1016/j.vaccine.2009.09.107; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; DiStefano DJ, 2005, J CLIN MICROBIOL, V43, P5876, DOI 10.1128/JCM.43.12.5876-5880.2005; *ICDDR B, 2008, HLTH DEM SURV SYST M, V40, P8; KNOWLTON DR, 1991, J VIROL METHODS, V33, P127, DOI 10.1016/0166-0934(91)90013-P; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; *MIN HLTH VIETN, 2005, HLTH STAT REP; Panozzo C. A., 2009, Morbidity and Mortality Weekly Report, V58, P1146; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; PATEL M, 2009, JAMA-J AM MED ASSOC, V310, P2243; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Phua KB, 2009, VACCINE, V27, P5936, DOI 10.1016/j.vaccine.2009.07.098; Rennels MB, 1996, J INFECT DIS, V173, P306, DOI 10.1093/infdis/173.2.306; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; *SAGE, 2006, WKLY EPIDEMIOL REC, V32, P2; Steele AD, 2009, J INFECT DIS, V200, pS63, DOI 10.1086/605042; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2007, INT J INFECT DIS, V11, pS29, DOI 10.1016/S1201-9712(07)60019-8; Vesikari T, 2006, VACCINE, V24, P4821, DOI 10.1016/j.vaccine.2006.03.025; Ward RL, 1997, J INFECT DIS, V176, P570, DOI 10.1086/514076; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P533; Zaman K, 2009, VACCINE, V27, P1333, DOI 10.1016/j.vaccine.2008.12.059	32	510	524	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					615	623		10.1016/S0140-6736(10)60755-6	http://dx.doi.org/10.1016/S0140-6736(10)60755-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20692031				2022-12-28	WOS:000281309100032
J	Bax, BD; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Gorrec, F; Giordano, I; Hann, MM; Hennessy, A; Hibbs, M; Huang, JZ; Jones, E; Jones, J; Brown, KK; Lewis, CJ; May, EW; Saunders, MR; Singh, O; Spitzfaden, CE; Shen, C; Shillings, A; Theobald, AJ; Wohlkonig, A; Pearson, ND; Gwynn, MN				Bax, Benjamin D.; Chan, Pan F.; Eggleston, Drake S.; Fosberry, Andrew; Gentry, Daniel R.; Gorrec, Fabrice; Giordano, Ilaria; Hann, Michael M.; Hennessy, Alan; Hibbs, Martin; Huang, Jianzhong; Jones, Emma; Jones, Jo; Brown, Kristin Koretke; Lewis, Ceri J.; May, Earl W.; Saunders, Martin R.; Singh, Onkar; Spitzfaden, Claus E.; Shen, Carol; Shillings, Anthony; Theobald, Andrew J.; Wohlkonig, Alexandre; Pearson, Neil D.; Gwynn, Michael N.			Type IIA topoisomerase inhibition by a new class of antibacterial agents	NATURE			English	Article							INFECTIOUS-DISEASES-SOCIETY; BREAKAGE-REUNION DOMAIN; DNA GYRASE; CRYSTAL-STRUCTURE; BAD BUGS; FUSION PROTEIN; MECHANISM; CLEAVAGE; IA; DRUGS	Despite the success of genomics in identifying new essential bacterial genes, there is a lack of sustainable leads in antibacterial drug discovery to address increasing multidrug resistance. Type IIA topoisomerases cleave and religate DNA to regulate DNA topology and are a major class of antibacterial and anticancer drug targets, yet there is no well developed structural basis for understanding drug action. Here we report the 2.1 angstrom crystal structure of a potent, new class, broad-spectrum antibacterial agent in complex with Staphylococcus aureus DNA gyrase and DNA, showing a new mode of inhibition that circumvents fluoroquinolone resistance in this clinically important drug target. The inhibitor 'bridges' the DNA and a transient non-catalytic pocket on the two-fold axis at the GyrA dimer interface, and is close to the active sites and fluoroquinolone binding sites. In the inhibitor complex the active site seems poised to cleave the DNA, with a single metal ion observed between the TOPRIM (topoisomerase/primase) domain and the scissile phosphate. This work provides new insights into the mechanism of topoisomerase action and a platform for structure-based drug design of a new class of antibacterial agents against a clinically proven, but conformationally flexible, enzyme class.	[Bax, Benjamin D.; Hann, Michael M.; Saunders, Martin R.; Singh, Onkar; Spitzfaden, Claus E.] GlaxoSmithKline, Med Res Ctr, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Chan, Pan F.; Gentry, Daniel R.; Huang, Jianzhong; May, Earl W.; Shen, Carol; Pearson, Neil D.; Gwynn, Michael N.] GlaxoSmithKline, Infect Dis Ctr Excellence Drug Discovery, Antibacterial Discovery Performance Unit, Collegeville, PA 19426 USA; [Eggleston, Drake S.; Fosberry, Andrew; Gorrec, Fabrice; Hibbs, Martin; Jones, Emma; Jones, Jo; Lewis, Ceri J.; Shillings, Anthony; Theobald, Andrew J.] GlaxoSmithKline, Mol Discovery Res, Harlow CM19 5AW, Essex, England; [Giordano, Ilaria; Hennessy, Alan; Wohlkonig, Alexandre] GlaxoSmithKline, Med Res Ctr, Antibacterial Discovery Performance Unit, Stevenage SG1 2NY, Herts, England; [Brown, Kristin Koretke] GlaxoSmithKline, Mol Discovery Res, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Bax, BD (corresponding author), GlaxoSmithKline, Med Res Ctr, Mol Discovery Res, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	benjamin.d.bax@gsk.com; mick.gwynn@gsk.com		Wohlkonig, Alexandre/0000-0003-3103-5022; Bax, Ben/0000-0003-1940-3785; Gorrec, Fabrice/0000-0002-9998-3611	Wellcome Trust Seeding Drug Discovery Initiative; US Department of Defense (DoD) [HDTRA1-07-9-0002]; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) [HDTRA1-07-9-0002]; Defense Threat Reduction Agency (DTRA); Transformational Medical Technologies (TMT)	Wellcome Trust Seeding Drug Discovery Initiative(Wellcome Trust); US Department of Defense (DoD)(United States Department of Defense); Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)(United States Department of DefenseDefense Threat Reduction Agency); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Transformational Medical Technologies (TMT)	We thank H. Hiasa, A. Maxwell, J. C. Wang and D. B. Wigley for discussions. We thank S. Erskine, A. West and S. Brooks for experimental work that helped initiate this project. We thank P. Rowland for help with data collection and processing, the antimicrobial profiling group at GlaxoSmithKline (GSK) for antibacterial data, and K. Smith and D. Payne and members of the project team for discussions. A. W. was supported by the Wellcome Trust Seeding Drug Discovery Initiative and contract HDTRA1-07-9-0002 with the US Department of Defense (DoD) Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD), and the Defense Threat Reduction Agency (DTRA) Transformational Medical Technologies (TMT). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the DoD or the US Government.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; Black MT, 2008, ANTIMICROB AGENTS CH, V52, P3339, DOI 10.1128/AAC.00496-08; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Clinical and Laboratory Standards Institute, 2008, METH DIL ANT SUSC TE; COATES WJ, 1999, Patent No. 1051413; Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deweese JE, 2008, NUCLEIC ACIDS RES, V36, P4883, DOI 10.1093/nar/gkn466; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1979, P NATL ACAD SCI USA, V76, P6289, DOI 10.1073/pnas.76.12.6289; Gmunder H, 1997, NUCLEIC ACIDS RES, V25, P604, DOI 10.1093/nar/25.3.604; Gomez L, 2007, BIOORG MED CHEM LETT, V17, P2723, DOI 10.1016/j.bmcl.2007.03.003; Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Jeffrey G.A., 2012, HYDROGEN BONDING BIO; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lavasani LS, 2001, BIOCHEMISTRY-US, V40, P8438, DOI 10.1021/bi0155201; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; MILLER WH, 2010, Patent No. 7691850; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Mueller-Planitz F, 2008, J BIOL CHEM, V283, P17463, DOI 10.1074/jbc.M710014200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Pan XS, 2009, ANTIMICROB AGENTS CH, V53, P3822, DOI 10.1128/AAC.00113-09; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; REECE RJ, 1991, J BIOL CHEM, V266, P3540; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tanaka M, 2000, J Infect Chemother, V6, P131, DOI 10.1007/s101560070010; Tretter EM, 2010, PROTEINS, V78, P492, DOI 10.1002/prot.22600; Trigueros S, 2002, GENES CELLS, V7, P249, DOI 10.1046/j.1365-2443.2002.00516.x; Wiener JJM, 2007, BIOORG MED CHEM LETT, V17, P2718, DOI 10.1016/j.bmcl.2007.03.004; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	53	506	519	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					935	U51		10.1038/nature09197	http://dx.doi.org/10.1038/nature09197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20686482				2022-12-28	WOS:000281030300026
J	Lee, ER; Baker, JL; Weinberg, Z; Sudarsan, N; Breaker, RR				Lee, Elaine R.; Baker, Jenny L.; Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.			An Allosteric Self-Splicing Ribozyme Triggered by a Bacterial Second Messenger	SCIENCE			English	Article							GROUP-I INTRONS; METABOLITE-BINDING RIBOSWITCHES; CYCLIC DI-GMP; LIGAND-BINDING; RNA; BACTERIOPHAGE-T4	Group I self-splicing ribozymes commonly function as components of selfish mobile genetic elements. We identified an allosteric group I ribozyme, wherein self-splicing is regulated by a distinct riboswitch class that senses the bacterial second messenger c-di-GMP. The tandem RNA sensory system resides in the 5' untranslated region of the messenger RNA for a putative virulence gene in the pathogenic bacterium Clostridium difficile. c-di-GMP binding by the riboswitch induces folding changes at atypical splice site junctions to modulate alternative RNA processing. Our findings indicate that some self-splicing ribozymes are not selfish elements but are harnessed by cells as metabolite sensors and genetic regulators.	[Lee, Elaine R.; Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Baker, Jenny L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, Box 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Weinberg, Zasha/0000-0002-6681-3624; Breaker, Ronald/0000-0002-2165-536X	NIH [PO1 GM022778]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Davis for assistance with genetic experiments and members of the Breaker laboratory for helpful discussions. We also thank L. Sonenshein for supplying C. difficile 630 spores and for training N.S. in C. difficile techniques. This work was supported by NIH grant PO1 GM022778 and by the Howard Hughes Medical Institute. Z.W. advises BioRelix. R.R.B. is a cofounder and Scientific Advisory Board member of BioRelix. Yale University has filed a provisional patent application on this riboswitch technology.	Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Nielsen H, 2009, RNA BIOL, V6, P375, DOI 10.4161/rna.6.4.9334; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Sandegren L, 2007, J BACTERIOL, V189, P980, DOI 10.1128/JB.01287-06; SHUB DA, 1987, COLD SPRING HARB SYM, V52, P193, DOI 10.1101/SQB.1987.052.01.024; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Thompson Kristin M, 2002, BMC Biotechnol, V2, P21, DOI 10.1186/1472-6750-2-21; Tseng Huei-Hun, 2009, Journal of Bioinformatics and Computational Biology, V7, P373, DOI 10.1142/S0219720009004126; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707	21	262	289	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					845	848		10.1126/science.1190713	http://dx.doi.org/10.1126/science.1190713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705859	Green Accepted			2022-12-28	WOS:000280809900052
J	Zhang, XZ; Saaddine, JB; Chou, CF; Cotch, MF; Cheng, YJ; Geiss, LS; Gregg, EW; Albright, AL; Klein, BEK; Klein, R				Zhang, Xinzhi; Saaddine, Jinan B.; Chou, Chin-Fang; Cotch, Mary Frances; Cheng, Yiling J.; Geiss, Linda S.; Gregg, Edward W.; Albright, Ann L.; Klein, Barbara E. K.; Klein, Ronald			Prevalence of Diabetic Retinopathy in the United States, 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; EYE CARE; POPULATION; DISEASE; PEOPLE; ADULTS; AGE; HEALTH	Context The prevalence of diabetes in the United States has increased. People with diabetes are at risk for diabetic retinopathy. No recent national population-based estimate of the prevalence and severity of diabetic retinopathy exists. Objectives To describe the prevalence and risk factors of diabetic retinopathy among US adults with diabetes aged 40 years and older. Design, Setting, and Participants Analysis of a cross-sectional, nationally representative sample of the National Health and Nutrition Examination Survey 2005-2008 (N=1006). Diabetes was defined as a self-report of a previous diagnosis of the disease (excluding gestational diabetes mellitus) or glycated hemoglobin A(1c) of 6.5% or greater. Two fundus photographs were taken of each eye with a digital nonmydriatic camera and were graded using the Airlie House classification scheme and the Early Treatment Diabetic Retinopathy Study severity scale. Prevalence estimates were weighted to represent the civilian, noninstitutionalized US population aged 40 years and older. Main Outcome Measurements Diabetic retinopathy and vision-threatening diabetic retinopathy. Results The estimated prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was 28.5% (95% confidence interval [Cl], 24.9%-32.5%) and 4.4% (95% Cl, 3.5%-5.7%) among US adults with diabetes, respectively. Diabetic retinopathy was slightly more prevalent among men than women with diabetes (31.6%; 95% Cl, 26.8%-36.8%; vs 25.7%; 95% Cl, 21.7%-30.1%; P=.04). Non-Hispanic black individuals had a higher crude prevalence than non-Hispanic white individuals of diabetic retinopathy (38.8%; 95% Cl, 31.9%-46.1%; vs 26.4%; 95% Cl, 21.4%-32.2%; P=.01) and vision-threatening diabetic retinopathy (9.3%; 95% Cl, 5.9%-14.4%; vs 3.2%; 95% Cl, 2.0%-5.1%; P=.01). Male sex was independently associated with the presence of diabetic retinopathy (odds ratio [OR], 2.07; 95% Cl, 1.39-3.10), as well as higher hemoglobin A(1c) level (OR, 1.45; 95% Cl, 1.20-1.75), longer duration of diabetes (OR, 1.06 per year duration; 95% Cl, 1.03-1.10), insulin use (OR, 3.23; 95% Cl, 1.99-5.26), and higher systolic blood pressure (OR, 1.03 per mm Hg; 95% Cl, 1.02-1.03). Conclusion In a nationally representative sample of US adults with diabetes aged 40 years and older, the prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was high, especially among Non-Hispanic black individuals. JAMA. 2010;304(6):649-656	[Zhang, Xinzhi; Saaddine, Jinan B.; Chou, Chin-Fang; Cheng, Yiling J.; Geiss, Linda S.; Gregg, Edward W.; Albright, Ann L.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Wisconsin System; University of Wisconsin Madison	Zhang, XZ (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,NE K-10, Atlanta, GA 30341 USA.	XZhang4@cdc.gov	Cheng, Yiling J/A-6547-2009	Cheng, Yiling J/0000-0002-5053-0814; Klein, Ronald/0000-0002-4428-6237; Gregg, Edward/0000-0003-2381-6822; Cotch, Mary Frances/0000-0002-2046-4350	National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC); Division of Diabetes Translation, CDC [05FED47304]; National Eye Institute, National Institutes of Health [Z01EY000402]; Division of Diabetes Translation; NATIONAL EYE INSTITUTE [Z01EY000402, ZIAEY000402] Funding Source: NIH RePORTER	National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of Diabetes Translation, CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Division of Diabetes Translation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). Funding for the National Health and Nutrition Examination Survey (NHANES) retinal component was provided by the Intra Agency Agreement 05FED47304 from the Division of Diabetes Translation, CDC. Funding for the vision component was provided by the National Eye Institute, National Institutes of Health, Intramural Research Program grant Z01EY000402.; The NCHS was involved in the design and conduct of the NHANES study and in data collection, but was not involved in the analysis or interpretation of the study results or in the preparation of the manuscript. The Division of Diabetes Translation provided funding support for the retinal component and was involved in the design and conduct of the study; in the collection, analysis, and interpretation of the data; and in the preparation, review, and approval of this article before submission.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1991, Ophthalmology, V98, P786; Burrows NR, 2010, DIABETES CARE, V33, P73, DOI 10.2337/dc09-0343; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Geiss Linda, 2005, Diabetes Technol Ther, V7, P198, DOI 10.1089/dia.2005.7.198; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Hirsch IB, 2010, JAMA-J AM MED ASSOC, V303, P2291, DOI 10.1001/jama.2010.785; HOLT D, 1991, STATISTICIAN, V40, P333, DOI 10.2307/2348286; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Klein R, 2004, ARCH OPHTHALMOL-CHIC, V122, P1642, DOI 10.1001/archopht.122.11.1642; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; KLEIN R, 1992, OPHTHALMOLOGY, V99, P58; KLEIN R, 1995, DIABETES AM, P293; Klein R, 2009, OPHTHALMOLOGY, V116, P1937, DOI 10.1016/j.ophtha.2009.03.012; Korn EL., 1999, ANAL HLTH SURVEYS; LEUREDUPREE AE, 1981, INVEST OPHTH VIS SCI, V21, P1; Liew G, 2009, HEART, V95, P391, DOI 10.1136/hrt.2008.146670; Mitchell P, 1998, OPHTHALMOLOGY, V105, P406, DOI 10.1016/S0161-6420(98)93019-6; *NAT DIAB DAT GROU, 1995, DIAB AM; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nkondi Mbadi ANsunguJ, 2009, MALI MED, V24, P17; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Nsiah-Kumi P, 2009, J NATL MED ASSOC, V101, P430, DOI 10.1016/S0027-9684(15)30929-9; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sloan FA, 2009, OPHTHALMOLOGY, V116, P1515, DOI 10.1016/j.ophtha.2009.03.010; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zhang XZ, 2007, ARCH OPHTHALMOL-CHIC, V125, P411, DOI 10.1001/archopht.125.3.411	42	690	726	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					649	656		10.1001/jama.2010.1111	http://dx.doi.org/10.1001/jama.2010.1111			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699456	Bronze, Green Accepted			2022-12-28	WOS:000280829200020
J	Franz, M				Franz, Marcel			In Praise of Exact Quantization	SCIENCE			English	Editorial Material							TOPOLOGICAL INSULATORS		Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Franz, M (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	franz@physics.ubc.ca						ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Garate I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.146802; Laughlin RB, 1999, REV MOD PHYS, V71, P863, DOI 10.1103/RevModPhys.71.863; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Yokoyama T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.121401	7	5	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					639	640		10.1126/science.1194123	http://dx.doi.org/10.1126/science.1194123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689008				2022-12-28	WOS:000280602700026
J	Lane, AA; Scadden, DT				Lane, Andrew A.; Scadden, David T.			Stem Cells and DNA Damage: Persist or Perish?	CELL			English	Editorial Material									[Lane, Andrew A.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Ctr Regenerat Med, Boston, MA 02114 USA; [Lane, Andrew A.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University	Lane, AA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Regenerat Med, Boston, MA 02114 USA.	aalane@partners.org; dscadden@mgh.harvard.edu		Lane, Andrew/0000-0001-7380-0226				Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059	6	24	24	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2010	142	3					360	362		10.1016/j.cell.2010.07.030	http://dx.doi.org/10.1016/j.cell.2010.07.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691895	Bronze			2022-12-28	WOS:000280609100011
J	Slavin, JA; Anderson, BJ; Baker, DN; Benna, M; Boardsen, SA; Gloeckler, G; Gold, RE; Ho, GC; Korth, H; Krimigis, SM; McNutt, RL; Nittler, LR; Raines, JM; Sarantos, M; Schriver, D; Solomon, SC; Starr, RD; Travnicek, PM; Zurbuchen, TH				Slavin, James A.; Anderson, Brian J.; Baker, Daniel N.; Benna, Mehdi; Boardsen, Scott A.; Gloeckler, George; Gold, Robert E.; Ho, George C.; Korth, Haje; Krimigis, Stamatios M.; McNutt, Ralph L., Jr.; Nittler, Larry R.; Raines, Jim M.; Sarantos, Menelaos; Schriver, David; Solomon, Sean C.; Starr, Richard D.; Travnicek, Pavel M.; Zurbuchen, Thomas H.			MESSENGER Observations of Extreme Loading and Unloading of Mercury's Magnetic Tail	SCIENCE			English	Article							SOLAR-WIND; MAGNETOSPHERE; RECONNECTION; MAGNETOTAIL; SUBSTORMS; TRANSPORT; MODEL	During MESSENGER's third flyby of Mercury, the magnetic field in the planet's magnetic tail increased by factors of 2 to 3.5 over intervals of 2 to 3 minutes. Magnetospheric substorms at Earth are powered by similar tail loading, but the amplitude is lower by a factor of similar to 10 and typical durations are similar to 1 hour. The extreme tail loading observed at Mercury implies that the relative intensity of substorms must be much larger than at Earth. The correspondence between the duration of tail field enhancements and the characteristic time for the Dungey cycle, which describes plasma circulation through Mercury's magnetosphere, suggests that such circulation determines the substorm time scale. A key aspect of tail unloading during terrestrial substorms is the acceleration of energetic charged particles, but no acceleration signatures were seen during the MESSENGER flyby.	[Slavin, James A.; Boardsen, Scott A.; Sarantos, Menelaos] NASA, Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD 20771 USA; [Anderson, Brian J.; Gold, Robert E.; Ho, George C.; Korth, Haje; Krimigis, Stamatios M.; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Baker, Daniel N.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Baker, Daniel N.] Univ Colorado, Dept Phys, Boulder, CO 80303 USA; [Baker, Daniel N.] Univ Colorado, Astrophys & Planetary Sci Dept, Boulder, CO 80303 USA; [Benna, Mehdi] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Benna, Mehdi; Boardsen, Scott A.; Sarantos, Menelaos] Univ Maryland Baltimore Cty, Goddard Earth Sci & Technol Ctr, Baltimore, MD 21228 USA; [Gloeckler, George; Raines, Jim M.; Zurbuchen, Thomas H.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Gloeckler, George] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Krimigis, Stamatios M.] Acad Athens, Athens 11527, Greece; [Nittler, Larry R.; Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Schriver, David; Travnicek, Pavel M.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; [Starr, Richard D.] Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; [Travnicek, Pavel M.] Acad Sci Czech Republ, Inst Astron, Prague 14131, Czech Republic	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; Academy of Athens; Carnegie Institution for Science; University of California System; University of California Los Angeles; Catholic University of America; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences	Slavin, JA (corresponding author), NASA, Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD 20771 USA.	james.a.slavin@nasa.gov	Sarantos, Menelaos/O-6644-2019; Travnicek, Pavel/G-8608-2014; Krimigis, Stamatios/G-4591-2019; Sarantos, Menelaos/H-8136-2013; Ho, George/G-3650-2015; McNutt, Ralph L/E-8006-2010; Benna, Mehdi/F-3489-2012; Slavin, James A/H-3170-2012; Raines, Jim M./O-5649-2016; Korth, Haje/C-3182-2016; Ho, George/GMW-9642-2022; Anderson, Brian J/I-8615-2012	Sarantos, Menelaos/0000-0003-0728-2971; Krimigis, Stamatios/0000-0003-2781-2386; Ho, George/0000-0003-1093-2066; McNutt, Ralph L/0000-0002-4722-9166; Slavin, James A/0000-0002-9206-724X; Korth, Haje/0000-0001-7394-7439; Ho, George/0000-0003-1093-2066; 	NASA [NAS5-97271, NASW-00002]; NSF Center for Integrated Space Weather Modeling	NASA(National Aeronautics & Space Administration (NASA)); NSF Center for Integrated Space Weather Modeling	We thank all those who contributed to the success of the MESSENGER flybys of Mercury. We thank J. Feggans and M. Marosy for data visualization and graphics support. The MESSENGER project is supported by the NASA Discovery Program under contracts NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington. Small parts of the work were supported by an NSF Center for Integrated Space Weather Modeling grant.	Alexeev II, 2010, ICARUS, V209, P23, DOI 10.1016/j.icarus.2010.01.024; Anderson BJ, 2008, SCIENCE, V321, P82, DOI 10.1126/science.1159081; Anderson BJ, 2007, SPACE SCI REV, V131, P417, DOI 10.1007/s11214-007-9246-7; Anderson BJ, 2010, SPACE SCI REV, V152, P307, DOI 10.1007/s11214-009-9544-3; Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; BAKER DN, 1986, J GEOPHYS RES, V91, P8742, DOI 10.1029/JA091iA08p08742; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; BOARDSEN SA, 2010, GEOPH RES ABSTR, V12; Christon S. P., 1987, MAGNETOTAIL PHYS, P393; Glassmeier KH, 1997, PLANET SPACE SCI, V45, P119, DOI 10.1016/S0032-0633(96)00095-5; Hasegawa H, 2004, NATURE, V430, P755, DOI 10.1038/nature02799; HONES EW, 1984, GEOPHYS RES LETT, V11, P5, DOI 10.1029/GL011i001p00005; Huang CS, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014232; Kidder A, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013038; Milan SE, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010350; MOLDWIN MB, 1993, J GEOPHYS RES-SPACE, V98, P81, DOI 10.1029/92JA02153; ODSTRCIL D, 2009, EOS S, V90; RUSSELL CT, 1973, SPACE SCI REV, V15, P205, DOI 10.1007/BF00169321; Shue JH, 1997, J GEOPHYS RES-SPACE, V102, P9497, DOI 10.1029/97JA00196; SISCOE GL, 1975, J GEOPHYS RES-SPACE, V80, P4359, DOI 10.1029/JA080i031p04359; Slavin JA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010878; Slavin JA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009557; Slavin JA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041485; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Slavin JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036158; STARR RD, 2009, EOS S, V90; Travnicek PM, 2010, ICARUS, V209, P11, DOI 10.1016/j.icarus.2010.01.008	27	154	154	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					665	668		10.1126/science.1188067	http://dx.doi.org/10.1126/science.1188067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20647422	Green Submitted			2022-12-28	WOS:000280602700034
J	Cvetkovic, A; Menon, AL; Thorgersen, MP; Scott, JW; Poole, FL; Jenney, FE; Lancaster, WA; Praissman, JL; Shanmukh, S; Vaccaro, BJ; Trauger, SA; Kalisiak, E; Apon, JV; Siuzdak, G; Yannone, SM; Tainer, JA; Adams, MWW				Cvetkovic, Aleksandar; Menon, Angeli Lal; Thorgersen, Michael P.; Scott, Joseph W.; Poole, Farris L., II; Jenney, Francis E., Jr.; Lancaster, W. Andrew; Praissman, Jeremy L.; Shanmukh, Saratchandra; Vaccaro, Brian J.; Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary; Yannone, Steven M.; Tainer, John A.; Adams, Michael W. W.			Microbial metalloproteomes are largely uncharacterized	NATURE			English	Article							ARCHAEON PYROCOCCUS-FURIOSUS; HYPERTHERMOPHILIC ARCHAEON; MASS-SPECTROMETRY; TRACE-ELEMENTS; KEY ROLE; PROTEINS; METABOLISM; RUBREDOXIN; INSIGHTS; DATABASE	Metal ion cofactors afford proteins virtually unlimited catalytic potential, enable electron transfer reactions and have a great impact on protein stability(1,2). Consequently, metalloproteins have key roles in most biological processes, including respiration (iron and copper), photosynthesis (manganese) and drug metabolism (iron). Yet, predicting from genome sequence the numbers and types of metal an organism assimilates from its environment or uses in its metalloproteome is currently impossible because metal coordination sites are diverse and poorly recognized(2-4). We present here a robust, metal-based approach to determine all metals an organism assimilates and identify its metalloproteins on a genome-wide scale. This shifts the focus from classical protein-based purification to metal-based identification and purification by liquid chromatography, high-throughput tandem mass spectrometry (HT-MS/MS) and inductively coupled plasma mass spectrometry (ICP-MS) to characterize cytoplasmic metalloproteins from an exemplary microorganism (Pyrococcus furiosus). Of 343 metal peaks in chromatography fractions, 158 did not match any predicted metalloprotein. Unassigned peaks included metals known to be used (cobalt, iron, nickel, tungsten and zinc; 83 peaks) plus metals the organism was not thought to assimilate (lead, manganese, molybdenum, uranium and vanadium; 75 peaks). Purification of eight of 158 unexpected metal peaks yielded four novel nickel- and molybdenum-containing proteins, whereas four purified proteins contained sub-stoichiometric amounts of misincorporated lead and uranium. Analyses of two additional microorganisms (Escherichia coli and Sulfolobus solfataricus) revealed species-specific assimilation of yet more unexpected metals. Metalloproteomes are therefore much more extensive and diverse than previously recognized, and promise to provide key insights for cell biology, microbial growth and toxicity mechanisms.	[Cvetkovic, Aleksandar; Menon, Angeli Lal; Thorgersen, Michael P.; Scott, Joseph W.; Poole, Farris L., II; Jenney, Francis E., Jr.; Lancaster, W. Andrew; Praissman, Jeremy L.; Shanmukh, Saratchandra; Vaccaro, Brian J.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Scripps Ctr Mass Spectrometry, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Yannone, Steven M.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University System of Georgia; University of Georgia; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	Tainer, John/GWQ-4878-2022; Vaccaro, Brian/F-8526-2017; Yannone, Steven/ABA-3524-2021; Yannone, Steven/G-1927-2011	Tainer, John/0000-0003-1659-2429; Jenney, Francis/0000-0002-1667-6924; Thorgersen, Michael/0000-0001-9552-762X; Siuzdak, Gary/0000-0002-4749-0014; Adams, Michael/0000-0002-9796-5014; Trauger, Sunia/0000-0002-1678-8715	Department of Energy [DE-FG0207ER64326]	Department of Energy(United States Department of Energy (DOE))	This research is part of the MAGGIE (Molecular Assemblies, Genes and Genomes Integrated Efficiently) project supported by Department of Energy grant (DE-FG0207ER64326). We thank S. Hammond, L. Wells, R. Hopkins and D. Phillips for help with in-gel MS analyses.	Adams MWW, 2001, J BACTERIOL, V183, P716, DOI 10.1128/JB.183.2.716-724.2001; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Aiuppa A, 2000, J VOLCANOL GEOTH RES, V98, P189, DOI 10.1016/S0377-0273(99)00156-0; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Atanassova Anelia, 2008, V426, P319, DOI 10.1007/978-1-60327-058-8_20; BLAKE PR, 1991, BIOCHEMISTRY-US, V30, P10885, DOI 10.1021/bi00109a012; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Cai Y, 2000, SPECTROCHIM ACTA B, V55, P1411, DOI 10.1016/S0584-8547(00)00247-0; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chai SC, 2008, J BIOL CHEM, V283, P26879, DOI 10.1074/jbc.M804345200; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Gray H.B., 2006, BIOL INORGANIC CHEM; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jenney FE, 2001, METHOD ENZYMOL, V334, P45; Karthikeyan S, 2006, ANAL CHIM ACTA, V576, P23, DOI 10.1016/j.aca.2006.05.051; Kasampalidis IN, 2007, PROTEINS, V68, P123, DOI 10.1002/prot.21384; Kosnett MJ, 2007, BASIC CLIN PHARMACOL, V10th, P945; Lobinski R, 2006, MASS SPECTROM REV, V25, P255, DOI 10.1002/mas.20069; Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9; Menon AL, 2009, MOL CELL PROTEOMICS, V8, P735, DOI 10.1074/mcp.M800246-MCP200; Messerschmidt A., 2005, HDB METALLOPROTEINS, V1-3; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Poole FL, 2005, J BACTERIOL, V187, P7325, DOI 10.1128/JB.187.21.7325-7332.2005; Ragsdale SW, 2009, J BIOL CHEM, V284, P18571, DOI 10.1074/jbc.R900020200; Sambrook J., 1989, MOL CLONING LAB MANU, P3; Sanz-Medel A, 2008, ANAL BIOANAL CHEM, V390, P3, DOI 10.1007/s00216-007-1615-2; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shi WX, 2005, STRUCTURE, V13, P1473, DOI 10.1016/j.str.2005.07.014; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886	37	276	280	5	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					779	U18		10.1038/nature09265	http://dx.doi.org/10.1038/nature09265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20639861	Green Submitted			2022-12-28	WOS:000280562500044
J	Dickersin, K				Dickersin, Kay			To Reform US Health Care, Start with Systematic Reviews	SCIENCE			English	Editorial Material							METAANALYSIS; MEDICINE; SCIENCE		[Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD 21205 USA; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, US Cochrane Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dickersin, K (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD 21205 USA.	kdickers@jhsph.edu						Ault A, 2003, SCIENCE, V300, P2024, DOI 10.1126/science.300.5628.2024; Borenstein M., 2009, INTRO METAANALYSIS; Centers for Disease Control and Prevention, GUID COMM PREV SERV; CHALMERS I, 1992, BMJ-BRIT MED J, V305, P786, DOI 10.1136/bmj.305.6857.786; Clark S, 2010, LANCET, V376, P10, DOI 10.1016/S0140-6736(10)61001-X; Department of Health United Kingdom, 2005, RES GOV FRAM HLTH SO; Dickersin K, 1998, CLIN OBSTET GYNECOL, V41, P315, DOI 10.1097/00003081-199806000-00012; Eden J, 2008, KNOWING WHAT WORKS H; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; HEDGES LV, 1987, AM PSYCHOL, V42, P443, DOI 10.1037/0003-066X.42.5.443; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horton R, 2010, LANCET, V376, P80, DOI 10.1016/S0140-6736(10)61052-5; KAPP MB, 1990, ARCH INTERN MED, V150, P496, DOI 10.1001/archinte.150.3.496; Light R.J., 1984, SUMMING SCI REV RES; MANN C, 1990, SCIENCE, V249, P476, DOI 10.1126/science.2382129; McGuire W, 2010, ARCH DIS CHILD-FETAL, V95, pF2, DOI 10.1136/adc.2007.133561; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; Newman L, 2000, LANCET, V356, P1990, DOI 10.1016/S0140-6736(05)72963-9; Richardson KM, 2008, J OCCUP HEALTH PSYCH, V13, P69, DOI 10.1037/1076-8998.13.1.69; Sackett D.L., 2000, EVIDENCE BASED MED P, DOI DOI 10.1016/S1031-170X(97)80036-0; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; *US GOV ACC OFF, 2009, GAO1030; Zhu C, 2010, SCIENCE, V327, P1429, DOI 10.1126/science.1188965; ZIMAN JM, 1969, NATURE, V224, P318, DOI 10.1038/224318a0	26	20	20	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					516	517		10.1126/science.1189330	http://dx.doi.org/10.1126/science.1189330			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633EX	20671173				2022-12-28	WOS:000280483500018
J	Young, J; Murthy, L; Westby, M; Akunne, A; O'Mahony, R				Young, John; Murthy, Lakshmi; Westby, Maggie; Akunne, Anayo; O'Mahony, Rachel		Guideline Dev Grp	Guidelines Diagnosis, prevention, and management of delirium: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFUSION ASSESSMENT METHOD		[Young, John] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Murthy, Lakshmi; Westby, Maggie; Akunne, Anayo; O'Mahony, Rachel] Royal Coll Physicians, Natl Clin Guideline Ctr, London, England	Bradford Royal Infirmary; Royal College of Physicians	Young, J (corresponding author), Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England.	john.young@bradfordhospitals.nhs.uk	Westby, Maggie/GWZ-2119-2022; Westby, Maggie/O-8794-2014	Westby, Maggie/0000-0003-4273-3942; young, john/0000-0003-4085-9306				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; *JOINT FORM COMM, 2009, BRIT NAT FORM; National Clinical Guideline Centre, 2010, PAT DEL EXP VID; National Clinical Guideline Centre, 2010, DEL DIAGN PREV MAN; National Collaborating Centre for Acute Care, 2006, NUTR SUPP AD OR NUTR; National Institute for Clinical Excellence, 2003, INF CONTR PREV HEALT; National Institute for Health and Clinical Excellence, 2006, PARK DIS NAT CLIN GU, V35; National Institute for Health and Clinical Excellence, 2005, VIOL SHORT TERM MAN; National Institute for Health and Clinical Excellence, 2007, AC ILL PAT HOSP REC; National Institute for Health and Clinical Excellence, 2007, DEM SUPP PEOPL DEM T, V42	12	151	155	2	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2010	341								c3704	10.1136/bmj.c3704	http://dx.doi.org/10.1136/bmj.c3704			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634GZ	20667955	Green Accepted			2022-12-28	WOS:000280570100002
J	Somani, BK; Watson, G; Townell, N				Somani, Bhaskar K.; Watson, Graham; Townell, Nick			Easily Missed? Testicular torsion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE SCROTUM; PEDIATRIC-PATIENTS; SPERMATIC CORD; ISCHEMIA; SALVAGE		[Somani, Bhaskar K.; Townell, Nick] Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Dundee	Townell, N (corresponding author), Ninewells Hosp, Dundee DD1 9SY, Scotland.	nicktownell@nhs.net	Somani, B. K./I-8429-2019	Somani, B. K./0000-0002-6248-6478				ANDERSON JB, 1988, BRIT J SURG, V75, P988, DOI 10.1002/bjs.1800751015; BARADA JH, 1989, J UROLOGY, V142, P746, DOI 10.1016/S0022-5347(17)38875-4; BENNETT S, 1987, BMJ-BRIT MED J, V294, P824, DOI 10.1136/bmj.294.6575.824; BRASSO K, 1993, SCAND J UROL NEPHROL, V27, P1; BURKS DD, 1990, RADIOLOGY, V175, P815, DOI 10.1148/radiology.175.3.2188301; CATTOLICA EV, 1982, J UROLOGY, V128, P66, DOI 10.1016/S0022-5347(17)52758-5; Ciftci AO, 2004, EUR J PEDIATR SURG, V14, P333, DOI 10.1055/s-2004-821210; Eaton SH, 2005, J UROLOGY, V174, P1532, DOI 10.1097/01.ju.0000177726.84913.cc; Jefferson RH, 1997, J UROLOGY, V158, P1198, DOI 10.1016/S0022-5347(01)64426-4; LEWIS AG, 1995, J PEDIATR SURG, V30, P277, DOI 10.1016/0022-3468(95)90574-X; Makela E, 2007, SCAND J SURG, V96, P62; MOLOKWU CN, 2010, BJU INT IN PRESS; Mushtaq I, 2003, ANZ J SURG, V73, P55, DOI 10.1046/j.1445-2197.2003.02612.x; Sessions AE, 2003, J UROLOGY, V169, P663, DOI 10.1016/S0022-5347(05)63987-0; SMITH GI, 1955, J UROLOGY, V73, P355, DOI 10.1016/S0022-5347(17)67408-1; Visser AJ, 2003, BJU INT, V92, P200, DOI 10.1046/j.1464-410X.2003.04307.x	16	8	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2010	341								c3213	10.1136/bmj.c3213	http://dx.doi.org/10.1136/bmj.c3213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634GX	20663836				2022-12-28	WOS:000280569900001
J	Debette, S; Markus, HS				Debette, Stephanie; Markus, H. S.			The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis	BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; SMALL-VESSEL DISEASE; CARDIOVASCULAR HEALTH COGNITION; AUSTRIAN STROKE PREVENTION; MEDIAL TEMPORAL ATROPHY; CEREBROVASCULAR-DISEASE; RISK-FACTORS; VASCULAR DEMENTIA; VOLUMETRIC MRI; BLOOD-PRESSURE	Objectives To review the evidence for an association of white matter hyperintensities with risk of stroke, cognitive decline, dementia, and death. Design Systematic review and meta-analysis. Data sources PubMed from 1966 to 23 November 2009. Study selection Prospective longitudinal studies that used magnetic resonance imaging and assessed the impact of white matter hyperintensities on risk of incident stroke, cognitive decline, dementia, and death, and, for the meta-analysis, studies that provided risk estimates for a categorical measure of white matter hyperintensities, assessing the impact of these lesions on risk of stroke, dementia, and death. Data extraction Population studied, duration of follow-up, method used to measure white matter hyperintensities, definition of the outcome, and measure of the association of white matter hyperintensities with the outcome. Data synthesis 46 longitudinal studies evaluated the association of white matter hyperintensities with risk of stroke (n=12), cognitive decline (n=19), dementia (n=17), and death (n=10). 22 studies could be included in a meta-analysis (nine of stroke, nine of dementia, eight of death). White matter hyperintensities were associated with an increased risk of stroke (hazard ratio 3.3, 95% confidence interval 2.6 to 4.4), dementia (1.9, 1.3 to 2.8), and death (2.0, 1.6 to 2.7). An association of white matter hyperintensities with a faster decline in global cognitive performance, executive function, and processing speed was also suggested. Conclusion White matter hyperintensities predict an increased risk of stroke, dementia, and death. Therefore white matter hyperintensities indicate an increased risk of cerebrovascular events when identified as part of diagnostic investigations, and support their use as an intermediate marker in a research setting. Their discovery should prompt detailed screening for risk factors of stroke and dementia.	[Debette, Stephanie; Markus, H. S.] St Georges Univ London, London, England; [Debette, Stephanie] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Debette, Stephanie] Lille Univ Hosp, Dept Neurol, Lille, France	St Georges University London; Boston University; Universite de Lille - ISITE; CHU Lille	Debette, S (corresponding author), St Georges Univ London, London, England.	sdebette@bu.edu	Debette, Stephanie/T-4946-2019	Debette, Stephanie/0000-0001-8675-7968; Dichgans, Martin/0000-0002-0654-387X	European Neurological Society; Bettencourt-Schueller; Lilly foundations	European Neurological Society; Bettencourt-Schueller; Lilly foundations	SD was supported by a grant from the European Neurological Society, a Fulbright grant, and an award from the Bettencourt-Schueller and the Lilly foundations.	Aharon-Peretz J, 2002, J NEUROL SCI, V203, P53, DOI 10.1016/S0022-510X(02)00261-7; Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Appelros P, 2005, CEREBROVASC DIS, V20, P34, DOI 10.1159/000086202; Atwood LD, 2004, STROKE, V35, P1609, DOI 10.1161/01.STR.0000129643.77045.10; Bokura Hirokazu, 2006, J Stroke Cerebrovasc Dis, V15, P57, DOI 10.1016/j.jstrokecerebrovasdis.2005.11.001; Bombois S, 2008, STROKE, V39, P2046, DOI 10.1161/STROKEAHA.107.505206; BOTS ML, 1993, LANCET, V341, P1232, DOI 10.1016/0140-6736(93)91144-B; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; Carmelli D, 1998, STROKE, V29, P1177, DOI 10.1161/01.STR.29.6.1177; Chui HC, 2006, ANN NEUROL, V60, P677, DOI 10.1002/ana.21009; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; Debette S, 2007, STROKE, V38, P2924, DOI 10.1161/STROKEAHA.107.488403; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; DeCarli C, 2004, NEUROLOGY, V63, P220, DOI 10.1212/01.WNL.0000130531.90205.EF; Dufouil C, 2005, CIRCULATION, V112, P1644, DOI 10.1161/CIRCULATIONAHA.104.501163; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Fazekas F, 2002, J NEURAL TRANSM-SUPP, P61; Firbank MJ, 2007, NEUROBIOL AGING, V28, P1664, DOI 10.1016/j.neurobiolaging.2006.07.009; Fu JH, 2005, J NEUROL NEUROSUR PS, V76, P793, DOI 10.1136/jnnp.2003.032771; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Gerdes VEA, 2006, ATHEROSCLEROSIS, V186, P166, DOI 10.1016/j.atherosclerosis.2005.07.008; Geroldi C, 2006, J NEUROL NEUROSUR PS, V77, P1219, DOI 10.1136/jnnp.2005.082651; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Ikram MA, 2009, NEUROBIOL AGING, V30, P450, DOI 10.1016/j.neurobiolaging.2007.07.009; Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85; Jokinen H, 2009, CEREBROVASC DIS, V27, P384, DOI 10.1159/000207442; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kerber KA, 2006, J NEUROL SCI, V250, P33, DOI 10.1016/j.jns.2006.06.022; Kobayashi S, 1997, STROKE, V28, P1932, DOI 10.1161/01.STR.28.10.1932; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Kovari E, 2004, STROKE, V35, P410, DOI 10.1161/01.STR.0000110791.51378.4E; Kramer JH, 2007, NEUROPSYCHOLOGY, V21, P412, DOI 10.1037/0894-4105.21.4.412; Kuller LH, 2007, NEUROBIOL AGING, V28, P1307, DOI 10.1016/j.neurobiolaging.2006.06.010; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Kuller LH, 2005, NEUROLOGY, V64, P1548, DOI 10.1212/01.WNL.0000160115.55756.DE; Kuller LH, 2003, NEUROEPIDEMIOLOGY, V22, P13, DOI 10.1159/000067109; Launer Lenore J, 2004, Top Magn Reson Imaging, V15, P365, DOI 10.1097/01.rmr.0000168216.98338.8d; LECHNER H, 1988, STROKE, V19, P263, DOI 10.1161/01.STR.19.2.263; Levy RM, 2003, AM J GERIAT PSYCHIAT, V11, P678, DOI 10.1176/appi.ajgp.11.6.678; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Longstreth WT, 2001, ARCH NEUROL-CHICAGO, V58, P635, DOI 10.1001/archneur.58.4.635; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meguro K, 2007, J NEUROL SCI, V260, P175, DOI 10.1016/j.jns.2007.04.051; Mungas D, 2005, NEUROLOGY, V65, P565, DOI 10.1212/01.wnl.0000172913.88973.0d; Mungas D, 2002, NEUROLOGY, V59, P867, DOI 10.1212/WNL.59.6.867; Naka H, 2006, AM J NEURORADIOL, V27, P830; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; Oksala NKJ, 2009, J NEUROL NEUROSUR PS, V80, P762, DOI 10.1136/jnnp.2008.154104; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rosano C, 2007, J NEUROIMAGING, V17, P148, DOI 10.1111/j.1552-6569.2007.00093.x; Schmidt R, 2005, ANN NEUROL, V58, P610, DOI 10.1002/ana.20630; Schmidt R, 2004, NEUROLOGY, V63, P139, DOI 10.1212/01.WNL.0000132635.75819.E5; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; Silbert LC, 2009, NEUROLOGY, V73, P120, DOI 10.1212/WNL.0b013e3181ad53fd; Smith EE, 2004, NEUROLOGY, V63, P1606, DOI 10.1212/01.WNL.0000142966.22886.20; Smith EE, 2008, ARCH NEUROL-CHICAGO, V65, P94, DOI 10.1001/archneurol.2007.23; Staekenborg SS, 2009, STROKE, V40, P1269, DOI 10.1161/STROKEAHA.108.531343; Steffens DC, 2007, AM J GERIAT PSYCHIAT, V15, P839, DOI 10.1097/JGP.0b013e318048a1a0; Steffens DC, 2000, LANCET, V356, P1686, DOI 10.1016/S0140-6736(05)70393-7; Symons MJ, 2002, J CLIN EPIDEMIOL, V55, P893, DOI 10.1016/S0895-4356(02)00443-2; Tapiola T, 2008, NEUROBIOL AGING, V29, P31, DOI 10.1016/j.neurobiolaging.2006.09.007; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; van den Heuvel DMJ, 2006, J NEUROL NEUROSUR PS, V77, P149, DOI 10.1136/jnnp.2005.070193; van der Flier WM, 2005, INT J GERIATR PSYCH, V20, P1060, DOI 10.1002/gps.1392; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; van Straaten ECW, 2008, J NEUROL, V255, P1302, DOI 10.1007/s00415-008-0874-y; VANSWIETEN JC, 1991, BRAIN, V114, P761; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Yamauchi H, 2002, J NEUROL NEUROSUR PS, V72, P576, DOI 10.1136/jnnp.72.5.576; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	87	1339	1380	1	113	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2010	341								c3666	10.1136/bmj.c3666	http://dx.doi.org/10.1136/bmj.c3666			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634GV	20660506	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000280569500002
J	Moseley, JB; Nurse, P				Moseley, James B.; Nurse, Paul			Cell Division Intersects with Cell Geometry	CELL			English	Article							BACILLUS-SUBTILIS; SPINDLE ORIENTATION; CHROMOSOME SEGREGATION; MICROTUBULE BUNDLES; SELF-ORGANIZATION; PROTEIN DIVIVA; AURORA-A; KINASE; LOCALIZATION; SHAPE		[Moseley, James B.; Nurse, Paul] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Moseley, JB (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	jmoseley@rockefeller.edu			Wellcome Trust [093917] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Daga RR, 2008, J CELL SCI, V121, P1973, DOI 10.1242/jcs.011825; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lutkenhaus J, 2008, ADV EXP MED BIOL, V641, P49; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Maruyama R, 2007, CURR BIOL, V17, P1555, DOI 10.1016/j.cub.2007.08.011; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; Stitzel ML, 2007, CURR BIOL, V17, P1545, DOI 10.1016/j.cub.2007.08.049; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vogel SK, 2007, CURR BIOL, V17, P438, DOI 10.1016/j.cub.2007.01.047; Wu LJ, 2009, EMBO J, V28, P1940, DOI 10.1038/emboj.2009.144; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	52	36	39	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					189	193		10.1016/j.cell.2010.07.004	http://dx.doi.org/10.1016/j.cell.2010.07.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655459	Bronze			2022-12-28	WOS:000280204300007
J	Swierczek, M; Cieluch, E; Sarewicz, M; Borek, A; Moser, CC; Dutton, PL; Osyczka, A				Swierczek, Monika; Cieluch, Ewelina; Sarewicz, Marcin; Borek, Arkadiusz; Moser, Christopher C.; Dutton, P. Leslie; Osyczka, Artur			An Electronic Bus Bar Lies in the Core of Cytochrome bc(1)	SCIENCE			English	Article							Q(O) SITE; Q-CYCLE; RHODOBACTER-CAPSULATUS; SUPEROXIDE-PRODUCTION; COMPLEX; MITOCHONDRIAL; MECHANISM; DOMAIN; OXIDATION; MOVEMENT	The ubiquinol-cytochrome c oxidoreductases, central to cellular respiration and photosynthesis, are homodimers. High symmetry has frustrated resolution of whether cross-dimer interactions are functionally important. This has resulted in a proliferation of contradictory models. Here, we duplicated and fused cytochrome b subunits, and then broke symmetry by introducing independent mutations into each monomer. Electrons moved freely within and between monomers, crossing an electron-transfer bridge between two hemes in the core of the dimer. This revealed an H-shaped electron-transfer system that distributes electrons between four quinone oxidation-reduction terminals at the corners of the dimer within the millisecond time scale of enzymatic turnover. Free and unregulated distribution of electrons acts like a molecular-scale bus bar, a design often exploited in electronics.	[Swierczek, Monika; Cieluch, Ewelina; Sarewicz, Marcin; Borek, Arkadiusz; Osyczka, Artur] Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Moser, Christopher C.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	Jagiellonian University; University of Pennsylvania	Osyczka, A (corresponding author), Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	artur.osyczka@uj.edu.pl	Moser, Christopher C/O-6559-2014	Moser, Christopher C/0000-0003-4814-8568; Sarewicz, Marcin/0000-0001-6813-5997; Borek, Arkadiusz/0000-0003-3195-3579; Osyczka, Artur/0000-0002-1637-2365	Wellcome Trust; United States National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041048, R01GM027309] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to F. Daldal (University of Pennsylvania, Philadelphia, USA) for the genetic system for cytochrome bc1 in R. capsulatus. This work was supported by The Wellcome Trust International Senior Research Fellowship (A.O.) and by the United States National Institutes of Health (P.L.D.)	Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Borek A, 2008, BIOCHEMISTRY-US, V47, P12365, DOI 10.1021/bi801207f; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Castellani M, 2010, J BIOL CHEM, V285, P502, DOI 10.1074/jbc.M109.072959; Cooley JW, 2009, BIOCHEMISTRY-US, V48, P1888, DOI 10.1021/bi802216h; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gopta OA, 1998, FEBS LETT, V431, P291, DOI 10.1016/S0014-5793(98)00768-6; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Lee DW, 2008, J BIOL CHEM, V283, P13973, DOI 10.1074/jbc.M800091200; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Sarewicz M, 2008, J BIOL CHEM, V283, P24826, DOI 10.1074/jbc.M802174200; Shinkarev VP, 2007, FEBS LETT, V581, P1535, DOI 10.1016/j.febslet.2007.03.037; Yu CA, 2008, BBA-BIOENERGETICS, V1777, P1038, DOI 10.1016/j.bbabio.2008.03.033; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004	27	100	100	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					451	454		10.1126/science.1190899	http://dx.doi.org/10.1126/science.1190899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651150	Green Accepted			2022-12-28	WOS:000280196500040
J	Moore, MJ; Wang, QQ; Kennedy, CJ; Silver, PA				Moore, Michael J.; Wang, Qingqing; Kennedy, Caleb J.; Silver, Pamela A.			An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis	CELL			English	Article							PRE-MESSENGER-RNA; PROTEIN; STRATEGY; KINASES	Alternative splicing is a vast source of biological regulation and diversity that is misregulated in cancer and other diseases. To investigate global control of alternative splicing in human cells, we analyzed splicing of mRNAs encoding Bcl2 family apoptosis factors in a genome-wide siRNA screen. The screen identified many regulators of Bcl-x and Mcl1 splicing, notably an extensive network of cell-cycle factors linked to aurora kinase A. Drugs or siRNAs that induce mitotic arrest promote proapoptotic splicing of Bcl-x, Mcl1, and caspase-9 and alter splicing of other apoptotic transcripts. This response precedes mitotic arrest, indicating coordinated upregulation of prodeath splice variants that promotes apoptosis in arrested cells. These shifts correspond to posttranslational turnover of splicing regulator ASF/SF2, which directly binds and regulates these target mRNAs and globally regulates apoptosis. Broadly, our results reveal an alternative splicing network linking cell-cycle control to apoptosis.	[Moore, Michael J.; Wang, Qingqing; Kennedy, Caleb J.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu			National Science Foundation; National Institutes of Health [NIHGM057476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057476] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Junying Yuan and Robin Reed for reagents, Jodene Moore for help with flow cytometry, and Jessica Hurt, Natalie Gilks-Farny, Daniel Ducat, William Senapedis, Faisal Aldaye, Deborah Flusberg, and Ian Swinburne for thoughtful critiques and discussions. RNAi screening capability was provided by the ICCB-Longwood screening facility at Harvard Medical School. We are indebted to ICCB-L staff Caroline Shamu, Sean Johnston, Stewart Rudnicki, Zac Cooper, and David Wrobel. M.J.M. was supported by funding from the National Science Foundation. Work was supported by grant NIHGM057476 to P.A.S. from the National Institutes of Health.	Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Dassah M, 2009, GENETICS, V182, P725, DOI 10.1534/genetics.109.103473; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ditchfield Claire, 2005, Methods Mol Biol, V296, P371; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	40	230	255	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					625	636		10.1016/j.cell.2010.07.019	http://dx.doi.org/10.1016/j.cell.2010.07.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20705336	Green Accepted, Bronze			2022-12-28	WOS:000281115900016
J	Petersen, KD; Nielsen, SB; Clausen, OR; Stephenson, R; Gerya, T				Petersen, K. D.; Nielsen, S. B.; Clausen, O. R.; Stephenson, R.; Gerya, T.			Small-Scale Mantle Convection Produces Stratigraphic Sequences in Sedimentary Basins	SCIENCE			English	Article								Cyclic sedimentary deposits link stratigraphic sequences that are now geographically distant but were once part of the same depositional environment. Some of these sequences occur at periods of 2 to 20 million years, and eustatic sea-level variations or regional tectonic events are likely causes of their formation. Using numerical modeling, we demonstrate that small-scale mantle convection can also cause the development of stratigraphic sequences through recurrent local and regional vertical surface movements. Small-scale convection-driven stratigraphic sequences occur at periods of 2 to 20 million years and correlate only at distances up to a few hundred kilometers. These results suggest that previous sequence stratigraphic analyses may contain erroneous conclusions regarding eustatic sea-level variations.	[Petersen, K. D.; Nielsen, S. B.; Clausen, O. R.] Aarhus Univ, Dept Earth Sci, DK-8000 Aarhus C, Denmark; [Stephenson, R.] Univ Aberdeen, Kings Coll, Sch Geosci Geol & Petr Geol, Aberdeen AB9 1FX, Scotland; [Gerya, T.] Swiss Fed Inst Technol, Dept Geosci, Zurich, Switzerland	Aarhus University; University of Aberdeen; Swiss Federal Institutes of Technology Domain; ETH Zurich	Petersen, KD (corresponding author), Aarhus Univ, Dept Earth Sci, DK-8000 Aarhus C, Denmark.	kenni@geo.au.dk	Nielsen, Søren/A-5288-2012; Petersen, Kenni Dinesen/A-3232-2012; Clausen, Ole Rønø/A-5290-2012; Stephenson, Randell A/A-3741-2012; Gerya, Taras/V-2330-2019	Stephenson, Randell A/0000-0003-4868-8601; Gerya, Taras/0000-0002-1062-2722; Petersen, Kenni Dinesen/0000-0002-6758-3656; Clausen, Ole Rono/0000-0002-6825-9065				Ballmer MD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031636; BUCK WR, 1985, NATURE, V313, P775, DOI 10.1038/313775a0; BUCK WR, 1986, EARTH PLANET SC LETT, V77, P362, DOI 10.1016/0012-821X(86)90146-9; Catuneanu O, 2009, EARTH-SCI REV, V92, P1, DOI 10.1016/j.earscirev.2008.10.003; CHRISTIEBLICK N, 1988, SCIENCE, V241, P596, DOI 10.1126/science.241.4865.596; CLOETINGH S, 1985, EARTH PLANET SC LETT, V75, P157, DOI 10.1016/0012-821X(85)90098-6; EMBRY A, 2009, SEARCH DISCOVERY; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Huang JS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002456; KARATO S, 1992, GEOPHYS RES LETT, V19, P2255, DOI 10.1029/92GL02603; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; KEEN CE, 1987, CONTINENTAL EXTENSIO, P67; King SD, 2000, SCIENCE, V290, P1137, DOI 10.1126/science.290.5494.1137; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; MIALL A. D, 1997, GEOLOGY STRATIGRAPHI; MIALL AD, 1992, GEOLOGY, V20, P787, DOI 10.1130/0091-7613(1992)020<0787:EGCCAE>2.3.CO;2; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mitchum Jr R., 1977, AAPG BULL, V26, P53, DOI DOI 10.1306/M26490C4; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; Nielsen SB, 2005, NATURE, V435, P195, DOI 10.1038/nature03599; PARSONS B, 1978, J GEOPHYS RES, V83, P4485, DOI 10.1029/JB083iB09p04485; Ranalli G., 1995, RHEOLOGY EARTH; RICHTER FM, 1973, J GEOPHYS RES, V78, P8735, DOI 10.1029/JB078i035p08735; SLOSS LL, 1963, GEOL SOC AM BULL, V74, P93, DOI 10.1130/0016-7606(1963)74[93:SITCIO]2.0.CO;2; Spasojevic S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033511; Stephenson R., 1980, MECH CONTINENTAL DRI, P111; Tackley PJ, 2008, NAT GEOSCI, V1, P157, DOI 10.1038/ngeo134	28	65	65	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					827	830		10.1126/science.1190115	http://dx.doi.org/10.1126/science.1190115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705857				2022-12-28	WOS:000280809900047
J	Richard, TL				Richard, Tom L.			Challenges in Scaling Up Biofuels Infrastructure	SCIENCE			English	Editorial Material							ENVIRONMENTAL-IMPACT; PIPELINE TRANSPORT; BIOMASS FEEDSTOCKS; SOLID BIOFUELS; CORN STOVER; ENERGY; COST; CERTIFICATION; STRATEGIES; EFFICIENCY	Rapid growth in demand for lignocellulosic bioenergy will require major changes in supply chain infrastructure. Even with densification and preprocessing, transport volumes by mid-century are likely to exceed the combined capacity of current agricultural and energy supply chains, including grain, petroleum, and coal. Efficient supply chains can be achieved through decentralized conversion processes that facilitate local sourcing, satellite preprocessing and densification for long-distance transport, and business models that reward biomass growers both nearby and afar. Integrated systems that are cost-effective and energy-efficient will require new ways of thinking about agriculture, energy infrastructure, and rural economic development. Implementing these integrated systems will require innovation and investment in novel technologies, efficient value chains, and socioeconomic and policy frameworks; all are needed to support an expanded biofuels infrastructure that can meet the challenges of scale.	Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Richard, TL (corresponding author), Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA.	trichard@psu.edu	Richard, Tom L/H-5058-2012; Langholtz, Matthew/B-9416-2012	Langholtz, Matthew/0000-0002-8153-7154; Richard, Tom/0000-0002-0833-4844				Aden A., 2002, LIGNOCELLULOSIC BIOM, DOI 10.2172/15001119; Alakangas E, 2006, BIOMASS BIOENERG, V30, P908, DOI 10.1016/j.biombioe.2006.06.001; Alfonso D, 2009, BIOMASS BIOENERG, V33, P1070, DOI 10.1016/j.biombioe.2009.04.002; [Anonymous], 2010, DOEEIA0484; Berndes G, 2003, BIOMASS BIOENERG, V25, P1, DOI 10.1016/S0961-9534(02)00185-X; Berndes G, 2010, BIOMASS BIOENERG, V34, P227, DOI 10.1016/j.biombioe.2009.07.007; Brown R.C., 2003, BIORENEWABLE RESOURC; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Carolan JE, 2007, J AGR FOOD IND ORG, DOI [10.2202/1542-0485.1203, DOI 10.2202/1542-0485.1203]; Eisentraut A., 2010, IEA ENERGY PAPERS; Eriksson L, 2010, BIOMASS BIOENERG, V34, P82, DOI 10.1016/j.biombioe.2009.10.002; Faaij A., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P343, DOI 10.1007/s11027-005-9004-7; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Gronalt M, 2007, BIOMASS BIOENERG, V31, P393, DOI 10.1016/j.biombioe.2007.01.007; Hess JR, 2007, BIOFUEL BIOPROD BIOR, V1, P181, DOI 10.1002/bbb.26; Huber GW, 2007, ANGEW CHEM INT EDIT, V46, P7184, DOI 10.1002/anie.200604504; Kaltschmitt M, 2006, BIOMASS BIOENERG, V30, P897, DOI 10.1016/j.biombioe.2006.06.009; Kumar A, 2005, BIORESOURCE TECHNOL, V96, P819, DOI 10.1016/j.biortech.2004.07.007; Kumar A, 2004, APPL BIOCHEM BIOTECH, V113, P27, DOI 10.1385/ABAB:113:1-3:027; Kumar A, 2003, BIOMASS BIOENERG, V24, P445, DOI 10.1016/S0961-9534(02)00149-6; Laser M, 2009, BIOFUEL BIOPROD BIOR, V3, P247, DOI 10.1002/bbb.136; Lenox M.J., 2003, BUS STRATEG ENVIRON, V12, P343, DOI [10.1002/bse.380, DOI 10.1002/BSE.380]; Lewandowski I, 2006, BIOMASS BIOENERG, V30, P83, DOI 10.1016/j.biombioe.2005.11.003; Magelli F, 2009, BIOMASS BIOENERG, V33, P434, DOI 10.1016/j.biombioe.2008.08.016; Mahmudi H, 2006, APPL BIOCHEM BIOTECH, V129, P88, DOI 10.1385/ABAB:129:1:88; Mapemba LD, 2008, BIOMASS BIOENERG, V32, P1016, DOI 10.1016/j.biombioe.2008.02.003; National Academy of Sciences National Academy of Engineering National Research Council, 2009, LIQ TRANSP FUELS COA; Phillips S., 2007, TP51041168 NREL; Ravula PP, 2008, BIORESOURCE TECHNOL, V99, P5710, DOI 10.1016/j.biortech.2007.10.044; Ren HY, 2006, BIOTECHNOL PROGR, V22, P78, DOI 10.1021/bp050174q; Searcy E, 2007, APPL BIOCHEM BIOTECH, V137, P639, DOI 10.1007/s12010-007-9085-8; Shinners KJ, 2010, T ASABE, V53, P359; Singh J, 2010, BIOMASS BIOENERG, V34, P483, DOI 10.1016/j.biombioe.2009.12.012; Smeets EMW, 2007, PROG ENERG COMBUST, V33, P56, DOI 10.1016/j.pecs.2006.08.001; Sokhansanj S, 2004, APPL ENG AGRIC, V20, P495; Sokhansanj S, 2010, BIOMASS BIOENERG, V34, P75, DOI 10.1016/j.biombioe.2009.10.001; Uslu A, 2008, ENERGY, V33, P1206, DOI 10.1016/j.energy.2008.03.007; van Dam J, 2008, BIOMASS BIOENERG, V32, P749, DOI 10.1016/j.biombioe.2008.01.018; [No title captured]; [No title captured]; [No title captured]	41	210	218	2	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					793	796		10.1126/science.1189139	http://dx.doi.org/10.1126/science.1189139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705852				2022-12-28	WOS:000280809900038
J	Mozaffarian, D; Ludwig, DS				Mozaffarian, Dariush; Ludwig, David S.			Dietary Guidelines in the 21st Century-a Time for Food	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; WOMEN; RISK; FAT		[Mozaffarian, Dariush; Ludwig, David S.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008	Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2003, DIET NUTR PREV CHRON; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; HARPER AE, 1987, ANNU REV NUTR, V7, P509, DOI 10.1146/annurev.nu.07.070187.002453; Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Heart Lung and Blood Institute, WE CAN WAYS ENH CHIL; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; *US DEP HHS, DIET GUID AM; [World Cancer Research Fund American Institute for Cancer Research], 2007, FOOD NUTR PHYS ACT P	10	155	157	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					681	682		10.1001/jama.2010.1116	http://dx.doi.org/10.1001/jama.2010.1116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699461				2022-12-28	WOS:000280829200025
J	Maquat, LE; Tarn, WY; Isken, O				Maquat, Lynne E.; Tarn, Woan-Yuh; Isken, Olaf			The Pioneer Round of Translation: Features and Functions	CELL			English	Article							MESSENGER-RNA DECAY; EXON-JUNCTION COMPLEX; UPF1 PHOSPHORYLATION; ENHANCE TRANSLATION; PROLONGED HYPOXIA; GENE-EXPRESSION; BINDING-PROTEIN; NONSENSE; MECHANISMS; INITIATION	In mammalian cells, newly synthesized mRNAs undergo a pioneer round of translation that is important for mRNA quality control. Following maturation of messenger ribonucleoprotein particles during and after the pioneer round, steady-state cycles of mRNA translation generate most of the cell's proteins. Translation factors, RNA-binding proteins, and targets of signaling pathways that are particular to newly synthesized mRNAs regulate critical functions of the pioneer round.	[Maquat, Lynne E.; Tarn, Woan-Yuh] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Maquat, Lynne E.; Tarn, Woan-Yuh] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Rochester, NY 14642 USA; [Isken, Olaf] Univ Lubeck, Inst Virol & Cell Biol, D-23562 Lubeck, Germany; [Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	University of Rochester; University of Rochester; University of Lubeck; Academia Sinica - Taiwan	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu; isken@molbio.uni-luebeck.de	Tarn, Woan-Yuh/N-8464-2018	Maquat, Lynne/0000-0002-2789-2075	NIGMS NIH HHS [GM59614, R01 GM074593-27, R01 GM074593, R01 GM059614, R37 GM074593, GM074593, R01 GM059614-11, R01 GM059614-11S1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074593, R01GM059614] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Boyne JR, 2010, EMBO J, V29, P1851, DOI 10.1038/emboj.2010.77; Cakmakci NG, 2008, MOL CELL BIOL, V28, P1182, DOI 10.1128/MCB.01500-07; Choe J, 2010, EMBO REP, V11, P380, DOI 10.1038/embor.2010.44; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; HATCHET O, 2004, NATURE, V428, P959; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lee HC, 2008, BIOCHEM BIOPH RES CO, V369, P1160, DOI 10.1016/j.bbrc.2008.03.017; Lee HC, 2009, BIOCHEM BIOPH RES CO, V384, P334, DOI 10.1016/j.bbrc.2009.04.123; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marin-Vinader L, 2006, BBA-GENE STRUCT EXPR, V1759, P535, DOI 10.1016/J.bbaexp.2006.10.003; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Oh N, 2007, FEBS LETT, V581, P5158, DOI 10.1016/j.febslet.2007.10.002; Oh N, 2007, BIOCHEM BIOPH RES CO, V362, P145, DOI 10.1016/j.bbrc.2007.07.169; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wilson KF, 2000, BIOL CHEM, V381, P357, DOI 10.1515/BC.2000.048; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	38	158	160	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					368	374		10.1016/j.cell.2010.07.022	http://dx.doi.org/10.1016/j.cell.2010.07.022			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691898	Green Accepted, Bronze			2022-12-28	WOS:000280609100014
J	Lorenz, RD				Lorenz, Ralph D.			PLANETARY SCIENCE Winds of Change on Titan	SCIENCE			English	Editorial Material							DUNES		Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Lorenz, RD (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	ralph.lorenz@jhuapl.edu	Lorenz, Ralph D/B-8759-2016	Lorenz, Ralph D/0000-0001-8528-4644				Aharonson O, 2009, NAT GEOSCI, V2, P851, DOI 10.1038/ngeo698; Clark RN, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003369; HADLEY G, 1735, PHILOS T R SOC LOND, V34, P58; Lorenz RD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032118; Lorenz RD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036850; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Mitchell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003017; Rubin DM, 2009, NAT GEOSCI, V2, P653, DOI 10.1038/NGEO610; Tokano T, 2010, AEOLIAN RES, V2, P113, DOI 10.1016/j.aeolia.2010.04.003; Wahlund JE, 2009, PLANET SPACE SCI, V57, P1857, DOI 10.1016/j.pss.2009.07.014; Wald C, 2009, SCIENCE, V323, P1418, DOI 10.1126/science.323.5920.1418	11	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					519	520		10.1126/science.1192840	http://dx.doi.org/10.1126/science.1192840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671175				2022-12-28	WOS:000280483500020
J	Yoder, BL; Bisson, R; Beck, RD				Yoder, Bruce L.; Bisson, Regis; Beck, Rainer D.			Steric Effects in the Chemisorption of Vibrationally Excited Methane on Ni(100)	SCIENCE			English	Article							GAS-SURFACE REACTIVITY; STATE; ADSORPTION; EXCITATION; SCATTERING; DYNAMICS; CH4; DISSOCIATION; PRODUCT; NO	Newly available, powerful infrared laser sources enable the preparation of intense molecular beams of quantum-state prepared and aligned molecules for gas/surface reaction dynamics experiments. We present a stereodynamics study of the chemisorption of vibrationally excited methane on the (100) surface of nickel. Using linearly polarized infrared excitation of the C-H stretch modes of two methane isotopologues [CH(4)(n(3)) and CD(3)H(n(1))], we aligned methane's angular momentum and vibrational transition dipole moment in the laboratory frame. An increase in methane reactivity of as much as 60% is observed when the laser polarization is parallel rather than normal to the surface. The dependence of the alignment effect on the rotational branch used for excitation indicates that alignment of the vibrational transition dipole moment of methane is responsible for the steric effect. Potential explanations for the steric effect in terms of an alignment-dependent reaction barrier height or electronically nonadiabatic effects are discussed.	[Yoder, Bruce L.; Bisson, Regis; Beck, Rainer D.] Ecole Polytech Fed Lausanne, Lab Chim Phys Mol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Beck, RD (corresponding author), Ecole Polytech Fed Lausanne, Lab Chim Phys Mol, Lausanne, Switzerland.	rainer.beck@epfl.ch	Beck, Rainer D/A-4422-2012; Bisson, Régis/A-9195-2008	Beck, Rainer D/0000-0002-8152-8290; Bisson, Régis/0000-0002-8819-1563	Swiss National Science Foundation [124666]; Ecole Polytechnique Federale de Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	We thank A. C. Luntz for helpful discussions. Financial support was provided by the Swiss National Science Foundation (grant no. 124666) and the Ecole Polytechnique Federale de Lausanne.	Abbott HL, 2004, J CHEM PHYS, V121, P3792, DOI 10.1063/1.1777221; Beck RD, 2003, SCIENCE, V302, P98, DOI 10.1126/science.1088996; Brandt M, 1998, PHYS REV LETT, V81, P2376, DOI 10.1103/PhysRevLett.81.2376; CEYER ST, 1993, INVESTIGATIONS SUR A; Dino WA, 1997, PHYS REV LETT, V78, P286, DOI 10.1103/PhysRevLett.78.286; GREELEY JN, 1995, J CHEM PHYS, V102, P4996, DOI 10.1063/1.469550; GREENE CH, 1982, PHYS REV A, V25, P2031, DOI 10.1103/PhysRevA.25.2031; Higgins J, 2001, J CHEM PHYS, V114, P5277, DOI 10.1063/1.1349895; Hou H, 1997, SCIENCE, V277, P80, DOI 10.1126/science.277.5322.80; Juurlink LBF, 1999, PHYS REV LETT, V83, P868, DOI 10.1103/PhysRevLett.83.868; Killelea DR, 2008, SCIENCE, V319, P790, DOI 10.1126/science.1152819; KUIPERS EW, 1989, PHYS REV LETT, V62, P2152, DOI 10.1103/PhysRevLett.62.2152; Maroni P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246104; Nave S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.233408; PERSSON BNJ, 1980, SOLID STATE COMMUN, V36, P175, DOI 10.1016/0038-1098(80)90677-8; PERSSON BNJ, 1984, PHYS REV B, V29, P4382, DOI 10.1103/PhysRevB.29.4382; POLANYI JC, 1988, J CHEM PHYS, V88, P3363, DOI 10.1063/1.453931; Schmid MP, 2003, REV SCI INSTRUM, V74, P4110, DOI 10.1063/1.1599064; Shenvi N, 2009, SCIENCE, V326, P829, DOI 10.1126/science.1179240; SIMPSON WR, 1995, J CHEM PHYS, V103, P7313, DOI 10.1063/1.470305; SWANG O, 1991, CHEM PHYS, V156, P379, DOI 10.1016/0301-0104(91)89006-V; Tiwari AK, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357415; Van Kleef EH, 1999, MOL PHYS, V96, P757, DOI 10.1080/00268979909483013; Vattuone L, 2004, ANGEW CHEM INT EDIT, V43, P5200, DOI 10.1002/anie.200461302; Wodtke AM, 2008, PROG SURF SCI, V83, P167, DOI 10.1016/j.progsurf.2008.02.001; Zare R. N., 1988, ANGULAR MOMENTUM UND; Zhu YA, 2007, J MOL CATAL A-CHEM, V264, P299, DOI 10.1016/j.molcata.2006.09.043	27	115	115	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					553	556		10.1126/science.1191751	http://dx.doi.org/10.1126/science.1191751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671185	Green Submitted, Green Published			2022-12-28	WOS:000280483500033
J	Boyce, DG; Lewis, MR; Worm, B				Boyce, Daniel G.; Lewis, Marlon R.; Worm, Boris			Global phytoplankton decline over the past century	NATURE			English	Article							OCEAN CHLOROPHYLL; FISH PRODUCTION; CLIMATE-CHANGE; VARIABILITY; PLANKTON	In the oceans, ubiquitous microscopic phototrophs (phytoplankton) account for approximately half the production of organic matter on Earth. Analyses of satellite-derived phytoplankton concentration (available since 1979) have suggested decadal-scale fluctuations linked to climate forcing, but the length of this record is insufficient to resolve longer-term trends. Here we combine available ocean transparency measurements and in situ chlorophyll observations to estimate the time dependence of phytoplankton biomass at local, regional and global scales since 1899. We observe declines in eight out of ten ocean regions, and estimate a global rate of decline of similar to 1% of the global median per year. Our analyses further reveal interannual to decadal phytoplankton fluctuations superimposed on long-term trends. These fluctuations are strongly correlated with basin-scale climate indices, whereas long-term declining trends are related to increasing sea surface temperatures. We conclude that global phytoplankton concentration has declined over the past century; this decline will need to be considered in future studies of marine ecosystems, geochemical cycling, ocean circulation and fisheries.	[Boyce, Daniel G.; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Lewis, Marlon R.] Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada	Dalhousie University; Dalhousie University	Boyce, DG (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	dboyce@dal.ca		Worm, Boris/0000-0002-5742-8716	Natural Sciences and Engineering Research Council of Canada; US Office of Naval Research; Canada Foundation for Climate and Atmospheric Sciences; National Aeronautics and Space Administration; Sloan Foundation; Lenfest Ocean Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US Office of Naval Research(Office of Naval Research); Canada Foundation for Climate and Atmospheric Sciences; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Sloan Foundation(Alfred P. Sloan Foundation); Lenfest Ocean Program	We are grateful to all data providers, to J. Mills-Flemming, W. Blanchard, M. Dowd, C. Field and C. Minto for statistical advice, to T. Boyer, J. Smart, D. Ricard and D. Tittensor for help with data extraction, and to J. Mills-Flemming, W. Blanchard, W. Li, H. Lotze, C. Muir and M. Dowd for critical review. Funding was provided by the Natural Sciences and Engineering Research Council of Canada, the US Office of Naval Research, the Canada Foundation for Climate and Atmospheric Sciences, the National Aeronautics and Space Administration, the Sloan Foundation (Census of Marine Life FMAP Program), and the Lenfest Ocean Program.	Antoine D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002620; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Broecker WS, 1999, SCIENCE, V286, P1132, DOI 10.1126/science.286.5442.1132; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; DICKSON RR, 1988, J PLANKTON RES, V10, P151, DOI 10.1093/plankt/10.1.151; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FALKOWSKI PG, 1992, NATURE, V358, P741, DOI 10.1038/358741a0; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Gregg WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021808; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; Hastie TJ., 2017, GEN ADDITIVE MODELS; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Jeffrey SW, 1997, PHYTOPLANKTON PIGMEN, P10; LEWIS MR, 1988, J GEOPHYS RES-OCEANS, V93, P6847, DOI 10.1029/JC093iC06p06847; Mann K.H., 1991, DYNAMICS MARINE ECOS, DOI 10.1002/9781118687901; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; McClain CR, 2009, ANNU REV MAR SCI, V1, P19, DOI 10.1146/annurev.marine.010908.163650; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murtugudde R, 2002, J CLIMATE, V15, P470, DOI 10.1175/1520-0442(2002)015<0470:EOPROT>2.0.CO;2; Orwin R.G., 1994, HDB RES SYNTHESIS; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Raitsos DE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022484; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; RYTHER JH, 1957, LIMNOL OCEANOGR, V2, P281, DOI 10.1002/lno.1957.2.3.0281; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Vantrepotte V, 2009, ICES J MAR SCI, V66, P1547, DOI 10.1093/icesjms/fsp107; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wiggert JD, 2006, DEEP-SEA RES PT II, V53, P644, DOI 10.1016/j.dsr2.2006.01.027; Worm B, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, P263, DOI 10.1016/B978-0-444-53301-2.00014-2; Yoder JA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001942	39	775	806	14	599	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					591	596		10.1038/nature09268	http://dx.doi.org/10.1038/nature09268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671703				2022-12-28	WOS:000280412100046
J	Johnson, RA; Wright, KD; Poppleton, H; Mohankumar, KM; Finkelstein, D; Pounds, SB; Rand, V; Leary, SES; White, E; Eden, C; Hogg, T; Northcott, P; Mack, S; Neale, G; Wang, YD; Coyle, B; Atkinson, J; DeWire, M; Kranenburg, TA; Gillespie, Y; Allen, JC; Merchant, T; Boop, FA; Sanford, RA; Gajjar, A; Ellison, DW; Taylor, MD; Grundy, RG; Gilbertson, RJ				Johnson, Robert A.; Wright, Karen D.; Poppleton, Helen; Mohankumar, Kumarasamypet M.; Finkelstein, David; Pounds, Stanley B.; Rand, Vikki; Leary, Sarah E. S.; White, Elsie; Eden, Christopher; Hogg, Twala; Northcott, Paul; Mack, Stephen; Neale, Geoffrey; Wang, Yong-Dong; Coyle, Beth; Atkinson, Jennifer; DeWire, Mariko; Kranenburg, Tanya A.; Gillespie, Yancey; Allen, Jeffrey C.; Merchant, Thomas; Boop, Fredrick A.; Sanford, Robert. A.; Gajjar, Amar; Ellison, David W.; Taylor, Michael D.; Grundy, Richard G.; Gilbertson, Richard J.			Cross-species genomics matches driver mutations and cell compartments to model ependymoma	NATURE			English	Article							LIPID-BINDING PROTEIN; NEURAL STEM; RADIAL GLIA; ASSOCIATION; PROGRESSION; EXPRESSION	Understanding the biology that underlies histologically similar but molecularly distinct subgroups of cancer has proven difficult because their defining genetic alterations are often numerous, and the cellular origins of most cancers remain unknown(1-3). We sought to decipher this heterogeneity by integrating matched genetic alterations and candidate cells of origin to generate accurate disease models. First, we identified subgroups of human ependymoma, a form of neural tumour that arises throughout the central nervous system (CNS). Subgroup-specific alterations included amplifications and homozygous deletions of genes not yet implicated in ependymoma. To select cellular compartments most likely to give rise to subgroups of ependymoma, we matched the transcriptomes of human tumours to those of mouse neural stem cells (NSCs), isolated from different regions of the CNS at different developmental stages, with an intact or deleted Ink4a/Arf locus (that encodes Cdkn2a and b). The transcriptome of human supratentorial ependymomas with amplified EPHB2 and deleted INK4A/ARF matched only that of embryonic cerebral Ink4a/Arf(-/-) NSCs. Notably, activation of Ephb2 signalling in these, but not other, NSCs generated the first mouse model of ependymoma, which is highly penetrant and accurately models the histology and transcriptome of one subgroup of human supratentorial tumour. Further, comparative analysis of matched mouse and human tumours revealed selective deregulation in the expression and copy number of genes that control synaptogenesis, pinpointing disruption of this pathway as a critical event in the production of this ependymoma subgroup. Our data demonstrate the power of cross-species genomics to meticulously match subgroup-specific driver mutations with cellular compartments to model and interrogate cancer subgroups.	[Johnson, Robert A.; Wright, Karen D.; Poppleton, Helen; Mohankumar, Kumarasamypet M.; White, Elsie; Eden, Christopher; Hogg, Twala; Atkinson, Jennifer; Kranenburg, Tanya A.; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Wright, Karen D.; DeWire, Mariko; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Finkelstein, David; Neale, Geoffrey; Wang, Yong-Dong] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Pounds, Stanley B.] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Rand, Vikki] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Leary, Sarah E. S.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Northcott, Paul; Mack, Stephen; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M4N 1X8, Canada; [Coyle, Beth; Grundy, Richard G.] Univ Nottingham, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England; [Gillespie, Yancey] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Allen, Jeffrey C.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Merchant, Thomas] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Boop, Fredrick A.; Sanford, Robert. A.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Newcastle University - UK; Seattle Children's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Nottingham; University of Alabama System; University of Alabama Birmingham; New York University; NYU Langone Medical Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	richard.gilbertson@stjude.org	Merchant, Thomas E/N-3344-2018; Ellison, David/N-4806-2018; Kumarasamypet Murugesan, Mohankumar/F-4231-2012; Gajjar, Amar/N-8059-2018; Wang, Yong-Dong/K-3563-2013; Gilbertson, Richard James/ABE-1346-2021; Kranenburg, Tanya/F-7138-2012; Atkinson, Jennifer/AAE-5466-2019; Pounds, Stanley B/N-2480-2018; Northcott, Paul A/N-4022-2018; Lien, Brian/AAI-7882-2020	Merchant, Thomas E/0000-0002-0412-6255; Gilbertson, Richard James/0000-0001-7539-9472; Kranenburg, Tanya/0000-0002-5329-4968; Atkinson, Jennifer/0000-0001-5164-5114; Pounds, Stanley B/0000-0002-9167-2114; Northcott, Paul A/0000-0002-1220-5252; Gillespie, George/0000-0001-6436-9542; Mack, Stephen C./0000-0001-9620-4742; Leary, Sarah/0000-0003-0225-6184; Allen, Jeffrey/0000-0001-9957-6664; Taylor, Michael/0000-0001-7009-3466; Rand, Vikki/0000-0002-2198-8949; KM, Mohankumar/0000-0001-9407-1800; Coyle, Beth/0000-0003-2957-1862	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities (ALSAC); NRSA [T32 CA070089]; NATIONAL CANCER INSTITUTE [P01CA096832, T32CA070089, R01CA129541, P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.J.G. holds the Howard C. Schott Research Chair from the Malia's Cord Foundation, and is supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765), the Collaborative Ependymoma Research Network (CERN) and by the American Lebanese Syrian Associated Charities (ALSAC). K. D. W. is supported by NRSA Training Grant T32 CA070089. We are grateful to N. Heintz for providing the Blbp-eGFP mouse, T. Pawson for providing mouse Ephb2 cDNA, M. Roussel for the pCX4-IRES-RFP virus, J. Downing and M. Relling for access to 500K SNP profiles of normal human DNA, and the staff of the Hartwell center for Bioinformatics and Biotechnology, Vector Production Core, ARC, AIC and Cell and Tissue Imaging at St Jude Children's Research Hospital for technical assistance.	Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Chess A, 2005, NAT GENET, V37, P120, DOI 10.1038/ng0205-120; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Dahlhaus M, 2008, J NEUROSCI, V28, P10794, DOI 10.1523/JNEUROSCI.1348-08.2008; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; McGuire CS, 2009, J NEUROSURG, V110, P725, DOI 10.3171/2008.9.JNS08117; Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nakano I, 2007, STEM CELLS, V25, P1975, DOI 10.1634/stemcells.2007-0046; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Puget S, 2009, J CLIN ONCOL, V27, P1884, DOI 10.1200/JCO.2007.15.4195; Rousseau E, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-47; Schmid RS, 2006, GLIA, V53, P345, DOI 10.1002/glia.20274; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974	30	257	264	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					632	636		10.1038/nature09173	http://dx.doi.org/10.1038/nature09173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20639864	Green Accepted, Green Submitted			2022-12-28	WOS:000280412100055
J	Chauhan, V; Mathur, G; Vaid, M				Chauhan, Veeraish; Mathur, Gaurav; Vaid, Megha			Platypnoea, clubbing, and epistaxis in a 61-year-old man	LANCET			English	Editorial Material							HEREDITARY HEMORRHAGIC TELANGIECTASIA; PULMONARY ARTERIOVENOUS-MALFORMATIONS		[Chauhan, Veeraish; Mathur, Gaurav] Drexel Univ, Coll Med, Dept Med, Philadelphia, PA 19102 USA; [Chauhan, Veeraish; Mathur, Gaurav] Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19102 USA; [Vaid, Megha] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Drexel University; Drexel University; Jefferson University	Chauhan, V (corresponding author), Drexel Univ, Coll Med, Dept Med, 245 N 15th St,Mail Stop 427, Philadelphia, PA 19102 USA.	veeraish.chauhan@drexelmed.edu						Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Pollak JS, 2006, J VASC INTERV RADIOL, V17, P35, DOI 10.1097/01.RVI.0000191410.13974.B6; Shovlin C, 2008, BRIT DENT J, V205, P531, DOI 10.1038/sj.bdj.2008.978; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 24	2010	376	9737					302	302		10.1016/S0140-6736(10)60811-2	http://dx.doi.org/10.1016/S0140-6736(10)60811-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20656127				2022-12-28	WOS:000280457200039
J	Druey, KM; Greipp, PR				Druey, Kirk M.; Greipp, Philip R.			Narrative Review: The Systemic Capillary Leak Syndrome	ANNALS OF INTERNAL MEDICINE			English	Review							ENDOTHELIAL GROWTH-FACTOR; MONOCLONAL GAMMOPATHY; CLARKSONS-DISEASE; PROINFLAMMATORY CYTOKINES; COMPARTMENT SYNDROME; SCHNITZLERS-SYNDROME; MULTIPLE-MYELOMA; VEGF; INVOLVEMENT; MUSCLE	The systemic capillary leak syndrome (SCLS) is a rare disease of reversible plasma extravasation and vascular collapse accompanied by hemoconcentration and hypoalbuminemia. Its cause is unknown, although it is believed to be a manifestation of transient endothelial dysfunction due to endothelial contraction, apoptosis, injury, or a combination of these. Fewer than 150 cases of SCLS have been reported, but the condition is probably underrecognized because of its nonspecific symptoms and signs and high mortality rate. Patients experience shock and massive edema, often after a nonspecific prodrome of weakness, fatigue, and myalgias, and are at risk for ischemia-induced organ failure, rhabdomyolysis and muscle compartment syndromes, and venous thromboembolism. Shock and edema reverse almost as quickly as they begin, at which time patients are at risk for death from flash pulmonary edema during rapid fluid remobilization. Diagnosis is made clinically and by exclusion of other diseases that cause similar symptoms and signs, most notably sepsis, anaphylaxis, and angioedema. Acute episodes are treated with vasopressor therapy and judicious fluid replacement, possibly with colloid solutions for their osmotic effects, to prevent the sequelae of underperfusion. Between episodes, patients may be treated with theophylline and terbutaline, which clinical experience suggests may reduce the severity and frequency of acute episodes. Prognosis is uncertain, but patients who survive an initial severe SCLS episode are estimated to have a 10-year survival rate greater than 70%. Much remains to be learned about SCLS, and clinicians should consider the diagnosis in patients with unexplained edema, increased hematocrit, and hypotension.	[Druey, Kirk M.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; Mayo Clin, Coll Med, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mayo Clinic	Druey, KM (corresponding author), NIAID, Lab Allerg Dis, NIH, 10 Ctr Dr,Room 11N242, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov			National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI001083 LAD]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001083] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: In part by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases, grant AI001083 LAD (Dr. Druey).	Airaghi L, 2000, J INTERN MED, V247, P731, DOI 10.1046/j.1365-2796.2000.00693.x; Albert C, 2002, MOL HUM REPROD, V8, P409, DOI 10.1093/molehr/8.5.409; Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Amoura Z, 1997, AM J MED, V103, P514, DOI 10.1016/S0002-9343(97)00272-6; Assaly R, 2001, CHEST, V120, P1301, DOI 10.1378/chest.120.4.1301; ATKINSON JP, 1977, MEDICINE, V56, P225, DOI 10.1097/00005792-197705000-00004; Beermann W, 1998, AM J MED, V105, P554; Bonadies N, 2006, EUR J INTERN MED, V17, P363, DOI 10.1016/j.ejim.2005.12.011; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Charlton SJ, 2009, BRIT J PHARMACOL, V158, P165, DOI 10.1111/j.1476-5381.2009.00352.x; Chihara R, 2002, INTERNAL MED, V41, P953, DOI 10.2169/internalmedicine.41.953; Cicardi M, 1997, J ALLERGY CLIN IMMUN, V99, P417, DOI 10.1016/S0091-6749(97)70061-7; CICARDI M, 1990, ANN INTERN MED, V113, P475, DOI 10.7326/0003-4819-113-6-475; Crouch R, 2007, AUSTRALAS J DERMATOL, V48, P178, DOI 10.1111/j.1440-0960.2007.00375.x; Cugno M, 2008, AUTOIMMUN REV, V8, P156, DOI 10.1016/j.autrev.2008.05.003; Dams K, 2007, CHEST, V132, P1393, DOI 10.1378/chest.07-0456; De Martino M, 2009, INTERN EMERG MED, V4, P357, DOI 10.1007/s11739-009-0257-0; Debourdeau P, 2007, REV MED INTERNE, V28, P711, DOI 10.1016/j.revmed.2007.01.020; Dell'Omo G, 2000, CLIN PHARMACOL THER, V68, P427, DOI 10.1067/mcp.2000.109787; Dhir V, 2007, INTERNAL MED, V46, P899, DOI 10.2169/internalmedicine.46.6129; Dispenzieri A, 2004, BLOOD, V104, P3400, DOI 10.1182/blood-2004-05-2046; DOLBERGSTOLIK OC, 1993, CHEST, V104, P123, DOI 10.1378/chest.104.1.123; DOORENBOS CJ, 1988, NETH J MED, V32, P178; Doubek M, 2005, ACTA HAEMATOL-BASEL, V113, P150, DOI 10.1159/000083455; Dowden AM, 2009, J ALLERGY CLIN IMMUN, V124, P1111, DOI 10.1016/j.jaci.2009.06.043; DRODER RM, 1992, AM J MED, V92, P523, DOI 10.1016/0002-9343(92)90749-2; Dybowski F, 2008, CLIN EXP RHEUMATOL, V26, P354; Ebihara I, 2008, THER APHER DIAL, V12, P285, DOI 10.1111/j.1744-9987.2008.00589.x; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fardet L, 2004, DERMATOLOGY, V209, P291, DOI 10.1159/000080851; FELLOWS IW, 1988, LANCET, V2, P1143; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOELDVARI I, 1995, J PEDIATR-US, V127, P739, DOI 10.1016/S0022-3476(95)70163-X; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gherardi RK, 1996, BLOOD, V87, P1458, DOI 10.1182/blood.V87.4.1458.bloodjournal8741458; Ghosh K, 2001, ACTA HAEMATOL-BASEL, V106, P118, DOI 10.1159/000046600; Gleich GJ, 2009, BRIT J HAEMATOL, V145, P271, DOI 10.1111/j.1365-2141.2009.07599.x; Gousseff M, 2009, REV MED INTERNE, V30, P754, DOI 10.1016/j.revmed.2009.01.005; Hiraoka E, 1995, INTERNAL MED, V34, P1220, DOI 10.2169/internalmedicine.34.1220; Hollenberg J, 2010, ACTA ANAESTH SCAND, V54, P649, DOI 10.1111/j.1399-6576.2010.02214.x; HORWITH M, 1967, J AMER MED ASSOC, V200, P101, DOI 10.1001/jama.200.2.101; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Ingegnoli F, 2009, RHEUMATOLOGY, V48, P201, DOI 10.1093/rheumatology/ken422; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; JACOX RF, 1973, AM J MED, V55, P105, DOI 10.1016/0002-9343(73)90156-3; Jensen BM, 2008, J PHARMACOL EXP THER, V324, P128, DOI 10.1124/jpet.107.125237; JOHANSSON BR, 1979, ACTA MED SCAND, V206, P413; KAO NL, 1993, CHEST, V104, P1637, DOI 10.1378/chest.104.5.1637c; Karatzios C, 2006, PEDIATR CRIT CARE ME, V7, P377, DOI 10.1097/01.PCC.0000227120.61949.FB; Kawabe S, 2002, INTERNAL MED, V41, P211, DOI 10.2169/internalmedicine.41.211; Keller KK, 2009, SCAND J RHEUMATOL, V38, P400, DOI 10.1080/03009740903161467; Kjaergaard Krista Dybtved, 2008, Ugeskr Laeger, V170, P3251; Koga Hironori, 2002, Eur J Intern Med, V13, P70, DOI 10.1016/S0953-6205(01)00199-6; Kumpers P, 2009, ANN RHEUM DIS, V68, P1638, DOI 10.1136/ard.2008.094664; Kumar S, 2003, LEUKEMIA, V17, P2025, DOI 10.1038/sj.leu.2403084; Kuwabara S, 2008, J NEUROL NEUROSUR PS, V79, P1255, DOI 10.1136/jnnp.2008.150177; Lambert M, 2008, CRIT CARE MED, V36, P2184, DOI 10.1097/CCM.0b013e31817d7c71; Lee Young Seok, 2007, Korean Journal of Internal Medicine, V22, P130; Lesterhuis WJ, 2009, AM J MED, V122, pE5, DOI 10.1016/j.amjmed.2009.01.020; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Lions C, 2007, ANN FR ANESTH, V26, P1079, DOI 10.1016/j.annfar.2007.09.017; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Matsumura M, 2007, INTERNAL MED, V46, P1585, DOI 10.2169/internalmedicine.46.0254; Merlini G, 2006, BLOOD, V108, P2520, DOI 10.1182/blood-2006-03-001164; Michiels JJ, 2006, SEMIN THROMB HEMOST, V32, P577, DOI 10.1055/s-2006-949663; Mosadik A, 2007, ANN FR ANESTH, V26, P715, DOI 10.1016/j.annfar.2007.03.026; NAVARRO C, 1990, HUM PATHOL, V21, P297, DOI 10.1016/0046-8177(90)90230-3; NOBLE RP, 1946, J CLIN INVEST, V25, P172, DOI 10.1172/JCI101696; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Onal H, 2007, ANN TROP PAEDIATR, V27, P81, DOI 10.1179/146532807X170556; Perry J, 2009, ANAESTHESIA, V64, P679, DOI 10.1111/j.1365-2044.2009.05891.x; Rajkumar SV, 2006, MAYO CLIN PROC, V81, P693, DOI 10.4065/81.5.693; Rizzi R, 2008, ACTA HAEMATOL-BASEL, V120, P1, DOI 10.1159/000143499; Sanghavi R, 2006, ANAESTH INTENS CARE, V34, P388, DOI 10.1177/0310057X0603400308; Sion-Sarid R, 2010, PEDIATRICS, V125, pE687, DOI 10.1542/peds.2009-1691; SOLOMON S, 2009, AM J EMERG MED, V27; Soubrier M, 1999, AM J KIDNEY DIS, V34, P633, DOI 10.1016/S0272-6386(99)70386-0; Staak JO, 2003, AM J MED, V115, P332, DOI 10.1016/S0002-9343(03)00349-8; Stirling CM, 1998, LANCET, V352, P450, DOI 10.1016/S0140-6736(98)05348-3; Tahirkheli NK, 1999, ANN INTERN MED, V130, P905, DOI 10.7326/0003-4819-130-11-199906010-00015; TEELUCKSINGH S, 1990, Q J MED, V75, P515; van Hinsbergh VWM, 2002, J ANAT, V200, P549, DOI 10.1046/j.1469-7580.2002.00060.x; Vigneau U, 2002, NEPHROL DIAL TRANSPL, V17, P492, DOI 10.1093/ndt/17.3.492; Wahl-Jensen VM, 2005, J VIROL, V79, P10442, DOI 10.1128/JVI.79.16.10442-10450.2005; WEINBREN I, 1963, LANCET, V2, P544; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; ZHANG W, 1993, CLIN EXP IMMUNOL, V93, P424, DOI 10.1111/j.1365-2249.1993.tb08195.x; Zivkovic SA, 2009, LEUKEMIA LYMPHOMA, V50, P1422, DOI 10.1080/10428190903111922	90	181	200	1	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2					90	W32		10.7326/0003-4819-153-2-201007200-00005	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643990	Green Accepted			2022-12-28	WOS:000280095400004
J	Ravanan, R; Udayaraj, U; Ansell, D; Collett, D; Johnson, R; O'Neill, J; Tomson, CRV; Dudley, CRK				Ravanan, R.; Udayaraj, U.; Ansell, D.; Collett, D.; Johnson, R.; O'Neill, J.; Tomson, C. R. V.; Dudley, C. R. K.			Variation between centres in access to renal transplantation in UK: longitudinal cohort study	BRITISH MEDICAL JOURNAL			English	Article							WAITING-LIST; KIDNEY-TRANSPLANTATION; UNITED-STATES; DIALYSIS; BARRIERS; GENDER; IMPACT; CARE	Objective To assess whether equity exists in access to renal transplantation in the UK after adjustment for case mix in incident patients with end stage renal disease. Design Longitudinal cohort study. Setting UK Renal Registry and UK Transplant Registry. Participants All incident renal replacement treatment patients (n=16 202) from 65 renal centres submitting data to the UK Renal Registry between 1 January 2003 and 31 December 2005, followed until 31 December 2008 (or until transplantation or death, whichever was earliest). Outcome measures Proportion of incident dialysis patients at each renal centre who were registered on the national transplant list; time taken to achieve registration; and proportion of patients subsequently transplanted. Results We found that recipients' age, ethnicity, and primary renal diagnosis were associated with the likelihood of accessing the waiting list or receiving a transplant. After adjustment for case mix, significant inter-centre variability existed in access to the transplant list (change in -2LogL=89.9, df=1, P<0.001), in the time taken to register patients on the waiting list (change in -2LogL=247.4, df=64, P<0.001), in receipt of a renal transplant from a donor after brain stem death (change in -2LogL=15.1, df=1, P=0.001), and in receipt of a renal transplant from a living donor or a donor after cardiac death (change in -2LogL=46.1, df=1, P<0.001). Conclusions Significant variation in access to renal transplantation exists between centres within the UK that cannot be explained by differences in case mix.	[Ravanan, R.; Udayaraj, U.; Dudley, C. R. K.] Southmead Hosp, Richard Bright Renal Unit, Bristol BS10 5NB, Avon, England; [Ansell, D.; Tomson, C. R. V.] Southmead Hosp, UK Renal Registry, Bristol BS10 5NB, Avon, England; [Collett, D.; Johnson, R.; O'Neill, J.] Organ Donat & Transplantat Directorate, Bristol BS34 8RR, Avon, England	Southmead Hospital; Southmead Hospital	Ravanan, R (corresponding author), Southmead Hosp, Richard Bright Renal Unit, Bristol BS10 5NB, Avon, England.	Rommel.Ravanan@nbt.nhs.uk		Johnson, Rachel/0000-0001-9199-3455; Ansell, David/0000-0001-9575-1509; Tomson, Charles/0000-0002-0224-8726				Abbott KC, 2003, J NEPHROL, V16, P40; Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Alexander GC, 2002, AM J KIDNEY DIS, V40, P824, DOI 10.1053/ajkd.2002.35695; Ansell D, 2008, UK RENAL REGISTRY 11; Axelrod DA, 2008, JAMA-J AM MED ASSOC, V299, P202, DOI 10.1001/jama.2007.50; Bayat S, 2006, NEPHROL DIAL TRANSPL, V21, P2900, DOI 10.1093/ndt/gfl329; Bloembergen WE, 1997, AM J KIDNEY DIS, V30, P733, DOI 10.1016/S0272-6386(97)90076-7; Cass A, 2003, ETHNIC HEALTH, V8, P111, DOI 10.1080/13557850303562; Collett D, 2002, MODELLING BINARY DAT; Dudley CRK, 2009, TRANSPLANTATION, V88, P96, DOI 10.1097/TP.0b013e3181aa901a; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; GAYLIN DS, 1993, JAMA-J AM MED ASSOC, V269, P603, DOI 10.1001/jama.269.5.603; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Sequist TD, 2004, AM J KIDNEY DIS, V44, P344, DOI 10.1053/j.ajkd.2004.04.039; Thamer M, 1999, HEALTH SERV RES, V34, P879; Wolfe RA, 2000, AM J KIDNEY DIS, V36, P1025, DOI 10.1053/ajkd.2000.19106	17	60	60	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2010	341								c3451	10.1136/bmj.c3451	http://dx.doi.org/10.1136/bmj.c3451			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GV	20647283	Green Published, hybrid			2022-12-28	WOS:000280411600004
J	Dray, N; Tessmar-Raible, K; Le Gouar, M; Vibert, L; Christodoulou, F; Schipany, K; Guillou, A; Zantke, J; Snyman, H; Behague, J; Vervoort, M; Arendt, D; Balavoine, G				Dray, Nicolas; Tessmar-Raible, Kristin; Le Gouar, Martine; Vibert, Laura; Christodoulou, Foteini; Schipany, Katharina; Guillou, Aurelien; Zantke, Juliane; Snyman, Heidi; Behague, Julien; Vervoort, Michel; Arendt, Detlev; Balavoine, Guillaume			Hedgehog Signaling Regulates Segment Formation in the Annelid Platynereis	SCIENCE			English	Article							DROSOPHILA EMBRYONIC EPIDERMIS; EXPRESSION PATTERNS; SPATIAL REGULATION; HOMEOBOX GENES; POLARITY GENE; PROTEIN; WINGLESS; ENCODES	Annelids and arthropods share a similar segmented organization of the body whose evolutionary origin remains unclear. The Hedgehog signaling pathway, prominent in arthropod embryonic segment patterning, has not been shown to have a similar function outside arthropods. We show that the ligand Hedgehog, the receptor Patched, and the transcription factor Gli are all expressed in striped patterns before the morphological appearance of segments in the annelid Platynereis dumerilii. Treatments with small molecules antagonistic to Hedgehog signaling disrupt segment formation. Platynereis Hedgehog is not necessary to establish early segment patterns but is required to maintain them. The molecular similarity of segment patterning functions of the Hedgehog pathway in an annelid and in arthropods supports a common origin of segmentation in protostomes.	[Dray, Nicolas; Le Gouar, Martine; Vibert, Laura; Behague, Julien; Vervoort, Michel; Balavoine, Guillaume] CNRS, Ctr Genet Mol, FRE 3144, F-91189 Gif Sur Yvette, France; [Tessmar-Raible, Kristin; Schipany, Katharina; Zantke, Juliane] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Tessmar-Raible, Kristin; Christodoulou, Foteini; Snyman, Heidi; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Guillou, Aurelien; Behague, Julien; Vervoort, Michel; Balavoine, Guillaume] Univ Paris Diderot, CNRS, Inst Jacques Monod, F-75205 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Balavoine, G (corresponding author), CNRS, Ctr Genet Mol, FRE 3144, Ave Terrasse, F-91189 Gif Sur Yvette, France.	balavoine.guillaume@ijm.univ-paris-diderot.fr	Tessmar-Raible, Kristin/F-9642-2011; Vervoort, Michel/S-1448-2019; Dray, Nicolas/E-1610-2011; dray, nicolas/B-6854-2009	Tessmar-Raible, Kristin/0000-0002-8038-1741; Dray, Nicolas/0000-0002-2632-6004; 	CNRS, University Paris-Diderot; Agence Nationale de la Recherche (France) [BLAN-0294]; Max F. Perutz Laboratories (MFPL); Austrian Science Fund (FWF) [AY0041321]; French Research Ministry; Fondation pour la recherche medicale (FRM); Boehringer Ingelheim Foundation; Marie Curie Research Training Networks [MRTN-CT-2004-005624]; Austrian Science Fund (FWF) [Y 413] Funding Source: researchfish	CNRS, University Paris-Diderot(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Max F. Perutz Laboratories (MFPL); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); French Research Ministry(Ministry of Research, France); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Marie Curie Research Training Networks(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge the following agencies for funding: the CNRS, University Paris-Diderot and the Agence Nationale de la Recherche (France) (ANR grant BLAN-0294); the Max F. Perutz Laboratories (MFPL) funds and the Austrian Science Fund (FWF) START award (AY0041321), the French Research Ministry and the Fondation pour la recherche medicale (FRM) for fellowships (N.D.); the Boehringer Ingelheim Foundation and the Marie Curie Research Training Networks ZOONET (MRTN-CT-2004-005624) for fellowships (K. T. R.). We also thank the platform ImagoSeine staff for help in confocal imagery. GenBank accession numbers for the gene sequences newly identified in this study are HM179271 to HM179276.	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WB, 2001, DEVELOPMENT, V128, P2385; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Farzana L, 2008, DEV GENES EVOL, V218, P181, DOI 10.1007/s00427-008-0207-2; Hatini V, 2001, TRENDS GENET, V17, P574, DOI 10.1016/S0168-9525(01)02448-9; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Jagla K, 1997, DEVELOPMENT, V124, P91; Kang DM, 2003, DEVELOPMENT, V130, P1645, DOI 10.1242/dev.00395; Pechmann M, 2009, P NATL ACAD SCI USA, V106, P1468, DOI 10.1073/pnas.0811150106; Prud'homme B, 2003, CURR BIOL, V13, P1876, DOI 10.1016/j.cub.2003.10.006; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Steinmetz PRH, 2007, P NATL ACAD SCI USA, V104, P2727, DOI 10.1073/pnas.0606589104; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0	21	76	78	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					339	342		10.1126/science.1188913	http://dx.doi.org/10.1126/science.1188913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647470	Green Accepted			2022-12-28	WOS:000279925900047
J	El-Bassel, N; Terlikbaeva, A; Pinkham, S				El-Bassel, Nabila; Terlikbaeva, Assel; Pinkham, Sophie			HIV and women who use drugs: double neglect, double risk	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; PREVENTION; METHADONE		[El-Bassel, Nabila] Columbia Univ, Sch Social Work, New York, NY 10025 USA; [El-Bassel, Nabila; Terlikbaeva, Assel] Columbia Univ, Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan; [Pinkham, Sophie] AIDS Fdn EW, Kiev, Ukraine	Columbia University	El-Bassel, N (corresponding author), Columbia Univ, Sch Social Work, 622 W 113th St, New York, NY 10025 USA.							Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Bryant J, 2010, DRUG ALCOHOL DEPEN, V107, P182, DOI 10.1016/j.drugalcdep.2009.10.007; Carael M, 2009, JAIDS-J ACQ IMM DEF, V52, pS111, DOI 10.1097/QAI.0b013e3181baeec2; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; El-Bassel N, 2005, AM J PUBLIC HEALTH, V95, P465, DOI 10.2105/AJPH.2003.023200; *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E; Latkin CA, 2009, SOC SCI MED, V68, P740, DOI 10.1016/j.socscimed.2008.11.019; *OP SOC I, 2009, WOM HARM RED HIV KEY; Pinkham S, 2008, REPROD HEALTH MATTER, V16, P168, DOI 10.1016/S0968-8080(08)31345-7; Wechsberg WM, 2008, SUBST USE MISUSE, V43, P1186, DOI 10.1080/10826080801918247	11	78	82	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2010	376	9738					312	314		10.1016/S0140-6736(10)61026-4	http://dx.doi.org/10.1016/S0140-6736(10)61026-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20650519				2022-12-28	WOS:000280717900008
J	De Vos, M; Devroey, P; Fauser, BCJM				De Vos, Michel; Devroey, Paul; Fauser, Bart C. J. M.			Primary ovarian insufficiency	LANCET			English	Article							ANTI-MULLERIAN HORMONE; GROWTH-DIFFERENTIATION FACTOR-9; TRANSCRIPTION FACTOR FOXL2; FRAGILE-X PREMUTATION; FERTILITY PRESERVATION; NATURAL MENOPAUSE; UNDERWENT OOPHORECTOMY; CARDIOVASCULAR-DISEASE; PREMENOPAUSAL WOMEN; SURGICAL MENOPAUSE	Primary ovarian insufficiency is a subclass of ovarian dysfunction in which the cause is within the ovary. In most cases, an unknown mechanism leads to premature exhaustion of the resting pool of primordial follicles. Primary ovarian insufficiency might also result from genetic defects, chemotherapy, radiotherapy, or surgery. The main symptom is absence of regular menstrual cycles, and the diagnosis is confirmed by detection of raised follicle-stimulating hormone and declined oestradiol concentrations in the serum, suggesting a primary ovarian defect. The disorder usually leads to sterility, and has a large effect on reproductive health when it arises at a young age. Fertility-preservation options can be offered to some patients with cancer and those at risk of early menopause, such as those with familial cases of primary ovarian insufficiency. Long-term deprivation of oestrogen has serious implications for female health in general; and for bone density, cardiovascular and neurological systems, wellbeing, and sexual health in particular.	[De Vos, Michel; Devroey, Paul] UZ Brussel, Ctr Reprod Med, B-1090 Brussels, Belgium; [Fauser, Bart C. J. M.] Univ Med Ctr, Dept Reprod Med & Gynaecol, Utrecht, Netherlands	University Hospital Brussels; Utrecht University; Utrecht University Medical Center	De Vos, M (corresponding author), UZ Brussel, Ctr Reprod Med, Laarbeeklaan 101, B-1090 Brussels, Belgium.	mdevos@uzbrussel.be	De Vos, Michel/AAG-3014-2020	De Vos, Michel/0000-0001-5019-5924	Andromed; Ardana; Ferring; Genovum; Glycotope; Merck-Serono; Organon; Pantharei; Bioscience; Philips; PregLem; Schering; Schering-Plough; Serono; Wyeth; Anecova; Besins	Andromed; Ardana; Ferring(Ferring Pharmaceuticals); Genovum; Glycotope; Merck-Serono(Merck & Company); Organon; Pantharei; Bioscience; Philips; PregLem; Schering; Schering-Plough(Merck & CompanySchering Plough Corporation); Serono(Merck & Company); Wyeth(Wyeth); Anecova; Besins	BCJMF has received fees and grant support from Andromed, Ardana, Ferring, Genovum, Glycotope, Merck-Serono, Organon, Pantharei Bioscience, Philips, PregLem, Schering, Schering-Plough, Serono, and Wyeth. PD has received fees and grants from Anecova, Besins, Ferring, Merck-Serono, and Schering-Plough. We declare that we have no other conflicts of interest.	Aboura A, 2009, J CLIN ENDOCR METAB, V94, P4540, DOI 10.1210/jc.2009-0186; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Albricht H, 1942, AM J MED SCI, V204, P625; Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244; Armstrong AY, 2007, NAT CLIN PRACT ENDOC, V3, P326, DOI 10.1038/ncpendmet0452; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Aubard Y, 1999, EUR J OBSTET GYN R B, V86, P1, DOI 10.1016/S0301-2115(99)00027-5; Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bedaiwy MA, 2006, FERTIL STERIL, V86, P220, DOI 10.1016/j.fertnstert.2005.12.030; Berry GT, 2008, ANN NY ACAD SCI, V1135, P112, DOI 10.1196/annals.1429.038; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; Blumenfeld Z, 2002, MOL CELL ENDOCRINOL, V187, P93, DOI 10.1016/S0303-7207(01)00712-2; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Busacca M, 2006, AM J OBSTET GYNECOL, V195, P421, DOI 10.1016/j.ajog.2006.03.064; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cervera R, 2008, HUM REPROD UPDATE, V14, P359, DOI 10.1093/humupd/dmn013; CHAPMAN RM, 1982, SEMIN ONCOL, V9, P84; Check JH, 2007, J ASSIST REPROD GEN, V24, P621, DOI 10.1007/s10815-007-9179-9; Clowse MEB, 2009, J WOMENS HEALTH, V18, P311, DOI 10.1089/jwh.2008.0857; Cobo A, 2008, FERTIL STERIL, V89, P1657, DOI 10.1016/j.fertnstert.2007.05.050; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Danilovich N, 2002, BIOL REPROD, V67, P370, DOI 10.1095/biolreprod67.2.370; Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437; Demirtas E, 2008, REPROD BIOMED ONLINE, V17, P520, DOI 10.1016/S1472-6483(10)60239-8; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Dolmans MM, 2007, REPRODUCTION, V134, P253, DOI 10.1530/REP-07-0131; Dolmans MM, 2009, HUM REPROD, V24, P2778, DOI 10.1093/humrep/dep289; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Farrag AF, 2002, DEMENT GERIATR COGN, V13, P193, DOI 10.1159/000048652; Fogle RH, 2007, J CLIN ENDOCR METAB, V92, P3040, DOI 10.1210/jc.2007-0581; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Gleicher N, 2009, FERTIL STERIL, V91, P1700, DOI 10.1016/j.fertnstert.2008.01.098; Hawkinsa SM, 2008, ANN NY ACAD SCI, V1135, P10, DOI 10.1196/annals.1429.018; Hehenkamp WJK, 2006, J CLIN ENDOCR METAB, V91, P4057, DOI 10.1210/jc.2006-0331; Henderson VW, 2007, MENOPAUSE, V14, P572, DOI 10.1097/gme.0b013e31803df49c; Hodis HN, 2002, AM J CARDIOL, V89, p19E; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hovatta O, 1999, ANN MED, V31, P106, DOI 10.3109/07853899708998785; Hreinsson JG, 2002, J CLIN ENDOCR METAB, V87, P316, DOI 10.1210/jc.87.1.316; Jacobsen BK, 2003, AM J EPIDEMIOL, V157, P923, DOI 10.1093/aje/kwg066; Jahnukainen K, 2001, CANCER RES, V61, P706; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Joakimsen O, 2000, J CLIN EPIDEMIOL, V53, P525, DOI 10.1016/S0895-4356(99)00197-3; Johnson AL, 2003, ANIM REPROD SCI, V78, P185, DOI 10.1016/S0378-4320(03)00090-3; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kagawa N, 2009, REPROD BIOMED ONLINE, V18, P568, DOI 10.1016/S1472-6483(10)60136-8; Keros V, 2009, HUM REPROD, V24, P1670, DOI 10.1093/humrep/dep079; Khoureiry R, 2008, J MED GENET, V45, P583, DOI 10.1136/jmg.2008.057943; Knauff EAH, 2008, MENOPAUSE, V15, P919, DOI 10.1097/gme.0b013e31816b4509; Knauff EAH, 2007, REPROD SCI, V14, P780, DOI 10.1177/1933719107308614; Knauff EAH, 2009, HUM REPROD, V24, P2372, DOI 10.1093/humrep/dep197; Knauff EAH, 2009, J CLIN ENDOCR METAB, V94, P786, DOI 10.1210/jc.2008-1818; Kok HS, 2006, MENOPAUSE, V13, P19, DOI 10.1097/01.gme.0000196592.36711.a0; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608, DOI 10.1016/S1472-6483(10)61169-8; La Marca A, 2009, HUM REPROD, V24, P2264, DOI 10.1093/humrep/dep210; Laissue P, 2009, J MED GENET, V46, P455, DOI 10.1136/jmg.2008.065086; Lambalk CB, 2004, HUM REPROD, V19, P1055, DOI 10.1093/humrep/deh216; Langrish JP, 2009, HYPERTENSION, V53, P805, DOI 10.1161/HYPERTENSIONAHA.108.126516; Lobo RA, 2007, MENOPAUSE, V14, P562, DOI 10.1097/gme.0b013e318038d333; Massin N, 2004, HUM REPROD, V19, P2555, DOI 10.1093/humrep/deh461; Massin N, 2008, MOL CELL ENDOCRINOL, V282, P95, DOI 10.1016/j.mce.2007.11.017; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McLaughlin EA, 2009, REPRODUCTION, V137, P1, DOI 10.1530/REP-08-0118; Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mhatre P, 2006, PEDIATR TRANSPLANT, V10, P782, DOI 10.1111/j.1399-3046.2006.00547.x; Mihmanli V., 2002, Archives of Gynecology and Obstetrics, V266, P96, DOI 10.1007/s004040100229; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; MORRISON JC, 1975, FERTIL STERIL, V26, P655; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Murray A, 1999, J MED GENET, V36, P767, DOI 10.1136/jmg.36.10.767; Nappi RE, 1999, GYNECOL OBSTET INVES, V47, P29, DOI 10.1159/000010058; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Nelson LM, 2005, FERTIL STERIL, V83, P1327, DOI 10.1016/j.fertnstert.2004.11.059; NELSON LM, 1994, J CLIN ENDOCR METAB, V79, P1470, DOI 10.1210/jc.79.5.1470; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Novosad Judy A, 2003, BMC Womens Health, V3, P2, DOI 10.1186/1472-6874-3-2; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; PADOS G, 1994, HUM REPROD, V9, P538, DOI 10.1093/oxfordjournals.humrep.a138541; Panay N, 2009, BEST PRACT RES CL OB, V23, P129, DOI 10.1016/j.bpobgyn.2008.10.008; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Popat VB, 2008, FERTIL STERIL, V89, P429, DOI 10.1016/j.fertnstert.2007.02.032; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; REBAR RW, 1982, FERTIL STERIL, V37, P35; REBAR RW, 1990, FERTIL STERIL, V53, P804; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Rees MCP, 2008, BRIT MED J, V336, P1148, DOI 10.1136/bmj.39583.774769.3A; Rivera CM, 2009, NEUROEPIDEMIOLOGY, V33, P32, DOI 10.1159/000211951; Rocca WA, 2008, NEUROLOGY, V70, P200, DOI 10.1212/01.wnl.0000280573.30975.6a; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Rocca WA, 2008, MENOPAUSE, V15, P1050, DOI [10.1097/gme.0b013e318174f155, 10.1097/GME.0000000000001229]; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; ROSSOUW J, 2007, JAMA-J AM MED ASSOC, V97, P146; RUSSELL P, 1982, INT J GYNECOL PATHOL, V1, P185, DOI 10.1097/00004347-198202000-00006; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schmidt PJ, 2006, JAMA-J AM MED ASSOC, V295, P1374, DOI 10.1001/jama.295.12.1374; SHAMBERGER RC, 1981, CANCER TREAT REP, V65, P739; Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032; Silber SJ, 2008, NEW ENGL J MED, V359, P2617, DOI 10.1056/NEJMc0804321; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Smith JA, 2004, ARCH OPHTHALMOL-CHIC, V122, P151, DOI 10.1001/archopht.122.2.151; Sonmezer M, 2004, HUM REPROD UPDATE, V10, P251, DOI 10.1093/humupd/dmh021; Soules MR, 1998, MATURITAS, V30, P193, DOI 10.1016/S0378-5122(98)00074-7; Sverrisdottir A, 2009, BREAST CANCER RES TR, V117, P561, DOI 10.1007/s10549-009-0313-5; Sybert VP, 2004, NEW ENGL J MED, V351, P1227, DOI 10.1056/NEJMra030360; Takahashi K, 1999, FERTIL STERIL, V71, P96, DOI 10.1016/S0015-0282(98)00409-9; Tarani L, 1998, GYNECOL ENDOCRINOL, V12, P83, DOI 10.3109/09513599809024955; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Tuohy VK, 2007, CURR OPIN OBSTET GYN, V19, P366, DOI 10.1097/GCO.0b013e328220e90c; van Dooren MF, 2009, CURR OPIN OBSTET GYN, V21, P313, DOI 10.1097/GCO.0b013e32832e0813; van Kasteren YM, 1999, HUM REPROD UPDATE, V5, P483, DOI 10.1093/humupd/5.5.483; vanderSchouw YT, 1996, LANCET, V347, P714, DOI 10.1016/S0140-6736(96)90075-6; Vearncombe KJ, 2009, MENOPAUSE, V16, P188, DOI 10.1097/gme.0b013e3181775eb4; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Vital-Reyes V, 2006, INT J GYNECOL PATHOL, V25, P90, DOI 10.1097/01.pgp.0000177648.45890.51; Vitt UA, 2000, ENDOCRINOLOGY, V141, P3814, DOI 10.1210/en.141.10.3814; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	142	413	424	8	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2010	376	9744					911	921		10.1016/S0140-6736(10)60355-8	http://dx.doi.org/10.1016/S0140-6736(10)60355-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653DW	20708256				2022-12-28	WOS:000282069100032
J	Lee, LK; Ginsburg, MA; Crovace, C; Donohoe, M; Stock, D				Lee, Lawrence K.; Ginsburg, Michael A.; Crovace, Claudia; Donohoe, Mhairi; Stock, Daniela			Structure of the torque ring of the flagellar motor and the molecular basis for rotational switching	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; PROTEIN FLIG; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SPREAD; MUTATIONAL ANALYSIS; CHARGED RESIDUES; ROTOR; REGION; LOCALIZATION; GENERATION	The flagellar motor drives the rotation of flagellar filaments at hundreds of revolutions per second(1,2), efficiently propelling bacteria through viscous media(3). The motor uses the potential energy from an electrochemical gradient of cations(4,5) across the cytoplasmic membrane to generate torque. A rapid switch from anticlockwise to clockwise rotation determines whether a bacterium runs smoothly forward or tumbles to change its trajectory(6,7). A protein called FliG forms a ring in the rotor of the flagellar motor that is involved in the generation of torque(8-13) through an interaction with the cation-channel-forming stator subunit MotA(12). FliG has been suggested to adopt distinct conformations that induce switching but these structural changes and the molecular mechanism of switching are unknown. Here we report the molecular structure of the full-length FliG protein, identify conformational changes that are involved in rotational switching and uncover the structural basis for the formation of the FliG torque ring. This allows us to propose a model of the complete ring and switching mechanism in which conformational changes in FliG reverse the electrostatic charges involved in torque generation.	[Lee, Lawrence K.; Ginsburg, Michael A.; Donohoe, Mhairi; Stock, Daniela] Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Darlinghurst, NSW 2010, Australia; [Crovace, Claudia] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	Victor Chang Cardiac Research Institute; MRC Laboratory Molecular Biology; University of New South Wales Sydney	Stock, D (corresponding author), Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Lowy Packer Bldg,405 Liverpool St, Darlinghurst, NSW 2010, Australia.	d.stock@victorchang.edu.au		Lee, Lawrence/0000-0002-4453-4886	US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Center for Research Resources [RR007707]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; Australian Nuclear Science Technology Organization; MRC; MRC [MC_U105170645] Funding Source: UKRI; Medical Research Council [MC_U105170645] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Nuclear Science Technology Organization; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the staff at beamline ID14-1 at the ESRF, and at beamlines 14-ID (BioCARS) and 23-ID (General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT)) at the APS for their support. Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science (contract DE-AC02-06CH11357), and use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Center for Research Resources (grant RR007707). GM/CA-CAT was funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). This work was supported by the Australian Synchrotron Research Program of the Australian Nuclear Science Technology Organization. D. Thomas is acknowledged for providing us with the electron microscopy density map of the clockwise-locked S. typhimurium mutant and O. Perisic and H. Huber are acknowledged for cloning vectors (pOPT-GST) and A. aeolicus genomic DNA, respectively. D. S. was initially funded by an MRC Career development award (UK) and C. C. by an MRC predoctoral fellowship (UK).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304; HIROTA N, 1983, J BIOL CHEM, V258, P577; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; LOWE G, 1987, NATURE, V325, P637, DOI 10.1038/325637a0; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Marykwas DL, 1996, J BACTERIOL, V178, P1289, DOI 10.1128/jb.178.5.1289-1294.1996; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Togashi F, 1997, J BACTERIOL, V179, P2994, DOI 10.1128/jb.179.9.2994-3003.1997; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Yorimitsu T, 2003, J MOL BIOL, V334, P567, DOI 10.1016/j.jmb.2003.09.052; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	40	129	130	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					996	U129		10.1038/nature09300	http://dx.doi.org/10.1038/nature09300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20676082	Green Accepted			2022-12-28	WOS:000281030300039
J	Abdo, AA; Ackermann, M; Ajello, M; Atwood, WB; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bouvier, A; Brandt, TJ; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Buehler, R; Burnett, TH; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Carrigan, S; Casandjian, JM; Cecchi, C; Celik, O; Charles, E; Chaty, S; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Conrad, J; Corbel, S; Corbet, R; DeCesar, ME; den Hartog, PR; Dermer, CD; de Palma, F; Digel, SW; Donato, D; Silva, EDE; Drell, PS; Dubois, R; Dubus, G; Dumora, D; Favuzzi, C; Fegan, SJ; Ferrara, EC; Fortin, P; Frailis, M; Fuhrmann, L; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giglietto, N; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guiriec, S; Hadasch, D; Harding, AK; Hayashida, M; Hays, E; Healey, SE; Hill, AB; Horan, D; Hughes, RE; Itoh, R; Jean, P; Johannesson, G; Johnson, AS; Johnson, RP; Johnson, TJ; Johnson, WN; Kamae, T; Katagiri, H; Kataoka, J; Kerr, M; Knodlseder, J; Koerding, E; Kuss, M; Lande, J; Lande, J; Lee, SH; Lemoine-Goumard, M; Garde, ML; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Makeev, A; Mazziotta, MN; McConville, W; McEnery, JE; Mehault, J; Michelson, PF; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Naumann-Godo, M; Nestoras, I; Nolan, PL; Norris, JP; Nuss, E; Ohno, M; Ohsugi, T; Okumura, A; Omodei, N; Orlando, E; Ormes, JF; Ozaki, M; Paneque, D; Panetta, JH; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Piron, F; Porter, TA; Raino, S; Rando, R; Ray, PS; Razzano, M; Razzaque, S; Rea, N; Reimer, A; Reimer, O; Reposeur, T; Ripken, J; Ritz, S; Romani, RW; Roth, M; Sadrozinski, HFW; Sander, A; Parkinson, PMS; Scargle, JD; Schinzel, FK; Sgro, C; Shaw, MS; Siskind, EJ; Smith, DA; Smith, PD; Sokolovsky, KV; Spandre, G; Spinelli, P; Stawarz, L; Strickman, MS; Suson, DJ; Takahashi, H; Takahashi, T; Tanaka, T; Tanaka, Y; Thayer, JB; Thayer, JG; Thompson, DJ; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Vandenbroucke, J; Vasileiou, V; Vilchez, N; Vitale, V; Waite, AP; Wallace, E; Wang, P; Winer, BL; Wolff, MT; Wood, KS; Yang, Z; Ylinen, T; Ziegler, M; Maehara, H; Nishiyama, K; Kabashima, F; Bach, U; Bower, GC; Falcone, A; Forster, JR; Henden, A; Kawabata, KS; Koubsky, P; Mukai, K; Nelson, T; Oates, SR; Sakimoto, K; Sasada, M; Shenavrin, VI; Shore, SN; Skinner, GK; Sokoloski, J; Stroh, M; Tatarnikov, AM; Uemura, M; Wahlgren, GM; Yamanaka, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Atwood, W. B.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bouvier, A.; Brandt, T. J.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Buehler, R.; Burnett, T. H.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Carrigan, S.; Casandjian, J. M.; Cecchi, C.; Celik, O.; Charles, E.; Chaty, S.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Conrad, J.; Corbel, S.; Corbet, R.; DeCesar, M. E.; den Hartog, P. R.; Dermer, C. D.; de Palma, F.; Digel, S. W.; Donato, D.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dubus, G.; Dumora, D.; Favuzzi, C.; Fegan, S. J.; Ferrara, E. C.; Fortin, P.; Frailis, M.; Fuhrmann, L.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giglietto, N.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guiriec, S.; Hadasch, D.; Harding, A. K.; Hayashida, M.; Hays, E.; Healey, S. E.; Hill, A. B.; Horan, D.; Hughes, R. E.; Itoh, R.; Jean, P.; Johannesson, G.; Johnson, A. S.; Johnson, R. P.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kerr, M.; Knodlseder, J.; Koerding, E.; Kuss, M.; Lande, J.; Lande, J.; Lee, S. -H.; Lemoine-Goumard, M.; Llena Garde, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Makeev, A.; Mazziotta, M. N.; McConville, W.; McEnery, J. E.; Mehault, J.; Michelson, P. F.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Naumann-Godo, M.; Nestoras, I.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohno, M.; Ohsugi, T.; Okumura, A.; Omodei, N.; Orlando, E.; Ormes, J. F.; Ozaki, M.; Paneque, D.; Panetta, J. H.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Ray, P. S.; Razzano, M.; Razzaque, S.; Rea, N.; Reimer, A.; Reimer, O.; Reposeur, T.; Ripken, J.; Ritz, S.; Romani, R. W.; Roth, M.; Sadrozinski, H. F. W.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Schinzel, F. K.; Sgro, C.; Shaw, M. S.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Sokolovsky, K. V.; Spandre, G.; Spinelli, P.; Stawarz, L.; Strickman, M. S.; Suson, D. J.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Tanaka, Y.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Vasileiou, V.; Vilchez, N.; Vitale, V.; Waite, A. P.; Wallace, E.; Wang, P.; Winer, B. L.; Wolff, M. T.; Wood, K. S.; Yang, Z.; Ylinen, T.; Ziegler, M.; Maehara, H.; Nishiyama, K.; Kabashima, F.; Bach, U.; Bower, G. C.; Falcone, A.; Forster, J. R.; Henden, A.; Kawabata, K. S.; Koubsky, P.; Mukai, K.; Nelson, T.; Oates, S. R.; Sakimoto, K.; Sasada, M.; Shenavrin, V. I.; Shore, S. N.; Skinner, G. K.; Sokoloski, J.; Stroh, M.; Tatarnikov, A. M.; Uemura, M.; Wahlgren, G. M.; Yamanaka, M.			Gamma-Ray Emission Concurrent with the Nova in the Symbiotic Binary V407 Cygni	SCIENCE			English	Article							LARGE-AREA TELESCOPE; RS OPHIUCHI; 2006 OUTBURST; BLAST WAVE; PHOTOMETRY; DISCOVERY; SPACE	Novae are thermonuclear explosions on a white dwarf surface fueled by mass accreted from a companion star. Current physical models posit that shocked expanding gas from the nova shell can produce x-ray emission, but emission at higher energies has not been widely expected. Here, we report the Fermi Large Area Telescope detection of variable gamma-ray emission (0.1 to 10 billion electron volts) from the recently detected optical nova of the symbiotic star V407 Cygni. We propose that the material of the nova shell interacts with the dense ambient medium of the red giant primary and that particles can be accelerated effectively to produce pi(0) decay gamma-rays from proton-proton interactions. Emission involving inverse Compton scattering of the red giant radiation is also considered and is not ruled out.	[Abdo, A. A.; Chekhtman, A.; Cheung, C. C.; Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Parent, D.; Ray, P. S.; Razzaque, S.; Strickman, M. S.; Wolff, M. T.; Wood, K. S.] US Navy, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Abdo, A. A.; Cheung, C. C.; Razzaque, S.] Natl Acad Sci, Natl Res Council Res Associate, Washington, DC 20001 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bouvier, A.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; den Hartog, P. R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Healey, S. E.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Lande, J.; Lee, S. -H.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Omodei, N.; Paneque, D.; Panetta, J. H.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; Shaw, M. S.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Waite, A. P.; Wang, P.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bouvier, A.; Bregeon, J.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Cohen-Tanugi, J.; den Hartog, P. R.; de Palma, F.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Healey, S. E.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Knodlseder, J.; Lande, J.; Lande, J.; Lee, S. -H.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Omodei, N.; Paneque, D.; Panetta, J. H.; Porter, T. A.; Rando, R.; Razzaque, S.; Reimer, A.; Reimer, O.; Romani, R. W.; Shaw, M. S.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Waite, A. P.; Wang, P.; Tatarnikov, A. M.; Uemura, M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Atwood, W. B.; Johnson, R. P.; Ritz, S.; Sadrozinski, H. F. W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA; [Atwood, W. B.; Johnson, R. P.; Ritz, S.; Sadrozinski, H. F. W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Lande, J.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.; Shore, S. N.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; Univ Paris Diderot, Lab AIM, CEA IRFU CNRS, Serv Astrophys,CEA Saclay, F-91191 Gif Sur Yvette, France; Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; Univ Trieste, Dipartmento Fis, I-34127 Trieste, Italy; Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-30128 Toulouse 4, France; Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; Ecole Polytech, CNRS IN2P3, Lab Leprince Ringuet, Palaiseau, France; Univ Washington, Dept Phys, Seattle, WA 98195 USA; CSIC, Inst Ciencies Espai IEEC, Campus UAB, Barcelona 08193, Spain; Ist Astrofis Spaziale & Fis Cosm, Ist Nazl Astrofis INAF, I-20133 Milan, Italy; [Celik, O.; Corbet, R.; DeCesar, M. E.; Donato, D.; Ferrara, E. C.; Gehrels, N.; Harding, A. K.; Hays, E.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Moiseev, A. A.; Thompson, D. J.; Vasileiou, V.; Mukai, K.; Nelson, T.; Skinner, G. K.; Wahlgren, G. M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Celik, O.; Donato, D.; Moiseev, A. A.; Vasileiou, V.; Skinner, G. K.] NASA, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Celik, O.; Corbet, R.; Vasileiou, V.; Mukai, K.; Nelson, T.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Celik, O.; Corbet, R.; Vasileiou, V.; Mukai, K.; Nelson, T.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Chekhtman, A.; Makeev, A.; Parent, D.] George Mason Univ, Fairfax, VA 22030 USA; Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Conrad, J.; Llena Garde, M.; Ripken, J.; Yang, Z.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; Llena Garde, M.; Ripken, J.; Yang, Z.; Ylinen, T.] Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Corbel, S.] Inst Univ France, F-75005 Paris, France; [DeCesar, M. E.; Donato, D.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Moiseev, A. A.; Skinner, G. K.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [DeCesar, M. E.; Donato, D.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Moiseev, A. A.; Skinner, G. K.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Dubus, G.; Hill, A. B.] Univ Grenoble 1, CNRS, Lab Astrophys Grenoble, CNRS,UMR 5571, F-38041 Grenoble 09, France; [Dumora, D.; Grondin, M. -H.; Lemoine-Goumard, M.; Lott, B.; Reposeur, T.; Smith, D. A.] Ctr Etud Nucl Bordeaux Gradignan, CNRS, IN2P3, F-33175 Gradignan, France; Univ Bordeaux, Ctr Etud Nucl Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [Frailis, M.] Grp Coll Udine, Ist Nazl Fis Nucl, Sez Trieste, I-33100 Udine, Italy; [Frailis, M.] Ist Nazl Astrofis, Osservatorio Astron Trieste, I-34143 Trieste, Italy; [Fuhrmann, L.; Nestoras, I.; Schinzel, F. K.; Sokolovsky, K. V.; Bach, U.] Max Planck Inst Radioastron, I-53121 Bonn, Germany; [Fukazawa, Y.; Itoh, R.; Katagiri, H.; Mizuno, T.; Sakimoto, K.; Sasada, M.; Yamanaka, M.] Hiroshima Univ, Dept Phys Sci, Higashihiroshima 7398526, Japan; [Gasparrini, D.] Agenzia Spaziale Italiana ASI Sci Data Ctr, I-00044 Frascati, Italy; INAF Ist Radioastron, I-40129 Bologna, Italy; [Giroletti, M.; Guiriec, S.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA; [Hadasch, D.; Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Kataoka, J.; Nakamori, T.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Ohno, M.; Okumura, A.; Ozaki, M.; Stawarz, L.; Takahashi, T.; Tanaka, Y.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan; [Ohsugi, T.; Takahashi, H.; Kawabata, K. S.; Uemura, M.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Reimer, A.; Reimer, O.] Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp, Lattingtown, NY 11560 USA; [Sokolovsky, K. V.] Lebedev Phys Inst, Astro Space Ctr, Moscow 117810, Russia; [Stawarz, L.] Jagiellonian Univ, Astron Observ, PL-30244 Krakow, Poland; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, LA 46323 USA; [Tramacere, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Tramacere, A.] INTEGRAL Sci Data Ctr, CH-1290 Versoix, Switzerland; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Ylinen, T.] Royal Inst Technol, Dept Phys, SE-10691 Stockholm, Sweden; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Maehara, H.] Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan; [Maehara, H.] Kyoto Univ, Hida Observ, Kyoto 6078471, Japan; [Nishiyama, K.; Kabashima, F.; Stroh, M.] Miyaki Argenteus Observ, Miyaki, Saga, Japan; [Bower, G. C.; Forster, J. R.] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [Falcone, A.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Forster, J. R.] Hat Creek Observ, Hat Creek, CA 96040 USA; [Henden, A.] Amer Assoc Variable Star Observers, Cambridge, MA 02138 USA; [Koubsky, P.] Acad Sci Czech Republ, Inst Astron, CS-25165 Ondrejov, Czech Republic; [Oates, S. R.] Univ Coll London, Mullard Space Sci Lab, Holmbury St Mary, Dorking RH5 6NT, Surrey, England; [Shenavrin, V. I.; Tatarnikov, A. M.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow, Russia; [Shore, S. N.] Univ Pisa, Dipartimento Fis Enrico Fermi, I-56127 Pisa, Italy; [Sokoloski, J.] Columbia Univ, Columbia Astrophys Lab, 538 W 120th St, New York, NY 10027 USA; [Wahlgren, G. M.] Catholic Univ Amer, Washington, DC 20064 USA	United States Department of Defense; United States Navy; National Academies of Sciences, Engineering & Medicine; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University System of Ohio; Ohio State University; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; George Mason University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Stockholm University; Oskar Klein Centre; Institut Universitaire de France; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Astrofisica (INAF); Max Planck Society; Hiroshima University; Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); University of Alabama System; University of Alabama Huntsville; ICREA; Waseda University; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Hiroshima University; Max Planck Society; University of Innsbruck; University of Innsbruck; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Jagiellonian University; Purdue University System; Purdue University; University of Geneva; University of Rome Tor Vergata; Royal Institute of Technology; Linnaeus University; University of Kalmar; Kyoto University; Kyoto University; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; University of London; University College London; Lomonosov Moscow State University; University of Pisa; Columbia University; Catholic University of America	Cheung, CC (corresponding author), US Navy, Res Lab, Div Space Sci, Washington, DC 20375 USA.	Teddy.Cheung.ctr@nrl.navy.mil; Adam.Hill@obs.ujfgrenoble.fr; Pierre.Jean@cesr.fr; srazzaque@ssd5.nrl.navy.mil; Kent.Wood@nrl.navy.mil	Kawabata, Koji S/G-1957-2017; Torres, Diego F./AAF-7931-2019; Morselli, Aldo/G-6769-2011; Moskalenko, Igor V/A-1301-2007; Okumura, Akira/I-2468-2014; Koubsky, Pavel/G-9031-2014; Parkinson, Pablo Miguel Saz/I-7980-2013; Gargano, Fabio/AAD-5121-2021; Sokolovsky, Kirill/D-2246-2015; Torres, Diego F./O-9422-2016; Rando, Riccardo/O-1302-2019; giglietto, nicola/I-8951-2012; Fukazawa, Yasushi/G-2081-2017; Tatarnikov, Andrey/ABH-7130-2020; tramacere, andrea/B-9424-2012; Bower, Geoffrey/ABC-8386-2020; lubrano, pasquale/F-7269-2012; Baldini, Luca/E-5396-2012; Jóhannesson, Guðlaugur/ABC-7216-2020; Reimer, Olaf/A-3117-2013; cohen-tanugi, Johann/ABB-1481-2021; Kuss, Michael W/H-8959-2012; Torres, Diego F/ABD-7940-2020; Gasparrini, Dario/X-6699-2019; Rea, Nanda/I-2853-2015; Jóhannesson, Guðlaugur/O-8741-2015; Hadasch, Daniela/N-7819-2016; Funk, Stefan/AAI-1568-2021; Caraveo, Patrizia/AAL-5708-2020; Rando, Riccardo/M-7179-2013; Reimer, Anita/K-5822-2015; Bastieri, Denis/AAC-5917-2020; Hays, Elizabeth/D-3257-2012; Sasada, Mahito/ABD-5766-2020; Giglietto, Nicola/Y-2425-2019; Takahashi, Hiromitsu H/T-2713-2017; Funk, Stefan/B-7629-2015; Mazziotta, Mario Nicola/O-8867-2015; Orlando, Elena/R-5594-2016; Chaty, Sylvain/B-8671-2016	Kawabata, Koji S/0000-0001-6099-9539; Torres, Diego F./0000-0002-1522-9065; Morselli, Aldo/0000-0002-7704-9553; Moskalenko, Igor V/0000-0001-6141-458X; Okumura, Akira/0000-0002-3055-7964; Gargano, Fabio/0000-0002-5055-6395; Sokolovsky, Kirill/0000-0001-5991-6863; Torres, Diego F./0000-0002-1522-9065; Rando, Riccardo/0000-0001-6992-818X; giglietto, nicola/0000-0002-9021-2888; Fukazawa, Yasushi/0000-0002-0921-8837; tramacere, andrea/0000-0002-8186-3793; Bower, Geoffrey/0000-0003-4056-9982; lubrano, pasquale/0000-0003-0221-4806; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Reimer, Olaf/0000-0001-6953-1385; cohen-tanugi, Johann/0000-0001-9022-4232; Gasparrini, Dario/0000-0002-5064-9495; Rea, Nanda/0000-0003-2177-6388; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Hadasch, Daniela/0000-0001-8663-6461; Funk, Stefan/0000-0002-2012-0080; Caraveo, Patrizia/0000-0003-2478-8018; Reimer, Anita/0000-0001-8604-7077; Bastieri, Denis/0000-0002-6954-8862; Giglietto, Nicola/0000-0002-9021-2888; Takahashi, Hiromitsu H/0000-0001-6314-5897; Funk, Stefan/0000-0002-2012-0080; Grenier, Isabelle/0000-0003-3274-674X; Cecchi, Claudia/0000-0002-2192-8233; Charles, Eric/0000-0002-3925-7802; Dubus, Guillaume/0000-0002-5130-2514; Schinzel, Frank/0000-0001-6672-128X; Pesce-Rollins, Melissa/0000-0003-1790-8018; Tibaldo, Luigi/0000-0001-7523-570X; Ray, Paul/0000-0002-5297-5278; Ackermann, Markus/0000-0001-8952-588X; de Palma, Francesco/0000-0001-5898-2834; Kerr, Matthew/0000-0002-0893-4073; Mazziotta, Mario Nicola/0000-0001-9325-4672; Katagiri, Hideaki/0000-0003-2347-8819; Hill, Adam/0000-0003-3470-4834; Lee, Shiu-Hang/0000-0002-2899-4241; Itoh, Ryosuke/0000-0002-1183-8955; Orlando, Elena/0000-0001-6406-9910; Sadrozinski, Hartmut/0000-0003-0019-5410; Tanaka, Takaaki/0000-0002-4383-0368; Porter, Troy/0000-0002-2621-4440; Baldini, Luca/0000-0002-9785-7726; Johnson, Tyrel/0000-0002-2771-472X; Ajello, Marco/0000-0002-6584-1703; Murgia, Simona/0000-0003-0516-9422; Fusco, Piergiorgio/0000-0002-9383-2425; Sasada, Mahito/0000-0001-5946-9960; Monzani, Maria Elena/0000-0002-8254-5308; Chaty, Sylvain/0000-0002-5769-8601; Pepe, Monica/0000-0001-5624-4010; Ciprini, Stefano/0000-0002-0712-2479; Casandjian, Jean-Marc/0000-0003-1404-0524; Razzaque, Soebur/0000-0002-0130-2460; Spandre, Gloria/0000-0003-0802-3453; Sgro', Carmelo/0000-0001-5676-6214; Bach, Uwe/0000-0002-7722-8412; Uemura, Makoto/0000-0002-7375-7405; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Buson, Sara/0000-0002-3308-324X; Buehler, Rolf/0000-0003-4425-6641; Frailis, Marco/0000-0002-7400-2135; SPINELLI, Paolo/0000-0001-6688-8864; Jean, Pierre/0000-0002-1757-9560; Omodei, Nicola/0000-0002-5448-7577; Cameron, Robert/0000-0003-0942-2747; Oates, Samantha/0000-0001-9309-7873; Cheung, Chi (Teddy)/0000-0002-4377-0174; Giroletti, Marcello/0000-0002-8657-8852	NASA; U.S. Department of Energy in the United States; CEA/Irfu and IN2P3/CNRS in France; ASI and Istituto Nazionale de Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology (MEXT); High Energy Accelerator Research Organization (KEK); JAXA in Japan; K. A. Wallenberg Foundation; Swedish Research Council; National Space Board in Sweden; INAF in Italy; Centre National d'Etudes Spatiales in France; Royal Swedish Academy of Sciences; European Community [ERC-StG-200911]; Astronomical Institute, Academy of Sciences of the Czech Republic (Ondrejov, Czech Republic); International Doctorate on Astroparticle Physics; ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy in the United States(United States Department of Energy (DOE)); CEA/Irfu and IN2P3/CNRS in France(French Atomic Energy CommissionCentre National de la Recherche Scientifique (CNRS)); ASI and Istituto Nazionale de Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); JAXA in Japan; K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board in Sweden; INAF in Italy(Istituto Nazionale Astrofisica (INAF)); Centre National d'Etudes Spatiales in France(Centre National D'etudes Spatiales); Royal Swedish Academy of Sciences; European Community(European Commission); Astronomical Institute, Academy of Sciences of the Czech Republic (Ondrejov, Czech Republic)(Czech Academy of SciencesCzech Republic Government); International Doctorate on Astroparticle Physics; ICREA(ICREA)	The Fermi-LAT Collaboration acknowledges support from a number of agencies and institutes for both the development and operation of the LAT, as well as for scientific data analysis. These organizations include NASA and the U.S. Department of Energy in the United States; CEA/Irfu and IN2P3/CNRS in France; ASI and Istituto Nazionale de Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology (MEXT), High Energy Accelerator Research Organization (KEK), and JAXA in Japan; and the K. A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board in Sweden. We also gratefully acknowledge additional support from INAF in Italy and the Centre National d'Etudes Spatiales in France for science analysis during the operations phase. We acknowledge with thanks the variable star observations from the American Association of Variable Star Observers International Database contributed by observers worldwide and used in this research. J. Conrad is a Royal Swedish Academy of Sciences Research Fellow, funded by a grant from the K. A. Wallenberg Foundation; G. D. and A. B. H. were funded by contract ERC-StG-200911 from the European Community; P.K. was supported by the Astronomical Institute, Academy of Sciences of the Czech Republic (Ondrejov, Czech Republic); and L. T. was partially supported by the International Doctorate on Astroparticle Physics program.	Abdo AA, 2010, ASTROPHYS J SUPPL S, V188, P405, DOI 10.1088/0067-0049/188/2/405; Abdo AA, 2010, ASTROPHYS J LETT, V710, pL92, DOI 10.1088/2041-8205/710/1/L92; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; BOWER GC, 2010, ASTRONOMERS TELEGRAM, V2529, P1; Deguchi S, 2005, PUBL ASTRON SOC JPN, V57, P933, DOI 10.1093/pasj/57.6.933; Drake JJ, 2009, ASTROPHYS J, V691, P418, DOI 10.1088/0004-637X/691/1/418; Giroletti M., 2010, ATEL, V2536, P1; GLASS IS, 1982, MON NOT R ASTRON SOC, V199, P245, DOI 10.1093/mnras/199.2.245; Hernanz M, 2008, CAM ASTROPH, P252; Hoffmeister C, 1949, VEROFF STERNW SONNEB, V1, P295; IVISON RJ, 1994, MON NOT R ASTRON SOC, V269, P218, DOI 10.1093/mnras/269.1.218; Kenyon S. J., 1992, IAU S, V151, P137; Kolotilov EA, 2003, ASTRON REP+, V47, P777, DOI 10.1134/1.1611218; MEINUNGER L, 1966, MITT VER STERNE, V87, P111; MUNARI U, 1990, MON NOT R ASTRON SOC, V242, P653, DOI 10.1093/mnras/242.4.653; Nestoras I., 2010, ATEL, V2506, P1; NISHIYAMA K, 2010, 2199 CENTR BUR ASTR; O'Brien TJ, 2006, NATURE, V442, P279, DOI 10.1038/nature04949; Rupen MP, 2008, ASTROPHYS J, V688, P559, DOI 10.1086/525555; Sedov L., 1959, SIMILARITY DIMENSION, DOI [10.1016/B978-1-4832-0088-0.50005-0, DOI 10.1016/B978-1-4832-0088-0.50005-0]; Shugarov SY, 2007, BALT ASTRON, V16, P23; Sokoloski JL, 2006, NATURE, V442, P276, DOI 10.1038/nature04893; Starrfield S, 2000, ASTROPHYS J SUPPL S, V127, P485, DOI 10.1086/313336; Tatarnikova AA, 2003, MON NOT R ASTRON SOC, V344, P1233, DOI 10.1046/j.1365-8711.2003.06911.x; Tatischeff V, 2007, ASTROPHYS J, V663, pL101, DOI 10.1086/520049; Wood-Vasey WM, 2006, ASTROPHYS J, V645, pL53, DOI 10.1086/506179; Yaron O, 2005, ASTROPHYS J, V623, P398, DOI 10.1086/428435	28	167	169	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					817	821		10.1126/science.1192537	http://dx.doi.org/10.1126/science.1192537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705855	Green Submitted			2022-12-28	WOS:000280809900044
J	Glasziou, P; Chalmers, I; Altman, DG; Bastian, H; Boutron, I; Brice, A; Jamtvedt, G; Farmer, A; Ghersi, D; Groves, T; Heneghan, C; Hill, S; Lewin, S; Michie, S; Perera, R; Pomeroy, V; Tilson, J; Shepperd, S; Williams, JW				Glasziou, Paul; Chalmers, Iain; Altman, Douglas G.; Bastian, Hilda; Boutron, Isabelle; Brice, Anne; Jamtvedt, Gro; Farmer, Andrew; Ghersi, Davina; Groves, Trish; Heneghan, Carl; Hill, Sophie; Lewin, Simon; Michie, Susan; Perera, Rafael; Pomeroy, Valerie; Tilson, Julie; Shepperd, Sasha; Williams, John W.			Taking healthcare interventions from trial to practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BEHAVIOR-CHANGE; STROKE		[Glasziou, Paul; Heneghan, Carl] Univ Oxford, Dept Publ Hlth & Primary Care, Ctr Evidence Based Med, Oxford OX3 7LF, England; [Chalmers, Iain] James Lind Initiat, Oxford OX2 7LG, England; [Altman, Douglas G.] Ctr Stat Med, Oxford OX2 6UD, England; [Bastian, Hilda] German Inst Qual & Efficiency Hlth Care, Cologne, Germany; [Boutron, Isabelle] Univ Paris, INSERM, F-75252 Paris, France; [Jamtvedt, Gro; Lewin, Simon] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Ghersi, Davina] WHO, Dept Res Policy & Cooperat, Geneva, Switzerland; [Hill, Sophie] La Trobe Univ, Australian Inst Primary Care, Ctr Hlth Commun & Participat, Bundoora, Vic 3086, Australia; [Michie, Susan] UCL, Div Psychol & Language Sci, London WC1E 7HB, England; [Pomeroy, Valerie] Univ E Anglia, Fac Hlth, Hlth & Social Sci Res Inst, Norwich NR4 7TJ, Norfolk, England; [Tilson, Julie] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Williams, John W.] Duke Univ, Duke Evidence Based Practice Ctr, Durham, NC USA; [Williams, John W.] Durham VA Med Ctr, Durham, NC USA	University of Oxford; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Norwegian Knowledge Centre for Health Services; World Health Organization; La Trobe University; University of London; University College London; University of East Anglia; University of Southern California; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Glasziou, P (corresponding author), Univ Oxford, Dept Publ Hlth & Primary Care, Ctr Evidence Based Med, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Altman, Douglas G/A-9714-2012; Glasziou, Paul/A-7832-2008; Hill, Sophie/A-9116-2012; Groves, Trish/A-9119-2009; Michie, Susan/A-1745-2010	Glasziou, Paul/0000-0001-7564-073X; Groves, Trish/0000-0001-7915-6419; Shepperd, Sasha/0000-0001-6384-8322; Bastian, Hilda/0000-0001-8544-7386; Perera, Rafael/0000-0003-2418-2091; Michie, Susan/0000-0003-0063-6378; Pomeroy, Valerie/0000-0003-4487-823X; Boutron, Isabelle/0000-0002-5263-6241	NIHR; Medical Research Council [G106/1161, MC_U145085839] Funding Source: researchfish; National Institute for Health Research [RSES/PDA/C2/017] Funding Source: researchfish; MRC [G106/1161, MC_U145085839] Funding Source: UKRI	NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Mike Clarke and the reviewers for helpful comments and Mary Hodgkinson for organising meetings. The costs of the meeting were in part covered by PG's NIHR fellowship.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Boutron I, 2008, ANN INTERN MED, V148, pW60, DOI 10.7326/0003-4819-148-4-200802190-00008-w1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dane AV, 1998, CLIN PSYCHOL REV, V18, P23, DOI 10.1016/S0272-7358(97)00043-3; Farmer AJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13150; Fransen M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004376.PUB2; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glenton C, 2006, J CLIN EPIDEMIOL, V59, P770, DOI 10.1016/j.jclinepi.2005.12.011; Gossec L, 2007, AM J MED SCI, V334, P248, DOI 10.1097/MAJ.0b013e318068dde8; Hardeman W, 2008, PSYCHOL HEALTH, V23, P11, DOI 10.1080/08870440701615948; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; JAMTVEDT G, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000259.PUB2; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lustria MLA, 2009, PATIENT EDUC COUNS, V74, P156, DOI 10.1016/j.pec.2008.08.023; Michie S, 2008, ADDICTION, V103, P1409, DOI 10.1111/j.1360-0443.2008.02291.x; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Pomeroy VM, 2005, NEUROREHAB NEURAL RE, V19, P350, DOI 10.1177/1545968305280581; RUBENSTEIN LV, 2009, EVIDENCE SYNTHESIS D; THABANE L, 2007, INT J OBES LOND; *WHO, WHO STAT SURG CHECKL; *WORK INT DEV EV R, 2009, WIDER REC IMPR REP C	26	132	133	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2010	341								c3852	10.1136/bmj.c3852	http://dx.doi.org/10.1136/bmj.c3852			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DU	20709714	Green Accepted			2022-12-28	WOS:000281029300001
J	Johnson, K; Scott, J; Rughita, B; Kisielewski, M; Asher, J; Ong, R; Lawry, L				Johnson, Kirsten; Scott, Jennifer; Rughita, Bigy; Kisielewski, Michael; Asher, Jana; Ong, Ricardo; Lawry, Lynn			Association of Sexual Violence and Human Rights Violations With Physical and Mental Health in Territories of the Eastern Democratic Republic of the Congo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNALLY DISPLACED PERSONS; SYMPTOMS; WAR	Context Studies from the Eastern Region of the Democratic Republic of the Congo (DRC) have provided anecdotal reports of sexual violence. This study offers a population-based assessment of the prevalence of sexual violence and human rights abuses in specific territories within Eastern DRC. Objective To assess the prevalence of and correlations with sexual violence and human rights violations on residents of specific territories of Eastern DRC including information on basic needs, health care access, and physical and mental health. Design, Setting, and Participants A cross-sectional, population-based, cluster survey of 998 adults aged 18 years or older using structured interviews and questionnaires, conducted over a 4-week period in March 2010. Main Outcome Measures Sexual violence prevalence and characteristics, symptoms of major depressive disorder (MDD) and posttraumatic stress disorder (PTSD), human rights abuses, and physical and mental health needs among Congolese adults in specific territories of Eastern DRC. Results Of the 1005 households surveyed 998 households participated, yielding a response rate of 98.9%. Rates of reported sexual violence were 39.7% (95% confidence interval [CI], 32.2%-47.2%; n=224/586) among women and 23.6% (95% CI, 17.3%-29.9%; n=107/399) among men. Women reported to have perpetrated conflict-related sexual violence in 41.1% (95% CI, 25.6%-56.6%; n=54/148) of female cases and 10.0% (95% CI, 1.5%-18.4%; n=8/66) of male cases. Sixty-seven percent(95% CI, 59.0%-74.5%; n=615/998) of households reported incidents of conflict-related human rights abuses. Forty-one percent (95% CI, 35.3%-45.8%; n=374/991) of the represented adult population metsymptom criteria for MDD and 50.1% (95% CI, 43.8%-56.3%; n=470/989) for PTSD. Conclusion Self-reported sexual violence and other human rights violations were prevalent in specific territories of Eastern DRC and were associated with physical and mental health outcomes. JAMA. 2010;304(5):553-562 www.jama.com	[Lawry, Lynn] OASD HA, Int Hlth Div, 5113 Leesburg Pike Sky 4,Ste 800A, Falls Church, VA 22041 USA; [Ong, Ricardo] Special Operat Command Africa US Africa Command, Stuttgart, Germany; [Lawry, Lynn] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Johnson, Kirsten] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada; [Johnson, Kirsten; Scott, Jennifer] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Scott, Jennifer; Lawry, Lynn] Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02115 USA; [Rughita, Bigy] Int Med Corps, Goma, DEM REP CONGO; [Asher, Jana] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Kisielewski, Michael; Asher, Jana] StatAid, Takoma Pk, MD USA	Uniformed Services University of the Health Sciences - USA; McGill University; Harvard University; Harvard University; Brigham & Women's Hospital; Carnegie Mellon University	Lawry, L (corresponding author), OASD HA, Int Hlth Div, 5113 Leesburg Pike Sky 4,Ste 800A, Falls Church, VA 22041 USA.	lynn.lawry.ctr@tma.osd.mil	Johnson, Kirsten/AAF-7009-2020; Asher, Jana Lynn/AAB-1393-2021; Lawry, Lynn/ABE-8391-2021	Asher, Jana Lynn/0000-0003-0559-0372; Lawry, Lynn/0000-0001-8229-8768	Center for Disaster and Humanitarian Assistance Medicine; Division of Women's Health at Brigham and Women's Hospital	Center for Disaster and Humanitarian Assistance Medicine; Division of Women's Health at Brigham and Women's Hospital	We are grateful to the following for their assistance with this project: Mukungo Munyanga, MD, PhD, Director of the Bukavu School of Public Health; Ann C. Macaulay, CM, MD, FCFP, McGill University Department of Family Medicine; and Maysaa Mahmoud, PhD, the International Health Division, Office of the Assistant Secretary of Defense for Health Affairs. We also thank Olivier Angbongo, Yann Machida, Cris Baguma, MD, Irene Kaindi, Lidija Zovko, Giorgio Trombatore, and Miel Hendrickson of IMC; without their logistical support and assistance in the field this project would not have been possible. We also thank the Center for Disaster and Humanitarian Assistance Medicine for their financial administration of this study, the Division of Women's Health at Brigham and Women's Hospital for its support of Dr Scott's travel expenses, and Juan Carlos Rosa for his technical support. We thank the paid Congolese supervisors and interviewers who assisted in data collection in very challenging and austere areas. Finally, we thank the volunteers from StatAid who assisted with data entry.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amowitz LL, 2002, JAMA-J AM MED ASSOC, V287, P513, DOI 10.1001/jama.287.4.513; [Anonymous], SAMPL SIZ CALC; Bartels S, 2010, WORLD IS ME INVESTIG; BETAMCOURT TS, 2008, PSYCHOSOCIAL ADJUST; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Burt CDB, 2001, MEM COGNITION, V29, P127, DOI 10.3758/BF03195747; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Heise L., 1999, POPULATION REPORTS S, V11; Human Rights Watch, WAR WAR SEX VIOL WOM; *INT STAND COMM GU, GUID GEND BAS VIOL I; Jewekes R., 2002, WORLD REPORT VIOLENC, P147; Johnson K, 2008, JAMA-J AM MED ASSOC, V300, P676, DOI 10.1001/jama.300.6.676; Kim G, 2007, AM J PUBLIC HEALTH, V97, P353, DOI 10.2105/AJPH.2005.073635; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lehtonen R., 1994, PRACTICAL METHODS DE; Lumley T., SURVEY ANAL R; Murray L., 2006, QUALITATIVE STUDY ID; *NIH, SUIC SUIC BEH; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; PRATT M, USAID DCHA ASSESSMEN; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; REIS C, 2002, PREVALENCE SEXUAL VI; Rodriguez MA, 2001, J FAM PRACTICE, V50, P338; SPERLING C, 2006, FORDHAM URBAN LAW J, V637, P1; Thompson J, 1997, MEMORY, V5, P615, DOI 10.1080/741941482; United Nations, 1998, CONT FORMS SLAV SYST, P7; United Nations Population Fund, 1999, REPR HLTH REF SIT IN; Vinck P., 2008, LIVING FEAR POPULATI; *WHO, ETH SAF REC RES DOC; WHO, 1991, WHOEPIMLM9111; 2 STAGE CLUSTER SAMP	32	202	203	1	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					553	562		10.1001/jama.2010.1086	http://dx.doi.org/10.1001/jama.2010.1086			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682935	Bronze			2022-12-28	WOS:000280525700023
J	Burns, JA				Burns, Joseph A.			The four hundred years of planetary science since Galileo and Kepler	NATURE			English	Review							PLANETESIMALS; SURFACE; SEARCH; ORIGIN; SYSTEM; LIGHT; MARS	For 350 years after Galileo's discoveries, ground-based telescopes and theoretical modelling furnished everything we knew about the Sun's planetary retinue. Over the past five decades, however, spacecraft visits to many targets transformed these early notions, revealing the diversity of Solar System bodies and displaying active planetary processes at work. Violent events have punctuated the histories of many planets and satellites, changing them substantially since their birth. Contemporary knowledge has finally allowed testable models of the Solar System's origin to be developed and potential abodes for extraterrestrial life to be explored. Future planetary research should involve focused studies of selected targets, including exoplanets.	[Burns, Joseph A.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Burns, Joseph A.] Cornell Univ, Coll Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Burns, JA (corresponding author), Cornell Univ, Dept Astron, 328 Space Sci Bldg, Ithaca, NY 14853 USA.	jab16@cornell.edu						ABELSON PH, 1970, SCIENCE, V170, P495; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Bagenal F., 2004, JUPITER PLANET SATEL; Baldwin RB, 1949, THE FACE OF THE MOON; Beckwith SVW, 1996, NATURE, V383, P139, DOI 10.1038/383139a0; Bell III J. F., 2008, MARTIAN SURFACE COMP; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; Bougher SW, 1997, VENUS; Brown RH, 2009, TITAN FROM CASSINI-HUYGENS, P1; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Brush Stephen G, 1996, FRUITFUL ENCOUNTERS; BURNS J, 1986, SATELLITES; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; Burns JA, 2007, NAT PHYS, V3, P664, DOI 10.1038/nphys744; BURROWS WE, 1990, VOYAGES SOLAR SYSTEM; CADBURY D, 2006, SPACE RACE EPIC BATT; Canup RM, 2008, ICARUS, V196, P518, DOI 10.1016/j.icarus.2008.03.011; Carr M. H, 2007, SURFACE MARS; Chambers JE, 2009, ANNU REV EARTH PL SC, V37, P321, DOI 10.1146/annurev.earth.031208.100122; Chyba CF, 2005, ANNU REV ASTRON ASTR, V43, P31, DOI 10.1146/annurev.astro.43.051804.102202; Cruickshank Dale P., 1999, AM ASTRONOMICAL SOC, P252; Cuzzi JN, 2010, SCIENCE, V327, P1470, DOI 10.1126/science.1179118; Deming D, 2009, NATURE, V462, P301, DOI 10.1038/nature08556; Denk T, 2010, SCIENCE, V327, P435, DOI 10.1126/science.1177088; Doel Ronald E., 1996, SOLAR SYSTEM ASTRONO; Dole SH, 1964, HABITABLE PLANETS MA; Dougherty MK, 2009, SATURN FROM CASSINI-HUYGENS, P1, DOI 10.1007/978-1-4020-9217-6; DUNCAN M, 1988, ASTROPHYS J, V328, pL69, DOI 10.1086/185162; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; FERNANDEZ JA, 1984, ICARUS, V58, P109, DOI 10.1016/0019-1035(84)90101-5; Festou C.M., 2004, COMETS 2; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; GOLDREICH P, 1982, ANNU REV ASTRON ASTR, V20, P249, DOI 10.1146/annurev.aa.20.090182.001341; Grady M.M., 2006, METEORITES EARLY SOL, P3; Harwit M., 1981, COSMIC DISCOVERY SEA; Hess H.H., 1962, PETROLOGIC STUDIES V, P500, DOI [DOI 10.1130/PETROLOGIC.1962.599, 10.1130/PETROLOGIC.1962.599]; Hubbard WB, 2002, ANNU REV ASTRON ASTR, V40, P103, DOI 10.1146/annurev.astro.40.060401.093917; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Kalas P, 2008, SCIENCE, V322, P1345, DOI 10.1126/science.1166609; KEPLER, 2010, SEARCH HABITABLE PLA; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; McDougall Walter A., 1985, HEAVENS EARTH POLITI; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Morbidelli A, 2002, ANNU REV EARTH PL SC, V30, P89, DOI 10.1146/annurev.earth.30.091201.140243; *NAT AC, 2010, PLAN SCI DEC PAN; NOLL KS, 1996, IAU C, V156; PATTERSON C, 1956, GEOCHIM COSMOCHIM AC, V10, P230, DOI 10.1016/0016-7037(56)90036-9; PEALE SJ, 1979, SCIENCE, V203, P892, DOI 10.1126/science.203.4383.892; Petit J.-M., 2008, SOLAR SYSTEM NEPTUNE; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Postberg F, 2009, NATURE, V459, P1098, DOI 10.1038/nature08046; Richardson DC, 2006, ANNU REV EARTH PL SC, V34, P47, DOI 10.1146/annurev.earth.32.101802.120208; Safronov V S., 1969, EVOLUTION PROTOPLANE; SCHORN R, 1998, PLANETARY ASTRONOMY; Shklovskii IS, 1966, INTELLIGENT LIFE UNI, V399, P639; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; STEINBAC.RH, 1972, SCIENCE, V175, P293, DOI 10.1126/science.175.4019.293; Stuart J. Q, 1926, ASTRONOMY REVISION Y; Tatarewicz Joseph N., 1990, SPACE TECHNOLOGY PLA; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Urey H.C., 1952, PLANETS THEIR ORIGIN, DOI [10.1063/1.3067687, DOI 10.1063/1.3067687]; WETHERILL GW, 1980, ANNU REV ASTRON ASTR, V18, P77, DOI 10.1146/annurev.aa.18.090180.000453; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; Wilhelms D.E., 1987, USGS PROFESSIONAL PA; WISDOM J, 1984, ICARUS, V58, P137, DOI 10.1016/0019-1035(84)90032-0; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; WRIGHT JT, 2010, EXOPLANET DATA EXPLO; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525	80	4	6	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					575	584		10.1038/nature09215	http://dx.doi.org/10.1038/nature09215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671701				2022-12-28	WOS:000280412100044
J	Whitaker, DL; Edwards, J				Whitaker, Dwight L.; Edwards, Joan			Sphagnum Moss Disperses Spores with Vortex Rings	SCIENCE			English	Article									[Whitaker, Dwight L.] Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; [Edwards, Joan] Williams Coll, Dept Biol, Williamstown, MA 01267 USA	Claremont Colleges; Pomona College; Williams College	Whitaker, DL (corresponding author), Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA.	dwight.whitaker@pomona.edu; joan.edwards@williams.edu			NSF [0722532]	NSF(National Science Foundation (NSF))	This work was supported in part by NSF Major Research Instrumentation award 0722532. The authors thank D. C. Smith and C. D. Mitescu for comments; R. Andrus for species identification; and E. Chang, A. Conwill, C. Hard, M. Hirai, N. Mitchell, and N. Piatczyc for technical assistance.	Batchelor G.K., 2000, INTRO FLUID DYNAMICS; Clymo RS, 1982, BRYOPHYTE ECOLOGY; Dabiri JO, 2009, ANNU REV FLUID MECH, V41, P17, DOI 10.1146/annurev.fluid.010908.165232; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Jeglum J., 2006, BIOL PEATLANDS; MAXWORTHY T, 1974, J FLUID MECH, V64, P227, DOI 10.1017/S0022112074002370; McQueen C. B., 2007, FLORA N AM N MEXICO, V27, P45; Nawaschin S., 1897, FLORA, V83, P151; Sundberg S, 2010, ANN BOT-LONDON, V105, P291, DOI 10.1093/aob/mcp288	9	45	49	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					406	406		10.1126/science.1190179	http://dx.doi.org/10.1126/science.1190179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651145				2022-12-28	WOS:000280196500027
J	Feldon, DF; Maher, MA; Timmerman, BE				Feldon, David F.; Maher, Michelle A.; Timmerman, Briana E.			GRADUATE EDUCATION Performance-Based Data in the Study of STEM Ph.D. Education	SCIENCE			English	Editorial Material							SUPERVISION; EXPERTISE; STUDENTS; FACULTY		[Feldon, David F.] Univ Virginia, Charlottesville, VA 22904 USA; [Maher, Michelle A.; Timmerman, Briana E.] Univ S Carolina, Columbia, SC 29208 USA	University of Virginia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Feldon, DF (corresponding author), Univ Virginia, Charlottesville, VA 22904 USA.	dff2j@virginia.edu						Anaya G, 1999, RES HIGH EDUC, V40, P499, DOI 10.1023/A:1018744326915; Austin AE, 2002, J HIGH EDUC, V73, P94, DOI 10.1353/jhe.2002.0001; Banta T.W., 2009, DESIGNING EFFECTIVE; Bowman NA, 2010, AM EDUC RES J, V47, P466, DOI 10.3102/0002831209353595; Dunning D, 2003, CURR DIR PSYCHOL SCI, V12, P83, DOI 10.1111/1467-8721.01235; Feldon DF, 2007, EDUC PSYCHOL REV, V19, P91, DOI 10.1007/s10648-006-9009-0; Gardner S., 2009, AHSE HIGHER ED REPOR, V34, P1, DOI DOI 10.1002/AEHE.3406; Gilbert R., 2004, HIGH EDUC RES DEV, V23, P375, DOI [10.1080/0729436042000235454, DOI 10.1080/0729436042000235454]; Golde C., 2001, CROSS PURPOSES WHAT; Golde C. M., 2006, ENVISIONING FUTURE D; Hinds PJ, 1999, J EXP PSYCHOL-APPL, V5, P205, DOI 10.1037/1076-898X.5.2.205; ISAAC PD, 1992, J HIGH EDUC, V63, P241, DOI 10.2307/1982014; Kam BH, 1997, HIGH EDUC, V34, P81; Lajoie S., 2003, EDUC RESEARCHER, V32, P21, DOI [DOI 10.3102/0013189X032008021, 10.3102/0013189X032008021]; Lovitts B.E., 2007, MAKING IMPLICIT EXPL; Lovitts BE, 2008, J HIGH EDUC, V79, P296, DOI 10.1353/jhe.0.0006; Lovitts BE., 2002, LEAVING IVORY TOWER; *NAT AC SCI I MED, 2007, RIS GATH STORM EN EM; Onwuegbuzie AJ, 2003, EDUC PSYCHOL MEAS, V63, P1020, DOI 10.1177/0013164402250989; Ostriker JP, 2003, ASSESSING RES DOCTOR; Paglis LL, 2006, RES HIGH EDUC, V47, P451, DOI 10.1007/s11162-005-9003-2; Pearson M, 2002, STUD HIGH EDUC, V27, P135, DOI 10.1080/03075070220119986c; Pole C., 2000, RES PAPERS ED, V15, P95, DOI [10.1080/02671520036296110.1080/026715200362961, DOI 10.1080/02671520036296110.1080/026715200362961]; Simonton DK, 2003, PSYCHOL BULL, V129, P475, DOI 10.1037/0033-2909.129.4.475; Sweitzer V, 2009, J HIGH EDUC, V80, P1; Timmerman BEC, 2011, ASSESS EVAL HIGH EDU, V36, P509, DOI 10.1080/02602930903540991	26	26	26	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					282	283		10.1126/science.1191269	http://dx.doi.org/10.1126/science.1191269			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625VW	20647452				2022-12-28	WOS:000279925900024
J	Orkin, SH; Higgs, DR				Orkin, Stuart H.; Higgs, Douglas R.			MEDICINE Sickle Cell Disease at 100 Years	SCIENCE			English	Editorial Material							FETAL-HEMOGLOBIN; BETA-THALASSEMIA; RISK-FACTORS; ANEMIA; BCL11A; EXPRESSION; BURDEN		[Orkin, Stuart H.] Childrens Hosp, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Higgs, Douglas R.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford 0X3 9DS, England	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu		Higgs, Douglas/0000-0003-3579-8705	Medical Research Council [G1000801b] Funding Source: researchfish; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL032259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bradner JE, 2006, NAT PROTOC, V1, P2344, DOI 10.1038/nprot.2006.282; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Herrick J.B., 1910, ARCH INTERN MED, V6, P517; Kaiser J, 2009, SCIENCE, V326, P1468, DOI 10.1126/science.326.5959.1468-b; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Tanguturi S. K., 2010, P NATL ACAD SCI US; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; WATSON J, 1948, AM J MED SCI, V215, P419, DOI 10.1097/00000441-194804000-00008; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348	21	27	29	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					291	292		10.1126/science.1194035	http://dx.doi.org/10.1126/science.1194035			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647458				2022-12-28	WOS:000279925900030
J	Siegel, JB; Zanghellini, A; Lovick, HM; Kiss, G; Lambert, AR; Clair, JLS; Gallaher, JL; Hilvert, D; Gelb, MH; Stoddard, BL; Houk, KN; Michael, FE; Baker, D				Siegel, Justin B.; Zanghellini, Alexandre; Lovick, Helena M.; Kiss, Gert; Lambert, Abigail R.; Clair, Jennifer L. St.; Gallaher, Jasmine L.; Hilvert, Donald; Gelb, Michael H.; Stoddard, Barry L.; Houk, Kendall N.; Michael, Forrest E.; Baker, David			Computational Design of an Enzyme Catalyst for a Stereoselective Bimolecular Diels-Alder Reaction	SCIENCE			English	Article							MACROPHOMATE SYNTHASE; CYCLODEXTRINS; ANTIBODIES; ORIGINS	The Diels-Alder reaction is a cornerstone in organic synthesis, forming two carbon-carbon bonds and up to four new stereogenic centers in one step. No naturally occurring enzymes have been shown to catalyze bimolecular Diels-Alder reactions. We describe the de novo computational design and experimental characterization of enzymes catalyzing a bimolecular Diels-Alder reaction with high stereoselectivity and substrate specificity. X-ray crystallography confirms that the structure matches the design for the most active of the enzymes, and binding site substitutions reprogram the substrate specificity. Designed stereoselective catalysts for carbon-carbon bond-forming reactions should be broadly useful in synthetic chemistry.	[Siegel, Justin B.; Zanghellini, Alexandre; Clair, Jennifer L. St.; Gallaher, Jasmine L.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Siegel, Justin B.; Zanghellini, Alexandre; Baker, David] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [Lovick, Helena M.; Gelb, Michael H.; Michael, Forrest E.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Kiss, Gert; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lambert, Abigail R.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; gelb, michael/0000-0001-7000-5219; Michael, Forrest/0000-0001-8071-4676	Defense Advanced Research Projects Agency (DARPA); Howard Hughes Medical Institute (HHMI); NIH; Lawrence Livermore National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075962, T32GM008268] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Defense Advanced Research Projects Agency (DARPA), the Howard Hughes Medical Institute (HHMI), a Molecular Biophysics traineeship from the NIH for J.B.S., and the Lawrence Livermore National Laboratory Lawrence Scholars program for G. K. We thank M. Toscano (ETH) and C. Rosewall (University of Washington) for chemical synthesis and B. Siegel and Y.-h. Lam for helpful comments on the manuscript. The x-ray crystallographic coordinates have been deposited in the Protein Data Bank with accession ID 3I1C. The University of Washington has submitted a patent application on the protein sequence coding for the engineered enzymes reported here as well as some of the design methodology.	[Anonymous], PYMOL MOL GRAPH SYST; BLAKE JF, 1994, J ORG CHEM, V59, P803, DOI 10.1021/jo00083a021; Boger D., 1999, MODERN ORGANIC SYNTH, P213; Breslow R, 1998, CHEM REV, V98, P1997, DOI 10.1021/cr970011j; Cannizzaro CE, 2003, J AM CHEM SOC, V125, P2489, DOI 10.1021/ja020879d; GOUVERNEUR VE, 1993, SCIENCE, V262, P204, DOI 10.1126/science.8211138; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kim SP, 2002, J ORG CHEM, V67, P4250, DOI 10.1021/jo011180d; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; YLIKAUHALUOMA JT, 1995, J AM CHEM SOC, V117, P7041, DOI 10.1021/ja00132a001; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	15	609	642	10	457	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					309	313		10.1126/science.1190239	http://dx.doi.org/10.1126/science.1190239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	625VW	20647463	Green Accepted			2022-12-28	WOS:000279925900037
J	Yang, GZ; Kelley, E; Darzi, A				Yang, Guang-Zhong; Kelley, Edward; Darzi, Ara			Patients' safety for global health	LANCET			English	Editorial Material									[Yang, Guang-Zhong; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England; [Kelley, Edward] WHO Patient Safety, Geneva, Switzerland	Imperial College London; World Health Organization	Yang, GZ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England.	g.z.yang@imperial.ac.uk						AGGARWAL R, 2010, QUAL SAF HLTH CAR S2, V19, P33; Ellison EC, 2008, SURG CLIN N AM, V88, P927, DOI 10.1016/j.suc.2008.05.007; Gruber J, 2010, NEW ENGL J MED, V362, P2050, DOI 10.1056/NEJMp1005117; HUCKVALE C, 2010, QUAL SAF HLTH CAR S2, V19, P24; MYTTON OT, 2010, QUAL SAF HLTH CAR S2, V19, P8; NEWTON R, 2010, QUAL SAF HLTH CAR S2, V19, P14; 2008, LANCET, V372, P1	7	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					886	887		10.1016/S0140-6736(10)61191-9	http://dx.doi.org/10.1016/S0140-6736(10)61191-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	20674965				2022-12-28	WOS:000288628800010
J	Ehrlich, PR				Ehrlich, Paul R.			Stephen Schneider (1945-2010)	SCIENCE			English	Biographical-Item									Stanford Univ, Dept Biol, Ctr Conservat Biol, Stanford, CA 94305 USA	Stanford University	Ehrlich, PR (corresponding author), Stanford Univ, Dept Biol, Ctr Conservat Biol, Stanford, CA 94305 USA.	pre@stanford.edu							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					776	776		10.1126/science.1195502	http://dx.doi.org/10.1126/science.1195502			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705843				2022-12-28	WOS:000280809900029
J	Hutt, D; Balch, WE				Hutt, Darren; Balch, William E.			The Proteome in Balance	SCIENCE			English	Editorial Material							CYSTIC-FIBROSIS; CHAPERONE; PROTEOSTASIS; DISEASE; CFTR		[Hutt, Darren; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Physiol Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hutt, D (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	webalch@scripps.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524, R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301, R01GM042336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079442, R01 HL095524-02, R01 HL079442-07, R01 HL095524] Funding Source: Medline; NIA NIH HHS [P01 AG031097] Funding Source: Medline; NIDDK NIH HHS [R01 DK051870-13, R01 DK051870] Funding Source: Medline; NIGMS NIH HHS [R01 GM033301-27, R01 GM042336-20, R01 GM042336, R01 GM033301] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Panowski SH, 2009, TRENDS ENDOCRIN MET, V20, P259, DOI 10.1016/j.tem.2009.03.006; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025	16	42	42	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					766	767		10.1126/science.1194160	http://dx.doi.org/10.1126/science.1194160			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705837	Green Accepted			2022-12-28	WOS:000280809900023
J	Trebble, TM; Hansi, N; Hydes, T; Smith, MA; Baker, M				Trebble, Timothy M.; Hansi, Navjyot; Hydes, Theresa; Smith, Melissa A.; Baker, Marc			Practice Pointer Process mapping the patient journey: an introduction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SATISFACTION; CARE		[Trebble, Timothy M.; Hansi, Navjyot; Hydes, Theresa] Portsmouth Hosp Trust, Dept Gastroenterol, Portsmouth PO6 3LY, Hants, England; [Smith, Melissa A.] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England	Portsmouth Hospitals NHS Trust; Guy's & St Thomas' NHS Foundation Trust	Trebble, TM (corresponding author), Portsmouth Hosp Trust, Dept Gastroenterol, Portsmouth PO6 3LY, Hants, England.	tim.trebble@porthosp.nhs.uk	HYDES, THERESA/H-1060-2019	HYDES, THERESA/0000-0002-7768-6886				BAKER M, 2009, ANAL SITUATION LEARN, P51; Ben-Tovim DI, 2008, MED J AUSTRALIA, V188, pS14; Benjamin A, 2008, BMJ-BRIT MED J, V336, P1241, DOI 10.1136/bmj.39527.628322.AD; Bevan H., 2006, PERFORMANCE MANAGEME, P75; del Rio AS, 2007, EUR J GASTROEN HEPAT, V19, P896, DOI 10.1097/MEG.0b013e3281532bae; EATON M, 2008, KEY LEAN CONCEPTS LE, P13; Fillingham D, 2007, LEADERSH HEALTH SERV, V20, P231, DOI 10.1108/17511870710829346; GEORGE ML, 2005, VALUE STREAM MAPPING, P33; GRABAN M, 2009, OVERVIEW LEAN HOSP L, P19; GRABAN M, 2009, LEAN HOSP, P35; Kim CS, 2006, J HOSP MED, V1, P191, DOI 10.1002/jhm.68; King Diane L, 2006, Emerg Med Australas, V18, P391, DOI 10.1111/j.1742-6723.2006.00872.x; KO HH, 2009, GASTROINTEST ENDOSC, V883, P91; Kollberg B, 2007, INT J PRODUCTIVITY P, V56, P7, DOI DOI 10.1108/17410400710717064; Layton A, 1998, QUAL HEALTH CARE, V7, pS30; LIKER JK, 2004, HEART TOYOTA PRODUCT, P27; Mould G, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.032961; NHS Modernisation Agency, 2005, PROCESS MAPPING ANAL, P1; PETERSON KM, 1996, DIS MANAGEMENT POPUL; Rath F, 2008, INT J RADIAT ONCOL, V71, pS187, DOI 10.1016/j.ijrobp.2007.07.2385; Seip B, 2008, SCAND J GASTROENTERO, V43, P1004, DOI 10.1080/00365520801958592; Taylor AJ, 2007, INT J PALLIAT NURS, V13, P163, DOI 10.12968/ijpn.2007.13.4.23489; VISSERS J, 2005, HLTH OPERATIONS MANA, P51; WESTWOOD N, 2007, GOING LEAN NHS LONDO; Womack James P., 2003, LEAN THINKING; WOMACK JP, 2003, INTRO LEAN THINKING, P15; Yanai H, 2008, DIGEST DIS, V26, P75, DOI 10.1159/000109392	27	150	150	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2010	341								c4078	10.1136/bmj.c4078	http://dx.doi.org/10.1136/bmj.c4078			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DU	20709715				2022-12-28	WOS:000281029300002
J	Kan, ZY; Jaiswal, BS; Stinson, J; Janakiraman, V; Bhatt, D; Stern, HM; Yue, P; Haverty, PM; Bourgon, R; Zheng, JB; Moorhead, M; Chaudhuri, S; Tomsho, LP; Peters, BA; Pujara, K; Cordes, S; Davis, DP; Carlton, VEH; Yuan, WL; Li, L; Wang, WR; Eigenbrot, C; Kaminker, JS; Eberhard, DA; Waring, P; Schuster, SC; Modrusan, Z; Zhang, ZM; Stokoe, D; de Sauvage, FJ; Faham, M; Seshagiri, S				Kan, Zhengyan; Jaiswal, Bijay S.; Stinson, Jeremy; Janakiraman, Vasantharajan; Bhatt, Deepali; Stern, Howard M.; Yue, Peng; Haverty, Peter M.; Bourgon, Richard; Zheng, Jianbiao; Moorhead, Martin; Chaudhuri, Subhra; Tomsho, Lynn P.; Peters, Brock A.; Pujara, Kanan; Cordes, Shaun; Davis, David P.; Carlton, Victoria E. H.; Yuan, Wenlin; Li, Li; Wang, Weiru; Eigenbrot, Charles; Kaminker, Joshua S.; Eberhard, David A.; Waring, Paul; Schuster, Stephan C.; Modrusan, Zora; Zhang, Zemin; Stokoe, David; de Sauvage, Frederic J.; Faham, Malek; Seshagiri, Somasekar			Diverse somatic mutation patterns and pathway alterations in human cancers	NATURE			English	Article							HUMAN BREAST; IDENTIFICATION; MELANOMA; INSIGHTS; REVEALS	The systematic characterization of somatic mutations in cancer genomes is essential for understanding the disease and for developing targeted therapeutics(1). Here we report the identification of 2,576 somatic mutations across similar to 1,800 megabases of DNA representing 1,507 coding genes from 441 tumours comprising breast, lung, ovarian and prostate cancer types and subtypes. We found that mutation rates and the sets of mutated genes varied substantially across tumour types and subtypes. Statistical analysis identified 77 significantly mutated genes including protein kinases, G-protein-coupled receptors such as GRM8, BAI3, AGTRL1 (also called APLNR) and LPHN3, and other druggable targets. Integrated analysis of somatic mutations and copy number alterations identified another 35 significantly altered genes including GNAS, indicating an expanded role for G alpha subunits in multiple cancer types. Furthermore, our experimental analyses demonstrate the functional roles of mutant GNAO1 (a G alpha subunit) and mutant MAP2K4 (a member of the JNK signalling pathway) in oncogenesis. Our study provides an overview of the mutational spectra across major human cancers and identifies several potential therapeutic targets.	[Kan, Zhengyan; Jaiswal, Bijay S.; Stinson, Jeremy; Janakiraman, Vasantharajan; Bhatt, Deepali; Chaudhuri, Subhra; Peters, Brock A.; Pujara, Kanan; Cordes, Shaun; Davis, David P.; Yuan, Wenlin; Modrusan, Zora; Stokoe, David; de Sauvage, Frederic J.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kan, Zhengyan; Yue, Peng; Haverty, Peter M.; Bourgon, Richard; Li, Li; Kaminker, Joshua S.; Zhang, Zemin] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Stern, Howard M.; Eberhard, David A.; Waring, Paul] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Zheng, Jianbiao; Moorhead, Martin; Carlton, Victoria E. H.; Faham, Malek] Affymetrix Inc, Santa Clara, CA 95051 USA; [Tomsho, Lynn P.; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Wang, Weiru; Eigenbrot, Charles] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Affymetrix; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Roche Holding; Genentech	Seshagiri, S (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	sekar@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Peters, Brock/0000-0002-5137-3902; Seshagiri, Somasekar/0000-0003-4272-6443; Wang, Weiru/0000-0001-8845-301X; Bourgon, Richard/0000-0002-5890-4374				Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Bastida Eizaguirre M, 2001, An Esp Pediatr, V54, P598; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cazillis M, 2004, ONCOGENE, V23, P4735, DOI 10.1038/sj.onc.1207619; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fakhrai-Rad H, 2004, GENOME RES, V14, P1404, DOI 10.1101/gr.2373904; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; Marson VJ, 2004, HISTOPATHOLOGY, V45, P125, DOI 10.1111/j.1365-2559.2004.01893.x; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peters BA, 2007, NAT METHODS, V4, P713, DOI 10.1038/NMETH1081; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Shiratsuchi T, 1997, CYTOGENET CELL GENET, V79, P103, DOI 10.1159/000134693; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Teng DHF, 1997, CANCER RES, V57, P4177; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; WEINSTEIN LS, 1993, CLIN BIOCHEM, V26, P333, DOI 10.1016/0009-9120(93)90109-J; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yue P, 2010, HUM MUTAT, V31, P264, DOI 10.1002/humu.21194; Zheng JB, 2009, P NATL ACAD SCI USA, V106, P6712, DOI 10.1073/pnas.0901902106	43	770	812	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					869	U103		10.1038/nature09208	http://dx.doi.org/10.1038/nature09208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20668451				2022-12-28	WOS:000280766100037
J	Lee, CH; Cook, JL; Mendelson, A; Moioli, EK; Yao, H; Mao, JJ				Lee, Chang H.; Cook, James L.; Mendelson, Avital; Moioli, Eduardo K.; Yao, Hai; Mao, Jeremy J.			Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study	LANCET			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; UNITED-STATES; TISSUE; CARTILAGE; OSTEOARTHRITIS; CHONDROCYTES; GROWTH; REPAIR	Background A common approach for tissue regeneration is cell delivery, for example by direct transplantation of stem or progenitor cells. An alternative, by recruitment of endogenous cells, needs experimental evidence. We tested the hypothesis that the articular surface of the synovial joint can regenerate with a biological cue spatially embedded in an anatomically correct bioscaffold. Methods In this proof of concept study, the surface morphology of a rabbit proximal humeral joint was captured with laser scanning and reconstructed by computer-aided design. We fabricated an anatomically correct bioscaffold using a composite of poly-e-caprolactone and hydroxyapatite. The entire articular surface of unilateral proximal humeral condyles of skeletally mature rabbits was surgically excised and replaced with bioscaffolds spatially infused with transforming growth factor beta 3 (TGF beta 3)-adsorbed or TGF beta 3-free collagen hydrogel. Locomotion and weightbearing were assessed 1-2, 3-4, and 5-8 weeks after surgery. At 4 months, regenerated cartilage samples were retrieved from in vivo and assessed for surface fissure, thickness, density, chondrocyte numbers, collagen type II and aggrecan, and mechanical properties. Findings Ten rabbits received TGF beta 3-infused bioscaffolds, ten received TGF beta 3-free bioscaffolds, and three rabbits underwent humeral-head excision without bioscaffold replacement. All animals in the TGF beta 3-delivery group fully resumed weightbearing and locomotion 3-4 weeks after surgery, more consistently than those in the TGF beta 3-free group. Defect-only rabbits limped at all times. 4 months after surgery, TGF beta 3-infused bioscaffolds were fully covered with hyaline cartilage in the articular surface. TGF beta 3-free bioscaffolds had only isolated cartilage formation, and no cartilage formation occurred in defect-only rabbits. TGF beta 3 delivery yielded uniformly distributed chondrocytes in a matrix with collagen type II and aggrecan and had significantly greater thickness (p=0.044) and density (p<0.0001) than did cartilage formed without TGF beta 3. Compressive and shear properties of TGF beta 3-mediated articular cartilage did not differ from those of native articular cartilage, and were significantly greater than those of cartilage formed without TGF beta 3. Regenerated cartilage was avascular and integrated with regenerated subchondral bone that had well defined blood vessels. TGF beta 3 delivery recruited roughly 130% more cells in the regenerated articular cartilage than did spontaneous cell migration without TGF beta 3. Interpretation Our findings suggest that the entire articular surface of the synovial joint can regenerate without cell transplantation. Regeneration of complex tissues is probable by homing of endogenous cells, as exemplified by stratified avascular cartilage and vascularised bone. Whether cell homing acts as an adjunctive or alternative approach of cell delivery for regeneration of tissues with different organisational complexity warrants further investigation.	[Lee, Chang H.; Mendelson, Avital; Moioli, Eduardo K.; Mao, Jeremy J.] Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, New York, NY 10032 USA; [Cook, James L.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Cook, James L.] Univ Missouri, Sch Med, Comparat Orthopaed Lab, Columbia, MO USA; [Yao, Hai] Clemson Univ, Clemson, SC 29631 USA; [Yao, Hai] Med Univ S Carolina, Dept Bioengn, Charleston, SC 29425 USA	Columbia University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Clemson University; Medical University of South Carolina	Mao, JJ (corresponding author), Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, 630 W 168 St,PH7E, New York, NY 10032 USA.	jmao@columbia.edu		Cook, James/0000-0002-0862-995X; Mendelson, Avital/0000-0002-1120-9593	New York State Stem Cell Science; US National Institutes of Health [R01EB002332]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020767] Funding Source: NIH RePORTER	New York State Stem Cell Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a research grant from the New York State Stem Cell Science and US National Institutes of Health grant R01EB002332. We thank ICM staff at Columbia University Medical Center for veterinary assistance, and members of J J M laboratory for administrative and additional technical support. Synovium cells were a generous gift from Elena Jones of University of Leeds, UK.	Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Boschetti F, 2008, BIORHEOLOGY, V45, P337, DOI 10.3233/BIR-2008-0479; Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879; Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102; Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187; GOLDBERG VM, 2004, ORTHOPEDIC TISSUE EN; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537; Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]; Noh MJ, 2010, CYTOTHERAPY, V12, P384, DOI 10.3109/14653240903470639; Park DK, 2009, J BONE JOINT SURG AM, V91A, P350, DOI 10.2106/JBJS.H.00302; PERRIN DE, 1997, HDB BIODEGRADABLE PO, P63; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103; Woodfield TBF, 2009, CELL PROLIFERAT, V42, P485, DOI 10.1111/j.1365-2184.2009.00608.x; YANG R, PLOS ONE IN PRESS; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	38	447	481	4	186	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					440	448		10.1016/S0140-6736(10)60668-X	http://dx.doi.org/10.1016/S0140-6736(10)60668-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20692530	Green Accepted			2022-12-28	WOS:000281012900029
J	Wilkinson, LS				Wilkinson, Lawrence S.			Which Parental Gene Gets the Upper Hand?	SCIENCE			English	Editorial Material									[Wilkinson, Lawrence S.] Cardiff Univ, Sch Med, Cardiff MRC Ctr Neuropsychiat Genet & Genom, Neurosci & Mental Hlth Res Inst,Behav Genet Grp, Cardiff CF10 3AT, S Glam, Wales; [Wilkinson, Lawrence S.] Cardiff Univ, Sch Psychol, Cardiff MRC Ctr Neuropsychiat Genet & Genom, Neurosci & Mental Hlth Res Inst,Behav Genet Grp, Cardiff CF10 3AT, S Glam, Wales	Cardiff University; Cardiff University	Wilkinson, LS (corresponding author), Cardiff Univ, Sch Med, Cardiff MRC Ctr Neuropsychiat Genet & Genom, Neurosci & Mental Hlth Res Inst,Behav Genet Grp, Cardiff CF10 3AT, S Glam, Wales.	wilkinsonl@cardiff.ac.uk			Medical Research Council [G0801418B] Funding Source: researchfish; Medical Research Council [G9723500] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Isles AR, 2009, TRENDS GENET, V25, P495, DOI 10.1016/j.tig.2009.09.010; Keverne EB, 2008, FRONT NEUROENDOCRIN, V29, P398, DOI 10.1016/j.yfrne.2008.03.001; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235	7	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					636	637		10.1126/science.1194692	http://dx.doi.org/10.1126/science.1194692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689006				2022-12-28	WOS:000280602700024
J	Srivastava, M; Simakov, O; Chapman, J; Fahey, B; Gauthier, MEA; Mitros, T; Richards, GS; Conaco, C; Dacre, M; Hellsten, U; Larroux, C; Putnam, NH; Stanke, M; Adamska, M; Darling, A; Degnan, SM; Oakley, TH; Plachetzki, DC; Zhai, YF; Adamski, M; Calcino, A; Cummins, SF; Goodstein, DM; Harris, C; Jackson, DJ; Leys, SP; Shu, SQ; Woodcroft, BJ; Vervoort, M; Kosik, KS; Manning, G; Degnan, BM; Rokhsar, DS				Srivastava, Mansi; Simakov, Oleg; Chapman, Jarrod; Fahey, Bryony; Gauthier, Marie E. A.; Mitros, Therese; Richards, Gemma S.; Conaco, Cecilia; Dacre, Michael; Hellsten, Uffe; Larroux, Claire; Putnam, Nicholas H.; Stanke, Mario; Adamska, Maja; Darling, Aaron; Degnan, Sandie M.; Oakley, Todd H.; Plachetzki, David C.; Zhai, Yufeng; Adamski, Marcin; Calcino, Andrew; Cummins, Scott F.; Goodstein, David M.; Harris, Christina; Jackson, Daniel J.; Leys, Sally P.; Shu, Shengqiang; Woodcroft, Ben J.; Vervoort, Michel; Kosik, Kenneth S.; Manning, Gerard; Degnan, Bernard M.; Rokhsar, Daniel S.			The Amphimedon queenslandica genome and the evolution of animal complexity	NATURE			English	Article							SEA-ANEMONE; MONOSIGA-BREVICOLLIS; TYROSINE KINASES; GENE REPERTOIRE; ORIGIN; SPONGE; PROTEIN; EXPRESSION; INFERENCE; ADHESION	Sponges are an ancient group of animals that diverged from other metazoans over 600 million years ago. Here we present the draft genome sequence of Amphimedon queenslandica, a demosponge from the Great Barrier Reef, and show that it is remarkably similar to other animal genomes in content, structure and organization. Comparative analysis enabled by the sequencing of the sponge genome reveals genomic events linked to the origin and early evolution of animals, including the appearance, expansion and diversification of pan-metazoan transcription factor, signalling pathway and structural genes. This diverse 'toolkit' of genes correlates with critical aspects of all metazoan body plans, and comprises cell cycle control and growth, development, somatic-and germ-cell specification, cell adhesion, innate immunity and allorecognition. Notably, many of the genes associated with the emergence of animals are also implicated in cancer, which arises from defects in basic processes associated with metazoan multicellularity.	[Srivastava, Mansi; Mitros, Therese; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Srivastava, Mansi; Mitros, Therese; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Simakov, Oleg] Heidelberg Univ, D-69117 Heidelberg, Germany; [Chapman, Jarrod; Hellsten, Uffe; Goodstein, David M.; Shu, Shengqiang; Rokhsar, Daniel S.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Fahey, Bryony; Gauthier, Marie E. A.; Richards, Gemma S.; Larroux, Claire; Adamska, Maja; Degnan, Sandie M.; Adamski, Marcin; Calcino, Andrew; Cummins, Scott F.; Harris, Christina; Jackson, Daniel J.; Woodcroft, Ben J.; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Conaco, Cecilia; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Dacre, Michael; Zhai, Yufeng; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; [Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Stanke, Mario] Abt Bioinformat, Inst Mikrobiol & Genet, D-37077 Gottingen, Germany; [Darling, Aaron] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Oakley, Todd H.; Plachetzki, David C.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Leys, Sally P.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Vervoort, Michel] Univ Paris 07, CNRS, UMR 7592, Dev & Neurobiol Program,Inst Jacques Monod, F-75205 Paris 13, France	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Ruprecht Karls University Heidelberg; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Queensland; University of California System; University of California Santa Barbara; Salk Institute; Rice University; University of California System; University of California Davis; University of California System; University of California Santa Barbara; University of Alberta; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Srivastava, M (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02138 USA.	mansi@wi.mit.edu; b.degnan@uq.edu.au; dsrokhsar@gmail.com	Adamska, Maja/M-4128-2014; Vervoort, Michel/S-1448-2019; Jackson, Daniel J./J-5158-2012; Gauthier, Marie-Emilie/Y-5909-2019; Darling, Aaron/G-8119-2017; Stanke, Mario/P-7876-2019; Simakov, Oleg/G-4572-2015; Degnan, Sandie/G-7338-2012; Adamska, Maja/L-3306-2015; Larroux, Claire/U-7981-2017; Putnam, Nicholas/B-9968-2008; Dacre, Michael/C-1131-2008; Simakov, Oleg/AAV-2494-2020; Leys, Sally/A-2660-2014; Manning, Gerard/C-8308-2009; Cummins, Scott/I-6420-2016	Jackson, Daniel J./0000-0001-9045-381X; Gauthier, Marie-Emilie/0000-0002-5256-9165; Stanke, Mario/0000-0001-8696-0384; Simakov, Oleg/0000-0002-3585-4511; Degnan, Sandie/0000-0001-8003-0426; Adamska, Maja/0000-0002-4223-8450; Larroux, Claire/0000-0002-3503-4150; Putnam, Nicholas/0000-0002-1315-782X; Dacre, Michael/0000-0002-5561-1656; Simakov, Oleg/0000-0002-3585-4511; Woodcroft, Ben/0000-0003-0670-7480; Goodstein, David/0000-0001-6287-2697; Manning, Gerard/0000-0002-5087-9151; Calcino, Andrew/0000-0002-3956-1273; Cummins, Scott/0000-0002-1454-2076; Degnan, Bernard/0000-0001-7573-8518; Rokhsar, Daniel/0000-0002-8704-2224; Shu, Shengqiang/0000-0002-4336-8994; Oakley, Todd/0000-0002-4478-915X; Darling, Aaron/0000-0003-2397-7925; Conaco, Cecilia/0000-0002-3594-2810	Australian Research Council; US Department of Energy Joint Genome Institute; NSF; NIH/NHGRI; University of Queensland; Sars International Centre for Marine Molecular Biology; DFG; ANR; CNRS; Gordon and Betty Moore Foundation; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); US Department of Energy Joint Genome Institute(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Queensland(University of Queensland); Sars International Centre for Marine Molecular Biology; DFG(German Research Foundation (DFG)); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by funds from the Australian Research Council (B. M. D., Maj.A), US Department of Energy Joint Genome Institute (B. M. D., D. S. R., S. P. L.) Harvey Karp (K. S. K.), NSF (T.H.O.), NIH/NHGRI (G. M.), University of Queensland Postdocotral Fellowship (Maj.A., S. F. C), Sars International Centre for Marine Molecular Biology (Maj.A.), DFG (M.St.), ANR (M. V.), CNRS (M. V.), Gordon and Betty Moore Foundation (D. S. R.) and Richard Melmon (D. S. R.). We thank J. Huelsenbeck and I. Hariharan for help with phylogenetic analyses and growth pathways, respectively. The work conducted by the US Department of Energy Joint Genome Institute was supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; de Jong D, 2009, MOL BIOL EVOL, V26, P1333, DOI 10.1093/molbev/msp042; DEGNAN B, 2009, EMERGING MODEL ORGAN, V1; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Exposito JY, 2008, J BIOL CHEM, V283, P28226, DOI 10.1074/jbc.M804573200; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Fernandez-Busquets X, 2003, CELL MOL LIFE SCI, V60, P88, DOI 10.1007/s000180300006; Gazave E, 2008, DEV GENES EVOL, V218, P479, DOI 10.1007/s00427-008-0242-z; Grant R.E., 1836, CYCLOPAEDIA ANATOMY, V1; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyman L.H., 1940, INVERTEBRATES, V1; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Muller W.E.G., 1996, Progress in Molecular and Subcellular Biology, V17, P183; Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3; Muller WEG, 1997, CELL TISSUE RES, V289, P383, DOI 10.1007/s004410050885; Muller WEG, 2003, INTEGR COMP BIOL, V43, P281, DOI 10.1093/icb/43.2.281; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; PAVANSDE.M, 1974, AM ZOOL, V14, P895; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Richards GS, 2008, CURR BIOL, V18, P1156, DOI 10.1016/j.cub.2008.06.074; Robertson AJ, 2006, DEV BIOL, V300, P321, DOI 10.1016/j.ydbio.2006.08.053; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Skorokhod A, 1999, BIOL BULL-US, V197, P198, DOI 10.2307/1542615; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; SOLLAS WJ, 1888, REPORT SCI RESULTS V; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-4; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Suga H, 2001, GENE, V280, P195, DOI 10.1016/S0378-1119(01)00784-3; Sullivan James C, 2006, Genome Inform, V17, P219; Team R. D. C., 2009, R LANGUAGE ENV STAT; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VALENTINE JW, 1994, P NATL ACAD SCI USA, V91, P6751, DOI 10.1073/pnas.91.15.6751; Wiens M, 2005, J BIOL CHEM, V280, P27949, DOI 10.1074/jbc.M504049200; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701	66	718	732	5	146	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					720	U3		10.1038/nature09201	http://dx.doi.org/10.1038/nature09201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686567	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000280562500031
J	Hubel, H; Hamel, DR; Fedrizzi, A; Ramelow, S; Resch, KJ; Jennewein, T				Huebel, Hannes; Hamel, Deny R.; Fedrizzi, Alessandro; Ramelow, Sven; Resch, Kevin J.; Jennewein, Thomas			Direct generation of photon triplets using cascaded photon-pair sources	NATURE			English	Article							INTERFERENCE	Non-classical states of light, such as entangled photon pairs and number states, are essential for fundamental tests of quantum mechanics and optical quantum technologies. The most widespread technique for creating these quantum resources is spontaneous parametric down-conversion of laser light into photon pairs(1). Conservation of energy and momentum in this process, known as phase-matching, gives rise to strong correlations that are used to produce two-photon entanglement in various degrees of freedom(2-9). It has been a longstanding goal in quantum optics to realize a source that can produce analogous correlations in photon triplets, but of the many approaches considered, none has been technically feasible(10-17). Here we report the observation of photon triplets generated by cascaded down-conversion. Each triplet originates from a single pump photon, and therefore quantum correlations will extend over all three photons(18) in a way not achievable with independently created photon pairs(19). Our photon-triplet source will allow experimental interrogation of novel quantum correlations(20), the generation of tripartite entanglement(12,21) without post-selection and the generation of heralded entangled photon pairs suitable for linear optical quantum computing(22). Two of the triplet photons have a wavelength matched for optimal transmission in optical fibres, suitable for three-party quantum communication(23). Furthermore, our results open interesting regimes of non-linear optics, as we observe spontaneous down-conversion pumped by single photons, an interaction also highly relevant to optical quantum computing.	[Huebel, Hannes; Hamel, Deny R.; Resch, Kevin J.; Jennewein, Thomas] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Huebel, Hannes; Hamel, Deny R.; Resch, Kevin J.; Jennewein, Thomas] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Fedrizzi, Alessandro] Univ Queensland, Dept Phys, Brisbane, Qld 4072, Australia; [Fedrizzi, Alessandro] Univ Queensland, Ctr Quantum Comp Technol, Brisbane, Qld 4072, Australia; [Ramelow, Sven] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-1090 Vienna, Austria; [Ramelow, Sven] Univ Vienna, Fac Phys, A-1090 Vienna, Austria	University of Waterloo; University of Waterloo; University of Queensland; University of Queensland; Austrian Academy of Sciences; University of Vienna	Hubel, H (corresponding author), Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada.	hhuebel@iqc.ca; tjennewe@iqc.ca	Ramelow, Sven/H-6798-2012; Hamel, Deny/C-7071-2017; Fedrizzi, Alessandro/E-2888-2010	Ramelow, Sven/0000-0002-7801-4440; Hamel, Deny/0000-0002-4788-7548; Fedrizzi, Alessandro/0000-0002-5089-3148	Canadian Institute for Advanced Research; Ontario Centres of Excellence; Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Council of Canada; Canadian Foundation for Innovation; FWF (CoQus)	Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Ontario Centres of Excellence; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); FWF (CoQus)(Austrian Science Fund (FWF))	The authors would like to thank H. Majedi and G. Weihs for providing equipment and infrastructure for implementing the experiment. Gratefully acknowledged is the financial support by the Canadian Institute for Advanced Research, the Ontario Centres of Excellence, the Ontario Ministry of Research and Innovation, the Natural Sciences and Engineering Council of Canada and the Canadian Foundation for Innovation. S. R. acknowledges support from the FWF (CoQus).	Banaszek K, 1997, PHYS REV A, V55, P2368, DOI 10.1103/PhysRevA.55.2368; Barreiro JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260501; Bencheikh K, 2007, CR PHYS, V8, P206, DOI 10.1016/j.crhy.2006.07.014; Bouwmeester D, 1999, PHYS REV LETT, V82, P1345, DOI 10.1103/PhysRevLett.82.1345; Brendel J, 1999, PHYS REV LETT, V82, P2594, DOI 10.1103/PhysRevLett.82.2594; Browne DE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010501; BURNHAM DC, 1970, PHYS REV LETT, V25, P84, DOI 10.1103/PhysRevLett.25.84; Douady J, 2004, OPT LETT, V29, P2794, DOI 10.1364/OL.29.002794; Fedrizzi A, 2007, OPT EXPRESS, V15, P15377, DOI 10.1364/OE.15.015377; Guo HC, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2099541; GUPTA SN, 1954, PHYS REV, V96, P1453, DOI 10.1103/PhysRev.96.1453; Hillery M, 1999, PHYS REV A, V59, P1829, DOI 10.1103/PhysRevA.59.1829; Keller TE, 1998, PHYS REV A, V57, P2076, DOI 10.1103/PhysRevA.57.2076; Kiesel N, 2003, J MOD OPTIC, V50, P1131, DOI 10.1080/0950034031000064861; KLYSHKO DN, 1967, JETP LETT-USSR, V6, P23; Kurtsiefer C, 2001, J MOD OPTIC, V48, P1997, DOI 10.1080/09500340110060100; Kurtsiefer C, 2001, J MOD OPTIC, V48, P2039, DOI 10.1080/09500340110070235; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Kwiat PG, 1997, J MOD OPTIC, V44, P2173, DOI 10.1080/095003497152438; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Munro WJ, 1998, PHYS REV LETT, V81, P4285, DOI 10.1103/PhysRevLett.81.4285; OU ZY, 1988, PHYS REV LETT, V61, P50, DOI 10.1103/PhysRevLett.61.50; Persson J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.233314; Ramelow S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.253601; Rarity JG, 1999, PHYS REV A, V59, pR35, DOI 10.1103/PhysRevA.59.R35; RARITY JG, 1990, PHYS REV LETT, V65, P1348, DOI 10.1103/PhysRevLett.65.1348; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; Tanzilli S, 2001, ELECTRON LETT, V37, P26, DOI 10.1049/el:20010009; Zeilinger A., 1992, NASA C PUBLICATION, V3135, P73; ZUKOWSKI M, 1995, ANN NY ACAD SCI, V755, P91, DOI 10.1111/j.1749-6632.1995.tb38959.x	31	128	133	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					601	603		10.1038/nature09175	http://dx.doi.org/10.1038/nature09175			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671705	Green Submitted			2022-12-28	WOS:000280412100048
J	Birkmeyer, NJO; Dimick, JB; Share, D; Hawasli, A; English, WJ; Genaw, J; Finks, JF; Carlin, AM; Birkmeyer, JD				Birkmeyer, Nancy J. O.; Dimick, Justin B.; Share, David; Hawasli, Abdelkader; English, Wayne J.; Genaw, Jeffrey; Finks, Jonathan F.; Carlin, Arthur M.; Birkmeyer, John D.		Michigan Bariatric Surg Collaborat	Hospital Complication Rates With Bariatric Surgery in Michigan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAPAROSCOPIC GASTRIC BYPASS; MORBID-OBESITY; SURGICAL QUALITY; PROVIDER VOLUME; OUTCOMES; EXCELLENCE; CENTERS; PROGRAMS; PAYERS; IMPACT	Context Despite the growing popularity of bariatric surgery, there remain concerns about perioperative safety and variation in outcomes across hospitals. Objective To assess complication rates of different bariatric procedures and variability in rates of serious complications across hospitals and according to procedure volume and center of excellence (COE) status. Design, Setting, and Patients Involving 25 hospitals and 62 surgeons statewide, the Michigan Bariatric Surgery Collaborative (MBSC) administers an externally audited, prospective clinical registry. We evaluated short-term morbidity in 15 275 Michigan patients undergoing 1 of 3 common bariatric procedures between 2006 and 2009. We used multilevel regression models to assess variation in risk-adjusted complication rates across hospitals and the effects of procedure volume and COE designation (by the American College of Surgeons or American Society for Metabolic and Bariatric Surgery) status. Main Outcome Measure Complications occurring within 30 days of surgery. Results Overall, 7.3% of patients experienced perioperative complications, most of which were wound problems and other minor complications. Serious complications were most common after gastric bypass (3.6%; 95% confidence interval [CI], 3.2%-4.0%), followed by sleeve gastrectomy (2.2%; 95% CI, 1.2%-3.2%), and laparoscopic adjustable gastric band (0.9%; 95% CI, 0.6%-1.1%) procedures (P<.001). Mortality occurred in 0.04% (95% CI, 0.001%-0.13%) of laparoscopic adjustable gastric band, 0 sleeve gastrectomy, and 0.14% (95% CI, 0.08%-0.25%) of the gastric bypass patients. After adjustment for patient characteristics and procedure mix, rates of serious complications varied from 1.6% (95% CI, 1.3-2.0) to 3.5% (95% CI, 2.4-5.0) (risk difference, 1.9; 95% CI, 0.08-3.7) across hospitals. Average annual procedure volume was inversely associated with rates of serious complications at both the hospital level (<150 cases, 4.1%; 95% CI, 3.0%-5.1%; 150-299 cases, 2.7%; 95% CI, 2.2-3.2; and >= 300 cases, 2.3%; 95% CI, 2.0%-2.6%; P=.003) and surgeon level (<100 cases, 3.8%; 95% CI, 3.2%-4.5%; 100-249 cases, 2.4%; 95% CI, 2.1%-2.8%; >= 250 cases, 1.9%; 95% CI, 1.4%-2.3%; P=.001). Adjusted rates of serious complications were similar in COE and non-COE hospitals (COE, 2.7%; 95% CI, 2.5%-3.1%; non-COE, 2.0%; 95% CI, 1.5%-2.4%; P=.41). Conclusions The frequency of serious complications among patients undergoing bariatric surgery in Michigan was relatively low. Rates of serious complications are inversely associated with hospital and surgeon procedure volume, but unrelated to COE accreditation by professional organizations. JAMA. 2010; 304(4): 435-442	[Birkmeyer, Nancy J. O.] Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, Ann Arbor, MI 48104 USA; [Birkmeyer, Nancy J. O.; Dimick, Justin B.; Finks, Jonathan F.; Birkmeyer, John D.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48104 USA; [Share, David] Univ Michigan, Dept Family Med, Ann Arbor, MI 48104 USA; [Hawasli, Abdelkader] St John Hosp & Med Ctr, Dept Surg, Detroit, MI USA; [English, Wayne J.] Marquette Gen Hosp, Dept Surg, Marquette, MI USA; [Genaw, Jeffrey; Carlin, Arthur M.] Henry Ford Hosp, Dept Surg, Detroit, MI 48202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; St. John Hospital & Medical Center; Henry Ford Health System; Henry Ford Hospital	Birkmeyer, NJO (corresponding author), Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, 211 N 4th Ave,Ste 2A & 2B, Ann Arbor, MI 48104 USA.	nbirkmey@umich.edu			Blue Cross and Blue Shield of Michigan; Blue Care Network; Agency for Healthcare Research and Quality [1R01HS018050, 1R01HS018728]; National Institute of Diabetes and Digestive and Kidney Diseases [1R21DK084397]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018050, R01HS018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084397] Funding Source: NIH RePORTER	Blue Cross and Blue Shield of Michigan; Blue Care Network; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Michigan Bariatric Surgery Collaborative is funded by an unrestricted longitudinal research contract from Blue Cross and Blue Shield of Michigan and Blue Care Network. Drs N. Birkmeyer and Dimick also receive support for research related to the Michigan Bariatric Surgery Collaborative from the Agency for Healthcare Research and Quality (1R01HS018050 and 1R01HS018728) and the National Institute of Diabetes and Digestive and Kidney Diseases (1R21DK084397).	Biertho L, 2003, J AM COLL SURGEONS, V197, P536, DOI 10.1016/S1072-7515(03)00730-0; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; Birkmeyer NJO, 2005, SURGERY, V138, P815, DOI 10.1016/j.surg.2005.06.037; Cottam DR, 2006, OBES SURG, V16, P534, DOI 10.1381/096089206776944913; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; Encinosa WE, 2009, MED CARE, V47, P531, DOI 10.1097/MLR.0b013e31819434c6; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Jan JC, 2005, J GASTROINTEST SURG, V9, P30, DOI 10.1016/j.gassur.2004.09.043; Kim TH, 2006, SURG ENDOSC, V20, P202, DOI 10.1007/s00464-005-0243-1; Latts L, 2010, ARCH SURG-CHICAGO, V145, P106, DOI 10.1001/archsurg.2009.256; Liu JH, 2003, AM SURGEON, V69, P823; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P319, DOI 10.1001/archsurg.2009.23; Murr MM, 2007, ANN SURG, V245, P699, DOI 10.1097/01.sla.0000256392.04141.04; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Pratt GM, 2010, ARCH SURG-CHICAGO, V145, P105, DOI 10.1001/archsurg.2009.254; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Shikora SA, 2010, ARCH SURG-CHICAGO, V145, P105, DOI 10.1001/archsurg.2009.255; te Riele WW, 2008, OBES SURG, V18, P11, DOI 10.1007/s11695-007-9254-4; Tice JA, 2008, AM J MED, V121, P885, DOI 10.1016/j.amjmed.2008.05.036; Weber M, 2004, ANN SURG, V240, P975, DOI 10.1097/01.sla.0000145924.64932.8f; Weller WE, 2006, J AM COLL SURGEONS, V202, P753, DOI 10.1016/j.jamcollsurg.2006.02.002; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	24	291	295	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					435	442		10.1001/jama.2010.1034	http://dx.doi.org/10.1001/jama.2010.1034			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664044	Bronze			2022-12-28	WOS:000280350100027
J	Fulzele, K; Riddle, RC; DiGirolamo, DJ; Cao, XM; Wan, C; Chen, DQ; Faugere, MC; Aja, S; Hussain, MA; Bruning, JC; Clemens, TL				Fulzele, Keertik; Riddle, Ryan C.; DiGirolamo, Douglas J.; Cao, Xuemei; Wan, Chao; Chen, Dongquan; Faugere, Marie-Claude; Aja, Susan; Hussain, Mehboob A.; Bruening, Jens C.; Clemens, Thomas L.			Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition	CELL			English	Article							TRANSCRIPTION FACTOR FOXO1; BETA-CELL FUNCTION; DIABETES-MELLITUS; COLLAGEN-SYNTHESIS; GLUCOSE-TOLERANCE; ENERGY-METABOLISM; RAT BONE; BB RATS; OSTEOCALCIN; GROWTH	Global energy balance in mammals is controlled by the actions of circulating hormones that coordinate fuel production and utilization in metabolically active tissues. Bone-derived osteocalcin, in its undercarboxylated, hormonal form, regulates fat deposition and is a potent insulin secretagogue. Here, we show that insulin receptor (IR) signaling in osteoblasts controls osteoblast development and osteocalcin expression by suppressing the Runx2 inhibitor Twist2. Mice lacking IR in osteoblasts have low circulating undercarboxylated osteocalcin and reduced bone acquisition due to decreased bone formation and deficient numbers of osteoblasts. With age, these mice develop marked peripheral adiposity and hyperglycemia accompanied by severe glucose intolerance and insulin resistance. The metabolic abnormalities in these mice are improved by infusion of undercarboxylated osteocalcin. These results indicate the existence of a bone-pancreas endocrine loop through which insulin signaling in the osteoblast ensures osteoblast differentiation and stimulates osteocalcin production, which in turn regulates insulin sensitivity and pancreatic insulin secretion.	[Fulzele, Keertik; Riddle, Ryan C.; DiGirolamo, Douglas J.; Wan, Chao; Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Faugere, Marie-Claude] Univ Kentucky, Dept Med, Lexington, KY 40536 USA; [Cao, Xuemei] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Dongquan] W Virginia Univ, Sch Med, Dept Med, Clin Translat Sci Inst, Morgantown, WV 26506 USA; [Bruening, Jens C.] Univ Cologne, Cologne Excellence Ctr Cellular Stress Responses, Ctr Mol Med, Inst Genet,Dept Mouse Genet & Metab, D-50937 Cologne, Germany; [Bruening, Jens C.] Univ Hosp Cologne, Dept Internal Med, D-50937 Cologne, Germany; [Bruening, Jens C.] Max Planck Inst Biol Aging, D-50937 Cologne, Germany; [Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Kentucky; University of Alabama System; University of Alabama Birmingham; West Virginia University; University of Cologne; University of Cologne; Max Planck Society; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Clemens, TL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA.	tclemen5@jhmi.edu	Wan, Chao/J-9277-2013	Wan, Chao/0000-0001-6780-2006	Veterans Administration; NIH [DK081472]; Baltimore Diabetes Research and Training Center [DK079637]; DFG [Br1492/7-1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, P30DK079637, R01DK081472] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baltimore Diabetes Research and Training Center; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for the assistance of the Small Animal Phenotyping Core and Metabolism Core Laboratory at the University of Alabama at Birmingham. We thank Dr. D. Accili for providing the tTR-IRKO mice and Dr. M. Bouxsein for assistance in analyzing the skeletal phenotype by micro-CT. We also thank Drs. T. Nagy and T. Garvey for helpful suggestions during the completion of this work. Support was provided by a Merit Review Grant from the Veterans Administration (T. L. C.) and grants from the NIH (M. H., DK081472), the Baltimore Diabetes Research and Training Center (M. H., DK079637), and DFG (J.C.B., Br1492/7-1). T. L. C. is also the recipient of a Research Career Scientist Award from the Veterans Administration.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; DELMAS PD, 1983, J CLIN ENDOCR METAB, V57, P1028, DOI 10.1210/jcem-57-5-1028; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200; Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; Herrero S, 1998, CALCIFIED TISSUE INT, V62, P260, DOI 10.1007/s002239900427; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hussain MA, 2006, MOL CELL BIOL, V26, P7747, DOI 10.1128/MCB.02353-05; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Irwin R, 2006, ENDOCRINOLOGY, V147, P5760, DOI 10.1210/en.2006-0700; ITUARTE EA, 1989, CALCIFIED TISSUE INT, V45, P27, DOI 10.1007/BF02556657; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KREAM BE, 1985, ENDOCRINOLOGY, V116, P296, DOI 10.1210/endo-116-1-296; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Lusk G, 1928, ELEMENTS SCI NUTR; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; PUN KK, 1989, J BONE MINER RES, V4, P853; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; ROSEN DM, 1983, ENDOCRINOLOGY, V112, P992, DOI 10.1210/endo-112-3-992; SHIRES R, 1981, J LAB CLIN MED, V97, P231; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Thrailkill K M, 2000, Diabetes Technol Ther, V2, P69, DOI 10.1089/152091599316775; VERHAEGHE J, 1992, J ENDOCRINOL, V134, P485, DOI 10.1677/joe.0.1340485; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; WEINREB M, 1990, J BONE MINER RES, V5, P831; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	43	529	563	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					309	319		10.1016/j.cell.2010.06.002	http://dx.doi.org/10.1016/j.cell.2010.06.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655471	Bronze, Green Accepted			2022-12-28	WOS:000280204300021
J	Minamishima, YA; Kaelin, WG				Minamishima, Yoji Andrew; Kaelin, William G., Jr.			Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss	SCIENCE			English	Article							INACTIVATION; ERYTHROPOIESIS; FAILURE		[Kaelin, William G., Jr.] Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	william_kaelin@dfci.harvard.edu	Minamishima, Yoji Andrew/E-5380-2010	Minamishima, Yoji Andrew/0000-0001-7995-9318	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA068490] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068490] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561	8	131	137	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					407	407		10.1126/science.1192811	http://dx.doi.org/10.1126/science.1192811			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651146	Green Accepted			2022-12-28	WOS:000280196500028
J	Goldhaber, SZ				Goldhaber, Samuel Z.			Magnetic resonance angiography and venography were sensitive but had poor technical adequacy for diagnosing pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Goldhaber, SZ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.								0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-12	10.7326/0003-4819-153-2-201007200-02012	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643978				2022-12-28	WOS:000280095400030
J	Pitt, B				Pitt, Bertram			Adding NT-proBNP-guided management to multidisciplinary care reduced heart failure rehospitalization days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Pitt, B (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-8	10.7326/0003-4819-153-2-201007200-02008	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643986				2022-12-28	WOS:000280095400026
J	Cantin, NE; Cohen, AL; Karnauskas, KB; Tarrant, AM; McCorkle, DC				Cantin, Neal E.; Cohen, Anne L.; Karnauskas, Kristopher B.; Tarrant, Ann M.; McCorkle, Daniel C.			Ocean Warming Slows Coral Growth in the Central Red Sea	SCIENCE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; TEMPERATURE; CALCIFICATION; MECHANISM; PHOTOSYNTHESIS; PORITES; RATES	Sea surface temperature (SST) across much of the tropics has increased by 0.4 degrees to 1 degrees C since the mid-1970s. A parallel increase in the frequency and extent of coral bleaching and mortality has fueled concern that climate change poses a major threat to the survival of coral reef ecosystems worldwide. Here we show that steadily rising SSTs, not ocean acidification, are already driving dramatic changes in the growth of an important reef-building coral in the central Red Sea. Three-dimensional computed tomography analyses of the massive coral Diploastrea heliopora reveal that skeletal growth of apparently healthy colonies has declined by 30% since 1998. The same corals responded to a short-lived warm event in 1941/1942, but recovered within 3 years as the ocean cooled. Combining our data with climate model simulations by the Intergovernmental Panel on Climate Change, we predict that should the current warming trend continue, this coral could cease growing altogether by 2070.	[Cantin, Neal E.; Cohen, Anne L.; Karnauskas, Kristopher B.; Tarrant, Ann M.; McCorkle, Daniel C.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Cantin, NE (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.		Tarrant, Ann/AAU-8263-2021	Tarrant, Ann/0000-0002-1909-7899	KAUST [USA 00002/KSA 00011]	KAUST(King Abdullah University of Science & Technology)	The authors thank G. P. Lohmann, C. Saenger, M. X. Weber, and A. Venti for their assistance with fieldwork. A. Al Suwailem; Y. Kattan; H. Al Jahdali; W. Moazen; Nageeb from King Abdullah University of Science and Technology (KAUST); and E. Mason, R. Maravilla, and the staff at Dream Divers provided logistical support in Saudi Arabia. D. Ketten and J. Arruda provided invaluable technical support and advice for the CAT scanning of our coral cores. Comments from D. Oppo and two anonymous reviewers helped to improve the original manuscript. This research was funded by award no. USA 00002/KSA 00011 from KAUST to A.L.C. and D.C.M.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; Clement AC, 2010, NAT GEOSCI, V3, P8, DOI 10.1038/ngeo728; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Devantier L, 2000, STATUS CORAL REEFS S; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Furla P, 2000, J EXP BIOL, V203, P3445; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; Hart DE, 2007, CORAL REEFS, V26, P53, DOI 10.1007/s00338-006-0168-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Saenger C, 2009, NAT GEOSCI, V2, P492, DOI 10.1038/ngeo552; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1	28	316	325	36	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					322	325		10.1126/science.1190182	http://dx.doi.org/10.1126/science.1190182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647466				2022-12-28	WOS:000279925900041
J	Farmer, P; Frenk, J; Knaul, FM; Shulman, LN; Alleyne, G; Armstrong, L; Atun, R; Blayney, D; Chen, L; Feachem, R; Gospodarowicz, M; Gralow, J; Gupta, S; Langer, A; Lob-Levyt, J; Neal, C; Mbewu, A; Mired, D; Piot, P; Reddy, KS; Sachs, JD; Sarhan, M; Seffrin, JR				Farmer, Paul; Frenk, Julio; Knaul, Felicia M.; Shulman, Lawrence N.; Alleyne, George; Armstrong, Lance; Atun, Rifat; Blayney, Douglas; Chen, Lincoln; Feachem, Richard; Gospodarowicz, Mary; Gralow, Julie; Gupta, Sanjay; Langer, Ana; Lob-Levyt, Julian; Neal, Claire; Mbewu, Anthony; Mired, Dina; Piot, Peter; Reddy, K. Srinath; Sachs, Jeffrey D.; Sarhan, Mahmoud; Seffrin, John R.			Expansion of cancer care and control in countries of low and middle income: a call to action	LANCET			English	Article							HEALTH SYSTEM REFORM; HIV PREVENTION; BREAST-CANCER; MEXICO; LESSONS; TRENDS	Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.	[Farmer, Paul] Harvard Univ, Sch Med, Boston, MA USA; [Frenk, Julio; Langer, Ana] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Knaul, Felicia M.] Harvard Global Equ Initiat, Boston, MA 02115 USA; [Shulman, Lawrence N.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Armstrong, Lance; Neal, Claire] Lance Armstrong Fdn, Austin, TX USA; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Blayney, Douglas] Amer Soc Clin Oncol, Alexandria, VA USA; [Chen, Lincoln] China Med Board, Cambridge, MA USA; [Feachem, Richard] Univ Calif Berkeley, Global Hlth Grp, Berkeley, CA 94720 USA; [Feachem, Richard] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Gospodarowicz, Mary] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Gralow, Julie] Seattle Canc Care Alliance, Seattle, WA USA; [Gupta, Sanjay] CNN, Atlanta, GA USA; [Lob-Levyt, Julian] Global Alliance Vaccine & Immunizat, Geneva, Switzerland; [Mbewu, Anthony] Global Forum Hlth Res, Geneva, Switzerland; [Mired, Dina] King Hussein Canc Fdn, Amman, Jordan; [Piot, Peter] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London, England; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Sachs, Jeffrey D.] Columbia Univ, Earth Inst, New York, NY USA; [Sarhan, Mahmoud] King Hussein Canc Ctr, Amman, Jordan; [Seffrin, John R.] Amer Canc Soc, Atlanta, GA 30329 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Pan American Health Organization; American Society of Clinical Oncology; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Seattle Cancer Care Alliance; Imperial College London; Public Health Foundation of India; Columbia University; King Hussein Cancer Center; American Cancer Society	Knaul, FM (corresponding author), Harvard Global Equ Initiat, 651 Huntington Ave,FXB Bldg 632, Boston, MA 02115 USA.	felicia_knaul@harvard.edu	Atun, Rifat/AAH-5537-2021; Blayney, Douglas/AAK-2920-2020; Harding, Richard/G-9729-2012	Blayney, Douglas/0000-0002-7931-4533; Knaul, Felicia/0000-0002-0512-4788; Atun, Rifat/0000-0002-1531-5983; Reddy, K Srinath/0000-0003-3416-3548	Genentech; Sanofi-Aventis; Roche; Amgen; Novartis	Genentech(Roche HoldingGenentech); Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); Amgen(Amgen); Novartis(Novartis)	PF, JF, LNS, GA, LA, DW, LC, RF, AL, CN, AM, DM, PP, KSR, JDS, MS, and JRS declare that they have no conflicts of interest. FMK is associated with a non-profit programme in Mexico (Tomatelo a Pecho) to promote early detection of breast cancer; receives honoraria from the Mexican Health Foundation, which has submitted research grant applications to GlaxoSmithKline and Roche; and has been nominated to become a board member (unpaid) for the International Union Against Cancer. MG serves as a board member (unpaid) for the International Union Against Cancer. JG's institution has received grants from Genentech, Sanofi-Aventis, Roche, Amgen, and Novartis. SG is a board member of non-profit organisation LIVESTRONG, a staff member of Emory Clinic Department of Neurosurgery, chief medical correspondent for CNN, and a medical contributor to CBS and Time Magazine.	American Cancer Society, 1950, CANC J CLIN, V1, P30; [Anonymous], 2010, LANCET, V376, P206, DOI 10.1016/S0140-6736(10)61124-5; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Beaulieu N, 2009, BREAKAWAY GLOBAL BUR; Bhatla N., 2010, PROTECTION CANC CAUS; Boyle P, 2008, WORLD CANC REPORT 20; CanTreat Int, 2010, ANN ONCOL, V21, P680, DOI 10.1093/annonc/mdq055; *CANTREAT INT, INT EXP CALL CONC AC; Comision Nacional de Proteccion Social en Salud, SIST PROT SOC SAL IN; *CONS NAC EV POL D, CONV DAR CON EST POB; Crisp Nigel., 2010, TURNING WORLD UPSIDE; Economist Intelligence Unit, QUAL DEATH RANK END; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; FARMER P, 2009, DELIVERING CANC CARE; Farmer P., 1999, INFECT INEQUALITIES; FERLAY J, 2003, GLOBOCAN 2002 CANC I; FRENK J, 2008, RETHINKING I ARCHITE; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; *GLOB TASK FORC EX, 2010, SUMM; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hesseling PB, 2008, LANCET ONCOL, V9, P512, DOI 10.1016/S1470-2045(08)70139-6; *HJ KAIS FAM FDN, GLOB HIV PREV PROGR; *I MED, 2009, US COMM GLOB HLTH RE; JAOUNI S, TAILORING STRATEGIES; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; JOINT UNITED NATIONS PROGRAMME ON HVI/AIDS [UNAIDS] & WHO, 2009, AIDS EP UPD DEC 2009, P7; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Kung HC, 2008, NATL VITAL STAT REPO; *LIVESTRONG L ARMS, WORLD CANC LIVESTRON; Lozano-Ascencio R, 2009, SALUD PUBLICA MEXICO, V51, pS147, DOI 10.1590/S0036-36342009000800004; Knaul FM, 2008, REPROD HEALTH MATTER, V16, P113, DOI 10.1016/S0968-8080(08)32414-8; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; *MIN PROT SOC REP, PLAN OBL SAL; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Ngoma T, 2006, ANN ONCOL, V17, P9, DOI [10.1093/annonc.mdl983, 10.1093/annonc/mdl982]; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; *PROGR DES HUM OP, 2010, IND RES 2010; Sarhan M, 2010, 3 REG C CANC BLOOD D; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Sloan F.A., 2007, I MED US COMMITTEE C; Soni A, 2009, HEALTH AFFAIR, V28, P1617, DOI 10.1377/hlthaff.28.6.1617; Taskforce on Innovative International Financing for Health Systems, MOR MON HLTH MOR HLT; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UICC, UICC WORLD CANC DECL; UNAIDS, 2008 REP GLOB AIDS E; WALSH J G, 1958, CA Cancer J Clin, V8, P83, DOI 10.3322/canjclin.8.3.83; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; *WHO, GROUPS RISK WHO REP; WHO, WHA5822 WHO	54	456	461	4	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2010	376	9747					1186	1193		10.1016/S0140-6736(10)61152-X	http://dx.doi.org/10.1016/S0140-6736(10)61152-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663UN	20709386				2022-12-28	WOS:000282915700035
J	Branco, T; Clark, BA; Hausser, M				Branco, Tiago; Clark, Beverley A.; Haeusser, Michael			Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons	SCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; BASAL DENDRITES; SYNAPTIC INTEGRATION; ACTION-POTENTIALS; SPIKES; PLASTICITY; REPRESENTATION; MECHANISM; NETWORK; CELLS	The detection and discrimination of temporal sequences is fundamental to brain function and underlies perception, cognition, and motor output. By applying patterned, two-photon glutamate uncaging, we found that single dendrites of cortical pyramidal neurons exhibit sensitivity to the sequence of synaptic activation. This sensitivity is encoded by both local dendritic calcium signals and somatic depolarization, leading to sequence-selective spike output. The mechanism involves dendritic impedance gradients and nonlinear synaptic N-methyl-D-aspartate receptor activation and is generalizable to dendrites in different neuronal types. This enables discrimination of patterns delivered to a single dendrite, as well as patterns distributed randomly across the dendritic tree. Pyramidal cell dendrites can thus act as processing compartments for the detection of synaptic sequences, thereby implementing a fundamental cortical computation.	[Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Clark, Beverley/C-1519-2008; Hausser, Michael/AAW-6827-2020; Branco, Tiago/C-1503-2008	Hausser, Michael/0000-0002-2673-8957; 	Wellcome Trust; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	We thank M. London, A. Roth, P. Dayan, J. Jack, and S. Smith for discussions; B. Judkewitz for help with image acquisition software; and C. Schmidt-Hieber for help with hippocampal granule cell experiments. This work was supported by grants from the Wellcome Trust and the Gatsby Charitable Foundation.	BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rall W, 1964, NEURAL THEORY MODELI, P73; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3	34	272	274	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1671	1675		10.1126/science.1189664	http://dx.doi.org/10.1126/science.1189664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20705816	Green Accepted			2022-12-28	WOS:000282098100049
J	Mendez-Ferrer, S; Michurina, TV; Ferraro, F; Mazloom, AR; MacArthur, BD; Lira, SA; Scadden, DT; Ma'ayan, A; Enikolopov, GN; Frenette, PS				Mendez-Ferrer, Simon; Michurina, Tatyana V.; Ferraro, Francesca; Mazloom, Amin R.; MacArthur, Ben D.; Lira, Sergio A.; Scadden, David T.; Ma'ayan, Avi; Enikolopov, Grigori N.; Frenette, Paul S.			Mesenchymal and haematopoietic stem cells form a unique bone marrow niche	NATURE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; NEURAL STEM; EXPRESSION; DIFFERENTIATION; OSTEOPONTIN; OSTEOBLASTS; COOPERATION; RECEPTORS; COMPONENT	The cellular constituents forming the haematopoietic stem cell (HSC) niche in the bone marrow are unclear, with studies implicating osteoblasts, endothelial and perivascular cells. Here we demonstrate that mesenchymal stem cells (MSCs), identified using nestin expression, constitute an essential HSC niche component. Nestin(+) MSCs contain all the bone-marrow colony-forming-unit fibroblastic activity and can be propagated as non-adherent 'mesenspheres' that can self-renew and expand in serial transplantations. Nestin(+) MSCs are spatially associated with HSCs and adrenergic nerve fibres, and highly express HSC maintenance genes. These genes, and others triggering osteoblastic differentiation, are selectively downregulated during enforced HSC mobilization or beta 3 adrenoreceptor activation. Whereas parathormone administration doubles the number of bone marrow nestin(+) cells and favours their osteoblastic differentiation, in vivo nestin(+) cell depletion rapidly reduces HSC content in the bone marrow. Purified HSCs home near nestin(+) MSCs in the bone marrow of lethally irradiated mice, whereas in vivo nestin(+) cell depletion significantly reduces bone marrow homing of haematopoietic progenitors. These results uncover an unprecedented partnership between two distinct somatic stem-cell types and are indicative of a unique niche in the bone marrow made of heterotypic stem-cell pairs.	[Mendez-Ferrer, Simon; Lira, Sergio A.; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Mendez-Ferrer, Simon; Frenette, Paul S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Michurina, Tatyana V.; Enikolopov, Grigori N.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ferraro, Francesca; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Mazloom, Amin R.; MacArthur, Ben D.; Ma'ayan, Avi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Frenette, Paul S.] Yeshiva Univ Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cold Spring Harbor Laboratory; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	simon.mendez-ferrer@cnic.es; paul.frenette@einstein.yu.edu	Ma'ayan, Avi/AAG-3131-2019; Enikolopov, Grigori/P-5731-2019; Méndez-Ferrer, Simón/ABG-8547-2020; Méndez-Ferrer, Simón/L-8088-2014; Frenette, Paul S/J-8272-2012	Ma'ayan, Avi/0000-0002-6904-1017; Enikolopov, Grigori/0000-0001-8178-8917; Méndez-Ferrer, Simón/0000-0002-9805-9988; Méndez-Ferrer, Simón/0000-0002-9805-9988; Frenette, Paul S/0000-0003-0862-9922; MacArthur, Ben/0000-0002-5396-9750	National Institutes of Health [DK056638, HL69438, HL097819]; Department of Defence [PC060271]; National Institute of Mental Health; Ira Hazan Fund; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ira Hazan Fund; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Garcia-Fernandez, Y. Kunisaki, C. Scheiermann, J. Isern, E. Nistal-Villan and D. Lucas for help with some experiments; M. Kiel and S. Morrison for advice about immunohistological analysis of HSCs; C. Lin for help with intravital microscopy imaging; G. Fishell for the gift of Nes-cre<SUP>ERT2</SUP> and RCE:loxP transgenic mice; J. Ahmed, W. Kao and J. Godbold for help with immunofluorescence and statistical analyses; S. Lymperi for advice about LT-CIC; L. Silberstein, G. Khitrov and W. Zhang for help with microarray experiments; M. Grisotto for help with cell sorting; and L. Shang, A. J. Peired and C. Prophete for help with animals. This work was supported by the National Institutes of Health (R01 grants DK056638, HL69438, HL097819) and the Department of Defence (Idea Development Award PC060271) to P. S. F. and by the National Institute of Mental Health and Ira Hazan Fund to G.N.E. S.M.-F. is the recipient of a Scholar Award by the American Society of Hematology. P. S. F. is an Established Investigator of the American Heart Association.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; CRISAN M, 2008, CURR PROTOC STEM CEL, V2; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mignone JL, 2007, CELL CYCLE, V6, P2161, DOI 10.4161/cc.6.17.4593; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOUSA VH, 2009, CEREB CORTEX S1, V19, P1, DOI DOI 10.1093/CERCOR/BHP038; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	43	2302	2403	13	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					829	U59		10.1038/nature09262	http://dx.doi.org/10.1038/nature09262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703299	Green Accepted			2022-12-28	WOS:000280766100028
J	Jurgens, R; Csete, J; Amon, JJ; Baral, S; Beyrer, C				Jurgens, Ralf; Csete, Joanne; Amon, Joseph J.; Baral, Stefan; Beyrer, Chris			HIV in people who use drugs 6 People who use drugs, HIV, and human rights	LANCET			English	Article							SYRINGE EXCHANGE PROGRAMS; HARM REDUCTION; RISK ENVIRONMENT; PUBLIC-HEALTH; ANTIRETROVIRAL TREATMENT; COST-EFFECTIVENESS; LAW-ENFORCEMENT; INJECT DRUGS; HEPATITIS-C; ACCESS	We reviewed evidence from more than 900 studies and reports on the link between human rights abuses experienced by people who use drugs and vulnerability to HIV infection and access to services. Published work documents widespread abuses of human rights, which increase vulnerability to HIV infection and negatively affect delivery of HIV programmes. These abuses include denial of harm-reduction services, discriminatory access to antiretroviral therapy, abusive law enforcement practices, and coercion in the guise of treatment for drug dependence. Protection of the human rights of people who use drugs therefore is important not only because their rights must be respected, protected, and fulfilled, but also because it is an essential precondition to improving the health of people who use drugs. Rights-based responses to HIV and drug use have had good outcomes where they have been implemented, and they should be replicated in other countries.	[Csete, Joanne] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Amon, Joseph J.] Human Rights Watch, New York, NY USA; [Baral, Stefan; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jurgens, R (corresponding author), 97 Koninck, Mille Isles, PQ J0R 1A0, Canada.	rjurgens@sympatico.ca	Baral, Stefan/AAG-4818-2020; Baral, Stefan/D-2930-2013	Baral, Stefan/0000-0002-5482-2419; Amon, Joseph/0000-0002-2455-6703				AITKEN C, 2002, INT J DRUG POLICY, V13, P192; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Ball A, 1995, MULTICENTRE STUDY DR; Ball A L, 1998, Public Health Rep, V113 Suppl 1, P170; Barrett D., 2009, HARM REDUCTION HUMAN; Barrett D, 2009, DIVERSITY OF INTERNATIONAL LAW: ESSAYS IN HONOUR OF PROFESSOR KALLIOPI K. KOUFA, P449; Bastos FI, 2000, SOC SCI MED, V51, P1771, DOI 10.1016/S0277-9536(00)00109-X; *BECKL FDN DRUG PO, 2008, REC REG NEED HUM RIG; Benson BL, 2001, J DRUG ISSUES, V31, P989, DOI 10.1177/002204260103100410; Best D, 2001, BRIT J CRIMINOL, V41, P738, DOI 10.1093/bjc/41.4.738; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Bobrik A, 2005, J PUBLIC HEALTH POL, V26, P30, DOI 10.1057/palgrave.jphp.3200002; Bobrova N, 2007, INT J DRUG POLICY, V18, P313, DOI 10.1016/j.drugpo.2007.01.015; BROADHEAD RS, 1995, J DRUG ISSUES, V531, P564; Burris S, 2006, AIDS, V20, P117, DOI 10.1097/01.aids.0000194806.81917.19; Burris S, 2004, MILBANK Q, V82, P125, DOI 10.1111/j.0887-378X.2004.00304.x; Burris Scott, 2002, J Am Pharm Assoc (Wash), V42, pS94, DOI 10.1331/1086-5802.42.0.S94.Burris; [Canadian HIV AIDS Legal Network], 2008, NOTH US US GREAT MEA; Canadian HIV/AIDS Legal Network, 2006, LEG HLTH HUM RIGHTS; Carey C., 2008, TIPPING BALANCE WHY; Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012; Cintra Ana Maria de Oliveira, 2006, Cad. Saúde Pública, V22, P791, DOI 10.1590/S0102-311X2006000400018; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Cohen J, 2008, AIDS, V22, pS93, DOI 10.1097/01.aids.0000327440.59032.20; *COMM EC SOC CULT, 2007, EC12UKRCO5 COMM EC S; Cooper HLF, 2009, INT J DRUG POLICY, V20, P217, DOI 10.1016/j.drugpo.2008.08.008; CROFTS N, 1995, J DRUG ISSUES, V25, P599, DOI 10.1177/002204269502500306; CSETE J, 2004, WAR DRUGS HIV AIDS H, P212; CSETE J, 2006, COMMUNICATION; DAVIS M, 2009, ASIA CATALYST   0223; DEGENHARDT L, 2010, LANCET, DOI DOI 10.1016/80140-6736(10)60742-8; DENICHENKO M, 2007, HIV AIDS POLICY LAW, V12, P67; Dolan KA, 1999, MED J AUSTRALIA, V171, P14, DOI 10.5694/j.1326-5377.1999.tb123490.x; Donoghoe MC, 2008, INT J DRUG POLICY, V19, pS5, DOI 10.1016/j.drugpo.2007.12.002; Elliott Richard, 2005, Health Hum Rights, V8, P104, DOI 10.2307/4065336; *EMCDA, 2005, STAT DRUGS PROBL EUR; Ezard N., 2001, INT J DRUG POLICY, V12, P207, DOI [DOI 10.1016/S0955-3959(01)00093-7, 10.1016/S0955-3959(01)00093-7]; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fitzgerald JL, 2005, INT J DRUG POLICY, V16, P203, DOI 10.1016/j.drugpo.2005.06.010; Friedman S R., 2001, Int J Drug Policy, V12, P3, DOI 10.1016/S0955-3959(01)00063-9; Gilmore N, 1996, J Contemp Health Law Policy, V12, P355; GOTFREDSEN N, 2009, HARM REDUCTION 2009; Greenwald G., 2009, DRUG DECRIMINALIZATI; GRUND JPC, 1992, J PSYCHOACTIVE DRUGS, V24, P41, DOI 10.1080/02791072.1992.10471617; GRUND JPC, 1995, J ACQ IMMUN DEF SYND, V10, P104, DOI 10.1097/00042560-199509000-00016; Guinness L, 2010, ADDICTION, V105, P319, DOI 10.1111/j.1360-0443.2009.02755.x; HAMMETT TM, 2005, INT J DRUG POLICY, V4, P245; Hoover J, 2009, HARM REDUCTION PRISO; Hughes R, 2000, DEVIANT BEHAV, V21, P451; *HUM RIGHTS WATCH, 2009, BARR TREATM PUN DRUG; *HUM RIGHTS WATCH, 2002, IGN ONLY HIV AIDS HU; *HUM RIGHTS WATCH, 2004, NOT EN GRAV WAR DRUG; *HUM RIGHTS WATCH, 2004, 16 HUM RIGHTS WATCH; Human Rights Watch, 2007, REH REQ RUSS HUM RIG; Human Rights Watch, 2010, SKIN CABL ILL ARR AR; Human Rights Watch, 2010, DARKN KNOWS NO LIM I; Human Rights Watch, 2008, UNBR CYCL DRUG DEP T; Human Rights Watch, 2009, PLEAS DO NOT MAK US; Human Rights Watch, 2006, RHET RISK HUM RIGHTS; Human Rights Watch and Thai AIDS Treatment Action Group, 2007, DEADL DEN BARR HIV A; Hunt Paul, 2008, HUMAN RIGHTS HLTH HA; *I HUM RES DEV, 2009, WHAT COST HIV HUM RI; *INT HARM RED ASS, 2009, DURGS HARM RED UN CO; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; KAPLAN C, 1992, INT J DRUG POLICY, V3, P186; Kerr T, 2006, INT J DRUG POLICY, V17, P61, DOI 10.1016/j.drugpo.2006.01.003; Kerr T, 2005, INT J DRUG POLICY, V16, P210, DOI 10.1016/j.drugpo.2005.04.005; *KINGS COLL LOND, 2010, PRIS BRIEF MODL REP; Larney S, 2010, ADDICTION, V105, P216, DOI 10.1111/j.1360-0443.2009.02826.x; LAWTON R, 2008, HLTH CAPITAL SUSTAIN, P435; Leonard L, 2008, INT J DRUG POLICY, V19, P255, DOI 10.1016/j.drugpo.2007.02.008; Li HZ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-137; Lines Rick, 2004, Can HIV AIDS Policy Law Rev, V9, P41; Lohman D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-8; Long J, 2001, BRIT MED J, V323, P1209, DOI 10.1136/bmj.323.7323.1209; MacDonald M., 2005, STUDY HLTH CARE PROV; Maher L, 1999, BRIT J CRIMINOL, V39, P488, DOI 10.1093/bjc/39.4.488; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Menoyo C, 2000, Can HIV AIDS Policy Law Rev, V5, P20; Midford R., 2002, INT J DRUG POLICY, V13, P185, DOI [10.1016/S0955-3959(02)00031-2, DOI 10.1016/S0955-3959(02)00031-2]; *MIN INT, 2003, NEEDL EXCH PRIS FRAM; Nelles J., 2006, PRISON NEEDLE EXCHAN; NELSONZLUPKO L, 1995, SOC WORK, V40, P45; NOWAK M, 2009, AHRC1044 UN; OINAM A, 2008, EXPLORING LINKS DRUG; *OP SOC I, 2006, DEL HIV CAR TREATM P; Pearshouse Richard, 2009, HIV AIDS Policy Law Rev, V14, P11; PINTILEI L, 2009, REV ESP SANID PENITE, V11, P14; Pollini RA, 2008, ADDICTION, V103, P101, DOI 10.1111/j.1360-0443.2007.02051.x; Pontali E, 2005, HIV CLIN TRIALS, V6, P25; Potts Helen, 2008, PARTICIPATION RIGHT, P19; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2006, J URBAN HEALTH, V83, P911, DOI 10.1007/s11524-006-9085-y; Rogan DP., 1995, JUSTICE Q, V12, P755, DOI [DOI 10.1080/07418829500096281, 10.1080/07418829500096281]; Sarang A, 2006, ADDICTION, V101, P1787, DOI 10.1111/j.1360-0443.2006.01617.x; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; SCHONTEICH M, 2008, SCALE CONSEQUENCES P; SEMAAN S, 2010, HUMAN RIGHTS HIV PRE; Sharma M, 2009, AIDS, V23, P1405, DOI 10.1097/QAD.0b013e32832bd7c9; STEPHENS D, 2010, LEGAL EMPOWERMENT WO, V12; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; SU J, 2004, CHINESE J DURG DEPEN, V13, P221; Taylor A, 2000, J INFECTION, V40, P176, DOI 10.1053/jinf.2000.0647; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; Thomson N, 2009, AM J PUBLIC HEALTH, V99, P1232, DOI 10.2105/AJPH.2008.136648; Tompkins CNE, 2006, DRUG-EDUC PREV POLIC, V13, P281, DOI 10.1080/09687630600700111; TRAUTMANN F, 2008, DRUGS PROBLEM DRUG P; *UN, 2007, REP UN SPEC RAPP RIG; *UN, 2009, REP SPEC RAPP PREV T; *UN, 1996, 199615 UN; *UN EC SOC COUNC, 2000, COMM EC SOC CULT RIG; *UN EC SOC COUNC, 1984, ECN419844 UN EC SOC; *UN INT DRUG CONTR, 2002, E1NCB2002W13SS5 UN I; *UN INT OFF DRUGS, 2009, WORLD DRUG REP; *UN SECR GEN, 1995, E199578 UN NAT SECR; United Nations, 2008, INT COV CIV POL RIGH; UNODC, 2004, SUBST AB TREATM CAR; *UNODC, 2008, HIV AIDS PLAC DET TO; Upshur REG, 2002, CAN J PUBLIC HEALTH, V93, P101, DOI 10.1007/BF03404547; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; *WHO, 2006, HARM RED APPR INJ DR; *WHO, 2007, INT ADDR HIV PRIS DR; WHO Western Pacific Region, 2009, ASS COMP TREATM PEOP; WODAK A, 2004, ILLICIT DRUG POLICIE; WOLFE D, 2004, ILLICIT DRUG POLITIC; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2004, CAN MED ASSOC J, V170, P1551, DOI 10.1503/cmaj.1031928; Wood E, 2003, J URBAN HEALTH, V80, P455, DOI 10.1093/jurban/jtg052; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed; World Health Organisation (WHO) Joint United Nations Programme on HIV/AIDS (UNAIDs), 2006, HIVAIDS PREVENTION C; World Health Organization, 2009, ACC CONTR MED PROGR	136	127	130	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					475	485		10.1016/S0140-6736(10)60830-6	http://dx.doi.org/10.1016/S0140-6736(10)60830-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639YK	20650514				2022-12-28	WOS:000281012900032
J	Kleinert, S				Kleinert, Sabine			Singapore embraces international research integrity	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Kleinert, S (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2010, 2 WORLD C RES INT JU; [Anonymous], 2008, NATURE, V454, P917; BATY P, 2010, TIMES HIGHER ED 0722; *ESF MEMB ORG FOR, 2010, FOST RES INT EUR EX; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; Vogel G, 2006, SCIENCE, V312, P516, DOI 10.1126/science.312.5773.516; INDEPENDENT CLIMATE; ESF ORI 1 WORLD C RE	8	4	4	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 7	2010	376	9739					400	401		10.1016/S0140-6736(10)61201-9	http://dx.doi.org/10.1016/S0140-6736(10)61201-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639YK	20692515				2022-12-28	WOS:000281012900009
J	Chen, YL; Chu, JH; Analytis, JG; Liu, ZK; Igarashi, K; Kuo, HH; Qi, XL; Mo, SK; Moore, RG; Lu, DH; Hashimoto, M; Sasagawa, T; Zhang, SC; Fisher, IR; Hussain, Z; Shen, ZX				Chen, Y. L.; Chu, J. -H.; Analytis, J. G.; Liu, Z. K.; Igarashi, K.; Kuo, H. -H.; Qi, X. L.; Mo, S. K.; Moore, R. G.; Lu, D. H.; Hashimoto, M.; Sasagawa, T.; Zhang, S. C.; Fisher, I. R.; Hussain, Z.; Shen, Z. X.			Massive Dirac Fermion on the Surface of a Magnetically Doped Topological Insulator	SCIENCE			English	Article							HGTE QUANTUM-WELLS; BI2TE3; SB2TE3; CONE	In addition to a bulk energy gap, topological insulators accommodate a conducting, linearly dispersed Dirac surface state. This state is predicted to become massive if time reversal symmetry is broken, and to become insulating if the Fermi energy is positioned inside both the surface and bulk gaps. We introduced magnetic dopants into the three-dimensional topological insulator dibismuth triselenide (Bi(2)Se(3)) to break the time reversal symmetry and further position the Fermi energy inside the gaps by simultaneous magnetic and charge doping. The resulting insulating massive Dirac fermion state, which we observed by angle-resolved photoemission, paves the way for studying a range of topological phenomena relevant to both condensed matter and particle physics.	[Chen, Y. L.; Chu, J. -H.; Analytis, J. G.; Liu, Z. K.; Kuo, H. -H.; Qi, X. L.; Moore, R. G.; Lu, D. H.; Zhang, S. C.; Fisher, I. R.; Shen, Z. X.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Chen, Y. L.; Chu, J. -H.; Analytis, J. G.; Liu, Z. K.; Kuo, H. -H.; Qi, X. L.; Hashimoto, M.; Zhang, S. C.; Fisher, I. R.; Shen, Z. X.] Stanford Univ, Geballe Lab Adv Mat, Dept Phys, Stanford, CA 94305 USA; [Chen, Y. L.; Chu, J. -H.; Analytis, J. G.; Liu, Z. K.; Kuo, H. -H.; Qi, X. L.; Hashimoto, M.; Zhang, S. C.; Fisher, I. R.; Shen, Z. X.] Stanford Univ, Geballe Lab Adv Mat, Dept Appl Phys, Stanford, CA 94305 USA; [Chen, Y. L.; Mo, S. K.; Hashimoto, M.; Hussain, Z.] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [Igarashi, K.; Sasagawa, T.] Tokyo Inst Technol, Mat & Struct Lab, Kanagawa 2268503, Japan	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tokyo Institute of Technology	Shen, ZX (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.	zxshen@stanford.edu	Mo, Sung-Kwan/F-3489-2013; Hussain, Zahid/HGU-8912-2022; Chen, Yulin/C-1918-2012; analytis, james/ABE-6100-2020; Sasagawa, Takao/E-6666-2014; Moore, Rob/CAG-8039-2022; Zhang, Shou-Cheng/B-2794-2010; Qi, Xiaoliang/F-9245-2010; Chu, Jiun-Haw/B-1613-2012	Mo, Sung-Kwan/0000-0003-0711-8514; Hussain, Zahid/0000-0003-4989-6496; analytis, james/0000-0002-7657-7688; Sasagawa, Takao/0000-0003-0149-6696; Moore, Rob/0000-0002-1608-5411; Qi, Xiaoliang/0000-0003-0388-5003; Chu, Jiun-Haw/0000-0001-6222-1210; Hashimoto, Makoto/0000-0003-1689-8997; Fisher, Ian/0000-0002-1278-7862	Department of Energy, Office of Basic Energy Science [DE-AC02-76SF00515]	Department of Energy, Office of Basic Energy Science(United States Department of Energy (DOE))	Supported by the Department of Energy, Office of Basic Energy Science, under contract DE-AC02-76SF00515.	Akhmerov AR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216404; Alpichshev Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016401; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Choi J, 2004, PHYS STATUS SOLIDI B, V241, P1541, DOI 10.1002/pssb.200304527; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266801; Fu L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216403; Hor YS, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195203; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lee WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245439; Liu Q, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156603; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Qi XL, 2009, SCIENCE, V323, P1184, DOI 10.1126/science.1167747; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Roy R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195321; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Seradjeh B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.066402; Wilczek Frank, 2009, Nature, V458, P129, DOI 10.1038/458129e; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Zang JD, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245125; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhou XT, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245317	25	904	920	7	426	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					659	662		10.1126/science.1189924	http://dx.doi.org/10.1126/science.1189924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689013	Green Submitted			2022-12-28	WOS:000280602700032
J	Vervack, RJ; McClintock, WE; Killen, RM; Sprague, AL; Anderson, BJ; Burger, MH; Bradley, ET; Mouawad, N; Solomon, SC; Izenberg, NR				Vervack, Ronald J., Jr.; McClintock, William E.; Killen, Rosemary M.; Sprague, Ann L.; Anderson, Brian J.; Burger, Matthew H.; Bradley, E. Todd; Mouawad, Nelly; Solomon, Sean C.; Izenberg, Noam R.			Mercury's Complex Exosphere: Results from MESSENGER's Third Flyby	SCIENCE			English	Article							SOLAR-WIND INTERACTION; MAGNETOSPHERE; SODIUM; SURFACE; ACCELERATION; ATMOSPHERE; DISCOVERY; EMISSION; MISSION; CALCIUM	During MESSENGER's third flyby of Mercury, the Mercury Atmospheric and Surface Composition Spectrometer detected emission from ionized calcium concentrated 1 to 2 Mercury radii tailward of the planet. This measurement provides evidence for tailward magnetospheric convection of photoions produced inside the magnetosphere. Observations of neutral sodium, calcium, and magnesium above the planet's north and south poles reveal altitude distributions that are distinct for each species. A two-component sodium distribution and markedly different magnesium distributions above the two poles are direct indications that multiple processes control the distribution of even single species in Mercury's exosphere.	[Vervack, Ronald J., Jr.; Anderson, Brian J.; Izenberg, Noam R.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [McClintock, William E.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Killen, Rosemary M.; Burger, Matthew H.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Sprague, Ann L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Bradley, E. Todd] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Mouawad, Nelly] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; State University System of Florida; University of Central Florida; University System of Maryland; University of Maryland College Park; Carnegie Institution for Science	Vervack, RJ (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	Ron.Vervack@jhuapl.edu	Izenberg, Noam R/F-3952-2015; Anderson, Brian J/I-8615-2012; Vervack, Ronald J/C-2702-2016; Killen, Rosemary M/E-7127-2012; Mouawad, Nelly/AAH-5398-2020	Izenberg, Noam R/0000-0003-1629-6478; Vervack, Ronald J/0000-0002-8227-9564; Mouawad, Nelly/0000-0003-1609-5625	NASA [NAS5-97271, NASW-00002]; MESSENGER Participating Scientist Program	NASA(National Aeronautics & Space Administration (NASA)); MESSENGER Participating Scientist Program	We thank M. Lankton and M. Kochte for their contributions to the acquisition and analysis of the data reported here and J. Slavin and D. Blewett for insightful comments. The MESSENGER project is supported by the NASA Discovery Program under contracts NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington. R. J. V., R. M. K., and A. L. S. are supported by the MESSENGER Participating Scientist Program.	Bida TA, 2000, NATURE, V404, P159, DOI 10.1038/35004521; Delcourt DC, 2003, ANN GEOPHYS-GERMANY, V21, P1723, DOI 10.5194/angeo-21-1723-2003; Delcourt DC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013829; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; Fujimoto M, 2007, SPACE SCI REV, V132, P529, DOI 10.1007/s11214-007-9245-8; Fulle M, 2007, ASTROPHYS J, V661, pL93, DOI 10.1086/518719; Ip WH, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA009171; Killen R, 2009, ASTROPHYS J SUPPL S, V181, P351, DOI 10.1088/0067-0049/181/2/351; Killen RM, 2005, ICARUS, V173, P300, DOI 10.1016/j.icarus.2004.08.022; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Leblanc F, 2007, PLANET SPACE SCI, V55, P1069, DOI 10.1016/j.pss.2006.11.008; McClintock WE, 2008, SCIENCE, V321, P92, DOI 10.1126/science.1159467; McClintock WE, 2007, SPACE SCI REV, V131, P481, DOI 10.1007/s11214-007-9264-5; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; Potter AE, 2008, ICARUS, V194, P1, DOI 10.1016/j.icarus.2007.09.023; Potter AE, 2007, ICARUS, V186, P571, DOI 10.1016/j.icarus.2006.09.025; Prockter LM, 2010, SCIENCE, V329, P668, DOI 10.1126/science.1188186; Slavin JA, 2010, SCIENCE, V329, P665, DOI 10.1126/science.1188067; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; SMYTH WH, 1995, ASTROPHYS J, V441, P839, DOI 10.1086/175407; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; SPRAGUE AL, 1992, J GEOPHYS RES-PLANET, V97, P18257, DOI 10.1029/92JE01690; SPRAGUE AL, 1992, ICARUS, V96, P27, DOI 10.1016/0019-1035(92)90004-Q	24	64	64	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					672	675		10.1126/science.1188572	http://dx.doi.org/10.1126/science.1188572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20647427				2022-12-28	WOS:000280602700036
J	Brook, RH				Brook, Robert H.			Medical Leadership in an Increasingly Complex World	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									RAND Hlth, Santa Monica, CA 90401 USA	RAND Corporation	Brook, RH (corresponding author), RAND Hlth, 1776 Main St,POB 2138, Santa Monica, CA 90401 USA.	robert_brook@rand.org						Bazelle R, NEW PROSTATE CANC TR; *I RECH DOC EC SAN, 2009, OECD HLTH DAT 2009 S; Marmot Michael, 2009, Glob Health Promot, VSuppl 1, P23, DOI 10.1177/1757975909103742; Yeats W. B., 1920, M ROBARTES DANCER	4	24	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					465	466		10.1001/jama.2010.1049	http://dx.doi.org/10.1001/jama.2010.1049			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664049				2022-12-28	WOS:000280350100032
J	Chan, SL; Mok, T				Chan, Stephen L.; Mok, Tony			PARP inhibition in BRCA-mutated breast and ovarian cancers	LANCET			English	Editorial Material							POLY(ADP-RIBOSE) POLYMERASE; PHASE-III; TUMORS		[Chan, Stephen L.] Chinese Univ Hong Kong, State Key Lab S China, Sir YK Pao Ctr Canc, Dept Clin Oncol,Hong Kong Canc Inst, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, SL (corresponding author), Chinese Univ Hong Kong, State Key Lab S China, Sir YK Pao Ctr Canc, Dept Clin Oncol,Hong Kong Canc Inst, Hong Kong, Hong Kong, Peoples R China.	l_chan@clo.cuhk.edu.hk	Mok, Tony Shu Kam/B-2310-2019; Chan, Stephen Lam/F-9149-2011	Mok, Tony Shu Kam/0000-0002-8251-0551; Chan, Stephen Lam/0000-0001-8998-5480				Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bang Y, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.3; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gelmon KA, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3002; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Harvey V, 2006, J CLIN ONCOL, V24, P4963, DOI 10.1200/JCO.2005.05.0294; Karlan BY, 2003, GYNECOL ONCOL, V88, pS11, DOI 10.1006/gyno.2002.6675; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6	17	41	44	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					211	213		10.1016/S0140-6736(10)61119-1	http://dx.doi.org/10.1016/S0140-6736(10)61119-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20656109				2022-12-28	WOS:000280457200006
J	Moore, CI; Carlen, M; Knoblich, U; Cardin, JA				Moore, Christopher I.; Carlen, Marie; Knoblich, Ulf; Cardin, Jessica A.			Neocortical Interneurons: From Diversity, Strength	CELL			English	Article							RAT SOMATOSENSORY CORTEX; GAMMA-OSCILLATIONS; CORTICAL INTERNEURONS; BASKET CELLS; INHIBITION; NETWORKS; DYNAMICS; HIPPOCAMPUS; NEURONS; SCHIZOPHRENIA		[Moore, Christopher I.; Carlen, Marie; Knoblich, Ulf; Cardin, Jessica A.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cim@mit.edu	Carlen, Marie Carlen/C-9112-2014; Knoblich, Ulf/A-1762-2010	Carlen, Marie Carlen/0000-0003-1658-1631; Knoblich, Ulf/0000-0002-0756-5587; Moore, Christopher/0000-0003-4534-1602	NINDS NIH HHS [R01 NS045130] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Moore CI, 2008, J NEUROPHYSIOL, V99, P2035, DOI 10.1152/jn.01366.2006; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	42	63	63	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					184	188		10.1016/j.cell.2010.07.005	http://dx.doi.org/10.1016/j.cell.2010.07.005			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655460	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000280204300008
J	Cai, JM; Ruffieux, P; Jaafar, R; Bieri, M; Braun, T; Blankenburg, S; Muoth, M; Seitsonen, AP; Saleh, M; Feng, XL; Mullen, K; Fasel, R				Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Muoth, Matthias; Seitsonen, Ari P.; Saleh, Moussa; Feng, Xinliang; Muellen, Klaus; Fasel, Roman			Atomically precise bottom-up fabrication of graphene nanoribbons	NATURE			English	Article							CARBON; FORM	Graphene nanoribbons-narrow and straight-edged stripes of graphene, or single-layer graphite-are predicted to exhibit electronic properties that make them attractive for the fabrication of nanoscale electronic devices(1-3). In particular, although the twodimensional parent material graphene(4,5) exhibits semimetallic behaviour, quantum confinement and edge effects(2,6) should render all graphene nanoribbons with widths smaller than 10 nm semiconducting. But exploring the potential of graphene nanoribbons is hampered by their limited availability: although they have been made using chemical(7-9), sonochemical(10) and lithographic(11,12) methods as well as through the unzipping of carbon nanotubes(13-16), the reliable production of graphene nanoribbons smaller than 10 nm with chemical precision remains a significant challenge. Here we report a simple method for the production of atomically precise graphene nanoribbons of different topologies and widths, which uses surface-assisted coupling(17,18) of molecular precursors into linear polyphenylenes and their subsequent cyclodehydrogenation(19,20). The topology, width and edge periphery of the graphene nanoribbon products are defined by the structure of the precursor monomers, which can be designed to give access to a wide range of different graphene nanoribbons. We expect that our bottom-up approach to the atomically precise fabrication of graphene nanoribbons will finally enable detailed experimental investigations of the properties of this exciting class of materials. It should even provide a route to graphene nanoribbon structures with engineered chemical and electronic properties, including the theoretically predicted intraribbon quantum dots(21), superlattice structures(22) and magnetic devices based on specific graphene nanoribbon edge states(3).	[Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-3602 Thun, Switzerland; [Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-8600 Dubendorf, Switzerland; [Muoth, Matthias] ETH, Dept Mech & Proc Engn Micro & Nanosyst, CH-8092 Zurich, Switzerland; [Seitsonen, Ari P.] Univ Zurich, Inst Phys Chem, CH-8057 Zurich, Switzerland; [Seitsonen, Ari P.] CNRS, IMPMC, F-75252 Paris, France; [Seitsonen, Ari P.] Univ Paris 06, F-75252 Paris, France; [Saleh, Moussa; Feng, Xinliang; Muellen, Klaus] Max Planck Inst Polymer Res, D-55124 Mainz, Germany; [Fasel, Roman] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; University of Bern	Fasel, R (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-3602 Thun, Switzerland.	muellen@mpip-mainz.mpg.de; roman.fasel@empa.ch	Seitsonen, Ari P/B-1552-2009; cai, jinming/G-7604-2015; Ruffieux, Pascal/E-8227-2010; Fasel, Roman/M-9992-2019; Fasel, Roman/B-5396-2011	Seitsonen, Ari P/0000-0003-4331-0650; cai, jinming/0000-0003-0869-1515; Ruffieux, Pascal/0000-0001-5729-5354; Fasel, Roman/0000-0002-1553-6487; Fasel, Roman/0000-0002-1553-6487; Bieri, Marco/0000-0002-9831-2146; Feng, Xinliang/0000-0003-3885-2703	Swiss National Science Foundation; NCCR Nanoscale Science; Max Planck Society; German Science Foundation (Korean-German IRTG); DFG [SPP 1355, DFG MU 334/32-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Nanoscale Science(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation (Korean-German IRTG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation and the NCCR Nanoscale Science. R.F. and P.R. thank O. Groning and P. Groning for stimulating discussions and continued support. A. P. S. acknowledges discussions with F. Mauri and M. Lazzeri. The Mainz group acknowledges financial support from the Max Planck Society through the program ENERCHEM, the German Science Foundation (Korean-German IRTG), the DFG Priority Program SPP 1355 and DFG MU 334/32-1.	Barone V, 2006, NANO LETT, V6, P2748, DOI 10.1021/nl0617033; BRIGGS D, 1992, HIGH RESOLUTION XPS; Caldwell JD, 2010, ACS NANO, V4, P1108, DOI 10.1021/nn901585p; Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d; Canas-Ventura ME, 2007, ANGEW CHEM INT EDIT, V46, P1814, DOI 10.1002/anie.200604083; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Classen T, 2005, ANGEW CHEM INT EDIT, V44, P6142, DOI 10.1002/anie.200502007; Datta SS, 2008, NANO LETT, V8, P1912, DOI 10.1021/nl080583r; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Gourdon A, 2008, ANGEW CHEM INT EDIT, V47, P6950, DOI 10.1002/anie.200802229; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Huang L, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/34/344203; Jiao LY, 2010, NAT NANOTECHNOL, V5, P321, DOI [10.1038/NNANO.2010.54, 10.1038/nnano.2010.54]; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Elias AL, 2010, NANO LETT, V10, P366, DOI 10.1021/nl901631z; Lee Y, 2010, NANO LETT, V10, P490, DOI 10.1021/nl903272n; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Otero G, 2008, NATURE, V454, P865, DOI 10.1038/nature07193; Rim KT, 2007, ANGEW CHEM INT EDIT, V46, P7891, DOI 10.1002/anie.200701117; Sevincli H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245402; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Vandescuren M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195401; Wakabayashi K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125428; Yang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.186801; Yang XY, 2008, J AM CHEM SOC, V130, P4216, DOI 10.1021/ja710234t	30	2602	2675	57	2189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					470	473		10.1038/nature09211	http://dx.doi.org/10.1038/nature09211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	628SJ	20651687				2022-12-28	WOS:000280141200031
J	Chang, TC; Pen, UL; Bandura, K; Peterson, JB				Chang, Tzu-Ching; Pen, Ue-Li; Bandura, Kevin; Peterson, Jeffrey B.			An intensity map of hydrogen 21-cm emission at redshift z approximate to 0.8	NATURE			English	Article							GALAXIES	Observations of 21-cm radio emission by neutral hydrogen at redshifts z approximate to 0.5 to similar to 2.5 are expected to provide a sensitive probe of cosmic dark energy(1,2). This is particularly true around the onset of acceleration at z approximate to 1, where traditional optical cosmology becomes very difficult because of the infrared opacity of the atmosphere. Hitherto, 21-cm emission has been detected(3) only to z = 0.24. More distant galaxies generally are too faint for individual detections but it is possible to measure the aggregate emission from many unresolved galaxies in the 'cosmic web'. Here we report a three-dimensional 21-cm intensity field at z=0.53 to 1.12. We then co-add neutral-hydrogen (H I) emission from the volumes surrounding about 10,000 galaxies (from the DEEP2 optical galaxy redshift survey(4)). We detect the aggregate 21-cm glow at a significance of 4s.	[Chang, Tzu-Ching] Acad Sinica, IAA, Taipei 10617, Taiwan; [Chang, Tzu-Ching; Pen, Ue-Li] Univ Toronto, CITA, Toronto, ON M5S 3H8, Canada; [Bandura, Kevin; Peterson, Jeffrey B.] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA	Academia Sinica - Taiwan; University of Toronto; Carnegie Mellon University	Chang, TC (corresponding author), Acad Sinica, IAA, POB 23-141, Taipei 10617, Taiwan.	tchang@cita.utoronto.ca	Pen, Ue-Li/GWV-1294-2022; Peterson, Jeffrey/O-4794-2014	Pen, Ue-Li/0000-0003-2155-9578; Peterson, Jeffrey/0000-0003-1340-818X; Bandura, Kevin/0000-0003-3772-2798; Chang, Tzu-Ching/0000-0001-5929-4187	NSERC; NSF; NRAO	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NRAO	We are grateful to the GBT support staff, in particular T. Minter and P. Ruffle, for their help with the observation. We thank K. Blagrave, O. Dore, P. McDonald, J. Sievers, K. Sigurdson and R. Yen for discussions. We acknowledge financial support by NSERC, NSF and NRAO. The NRAO is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc.	Chang TC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.091303; Coil AL, 2004, ASTROPHYS J, V609, P525, DOI 10.1086/421337; Davis M, 2001, ESO ASTROPHY SYMP, P241, DOI 10.1007/10854354_66; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Lah P, 2007, MON NOT R ASTRON SOC, V376, P1357, DOI 10.1111/j.1365-2966.2007.11540.x; Loeb A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.161301; Madgwick DS, 2003, MON NOT R ASTRON SOC, V344, P847, DOI 10.1046/j.1365-8711.2003.06861.x; MASUI KW, 2010, NEAR TERM MEASUREMEN; Pen UL, 2009, MON NOT R ASTRON SOC, V399, P181, DOI [10.1111/j.1365-2966.2009.14980.x, 10.1111/j.1365-2966.2009.149S0.X]; Prochaska JX, 2009, ASTROPHYS J, V696, P1543, DOI 10.1088/0004-637X/696/2/1543; Rao SM, 2006, ASTROPHYS J, V636, P610, DOI 10.1086/498132; Zwaan MA, 2005, MON NOT R ASTRON SOC, V359, pL30, DOI 10.1111/j.1745-3933.2005.00029.x	12	246	253	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					463	465		10.1038/nature09187	http://dx.doi.org/10.1038/nature09187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651685				2022-12-28	WOS:000280141200029
J	Pedchenko, V; Bondar, O; Fogo, AB; Vanacore, R; Voziyan, P; Kitching, AR; Wieslander, J; Kashtan, C; Borza, DB; Neilson, EG; Wilson, CB; Hudson, BG				Pedchenko, Vadim; Bondar, Olga; Fogo, Agnes B.; Vanacore, Roberto; Voziyan, Paul; Kitching, A. Richard; Wieslander, Joergen; Kashtan, Clifford; Borza, Dorin-Bogdan; Neilson, Eric G.; Wilson, Curtis B.; Hudson, Billy G.			Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM Nephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BASEMENT-MEMBRANE ANTIBODY; IV COLLAGEN; ALPHA-3 CHAIN; GRAVES-DISEASE; RENAL-TRANSPLANTATION; NONCOLLAGENOUS DOMAIN; CRYPTIC EPITOPES; IMMUNE PRIVILEGE; ALPORT-SYNDROME; NC1 DOMAIN	BACKGROUND In Goodpasture's disease, circulating autoantibodies bind to the noncollagenous-1 (NC1) domain of type IV collagen in the glomerular basement membrane (GBM). The specificity and molecular architecture of epitopes of tissue-bound autoantibodies are unknown. Alport's post-transplantation nephritis, which is mediated by allo-antibodies against the GBM, occurs after kidney transplantation in some patients with Alport's syndrome. We compared the conformations of the antibody epitopes in Goodpasture's disease and Alport's post-transplantation nephritis with the intention of finding clues to the pathogenesis of anti-GBM glomerulonephritis. METHODS We used an enzyme-linked immunosorbent assay to determine the specificity of circulating autoantibodies and kidney-bound antibodies to NC1 domains. Circulating antibodies were analyzed in 57 patients with Goodpasture's disease, and kidney-bound antibodies were analyzed in 14 patients with Goodpasture's disease and 2 patients with Alport's post-transplantation nephritis. The molecular architecture of key epitope regions was deduced with the use of chimeric molecules and a three-dimensional model of the alpha 345NC1 hexamer. RESULTS In patients with Goodpasture's disease, both autoantibodies to the alpha 3NC1 monomer and antibodies to the alpha 5NC1 monomer (and fewer to the alpha 4NC1 monomer) were bound in the kidneys and lungs, indicating roles for the alpha 3NC1 and alpha 5NC1 monomers as autoantigens. High antibody titers at diagnosis of anti-GBM disease were associated with ultimate loss of renal function. The antibodies bound to distinct epitopes encompassing region Ea in the alpha 5NC1 monomer and regions E-A and Eb in the alpha 3NC1 monomer, but they did not bind to the native cross-linked alpha 345NC1 hexamer. In contrast, in patients with Alport's post-transplantation nephritis, allo-antibodies bound to the E-A region of the alpha 5NC1 subunit in the intact hexamer, and binding decreased on dissociation. CONCLUSIONS The development of Goodpasture's disease may be considered an autoimmune "conformeropathy" that involves perturbation of the quaternary structure of the alpha 345NC1 hexamer, inducing a pathogenic conformational change in the alpha 3NC1 and alpha 5NC1 subunits, which in turn elicits an autoimmune response.	[Pedchenko, Vadim; Bondar, Olga; Fogo, Agnes B.; Vanacore, Roberto; Voziyan, Paul; Borza, Dorin-Bogdan; Neilson, Eric G.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Div Nephrol, Ctr Matrix Biol,Dept Med, Nashville, TN 37232 USA; [Fogo, Agnes B.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Fogo, Agnes B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Kitching, A. Richard] Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [Wieslander, Joergen] Univ Lund Hosp, Dept Nephrol, S-22185 Lund, Sweden; [Kashtan, Clifford] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Wilson, Curtis B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Monash University; Lund University; Skane University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, Ctr Matrix Biol,Dept Med, S 3223 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020; Kitching, A Richard/B-6947-2013; Borza, Dorin-Bogdan/AAF-2156-2020; Vanacore, Roberto/C-9763-2012	Vanacore, Roberto/0000-0002-2886-0606; Kitching, A Richard/0000-0002-2713-2391; Borza, Dorin-Bogdan/0000-0003-4568-279X; Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	National Institute of Diabetes and Digestive and Kidney Diseases [DK18381-37]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080799, R37DK018381, R01DK018381] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant (DK18381-37) from the National Institute of Diabetes and Digestive and Kidney Diseases (to Dr. Hudson). Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Abbate M, 1998, KIDNEY INT, V54, P1550, DOI 10.1046/j.1523-1755.1998.00153.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bondar O, 2002, J AM SOC NEPHROL, V13, p173A; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Calvete JJ, 2006, PROTEOMICS, V6, pS237, DOI 10.1002/pmic.200500495; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Clyne S, 2009, AM J KIDNEY DIS, V54, P1116, DOI 10.1053/j.ajkd.2009.04.026; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; GUNWAR S, 1991, J BIOL CHEM, V266, P14088; HELLMARK T, 1994, KIDNEY INT, V46, P823, DOI 10.1038/ki.1994.338; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kalluri R, 1996, J BIOL CHEM, V271, P9062, DOI 10.1074/jbc.271.15.9062; Kalluri R, 1996, P ASSOC AM PHYSICIAN, V108, P134; KALLURI R, 1994, P NATL ACAD SCI USA, V91, P6201, DOI 10.1073/pnas.91.13.6201; KALLURI R, 1995, J AM SOC NEPHROL, V6, P1178; Kang JS, 2007, J BIOL CHEM, V282, P10670, DOI 10.1074/jbc.M611892200; Kasahara H, 2005, INT IMMUNOL, V17, P1533, DOI 10.1093/intimm/dxh330; Kashtan CE, 2006, PEDIATR TRANSPLANT, V10, P651, DOI 10.1111/j.1399-3046.2006.00528.x; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; MARQUARDT H, 1973, KIDNEY INT, V3, P57, DOI 10.1038/ki.1973.12; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Sado Y, 1998, KIDNEY INT, V54, P311; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAXENA R, 1989, CLIN EXP IMMUNOL, V78, P31; Schott M, 2005, TRENDS ENDOCRIN MET, V16, P243, DOI 10.1016/j.tem.2005.05.009; Segelmark M, 2003, NEPHRON CLIN PRACT, V94, pC59, DOI 10.1159/000072022; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Zhao J, 2009, KIDNEY INT, V76, P1108, DOI 10.1038/ki.2009.348	40	214	225	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					343	354		10.1056/NEJMoa0910500	http://dx.doi.org/10.1056/NEJMoa0910500			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660402	Green Accepted			2022-12-28	WOS:000280139300007
J	Seymour, JR; Simo, R; Ahmed, T; Stocker, R				Seymour, Justin R.; Simo, Rafel; Ahmed, Tanvir; Stocker, Roman			Chemoattraction to Dimethylsulfoniopropionate Throughout the Marine Microbial Food Web	SCIENCE			English	Article							CHEMICAL DEFENSE; DIMETHYL SULFIDE; OXYRRHIS-MARINA; DMSP; CHEMOTAXIS; SULFUR; BEHAVIOR; PLANKTON; ECOLOGY; FLUX	Phytoplankton-produced dimethylsulfoniopropionate (DMSP) provides underwater and atmospheric foraging cues for several species of marine invertebrates, fish, birds, and mammals. However, its role in the chemical ecology of marine planktonic microbes is largely unknown, and there is evidence for contradictory functions. By using microfluidics and image analysis of swimming behavior, we observed attraction toward microscale pulses of DMSP and related compounds among several motile strains of phytoplankton, heterotrophic bacteria, and bacterivore and herbivore microzooplankton. Because microbial DMSP cycling is the main natural source of cloud-forming sulfur aerosols, our results highlight how adaptations to microscale chemical seascapes shape planktonic food webs, while potentially influencing climate at the global scale.	[Seymour, Justin R.; Ahmed, Tanvir; Stocker, Roman] MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Seymour, Justin R.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Seymour, Justin R.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Simo, Rafel] CSIC, ICM, Barcelona 08003, Catalonia, Spain	Massachusetts Institute of Technology (MIT); Flinders University South Australia; University of Technology Sydney; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Seymour, JR (corresponding author), MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	Justin.Seymour@uts.edu.au	Stocker, Roman/T-9456-2017; Ahmed, Tanvir/AAL-3026-2020; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; Simo, Rafel/0000-0003-3276-7663; Seymour, Justin/0000-0002-3745-6541	Australian Research Council [DP0772186]; Martin Fellowship for Sustainability; Spanish Ministry of Science and Innovation; La Cambra de Barcelona; Hayashi Fund; NSF;  [OCE-0744641-CAREER]	Australian Research Council(Australian Research Council); Martin Fellowship for Sustainability; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); La Cambra de Barcelona; Hayashi Fund; NSF(National Science Foundation (NSF)); 	This research was funded by Australian Research Council grant DP0772186 to J.R.S., a Martin Fellowship for Sustainability to T. A., the Spanish Ministry of Science and Innovation project SUMMER to R. Si., funding from La Cambra de Barcelona to R. Si. and R. S., and support from the Hayashi Fund, a Doherty Professorship and NSF grant OCE-0744641-CAREER to R. S. We thank P. Jimenez and A. Calbet for growing and providing O. marina, W. M. Durham for preparing M. pusilla, Marcos for preparing N. designis, and R. Belas for providing Silicibacter. We thank S. Strom and J. G. Mitchell for comments on an earlier version of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; DeBose JL, 2008, SCIENCE, V319, P1356, DOI 10.1126/science.1151109; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; FUSE H, 1995, BIOSCI BIOTECH BIOCH, V59, P1773, DOI 10.1271/bbb.59.1773; Hartz AJ, 2008, J EUKARYOT MICROBIOL, V55, P18, DOI 10.1111/j.1550-7408.2007.00297.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 2006, LIMNOL OCEANOGR-METH, V4, P80, DOI 10.4319/lom.2006.4.80; LEDYARD KM, 1993, ARCH MICROBIOL, V160, P312, DOI 10.1007/BF00292083; Malmstrom RR, 2005, LIMNOL OCEANOGR, V50, P1924, DOI 10.4319/lo.2005.50.6.1924; Miller TR, 2004, APPL ENVIRON MICROB, V70, P4692, DOI 10.1128/AEM.70.8.4692-4701.2004; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Salo V, 2009, ENVIRON MICROBIOL, V11, P3063, DOI 10.1111/j.1462-2920.2009.02011.x; Seymour JR, 2008, LIMNOL OCEANOGR-METH, V6, P477, DOI 10.4319/lom.2008.6.477; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Simo R, 2009, AQUAT MICROB ECOL, V57, P43, DOI 10.3354/ame01325; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Strom S, 2003, LIMNOL OCEANOGR, V48, P230, DOI 10.4319/lo.2003.48.1.0230; Van Alstyne KL, 2001, MAR ECOL PROG SER, V213, P53, DOI 10.3354/meps213053; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Welsh DT, 2000, FEMS MICROBIOL REV, V24, P263, DOI 10.1111/j.1574-6976.2000.tb00542.x; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; Wolfe GV, 2000, BIOL BULL-US, V198, P225, DOI 10.2307/1542526; ZimmerFaust RK, 1996, LIMNOL OCEANOGR, V41, P1330, DOI 10.4319/lo.1996.41.6.1330	30	245	249	5	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					342	345		10.1126/science.1188418	http://dx.doi.org/10.1126/science.1188418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647471				2022-12-28	WOS:000279925900048
J	Campbell, NRC; Legowski, B; Legetic, B				Campbell, Norm R. C.; Legowski, Barbara; Legetic, Branka			Mobilising the Americas for dietary salt reduction	LANCET			English	Editorial Material							HYPERTENSION; HEALTH		[Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Med, Calgary, AB T2N 4Z6, Canada; [Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada; [Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Pharmacol & Therapeut, Calgary, AB T2N 4Z6, Canada; [Legowski, Barbara; Legetic, Branka] PAHO Secretariat, Reg Expert Grp Cardiovasc Dis Prevent Dietary Sal, Washington, DC USA; [Legetic, Branka] PAHO, Unit Noncommunicable Dis, Washington, DC USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Pan American Health Organization	Campbell, NRC (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Dept Med, Calgary, AB T2N 4Z6, Canada.	ncampbel@ucalgary.ca						Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; *GOV BARB, 2009, SALT RED HIGH CNCD C; *HLTH CAN, ISS SOD; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; MATTES RD, 1991, J AM COLL NUTR, V10, P383; *MIN HLTH ARG, 2009, MIN HLTH LAUNCH CAMP; *MIN HLTH CHIL, GLOB STRAT OB EGO CH; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; *PAN AM HLTH ORG, 2009, CARD DIS PREV DIET S; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Sanchez RA, 2009, J HYPERTENS, V27, P905, DOI 10.1097/HJH.0b013e32832aa6d2; *SECR HLTH MEX, 2010, NAT NUTR HLTH STRAT; 2010, LANCET, V375, P254	13	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					793	795		10.1016/S0140-6736(10)60489-8	http://dx.doi.org/10.1016/S0140-6736(10)60489-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	20663548				2022-12-28	WOS:000288628500009
J	Medina, PP; Nolde, M; Slack, FJ				Medina, Pedro P.; Nolde, Mona; Slack, Frank J.			OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma	NATURE			English	Article							ONCOGENE ADDICTION; EXPRESSION; CANCER; MICRORNAS; PROGNOSIS; INVASION; MIR-21; MYC	MicroRNAs (miRNAs) belong to a recently discovered class of small RNA molecules that regulate gene expression at the post-transcriptional level. miRNAs have crucial functions in the development and establishment of cell identity, and aberrant metabolism or expression of miRNAs has been linked to human diseases, including cancer(1). Components of the miRNA machinery and miRNAs themselves are involved in many cellular processes that are altered in cancer, such as differentiation, proliferation and apoptosis. Some miRNAs, referred to as oncomiRs(2), show differential expression levels in cancer and are able to affect cellular transformation, carcinogenesis and metastasis, acting either as oncogenes or tumour suppressors. The phenomenon of 'oncogene addiction' reveals that despite the multistep nature of tumorigenesis, targeting of certain single oncogenes can have therapeutic value(3,4), and the possibility of oncomiR addiction has been proposed but never demonstrated(3). MicroRNA-21 (miR-21) is a unique miRNA in that it is overexpressed in most tumour types analysed so far. Despite great interest in miR-21, most of the data implicating it in cancer have been obtained through miRNA profiling and limited in vitro functional assays. To explore the role of miR-21 in cancer in vivo, we used Cre and Tet-off technologies to generate mice conditionally expressing miR-21. Here we show that overexpression of miR-21 leads to a pre-B malignant lymphoid-like phenotype, demonstrating that mir-21 is a genuine oncogene. When miR-21 was inactivated, the tumours regressed completely in a few days, partly as a result of apoptosis. These results demonstrate that tumours can become addicted to oncomiRs and support efforts to treat human cancers through pharmacological inactivation of miRNAs such as miR-21.	[Medina, Pedro P.; Nolde, Mona; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	frank.slack@yale.edu	Vico, Pedro Pablo Medina/D-1688-2013	Vico, Pedro Pablo Medina/0000-0002-7834-7093; Slack, Frank/0000-0001-8263-0409	Hope Funds for Cancer Research; James McDonnell Foundation; Yale Comprehensive Cancer Center	Hope Funds for Cancer Research; James McDonnell Foundation; Yale Comprehensive Cancer Center	We thank X. Liang for help in mouse colony maintenance and genotyping; D. Scavone and T. Nottoli for assistance with generating the transgenic mice; Yale rodent care staff M. Bonk, K. Mclaughlin, J. Graham, D. Clark; C. Zeiss, L. Johnson and G. Terwilliger for help with the necropsy/pathological analysis; and I. Babar, P. Trang and J. Sklar for critical reading of the manuscript. P. P. M. is the recipient of a Postdoctoral Fellowship from Hope Funds for Cancer Research. This work was funded by a grant from the James McDonnell Foundation to F. J. S. and J. B. Weidhaas, and a pilot grant from the Yale Comprehensive Cancer Center.	Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Imai Y, 2010, STEM CELLS DEV, V19, P461, DOI 10.1089/scd.2009.0251; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Mao JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni146; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; PENNYCOOK JL, 1993, J EXP MED, V178, P1007, DOI 10.1084/jem.178.3.1007; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; YOKOYAMA K, 1987, P NATL ACAD SCI USA, V84, P7363, DOI 10.1073/pnas.84.21.7363; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	30	731	808	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					86	U119		10.1038/nature09284	http://dx.doi.org/10.1038/nature09284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20693987				2022-12-28	WOS:000281461200040
J	Beyrer, C; Malinowska-Sempruch, K; Kamarulzaman, A; Kazatchkine, M; Sidibe, M; Strathdee, SA				Beyrer, Chris; Malinowska-Sempruch, Kasia; Kamarulzaman, Adeeba; Kazatchkine, Michel; Sidibe, Michel; Strathdee, Steffanie A.			HIV in people who use drugs 7 Time to act: a call for comprehensive responses to HIV in people who use drugs	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HARM REDUCTION; TREATMENT OUTCOMES; COST-EFFECTIVENESS; HEPATITIS-C; RISK; INCARCERATION; PREVALENCE; INFECTION; SEX	The published work on HIV in people who use drugs shows that the global burden of HIV infection in this group can he reduced. Concerted action by governments, multilateral organisations. health systems, and individuals could lead to enormous benefits for families, communities, and societies. We review the evidence and identify synergies between biomedical science, public health, and human rights. Cost-effective interventions, including needle and syringe exchange programmes, opioid substitution therapy, and expanded access to HIV treatment and care, are supported on public health and human rights grounds; however, only around 10% of people who use drugs worldwide are being reached. and far too many are imprisoned for minor offences or detained without trial. To change this situation will take commitment, advocacy, and political courage to advance the action agenda. Failure to do so will exacerbate the spread of HIV infection, undermine treatment programmes, and continue to expand prison populations with patients in need of care.	[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Malinowska-Sempruch, Kasia] Open Soc Inst, Drug Policy Program, Warsaw, Poland; [Kamarulzaman, Adeeba] Univ Malaya, Kuala Lumpur, Malaysia; [Kazatchkine, Michel] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Sidibe, Michel] UNAIDS, Geneva, Switzerland; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; UNAIDS; University of California System; University of California San Diego	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, 615 N Wolfe St,E 7152, Baltimore, MD 21205 USA.	cbeyrer@jhsph.edu	KAMARULZAMAN, ADEEBA/B-5216-2010; Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X	Open Society Institute; US National Institute on Drug Abuse [DA027772-S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023877, R01DA019829, R01DA027772] Funding Source: NIH RePORTER	Open Society Institute; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Series was funded by a grant from the Global Drug Policy Program of the Open Society Institute to CB's Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; and was funded in part by the US National Institute on Drug Abuse grant DA027772-S1, awarded to SAS's programme in Global Health at University of California, San Diego, CA, USA. We thank Chiara Bucello, Bradley Mathers, Louisa Degenhardt, and the members of the Reference Group to the UN on HIV and Injecting Drug Use for providing figure 1, Ralf Jurgens and Daniel Wolfe for thoughtful review, and Andrea Wirtz (Center for Public Health and Human Rights) for invaluable work on the report since its inception.	Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; AMON J, 2010, DARKNESS KNOWS LIMIT; [Anonymous], 2000, ACH BAL NAT OP CONTR; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Balakiryeva O, 2006, EVALUATION SIZE MOST; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Beyrer C, 2007, VACCINE, V25, P7014, DOI 10.1016/j.vaccine.2007.07.028; Beyrer C, 2009, AIDS RES HUM RETROV, V25, P853, DOI 10.1089/aid.2008.0206; *CDC, CDC TRIALS PREEXP PR; Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012; COLFAX G, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60753-2; CROFTS N, 1995, J DRUG ISSUES, V25, P599, DOI 10.1177/002204269502500306; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Gelmon L, 2009, KENYA HIV PREVENTION; GROVER A, 2009, INT C REAL RIGHTS HL; Guinness L, 2010, ADDICTION, V105, P319, DOI 10.1111/j.1360-0443.2009.02755.x; *HUM RIGHTS WATCH, 2009, HUM RIGHTS WATCH INT; Johnston L., 2008, 17 INT AIDS C MEX CI; JURGENS R, 2010, LANCET, DOI DOI 10.1016/S0140-6736(10)608304; Kamarulzaman A, 2010, INT J DRUG POLICY, V21, P115, DOI 10.1016/j.drugpo.2009.11.003; KATES J, 2008, FIN RESP AIDS LOW MI; Khan MR, 2009, J URBAN HEALTH, V86, P584, DOI 10.1007/s11524-009-9348-5; Kheirandish P, 2010, JAIDS-J ACQ IMM DEF, V53, P273, DOI 10.1097/QAI.0b013e3181be6dde; Kwon JA, 2009, JAIDS-J ACQ IMM DEF, V51, P462, DOI 10.1097/QAI.0b013e3181a2539a; LEVU S, 2010, 17 C RETR OPP INF SA; Lohman D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-8; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mauer M., 2007, UNEVEN JUSTICE STATE; MICHAEL N, 2010, 17 C RETR OPP INF SA; MUMOLA C, 2006, DRUG US DEP STAT FED; Niccolai LM, 2009, J URBAN HEALTH, V86, pS131, DOI 10.1007/s11524-009-9369-0; *PAIN POL STUD GRO, 2005, OP AV E EUR CENTR EU; Palepu A, 2004, ADDICTION, V99, P361, DOI 10.1111/j.1360-0443.2003.00670.x; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Sabol W. J., 2008, PRISONERS 2007; Santibanez SS, 2006, J URBAN HEALTH, V83, P86, DOI 10.1007/s11524-005-9009-2; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Todd CS, 2007, EMERG INFECT DIS, V13, P1327, DOI 10.3201/eid1309.070036; Tovanabutra S, 2004, AIDS RES HUM RETROV, V20, P465, DOI 10.1089/088922204323087705; Tovanabutra S, 2007, AIDS RES HUM RETROV, V23, P829, DOI 10.1089/aid.2006.0300; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2007, FIN RES REQ ACH UN A; *UNODC, WORLD DRUG REP 2009; *UNODC, 2009, ANT FORC AFGH OP SUR; UNODC, ADD CRIM INS TRANSN; UNODC, 2022, BOOKL 4 DRUG MARK TR; *US DEP STAT, 2009, BACKGR NOT UKR; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Walmsley R, 2015, WORLD PRISON POPULAT; Werb D, 2008, J PUBLIC HEALTH-UK, V30, P126, DOI 10.1093/pubmed/fdn021; WHO UNODC, 2009, UNAIDS TECHN GUID CO; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2003, J URBAN HEALTH, V80, P455, DOI 10.1093/jurban/jtg052; WOOD E, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60958-0; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organization, 2009, ASS COMP TREATM PEOP; World Health Organization, 2009, ACC CONTR MED PROGR; World Health Organization, 2008, POL GUID COLL TB HIV; 2010, NY TIMES NEW YO 0303	66	111	111	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					551	563		10.1016/S0140-6736(10)60928-2	http://dx.doi.org/10.1016/S0140-6736(10)60928-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20650515	Green Accepted			2022-12-28	WOS:000281266800034
J	El-Hamamsy, I; Eryigit, Z; Stevens, LM; Sarang, Z; George, R; Clark, L; Melina, G; Takkenberg, JJM; Yacoub, MH				El-Hamamsy, Ismail; Eryigit, Zeynep; Stevens, Louis-Mathieu; Sarang, Zubair; George, Robert; Clark, Lucy; Melina, Giovanni; Takkenberg, Johanna J. M.; Yacoub, Magdi H.			Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial	LANCET			English	Article							PULMONARY AUTOGRAFT; BIOPROSTHETIC VALVE; ROSS OPERATION; DIMENSIONS; ALLOGRAFTS	Background The ideal substitute for aortic valve replacement in patients with aortic valve disease is not known. Our hypothesis was that the regulatory and adaptive properties of a living valve substitute could improve the long-term outcomes in patients. We therefore compared these outcomes after autograft aortic root replacement (Ross procedure) versus homograft aortic root replacement in adults. Methods Male and female patients (<69 years) requiring aortic valve surgery were randomly assigned in a one-to-one ratio to receive an autograft or a homograft aortic root replacement in one centre in the UK. The random allocation sequence was computer generated. Treatment was not masked. The primary endpoint was survival of patients at 10 years after surgery. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN03530985. Findings 228 patients were randomly assigned to receive an autograft or a homograft aortic root replacement. 12 patients were excluded because they were younger than 18 years; 108 in each group received the surgery they were assigned to and were analysed. There was one (<1%) perioperative death in the autograft group versus three (3%) in the homograft group (p=0.621). At 10 years, four patients died in the autograft group versus 15 in the homograft group. Actuarial survival at 10 years was 97% (SD 2) in the autograft group versus 83% (4) in the homograft group. Hazard ratio for death in the homograft group was 4.61 (95% CI 1.71-16.03; p=0.0060). Survival of patients in the autograft group was similar to that in an age-matched and sex-matched British population (96%). Interpretation Our findings support the hypothesis that a living valve implanted in the aortic position can significantly improve the long-term outcomes in patients.	[El-Hamamsy, Ismail; George, Robert; Melina, Giovanni; Yacoub, Magdi H.] Royal Brompton & Harefield NHS Trust, Dept Cardiac Surg, London, England; [El-Hamamsy, Ismail; Eryigit, Zeynep; Sarang, Zubair; George, Robert; Clark, Lucy; Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Stevens, Louis-Mathieu] CHU Montreal, Dept Cardiac Surg & Epidemiol, Montreal, PQ, Canada; [Eryigit, Zeynep; Takkenberg, Johanna J. M.] Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, Rotterdam, Netherlands	Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London; Universite de Montreal; Erasmus University Rotterdam; Erasmus MC	Yacoub, MH (corresponding author), Magdi Yacoub Inst, Hill End Rd, Harefield UB9 6JH, Middx, England.	m.yacoub@imperial.ac.uk	Takkenberg, Johanna/B-9368-2009; Stevens, Louis-Mathieu/E-6453-2016	Takkenberg, Johanna/0000-0001-9809-5623; Stevens, Louis-Mathieu/0000-0003-3372-3419; George, Robert/0000-0002-1248-8299	Magdi Yacoub Institute; Canadian Institutes of Health; Dutch Heart Foundation	Magdi Yacoub Institute; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Dutch Heart Foundation(Netherlands Heart Foundation)	The study was funded by a research grant from the Magdi Yacoub Institute. IEH is supported by a Canadian Institutes of Health Research Fellowship Award and by the Magdi Yacoub Institute. ZE was supported by the Dr E Dekker Fund from the Dutch Heart Foundation. We thank Sue Edwards for her invaluable contribution in data gathering.	Akins CW, 2008, J THORAC CARDIOV SUR, V135, P732, DOI 10.1016/j.jtcvs.2007.12.002; Carr-White GS, 2001, CIRCULATION, V104, pI16; Dagum P, 1999, CIRCULATION, V100, P54; David TE, 2000, J THORAC CARDIOV SUR, V119, P210, DOI 10.1016/S0022-5223(00)70175-9; Davies JE, 2008, HEART, V94, P1545, DOI 10.1136/hrt.2008.144808; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Elkins RC, 2008, J THORAC CARDIOV SUR, V136, P623, DOI 10.1016/j.jtcvs.2008.02.080; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Katayama S, 2008, J THORAC CARDIOV SUR, V136, P1528, DOI 10.1016/j.jtcvs.2008.05.054; Kulik A, 2006, EUR J CARDIO-THORAC, V30, P485, DOI 10.1016/j.ejcts.2006.06.013; Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7; Lansac E, 2002, EUR J CARDIO-THORAC, V22, P497, DOI 10.1016/S1010-7940(02)00405-0; LIVANAINEN AM, 1996, AM J CARDIOL, V78, P97; Lund O, 1999, J THORAC CARDIOV SUR, V117, P77, DOI 10.1016/S0022-5223(99)70471-X; Mitchell RN, 1998, J THORAC CARDIOV SUR, V115, P118, DOI 10.1016/S0022-5223(98)70450-7; O'Brien MF, 2001, J HEART VALVE DIS, V10, P334; *ONS, OFF NAT STAT ANN LIF; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952, DOI 10.1016/S0735-1097(87)80254-1; Rabkin-Aikawa E, 2004, J THORAC CARDIOV SUR, V128, P552, DOI 10.1016/j.jtcvs.2004.04.016; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Ross J Jr, 1968, Circulation, V38, P61; *SF 36 ORG, COMM MEAS HLTH OUTC; Sievers HH, 2006, CIRCULATION, V114, pI504, DOI 10.1161/CIRCULATIONAHA.105.000406; Smedira NG, 2006, J THORAC CARDIOV SUR, V131, P558, DOI 10.1016/j.jtcvs.2005.09.016; Stassano P, 2009, J AM COLL CARDIOL, V54, P1862, DOI 10.1016/j.jacc.2009.07.032; Svensson LG, 2003, CURR PROB CARDIOLOGY, V28, P417, DOI 10.1016/j.cpcardiol.2003.08.002; Takkenberg JJM, 2006, J HEART VALVE DIS, V15, P100; YACOUB M, 1995, J THORAC CARDIOV SUR, V110, P186, DOI 10.1016/S0022-5223(05)80025-X; Yacoub M, 2007, PHILOS T R SOC B, V362, P1253, DOI 10.1098/rstb.2007.2112; Yacoub MH, 2006, J HEART VALVE DIS, V15, P531; Yacoub MH, 1999, ANN THORAC SURG, V68, pS37, DOI 10.1016/S0003-4975(99)00745-6; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112	33	232	238	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					524	531		10.1016/S0140-6736(10)60828-8	http://dx.doi.org/10.1016/S0140-6736(10)60828-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20684981				2022-12-28	WOS:000281266800031
J	Maggiolo, F; Leone, S				Maggiolo, Franco; Leone, Sebastiano			Is HAART modifying the HIV epidemic?	LANCET			English	Editorial Material							COMBINATION ANTIRETROVIRAL THERAPY; SEXUAL TRANSMISSION; PREVENTION; COHORT		[Maggiolo, Franco; Leone, Sebastiano] Osped Riuniti Bergamo, Div Infect Dis, I-24128 Bergamo, Italy	Ospedali Riuniti di Bergamo	Maggiolo, F (corresponding author), Osped Riuniti Bergamo, Div Infect Dis, I-24128 Bergamo, Italy.	franco31556@hotmail.com						Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Castel A, 2010, 17 C RETR OPP INF CR; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8	12	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					492	493		10.1016/S0140-6736(10)61057-4	http://dx.doi.org/10.1016/S0140-6736(10)61057-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20638714				2022-12-28	WOS:000281266800006
J	Somerville, C; Youngs, H; Taylor, C; Davis, SC; Long, SP				Somerville, Chris; Youngs, Heather; Taylor, Caroline; Davis, Sarah C.; Long, Stephen P.			Feedstocks for Lignocellulosic Biofuels	SCIENCE			English	Editorial Material							ENERGY-CONVERSION; MISCANTHUS; BIOENERGY; GROWTH; CROP; LANDS; YIELD	In 2008, the world produced approximately 87 gigaliters of liquid biofuels, which is roughly equal to the volume of liquid fuel consumed by Germany that year. Essentially, all of this biofuel was produced from crops developed for food production, raising concerns about the net energy and greenhouse gas effects and potential competition between use of land for production of fuels, food, animal feed, fiber, and ecosystem services. The pending implementation of improved technologies to more effectively convert the nonedible parts of plants (lignocellulose) to liquid fuels opens diverse options to use biofuel feedstocks that reach beyond current crops and the land currently used for food and feed. However, there has been relatively little discussion of what types of plants may be useful as bioenergy crops.	[Somerville, Chris; Youngs, Heather; Taylor, Caroline] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Davis, Sarah C.; Long, Stephen P.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign	Somerville, C (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	crs@berkeley.edu	Long, Stephen P/A-2488-2008; Somerville, Christopher R/A-4048-2009; Long, Stephen/AAA-1741-2019	Long, Stephen P/0000-0002-8501-7164; Somerville, Christopher R/0000-0003-4647-0094; Long, Stephen/0000-0002-8501-7164				BEALE CV, 1995, PLANT CELL ENVIRON, V18, P641, DOI 10.1111/j.1365-3040.1995.tb00565.x; Borland AM, 2009, J EXP BOT, V60, P2879, DOI 10.1093/jxb/erp118; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Centro de Gestao e Estudos Estrategicos (CGEE), 2008, SUG CAN BAS BIOETH E; Christian DG, 2008, IND CROP PROD, V28, P320, DOI 10.1016/j.indcrop.2008.02.009; Clifton-Brown JC, 2007, GLOBAL CHANGE BIOL, V13, P2296, DOI 10.1111/j.1365-2486.2007.01438.x; Committee on America's Energy Future, 2009, AM EN FUT; Davis SC, 2010, ECOSYSTEMS, V13, P144, DOI 10.1007/s10021-009-9306-9; Dohleman FG, 2009, PLANT CELL ENVIRON, V32, P1525, DOI 10.1111/j.1365-3040.2009.02017.x; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Goldemberg J, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-6; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Long SP, 1992, PRIMARY PRODUCTIVITY; Lynd L, 2006, SCIENCE, V312, P1746; Miguez FE, 2008, AGR FOREST METEOROL, V148, P1280, DOI 10.1016/j.agrformet.2008.03.010; Miguez FE, 2009, GCB BIOENERGY, V1, P282, DOI 10.1111/j.1757-1707.2009.01019.x; Mitchell CP, 1995, BIOMASS BIOENERG, V9, P11, DOI 10.1016/0961-9534(95)00076-3; Nobel PS, 1988, ENV BIOL AGAVES CACT; Purseglove J. W., 1972, TROPICAL CROPS MONOC; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Sokhansanj S, 2002, BIOMASS BIOENERG, V23, P347, DOI 10.1016/S0961-9534(02)00063-6; UNEP, 2007, GLOB ENV OUTL ENV DE; *UNICA, 2010, SUG PROD BRAZ	25	907	941	13	445	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					790	792		10.1126/science.1189268	http://dx.doi.org/10.1126/science.1189268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705851				2022-12-28	WOS:000280809900037
J	Kessels, HW; Nguyen, LN; Nabavi, S; Malinow, R				Kessels, Helmut W.; Nguyen, Louis N.; Nabavi, Sadegh; Malinow, Roberto			The prion protein as a receptor for amyloid-beta	NATURE			English	Letter							ALZHEIMERS-DISEASE; NATURAL OLIGOMERS; MEMORY		[Kessels, Helmut W.; Nguyen, Louis N.; Nabavi, Sadegh; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kessels, HW (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, 9500 Gilman Dr 0634, La Jolla, CA 92093 USA.	rmalinow@ucsd.edu		Nabavi, Sadegh/0000-0002-3940-1210; Kessels, Helmut/0000-0002-1122-745X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049159, R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG032132-15, R01 AG032132-18, R01 AG032132, R01 AG032132-14, R01 AG032132-17] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NIMH NIH HHS [R01 MH049159-09, R01 MH049159-21, R01 MH049159-22, R01 MH049159] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	14	221	227	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					E3	E4		10.1038/nature09217	http://dx.doi.org/10.1038/nature09217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703260	Green Accepted			2022-12-28	WOS:000280766100043
J	Katz, MH				Katz, Mitchell H.			Future of the Safety Net Under Health Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; HOME		San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA	San Francisco Department of Public Health	Katz, MH (corresponding author), San Francisco Dept Publ Hlth, 101 Grove St,Room 308, San Francisco, CA 94102 USA.	mitch.katz@sfdph.org						Adashi EY, 2010, NEW ENGL J MED, V362, P2047, DOI 10.1056/NEJMp1003729; Cunningham PJ, 1997, HEALTH AFFAIR, V16, P167, DOI 10.1377/hlthaff.16.4.167; Felland Laurie E, 2008, Issue Brief Cent Stud Health Syst Change, P1; Felt-Lisk S, 2002, HEALTH AFFAIR, V21, P277, DOI 10.1377/hlthaff.21.5.277; Forrest CB, 2006, JAMA-J AM MED ASSOC, V295, P1062, DOI 10.1001/jama.295.9.1062; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Institute of Medicine, 2000, AM HLTH CAR SAF NET; Lewin ME, 2007, HEALTH AFFAIR, V26, P1490, DOI 10.1377/hlthaff.26.5.1490; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317	9	49	49	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					679	680		10.1001/jama.2010.1126	http://dx.doi.org/10.1001/jama.2010.1126			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	637PA	20699460				2022-12-28	WOS:000280829200024
J	Colfax, G; Santos, GM; Chu, P; Vittinghoff, E; Pluddemann, A; Kumar, S; Hart, C				Colfax, Grant; Santos, Glenn-Milo; Chu, Priscilla; Vittinghoff, Eric; Pluddemann, Andreas; Kumar, Suresh; Hart, Carl			HIV in people who use drugs 5 Amphetamine-group substances and HIV	LANCET			English	Article							SEXUAL RISK BEHAVIORS; CRYSTAL METHAMPHETAMINE USE; CONTINGENCY MANAGEMENT; TRANSMITTED INFECTIONS; ABUSE TREATMENT; USE DISORDERS; POSITIVE MEN; MEDICATION ADHERENCE; SUBJECTIVE RESPONSE; TREATMENT-SEEKING	Amphetamine-group substances are used worldwide and are more prevalent than either cocaine or opioids. We reviewed published reports about amphetamine-group substances and did a meta-analysis of randomised controlled trials of behavioural interventions for their use. Most research was done in developed countries. Many, but not all, studies show an association between amphetamine-group substance use and risk of HIV infection. Much use of amphetamine-group substances is non-injection and is associated with increased HIV risk, particularly in men who have sex with men. The structural, social, interpersonal, and personal factors that link to amphetamine-group substance use and HIV risk are poorly understood. 13 studies, with a cumulative sample size of 1997 individuals, qualified for the meta-analysis. Overall, high-intensity behavioural interventions were moderately effective in reducing use of amphetamine-group substances (effect size 0.28, 95% CI 0.13-0.44). We did not find conclusive evidence that behavioural interventions as a group are more effective than are passive or minium treatment for reduction of amphetamine-group substance use or sexual risk behaviours. The search for effective, scalable, and sustainable interventions for amphetamine-group substance use, including pharmacotherapies, should be supported and encouraged.	[Colfax, Grant; Santos, Glenn-Milo; Chu, Priscilla] San Francisco Dept Publ Hlth, HIV Prevent Sect, San Francisco, CA 94102 USA; [Colfax, Grant; Vittinghoff, Eric] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Pluddemann, Andreas] S African MRC, Cape Town, South Africa; [Hart, Carl] Columbia Univ, New York, NY USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; South African Medical Research Council; Columbia University	Colfax, G (corresponding author), San Francisco Dept Publ Hlth, HIV Prevent Sect, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA.	grant.colfax@sfdph.org		Santos, Glenn-Milo/0000-0003-1009-5317	US National Institute on Drug Abuse [R01-DA022155, R01-DA022190, R01-DA023387]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022155, R01DA022190, R01DA023387] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was partly funded by the US National Institute on Drug Abuse (grant numbers: R01-DA022155, R01-DA022190, and R01-DA023387). We thank Stephen Bent, Chris Beyrer, David Celentano, Rand Dadasovich, Moupali Das, Louisa Degenhardt, Kelly Fung, Uyen Kao, Kasia Malinnowska-Sempruch, Tim Matheson, Thomas Patterson, Jessica Peirce, Deirdre Santos, Susan Sherman, Steve Shoptaw, Bangorn Sirirojn, Michaela Varisto, and Gloria Won.	Baker A, 2005, ADDICTION, V100, P367, DOI 10.1111/j.1360-0443.2005.01002.x; Baker A, 2002, ACTA PSYCHIAT SCAND, V106, P233, DOI 10.1034/j.1600-0447.2002.01118.x; Baker A, 2001, ADDICTION, V96, P1279, DOI 10.1046/j.1360-0443.2001.96912797.x; Baker A, 2006, BRIT J PSYCHIAT, V188, P439, DOI 10.1192/bjp.188.5.439; Bellis MA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-155; Beyrer C, 2004, INT J STD AIDS, V15, P697, DOI 10.1258/0956462041944376; *BLUE MOON RES PLA, 2008, PATT US HARMS ASS SP; Bonell CP, 2010, INT J DRUG POLICY, V21, P244, DOI 10.1016/j.drugpo.2009.07.002; Booth RE, 2007, JAIDS-J ACQ IMM DEF, V46, P112; Booth RE, 2009, ADDICTION, V104, P1864, DOI 10.1111/j.1360-0443.2009.02660.x; Bradbeer TM, 1998, DRUG ALCOHOL REV, V17, P299, DOI 10.1080/09595239800187131; Braine N, 2005, AIDS EDUC PREV, V17, P515, DOI 10.1521/aeap.2005.17.6.515; Brouwer KC, 2006, SUBST USE MISUSE, V41, P707, DOI 10.1080/10826080500411478; BURCHAM JL, 1989, MED J AUSTRALIA, V150, P634, DOI 10.5694/j.1326-5377.1989.tb136727.x; Cachay Edward R, 2007, Open AIDS J, V1, P5, DOI 10.2174/1874613600701010005; Cadet JL, 2007, NEUROTOX RES, V12, P181, DOI 10.1007/BF03033915; Cartier JJ, 2008, J PSYCHOACTIVE DRUGS, V40, P437, DOI 10.1080/02791072.2008.10400650; Celentano DD, 2008, SEX TRANSM DIS, V35, P400, DOI 10.1097/OLQ.0b013e31815fd412; Chang BR, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/01/016; Cheng WS, 2009, AM J DRUG ALCOHOL AB, V35, P295, DOI 10.1080/00952990902968585; Cheng WS, 2010, SUBST USE MISUSE, V45, P116, DOI 10.3109/10826080902869620; CHETTIAR J, 2010, J PUBLIC HLTH OXF, DOI DOI 10.1093/PUBMED/1DP126; Chintalova-Dallas R, 2009, INT J DRUG POLICY, V20, P347, DOI 10.1016/j.drugpo.2008.09.003; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Colfax G, 2006, CLIN INFECT DIS, V42, P1463, DOI 10.1086/503259; Colfax G, 2004, AM J EPIDEMIOL, V159, P1002, DOI 10.1093/aje/kwh135; COLFAX G, 2005, J URBAN HLTH S1, V82, P62; Colfax Grant, 2005, Curr HIV/AIDS Rep, V2, P194, DOI 10.1007/s11904-005-0016-4; Colfax GN, 2007, AIDS, V21, P239, DOI 10.1097/QAD.0b013e3280114a29; Cunningham JK, 2009, ADDICTION, V104, P441, DOI 10.1111/j.1360-0443.2008.02458.x; DARKE S, 1994, ADDICTION, V89, P1683, DOI 10.1111/j.1360-0443.1994.tb03769.x; DARKE S, 1994, ADDICTION, V89, P1077, DOI 10.1111/j.1360-0443.1994.tb02784.x; DARROW WW, 1987, AM J PUBLIC HEALTH, V77, P479, DOI 10.2105/AJPH.77.4.479; Das-Douglas M, 2008, J URBAN HEALTH, V85, P239, DOI 10.1007/s11524-007-9249-4; DEGENHARDT L, 2007, BEHALF REFERENCE GRO; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P243, DOI 10.1080/09595230801950572; Degenhardt Louisa, 2010, Lancet, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Dlugos AM, 2009, PSYCHOPHARMACOLOGY, V206, P501, DOI 10.1007/s00213-009-1628-y; Drumright LN, 2006, SUBST USE MISUSE, V41, P1551, DOI 10.1080/10826080600847894; Dutra L, 2008, AM J PSYCHIAT, V165, P179, DOI 10.1176/appi.ajp.2007.06111851; Elkashef A, 2008, SUBST ABUS, V29, P31, DOI 10.1080/08897070802218554; Embry D, 2009, ADDICT BEHAV, V34, P343, DOI 10.1016/j.addbeh.2008.11.019; *EUR MON CTR DRUGS, 2009, METH EUR UN PERSP GL; Fairbairn N, 2008, PUBLIC HEALTH, V122, P70, DOI 10.1016/j.puhe.2007.02.016; Fairbairn N, 2007, DRUG ALCOHOL DEPEN, V88, P313, DOI 10.1016/j.drugalcdep.2006.10.019; Green R, 2009, INT J DRUG POLICY, V20, P402, DOI 10.1016/j.drugpo.2008.12.002; Griffiths P, 2008, DRUG ALCOHOL REV, V27, P236, DOI 10.1080/09595230801932588; Halkitis PN, 2007, ADDICTION, V102, P76, DOI 10.1111/j.1360-0443.2007.01769.x; Halkitis PN, 2009, AIDS BEHAV, V13, P783, DOI 10.1007/s10461-008-9432-y; Halkitis PN, 2009, J HEALTH PSYCHOL, V14, P222, DOI 10.1177/1359105308100206; Halkitis PN, 2005, AIDS, V19, pS77, DOI 10.1097/01.aids.0000167354.09912.83; HALKITIS PN, 2005, J URBAN HLTH S1, V82, P18; Hser YI, 2008, J ADDICT DIS, V27, P13, DOI 10.1080/10550880802122554; *HUM RIGHTS WATCH, 2004, NOT EN GRAV WAR DRUG; Ihunwo A O, 2004, East Afr Med J, V81, P468; Inglez-Dias A, 2008, DRUG ALCOHOL REV, V27, P286, DOI 10.1080/09595230801914784; Jayaram-Lindstrom N, 2008, AM J PSYCHIAT, V165, P1442, DOI 10.1176/appi.ajp.2008.08020304; Jayaram-Lindstrom N, 2008, NEUROPSYCHOPHARMACOL, V33, P1856, DOI 10.1038/sj.npp.1301572; Johnson WD, 2002, J ACQ IMMUN DEF SYND, V30, pS62, DOI 10.1097/01.QAI.0000018888.47949.1B; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Kalechstein AD, 2003, J NEUROPSYCH CLIN N, V15, P215, DOI 10.1176/appi.neuropsych.15.2.215; Kelly BC, 2007, AM J DRUG ALCOHOL AB, V33, P875, DOI 10.1080/00952990701667347; Kinner SA, 2008, DRUG ALCOHOL REV, V27, P292, DOI 10.1080/09595230801919452; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 2007, SUBST USE MISUSE, V42, P1613, DOI 10.1080/10826080701212519; Lampinen TM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-35; Lee NK, 2008, DRUG ALCOHOL REV, V27, P309, DOI 10.1080/09595230801919494; LEIGH BC, 1993, AM PSYCHOL, V48, P1035, DOI 10.1037/0003-066X.48.10.1035; LEONARD W, 2008, MONOGRAPH SERIES TRO, V67; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Lorvick J, 2006, J URBAN HEALTH, V83, P497, DOI 10.1007/s11524-006-9039-4; Lott DC, 2006, AM J ADDICTION, V15, P327, DOI 10.1080/10550490600859868; Lott DC, 2005, NEUROPSYCHOPHARMACOL, V30, P602, DOI 10.1038/sj.npp.1300637; Malta M, 2006, AIDS CARE, V18, P489, DOI 10.1080/09540120500235241; Marquez C, 2009, AIDS CARE, V21, P575, DOI 10.1080/09540120802385579; MATIC S, 2006, HIV AIDS EUROPE MOVI; Matsumoto T, 2002, ADDICTION, V97, P809, DOI 10.1046/j.1360-0443.2002.00143.x; Mausbach BT, 2007, ANN BEHAV MED, V34, P263, DOI 10.1007/BF02874551; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; Mayer KH, 2010, SEX TRANSM INFECT, V86, P66, DOI 10.1136/sti.2009.036608; McGregor C, 2005, ADDICTION, V100, P1320, DOI 10.1111/j.1360-0443.2005.01160.x; McKetin R, 2008, DRUG ALCOHOL REV, V27, P277, DOI 10.1080/09595230801919486; McKetin R, 2007, DRUG ALCOHOL REV, V26, P161, DOI 10.1080/09595230601146652; McKetin R, 2006, DRUG ALCOHOL DEPEN, V85, P198, DOI 10.1016/j.drugalcdep.2006.04.007; McKirnan DJ, 2001, J SUBST ABUSE, V13, P137, DOI 10.1016/S0899-3289(01)00063-3; Morineau G, 2011, AIDS BEHAV, V15, P1033, DOI 10.1007/s10461-009-9590-6; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nanin JE, 2006, J DRUG EDUC, V36, P297, DOI 10.2190/9818-1W43-1876-2062; Ober A, 2009, DRUG ALCOHOL DEPEN, V102, P123, DOI 10.1016/j.drugalcdep.2009.02.002; *OFF APPL STUD, 2005, NSDUH REP METH US AB; Ostrow DG, 2009, JAIDS-J ACQ IMM DEF, V51, P349, DOI 10.1097/QAI.0b013e3181a24b20; PAQUETTE M, 2008, 17 INT AIDS C MEX CI; Patterson TL, 2009, AIDS, V23, P1763, DOI 10.1097/QAD.0b013e32832f08a1; Peck JA, 2005, J ADDICT DIS, V24, P115, DOI 10.1300/J069v24n03_10; Peirce JM, 2006, ARCH GEN PSYCHIAT, V63, P201, DOI 10.1001/archpsyc.63.2.201; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; Pluddemann A, 2008, DRUG ALCOHOL REV, V27, P687, DOI 10.1080/09595230802245253; Pluddemann A, 2008, DRUG ALCOHOL REV, V27, P185, DOI 10.1080/09595230701829363; Prendergast ML, 2002, DRUG ALCOHOL DEPEN, V67, P53, DOI 10.1016/S0376-8716(02)00014-5; Rawson R, 2000, J PSYCHOACTIVE DRUGS, V32, P233, DOI 10.1080/02791072.2000.10400234; Rawson RA, 2006, ADDICTION, V101, P267, DOI 10.1111/j.1360-0443.2006.01312.x; Rawson RA, 2004, ADDICTION, V99, P708, DOI 10.1111/j.1360-0443.2004.00707.x; Rawstorne P, 2007, ARCH SEX BEHAV, V36, P646, DOI 10.1007/s10508-007-9206-z; Reback CJ, 2004, AIDS BEHAV, V8, P87, DOI 10.1023/B:AIBE.0000017528.39338.75; Reback CJ, 2003, AIDS CARE, V15, P775, DOI 10.1080/09540120310001618621; REMBERG B, 1999, DRUG CHARACTERIZATIO; Roll JM, 2006, AM J PSYCHIAT, V163, P1993, DOI 10.1176/appi.ajp.163.11.1993; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Rose Valerie J, 2006, Harm Reduct J, V3, P29, DOI 10.1186/1477-7517-3-29; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Semple S, 2009, AM J ADDICTION, V18, P65, DOI 10.1080/10550490802544466; Semple SJ, 2009, ARCH SEX BEHAV, V38, P583, DOI 10.1007/s10508-007-9292-y; Semple SJ, 2005, AM J ADDICTION, V14, P367, DOI 10.1080/10550490591006924; Semple SJ, 2004, DRUG ALCOHOL DEPEN, V76, P203, DOI 10.1016/j.drugalcdep.2004.05.003; Semple SJ, 2004, ADDICT BEHAV, V29, P807, DOI 10.1016/j.addbeh.2004.02.013; Sharpe TT, 2001, QUAL HEALTH RES, V11, P612, DOI 10.1177/104973201129119334; Sherman SG, 2009, J ADOLESCENT HEALTH, V44, P169, DOI 10.1016/j.jadohealth.2008.06.021; Sherman SG, 2009, SOC SCI MED, V68, P69, DOI 10.1016/j.socscimed.2008.09.061; Shoptaw S, 1998, J ADDICT DIS, V17, P19, DOI 10.1300/J069v17n04_03; Shoptaw S, 2005, DRUG ALCOHOL DEPEN, V78, P125, DOI 10.1016/j.drugalcdep.2004.10.004; Shoptaw S, 2008, J SUBST ABUSE TREAT, V35, P285, DOI 10.1016/j.jsat.2007.11.004; Shoptaw S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-214; Shoptaw S, 2006, DRUG ALCOHOL DEPEN, V85, P12, DOI 10.1016/j.drugalcdep.2006.03.005; Springer AE, 2007, PREV SCI, V8, P103, DOI 10.1007/s11121-007-0065-6; Srisurapanont M, 2007, AM J ADDICTION, V16, P111, DOI 10.1080/10550490601184431; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Talu A, 2010, INT J DRUG POLICY, V21, P56, DOI 10.1016/j.drugpo.2009.02.007; Taylor MM, 2007, INT J STD AIDS, V18, P93, DOI 10.1258/095646207779949709; Thirthalli J, 2009, CURR OPIN PSYCHIATR, V22, P274, DOI 10.1097/YCO.0b013e32832a1dc0; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; *UN OFF DRUGS CRIM, 2009, WORLD DRUG REP 2009; *UN OFF DRUGS CRIM, 2008, AMPH ECST 2008 GLOB; Verachai Viroj, 2001, Journal of the Medical Association of Thailand, V84, P24; Vocci F, 2005, PHARMACOL THERAPEUT, V108, P94, DOI 10.1016/j.pharmthera.2005.06.010; Volkow ND, 2007, AM J PSYCHIAT, V164, P157, DOI 10.1176/appi.ajp.164.1.157; Werb D, 2009, SUBST ABUSE TREAT PR, V4, DOI 10.1186/1747-597X-4-16; Wodak A, 2006, SUBST USE MISUSE, V41, P777, DOI 10.1080/10826080600669579; WOLFE D, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60832-X; Woolf SE, 2009, AIDS BEHAV, V13, P757, DOI 10.1007/s10461-007-9354-0; Yen CF, 2004, J NERV MENT DIS, V192, P788, DOI 10.1097/01.nmd.0000144699.80765.7f; THAILANDS WAR DRUGS	143	128	134	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					458	474		10.1016/S0140-6736(10)60753-2	http://dx.doi.org/10.1016/S0140-6736(10)60753-2			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639YK	20650520				2022-12-28	WOS:000281012900031
J	Huang, KG				Huang, Kenneth G.			China's Innovation Landscape	SCIENCE			English	Editorial Material							PATENT CITATIONS; CAPACITY; INDICATORS; ASIA		Singapore Management Univ, Lee Kong Chian Sch Business, Singapore 178899, Singapore	Singapore Management University	Huang, KG (corresponding author), Singapore Management Univ, Lee Kong Chian Sch Business, Singapore 178899, Singapore.	kennethhuang@smu.edu.sg	HUANG, Kenneth Guang-Lih/D-2205-2010	HUANG, Kenneth Guang-Lih/0000-0002-4811-5638				[Anonymous], 2000, PROTECTING THEIR INT; Archibugi D., 1992, TECHNOLOGICAL SPECIA; Feldman MP, 1999, EUR ECON REV, V43, P409, DOI 10.1016/S0014-2921(98)00047-6; Furman JL, 2002, RES POLICY, V31, P899, DOI 10.1016/S0048-7333(01)00152-4; Gittelman M, 2008, ACAD MANAGE PERSPECT, V22, P21, DOI 10.5465/AMP.2008.34587992; GRILICHES Z, 1990, J ECON LIT, V28, P1661, DOI 10.3386/w3301; Hall BH, 2001, RAND J ECON, V32, P101, DOI 10.2307/2696400; Hu AG, 2009, J DEV ECON, V90, P57, DOI 10.1016/j.jdeveco.2008.11.004; Hu MC, 2005, RES POLICY, V34, P1322, DOI 10.1016/j.respol.2005.04.009; Hu MC, 2008, RES POLICY, V37, P1465, DOI 10.1016/j.respol.2008.07.003; Huang KG, 2010, RES POLICY, V39, P567, DOI 10.1016/j.respol.2010.02.004; Huang KG, 2009, ACAD MANAGE J, V52, P1193, DOI 10.5465/AMJ.2009.47084665; HUANG KG, 2009, ACAD MANAGEMENT BEST, P1; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; LEVIN RC, 1987, BROOKINGS PAP ECO AC, P783; Lundvall B.-A., 1992, NATL INNOVATION SYST; Mahmood IP, 2003, RES POLICY, V32, P1031, DOI 10.1016/S0048-7333(02)00109-9; MANSFIELD E, 1986, MANAGE SCI, V32, P173, DOI 10.1287/mnsc.32.2.173; SOETE L, 1987, RES POLICY, V16, P101, DOI 10.1016/0048-7333(87)90026-6; Trajtenberg, 2002, PATENTS CITATIONS IN, DOI 10.7551/mitpress/5263.001.0001; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Zhao MY, 2006, MANAGE SCI, V52, P1185, DOI 10.1287/mnsc.1060.0516	22	40	42	5	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					632	633		10.1126/science.1190212	http://dx.doi.org/10.1126/science.1190212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	634RV	20689003	Green Accepted			2022-12-28	WOS:000280602700021
J	Ieda, M; Fu, JD; Delgado-Olguin, P; Vedantham, V; Hayashi, Y; Bruneau, BG; Srivastava, D				Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Vedantham, Vasanth; Hayashi, Yohei; Bruneau, Benoit G.; Srivastava, Deepak			Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors	CELL			English	Article							EMBRYONIC STEM-CELLS; CARDIAC FIBROBLASTS; PROGENITOR CELLS; BETA-CELLS; HEART; TRANSCRIPTION; EXPRESSION; CHROMATIN; TBX5; DIFFERENTIATION	The reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs) raises the possibility that a somatic cell could be reprogrammed to an alternative differentiated fate without first becoming a stem/progenitor cell. A large pool of fibroblasts exists in the postnatal heart, yet no single "master regulator'' of direct cardiac reprogramming has been identified. Here, we report that a combination of three developmental transcription factors (i.e., Gata4, Mef2c, and Tbx5) rapidly and efficiently reprogrammed postnatal cardiac or dermal fibroblasts directly into differentiated cardiomyocyte-like cells. Induced cardiomyocytes expressed cardiac-specific markers, had a global gene expression profile similar to cardiomyocytes, and contracted spontaneously. Fibroblasts transplanted into mouse hearts one day after transduction of the three factors also differentiated into cardiomyocyte-like cells. We believe these findings demonstrate that functional cardiomyocytes can be directly reprogrammed from differentiated somatic cells by defined factors. Reprogramming of endogenous or explanted fibroblasts might provide a source of cardiomyocytes for regenerative approaches.	[Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Vedantham, Vasanth; Hayashi, Yohei; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Ieda, Masaki; Fu, Ji-Dong; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Delgado-Olguin, Paul; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Vedantham, Vasanth] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ieda, M (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	ieda@cpnet.med.keio.ac.jp; dsrivastava@gladstone.ucsf.edu	Fu, Jidong/E-8173-2012; Hayashi, Yohei/L-8190-2019; Olguin, Paul Delgado/H-9293-2019; Wilson, Matthew H/K-3193-2013; Hayashi, Yohei/AAF-6059-2020	Olguin, Paul Delgado/0000-0002-5355-247X; Hayashi, Yohei/0000-0001-5490-7052; Vedantham, Vasanth/0000-0003-1032-700X; Fu, Jidong/0000-0003-2797-5193; Bruneau, Benoit/0000-0002-0804-7597	Uehara Memorial Foundation; GlaxoSmithKline Cardiovascular Research and Education Foundation; NHLBI/NIH; California Institute for Regenerative Medicine; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080592, R01HL057181, P01HL089707, U01HL100406, K08HL101989] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); GlaxoSmithKline Cardiovascular Research and Education Foundation; NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to members of the Srivastava lab, to K. Tomoda for critical discussions and comments on the manuscript, to J. Olgin and C. Ding for electrophysiology assistance, to Z. Yang and K. Worringer for help with lentivirus experiments, to Y. Huang for cell transplantation experiments, to B. Taylor, G. Howard, and S. Ordway for editorial assistance and manuscript preparation, to C. Barker and L. Ta in the Gladstone Genomics core, to C. Miller and J. Fish in the Gladstone Histology core, to A. Holloway in the Gladstone Bioinformatics core, and to S. Elmes in the Laboratory for Cell Analysis in UCSF. We also thank S. Yamanaka for helpful discussions and providing pMXs-DsRed Express plasmid, T. Kitamura for Plat-E cells, J. Robbins for alpha-MHC promoter plasmid, T.M. Jessell for Isl1-Cre mice, and F. Costantini for R26R-EYFP mice. M.I. and Y.H. are supported by a grant from the Uehara Memorial Foundation. V.V. is supported by grants from the GlaxoSmithKline Cardiovascular Research and Education Foundation and the NIH/NHLBI. P.D.-O. was a postdoctoral scholar of the California Institute for Regenerative Medicine. D.S. and B.G.B are supported by grants from NHLBI/NIH and the California Institute for Regenerative Medicine. The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. D.S. is a member of the Scientific Advisory Board of iPierian, Inc., and RegeneRx. B.G.B. is a member of the Scientific Advisory Board of iPierian Inc.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hudon-David F, 2007, J MOL CELL CARDIOL, V42, P991, DOI 10.1016/j.yjmcc.2007.02.009; Ieda M, 2007, NAT MED, V13, P604, DOI 10.1038/nm1570; Ivey KN, 2006, J CLIN INVEST, V116, P2863, DOI 10.1172/JCI30349; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Saga Y, 1999, DEVELOPMENT, V126, P3437; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	38	1719	1879	3	328	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					375	386		10.1016/j.cell.2010.07.002	http://dx.doi.org/10.1016/j.cell.2010.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691899	Bronze, Green Accepted			2022-12-28	WOS:000280609100015
J	Kaya, M; Higuchi, H				Kaya, Motoshi; Higuchi, Hideo			Nonlinear Elasticity and an 8-nm Working Stroke of Single Myosin Molecules in Myofilaments	SCIENCE			English	Article							SKELETAL-MUSCLE; FORCE; ACTIN; SIZE; CONTRACTION; DEPENDENCE; STIFFNESS; DYNAMICS; FIBERS; MOTION	Using optical trapping and fluorescence imaging techniques, we measured the step size and stiffness of single skeletal myosins interacting with actin filaments and arranged on myosin-rod cofilaments that approximate myosin mechanics during muscle contraction. Stiffness is dramatically lower for negatively compared to positively strained myosins, consistent with buckling of myosin's subfragment 2 rod domain. Low stiffness minimizes drag of negatively strained myosins during contraction at loaded conditions. Myosin's elastic portion is stretched during active force generation, reducing apparent step size with increasing load, even though the working stroke is approximately constant at about 8 nanometers. Taking account of the nonlinear nature of myosin elasticity is essential to relate myosin's internal structural changes to physiological force generation and filament sliding.	[Kaya, Motoshi; Higuchi, Hideo] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Higuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	higuchi@phys.s.u-tokyo.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency; Japan Society for the Promotion of Science	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to J. Kerssemakers and M. Dogterom for generously providing their step-finding algorithm, W. Herzog and Y. Goldman for valuable discussion and critical reading of this manuscript, and T. Kambara for comments. This work has been supported by Grants-in-Aid for Scientific Research in Priority Areas from the Japan Ministry of Education, Culture, Sports, Science, and Technology (H. H.), Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency (H. H.), and Young Scientists from the Japan Society for the Promotion of Science (M.K.).	Adamovic I, 2008, BIOPHYS J, V94, P3779, DOI 10.1529/biophysj.107.122028; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GOLDMAN YE, 1988, J PHYSL, V398, P72; HIGUCHI H, 1995, BIOPHYS J, V69, P1000, DOI 10.1016/S0006-3495(95)79975-1; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Howard J, 1996, Proc Natl Acad Sci U S A, V93, P4462; Howard J, 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1971, J PHYSIOL, V218, P59; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Lewalle A, 2008, BIOPHYS J, V94, P2160, DOI 10.1529/biophysj.107.119396; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Nishizaka T, 2000, BIOPHYS J, V79, P962, DOI 10.1016/S0006-3495(00)76350-8; PATE E, 1993, P NATL ACAD SCI USA, V90, P2451, DOI 10.1073/pnas.90.6.2451; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Steffen W, 2003, P NATL ACAD SCI USA, V100, P6434, DOI 10.1073/pnas.1231998100; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; WINKELMANN DA, 1995, BIOPHYS J, V68, P2444, DOI 10.1016/S0006-3495(95)80426-1	26	127	130	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					686	689		10.1126/science.1191484	http://dx.doi.org/10.1126/science.1191484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689017				2022-12-28	WOS:000280602700040
J	Foster, GD; Wyatt, HR; Hill, JO; Makris, AP; Rosenbaum, DL; Brill, C; Stein, RI; Mohammed, BS; Miller, B; Rader, DJ; Zemel, B; Wadden, TA; Tenhave, T; Newcomb, CW; Klein, S				Foster, Gary D.; Wyatt, Holly R.; Hill, James O.; Makris, Angela P.; Rosenbaum, Diane L.; Brill, Carrie; Stein, Richard I.; Mohammed, B. Selma; Miller, Bernard; Rader, Daniel J.; Zemel, Babette; Wadden, Thomas A.; Tenhave, Thomas; Newcomb, Craig W.; Klein, Samuel			Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; MAINTENANCE; APPETITE; ORLISTAT; ORNISH; ATKINS; ZONE	Background: Previous studies comparing low-carbohydrate and low-fat diets have not included a comprehensive behavioral treatment, resulting in suboptimal weight loss. Objective: To evaluate the effects of 2-year treatment with a low-carbohydrate or low-fat diet, each of which was combined with a comprehensive lifestyle modification program. Design: Randomized parallel-group trial. (ClinicalTrials.gov registration number: NCT00143936) Setting: 3 academic medical centers. Patients: 307 participants with a mean age of 45.5 years (SD, 9.7 years) and mean body mass index of 36.1 kg/m(2) (SD, 3.5 kg/m2). Intervention: A low-carbohydrate diet, which consisted of limited carbohydrate intake (20 g/d for 3 months) in the form of low-glycemic index vegetables with unrestricted consumption of fat and protein. After 3 months, participants in the low-carbohydrate diet group increased their carbohydrate intake (5 g/d per wk) until a stable and desired weight was achieved. A low-fat diet consisted of limited energy intake (1200 to 1800 kcal/d; <= 30% calories from fat). Both diets were combined with comprehensive behavioral treatment. Measurements: Weight at 2 years was the primary outcome. Secondary measures included weight at 3, 6, and 12 months and serum lipid concentrations, blood pressure, urinary ketones, symptoms, bone mineral density, and body composition throughout the study. Results: Weight loss was approximately 11 kg (11%) at 1 year and 7 kg (7%) at 2 years. There were no differences in weight, body composition, or bone mineral density between the groups at any time point. During the first 6 months, the low-carbohydrate diet group had greater reductions in diastolic blood pressure, triglyceride levels, and very-low-density lipoprotein cholesterol levels, lesser reductions in low-density lipoprotein cholesterol levels, and more adverse symptoms than did the low-fat diet group. The low-carbohydrate diet group had greater increases in high-density lipoprotein cholesterol levels at all time points, approximating a 23% increase at 2 years. Limitation: Intensive behavioral treatment was provided, patients with dyslipidemia and diabetes were excluded, and attrition at 2 years was high. Conclusion: Successful weight loss can be achieved with either a low-fat or low-carbohydrate diet when coupled with behavioral treatment. A low-carbohydrate diet is associated with favorable changes in cardiovascular disease risk factors at 2 years.	[Foster, Gary D.] Temple Univ, Ctr Obes Res & Educ, Philadelphia, PA 19140 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Colorado, Denver, CO 80202 USA; Washington Univ, Sch Med, St Louis, MO USA; Univ Missouri, St Louis, MO 63121 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Colorado System; University of Colorado Denver; Washington University (WUSTL); University of Missouri System; University of Missouri Saint Louis	Foster, GD (corresponding author), Temple Univ, Ctr Obes Res & Educ, 3223 N Broad St,Suite 175, Philadelphia, PA 19140 USA.	gfoster@temple.edu	Biguzzi, Felipe A/E-4724-2015; Zemel, Babette S./D-1117-2009; Rosenbaum, Diane/ABL-2970-2022	Zemel, Babette S./0000-0002-6164-7348; Stein, Richard/0000-0003-1614-4845; Ten Have, Thomas/0000-0003-0026-3073; Hill, James/0000-0003-4690-2264	National Institutes of Health (NIH) [R01 AT1103, UL1RR024134, UL1 RR000051, UL1 RR024992, DK 56341]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT001103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, UL1RR024992, M01RR000051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health (NIH) grant R01 AT1103 to Temple University; NIH grant UL1RR024134 to University of Pennsylvania; NIH grant UL1 RR000051 to University of Colorado; and NIH grant UL1 RR024992 and DK 56341 to Washington University.	Adam-Perrot A, 2006, OBES REV, V7, P49, DOI 10.1111/j.1467-789X.2006.00222.x; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Atkins RC, 1998, ATKINS NEW DIET REVO; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Boden G, 2005, ANN INTERN MED, V142, P403, DOI 10.7326/0003-4819-142-6-200503150-00006; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Dattilo DJ, 1996, J ORAL MAXIL SURG, V54, P915, DOI 10.1016/S0278-2391(96)90549-2; Foster GD, 2005, AM J CLIN NUTR, V82, p230S, DOI 10.1093/ajcn/82.1.230S; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Golay A, 1996, AM J CLIN NUTR, V63, P174, DOI 10.1093/ajcn/63.2.174; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; Krauss RM, 2006, AM J CLIN NUTR, V83, P1025, DOI 10.1093/ajcn/83.5.1025; KrisEtherton PM, 1997, AM J CLIN NUTR, V65, P560, DOI 10.1093/ajcn/65.2.560; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Makris A, 2008, HDB OBESITY, P269; Malik VS, 2007, NAT CLIN PRACT CARD, V4, P34, DOI 10.1038/ncpcardio0726; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Szapary Philippe O., 2001, Current Opinion in Pharmacology, V1, P113, DOI 10.1016/S1471-4892(01)00028-5; Villareal DT, 2006, ARCH INTERN MED, V166, P2502, DOI 10.1001/archinte.166.22.2502; WADDEN TA, 1987, INT J OBESITY, V11, P239; Wadden TA, 2007, GASTROENTEROLOGY, V132, P2226, DOI 10.1053/j.gastro.2007.03.051; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Yancy WS, 2010, ARCH INTERN MED, V170, P136, DOI 10.1001/archinternmed.2009.492; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006; YANG MU, 1976, J CLIN INVEST, V58, P722, DOI 10.1172/JCI108519	33	343	351	4	130	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					147	U37		10.7326/0003-4819-153-3-201008030-00005	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00005			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679559	Green Accepted			2022-12-28	WOS:000280557600002
J	Evans, J; Rzhetsky, A				Evans, James; Rzhetsky, Andrey			Machine Science	SCIENCE			English	Editorial Material							HYPOTHESIS GENERATION; KNOWLEDGE; SYSTEMS; NETWORK		[Evans, James; Rzhetsky, Andrey] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	University of Chicago	Evans, J (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	jevans@uchicago.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405	NIGMS NIH HHS [R01 GM061372-09, R01 GM061372, R01 GM061372-08] Funding Source: Medline; NIMH NIH HHS [P50 MH094267] Funding Source: Medline; NLM NIH HHS [R01 LM010132-02, R01 LM010132-01, R01 LM010132] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010132] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BLAKE J, 2009, COMMUNICATION   0205; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; Feret J, 2009, P NATL ACAD SCI USA, V106, P6453, DOI 10.1073/pnas.0809908106; Golub TR, 2010, NATURE, V464, P679, DOI 10.1038/464679a; Harris Z., 1989, FORM INFORM SCI ANAL; Harris Zellig, 1982, SUBLANGUAGE STUDIES, P231; HOOD L, 2004, BIOCOMMERCE WEE 0909; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; O'Malley MA, 2009, CELL, V138, P611, DOI 10.1016/j.cell.2009.08.008; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Ruths DA, 2006, J COMPUT BIOL, V13, P1546, DOI 10.1089/cmb.2006.13.1546; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Twain Mark., 1889, CONNECTICUT YANKEE K; Weeber M, 2003, J AM MED INFORM ASSN, V10, P252, DOI 10.1197/jamia.M1158; Wren JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-145	24	39	40	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					399	400		10.1126/science.1189416	http://dx.doi.org/10.1126/science.1189416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KJ	20651141	Green Accepted			2022-12-28	WOS:000280196500023
J	Greenberg, SM; Rapalino, O; Frosch, MP				Greenberg, Steven M.; Rapalino, Otto; Frosch, Matthew P.			A Woman with Dementia and a Seizure Inflammatory cerebral amyloid angiopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER LESIONS; ALZHEIMER-DISEASE; PRIMARY ANGIITIS; REVERSIBLE LEUKOENCEPHALOPATHY; MICROBLEEDS; MRI; ENCEPHALOPATHY; DIAGNOSIS; INFARCTS		[Greenberg, Steven M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Greenberg, Steven M.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Rapalino, Otto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, SM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021; Demchuk, Andrew M/E-1103-2012	Frosch, Matthew P/0000-0002-3940-9861; Demchuk, Andrew M/0000-0002-4930-7789				Alcalay RN, 2009, J NEUROIMAGING, V19, P89, DOI 10.1111/j.1552-6569.2008.00241.x; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Arias M, 2008, MULT SCLER J, V14, P1139, DOI 10.1177/1352458508094642; Ay H, 2002, AM J NEURORADIOL, V23, P1561; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Blitstein MK, 2007, AM J ROENTGENOL, V189, P720, DOI 10.2214/AJR.07.2249; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Eng JA, 2004, ANN NEUROL, V55, P250, DOI 10.1002/ana.10810; Greenberg SM, 1997, STROKE, V28, P1418, DOI 10.1161/01.STR.28.7.1418; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haglund M, 2002, DEMENT GERIATR COGN, V14, P161, DOI 10.1159/000063606; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Kimberly WT, 2009, NEUROLOGY, V72, P1230, DOI 10.1212/01.wnl.0000345666.83318.03; Kinnecom C, 2007, NEUROLOGY, V68, P1411, DOI 10.1212/01.wnl.0000260066.98681.2e; Liem MK, 2008, RADIOLOGY, V249, P964, DOI 10.1148/radiol.2492080357; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Oh U, 2004, NEUROLOGY, V62, P494, DOI 10.1212/01.WNL.0000106951.94624.DF; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pettersen JA, 2008, ARCH NEUROL-CHICAGO, V65, P790, DOI 10.1001/archneur.65.6.790; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Rosand J, 2005, ANN NEUROL, V58, P459, DOI 10.1002/ana.20596; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sarazin M, 2002, EUR J NEUROL, V9, P353, DOI 10.1046/j.1468-1331.2002.00393.x; Scolding NJ, 2005, BRAIN, V128, P500, DOI 10.1093/brain/awh379; Topuz S, 2008, CLIN EXP OBSTET GYN, V35, P194; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x	33	8	8	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					373	381		10.1056/NEJMcpc1004364	http://dx.doi.org/10.1056/NEJMcpc1004364			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660406				2022-12-28	WOS:000280139300013
J	Titus, S; Bosch, X				Titus, Sandra; Bosch, Xavier			Tie funding to research integrity	NATURE			English	Editorial Material							METAANALYSIS; INSTRUCTION		[Titus, Sandra] Off Res Integr, Rockville, MD 20852 USA; [Bosch, Xavier] Univ Barcelona, Dept Internal Med, Hosp Clin, IDIBAPS, E-08007 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Titus, S (corresponding author), Off Res Integr, 1101 Wootton Pkwy,Suite 750, Rockville, MD 20852 USA.	sandra.titus@hhs.gov; xavbosch@clinic.ub.es						Adams Douglas, 2005, Account Res, V12, P225, DOI 10.1080/08989620500217495; Antes AL, 2009, ETHICS BEHAV, V19, P379, DOI 10.1080/10508420903035380; DuBois JM, 2009, J RES ADMIN, V40, P49; DYER KA, 2010, TECHNOLOGY COLL COMM; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Martinson BC, 2006, J EMPIR RES HUM RES, V1, P51, DOI 10.1525/jer.2006.1.1.51; McCabe DL, 2005, INT J EDUC INTEGR, V1; Steneck NH, 2007, ACAD MED, V82, P829, DOI 10.1097/ACM.0b013e31812f7d4d; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; 2008, LANCET, V374, P1568	10	16	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					436	437		10.1038/466436a	http://dx.doi.org/10.1038/466436a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	628SJ	20651673				2022-12-28	WOS:000280141200017
J	Severe, P; Juste, MAJ; Ambroise, A; Eliacin, L; Marchand, C; Apollon, S; Edwards, A; Bang, H; Nicotera, J; Godfrey, C; Gulick, RM; Johnson, WD; Pape, JW; Fitzgerald, DW				Severe, Patrice; Juste, Marc Antoine Jean; Ambroise, Alex; Eliacin, Ludger; Marchand, Claudel; Apollon, Sandra; Edwards, Alison; Bang, Heejung; Nicotera, Janet; Godfrey, Catherine; Gulick, Roy M.; Johnson, Warren D., Jr.; Pape, Jean William; Fitzgerald, Daniel W.			Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESOURCE-LIMITED SETTINGS; RANDOMIZED-TRIAL; CLINICAL-TRIALS; COTE-DIVOIRE; SOUTH-AFRICA; TUBERCULOSIS; AIDS; COHORT; PROPHYLAXIS; PROGRESSION	Background: For adults with human immunodeficiency virus (HIV) infection who have CD4+ T-cell counts that are greater than 200 and less than 350 per cubic millimeter and who live in areas with limited resources, the optimal time to initiate antiretroviral therapy remains uncertain. Methods: We conducted a randomized, open-label trial of early initiation of antiretroviral therapy, as compared with the standard timing for initiation of therapy, among HIV-infected adults in Haiti who had a confirmed CD4+ T-cell count that was greater than 200 and less than 350 per cubic millimeter at baseline and no history of an acquired immunodeficiency syndrome (AIDS) illness. The primary study end point was survival. The early-treatment group began taking zidovudine, lamivudine, and efavirenz therapy within 2 weeks after enrollment. The standard-treatment group started the same regimen of antiretroviral therapy when their CD4+ T-cell count fell to 200 per cubic millimeter or less or when clinical AIDS developed. Participants in both groups underwent monthly follow-up assessments and received isoniazid and trimethoprim-sulfamethoxazole prophylaxis with nutritional support. Results: Between 2005 and 2008, a total of 816 participants -- 408 per group -- were enrolled and were followed for a median of 21 months. The CD4+ T-cell count at enrollment was approximately 280 per cubic millimeter in both groups. There were 23 deaths in the standard-treatment group, as compared with 6 in the early-treatment group (hazard ratio with standard treatment, 4.0; 95% confidence interval [CI], 1.6 to 9.8; P=0.001). There were 36 incident cases of tuberculosis in the standard-treatment group, as compared with 18 in the early-treatment group (hazard ratio, 2.0; 95% CI, 1.2 to 3.6; P=0.01). Conclusions: Early initiation of antiretroviral therapy decreased the rates of death and incident tuberculosis. Access to antiretroviral therapy should be expanded to include all HIV-infected adults who have CD4+ T-cell counts of less than 350 per cubic millimeter, including those who live in areas with limited resources. (ClinicalTrials.gov number, NCT00120510.) N Engl J Med 2010;363:257-65.	[Fitzgerald, Daniel W.] Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, Dept Med, New York, NY 10065 USA; [Severe, Patrice; Juste, Marc Antoine Jean; Ambroise, Alex; Eliacin, Ludger; Marchand, Claudel; Apollon, Sandra; Pape, Jean William] GHESKIO, Port Au Prince, Haiti; [Edwards, Alison; Bang, Heejung] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA; [Nicotera, Janet] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Godfrey, Catherine] NIAID, Bethesda, MD 20892 USA	Cornell University; Cornell University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fitzgerald, DW (corresponding author), Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, Dept Med, Rm A-421,1300 York Ave, New York, NY 10065 USA.	dfitzgerald@gheskio.org			National Institute of Allergy and Infectious Diseases [AI58257, AI69421, AI51966]; Fogarty International Center [TW006896, TW006901, TW 00018]; Fondation Merieux; FOGARTY INTERNATIONAL CENTER [U2RTW006896, U2RTW006901, D43TW000018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058257, K24AI051966, U01AI069421, UM1AI069421] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fondation Merieux; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by grants from the National Institute of Allergy and Infectious Diseases (AI58257, AI69421, and AI51966) and from the Fogarty International Center (TW006896, TW006901, and TW 00018). Support for antiretroviral medications was provided by the Global Fund to Fight AIDS, Tuberculosis, and Malaria, GlaxoSmithKline, and Abbott. Laboratory training and infrastructure were supported by a grant from Fondation Merieux.	American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 1994, WKLY EPIDEMIOL REC, V69, P273; [Anonymous], 2009, LANCET, V373, P1352; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; *BRIT HIV ASS, 2008, TREATM HIV 1 INF AD; Burgess AL, 2001, AIDS, V15, P1875, DOI 10.1097/00002030-200109280-00018; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; *EACS, GUID CLIN MAN TREATM; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Fitzgerald DW, 2002, LANCET, V360, P1301, DOI 10.1016/S0140-6736(02)11338-9; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Klein J. P., 2003, SURVIVAL ANAL TECHNI; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Leger P, 2009, NEW ENGL J MED, V361, P828, DOI 10.1056/NEJMc0809485; Nunn P, 2007, J INFECT DIS, V196, pS5, DOI 10.1086/518660; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; *REG COMPL CTR DIV, 2009, MAN GRAD SEV AD PED; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WHO, 2009, GLOB TUB CONTR 2009; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2006, GUID PROGR MAN DRUG; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2006, ANT THER HIV INF AD; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; 2005, MMWR RECOMM REP, V53, P1203	34	273	291	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					257	265		10.1056/NEJMoa0910370	http://dx.doi.org/10.1056/NEJMoa0910370			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647201	Green Accepted			2022-12-28	WOS:000279864200008
J	Mercier, JC; Hummler, H; Durrmeyer, X; Sanchez-Luna, M; Carnielli, V; Field, D; Greenough, A; Van Overmeire, B; Jonsson, B; Hallman, M; Baldassarre, J				Mercier, Jean-Christophe; Hummler, Helmut; Durrmeyer, Xavier; Sanchez-Luna, Manuel; Carnielli, Virgilio; Field, David; Greenough, Anne; Van Overmeire, Bart; Jonsson, Baldvin; Hallman, Mikko; Baldassarre, James		EUNO Study Grp	Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial	LANCET			English	Article							SEVERE RESPIRATORY-FAILURE; ENDOTHELIAL GROWTH-FACTOR; PERSISTENT PULMONARY-HYPERTENSION; PRETERM INFANTS; LUNG INJURY; NEURODEVELOPMENTAL OUTCOMES; THERAPY; ANGIOGENESIS; HYPEROXIA	Background In animal models, inhaled nitric oxide improved gas exchange and lung structural development, but its use in premature infants at risk of developing bronchopulmonary dysplasia remains controversial. We therefore tested the hypothesis that inhaled nitric oxide at a low concentration, started early and maintained for an extended period in babies with mild respiratory failure, might reduce the incidence of bronchopulmonary dysplasia. Methods 800 preterm infants with a gestational age at birth of between 24 weeks and 28 weeks plus 6 days (inclusive), weighing at least 500 g, requiring surfactant or continuous positive airway pressure for respiratory distress syndrome within 24 h of birth were randomly assigned in a one-to-one ratio to inhaled nitric oxide (5 parts per million) or placebo gas (nitrogen gas) for a minimum of 7 days and a maximum of 21 days in a double-blind study done at 36 centres in nine countries in the European Union. Care providers and investigators were masked to the computer-generated treatment assignment The primary outcome was survival without development of bronchopulmonary dysplasia at postmenstrual age 36 weeks. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00551642. Findings 399 infants were assigned to inhaled nitric oxide, and 401 to placebo. 395 and 400, respectively, were analysed. Treatment with inhaled nitric oxide and placebo did not result in significant differences in survival of infants without development of bronchopulmonary dysplasia (258 [65%] of 395 vs 262 [66%] of 400, respectively; relative risk 1.05, 95% CI 0.78-1.43); in survival at 36 weeks' postmenstrual age (343 [86%) of 399 vs 359 [90%] of 401, respectively; 0 74, 0.48-1 15); and in development of bronchopulmonary dysplasia (81 [24%] of 339 vs 96 [27%] of 358, respectively; 0.83, 0 58-1.17). Interpretation Early use of low-dose inhaled nitric oxide in very premature babies did not improve survival without bronchopulmonary dysplasia or brain injury, suggesting that such a preventive treatment strategy is unsuccessful.	[Mercier, Jean-Christophe] Univ Paris 07, Hop Robert Debre, AP HP, F-75019 Paris, France; [Mercier, Jean-Christophe] Univ Ulm, Childrens Hosp, Dept Paediat Emergency Med, Ulm, Germany; [Hummler, Helmut] Univ Ulm, Childrens Hosp, Div Neonatol, Ulm, Germany; [Durrmeyer, Xavier] Ctr Hosp Intercommunal Creteil, Dept Neonatol, Creteil, France; [Sanchez-Luna, Manuel] Hosp Univ Gregorio Maranon, Dept Neonatology, Madrid, Spain; [Carnielli, Virgilio] Polytech Univ Marche, Dept Neonatol, Mother & Child Inst, Osped Salesi Azienda Osped,Univ Osped Riuniti, Ancona, Italy; [Field, David] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Greenough, Anne] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Van Overmeire, Bart] Univ Antwerp Hosp, Dept Neonatol, Antwerp, Belgium; [Jonsson, Baldvin] Karolinska Inst, Dept Neonatol, Stockholm, Sweden; [Hallman, Mikko] Oulu Univ Hosp, Dept Paediat, Oulu, Finland; [Baldassarre, James] Ikaria, Dept Clin Dev, Clinton, NJ USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Ulm University; Ulm University; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; General University Gregorio Maranon Hospital; Marche Polytechnic University; University of Leicester; University of London; King's College London; University of Antwerp; Karolinska Institutet; University of Oulu	Mercier, JC (corresponding author), Univ Paris 07, Hop Robert Debre, AP HP, 48 Blvd Serurier, F-75019 Paris, France.		Sanchez Luna, Manuel/H-2165-2014; DOMENECH, EDUARDO/I-1239-2015; Hummler, Helmut/AAN-7297-2021; Durrmeyer, Xavier/AAB-7519-2020; roze, jean christophe/B-5433-2012; Zemlin, Michael/AAB-5746-2020; Senn, Stephen/B-2903-2013; Sanchez Luna, Manuel/F-5827-2012; Hallman, Niilo/AHD-9810-2022; Valls, Adolfo/E-1358-2012	Sanchez Luna, Manuel/0000-0001-9543-7392; DOMENECH, EDUARDO/0000-0002-5363-212X; Durrmeyer, Xavier/0000-0002-6303-7252; Zemlin, Michael/0000-0001-9528-7419; Senn, Stephen/0000-0002-7558-8473; Roze, Jean-Christophe/0000-0003-3367-512X; Greenough, Anne/0000-0002-8672-5349; Halliday, Henry/0000-0001-7978-4992; Jonsson, Baldvin/0000-0002-9812-732X; Vento, Giovanni/0000-0003-3121-9569; Pratesi, Simone/0000-0002-8943-7246	Ikaria; INO Therapeutics (Clinton, New Jersey, USA); British Heart Foundation AG; ventilator manufacturers	Ikaria; INO Therapeutics (Clinton, New Jersey, USA); British Heart Foundation AG; ventilator manufacturers	J-CM has received advisory board consulting fees from Ikaria and INO Therapeutics HH has received speaker's fees from Linde Gas Therapeutics XD has received travel support for abstract presentation from INO Therapeutics MS-L, VC, DF, AG, BVO, BJ. and MH have received advisory board consulting fees and travel support from INO Therapeutics JB is an employee of Ikana All other authors declare that they have no conflicts of interests; INO Therapeutics (Clinton, New Jersey, USA) sponsored the study J-CM has received research grants from Ikaria and INO Therapeutics, and the French Ministry of Health to study the effects of inhaled nitric oxide on the developing brain of the rat pup DF has received research grants from the British Heart Foundation AG has received research grants from the ventilator manufacturers. Abbott Laboratories and MedImmune The report was edited by Peloton Advantage	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Barrington KJ, 2007, PEDIATRICS, V120, P1088, DOI 10.1542/peds.2007-0726; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; Davidson D, 1998, PEDIATRICS, V101, P325, DOI 10.1542/peds.101.3.325; Day RW, 1997, CHEST, V112, P1324, DOI 10.1378/chest.112.5.1324; Deeg KH, 1999, ULTRASCHALL MED, V20, P165; Field D, 2005, PEDIATRICS, V115, P926, DOI 10.1542/peds.2004-1209; Finer N, 1997, PEDIATRICS, V99, P838; Goldenberg RL, 2001, JAMA-J AM MED ASSOC, V285, P633, DOI 10.1001/jama.285.5.633; Gutierrez HH, 1996, FREE RADICAL BIO MED, V21, P43, DOI 10.1016/0891-5849(95)02226-0; Hintz SR, 2007, J PEDIATR-US, V151, P16, DOI 10.1016/j.jpeds.2007.03.017; *I MED NAT AC, 2006, PIET BIRTH CAUS CONS; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kinsella JP, 2006, NEW ENGL J MED, V355, P354, DOI 10.1056/NEJMoa060442; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; Lorch SA, 2007, J PEDIATR-US, V151, P604, DOI 10.1016/j.jpeds.2007.04.052; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; Mestan KKL, 2005, NEW ENGL J MED, V353, P23, DOI 10.1056/NEJMoa043514; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Stocker C, 2003, INTENS CARE MED, V29, P1996, DOI 10.1007/s00134-003-2016-4; Tang JR, 2007, AM J PHYSIOL-LUNG C, V293, pL1271, DOI 10.1152/ajplung.00224.2007; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; VanMeurs KP, 1997, PEDIATR PULM, V24, P319; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963	36	121	129	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					346	354		10.1016/S0140-6736(10)60664-2	http://dx.doi.org/10.1016/S0140-6736(10)60664-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636FW	20655106				2022-12-28	WOS:000280717900033
J	Wood, E; Werb, D; Kazatchkine, M; Kerr, T; Hankins, C; Gorna, R; Nutt, D; Jarlais, DD; Barre-Sinoussi, F; Montaner, J				Wood, Evan; Werb, Dan; Kazatchkine, Michel; Kerr, Thomas; Hankins, Catherine; Gorna, Robin; Nutt, David; Jarlais, Don Des; Barre-Sinoussi, Francoise; Montaner, Julio			Vienna Declaration: a call for evidence-based drug policies	LANCET			English	Editorial Material							LOST; HIV		[Wood, Evan; Werb, Dan; Kerr, Thomas; Montaner, Julio] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Kazatchkine, Michel] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Hankins, Catherine] Joint UN Programme HIV AIDS, Geneva, Switzerland; [Gorna, Robin] Int AIDS Soc, Geneva, Switzerland; [Nutt, David] Univ London Imperial Coll Sci Technol & Med, Dept Neuropsychopharmacol & Mol Imaging, London, England; [Jarlais, Don Des] Ctr Drug Use & HIV Res, New York, NY USA; [Barre-Sinoussi, Francoise] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Imperial College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wood, E (corresponding author), Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.		Montaner, Julio/K-7621-2012; Barre-Sinoussi, Françoise/G-8355-2011	Hankins, Catherine/0000-0002-1642-8592	NIDA NIH HHS [DP1 DA026182] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 2000, NATURE, V406, P15, DOI 10.1038/35017662; [Anonymous], 2001, LANCET, V357, P971; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Finnerty E, 2006, LANCET, V368, P1066, DOI 10.1016/S0140-6736(06)69439-7; Lurie P, 1997, LANCET, V349, P604, DOI 10.1016/S0140-6736(96)05439-6; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Pearson H, 2004, NATURE, V430, P394, DOI 10.1038/430394a; Reuter P, 2009, ADDICTION, V104, P510, DOI 10.1111/j.1360-0443.2009.02536.x; *UNAIDS, 2008, 2008 REP GLOB AIDS E; WHO UNODC UNAIDS, 2009, TECHN GUID COUNTR SE; Wood E, 2008, LANCET INFECT DIS, V8, P142, DOI 10.1016/S1473-3099(08)70021-5; Wood E, 2009, LANCET, V373, P989, DOI 10.1016/S0140-6736(09)60455-4	13	53	53	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					310	312		10.1016/S0140-6736(10)60958-0	http://dx.doi.org/10.1016/S0140-6736(10)60958-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20650517				2022-12-28	WOS:000280717900007
J	Wang, FW; Dai, J; Daum, JR; Niedzialkowska, E; Banerjee, B; Stukenberg, PT; Gorbsky, GJ; Higgins, JMG				Wang, Fangwei; Dai, Jun; Daum, John R.; Niedzialkowska, Ewa; Banerjee, Budhaditya; Stukenberg, P. Todd; Gorbsky, Gary J.; Higgins, Jonathan M. G.			Histone H3 Thr-3 Phosphorylation by Haspin Positions Aurora B at Centromeres in Mitosis	SCIENCE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; HELA-CELLS; SURVIVIN; SPINDLE; KINASE; MCAK; ALIGNMENT; BOREALIN; KINETOCHORES; SMAC/DIABLO	Aurora B is a component of the chromosomal passenger complex (CPC) required for correct spindle-kinetochore attachments during chromosome segregation and for cytokinesis. The chromatin factors that recruit the CPC to centromeres are unknown, however. Here we show that phosphorylation of histone H3 threonine 3 (H3T3ph) by Haspin is necessary for CPC accumulation at centromeres and that the CPC subunit Survivin binds directly to H3T3ph. A nonbinding Survivin-D70A/D71A mutant does not support centromeric CPC concentration, and both Haspin depletion and Survivin-D70A/D71A mutation diminish centromere localization of the kinesin MCAK and the mitotic checkpoint response to taxol. Survivin-D70A/D71A mutation and microinjection of H3T3ph-specific antibody both compromise centromeric Aurora B functions but do not prevent cytokinesis. Therefore, H3T3ph generated by Haspin positions the CPC at centromeres to regulate selected targets of Aurora B during mitosis.	[Wang, Fangwei; Dai, Jun; Higgins, Jonathan M. G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Daum, John R.; Gorbsky, Gary J.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Res Program, Oklahoma City, OK 73104 USA; [Niedzialkowska, Ewa; Banerjee, Budhaditya; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Oklahoma Medical Research Foundation; University of Virginia	Higgins, JMG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Smith Bldg,1 Jimmy Fund Way, Boston, MA 02115 USA.	jhiggins@rics.bwh.harvard.edu	Dai, Jun/J-9718-2015	Niedzialkowska, Ewa/0000-0002-0348-3154; Higgins, Jonathan/0000-0001-6622-8268; Gorbsky, Gary/0000-0003-3076-4725; Stukenberg, Todd/0000-0002-6788-2111; Wang, Fangwei/0000-0001-5617-282X	American Cancer Society [RSG-05-13401-GMC]; National Institutes of Health [R01-GM074210, R01-GM050412, R01-GM063045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074210, R01GM050412, R01GM063045] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. C. Earnshaw, H. Funabiki, M. A. Lampson, S. M. A. Lens, J. P. Noel, S. S. Taylor, L. Wordeman, and Y. Zheng for cDNAs and antibodies; C. Crafter of AstraZeneca for ZM447439; and H. Funabiki and A. Kelly for sharing unpublished results. J. D. and J. M. G. H. have patents pending on Haspin inhibitors. This work was funded by grants from the American Cancer Society (RSG-05-13401-GMC to J. M. G. H) and the National Institutes of Health (R01-GM074210 to J. M. G. H., R01-GM050412 to G. J. G., and R01-GM063045 to P.T.S.).	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Cao LH, 2006, BIOCHEM BIOPH RES CO, V346, P400, DOI 10.1016/j.bbrc.2006.05.131; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lens SMA, 2006, MOL BIOL CELL, V17, P1897, DOI 10.1091/mbc.E05-08-0727; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	30	329	340	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					231	235		10.1126/science.1189435	http://dx.doi.org/10.1126/science.1189435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20705812	Green Accepted			2022-12-28	WOS:000282644600045
J	Sox, HC				Sox, Harold C.			Comparative Effectiveness Research: A Progress Report	ANNALS OF INTERNAL MEDICINE			English	Article								Sixteen months ago, comparative effectiveness research (CER) began its rapid rise, when the American Recovery and Reinvestment Act of 2009 allocated $1.1 billion for CER. This progress report summarizes how the recipients of the funds-the National Institutes of Health, Agency for Healthcare Research and Quality, and Office of the Secretary of the U. S. Department of Health and Human Services-are spending the $1.1 billion, how the Institute of Medicine priority topics have fared in the agencies' funding programs, and the developing plans for a national CER program. As the United States works to absorb 32 million currently uninsured people into the health care system while simultaneously improving the quality of care and slowing cost increases, CER will increasingly be a necessary component of this change.	[Sox, Harold C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA	Dartmouth College	Sox, HC (corresponding author), 31 Faraway Lane, W Lebanon, NH 03784 USA.	hsox@comcast.net			CER	CER	The author thanks Michael S. Lauer (NIH), Jean Slutsky (AHRQ), and Kate Goodrich (OS-DHSS) for personal communications that facilitated the task of characterizing the federal government's response to the Reinvestment Act funding of CER.	Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Clancy C, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001235; DETRE K, 1981, CIRCULATION, V63, P1329, DOI 10.1161/01.CIR.63.6.1329; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Horwitz RI, 1996, J CLIN EPIDEMIOL, V49, P395, DOI 10.1016/0895-4356(95)00058-5; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Lauer MS, 2010, JAMA-J AM MED ASSOC, V303, P2182, DOI 10.1001/jama.2010.726; *US DEP HHS, RES PORTF ONL REP TO; *US DEP HHS, AR RES TOP CHOS; *US DEP HHS, COMP EFF RES GRANT A; *US DEP HHS, FACT SHEETS REC ACT; *US DEP HHS, REC ACT AW INV EV AW; VanLare JM, 2010, NEW ENGL J MED, V362, P970, DOI 10.1056/NEJMp1000096	13	52	53	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2010	153	7					469	+		10.7326/0003-4819-153-7-201010050-00269	http://dx.doi.org/10.7326/0003-4819-153-7-201010050-00269			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VG	20679544				2022-12-28	WOS:000282517000006
J	Knispel, B; Allen, B; Cordes, JM; Deneva, JS; Anderson, D; Aulbert, C; Bhat, NDR; Bock, O; Bogdanov, S; Brazier, A; Camilo, F; Champion, DJ; Chatterjee, S; Crawford, F; Demorest, PB; Fehrmann, H; Freire, PCC; Gonzalez, ME; Hammer, D; Hessels, JWT; Jenet, FA; Kasian, L; Kaspi, VM; Kramer, M; Lazarus, P; van Leeuwen, J; Lorimer, DR; Lyne, AG; Machenschalk, B; McLaughlin, MA; Messenger, C; Nice, DJ; Papa, MA; Pletsch, HJ; Prix, R; Ransom, SM; Siemens, X; Stairs, IH; Stappers, BW; Stovall, K; Venkataraman, A				Knispel, B.; Allen, B.; Cordes, J. M.; Deneva, J. S.; Anderson, D.; Aulbert, C.; Bhat, N. D. R.; Bock, O.; Bogdanov, S.; Brazier, A.; Camilo, F.; Champion, D. J.; Chatterjee, S.; Crawford, F.; Demorest, P. B.; Fehrmann, H.; Freire, P. C. C.; Gonzalez, M. E.; Hammer, D.; Hessels, J. W. T.; Jenet, F. A.; Kasian, L.; Kaspi, V. M.; Kramer, M.; Lazarus, P.; van Leeuwen, J.; Lorimer, D. R.; Lyne, A. G.; Machenschalk, B.; McLaughlin, M. A.; Messenger, C.; Nice, D. J.; Papa, M. A.; Pletsch, H. J.; Prix, R.; Ransom, S. M.; Siemens, X.; Stairs, I. H.; Stappers, B. W.; Stovall, K.; Venkataraman, A.			Pulsar Discovery by Global Volunteer Computing	SCIENCE			English	Article												benjamin.knispel@aei.mpg.de	Bhat, Ramesh/B-7396-2013; Freire, Paulo/ABE-8926-2021; Allen, Bruce/K-2327-2012; Hessels, Jason/GTO-3261-2022; Stovall, Kevin/D-9844-2014; Chatterjee, Shami/AAE-8374-2022; Lorimer, Duncan/ABH-7909-2020; Crawford, Fronefield/AAX-1677-2021	Freire, Paulo/0000-0003-1307-9435; Allen, Bruce/0000-0003-4285-6256; Hessels, Jason/0000-0003-2317-1446; Stovall, Kevin/0000-0002-7261-594X; Crawford, Fronefield/0000-0002-2578-0360; van Leeuwen, Joeri/0000-0001-8503-6958; Prix, Reinhard/0000-0002-3789-6424; McLaughlin, Maura/0000-0001-7697-7422; Knispel, Benjamin/0000-0003-3168-0929; Bhat, Ramesh/0000-0002-8383-5059; Kramer, Michael/0000-0002-4175-2271; Messenger, Chris/0000-0001-7488-5022; Papa, M.Alessandra/0000-0002-1007-5298; Chatterjee, Shami/0000-0002-2878-1502; Ransom, Scott/0000-0001-5799-9714; Bogdanov, Slavko/0000-0002-9870-2742; Champion, David/0000-0003-1361-7723; Aulbert, Carsten/0000-0002-1481-8319; Nice, David/0000-0002-6709-2566	Canada Foundation for Innovation; Canadian Institute for Advanced Research; Fonds quebecois de la recherche sur la nature et les technologies; Max Planck Gesellschaft; National Astronomy and Ionosphere Center; National Radio Astronomy Observatory; Natural Sciences and Engineering Research Council (of Canada); NSF; Netherlands Organization for Scientific Research; Science and Technology Facilities Council; STFC [ST/F002874/1, ST/G002487/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002874/1, ST/G002487/1] Funding Source: researchfish	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Max Planck Gesellschaft(Max Planck Society); National Astronomy and Ionosphere Center; National Radio Astronomy Observatory; Natural Sciences and Engineering Research Council (of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank Einstein@Home volunteers, who made this discovery possible. The computers of C. and H. Colvin (Ames, Iowa, USA) and D. Gebhardt (Universitat Mainz, Musikinformatik, Germany) identified J2007+2722 with the highest significance. This work was supported by Canada Foundation for Innovation, Canadian Institute for Advanced Research, fonds quebecois de la recherche sur la nature et les technologies, Max Planck Gesellschaft, National Astronomy and Ionosphere Center, National Radio Astronomy Observatory, Natural Sciences and Engineering Research Council (of Canada), NSF, and Netherlands Organization for Scientific Research, Science and Technology Facilities Council; see the SOM for details.	Abbott BP, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.042003; Anderson D. P., 2006, P 2006 ACM IEEE C SU, P126; BELCZYNSKI K, MON NOT R A IN PRESS; CORDES JM, NE2001 NEW MODEL GAL; Halpern JP, 2010, ASTROPHYS J, V709, P436, DOI 10.1088/0004-637X/709/1/436	5	44	46	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1305	1305		10.1126/science.1195253	http://dx.doi.org/10.1126/science.1195253			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20705813	Green Submitted			2022-12-28	WOS:000281657300027
J	Faulkner, T; Iqbal, N; Liu, H; McGreevy, J; Vegh, D				Faulkner, Thomas; Iqbal, Nabil; Liu, Hong; McGreevy, John; Vegh, David			Strange Metal Transport Realized by Gauge/Gravity Duality	SCIENCE			English	Article							QUANTUM CRITICAL-BEHAVIOR; NORMAL-STATE; LIQUID BEHAVIOR; GAUGE-THEORY; BLACK-HOLES; TEMPERATURE	Fermi liquid theory explains the thermodynamic and transport properties of most metals. The so-called non-Fermi liquids deviate from these expectations and include exotic systems such as the strange metal phase of cuprate superconductors and heavy fermion materials near a quantum phase transition. We used the anti-de-Sitter/conformal field theory correspondence to identify a class of non-Fermi liquids; their low-energy behavior is found to be governed by a nontrivial infrared fixed point, which exhibits nonanalytic scaling behavior only in the time direction. For some representatives of this class, the resistivity has a linear temperature dependence, as is the case for strange metals.	[Iqbal, Nabil; Liu, Hong; McGreevy, John] MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA; [Faulkner, Thomas] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Vegh, David] SUNY Stony Brook, Simons Ctr Geometry & Phys, Stony Brook, NY 11794 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, H (corresponding author), MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA.	hong_liu@mit.edu		McGreevy, John/0000-0002-7077-1041	U.S. Department of Energy (DOE) [DE-FG0205ER41360]; Outstanding Junior Investigator program; Alfred P. Sloan fellowship; NSF [NSF PHY05-51164]; University of California; Santa Barbara Department of Physics	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Outstanding Junior Investigator program; Alfred P. Sloan fellowship(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); University of California(University of California System); Santa Barbara Department of Physics	We thank E. Abrahams, P. Coleman, S. Hartnoll, G. Horowitz, S. Kachru, P. Lee, S.-S. Lee, J. Maldacena, J. Polchinski, K. Rajagopal, S. Sachdev, K. Schalm, E. Silverstein, S. Trivedi, C. M. Varma, J. Zaanen, and in particular T. Senthil for discussions and encouragement. This work was supported in part by funds provided by the U.S. Department of Energy (DOE) under cooperative research agreement DE-FG0205ER41360 and the Outstanding Junior Investigator program, and in part by an Alfred P. Sloan fellowship. Also supported in part by by NSF under grant no. NSF PHY05-51164 and the University of California, Santa Barbara Department of Physics.	Abrahams E, 2000, P NATL ACAD SCI USA, V97, P5714, DOI 10.1073/pnas.100118797; Aeppli G, 1997, SCIENCE, V278, P1432, DOI 10.1126/science.278.5342.1432; Aji V, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184501; Aji V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067003; ANDERSON PW, 1990, PHYS REV LETT, V64, P1839, DOI 10.1103/PhysRevLett.64.1839; BEKENSTEIN JD, 1973, PHYS REV D, V7, P2333, DOI 10.1103/PhysRevD.7.2333; Chamblin A, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.064018; Cubrovic M, 2009, SCIENCE, V325, P439, DOI 10.1126/science.1174962; Faulkner T, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2010)121; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Gubser SS, 1996, PHYS REV D, V54, P3915, DOI 10.1103/PhysRevD.54.3915; Gubser SS, 1998, PHYS LETT B, V428, P105, DOI 10.1016/S0370-2693(98)00377-3; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Hartnoll SA, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2010)120; HAWKING SW, 1976, COMMUN MATH PHYS, V46, P206, DOI 10.1007/BF01608497; HAWKING SW, 1975, COMMUN MATH PHYS, V43, P199, DOI 10.1007/BF02345020; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; LEE PA, 1992, PHYS REV B, V46, P5621, DOI 10.1103/PhysRevB.46.5621; Lee SS, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165102; Lee SS, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.086006; Maldacena J., 1999, International Journal of Theoretical Physics, V38, P1113, DOI 10.1023/A:1026654312961; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035103; Shekhter A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045117; Tallon JL, 1999, PHYS STATUS SOLIDI B, V215, P531, DOI 10.1002/(SICI)1521-3951(199909)215:1<531::AID-PSSB531>3.0.CO;2-W; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI [10.4310/ATMP.1998.v2.n2.a2, DOI 10.4310/ATMP.1998.V2.N2.A2]; Zaanen Jan, 2009, Nature, V462, P15, DOI 10.1038/462015f	31	112	112	4	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1043	1047		10.1126/science.1189134	http://dx.doi.org/10.1126/science.1189134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20688983				2022-12-28	WOS:000281253500031
J	Mariappan, M; Li, XZ; Stefanovic, S; Sharma, A; Mateja, A; Keenan, RJ; Hegde, RS				Mariappan, Malaiyalam; Li, Xingzhe; Stefanovic, Sandra; Sharma, Ajay; Mateja, Agnieszka; Keenan, Robert J.; Hegde, Ramanujan S.			A ribosome-associating factor chaperones tail-anchored membrane proteins	NATURE			English	Article							ENDOPLASMIC-RETICULUM; ER MEMBRANE; INSERTION; GET3; COMPLEX; RECOGNITION; BINDING; IDENTIFICATION; TRANSLATION; TERMINATION	Hundreds of proteins are inserted post-translationally into the endoplasmic reticulum (ER) membrane by a single carboxyterminal transmembrane domain (TMD)(1). During targeting through the cytosol, the hydrophobic TMD of these tail-anchored (TA) proteins requires constant chaperoning to prevent aggregation or inappropriate interactions. A central component of this targeting system is TRC40, a conserved cytosolic factor that recognizes the TMD of TA proteins and delivers them to the ER for insertion(2-4). The mechanism that permits TRC40 to find and capture its TA protein cargos effectively in a highly crowded cytosol is unknown. Here we identify a conserved three-protein complex composed of Bat3, TRC35 and Ubl4A that facilitates TA protein capture by TRC40. This Bat3 complex is recruited to ribosomes synthesizing membrane proteins, interacts with the TMDs of newly released TA proteins, and transfers them to TRC40 for targeting. Depletion of the Bat3 complex allows non-TRC40 factors to compete for TA proteins, explaining their mislocalization in the analogous yeast deletion strains(5-7). Thus, the Bat3 complex acts as a TMD-selective chaperone that effectively channels TA proteins to the TRC40 insertion pathway.	[Mariappan, Malaiyalam; Li, Xingzhe; Stefanovic, Sandra; Sharma, Ajay; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Li, Xingzhe] Peking Univ, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Mateja, Agnieszka; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Peking University; University of Chicago	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	hegder@mail.nih.gov	mariappan, malaiyalam/K-9024-2012	Hegde, Ramanujan/0000-0001-8338-852X; Keenan, Robert/0000-0003-1466-0889	National Institutes of Health; Edward Mallinckrodt Jr Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank S. Appathurai and M. Downing for technical assistance, Hegde lab members for advice, and J. Weissman and W. Clemons for useful discussions and sharing results before publication. This work was supported by the Intramural Research Program of the National Institutes of Health (R.S.H.) and Edward Mallinckrodt Jr Foundation (R.J.K.).	Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Bozkurt G, 2010, FEBS LETT, V584, P1509, DOI 10.1016/j.febslet.2010.02.070; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Cao JH, 1996, MOL CELL BIOL, V16, P603; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Copic A, 2009, GENETICS, V182, P757, DOI 10.1534/genetics.109.101105; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; HOBDEN AN, 1978, BIOCHEM J, V170, P57, DOI 10.1042/bj1700057; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; LODISH HF, 1972, J BIOL CHEM, V247, P3622; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	30	196	201	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1120	U138		10.1038/nature09296	http://dx.doi.org/10.1038/nature09296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20676083	Green Accepted			2022-12-28	WOS:000281203600043
J	Lentini, S				Lentini, Salvatore			Ross principle and concept of a living valve	LANCET			English	Editorial Material									Policlin Univ G Martino, Dipartimento Cardiotoracovasc, I-98125 Messina, Italy	AOU Policlinico Gaetano Martino; University of Messina	Lentini, S (corresponding author), Policlin Univ G Martino, Dipartimento Cardiotoracovasc, I-98125 Messina, Italy.	salvolentini@alice.it		Lentini, Salvatore/0000-0001-5340-2589				El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Klieverik LMA, 2007, EUR HEART J, V28, P1993, DOI 10.1093/eurheartj/ehl550; Lansac E, 2002, EUR J CARDIO-THORAC, V22, P497, DOI 10.1016/S1010-7940(02)00405-0; Luciani GB, 2003, CIRCULATION, V108, P61, DOI 10.1161/01.cir.0000089183.92233.75; Rahimtoola SH, 2010, J AM COLL CARDIOL, V55, P2413, DOI 10.1016/j.jacc.2009.10.085; ROSS DN, 1967, LANCET, V2, P956; Yacoub MH, 1999, ANN THORAC SURG, V68, pS37, DOI 10.1016/S0003-4975(99)00745-6	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					490	491		10.1016/S0140-6736(10)60966-X	http://dx.doi.org/10.1016/S0140-6736(10)60966-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20684980				2022-12-28	WOS:000281266800005
J	Southall, D; Cham, M; Sey, O				Southall, David; Cham, Mamady; Sey, Omar			Health workers lost to international bodies in poor countries	LANCET			English	Editorial Material									[Southall, David] Maternal & Childhlth Advocacy Int, Nottingham NG1 5BB, England; [Cham, Mamady; Sey, Omar] Minist Hlth & Social Welf, Banjul, Gambia		Southall, D (corresponding author), Maternal & Childhlth Advocacy Int, Nottingham NG1 5BB, England.	davids@doctors.org.uk						*HLTH ALL INT, NGO COD COND HLTH SY; *MCAI, MCAI ESS EMCH ESS SU; *NUFF COUNC BIOETH, 2005, ETH HEALTHC REL RES; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; *WHO GLOB HTLH WOR, 2008, KAMP DECL AG GLOB AC; 2008, LANCET, V371, P623	7	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					498	499		10.1016/S0140-6736(10)61157-9	http://dx.doi.org/10.1016/S0140-6736(10)61157-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20709218				2022-12-28	WOS:000281266800010
J	Mellman, I; Clausen, BE				Mellman, Ira; Clausen, Bjorn E.			beta-Catenin Balances Immunity	SCIENCE			English	Editorial Material							MOUSE LYMPH-NODES; DENDRITIC CELLS; T-CELLS		[Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [Clausen, Bjorn E.] Erasmus MC, Univ Med Ctr, Dept Immunol, NL-3015 GE Rotterdam, Netherlands	Roche Holding; Genentech; Erasmus University Rotterdam; Erasmus MC	Mellman, I (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	mellman.ira@gene.com; b.clausen@erasmusmc.nl	Mellman, Ira/ABG-5896-2020; CLAUSEN, Björn Erik/A-8229-2010	CLAUSEN, Björn Erik/0000-0002-2484-7842				Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stoitzner P, 2005, J INVEST DERMATOL, V125, P116, DOI 10.1111/j.0022-202X.2005.23757.x; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488	13	14	14	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					767	769		10.1126/science.1194185	http://dx.doi.org/10.1126/science.1194185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705838				2022-12-28	WOS:000280809900024
J	Ephgrave, KS				Ephgrave, Kimberly S.			Maintenance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kimberly-ephgrave@uiowa.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					615	616		10.1001/jama.2010.1118	http://dx.doi.org/10.1001/jama.2010.1118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699446				2022-12-28	WOS:000280829200001
J	Rait, G; Walters, K; Bottomley, C; Petersen, I; Iliffe, S; Nazareth, I				Rait, Greta; Walters, Kate; Bottomley, Christian; Petersen, Irene; Iliffe, Steve; Nazareth, Irwin			Survival of people with clinical diagnosis of dementia in primary care: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; MORTALITY; SERVICES; VALIDATION; ONSET; UK	Objectives To estimate survival after a diagnosis of dementia in primary care, compared with people without dementia, and to determine incidence of dementia. Design Cohort study using data from The Health Improvement Network (THIN), a primary care database. Setting 353 general practices in the United Kingdom providing data to THIN. Participants All adults aged 60 years or over with a first ever code for dementia from 1990 to 2007 (n=22 529); random sample of five participants without dementia for every participant with dementia matched on practice and time period (n=112 645). Main outcome measures Median survival by age and sex; mortality rates; incidence of dementia by age, sex, and deprivation. Results The median survival of people with dementia diagnosed at age 60-69 was 6.7 (interquartile range 3.1-10.8) years, falling to 1.9 (0.7-3.6) years for those diagnosed at age 90 or over. Adjusted mortality rates were highest in the first year after diagnosis (relative risk 3.68, 95% confidence interval 3.44 to 3.94). This dropped to 2.49 (2.29 to 2.71) in the second year. The incidence of recorded dementia remained stable over time (3-4/1000 person years at risk). The incidence was higher in women and in younger age groups (60-79 years) living in deprived areas. Conclusions Median survival was much lower than in screened populations. These clinically relevant estimates can assist patients and carers, clinicians, and policy makers when planning support for this population. The high risk of death in the first year after diagnosis may reflect diagnoses made at times of crisis or late in the disease trajectory. Late recording of diagnoses of dementia in primary care may result in missed opportunities for potential early interventions.	[Rait, Greta; Nazareth, Irwin] Med Res Council Gen Practice Res Framework, London NW1 2ND, England; [Walters, Kate; Bottomley, Christian; Petersen, Irene; Iliffe, Steve] UCL Med Sch, Res Dept Primary Care & Populat Hlth, London NW3 2PT, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London	Rait, G (corresponding author), Med Res Council Gen Practice Res Framework, London NW1 2ND, England.	gr@gprf.mrc.ac.uk	Petersen, Irene/C-5702-2009; Petersen, Irene/I-2751-2012; Iliffe, Steve/L-8379-2019	Petersen, Irene/0000-0002-0037-7524; Rait, Greta/0000-0002-7216-7294; Iliffe, Stephen/0000-0003-2806-3997; Nazareth, Irwin/0000-0003-2146-9628; Bottomley, Christian/0000-0002-5241-8412; Walters, Kate/0000-0003-2173-2430	North Central London Research Consortium; UCL; Medical Research Council (UK); Medical Research Council [G0900701, G0700837, MC_U122797163] Funding Source: researchfish; MRC [G0900701, G0700837, MC_U122797163] Funding Source: UKRI	North Central London Research Consortium; UCL; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Research Department of Primary Care and Population Health, University College London (UCL), holds a license to analyse data from THIN. This study was funded by the North Central London Research Consortium and sponsored by UCL. These sources were not involved in the analysis, interpretation, or decision to submit for publication. KW and IP were supported by a special training fellowship in health services research from the Medical Research Council (UK). This sponsor had no involvement in the analysis, interpretation, or decision to submit for publication.	Aguero-Torres H, 1999, J CLIN EPIDEMIOL, V52, P737, DOI 10.1016/S0895-4356(99)00067-0; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Bamford C, 2007, FAM PRACT, V24, P108, DOI 10.1093/fampra/cml068; Bourke Alison, 2004, Inform Prim Care, V12, P171; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Comas-Herrera A, 2007, INT J GERIATR PSYCH, V22, P1037, DOI 10.1002/gps.1830; Department of Health, 2009, LIVING WELL DEMENTIA; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P91, DOI 10.1097/01.wad.0000165511.52746.1f; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fitzpatrick AL, 2005, J NEUROL SCI, V229, P43, DOI 10.1016/j.jns.2004.11.022; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Iliffe S, 2006, FAM PRACT, V23, P353, DOI 10.1093/fampra/cmi116; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P85, DOI 10.1001/archneur.60.1.85; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Lester H, 2006, BRIT J GEN PRACT, V56, P244; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Lopponen M, 2003, AGE AGEING, V32, P606, DOI 10.1093/ageing/afg097; Lowin A, 2001, INT J GERIATR PSYCH, V16, P1143, DOI 10.1002/gps.499; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; MOLSA PK, 1995, ACTA NEUROL SCAND, V91, P159; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; *OFF NAT STAT, CENS 2001; *OFF NAT STAT, 2008, NAT POP PROJ 2006 BA; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Turner S, 2004, AGE AGEING, V33, P461, DOI 10.1093/ageing/afh140; Villars H, 2010, J NUTR HEALTH AGING, V14, P110, DOI 10.1007/s12603-010-0022-0; Wimo A, 2007, ALZHEIMERS DEMENT, V3, P81, DOI 10.1016/j.jalz.2007.02.001; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25	33	135	135	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2010	341								c3584	10.1136/bmj.c3584	http://dx.doi.org/10.1136/bmj.c3584			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636WK	20688840	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000280774200003
J	Shannon, K; Csete, J				Shannon, Kate; Csete, Joanne			Violence, Condom Negotiation, and HIV/STI Risk Among Sex Workers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV; INTERVENTIONS; PREVENTION; POLICY		[Shannon, Kate] Univ British Columbia, BC Ctr Excellence HIV AIDS, Dept Med, Div Aids, Vancouver, BC V6Z 1Y6, Canada; [Shannon, Kate] Univ British Columbia, Fac Med, Vancouver, BC V6Z 1Y6, Canada; [Csete, Joanne] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; Columbia University	Shannon, K (corresponding author), Univ British Columbia, BC Ctr Excellence HIV AIDS, Dept Med, Div Aids, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	kshannon@cfenet.ubc.ca						Blankenship KM, 2002, J LAW MED ETHICS, V30, P548, DOI 10.1111/j.1748-720X.2002.tb00425.x; Cohen J, 2004, SCIENCE, V304, P506, DOI 10.1126/science.304.5670.506; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; *OP SOC I, SEX WORK ACT NETW AR; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rhodes T., 2008, BMJ-BRIT MED J, V337/7669, P560; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Shannon Kate, 2009, BRIT MED J, V339, P442	10	171	173	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					573	574		10.1001/jama.2010.1090	http://dx.doi.org/10.1001/jama.2010.1090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682941				2022-12-28	WOS:000280525700029
J	Taylor, DR				Taylor, Daniel R.			The Haircut	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												daniel.taylor@drexelmed.edu	taylor, daniel/GYU-3348-2022					Canada G., 1995, FIST STICK KNIFE GUN; FERRICK TA, 2007, PHILADELPHIA INQ 072; Hurt H, 2001, ARCH PEDIAT ADOL MED, V155, P1351, DOI 10.1001/archpedi.155.12.1351; PRESTON SH, 2006, WASHINGTON POST 0826	4	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					504	505		10.1001/jama.2010.1085	http://dx.doi.org/10.1001/jama.2010.1085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633SQ	20682924				2022-12-28	WOS:000280525700001
J	Seckl, MJ; Sebire, NJ; Berkowitz, RS				Seckl, Michael J.; Sebire, Neil J.; Berkowitz, Ross S.			Gestational trophoblastic disease	LANCET			English	Article							HUMAN CHORIONIC-GONADOTROPIN; COMPLETE HYDATIDIFORM MOLE; POLYMERASE CHAIN-REACTION; RETROSPECTIVE COHORT SURVEY; REPEAT UTERINE EVACUATION; HIGH-DOSE CHEMOTHERAPY; FREE BETA-SUBUNIT; SUBSEQUENT PREGNANCY; ACTINOMYCIN-D; VINCRISTINE CHEMOTHERAPY	Gestational trophoblastic disease encompasses a range of pregnancy-related disorders, consisting of the premalignant disorders of complete and partial hydatidiform mole, and the malignant disorders of invasive mole, choriocarcinoma, and the rare placental-site trophoblastic tumour. These malignant forms are termed gestational trophoblastic tumours or neoplasia. Improvements in management and follow-up protocols mean that overall cure rates can exceed 98% with fertility retention, whereas most women would have died from malignant disease 60 years ago This success can be explained by the development of effective treatments, the use of human chorionic gonadotropin as a biomarker, and centralisation of care. We summarise strategies for management of gestational trophoblastic disease and address some of the controversies and future research directions.	[Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp Campus, Charing Cross Gestat Trophoblast Dis Ctr, Dept Canc Med, London W6 8RF, England; [Sebire, Neil J.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp Campus, Charing Cross Gestat Trophoblast Dis Ctr, Dept Histopathol, London W6 8RF, England; [Berkowitz, Ross S.] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst,Div Gynecol Oncol,Sch Med, Dept Obstet & Gynecol,New England Trophoblast Dis, Boston, MA 02115 USA	Imperial College London; Imperial College London; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Seckl, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp Campus, Charing Cross Gestat Trophoblast Dis Ctr, Dept Canc Med, London W6 8RF, England.		CUNHA, TERESA MARGARIDA/O-6601-2014; Kacperczyk-Bartnik, Joanna P./U-5928-2017	CUNHA, TERESA MARGARIDA/0000-0003-2411-0207; Kacperczyk-Bartnik, Joanna P./0000-0003-2539-3894; Sebire, Neil/0000-0001-5348-9063	Department of Health; National Commissioning Group; Cancer Treatment and Research Trust; Imperial College Experimental Cancer Medicine Centre; Biomedical Research Centre; Donald P Goldstein MD Trophoblaslic Registry Endowment Fund; Chonocarenoma Research Fund	Department of Health; National Commissioning Group; Cancer Treatment and Research Trust; Imperial College Experimental Cancer Medicine Centre; Biomedical Research Centre; Donald P Goldstein MD Trophoblaslic Registry Endowment Fund; Chonocarenoma Research Fund	MJS and NJS thank the Department of Health, National Commissioning Group, and the Cancer Treatment and Research Trust for their continued support MJS acknowledges support from the Imperial College Experimental Cancer Medicine Centre and Biomedical Research Centre grants RSB acknowledges the Donald P Goldstein MD Trophoblaslic Registry Endowment Fund and the Chonocarenoma Research Fund	Agarwal R, 2002, CLIN CANCER RES, V8, P1142; Alazzam M, 2009, COCHRANE DB SYST REV, V1; ATHANASSIOU A, 1983, CANCER, V52, P1728, DOI 10.1002/1097-0142(19831101)52:9<1728::AID-CNCR2820520929>3.0.CO;2-U; AZUMA C, 1991, GYNECOL ONCOL, V40, P29, DOI 10.1016/0090-8258(91)90080-O; Baergen RN, 2006, GYNECOL ONCOL, V100, P511, DOI 10.1016/j.ygyno.2005.08.058; BAGSHAWE KD, 1990, LANCET, V335, P1074, DOI 10.1016/0140-6736(90)92641-T; BAGSHAWE KD, 1986, LANCET, V2, P673; BAGSHAWE KD, 1977, RECENT RES CANCER, V62, P192; Benson CB, 2000, ULTRASOUND OBST GYN, V16, P188, DOI 10.1046/j.1469-0705.2000.00201.x; Berkowitz RS, 2009, NEW ENGL J MED, V360, P1639, DOI 10.1056/NEJMcp0900696; Berkowitz RS, 2009, GYNECOL ONCOL, V112, P654, DOI 10.1016/j.ygyno.2008.09.005; BERKOWITZ RS, 1985, OBSTET GYNECOL, V66, P677; BERKOWITZ RS, 1985, AM J OBSTET GYNECOL, V152, P1016, DOI 10.1016/0002-9378(85)90550-2; BERKOWITZ RS, 1986, GYNECOL ONCOL, V23, P111, DOI 10.1016/0090-8258(86)90123-X; Beyer J, 1996, J CLIN ONCOL, V14, P2638, DOI 10.1200/JCO.1996.14.10.2638; Blagden SP, 2002, BRIT J CANCER, V86, P26, DOI 10.1038/sj.bjc.6600041; BOLIS G, 1988, GYNECOL ONCOL, V31, P439, DOI 10.1016/S0090-8258(88)80029-5; Bower M, 1997, J CLIN ONCOL, V15, P2636, DOI 10.1200/JCO.1997.15.7.2636; Bower M, 1998, EUR J CANCER, V34, P1204, DOI 10.1016/S0959-8049(98)00059-8; BRACKEN MB, 1987, BRIT J OBSTET GYNAEC, V94, P1123, DOI 10.1111/j.1471-0528.1987.tb02311.x; BUCKLEY JD, 1988, CANCER RES, V48, P1004; Castrillon DH, 2001, AM J SURG PATHOL, V25, P1225, DOI 10.1097/00000478-200110000-00001; Cole LA, 2001, CLIN CHEM, V47, P308; Cole LA, 2006, GYNECOL ONCOL, V102, P160, DOI 10.1016/j.ygyno.2005.12.046; Cole LA, 2006, GYNECOL ONCOL, V102, P151, DOI 10.1016/j.ygyno.2005.12.045; Cole LA, 2009, EXPERT REV MOL DIAGN, V9, P721, DOI [10.1586/erm.09.51, 10.1586/ERM.09.51]; Costa HLFF, 2006, GYNECOL ONCOL, V100, P579, DOI 10.1016/j.ygyno.2005.09.031; CRADE M, 1991, J ULTRAS MED, V10, P473; Crawford RAF, 1997, BRIT J OBSTET GYNAEC, V104, P105, DOI 10.1111/j.1471-0528.1997.tb10659.x; CZERNOBILSKY B, 1982, OBSTET GYNECOL, V59, P75; Darby S, 2009, GYNECOL ONCOL, V112, P155, DOI 10.1016/j.ygyno.2008.10.003; DENG L, 2009, COCHRANE DB SYST REV, V3; Deveault C, 2009, HUM MOL GENET, V18, P888, DOI 10.1093/hmg/ddn418; Dhillon T, 2006, J REPROD MED, V51, P879; El-Helw LM, 2005, BRIT J CANCER, V93, P620, DOI 10.1038/sj.bjc.6602771; ELIAS K, 2009, J REPROD ME IN PRESS; Feltmate CM, 2002, J REPROD MED, V47, P337; Feltmate CM, 2006, J REPROD MED, V51, P902; FINE C, 1989, OBSTET GYNECOL, V73, P414; Fisher RA, 2002, HUM MOL GENET, V11, P3267, DOI 10.1093/hmg/11.26.3267; Fisher RA, 2004, J REPROD MED, V49, P595; FISHER RA, 1995, INT J GYNECOL CANCER, V5, P64, DOI 10.1046/j.1525-1438.1995.05010064.x; FISHER RA, 1993, AM J OBSTET GYNECOL, V168, P563, DOI 10.1016/0002-9378(93)90494-4; Fisher RA, 1998, J REPROD MED, V43, P87; Fisher RA, 2007, GYNECOL ONCOL, V107, P413, DOI 10.1016/j.ygyno.2007.07.081; Fowler DJ, 2007, ULTRASOUND OBST GYN, V29, P76, DOI 10.1002/uog.3880; Fowler DJ, 2006, ULTRASOUND OBST GYN, V27, P56, DOI 10.1002/uog.2592; Fox H, 2007, PATHOLOGY PLACENTA, V3rd; Garner EIO, 2005, GYNECOL ONCOL, V99, P3, DOI 10.1016/j.ygyno.2005.08.001; Garrett LA, 2008, J REPROD MED, V53, P481; Genest DR, 2002, J REPROD MED, V47, P363; Growdon WB, 2009, GYNECOL ONCOL, V112, P353, DOI 10.1016/j.ygyno.2008.11.003; Hancock BW, 2006, J REPROD MED, V51, P764; Hancock BW, 2002, J REPROD MED, V47, P347; Harvey RA, 2008, J REPROD MED, V53, P643; Hou JL, 2008, J REPROD MED, V53, P629; Jauniaux E, 1997, ULTRASOUND OBST GYN, V9, P17, DOI 10.1046/j.1469-0705.1997.09010017.x; JEFFERS MD, 1993, INT J GYNECOL PATHOL, V12, P315, DOI 10.1097/00004347-199310000-00006; Johns J, 2005, ULTRASOUND OBST GYN, V25, P493, DOI 10.1002/uog.1888; Jones WB, 1996, GYNECOL ONCOL, V61, P126, DOI 10.1006/gyno.1996.0110; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kohorn EI, 2002, J REPROD MED, V47, P445; Kohorn EI, 2002, GYNECOL ONCOL, V85, P36, DOI 10.1006/gyno.2001.6533; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; KUN SJ, 1998, INT J GYNECOL OBS S1, V60, pS85; LAGE JM, 1992, OBSTET GYNECOL, V79, P403, DOI 10.1097/00006250-199203000-00016; LAWLER SD, 1991, AM J OBSTET GYNECOL, V164, P1270, DOI 10.1016/0002-9378(91)90698-Q; Leiserowitz GS, 1996, OBSTET GYNECOL, V88, P696, DOI 10.1016/0029-7844(96)00124-X; LIM A, 2009, INT SOC STUD TROPH D, P27; Lu WG, 2008, INT J GYNECOL CANCER, V18, P357, DOI 10.1111/j.1525-1438.2007.00999.x; Lurain JR, 2005, GYNECOL ONCOL, V97, P618, DOI 10.1016/j.ygyno.2005.02.004; Machtinger R, 2005, GYNECOL ONCOL, V96, P56, DOI 10.1016/j.ygyno.2004.08.049; Makrydimas G, 2002, HUM REPROD, V17, P2459, DOI 10.1093/humrep/17.9.2459; Martin BH, 1998, J REPROD MED, V43, P60; Matsui H, 2000, HUM REPROD, V15, P608, DOI 10.1093/humrep/15.3.608; McGrath S, 2010, BRIT J CANCER, V102, P810, DOI 10.1038/sj.bjc.6605529; McMeish I, 2004, BRIT J CANCER, V90, P1169, DOI 10.1038/sj.bjc.6601664; McNeish IA, 2002, J CLIN ONCOL, V20, P1838, DOI 10.1200/JCO.2002.07.166; Mitchell H, 2007, MOL CELL ENDOCRINOL, V260, P310, DOI 10.1016/j.mce.2006.09.003; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; MUELLER UW, 1990, LANCET, V336, P197, DOI 10.1016/0140-6736(90)91731-O; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Newlands ES, 1998, J REPROD MED, V43, P53; NEWLANDS ES, 1991, BRIT J OBSTET GYNAEC, V98, P550, DOI 10.1111/j.1471-0528.1991.tb10369.x; Newlands ES, 2000, J CLIN ONCOL, V18, P854, DOI 10.1200/JCO.2000.18.4.854; Newlands ES, 2003, BEST PRACT RES CL OB, V17, P905, DOI 10.1016/S1521-6934(03)00092-0; Newlands ES, 2002, J REPROD MED, V47, P465; Newlands ES, 1999, HEMATOL ONCOL CLIN N, V13, P225, DOI 10.1016/S0889-8588(05)70162-3; Ngan HYS, 1998, GYNECOL ONCOL, V70, P192, DOI 10.1006/gyno.1998.5088; Ngan S, 2007, CURR OPIN ONCOL, V19, P486, DOI 10.1097/CCO.0b013e3282dc94e5; OBER WB, 1971, ANN NY ACAD SCI, V172, P299, DOI 10.1111/j.1749-6632.1971.tb34943.x; OSADA H, 1995, GYNECOL ONCOL, V56, P90, DOI 10.1006/gyno.1995.1015; Osborne R, 2008, GYNECOL ONCOL, V108, pS2; Osborne R, 2004, J REPROD MED, V49, P655; Palmer JR, 1999, J NATL CANCER I, V91, P635, DOI 10.1093/jnci/91.7.635; PALMER JR, 1994, J REPROD MED, V39, P155; Palmieri C, 2005, LANCET, V366, P688, DOI 10.1016/S0140-6736(05)67143-7; Palmieri C, 2007, GYNECOL ONCOL, V106, P35, DOI 10.1016/j.ygyno.2007.01.053; Pandian Z, 2004, BJOG-INT J OBSTET GY, V111, P382, DOI 10.1111/j.1471-0528.2004.00065x.x; Papadopoulos AJ, 2002, J REPROD MED, V47, P460; PARAZZINI F, 1991, OBSTET GYNECOL, V78, P1039; PARAZZINI F, 1988, AM J OBSTET GYNECOL, V158, P93, DOI 10.1016/0002-9378(88)90785-5; Patten DK, 2008, J CLIN ONCOL, V26, P5126, DOI 10.1200/JCO.2008.16.4129; PATTILLO RA, 1981, AM J OBSTET GYNECOL, V141, P104; Pezeshki M, 2004, GYNECOL ONCOL, V95, P423, DOI 10.1016/j.ygyno.2004.08.045; Pfeffer PE, 2007, LANCET ONCOL, V8, P744, DOI 10.1016/S1470-2045(07)70243-7; Powles T, 2007, BRIT J CANCER, V96, P732, DOI 10.1038/sj.bjc.6603608; Powles T, 2006, BRIT J CANCER, V94, P51, DOI 10.1038/sj.bjc.6602899; Powles T, 2006, BRIT J CANCER, V95, P1145, DOI 10.1038/sj.bjc.6603416; REID MH, 1983, AM J ROENTGENOL, V140, P307, DOI 10.2214/ajr.140.2.307; Royal College of Obstetricians and Gynaecologists, 2006, MAN EARL PREGN LOSS, P1; Rustin GJS, 1996, J CLIN ONCOL, V14, P2769, DOI 10.1200/JCO.1996.14.10.2769; RUSTIN GJS, 1984, BRIT MED J, V288, P103, DOI 10.1136/bmj.288.6411.103; SANTOSRAMOS R, 1980, OBSTET GYNECOL, V56, P186; Savage P, 2005, GYNECOL ONCOL, V99, P251, DOI 10.1016/j.ygyno.2005.07.025; Schmid P, 2009, LANCET, V374, P48, DOI 10.1016/S0140-6736(09)60618-8; Sebire NJ, 2007, BJOG-INT J OBSTET GY, V114, P760, DOI 10.1111/j.1471-0528.2007.01320.x; Sebire NJ, 2005, FETAL PEDIATR PATHOL, V24, P21, DOI 10.1080/15227950590961180; Sebire NJ, 2003, ANTICANCER RES, V23, P1723; Sebire NJ, 2003, PEDIATR DEVEL PATHOL, V6, P69, DOI 10.1007/s10024-002-0079-9; Sebire NJ, 2003, BJOG-INT J OBSTET GY, V110, P22, DOI 10.1016/S1470-0328(02)02988-9; Sebire NJ, 2002, LANCET, V359, P2165, DOI 10.1016/S0140-6736(02)09085-2; Sebire NJ, 2002, BJOG-INT J OBSTET GY, V109, P99, DOI 10.1111/j.1471-0528.2002.t01-1-01037.x; Sebire NJ, 2001, ULTRASOUND OBST GYN, V18, P662, DOI 10.1046/j.0960-7692.2001.00589.x; Sebire NJ, 2008, BMJ-BRIT MED J, V337, P1193; SECKL MJ, 1991, LANCET, V338, P1313, DOI 10.1016/0140-6736(91)92603-Y; Seckl MJ, 2000, LANCET, V356, P36, DOI 10.1016/S0140-6736(00)02432-6; Seckl MJ, 2004, LANCET, V364, P705, DOI 10.1016/S0140-6736(04)16898-0; Seckl MJ, 2004, J REPROD MED, V49, P527; SECKL MJ, 2009, INT SOC STUD TROPH D, P89; SECKL MJ, GESTATIONAL TROPHOBL, pCH12; SHERER DM, 1991, J CLIN ULTRASOUND, V19, P224, DOI 10.1002/jcu.1870190407; Shih IM, 1998, AM J SURG PATHOL, V22, P1393, DOI 10.1097/00000478-199811000-00010; Shorbagi A, 2005, GYNECOL ONCOL, V97, P722, DOI 10.1016/j.ygyno.2005.02.009; STONE M, 1976, BRIT J OBSTET GYNAEC, V83, P913, DOI 10.1111/j.1471-0528.1976.tb00774.x; Sturgeon CM, 2009, CLIN CHEM, V55, P1484, DOI 10.1373/clinchem.2009.124578; SZULMAN AE, 1978, AM J OBSTET GYNECOL, V131, P665, DOI 10.1016/0002-9378(78)90829-3; Termrungruanglert W, 1996, ANTI-CANCER DRUG, V7, P503, DOI 10.1097/00001813-199607000-00001; TIDY JA, 2004, MANAGEMENT GESTATION; Tsuji Y, 2002, GYNECOL ONCOL, V87, P303, DOI 10.1006/gyno.2002.6827; Tuncer ZS, 1999, GYNECOL ONCOL, V75, P224, DOI 10.1006/gyno.1999.5562; Turan T, 2006, INT J GYNECOL CANCER, V16, P1432, DOI 10.1111/j.1525-1438.2006.00606.x; van Trommel NE, 2005, GYNECOL ONCOL, V99, P6, DOI 10.1016/j.ygyno.2005.06.032; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Wang J, 2008, ANN ONCOL, V19, P1578, DOI 10.1093/annonc/mdn181; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Wiesma S, 2006, AUST NZ J OBSTET GYN, V46, P119, DOI 10.1111/j.1479-828X.2006.00539.x; Wiesma S, 2006, AUST NZ J OBSTET GYN, V46, P112, DOI 10.1111/j.1479-828X.2006.00538.x; WOO JSK, 1983, J ULTRAS MED, V2, P261; Woolas RP, 1998, BRIT J OBSTET GYNAEC, V105, P1032, DOI 10.1111/j.1471-0528.1998.tb10271.x; XIA ZG, 1980, CHINESE MED J-PEKING, V93, P605; YAMASHITA K, 1981, GYNECOL ONCOL, V12, P68, DOI 10.1016/0090-8258(81)90096-2; Yang JJ, 2006, GYNECOL ONCOL, V103, P479, DOI 10.1016/j.ygyno.2006.03.015	153	525	559	0	76	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2010	376	9742					717	729		10.1016/S0140-6736(10)60280-2	http://dx.doi.org/10.1016/S0140-6736(10)60280-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20673583				2022-12-28	WOS:000281582900031
J	Singh, H; Graber, M				Singh, Hardeep; Graber, Mark			Reducing Diagnostic Error Through Medical Home-Based Primary Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SAFETY		[Singh, Hardeep] Baylor Coll Med, Houston VA Hlth Serv Res & Dev Serv Ctr Excellenc, Houston, TX 77030 USA; [Singh, Hardeep] Baylor Coll Med, Ctr Inquiry Improve Outpatient Safety Effect Elec, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA; [Singh, Hardeep] Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA; [Graber, Mark] Northport VA Med Ctr, Northport, NY USA; [Graber, Mark] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Singh, H (corresponding author), VA Med Ctr 152, 2002 Holcombe Blvd, Houston, TX 77030 USA.	hardeeps@bcm.tmc.edu		Graber, Mark/0000-0002-3600-0446	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R13HS018321, R18HS017820] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K23CA125585] Funding Source: NIH RePORTER; AHRQ HHS [1R1 3HS018321-01, R18 HS 17820] Funding Source: Medline; NCI NIH HHS [K23CA125585, K23 CA125585-05, K23 CA125585] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chandra A, 2005, HLTH AFF MILLWOOD; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Schiff GD, 2010, NEW ENGL J MED, V362, P1066, DOI 10.1056/NEJMp0911734; Singh H, 2007, ARCH INTERN MED, V167, P302, DOI 10.1001/archinte.167.3.302; Singh H, 2009, AM J GASTROENTEROL, V104, P2543, DOI 10.1038/ajg.2009.324; Singh H, 2009, ADV HEALTH SCI EDUC, V14, P57, DOI 10.1007/s10459-009-9177-z; Singh H, 2009, ARCH INTERN MED, V169, P1578, DOI 10.1001/archinternmed.2009.263; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154	9	37	37	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					463	464		10.1001/jama.2010.1035	http://dx.doi.org/10.1001/jama.2010.1035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664048	Green Accepted			2022-12-28	WOS:000280350100031
J	Russo, G; Graffin, G				Russo, Gene; Graffin, Greg			TURNING POINT	NATURE			English	Editorial Material																			0	8	8	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1143	1143		10.1038/nj7319-1143a	http://dx.doi.org/10.1038/nj7319-1143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20641178				2022-12-28	WOS:000283548600056
J	Signore, LB; Mulvihill, JJ; Green, DM; Munro, HM; Stovall, M; Weathers, RE; Mertens, AC; Whitton, JA; Robison, LL; Boice, JD				Signore, Lisa B.; Mulvihill, John J.; Green, Daniel M.; Munro, Heather M.; Stovall, Marilyn; Weathers, Rita E.; Mertens, Ann C.; Whitton, John A.; Robison, Leslie L.; Boice, John D., Jr.			Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study	LANCET			English	Article							CHILDHOOD-CANCER SURVIVORS; ATOMIC-BOMB SURVIVORS; POPULATION-BASED COHORT; WILMS-TUMOR; CONGENITAL-MALFORMATIONS; RADIOTHERAPY; CHILDREN; PREGNANCY; WORKERS	Background The reproductive implications of mutagenic treatments given to children with cancer are not clear. By studying the risk of untoward pregnancy outcomes, we indirectly assessed the risk of transmission of germline damage to the offspring of survivors of childhood cancer who were given radiotherapy and chemotherapy. Methods We did a retrospective cohort analysis, within the Childhood Cancer Survivor Study (CCSS), of the risk of stillbirth and neonatal death among the offspring of men and women who had survived childhood cancer. Patients in CCSS were younger than 21 years at initial diagnosis of an eligible cancer, were treated at 25 US institutions and one Canadian institution, and had survived for at least 5 years after diagnosis. We quantified the chemotherapy given to patients, and the preconception radiation doses to the testes, ovaries, uterus, and pituitary gland, and related these to the risk of stillbirth or neonatal death using Poisson regression analysis. Findings Among 1148 men and 1657 women who had survived childhood cancer, there were 4946 pregnancies. Irradiation of the testes (16 [1%] of 1270; adjusted relative risk 0.8 [95% CI 0.4-1.6]; mean dose 0.53 Gy [SD 1.40]) and pituitary gland (17 [3%] of 510, 1.1 [0.5-2.4] for more than 20.00 Gy; mean dose 10.20 Gy [13.0] for women), and chemotherapy with alkylating drugs (26 [2%] of 1195 women, 0.9 [0.5-1.5]; ten [1%] of 732 men, 1.2 [0.5-2.5]) were not associated with an increased risk of stillbirth or neonatal death. Uterine and ovarian irradiation significantly increased risk of stillbirth and neonatal death at doses greater than 10.00 Gy (five [18%] of 28, 9.1 [3.4-24.6]). For girls treated before menarche, irradiation of the uterus and ovaries at doses as low as 1.00-2.49 Gy significantly increased the risk of stillbirth or neonatal death (three [4%] of 69, 4.7 [1.2-19.0]). Interpretation Our findings do not support concern about heritable genetic changes affecting the risk of stillbirth and neonatal death in the offspring of men exposed to gonadal irradiation. However, uterine and ovarian irradiation had serious adverse effects on the offspring that were probably related to uterine damage. Careful management is warranted of pregnancies in women given high doses of pelvic irradiation before puberty.	[Signore, Lisa B.; Munro, Heather M.; Boice, John D., Jr.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Signore, Lisa B.; Boice, John D., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Signore, Lisa B.; Boice, John D., Jr.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Mulvihill, John J.] Univ Oklahoma, Dept Pediat, Oklahoma City, OK USA; [Green, Daniel M.; Robison, Leslie L.] St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Stovall, Marilyn; Weathers, Rita E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Mertens, Ann C.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Whitton, John A.] Fred Hutchinson Canc Res Ctr, Dept Biostat, Seattle, WA 98104 USA	Vanderbilt University; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; St Jude Children's Research Hospital; University of Texas System; UTMD Anderson Cancer Center; Emory University; Fred Hutchinson Cancer Center	Signore, LB (corresponding author), Int Epidemiol Inst, 1455 Res Blvd,Suite 550, Rockville, MD 20850 USA.	lisa@iei.us	Robison, Leslie/N-8122-2018		Westlakes Research Institute [01/12/99 DC]; National Cancer Institute [U24 CA55727, 5RO1 CA104666]; University of Minnesota, Minneapolis, MN, USA; NATIONAL CANCER INSTITUTE [R01CA104666, U24CA055727] Funding Source: NIH RePORTER	Westlakes Research Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Minnesota, Minneapolis, MN, USA(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partly supported by contracts and grants from Westlakes Research Institute (agreement number 01/12/99 DC), the National Cancer Institute (U24 CA55727 and 5RO1 CA104666), and the Children's Cancer Research Fund (University of Minnesota, Minneapolis, MN, USA). The programme of studies would not have been possible without the efforts of the many participating survivors of cancer, data abstractors, a large field staff, central clerical and data-processing staff, and clinical collaborators. We gratefully acknowledge the advice and guidance of Gerald Draper (Childhood Cancer Research Group, Oxford, UK) and Godfrey Oakley (Emory University, Atlanta, GA, USA) during the preparation of this report.	Abrahamson Seymour, 2001, Journal of Radiological Protection, V21, P133, DOI 10.1088/0952-4746/21/2/303; Boice JD, 2003, HEALTH PHYS, V85, P65, DOI 10.1097/00004032-200307000-00013; Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; *COMARE, 2004, PAR OCC EXP RAD PRIO; Doll R, 2000, LANCET, V355, P493, DOI 10.1016/S0140-6736(00)82044-9; Doyle P, 2000, LANCET, V356, P1293, DOI 10.1016/S0140-6736(00)02812-9; Doyle P, 2000, LANCET, V355, P492, DOI 10.1016/S0140-6736(00)82041-3; Green DM, 2002, J CLIN ONCOL, V20, P2506, DOI 10.1200/JCO.2002.07.159; Inskip H, 1999, LANCET, V354, P1400, DOI 10.1016/S0140-6736(99)00289-5; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Leisenring WM, 2009, J CLIN ONCOL, V27, P2319, DOI 10.1200/JCO.2008.21.1813; LI FP, 1987, JAMA-J AM MED ASSOC, V257, P216, DOI 10.1001/jama.257.2.216; Nakamura N, 2006, J RADIAT RES, V47, pB67, DOI 10.1269/jrr.47.B67; NEEL JV, 1990, ANNU REV GENET, V24, P327; Nicholson HS, 1996, CANCER, V78, P887; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; Parker L, 1999, LANCET, V354, P1407, DOI 10.1016/S0140-6736(99)04138-0; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Russell WL, 1998, GENETICS, V148, P1567; Schull WJ, 2003, J RADIOL PROT, V23, P369, DOI 10.1088/0952-4746/23/4/R302; Selby PB, 2000, LANCET, V355, P492, DOI 10.1016/S0140-6736(00)82042-5; Signorello LB, 2006, JNCI-J NATL CANCER I, V98, P1453, DOI 10.1093/jnci/djj394; Stovall M, 2004, INT J RADIAT ONCOL, V60, P542, DOI 10.1016/j.ijrobp.2004.03.017; Tawn EJ, 2000, LANCET, V355, P493, DOI 10.1016/S0140-6736(00)82045-0; United Nations Scientific Committee on the Effects of Atomic Radiation, 2001, REP GEN ASS SCI ANN; Winther JF, 2009, CLIN GENET, V75, P50, DOI 10.1111/j.1399-0004.2008.01109.x; Winther JF, 2008, J CLIN ONCOL, V26, P4340, DOI 10.1200/JCO.2007.15.2884; Winther JF, 2004, AM J HUM GENET, V74, P1282, DOI 10.1086/421473; Wo JY, 2009, INT J RADIAT ONCOL, V73, P1304, DOI 10.1016/j.ijrobp.2008.12.016; Wyrobek AJ, 2007, ENVIRON MOL MUTAGEN, V48, P71, DOI 10.1002/em.20284	30	103	107	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					624	630		10.1016/S0140-6736(10)60752-0	http://dx.doi.org/10.1016/S0140-6736(10)60752-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20655585	Green Accepted			2022-12-28	WOS:000281309100033
J	Wang, G; Chen, HW; Oktay, Y; Zhang, J; Allen, EL; Smith, GM; Fan, KC; Hong, JS; French, SW; McCaffery, JM; Lightowlers, RN; Morse, HC; Koehler, CM; Teitell, MA				Wang, Geng; Chen, Hsiao-Wen; Oktay, Yavuz; Zhang, Jin; Allen, Eric L.; Smith, Geoffrey M.; Fan, Kelly C.; Hong, Jason S.; French, Samuel W.; McCaffery, J. Michael; Lightowlers, Robert N.; Morse, Herbert C., III; Koehler, Carla M.; Teitell, Michael A.			PNPASE Regulates RNA Import into Mitochondria	CELL			English	Article							HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; HELA-CELL MITOCHONDRIA; POLY(A) POLYMERASE; P-ACTIVITY; PROTEIN; LIVER; CONTAINS; BINDING	RNA import into mammalian mitochondria is considered essential for replication, transcription, and translation of the mitochondrial genome but the pathway(s) and factors that control this import are poorly understood. Previously, we localized polynucleotide phosphorylase (PNPASE), a 3' -> 5' exoribonuclease and poly-A polymerase, in the mitochondrial intermembrane space, a location lacking resident RNAs. Here, we show a new role for PNPASE in regulating the import of nuclear-encoded RNAs into the mitochondrial matrix. PNPASE reduction impaired mitochondrial RNA processing and polycistronic transcripts accumulated. Augmented import of RNase P, 5S rRNA, and MRP RNAs depended on PNPASE expression and PNPASE-imported RNA interactions were identified. PNPASE RNA processing and import activities were separable and a mitochondrial RNA targeting signal was isolated that enabled RNA import in a PNPASE-dependent manner. Combined, these data strongly support an unanticipated role for PNPASE in mediating the translocation of RNAs into mitochondria.	[Wang, Geng; Oktay, Yavuz; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Broad Stem Cell Res Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Ctr Cell Control, Los Angeles, CA 90095 USA; [Chen, Hsiao-Wen] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Zhang, Jin; Allen, Eric L.; Smith, Geoffrey M.; Fan, Kelly C.; Hong, Jason S.; French, Samuel W.; Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA; [Lightowlers, Robert N.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Morse, Herbert C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD 20852 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	koehler@chem.ucla.edu; mteitell@mednet.ucla.edu	Oktay, Yavuz/G-4794-2015; ZHANG, JIN/D-1435-2013	Oktay, Yavuz/0000-0002-0158-2693; Morse, Herbert/0000-0002-9331-3705	NIH [R01GM061721, R01GM073981, R01CA90571, PN2EY018228, K22CA120147]; NIH, National Institute of Allergy and Infectious Diseases; Muscular Dystrophy Association [022398]; American Heart Association [0640076N]; California Institute of Regenerative Medicine [RS1-00313, RB1-01397]; NATIONAL CANCER INSTITUTE [R01CA107300, R01CA156674, K22CA120147, R01CA090571] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858, ZIAAI001024, ZIAAI001057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R01GM073981] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michelle Husain for expertise in TEM. Supported by NIH grants R01GM061721 and R01GM073981 (C.M.K.), R01CA90571 (M.A.T.) and PN2EY018228 (Roadmap for Medical Research Nanomedicine Initiative) (M.A.T.), and K22CA120147 (S.W.F.), the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (H.C.M. III), the Muscular Dystrophy Association 022398 (C.M.K.), the American Heart Association 0640076N (C.M.K.), and the California Institute of Regenerative Medicine (RS1-00313 and RB1-01397, M.A.T.). C.M.K. is an Established Investigator of the American Heart Association and M.A.T. is a Scholar of the Leukemia and Lymphoma Society.	Alfonzo JD, 2009, BIOL CHEM, V390, P717, DOI 10.1515/BC.2009.101; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664; Mukherjee S, 2007, EMBO REP, V8, P589, DOI 10.1038/sj.embor.7400979; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Walker SC, 2008, CELL, V135, P412, DOI 10.1016/j.cell.2008.10.010; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; [No title captured]	37	240	249	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					456	467		10.1016/j.cell.2010.06.035	http://dx.doi.org/10.1016/j.cell.2010.06.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691904	Green Accepted, Bronze			2022-12-28	WOS:000280609100022
J	Alboussiere, T; Deguen, R; Melzani, M				Alboussiere, Thierry; Deguen, Renaud; Melzani, Mickael			Melting-induced stratification above the Earth's inner core due to convective translation	NATURE			English	Article							SEISMIC VELOCITY; TRAVEL-TIMES; ANISOTROPY; HETEROGENEITY; BOUNDARY; MODEL; IRON; CONSTRAINTS; ATTENUATION; BASE	In addition to its global North-South anisotropy(1), there are two other enigmatic seismological observations related to the Earth's inner core: asymmetry between its eastern and western hemispheres(2-6) and the presence of a layer of reduced seismic velocity at the base of the outer core(6-12). This 250-km-thick layer has been interpreted as a stably stratified region of reduced composition in light elements(13). Here we show that this layer can be generated by simultaneous crystallization and melting at the surface of the inner core, and that a translational mode of thermal convection in the inner core can produce enough melting and crystallization on each hemisphere respectively for the dense layer to develop. The dynamical model we propose introduces a clear asymmetry between a melting and a crystallizing hemisphere which forms a basis for also explaining the East-West asymmetry. The present translation rate is found to be typically 100 million years for the inner core to be entirely renewed, which is one to two orders of magnitude faster than the growth rate of the inner core's radius. The resulting strong asymmetry of buoyancy flux caused by light elements is anticipated to have an impact on the dynamics of the outer core and on the geodynamo.	[Alboussiere, Thierry; Deguen, Renaud; Melzani, Mickael] Univ Grenoble 1, CNRS, Observ Grenoble, Lab Geophys Interne & Tectonophys, F-38041 Grenoble 9, France; [Alboussiere, Thierry] UCB Lyon 1, UMR5570, CNRS, F-69622 Villeurbanne, France; [Alboussiere, Thierry] Univ Lyon 1, ENS Lyon, F-69622 Villeurbanne, France; [Deguen, Renaud] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Johns Hopkins University	Alboussiere, T (corresponding author), Univ Grenoble 1, CNRS, Observ Grenoble, Lab Geophys Interne & Tectonophys, BP 53, F-38041 Grenoble 9, France.	thierry.alboussiere@ens-lyon.fr	Alboussiere, Thierry/C-8171-2012; Deguen, Renaud/H-2225-2014		LGIT; ANR (Agence Nationale de la Recherche) [ANR-08-BLAN-0234-01]	LGIT; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This work has benefited from discussions during the CNRS-INSU SEDIT meetings. We thank M. Bergman for discussions regarding inner-core crystallization. The LGIT and the ANR (Agence Nationale de la Recherche) (ANR-08-BLAN-0234-01) have provided financial support for the experiments.	Alfe D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165118; Anderson OL, 1997, J GEOPHYS RES-SOL EA, V102, P22659, DOI 10.1029/97JB01641; Buffett BA, 2009, GEOPHYS J INT, V179, P711, DOI 10.1111/j.1365-246X.2009.04311.x; Calvet M, 2008, EARTH PLANET SC LETT, V267, P200, DOI 10.1016/j.epsl.2007.11.048; Calvet M, 2006, PHYS EARTH PLANET IN, V156, P21, DOI 10.1016/j.pepi.2006.01.008; CREAGER KC, 1999, J GEOPHYS RES, V104, P309; Dalziel SB, 2000, EXP FLUIDS, V28, P322, DOI 10.1007/s003480050391; Deguen R, 2009, NAT GEOSCI, V2, P418, DOI 10.1038/NGEO522; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Garcia R, 2000, GEOPHYS RES LETT, V27, P3121, DOI 10.1029/2000GL008520; Gostiaux L, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2472511; Gubbins D, 2004, GEOPHYS J INT, V157, P1407, DOI 10.1111/j.1365-246X.2004.02219.x; Gubbins D, 2008, GEOPHYS J INT, V174, P1007, DOI 10.1111/j.1365-246X.2008.03879.x; JEANLOZ R, 1988, GEOPHYS RES LETT, V15, P72, DOI 10.1029/GL015i001p00072; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Labrosse S, 2003, PHYS EARTH PLANET IN, V140, P127, DOI 10.1016/j.pepi.2003.07.006; LOPER DE, 1981, PHYS EARTH PLANET IN, V24, P302, DOI 10.1016/0031-9201(81)90117-5; MASTERS G, 1982, NATURE, V298, P609, DOI 10.1038/298609a0; NIMMO F, 2007, TREATISE GEOPHYS, V2, P31; Niu FL, 2001, NATURE, V410, P1081, DOI 10.1038/35074073; POIRIER JP, 1993, GEOPHYS J INT, V115, P147, DOI 10.1111/j.1365-246X.1993.tb05594.x; POIRIER JP, 1994, CR ACAD SCI II, V318, P341; POUPINET G, 1983, NATURE, V305, P204, DOI 10.1038/305204a0; SONG XD, 1995, J GEOPHYS RES-SOL EA, V100, P9817, DOI 10.1029/94JB03135; SOURIAU A, 1995, GEOPHYS J INT, V123, P572, DOI 10.1111/j.1365-246X.1995.tb06872.x; SOURIAU A, 1991, GEOPHYS RES LETT, V18, P2023, DOI 10.1029/91GL02417; STACEY FD, 2008, PHYS EARTH, pCH19; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; Tritton D. J., 1988, PHYS FLUID DYNAMICS, V536, P1; Vocadlo L., 2007, TREATISE GEOPHYS, V2, P91, DOI [10.1016/b978-044452748-6/00032-8, DOI 10.1016/B978-044452748-6/00032-8]; WEBER P, 1992, GEOPHYS RES LETT, V19, P2107, DOI 10.1029/92GL02148; Wenk HR, 2000, J GEOPHYS RES-SOL EA, V105, P5663, DOI 10.1029/1999JB900346; Yu WC, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2003JB002928; Zou ZH, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005316	35	161	164	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					744	U9		10.1038/nature09257	http://dx.doi.org/10.1038/nature09257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686572	Green Submitted			2022-12-28	WOS:000280562500036
J	Taniguchi, Y; Choi, PJ; Li, GW; Chen, HY; Babu, M; Hearn, J; Emili, A; Xie, XS				Taniguchi, Yuichi; Choi, Paul J.; Li, Gene-Wei; Chen, Huiyi; Babu, Mohan; Hearn, Jeremy; Emili, Andrew; Xie, X. Sunney			Quantifying E-coli Proteome and Transcriptome with Single-Molecule Sensitivity in Single Cells	SCIENCE			English	Article							STOCHASTIC GENE-EXPRESSION; REGULATORY NETWORKS; NOISE; REVEALS; LEVEL; YEAST; TIME	Protein and messenger RNA (mRNA) copy numbers vary from cell to cell in isogenic bacterial populations. However, these molecules often exist in low copy numbers and are difficult to detect in single cells. We carried out quantitative system-wide analyses of protein and mRNA expression in individual cells with single-molecule sensitivity using a newly constructed yellow fluorescent protein fusion library for Escherichia coli. We found that almost all protein number distributions can be described by the gamma distribution with two fitting parameters which, at low expression levels, have clear physical interpretations as the transcription rate and protein burst size. At high expression levels, the distributions are dominated by extrinsic noise. We found that a single cell's protein and mRNA copy numbers for any given gene are uncorrelated.	[Taniguchi, Yuichi; Choi, Paul J.; Li, Gene-Wei; Chen, Huiyi; Hearn, Jeremy; Xie, X. Sunney] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Li, Gene-Wei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Chen, Huiyi] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Babu, Mohan; Emili, Andrew] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Harvard University; Harvard University; Harvard University; University of Toronto; University of Toronto	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Taniguchi, Yuichi/N-5986-2015; Li, Gene-Wei/E-7657-2010; Mohan, Babu P./I-7362-2019	Taniguchi, Yuichi/0000-0001-5677-8901; Li, Gene-Wei/0000-0001-7036-8511	Gates Foundation; NIH; Canadian Institutes of Health Research [MOP-77639]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; Marubun Research Promotion Foundation; John and Fannie Hertz Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Marubun Research Promotion Foundation; John and Fannie Hertz Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Xun, N. K. Lee, D. Court, C. Zong, R. Roy, and J. Agresti for experimental assistance; and E. Rubin, L. Cai, and J. Elf for helpful discussions. This work was supported by the Gates Foundation (X.S.X.), the NIH Pioneer Director's Award (X.S.X.), and the Canadian Institutes of Health Research (MOP-77639) (A.E.). Y.T. acknowledges additional support from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, and the Marubun Research Promotion Foundation, and P.J.C. from the John and Fannie Hertz Foundation.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	31	1381	1403	9	491	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					533	538		10.1126/science.1188308	http://dx.doi.org/10.1126/science.1188308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671182	Green Accepted			2022-12-28	WOS:000280483500027
J	Calais, E; Freed, AM; Van Arsdale, R; Stein, S				Calais, E.; Freed, A. M.; Van Arsdale, R.; Stein, S.			Triggering of New Madrid seismicity by late-Pleistocene erosion	NATURE			English	Article							INTRAPLATE SEISMICITY; EARTHQUAKES; STRESS; FAULT; DEFORMATION; EVOLUTION; HAZARD; CRUST	The spatiotemporal behaviour of earthquakes within continental plate interiors is different from that at plate boundaries. At plate margins, tectonic motions quickly reload earthquake ruptures, making the location of recent earthquakes and the average time between them consistent with the faults' geological, palaeoseismic and seismic histories. In contrast, what determines the activation of a particular mid-continental fault and controls the duration of its seismic activity remains poorly understood(1). Here we argue that the concentration of magnitude-7 or larger earthquakes in the New Madrid seismic zone of the central United States(2,3) since the end of the last ice age results from the recent, climate-controlled, erosional history of the northern Mississippi embayment. We show that the upward flexure of the lithosphere caused by unloading from river incision between 16,000 and 10,000 years ago caused a reduction of normal stresses in the upper crust sufficient to unclamp preexisting faults close to failure equilibrium. Models indicate that fault segments that have already ruptured are unlikely to fail again soon, but stress changes from sediment unloading and previous earthquakes may eventually be sufficient to bring to failure other nearby segments that have not yet ruptured.	[Calais, E.; Freed, A. M.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Van Arsdale, R.] Univ Memphis, Dept Earth Sci, Memphis, TN 38152 USA; [Stein, S.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Memphis; Northwestern University	Calais, E (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA.	ecalais@purdue.edu	Calais, Eric/K-8219-2012	Calais, Eric/0000-0002-5935-8117	US Geological Survey through the Department of the Interior [07HQGR0049]	US Geological Survey through the Department of the Interior(United States Geological Survey)	This work was partly supported by the US Geological Survey through the Department of the Interior, under USGS award number 07HQGR0049. We thank M. Zoback for his comments.	Allmann BP, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005821; Baldwin JN, 2005, SEISMOL RES LETT, V76, P772, DOI 10.1785/gssrl.76.6.772; Calais E, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004253; Calais E, 2009, SCIENCE, V323, P1442, DOI 10.1126/science.1168122; CARTER NL, 1987, TECTONOPHYSICS, V136, P27, DOI 10.1016/0040-1951(87)90333-7; Cox RT, 2006, TECTONICS, V25, DOI 10.1029/2005TC001829; Crone AJ, 2003, B SEISMOL SOC AM, V93, P1913, DOI 10.1785/0120000094; Freed AM, 2005, ANNU REV EARTH PL SC, V33, P335, DOI 10.1146/annurev.earth.33.092203.122505; Freed AM, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003894; Freed AM, 2007, GEOPHYS J INT, V169, P1164, DOI [10.1111/j.1365-246X.2007.03391.x, 10.1111/j.1365-246X2007.03391-x]; Grana JP, 1996, J GEOPHYS RES-SOL EA, V101, P5445, DOI 10.1029/95JB03255; Grollimund B, 2001, GEOLOGY, V29, P175, DOI 10.1130/0091-7613(2001)029<0175:DDTISI>2.0.CO;2; Guccione MJ, 2005, GEOL SOC AM BULL, V117, P319, DOI 10.1130/B25435.1; Hough SE, 2000, J GEOPHYS RES-SOL EA, V105, P23839, DOI 10.1029/2000JB900110; Johnston AC, 1996, GEOPHYS J INT, V126, P314, DOI 10.1111/j.1365-246X.1996.tb05294.x; KARATO S, 1997, EARTHS DEEP INTERIOR, P223; Kenner SJ, 2000, SCIENCE, V289, P2329, DOI 10.1126/science.289.5488.2329; KIRBY SH, 1987, REV GEOPHYS, V25, P1219, DOI 10.1029/RG025i006p01219; Li QS, 2009, B SEISMOL SOC AM, V99, P52, DOI 10.1785/0120080005; Liu LB, 1997, TECTONICS, V16, P585, DOI 10.1029/97TC01467; MCKENNA J, 2007, SPEC PAP GEOL SOC AM, V425, P167; Mueller K, 2004, NATURE, V429, P284, DOI 10.1038/nature02557; Newman A, 1999, SCIENCE, V284, P619, DOI 10.1126/science.284.5414.619; Pollitz FF, 2001, B SEISMOL SOC AM, V91, P1882, DOI 10.1785/0120000277; Rittenour TM, 2007, GEOL SOC AM BULL, V119, P586, DOI 10.1130/B25934.1; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Tuttle MP, 2002, B SEISMOL SOC AM, V92, P2080, DOI 10.1785/0120010227; Van Arsdale R, 2000, ENG GEOL, V55, P219, DOI 10.1016/S0013-7952(99)00093-9; Van Arsdale R, 2007, GEOL SOC AM SPEC PAP, V425, P177, DOI 10.1130/2007.2425(13); Wu P, 2000, GEOPHYS RES LETT, V27, P1323, DOI 10.1029/1999GL011070	30	108	110	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					608	U2		10.1038/nature09258	http://dx.doi.org/10.1038/nature09258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671707				2022-12-28	WOS:000280412100050
J	Hibbard, JU; Wilkins, I; Sun, LP; Gregory, K; Haberman, S; Hoffman, M; Kominiarek, MA; Reddy, U; Bailit, J; Branch, DW; Burkman, R; Quintero, VHG; Hatjis, CG; Landy, H; Ramirez, M; VanVeldhuisen, P; Troendle, J; Zhang, J				Hibbard, Judith U.; Wilkins, Isabelle; Sun, Liping; Gregory, Kimberly; Haberman, Shoshana; Hoffman, Matthew; Kominiarek, Michelle A.; Reddy, Uma; Bailit, Jennifer; Branch, D. Ware; Burkman, Ronald; Quintero, Victor Hugo Gonzalez; Hatjis, Christos G.; Landy, Helain; Ramirez, Mildred; VanVeldhuisen, Paul; Troendle, James; Zhang, Jun		Consortium Safe Labor	Respiratory Morbidity in Late Preterm Births	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL-MORTALITY; TERM; RATES; EPIDEMIOLOGY; DELIVERY; INFANTS	Context Late preterm births (34(0)/(7)-36(6)/(7) weeks) account for an increasing proportion of prematurity-associated short-term morbidities, particularly respiratory, that require specialized care and prolonged neonatal hospital stays. Objective To assess short-term respiratory morbidity in late preterm births compared with term births in a contemporary cohort of deliveries in the United States. Design, Setting, and Participants Retrospective collection of electronic data from 12 institutions (19 hospitals) across the United States on 233 844 deliveries between 2002 and 2008. Charts were abstracted for all neonates with respiratory compromise admitted to a neonatal intensive care unit (NICU), and late preterm births were compared with term births in regard to resuscitation, respiratory support, and respiratory diagnoses. A multivariate logistic regression analysis compared infants at each gestational week, controlling for factors that influence respiratory outcomes. Main Outcome Measures Respiratory distress syndrome, transient tachypnea of the newborn, pneumonia, respiratory failure, and standard and oscillatory ventilator support. Results Of 19 334 late preterm births, 7055 (36.5%) were admitted to a NICU and 2032 had respiratory compromise. Of 165 993 term infants, 11 980 (7.2%) were admitted to a NICU, 1874 with respiratory morbidity. The incidence of respiratory distress syndrome was 10.5% (390/3700) for infants born at 34 weeks' gestation vs 0.3% (140/41 764) at 38 weeks. Similarly, incidence of transient tachypnea of the newborn was 6.4%(n = 236) for those born at 34 weeks vs 0.4% (n = 155) at 38 weeks, pneumonia was 1.5% (n = 55) vs 0.1% (n = 62), and respiratory failure was 1.6% (n = 61) vs 0.2% (n = 63). Standard and oscillatory ventilator support had similar patterns. Odds of respiratory distress syndrome decreased with each advancing week of gestation until 38 weeks compared with 39 to 40 weeks (adjusted odds ratio [OR] at 34 weeks, 40.1; 95% confidence interval [CI], 32.0-50.3 and at 38 weeks, 1.1; 95% CI, 0.9-1.4). At 37 weeks, odds of respiratory distress syndrome were greater than at 39 to 40 weeks (adjusted OR, 3.1; 95% CI, 2.5-3.7), but the odds at 38 weeks did not differ from 39 to 40 weeks. Similar patterns were noted for transient tachypnea of the newborn (adjusted OR at 34 weeks, 14.7; 95% CI, 11.7-18.4 and at 38 weeks, 1.0; 95% CI, 0.8-1.2), pneumonia (adjusted OR at 34 weeks, 7.6; 95% CI, 5.2-11.2 and at 38 weeks, 0.9; 95% CI, 0.6-1.2), and respiratory failure (adjusted OR at 34 weeks, 10.5; 95% CI, 6.9-16.1 and at 38 weeks, 1.4; 95% CI, 1.0-1.9). Conclusion In a contemporary cohort, late preterm birth, compared with term delivery, was associated with increased risk of respiratory distress syndrome and other respiratory morbidity. JAMA. 2010;304(4):419-425 www.jama.com	[Hibbard, Judith U.] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA; [Sun, Liping; Reddy, Uma; Troendle, James; Zhang, Jun] NICHHD, Div Epidemiol Stat & Prevent Res, Bethesda, MD 20892 USA; [Gregory, Kimberly] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Haberman, Shoshana] Maimonides Hosp, Brooklyn, NY 11219 USA; [Hoffman, Matthew] Christiana Care Hlth Syst, Newark, DE USA; [Kominiarek, Michelle A.] Indiana Univ Clarian Hlth, Indianapolis, IN USA; [Reddy, Uma] NICHHD, Pregnancy & Perinatol Branch, Bethesda, MD 20892 USA; [Bailit, Jennifer] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Branch, D. Ware] Intermt Healthcare, Salt Lake City, UT USA; [Branch, D. Ware] Univ Utah, Salt Lake City, UT USA; [Burkman, Ronald] Tufts Univ, Springfield, MA USA; [Quintero, Victor Hugo Gonzalez] Univ Miami, Miami, FL USA; [Hatjis, Christos G.] Akron City Hosp, Summa Hlth Syst, Akron, OH USA; [Landy, Helain] Georgetown Univ Hosp, Washington, DC 20007 USA; [Ramirez, Mildred] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [VanVeldhuisen, Paul] EMMES Corp, Rockville, MD USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cedars Sinai Medical Center; Maimonides Medical Center; Christiana Care Health System; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Case Western Reserve University; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Tufts University; University of Miami; Summa Health System; Georgetown University; University of Texas System; University of Texas Health Science Center Houston; Emmes Corporation	Hibbard, JU (corresponding author), Univ Illinois, Dept Obstet & Gynecol, 820 S Wood St,M-C 808, Chicago, IL 60612 USA.	jhibbar@uic.edu	Landy, Helain/AAC-4016-2019	kominiarek, michelle/0000-0003-0064-2399	Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health [HHSN267200603425C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008794] Funding Source: NIH RePORTER	Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Intramural Research Program of the Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health, through contract HHSN267200603425C.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Bailit JL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.051; Cheng YW, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.08.008; De Luca R, 2009, PEDIATRICS, V123, pE1064, DOI 10.1542/peds.2008-2407; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Kominiarek MA, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.024; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lubow JM, 2009, AM J OBSTET GYNECOL, V200, pE30, DOI 10.1016/j.ajog.2008.09.022; Martinez Gustavo, 2009, Journal of Taphonomy, V7, P1; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Melamed N, 2009, OBSTET GYNECOL, V114, P253, DOI 10.1097/AOG.0b013e3181af6931; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P244; Rubaltelli FF, 1998, BIOL NEONATE, V74, P7, DOI 10.1159/000014005; Rubaltelli FF, 1998, ACTA PAEDIATR, V87, P1261, DOI 10.1080/080352598750030951; Shapiro-Mendoza CK, 2008, PEDIATRICS, V121, pE223, DOI 10.1542/peds.2006-3629; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Yoder BA, 2008, OBSTET GYNECOL, V111, P814, DOI 10.1097/AOG.0b013e31816499f4; ZHANG J, AM J OBSTET GYNECOL	21	368	381	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					419	425		10.1001/jama.2010.1015	http://dx.doi.org/10.1001/jama.2010.1015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664042	Bronze, Green Accepted			2022-12-28	WOS:000280350100025
J	Karagas, MR				Karagas, Margaret R.			Arsenic-related mortality in Bangladesh	LANCET			English	Editorial Material							EXPOSURE		Dartmouth Med Sch, Lebanon, NH 03756 USA	Dartmouth College	Karagas, MR (corresponding author), Dartmouth Med Sch, 1 Med Ctr Dr,7927 Rubin Bldg, Lebanon, NH 03756 USA.	margaret.karagas@dartmouth.edu			NATIONAL CANCER INSTITUTE [R01CA057494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, P20ES018175, P42ES007373] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; *INT AG RES CANC, 2004, IARC MONOGR EVAL CAR, V84, P97; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Liaw J, 2008, CANCER EPIDEM BIOMAR, V17, P1982, DOI 10.1158/1055-9965.EPI-07-2816; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; United Nations Environment Programme, 2008, VIT WAT GRAPH OV STA; Waalkes MP, 2007, TOXICOL APPL PHARM, V222, P271, DOI 10.1016/j.taap.2006.12.034	9	16	16	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					213	214		10.1016/S0140-6736(10)61002-1	http://dx.doi.org/10.1016/S0140-6736(10)61002-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20646757	Green Accepted			2022-12-28	WOS:000280457200007
J	Ye, J; Lenain, C; Bauwens, S; Rizzo, A; Saint-Leger, A; Poulet, A; Benarroch, D; Magdinier, F; Morere, J; Amiard, S; Verhoeyen, E; Britton, S; Calsou, P; Salles, B; Bizard, A; Nadal, M; Salvati, E; Sabatier, L; Wu, YL; Biroccio, A; Londono-Vallejo, A; Giraud-Panis, MJ; Gilson, E				Ye, Jing; Lenain, Christelle; Bauwens, Serge; Rizzo, Angela; Saint-Leger, Adelaide; Poulet, Anais; Benarroch, Delphine; Magdinier, Frederique; Morere, Julia; Amiard, Simon; Verhoeyen, Els; Britton, Sebastien; Calsou, Patrick; Salles, Bernard; Bizard, Anna; Nadal, Marc; Salvati, Erica; Sabatier, Laure; Wu, Yunlin; Biroccio, Annamaria; Londono-Vallejo, Arturo; Giraud-Panis, Marie-Josephe; Gilson, Eric			TRF2 and Apollo Cooperate with Topoisomerase 2 alpha to Protect Human Telomeres from Replicative Damage	CELL			English	Article							DNA-REPLICATION; ATM; MAINTENANCE; INTERACTS; NUCLEASE; BINDING; END	Human telomeres are protected from DNA damage by a nucleoprotein complex that includes the repeat-binding factor TRF2. Here, we report that TRF2 regulates the 5' exonuclease activity of its binding partner, Apollo, a member of the metallo-beta-lactamase family that is required for telomere integrity during S phase. TRF2 and Apollo also suppress damage to engineered interstitial telomere repeat tracts that were inserted far away from chromosome ends. Genetic data indicate that DNA topoisomerase 2 alpha acts in the same pathway of telomere protection as TRF2 and Apollo. Moreover, TRF2, which binds preferentially to positively supercoiled DNA substrates, together with Apollo, negatively regulates the amount of TOP1, TOP2 alpha, and TOP2 beta at telomeres. Our data are consistent with a model in which TRF2 and Apollo relieve topological stress during telomere replication. Our work also suggests that cellular senescence may be caused by topological problems that occur during the replication of the inner portion of telomeres.	[Ye, Jing; Lenain, Christelle; Bauwens, Serge; Saint-Leger, Adelaide; Poulet, Anais; Benarroch, Delphine; Magdinier, Frederique; Morere, Julia; Amiard, Simon; Salvati, Erica; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Biol Mol Cellule,UMR 5239, F-69364 Lyon, France; [Ye, Jing; Wu, Yunlin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai 200025, Peoples R China; [Ye, Jing; Saint-Leger, Adelaide; Benarroch, Delphine; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Nice Sophia Antipolis, CNRS, UMR 6267, Lab Biol & Pathol Genomes,INSERM,U998, F-06107 Nice, France; [Rizzo, Angela; Amiard, Simon; Salvati, Erica; Biroccio, Annamaria] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, I-00158 Rome, Italy; [Poulet, Anais; Benarroch, Delphine; Amiard, Simon; Giraud-Panis, Marie-Josephe] Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Joliot Curie,USR 3010, F-69364 Lyon, France; [Verhoeyen, Els] Univ Lyon, Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France; [Britton, Sebastien; Calsou, Patrick; Salles, Bernard] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Bizard, Anna; Nadal, Marc] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Sabatier, Laure] Inst Radiobiol Cellulaire & Mol, Direct Sci Vivant, Commissariat Energie Atom, Lab Radiobiol & Oncol, F-92265 Fontenay Aux Roses, France; [Londono-Vallejo, Arturo] Univ Paris 06, CNRS, UMR 3244, Inst Curie,Telomeres & Canc Lab, F-75248 Paris, France; [Gilson, Eric] Ctr Hosp Univ Nice, Dept Med Genet, F-06202 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Shanghai Jiao Tong University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; CHU Nice	Gilson, E (corresponding author), Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Biol Mol Cellule,UMR 5239, F-69364 Lyon, France.	eric.gilson@ens-lyon.fr	Benarroch, Delphine/E-9983-2017; Magdinier, Frederique/I-4735-2016; Rizzo, Angela/ABH-6753-2020; Benarroch-Popivker, Delphine/T-1990-2019; Biroccio, Annamaria/B-2861-2018; Verhoeyen, Els/H-6360-2016; calsou, patrick/AAB-5123-2020; amiard, simon/J-6951-2015; Londono-Vallejo, Arturo/ABH-5555-2020; Britton, Sébastien/AAL-1862-2020; Verhoeyen, Els/AAW-4853-2021	Magdinier, Frederique/0000-0002-0159-9559; Rizzo, Angela/0000-0001-5421-3085; Biroccio, Annamaria/0000-0003-3198-3532; amiard, simon/0000-0002-0427-1647; Londono-Vallejo, Arturo/0000-0003-3535-7563; Britton, Sébastien/0000-0002-7008-5316; Verhoeyen, Els/0000-0001-9224-5491; Giraud-Panis, Marie-Josephe/0000-0001-7941-2873; ye, jing/0000-0002-9471-3321; NADAL, Marc/0000-0001-9637-7694; Calsou, Patrick/0000-0001-7951-9806; Sabatier, Laure/0000-0003-0552-6549; Bizard, Anna/0000-0003-1858-3999; Salvati, Erica/0000-0002-3373-7442	Ligue Nationale contre le Cancer; Institut National du Cancer; Agence Nationale de la Recherche; European Community [RISC-RAD FI6R-CT-2003-508842, TELOMARKER Health-F2-2007-200950]; Italian Association for Cancer Research; Association pour la Recherche sur le Cancer	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community(European Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank S. Gasser and F. Palladino for critical reading and also M. Foiani and T. Weinert for stimulating discussions. We are also grateful to E. Giulotto for advice concerning the choice of the natural ITS sequences, J.P. de Villartay for the primary fibroblast cells, and J.P. Murnane for SNG28 cell line. This work was supported by grants from the Ligue Nationale contre le Cancer (E. G., "equipe labellisee"), from the Institut National du Cancer (E. G., B. S., A. L. V., and L. S., program TELINCA), from Agence Nationale de la Recherche (E. G., programs TELOREG and TELOREP) and from the European Community (E. G. and L. S., RISC-RAD FI6R-CT-2003-508842; E. G., TELOMARKER Health-F2-2007-200950). The work of A. Biroccio's group was supported by grants from Italian Association for Cancer Research. Microscopy and image processing and analysis were performed at the imaging facility Plateau Technique Imagerie/Microscopie of IFR128. J.Y. and C. L. were supported by a fellowship from the Association pour la Recherche sur le Cancer.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; ARNOULT N, 2009, GENE DEV, V15, P1915; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Damelin M, 2007, BRIT J CANCER, V96, P201, DOI 10.1038/sj.bjc.6603537; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Demuth I, 2008, DNA REPAIR, V7, P1192, DOI 10.1016/j.dnarep.2008.03.020; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Desmaze C, 2004, CYTOGENET GENOME RES, V104, P123, DOI 10.1159/000077476; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Freibaum BD, 2008, J BIOL CHEM, V283, P23671, DOI 10.1074/jbc.M800388200; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Germe T, 2009, EMBO J, V28, P2803, DOI 10.1038/emboj.2009.223; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Mignon-Ravix C, 2002, EUR J HUM GENET, V10, P107, DOI 10.1038/sj.ejhg.5200775; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stansel RM, 2001, EMBO J, V20, P5532; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vannier JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000380; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	51	136	140	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					230	242		10.1016/j.cell.2010.05.032	http://dx.doi.org/10.1016/j.cell.2010.05.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655466	Bronze			2022-12-28	WOS:000280204300015
J	Lo, J; You, SM; Liebau, J; Lee, H; Grinspoon, S				Lo, Janet; You, Sung Min; Liebau, James; Lee, Hang; Grinspoon, Steven			Effects of Low-Dose Growth Hormone Withdrawal in Patients With HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ACCUMULATION		[Lo, Janet; You, Sung Min; Liebau, James; Grinspoon, Steven] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lo, J (corresponding author), Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA.	sgrinspoon@partners.org			NCRR NIH HHS [1 UL1 RR025758, M01 RR001066, M01 RR01066, UL1 RR025758] Funding Source: Medline; NHLBI NIH HHS [K23 HL092792] Funding Source: Medline; NIDDK NIH HHS [R01 DK63639, R01 DK063639, P30 DK040561-15, K24 DK064545, P30 DK040561] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR001066] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R01DK063639, K24DK064545] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Grunfeld C, 2007, JAIDS-J ACQ IMM DEF, V45, P286; Kotler DP, 2004, JAIDS-J ACQ IMM DEF, V35, P239, DOI 10.1097/00126334-200403010-00004; Lo J, 2008, JAMA-J AM MED ASSOC, V300, P509, DOI 10.1001/jama.300.5.509	3	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					272	274		10.1001/jama.2010.989	http://dx.doi.org/10.1001/jama.2010.989			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639560	Green Accepted			2022-12-28	WOS:000280107500016
J	Dyer, C				Dyer, Clare			Child Protection Expert witnesses above the parapet	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9RJ, England			ClareDyer@aol.com							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 20	2010	341								c3672	10.1136/bmj.c3672	http://dx.doi.org/10.1136/bmj.c3672			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GV	20647287				2022-12-28	WOS:000280411600006
J	Behr, MA; Divangahi, M; Lalande, JD				Behr, Marcel A.; Divangahi, Maziar; Lalande, Jean-Daniel			What's in a name? The (mis)labelling of Crohn's as an autoimmune disease	LANCET			English	Editorial Material							ACUTE-INFLAMMATION; AUTOANTIBODIES; INFECTIONS; ANTIBODIES		[Behr, Marcel A.; Divangahi, Maziar; Lalande, Jean-Daniel] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Divangahi, Maziar] McGill Univ, Meakins Christie Labs, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Behr, MA (corresponding author), McGill Univ, Dept Med, Ctr Hlth, A5-156,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	marcel.behr@mcgill.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; Desplat-Jego S, 2007, WORLD J GASTROENTERO, V13, P2312, DOI 10.3748/wjg.v13.i16.2312; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Dos KM, 2008, INFLAMM BOWEL DIS, V14, pS97, DOI 10.1002/ibd.20723; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lidar M, 2009, ANN NY ACAD SCI, V1173, P640, DOI 10.1111/j.1749-6632.2009.04673.x; Lowe AM, 2008, LANCET INFECT DIS, V8, P720, DOI 10.1016/S1473-3099(08)70257-3; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schoepfer AM, 2009, INFLAMM BOWEL DIS, V15, P1358, DOI 10.1002/ibd.20892; Seibold F, 1997, GUT, V40, P481, DOI 10.1136/gut.40.4.481; Seidelin JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007794; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Stetson DB, 2007, IMMUNITY, V27, P546, DOI 10.1016/j.immuni.2007.10.005; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816	20	18	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					202	203		10.1016/S0140-6736(10)60282-6	http://dx.doi.org/10.1016/S0140-6736(10)60282-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20638565				2022-12-28	WOS:000280313100028
J	Kiefer, T				Kiefer, Thorsten			OCEAN SCIENCE When Still Waters Ran Deep	SCIENCE			English	Editorial Material							LAST DEGLACIATION; NORTH PACIFIC; MONSOON; RECORD; AGES		PAGES Int Project Off, CH-3012 Bern, Switzerland		Kiefer, T (corresponding author), PAGES Int Project Off, CH-3012 Bern, Switzerland.	kiefer@pages.unibe.ch						Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; Ahagon N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018287; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Emile-Geay J, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001058; Fasullo J, 2002, J CLIMATE, V15, P3082, DOI [10.1175/1520-0442(2002)015<3082:HSRTAS>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3082:HSRTAS&gt;2.0.CO;2]; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Keigwin LD, 1998, PALEOCEANOGRAPHY, V13, P323, DOI 10.1029/98PA00874; Leduc G, 2007, NATURE, V445, P908, DOI 10.1038/nature05578; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Okazaki Y, 2010, SCIENCE, V329, P200, DOI 10.1126/science.1190612; Rashid H, 2007, QUATERNARY SCI REV, V26, P2586, DOI 10.1016/j.quascirev.2007.07.002; SARNTHEIN M, 2007, GEOPHYS MONOGR SER, V173, P175, DOI DOI 10.1029/173GM13; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; WARREN BA, 1983, J MAR RES, V41, P327, DOI 10.1357/002224083788520207	14	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					290	291		10.1126/science.1192295	http://dx.doi.org/10.1126/science.1192295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647457				2022-12-28	WOS:000279925900029
J	Manolio, TA				Manolio, Teri A.			Genomewide Association Studies and Assessment of the Risk of Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; COMMON VARIANTS; GENETIC-VARIANTS; PROSTATE-CANCER; CROHN-DISEASE; LARGE-SCALE; PREDICTION; COMPLEMENT; HERITABILITY		NHGRI, Off Populat Genom, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Manolio, TA (corresponding author), NHGRI, Off Populat Genom, Bldg 31,Rm 4B-09,31 Ctr Dr,MSC 2152, Bethesda, MD 20892 USA.	manolio@nih.gov	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899				1000 Genomes, 1000 GEN DEEP CAT HU; ABECASIS GR, 2009, 1000 GENOMES PROJ EC, P246; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; BARRETT JC, 2009, NAT GENET       0510; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bora NS, 2008, SEMIN IMMUNOPATHOL, V30, P85, DOI 10.1007/s00281-008-0110-y; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Franke A, 2008, GASTROENTEROLOGY, V135, P1207, DOI 10.1053/j.gastro.2008.07.017; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; HINDORFF LA, NHGRI CATALOG PUBLIS; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; *HL SEL COMM SCI T, 2009, 1071 HL SEL COMM SCI, P104; Hoover RN, 2007, EPIDEMIOLOGY, V18, P13, DOI 10.1097/01.ede.0000249532.81073.b2; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; JALLOW M, 2009, NAT GENET       0524; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kaye J, 2008, HUM MOL GENET, V17, pR180, DOI 10.1093/hmg/ddn253; Kingsmore SF, 2008, NAT REV DRUG DISCOV, V7, P221, DOI 10.1038/nrd2519; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P2150; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; van der Net JB, 2009, AM HEART J, V158, P105, DOI 10.1016/j.ahj.2009.04.022; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Xu JF, 2009, PROSTATE, V69, P1565, DOI 10.1002/pros.21002; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	74	990	1055	4	139	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					166	176		10.1056/NEJMra0905980	http://dx.doi.org/10.1056/NEJMra0905980			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20647212	Bronze			2022-12-28	WOS:000279574100009
J	Sosenko, IRS; Bancalari, E				Sosenko, Ilene R. S.; Bancalari, Eduardo			NO for preterm infants at risk of bronchopulmonary dysplasia	LANCET			English	Editorial Material							INHALED NITRIC-OXIDE; RESPIRATORY-FAILURE		[Sosenko, Ilene R. S.; Bancalari, Eduardo] Univ Miami, Miller Sch Med, Dept Pediat, Div Neonatol, Miami, FL 33101 USA	University of Miami	Bancalari, E (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat, Div Neonatol, Miami, FL 33101 USA.							Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Field D, 2005, PEDIATRICS, V115, P926, DOI 10.1542/peds.2004-1209; Gutierrez HH, 1996, FREE RADICAL BIO MED, V21, P43, DOI 10.1016/0891-5849(95)02226-0; Kinsella JP, 2006, NEW ENGL J MED, V355, P354, DOI 10.1056/NEJMoa060442; Kinsella JP, 1997, PEDIATR RES, V41, P457, DOI 10.1203/00006450-199704000-00002; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; Mercier JC, 1999, LANCET, V354, P1066; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; Subhedar NV, 1997, ARCH DIS CHILD-FETAL, V77, pF185, DOI 10.1136/fn.77.3.F185; TERHORST SA, 2007, AM J PHYSIOL-LUNG C, V293, P135; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927	13	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					308	310		10.1016/S0140-6736(10)61051-3	http://dx.doi.org/10.1016/S0140-6736(10)61051-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20655103				2022-12-28	WOS:000280717900006
J	Gilbert, PM; Havenstrite, KL; Magnusson, KEG; Sacco, A; Leonardi, NA; Kraft, P; Nguyen, NK; Thrun, S; Lutolf, MP; Blau, HM				Gilbert, P. M.; Havenstrite, K. L.; Magnusson, K. E. G.; Sacco, A.; Leonardi, N. A.; Kraft, P.; Nguyen, N. K.; Thrun, S.; Lutolf, M. P.; Blau, H. M.			Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture	SCIENCE			English	Article							SATELLITE CELLS; REGENERATION; EXPANSION; FATES	Stem cells that naturally reside in adult tissues, such as muscle stem cells (MuSCs), exhibit robust regenerative capacity in vivo that is rapidly lost in culture. Using a bioengineered substrate to recapitulate key biophysical and biochemical niche features in conjunction with a highly automated single-cell tracking algorithm, we show that substrate elasticity is a potent regulator of MuSC fate in culture. Unlike MuSCs on rigid plastic dishes (similar to 10(6) kilopascals), MuSCs cultured on soft hydrogel substrates that mimic the elasticity of muscle (12 kilopascals) self-renew in vitro and contribute extensively to muscle regeneration when subsequently transplanted into mice and assayed histologically and quantitatively by noninvasive bioluminescence imaging. Our studies provide novel evidence that by recapitulating physiological tissue rigidity, propagation of adult muscle stem cells is possible, enabling future cell-based therapies for muscle-wasting diseases.	[Gilbert, P. M.; Havenstrite, K. L.; Magnusson, K. E. G.; Sacco, A.; Leonardi, N. A.; Kraft, P.; Nguyen, N. K.; Blau, H. M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Baxter Lab Stem Cell Biol,Dept Microbiol & Immuno, Stanford, CA 94305 USA; [Havenstrite, K. L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Magnusson, K. E. G.] Royal Inst Technol KTH, Signal Proc Lab, Sch Elect Engn, SE-10044 Stockholm, Sweden; [Leonardi, N. A.; Lutolf, M. P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Leonardi, N. A.; Lutolf, M. P.] Ecole Polytech Fed Lausanne, Lab Stem Cell Bioengn, CH-1015 Lausanne, Switzerland; [Thrun, S.] Stanford Univ, Dept Comp Sci, Stanford Artificial Intelligence Lab, Stanford, CA 94305 USA	Stanford University; Stanford University; Royal Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stanford University	Blau, HM (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Baxter Lab Stem Cell Biol,Dept Microbiol & Immuno, Stanford, CA 94305 USA.	hblau@stanford.edu	Lutolf, Matthias P/E-5914-2010	Gilbert, Penney/0000-0001-5509-9616	PHS [CA09151]; CIRM [TG2-01159, RT1-01001]; Leukemia and Lymphoma Society; European Young Investigator Award; NSF; NIH [2 T32 HD007249, HL096113, AG009521, AG020961, U01 HL100397]; Muscular Dystrophy Association (MDA) [4063, 4320]; EPFL; Swiss Study Foundation; John och Karin Engbloms Stipendiefond; Bio X Undergraduate Research Award; Howard Hughes Medical Institute [52005886]; JDRF [34-2008-623]; LLS [TR6025-09]; Stanford Bio-X Award [IIP3-34]; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R37AG009521, R01AG009521] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CIRM(California Institute for Regenerative Medicine); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Young Investigator Award; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); EPFL; Swiss Study Foundation; John och Karin Engbloms Stipendiefond; Bio X Undergraduate Research Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); JDRF(Juvenile Diabetes Research Foundation); LLS; Stanford Bio-X Award; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Koleckar, R. Tran, IBM Almaden, the Stanford Center for Innovation in In-Vivo Imaging, and the Stanford Shared FACS Facility core facilities for technical support; J. Sly, R. D. Miller, S. Kobal, S. Gobaa, R. Doyonnas, and A. Barron for valuable discussions; and F. Rossi and M. Kyba for providing alpha-7 integrin antibody and Pax7-ZsGreen mice, respectively. This work was financially supported by PHS CA09151 and CIRM TG2-01159 (P.M.G.); Leukemia and Lymphoma Society Fellow and European Young Investigator Award (M.P.L.); NSF and NIH Training Grant 2 T32 HD007249 (K.H.); Muscular Dystrophy Association (MDA) grant 4063 (A.S.); EPFL Excellence Scholarship and the Swiss Study Foundation (N.A.L.); John och Karin Engbloms Stipendiefond (K.E.G.M.); Bio X Undergraduate Research Award and Howard Hughes Medical Institute grant 52005886 (N.K.N.); and NIH grants HL096113, AG009521, AG020961, U01 HL100397, JDRF 34-2008-623, MDA grant 4320, LLS grant TR6025-09, CIRM grant RT1-01001, Stanford Bio-X Award IIP3-34, and the Baxter Foundation (H.M.B.).	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Callister W.D., 2000, FUNDAMENTALS MAT SCI, V5th; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Heslop L, 2000, J CELL SCI, V113, P2299; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Partridge T A, 1997, Methods Mol Biol, V75, P131; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	26	1117	1145	19	398	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1078	1081		10.1126/science.1191035	http://dx.doi.org/10.1126/science.1191035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20647425	Green Accepted			2022-12-28	WOS:000281253500041
J	Armah, GE; Sow, SO; Breiman, RF; Dallas, MJ; Tapia, MD; Feikin, DR; Binka, FN; Steele, AD; Laserson, KF; Ansah, NA; Levine, MM; Lewis, K; Coia, ML; Attah-Poku, M; Ojwando, J; Rivers, SB; Victor, JC; Nyambane, G; Hodgson, A; Schodel, F; Ciarlet, M; Neuzil, KM				Armah, George E.; Sow, Samba O.; Breiman, Robert F.; Dallas, Michael J.; Tapia, Milagritos D.; Feikin, Daniel R.; Binka, Fred N.; Steele, A. Duncan; Laserson, Kayla F.; Ansah, Nana A.; Levine, Myron M.; Lewis, Kristen; Coia, Michele L.; Attah-Poku, Margaret; Ojwando, Joel; Rivers, Stephen B.; Victor, John C.; Nyambane, Geoffrey; Hodgson, Abraham; Schoedel, Florian; Ciarlet, Max; Neuzil, Kathleen M.			Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							CHILDHOOD DIARRHEA; FINNISH CHILDREN; CONCOMITANT USE; MORTALITY; SAFETY; IMMUNOGENICITY; DISEASE; ZINC	Background Rotavirus gastroenteritis causes many deaths in infants in sub-Saharan Africa. Because rotavirus vaccines have proven effective in developed countries but had not been tested in developing countries, we assessed efficacy of a pentavalent rotavirus vaccine against severe disease in Ghana, Kenya, and Mali between April, 2007, and March, 2009. Methods In our multicentre, double-blind, placebo-controlled trial, undertaken in rural areas of Ghana and Kenya and an urban area of Mali, we randomly assigned infants aged 4-12 weeks without symptoms of gastrointestinal disorders in a 1:1 ratio to receive three oral doses of pentavalent rotavirus vaccine 2 mL or placebo at around 6 weeks, 10 weeks, and 14 weeks of age. Infants with HIV infection were not excluded. Randomisation was done by computer-generated randomisation sequence in blocks of six. We obtained data for gastrointestinal symptoms from parents on presentation to health-care facilities and clinical data were obtained prospectively by clinicians. The primary endpoint was severe rotavirus gastroenteritis (Vesikari score >= 11), detected by enzyme immunoassay, arising 14 days or more after the third dose of placebo or vaccine to end of study (March 31,2009; around 21 months of age). Analysis was per protocol; infants who received scheduled doses of vaccine or placebo without intervening laboratory-confirmed naturally occurring rotavirus disease earlier than 14 days after the third dose and had complete clinical and laboratory results were included in the analysis. This study is registered with ClinicalTrials.gov, number NCT00362648. Findings 5468 infants were randomly assigned to receive pentavalent rotavirus vaccine (n=2733) or placebo (n=2735). 2357 infants assigned to vaccine and 2348 assigned to placebo were included in the per-protocol analysis. 79 cases of severe rotavirus gastroenteritis were reported in 2610.6 person-years in the vaccine group, compared with 129 cases in 2585.9 person-years in the placebo group, resulting in a vaccine efficacy against severe rotavirus gastroenteritis of 39.3% (95% CI 19.1-54.7, p=0.0003 for efficacy >0%). Median follow-up in both groups was 527 days starting 14 days after the third dose of vaccine or placebo was given. 42 (1.5%) of 2723 infants assigned to receive vaccine and 45 (1.7%) of 2724 infants assigned to receive placebo had a serious adverse event within 14 days of any dose. The most frequent serious adverse event was gastroenteritis (vaccine 17 [0.6%]; placebo 17 [0.6%]). Interpretation Pentavalent rotavirus vaccine is effective against severe rotavirus gastroenteritis in the first 2 years of life in African countries with high mortality in infants younger than 5 years. We support WHO's recommendation for adoption of rotavirus vaccine into national expanded programmes on immunisation in Africa.	[Lewis, Kristen; Victor, John C.; Neuzil, Kathleen M.] PATH, Seattle, WA 98108 USA; [Armah, George E.; Attah-Poku, Margaret] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Binka, Fred N.] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Sow, Samba O.; Tapia, Milagritos D.] Ctr Vaccine Dev, Bamako, Mali; [Breiman, Robert F.; Feikin, Daniel R.; Ojwando, Joel; Nyambane, Geoffrey] Ctr Dis Control & Prevent, Int Emerging Infect Program, Atlanta, GA USA; [Breiman, Robert F.; Laserson, Kayla F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Breiman, Robert F.; Feikin, Daniel R.; Laserson, Kayla F.; Ojwando, Joel; Nyambane, Geoffrey] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Breiman, Robert F.; Feikin, Daniel R.; Laserson, Kayla F.; Ojwando, Joel; Nyambane, Geoffrey] Ctr Dis Control & Prevent, Res & Publ Hlth Collaborat, Kisumu, Kenya; [Dallas, Michael J.; Coia, Michele L.; Rivers, Stephen B.; Schoedel, Florian; Ciarlet, Max] Merck Res Labs, N Wales, PA USA; [Tapia, Milagritos D.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Steele, A. Duncan] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland; [Ansah, Nana A.; Hodgson, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana	University of Ghana; University of Ghana; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Merck & Company; University System of Maryland; University of Maryland Baltimore; World Health Organization; Navrongo Health Research Center	Neuzil, KM (corresponding author), PATH, POB 900922, Seattle, WA 98108 USA.	kneuzil@path.org		Victor, John/0000-0002-7970-6588; Steele, Andrew Duncan/0000-0002-4946-037X	PATH's Rotavirus Vaccine Program; GAVI Alliance	PATH's Rotavirus Vaccine Program; GAVI Alliance	This study, with protocol V260-015, was designed, managed, undertaken, and analysed by the co-sponsors in collaboration with the site investigators and under the supervision and advice of the data and safety monitoring board. Investigators and their institutions were funded by PATH's Rotavirus Vaccine Program, with a grant from the GAVI Alliance. This report is published with the permission of the Director of Kenya Medical Research Institute. We thank the volunteers and their families; the Kasena-Nankana District Health Management team and Ernest Opoku, Michael Babayara, Abdul Wahab Ernest Sobe, Susan Damanka, and Belinda Lartey (Ghana); Earnest Cook, Daveline Nyakundi, Janet Oyieko, Tony Sang, and Allan Audi (Kenya); the study coordinators Fadima Cheick Haidara, Fatoumata Diallo, and Rokiatou Dembele (Mali); Mamoudou Kodio for vaccine management (Mali); field supervisors Moussa Doumbia, Oumou Traore Kone, Kindia Camara, and Glodie Doumbia (Mali); Uma Uduma Onwuchekwa, Boubacar Diallo, Kadiatou Kone, Mamadou B Traore, and Oualy Diawara for overall data management (Mali); the numerous field workers (Mali); the members of the data and safety monitoring board (King Holmes [Chairman], Wasif Ali Khan, Edward Tsiri Agbenyega, Grace Irimu, Mamadou Marouf Keita, Dinh Sy Hien, Nik Zarifah Nik Hussain Reed, and Janet Wittes); Joyce Erickson (PATH) for contracting and financial analysis; Carolien Bakker and David Oxley (PATH) for administrative assistance; Penny M Heaton and Michelle G Goveia for their contribution to the design of the study; Bradley Raybold for contributions to the initiation and implementation of the study; Jody Lawrence for overseeing medical monitoring; Fay DiCandilo and Margaret Nelson for contributing to careful review of the data; Donna Hyatt for data management; Laura Mallette and Vladimir Liska for laboratory data coordination; Richard Ward and Monica McNeal for overseeing laboratory assays; Tracy Burke for ensuring adequate vaccine and placebo supplies; and Family Health International and PharmaLink, especially Carolyn Enloe, Vivian Bragg, Laura Niver, Jen Auerbach, Linda McNeil, and all the Family Health International field monitors and safety-reporting staff.	Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P2; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; BERNSTEIN DI, 1990, J INFECT DIS, V162, P1055, DOI 10.1093/infdis/162.5.1055; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Block SL, 2007, PEDIATRICS, V119, P11, DOI 10.1542/peds.2006-2058; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; BRUSSOW H, 1993, J CLIN MICROBIOL, V31, P593; Chang HGH, 2010, VACCINE, V28, P754, DOI 10.1016/j.vaccine.2009.10.075; Ciarlet M, 2008, PEDIATR INFECT DIS J, V27, P874, DOI 10.1097/INF.0b013e3181782780; Ciarlet M, 2009, VACCINE, V27, pG72, DOI 10.1016/j.vaccine.2009.09.107; CLARK HF, 1988, J INFECT DIS, V158, P570, DOI 10.1093/infdis/158.3.570; DiStefano DJ, 2005, J CLIN MICROBIOL, V43, P5876, DOI 10.1128/JCM.43.12.5876-5880.2005; Ellis AA, 2007, SOC SCI MED, V64, P701, DOI 10.1016/j.socscimed.2006.10.011; GILCHRIST MJR, 1987, DIAGN MICR INFEC DIS, V8, P221, DOI 10.1016/0732-8893(87)90053-8; Glass R I, 1991, Adv Exp Med Biol, V310, P249; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rodriguez ZM, 2007, PEDIATR INFECT DIS J, V26, P221, DOI 10.1097/01.inf.0000254391.71103.e8; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; RUUSKA T, 1991, ACTA PAEDIATR SCAND, V80, P500, DOI 10.1111/j.1651-2227.1991.tb11893.x; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Staat A. M., 2008, Morbidity and Mortality Weekly Report, V57, P697; STEELE AD, J INFECT DI IN PRESS; SUHARYONO, 1992, LANCET, V340, P689, DOI 10.1016/0140-6736(92)92231-4; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2007, INT J INFECT DIS, V11, pS29, DOI 10.1016/S1201-9712(07)60019-8; Walker CLF, 2009, B WORLD HEALTH ORGAN, V87, P780, DOI 10.2471/BLT.08.058990; *WHO, 2008, WKLY EPIDEMIOL REC, V83, P421; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P385; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zaman K, 2009, VACCINE, V27, P1333, DOI 10.1016/j.vaccine.2008.12.059	38	531	545	2	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					606	614		10.1016/S0140-6736(10)60889-6	http://dx.doi.org/10.1016/S0140-6736(10)60889-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20692030				2022-12-28	WOS:000281309100031
J	Folco, L; Di Martino, M; El Barkooky, A; D'Orazio, M; Lethy, A; Urbini, S; Nicolosi, I; Hafez, M; Cordier, C; van Ginneken, M; Zeoli, A; Radwan, AM; El Khrepy, S; El Gabry, M; Gomaa, M; Barakat, AA; Serra, R; El Sharkawi, M				Folco, Luigi; Di Martino, Mario; El Barkooky, Ahmed; D'Orazio, Massimo; Lethy, Ahmed; Urbini, Stefano; Nicolosi, Iacopo; Hafez, Mahfooz; Cordier, Carole; van Ginneken, Matthias; Zeoli, Antonio; Radwan, Ali M.; El Khrepy, Sami; El Gabry, Mohamed; Gomaa, Mahomoud; Barakat, Aly A.; Serra, Romano; El Sharkawi, Mohamed			The Kamil Crater in Egypt	SCIENCE			English	Article							EARTH; IMPACT		[Folco, Luigi; Cordier, Carole; van Ginneken, Matthias; Zeoli, Antonio] Univ Siena, Museo Nazl Antartide, I-53100 Siena, Italy; [Di Martino, Mario] Osserv Astron Torino, Ist Nazl Astrofis, I-10025 Pino Torinese, Italy; [El Barkooky, Ahmed; El Sharkawi, Mohamed] Cairo Univ, Fac Sci, Dept Geol, Giza, Egypt; [D'Orazio, Massimo] Univ Pisa, Dipartimento Sci Terra, I-56126 Pisa, Italy; [Lethy, Ahmed; Hafez, Mahfooz; Radwan, Ali M.; El Khrepy, Sami; El Gabry, Mohamed; Gomaa, Mahomoud] Natl Res Inst Astron & Geophys, Helwan, Egypt; [Urbini, Stefano; Nicolosi, Iacopo] Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy; [Barakat, Aly A.] Egyptian Mineral Resources Author, Cairo, Egypt; [Serra, Romano] Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy	University of Siena; Istituto Nazionale Astrofisica (INAF); University of Turin; Egyptian Knowledge Bank (EKB); Cairo University; University of Pisa; Egyptian Knowledge Bank (EKB); National Research Institute of Astronomy & Geophysics - NRIAG; Istituto Nazionale Geofisica e Vulcanologia (INGV); Egyptian Mineral Resources Authority; University of Bologna	Folco, L (corresponding author), Univ Siena, Museo Nazl Antartide, Via Laterina 8, I-53100 Siena, Italy.	folco@unisi.it	Folco, Luigi/AAA-6351-2020; ElGabry, Mohamed N./D-8979-2017; Folco, Luigi/AAB-8586-2021; Radwan, Ali/Q-1864-2019; lethy, Ahmed/Q-2021-2019; Hafez, Mahfooz/P-6046-2019; Elkhrepy, Sami/Q-1843-2019; Radwan, Ali A./AAF-8845-2021; Nicolosi, Iacopo/AAF-1614-2021	Folco, Luigi/0000-0002-7276-3483; ElGabry, Mohamed N./0000-0003-2925-4242; Radwan, Ali/0000-0002-5230-0115; lethy, Ahmed/0000-0002-9533-4905; Hafez, Mahfooz/0000-0001-8300-4733; Elkhrepy, Sami/0000-0002-4138-5416; Radwan, Ali A./0000-0001-5497-8395; Nicolosi, Iacopo/0000-0002-0711-9923; urbini, stefano/0000-0002-8053-4197; D'Orazio, Massimo/0000-0003-1366-3260; Gomaa, Mahmoud/0000-0002-9697-3506; Cordier, Carole/0000-0002-6100-4393	European Commission; Fondazione Cassa di Risparmio di Torino; Banca Monte dei Paschi di Siena S.p.A.; Telespazio S.p.A. (European Space Agency)	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Cassa di Risparmio di Torino(Fondazione CRT); Banca Monte dei Paschi di Siena S.p.A.; Telespazio S.p.A. (European Space Agency)(European Space Agency)	Work carried out within the "2009 Egyptian-Italian Year of Science and Technology" framework. T. Hussein and F. Porcelli provided diplomatic support; the Egyptian Army, logistical support; G. Negro, field assistance; F. Speranza and P. Rochette, helpful discussion; the European Commission (Marie Curie Actions-RTNs ORIGINS project), Fondazione Cassa di Risparmio di Torino, Banca Monte dei Paschi di Siena S.p.A., and Telespazio S.p.A. (in the European Space Agency-Space Situational Awareness program framework), financial support.	Bland PA, 2006, METEORIT PLANET SCI, V41, P607, DOI 10.1111/j.1945-5100.2006.tb00485.x; Bland PA, 2003, NATURE, V424, P288, DOI 10.1038/nature01757; Brown P, 2002, NATURE, V420, P294, DOI 10.1038/nature01238; Collins GS, 2005, METEORIT PLANET SCI, V40, P817, DOI 10.1111/j.1945-5100.2005.tb00157.x; D'Orazio M, 2003, GEOSTANDARD NEWSLETT, V27, P215, DOI 10.1111/j.1751-908X.2003.tb00723.x; Herd CDK, 2008, GEOLOGY, V36, P955, DOI 10.1130/G25236A.1; HUSSEIN T, 2009 EGYPTIAN ITALIA; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; EARTH IMPACT DATABAS	9	47	47	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					804	804		10.1126/science.1190990	http://dx.doi.org/10.1126/science.1190990			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20651117				2022-12-28	WOS:000280809900041
J	Malakoff, D; Yeston, J; Smith, J				Malakoff, David; Yeston, Jake; Smith, Jesse			Getting Better To Get Bigger INTRODUCTION	SCIENCE			English	Editorial Material																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					779	779		10.1126/science.329.5993.779	http://dx.doi.org/10.1126/science.329.5993.779			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637ID	20705844				2022-12-28	WOS:000280809900030
J	Rosa, EA; Tuler, SP; Fischhoff, B; Webler, T; Friedman, SM; Sclove, RE; Shrader-Frechette, K; English, MR; Kasperson, RE; Goble, RL; Leschine, TM; Freudenburg, W; Chess, C; Perrow, C; Erikson, K; Short, JF				Rosa, Eugene A.; Tuler, Seth P.; Fischhoff, Baruch; Webler, Thomas; Friedman, Sharon M.; Sclove, Richard E.; Shrader-Frechette, Kristin; English, Mary R.; Kasperson, Roger E.; Goble, Robert L.; Leschine, Thomas M.; Freudenburg, William; Chess, Caron; Perrow, Charles; Erikson, Kai; Short, James F.			Nuclear Waste: Knowledge Waste?	SCIENCE			English	Editorial Material							RISK		[Rosa, Eugene A.; Short, James F.] Washington State Univ, Pullman, WA 99164 USA; [Rosa, Eugene A.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Tuler, Seth P.; Webler, Thomas] Social & Environm Res Inst, Greenfield, MA 01301 USA; [Fischhoff, Baruch] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Friedman, Sharon M.] Lehigh Univ, Bethlehem, PA 18015 USA; [Sclove, Richard E.] Loka Inst, Amherst, MA 01002 USA; [Shrader-Frechette, Kristin] Univ Notre Dame, Notre Dame, IN 46556 USA; [English, Mary R.] Univ Tennessee, Knoxville, TN 37996 USA; [Kasperson, Roger E.; Goble, Robert L.] Clark Univ, Worcester, MA 01610 USA; [Leschine, Thomas M.] Univ Washington, Seattle, WA 98105 USA; [Freudenburg, William] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Chess, Caron] Rutgers State Univ, New Brunswick, NJ 08901 USA; [Perrow, Charles; Erikson, Kai] Yale Univ, New Haven, CT 06520 USA	Washington State University; Stanford University; Carnegie Mellon University; Lehigh University; University of Notre Dame; University of Tennessee System; University of Tennessee Knoxville; Clark University; University of Washington; University of Washington Seattle; University of California System; University of California Santa Barbara; Rutgers State University New Brunswick; Yale University	Rosa, EA (corresponding author), Washington State Univ, Pullman, WA 99164 USA.	rosa@wsu.edu	Fischhoff, Baruch/I-9859-2014; Webler, Thomas/ABE-3201-2021	Fischhoff, Baruch/0000-0002-3030-6874; 				DEUTSCH JM, 2009, UPDATE MIT 2003 FUTU; Dietz T., 2008, PUBLIC PARTICIPATION; Dunlap R.E., 1993, PUBLIC REACTIONS NUC; *FDA RISK COMM ADV, 2009, FDAS STRAT PLAN RISK; Fischhoff B., 2009, Oxford textbook of public health, Volume 2: the methods of public health, P940; Flint AL, 2001, REV GEOPHYS, V39, P447, DOI 10.1029/1999RG000075; FLYNN J, 1992, RISK ANAL, V12, P417, DOI 10.1111/j.1539-6924.1992.tb00694.x; GEMAN B, 2009, SCI AM          0507; JENKINSSMITH H, 1999, NUCL REACTIONS SYNTH; KUNREUTHER H, 1996, J POLICY ANAL MANAG, V15, P601; LEE W, 2002, DETERMINING OUR ENV; Macfarlane A. M., 2006, UNCERTAINTY UNDERGRO, P393, DOI [DOI 10.7551/MITPRESS/6965.003.0035, 10.7551/mitpress/6965.003.0035]; MacFarlane Allison, 2006, UNCERTAINTY UNDERGRO; McComas K, 2007, J APPL SOC PSYCHOL, V37, P905, DOI 10.1111/j.1559-1816.2007.00192.x; McCombie C, 2010, DAEDALUS-US, V139, P32, DOI 10.1162/daed.2010.139.1.32; Metlay D., 1999, SOCIAL TRUST MANAGEM, P100; *NAT RES COUNC, 2003, ON STEP TIM STAG DEV; National Research Council, 1995, TECHN BAS YUCC MOUNT; *OFF PRESS SECR PR, 2010, BLUE RIBB COMM AM NU; Ramana MV, 2009, ANNU REV ENV RESOUR, V34, P127, DOI 10.1146/annurev.environ.033108.092057; *SEAB, 1993, EARN PUBL TRUST CONF; SHRADERFRECHETT.K, 1993, PUBLIC AFF Q, V4, P363; SLOVIC P, 1991, SCIENCE, V254, P1603, DOI 10.1126/science.254.5038.1603; Slovic P., 1995, 100 CENTURIES SOLITU; Stern P. C., 1996, UNDERSTANDING RISK I; TETREAULT S, 2010, LAS VEGAS REV J 0709; *US NUCL REG COMM, EXP NEW NUCL POW PLA; *US OFF MAN BUDG, 2009, TERM RED SAV BUDG US, P68; WEBLER T, 2008, GOVERNANCE REFORM RE, P125; *WHIT HOUS, WHIT HOUS FACT SHEET; Whitfield SC, 2009, RISK ANAL, V29, P425, DOI 10.1111/j.1539-6924.2008.01155.x; 2010, REMARKS PRESIDENT EN	32	29	30	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					762	763		10.1126/science.1193205	http://dx.doi.org/10.1126/science.1193205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637ID	20705835				2022-12-28	WOS:000280809900021
J	Judge, A; Welton, NJ; Sandhu, J; Ben-Shlomo, Y				Judge, Andy; Welton, Nicky J.; Sandhu, Jat; Ben-Shlomo, Yoav			Equity in access to total joint replacement of the hip and knee in England: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; AGED 55 YEARS; SOCIOECONOMIC VARIATIONS; POPULATION REQUIREMENT; COST-EFFECTIVENESS; OLDER-AGE; ARTHROPLASTY; SURGERY; NEED	Objective To explore geographical and sociodemographic factors associated with variation in equity in access to total hip and knee replacement surgery. Design Combining small area estimates of need and provision to explore equity in access to care. Setting English census wards. Subjects Patients throughout England who needed total hip or knee replacement and numbers who received surgery. Main outcome measures Predicted rates of need (derived from the Somerset and Avon Survey of Health and English Longitudinal Study of Ageing) and provision (derived from the hospital episode statistics database). Equity rate ratios comparing rates of provision relative to need by sociodemographic, hospital, and distance variables. Results For both operations there was an "n" shaped curve by age. Compared with people aged 50-59, those aged 60-84 got more provision relative to need, while those aged >= 85 received less total hip replacement (adjusted rate ratio 0.68, 95% confidence interval 0.65 to 0.72) and less total knee replacement (0.87, 0.82 to 0.93). Compared with women, men received more provision relative to need for total hip replacement (1.08, 1.05 to 1.10) and total knee replacement (1.31, 1.28 to 1.34). Compared with the least deprived, residents in the most deprived areas got less provision relative to need for total hip replacement (0.31, 0.30 to 0.33) and total knee replacement (0.33, 0.31 to 0.34). For total knee replacement, those in urban areas got higher provision relative to need, but for total hip replacement it was highest in villages/isolated areas. For total knee replacement, patients living in non-white areas received more provision relative to need (1.04, 1.00 to 1.07) than those in predominantly white areas, but for total hip replacement there was no effect. Adjustment for hospital characteristics did not attenuate the effects. Conclusions There is evidence of inequity in access to total hip and total knee replacement surgery by age, sex, deprivation, rurality, and ethnicity. Adjustment for hospital and distance did not attenuate these effects. Policy makers should examine factors at the level of patients or primary care to understand the determinants of inequitable provision.	[Judge, Andy] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Judge, Andy; Sandhu, Jat; Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Welton, Nicky J.] Univ Bristol, Dept Community Based Med, Bristol BS6 6JL, Avon, England; [Sandhu, Jat] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 4C2, Canada	University of Oxford; University of Bristol; University of Bristol; University of British Columbia	Judge, A (corresponding author), Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	Andrew.Judge@ndorms.ox.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021	Ben-Shlomo, Yoav/0000-0001-6648-3007; Judge, Andrew/0000-0003-3015-0432; Welton, Nicky/0000-0003-2198-3205	South West Public Health Observatory; National Institute of Aging in the United States; English Longitudinal Study of Ageing; ESRC; JISC; Department of Social Medicine, University of Bristol; Medical Research Council; National Coordinating Centre for Research Capacity Development (NCCRCD) Department of Health (DH) Public Health Initiative; UK Medical Research Council (MRC); National Institute for Health research (NIHR) Biomedical Research Unit (BRU) Musculoskeletal Research Group, University of Oxford; MRC [G0802413] Funding Source: UKRI; Medical Research Council [G0802413] Funding Source: researchfish	South West Public Health Observatory; National Institute of Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); English Longitudinal Study of Ageing; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); JISC; Department of Social Medicine, University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Coordinating Centre for Research Capacity Development (NCCRCD) Department of Health (DH) Public Health Initiative; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health research (NIHR) Biomedical Research Unit (BRU) Musculoskeletal Research Group, University of Oxford(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Hospital Episode Statistics data were made available by the Department of Health. Hospital Episode Statistics analyses conducted within the Department of Social Medicine are supported by the South West Public Health Observatory. English Longitudinal Study of Ageing data were made available through the UK Data Archive (UKDA). The English Longitudinal Study of Ageing was developed by a team of researchers based at the National Centre for Social Research, University College London and the Institute for Fiscal Studies. The data were collected by the National Centre for Social Research. The funding is provided by the National Institute of Aging in the United States, and a consortium of UK government departments coordinated by the Office for National Statistics. The developers and funders of the English Longitudinal Study of Ageing and the Archive do not bear any responsibility for the analyses or interpretations presented here. This work is based on data provided through EDINA UKBorders with support from the ESRC and JISC and used material that is copyright of the Crown. We thank Mary Shaw at the Department of Social Medicine, University of Bristol, for support and advice throughout the project, Richard Harris for help and advice with Geographical Information Systems software, and Kelvyn Jones for statistical advice on multilevel modelling, both from the Department of Geographical Sciences, University of Bristol.; This study was part of a PhD studentship, funded by the Medical Research Council/Health Services Research Collaboration at the Department of Social Medicine, University of Bristol. The work is part of a wider programme by JS on measuring and monitoring inequalities in health care. JS received funding from a National Coordinating Centre for Research Capacity Development (NCCRCD) Department of Health (DH) Public Health Initiative 2003. NJW is funded by the UK Medical Research Council (MRC). AJ acknowledges support from the National Institute for Health research (NIHR) Biomedical Research Unit (BRU) Musculoskeletal Research Group, University of Oxford. The opinions expressed by the authors are theirs alone and do not represent the opinions of supporting organisations.	*AUD COMM, 2001, DAT REM IMPR QUAL PA; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Ballantyne PJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P27, DOI 10.1002/art.22472; BENSHLOMO Y, 1995, J EPIDEMIOL COMMUN H, V49, P200, DOI 10.1136/jech.49.2.200; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Bowling A, 2001, HEART, V85, P680, DOI 10.1136/heart.85.6.680; BOWLING A, 2008, J HLTH SURV RES PO S, V13, P8; *BRIT MED ASS, 2002, HEALTHC FUND REV; Byrne MM, 2006, J CLIN EPIDEMIOL, V59, P1078, DOI 10.1016/j.jclinepi.2006.01.010; CALLAHAN CM, 1995, J ARTHROPLASTY, V10, P141, DOI 10.1016/S0883-5403(05)80120-2; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Chang RW, 1996, JAMA-J AM MED ASSOC, V275, P858, DOI 10.1001/jama.275.11.858; CHATURVEDI N, 1995, BRIT J GEN PRACT, V45, P127; *COMM HLTH IMPR, 2001, REP CLIN GOV KINGS C; *DEP HLTH, 2006, TACKL HLTH IN STAT R; *DEP HLTH, 2006, STAT PUBL HLTH ANN R; *DEP HLTH, 2003, BUILD BEST CHOIC RES; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2006, JOINT DOCTRINE INTER; Department of Health, 2004, HLTH EQ AUD SELF ASS; DIEPPE P, 2008, J HLTH SERV RES PO S, V13, P56; Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724; Dong W, 1998, SOC SCI MED, V47, P1773, DOI 10.1016/S0277-9536(98)00242-1; Dunsmuir RA, 1996, BRIT MED J, V313, P1370, DOI 10.1136/bmj.313.7069.1370; ELDER AT, 1991, BRIT MED J, V303, P950, DOI 10.1136/bmj.303.6808.950; Fear J, 1997, BRIT J RHEUMATOL, V36, P74; Feder G, 2002, BRIT MED J, V324, P511, DOI 10.1136/bmj.324.7336.511; FINDLAY IN, 1991, BRIT HEART J, V66, P70; Frankel S, 1999, LANCET, V353, P1304, DOI 10.1016/S0140-6736(98)06451-4; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Goddard M, 1998, EQUITY ACCESS HLTH C; Harries C, 2007, QUAL SAF HEALTH CARE, V16, P23, DOI 10.1136/qshc.2006.018036; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Hawker GA, 2002, ARTHRITIS RHEUM-US, V46, P3331, DOI 10.1002/art.10682; Hawker GA, 2004, ARTHRIT RHEUM-ARTHR, V51, P635, DOI 10.1002/art.20524; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hawker GA, 2006, ARTHRITIS RHEUM, V54, P3212, DOI 10.1002/art.22146; Hippisley-Cox J, 2000, BRIT J GEN PRACT, V50, P449; Hudak PL, 2002, MED DECIS MAKING, V22, P272, DOI 10.1177/02789X02022003009; Ibrahim SA, 2002, ARTHRITIS RHEUM-US, V46, P2429, DOI 10.1002/art.10494; Jinks C, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-59; JUDGE AD, 2008, THESIS U BRISTOL; Judge A, 2009, ARTHRIT RHEUM-ARTHR, V61, P1657, DOI 10.1002/art.24892; Judge A, 2009, ARTHRIT RHEUM-ARTHR, V61, P1667, DOI 10.1002/art.24732; Judge A, 2009, J PUBLIC HEALTH-UK, V31, P413, DOI 10.1093/pubmed/fdp061; Juni P, 2003, RHEUMATOLOGY, V42, P516, DOI 10.1093/rheumatology/keg196; KEE F, 1993, BRIT MED J, V307, P1305, DOI 10.1136/bmj.307.6915.1305; KIRWAN JR, 1994, BRIT J RHEUMATOL, V33, P357; LIANG MH, 1986, ARTHRITIS RHEUM, V29, P937, DOI 10.1002/art.1780290801; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; MAJEED FA, 1994, BMJ-BRIT MED J, V308, P1426, DOI 10.1136/bmj.308.6941.1426; MARMOT M, 2008, ENGLISH LONGITUDINAL; McMurray A, 2002, J ADV NURS, V40, P663, DOI 10.1046/j.1365-2648.2002.02426.x; Merx H, 2003, ANN RHEUM DIS, V62, P222, DOI 10.1136/ard.62.3.222; Millar Wayne J, 2002, Health Rep, V14, P37; Milner PC, 2004, EUR J PUBLIC HEALTH, V14, P58, DOI 10.1093/eurpub/14.1.58; *NAT JOINT REG, 2009, NAT JOINT REG ENGL W; *NHS CTR REV DISS, 1996, EFF HLTH CAR B TOT H; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; PETTICREW M, 1993, BMJ-BRIT MED J, V306, P1164, DOI 10.1136/bmj.306.6886.1164; RAND JA, 1991, J BONE JOINT SURG AM, V73A, P397, DOI 10.2106/00004623-199173030-00011; Richards Helen M, 2002, J Am Med Womens Assoc (1972), V57, P79; Richards HM, 2002, BRIT MED J, V324, P1308, DOI 10.1136/bmj.324.7349.1308; Sanders C, 2002, SOCIOL HEALTH ILL, V24, P227, DOI 10.1111/1467-9566.00292; Sanders C, 2004, RHEUMATOLOGY, V43, P353, DOI 10.1093/rheumatology/keh044; SCUDERI GR, 1989, J BONE JOINT SURG BR, V71, P798, DOI 10.1302/0301-620X.71B5.2584250; Shaw M, 2004, SOC SCI MED, V59, P2499, DOI 10.1016/j.socscimed.2004.03.036; SPIEGELHALTER DJ, 2001, WINBUGS USER MANUAL; Steel N, 2006, RHEUMATOLOGY, V45, P1437, DOI 10.1093/rheumatology/kel131; TENNANT A, 1995, BMJ-BRIT MED J, V310, P1291, DOI 10.1136/bmj.310.6990.1291; Walker DJ, 2002, RHEUMATOLOGY, V41, P755, DOI 10.1093/rheumatology/41.7.755; Williams B, 2000, BRIT MED J, V320, P904, DOI 10.1136/bmj.320.7239.904; WILLIAMS MH, 1994, HLTH CARE NEEDS ASSE, V1; Yong PFK, 2004, ANN RHEUM DIS, V63, P1483, DOI 10.1136/ard.2003.013938	77	98	98	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2010	341								c4092	10.1136/bmj.c4092	http://dx.doi.org/10.1136/bmj.c4092			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DR	20702550	Green Published, hybrid			2022-12-28	WOS:000281028900006
J	Fritz, K; Morojele, N; Kalichman, S				Fritz, Katherine; Morojele, Neo; Kalichman, Seth			Alcohol: the forgotten drug in HIV/AIDS	LANCET			English	Editorial Material							INTERVENTION; INFECTION; BEHAVIOR; PATTERNS		[Fritz, Katherine] Int Ctr Res Women, Washington, DC 20036 USA; [Morojele, Neo] MRC, Alcohol & Drug Abuse Res Unit, Pretoria, Gauteng Prov, South Africa; [Kalichman, Seth] Univ Connecticut, Dept Psychol, Storrs, CT USA	University of Connecticut	Fritz, K (corresponding author), Int Ctr Res Women, Washington, DC 20036 USA.	kfritz@icrw.org	Morojele, Neo/AAS-1221-2021; Morojele, Neo/AAI-3372-2021	Morojele, Neo/0000-0003-2891-2557	NIAAA NIH HHS [R01 AA018074-01, R01 AA018074, R01 AA017399-01, R01 AA017399] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018074, R01AA017399] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Fritz K. E., 2002, AIDS BEHAV, V6, P221, DOI DOI 10.1023/A:1019887707474; George W H, 2000, Annu Rev Sex Res, V11, P92; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kalichman SC, 2006, PSYCHOL ADDICT BEHAV, V20, P298, DOI 10.1037/0893-164X.20.3.298; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Lewis JJC, 2005, SEX TRANSM DIS, V32, P364, DOI 10.1097/01.olq.0000154506.84492.61; Morisky DE, 2006, HEALTH PSYCHOL, V25, P595, DOI 10.1037/0278-6133.25.5.595; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X	12	78	78	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					398	400		10.1016/S0140-6736(10)60884-7	http://dx.doi.org/10.1016/S0140-6736(10)60884-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639YK	20650516	Green Accepted			2022-12-28	WOS:000281012900008
J	Frick, WF; Pollock, JF; Hicks, AC; Langwig, KE; Reynolds, DS; Turner, GG; Butchkoski, CM; Kunz, TH				Frick, Winifred F.; Pollock, Jacob F.; Hicks, Alan C.; Langwig, Kate E.; Reynolds, D. Scott; Turner, Gregory G.; Butchkoski, Calvin M.; Kunz, Thomas H.			An Emerging Disease Causes Regional Population Collapse of a Common North American Bat Species	SCIENCE			English	Article							WHITE-NOSE SYNDROME; ECOLOGY; CHYTRIDIOMYCOSIS; BIODIVERSITY; CONSERVATION; MORTALITY; DECLINES; BEHAVIOR; THREATS	White-nose syndrome (WNS) is an emerging disease affecting hibernating bats in eastern North America that causes mass mortality and precipitous population declines in winter hibernacula. First discovered in 2006 in New York State, WNS is spreading rapidly across eastern North America and currently affects seven species. Mortality associated with WNS is causing a regional population collapse and is predicted to lead to regional extinction of the little brown myotis (Myotis lucifugus), previously one of the most common bat species in North America. Novel diseases can have serious impacts on naive wildlife populations, which in turn can have substantial impacts on ecosystem integrity.	[Frick, Winifred F.; Langwig, Kate E.; Reynolds, D. Scott; Kunz, Thomas H.] Boston Univ, Dept Biol, CECB, Boston, MA 02215 USA; [Frick, Winifred F.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Pollock, Jacob F.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hicks, Alan C.; Langwig, Kate E.] New York State Dept Environm Conservat, Endangered Species Unit, Albany, NY 12233 USA; [Reynolds, D. Scott] St Pauls Sch, Concord, NH 03301 USA; [Turner, Gregory G.; Butchkoski, Calvin M.] Penn Game Commiss, Wildlife Divers Div, Harrisburg, PA 16669 USA	Boston University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Frick, WF (corresponding author), Boston Univ, Dept Biol, CECB, 5 Cummington St, Boston, MA 02215 USA.	wfrick@batresearch.org	Frick, Winifred/ABA-3519-2020; Frick, Winifred F/G-3501-2012	Frick, Winifred/0000-0002-9469-1839; 	U.S. Fish and Wildlife Service (USFWS); USFWS Section 6; State Wildlife Grants; Federal Aid in Wildlife Restoration [WE-173-G]	U.S. Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); USFWS Section 6(US Fish & Wildlife Service); State Wildlife Grants; Federal Aid in Wildlife Restoration	Funding was provided by grants from the U.S. Fish and Wildlife Service (USFWS) to W. F. F., J.F.P., D. S. R., T. H. K., and G. G. T. We thank three anonymous reviewers, J. P. Hayes, and D. F. Doak for helpful reviews and A. M. Kilpatrick for fruitful discussion. Funding for winter counts of bats at hibernacula was provided by USFWS Section 6 and State Wildlife Grants issued to the Pennsylvania Game Commission, and by Federal Aid in Wildlife Restoration Grant WE-173-G issued to the New York State Department of Environmental Conservation. Count data from hibernating colonies were kindly provided by the Connecticut Department of Environmental Protection; the Pennsylvania Game Commission; the New York Department of Environmental Conservation; Vermont Fish and Game; the Massachusetts Division of Fisheries and Wildlife; and K. Berner, State University of New York at Cobleskill. We are grateful to the many individuals who were involved in conducting annual counts of bats at hibernacula over the past 30 years. Data are available upon request from the authors.	Barbour R.W., 1969, BATS AM; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Fenner F, 2000, FEMS MICROBIOL REV, V24, P123, DOI 10.1111/j.1574-6976.2000.tb00536.x; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; GELUSO KN, 1976, SCIENCE, V194, P184, DOI 10.1126/science.959845; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kunz TH, 2003, BAT ECOLOGY, P3; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; Morris W. F., 2002, QUANTITATIVE CONSERV; OSHEA TJ, 2003, USGSBRDITR2003003; POSLUSZNY ET, 2000, P BAT CONS MIN TECHN, P159; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Tuttle M.D., 1993, Bats (Austin), V11, P3	25	587	612	5	575	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					679	682		10.1126/science.1188594	http://dx.doi.org/10.1126/science.1188594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689016	Green Submitted			2022-12-28	WOS:000280602700038
J	Huarte, M; Guttman, M; Feldser, D; Garber, M; Koziol, MJ; Kenzelmann-Broz, D; Khalil, AM; Zuk, O; Amit, I; Rabani, M; Attardi, LD; Regev, A; Lander, ES; Jacks, T; Rinn, JL				Huarte, Maite; Guttman, Mitchell; Feldser, David; Garber, Manuel; Koziol, Magdalena J.; Kenzelmann-Broz, Daniela; Khalil, Ahmad M.; Zuk, Or; Amit, Ido; Rabani, Michal; Attardi, Laura D.; Regev, Aviv; Lander, Eric S.; Jacks, Tyler; Rinn, John L.			A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response	CELL			English	Article							BINDING-SITE; TRANSCRIPTION; APOPTOSIS; PROTEINS; PATHWAY	Recently, more than 1000 large intergenic noncoding RNAs (lincRNAs) have been reported. These RNAs are evolutionarily conserved in mammalian genomes and thus presumably function in diverse biological processes. Here, we report the identification of lincRNAs that are regulated by p53. One of these lincRNAs (lincRNA-p21) serves as a repressor in p53-dependent transcriptional responses. Inhibition of lincRNA-p21 affects the expression of hundreds of gene targets enriched for genes normally repressed by p53. The observed transcriptional repression by lincRNA-p21 is mediated through the physical association with hnRNP-K. This interaction is required for proper genomic localization of hnRNP-K at repressed genes and regulation of p53 mediates apoptosis. We propose a model whereby transcription factors activate lincRNAs that serve as key repressors by physically associating with repressive complexes and modulate their localization to sets of previously active genes.	[Huarte, Maite; Guttman, Mitchell; Garber, Manuel; Koziol, Magdalena J.; Khalil, Ahmad M.; Zuk, Or; Amit, Ido; Rabani, Michal; Regev, Aviv; Lander, Eric S.; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Huarte, Maite; Koziol, Magdalena J.; Khalil, Ahmad M.; Rinn, John L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Guttman, Mitchell; Feldser, David; Regev, Aviv; Lander, Eric S.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Feldser, David; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kenzelmann-Broz, Daniela; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Kenzelmann-Broz, Daniela; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Harvard University; Harvard Medical School	Huarte, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	mhuarte@broadinstitute.org; jrinn@broadinstitute.org	Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493; Koziol, Magdalena/0000-0002-4123-4343; Rinn, John/0000-0002-7231-7539	National Institutes of Health (NIH) [1R01CA119176-01]; Smith Family Foundation; Damon Runyon Cancer Foundation; Searle Scholar Program; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670, DP1OD003958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation; Damon Runyon Cancer Foundation; Searle Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Loyal A. Goff (Massachusetts Institute of Technology [MIT]) for bioinformatic support, Nadya Dimitrova (MIT) for input on the manuscript, David Garcia (MIT) for experimental assistance, and Sigrid Hart (Broad Institute) for illustration support. J.L.R. is a Damon Runyon-Rachleff, Searle, and Smith Family Foundation Scholar. J.L.R. and A. R. are Richard Merkin Foundation Scholars. This work was supported by the National Institutes of Health (NIH) Director's New Innovator Award, Smith Family Foundation, Damon Runyon Cancer Foundation, Searle Scholar Program, and NIH 1R01CA119176-01.	BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	32	1587	1722	5	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					409	419		10.1016/j.cell.2010.06.040	http://dx.doi.org/10.1016/j.cell.2010.06.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20673990	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000280609100018
J	Rubenstein, LS; Xenakis, SN				Rubenstein, Leonard S.; Xenakis, Stephen N.			Roles of CIA Physicians in Enhanced Interrogation and Torture of Detainees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rubenstein, Leonard S.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Xenakis, Stephen N.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Uniformed Services University of the Health Sciences - USA	Rubenstein, LS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, 615 N Wolfe St, Baltimore, MD 21205 USA.	lrubenst@jhsph.edu						*CENTR INT AG OFF, 2004, SPEC REV COUNT DENT; Central Intelligence Agency, 2004, OMS GUID MED PSYCH S; Physicians for Human Rights, 2010, EXP TORT EV HUM SUBJ; Physicians for Human Rights and Human Rights First, 2007, LEAV NO MARKS ENH IN; *UN GEN ASS, 2007, REP SPEC RAPP PROM P	5	13	13	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					569	570		10.1001/jama.2010.1057	http://dx.doi.org/10.1001/jama.2010.1057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633SQ	20682939				2022-12-28	WOS:000280525700027
J	Tiwari, A; Fong, DYT; Yuen, KH; Yuk, H; Pang, P; Humphreys, J; Bullock, L				Tiwari, Agnes; Fong, Daniel Yee Tak; Yuen, Kwan Hok; Yuk, Helina; Pang, Polly; Humphreys, Janice; Bullock, Linda			Effect of an Advocacy Intervention on Mental Health in Chinese Women Survivors of Intimate Partner Violence A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANT-WOMEN; HONG-KONG; ABUSE; DISORDERS; PROGRAM	Context Intimate partner violence (IPV) against women can have negative mental health consequences for survivors; however, the effect of interventions designed to improve survivors' depressive symptoms is unclear. Objective To determine whether an advocacy intervention would improve the depressive symptoms of Chinese women survivors of IPV. Design, Setting, and Participants Assessor-blinded randomized controlled trial of 200 Chinese women 18 years or older with a history of IPV, conducted from February 2007 to June 2009 in a community center in Hong Kong, China. Intervention The intervention group (n = 100) received a 12-week advocacy intervention comprising empowerment and telephone social support. The control group (n = 100) received usual community services including child care, health care and promotion, and recreational programs. Main Outcome Measures Primary outcome was change in depressive symptoms (Chinese version of the Beck Depression Inventory II) between baseline and 9 months. Secondary outcomes were changes in IPV (Chinese Revised Conflict Tactics Scales), health-related quality of life (12-Item Short Form Health Survey), and perceived social support (Interpersonal Support Evaluation List) between baseline and 9 months. Usefulness of the intervention and usual community services was evaluated at 9 months. Results At 3 months, the mean change in depressive symptom score was 11.6 (95% CI, 9.5 to 13.7) in the control group and 14.9 (95% CI, 12.4 to 17.5) in the intervention group; respective changes at 9 months were 19.6 (95% CI, 16.6 to 22.7) and 23.2 (95% CI, 20.4 to 26.0). Intervention effects at 3 and 9 months were not significantly different (P=.86). The intervention significantly reduced depressive symptoms by 2.66 (95% CI, 0.26 to 5.06; P=.03) vs the control, less than the 5-unit minimal clinically important difference. Statistically significant improvement was found in partner psychological aggression (-1.87 [95% CI, -3.34 to -0.40]; mean change at 3 months, 1.5 [95% CI, -1.0 to 3.9] in the control group and 0.3 [95% CI, -0.7 to 1.4] in the intervention group; mean change at 9 months, -6.4 [95% CI, -7.8 to -5.0] and -8.9 [95% CI, -10.6 to -7.2]) and perceived social support (2.18 [95% CI, 0.48 to 3.89]; mean change at 3 months, 6.4 [95% CI, 4.9 to 7.8] and 9.2 [95% CI, 7.7 to 10.8]; mean change at 9 months, 12.4 [95% CI, 10.5 to 14.3] and 14.4 [95% CI, 12.7 to 16.1]) but not in physical assault, sexual coercion, or health-related quality of life. By end of study, more women in the intervention group found the advocacy intervention useful or extremely useful in improving intimate relationships vs those in the control group receiving usual community services (93.8% vs 81.7%; difference, 12.1% [95% CI, 2.1% to 22.0%]; P=.02) and in helping them to resolve conflicts with their intimate partners (97.5% vs 84.1%; difference, 13.4% [95% CI, 4.7% to 22.0%]; P=.001). Conclusion Among community-dwelling abused Chinese women, an advocacy intervention did not result in a clinically meaningful improvement in depressive symptoms.	[Tiwari, Agnes; Fong, Daniel Yee Tak; Yuen, Kwan Hok] Univ Hong Kong, Sch Nursing, Pokfulam, Hong Kong, Peoples R China; [Yuk, Helina; Pang, Polly] Hong Kong SKH Lady MacLehose Ctr, Hong Kong, Hong Kong, Peoples R China; [Humphreys, Janice] Univ Calif San Francisco, Sch Nursing, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA; [Bullock, Linda] Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65211 USA	University of Hong Kong; University of California System; University of California San Francisco; University of Missouri System; University of Missouri Columbia	Tiwari, A (corresponding author), Univ Hong Kong, Sch Nursing, 4-F,William MW Mong Block 21,Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	afytiwar@hkucc.hku.hk	Fong, Daniel YT/C-4269-2009	Fong, Daniel YT/0000-0001-7365-9146; Tiwari, Agnes/0000-0002-3993-8552	Food and Health Bureau of the Hong Kong SAR Government [04060741]	Food and Health Bureau of the Hong Kong SAR Government	This study was supported by the Health and Health Services Research Fund awarded by the Food and Health Bureau of the Hong Kong SAR Government (project 04060741).	Byrne B., 2004, INT J TESTING, V4, P199, DOI [10.1207/s15327574ijt0403_1, DOI 10.1207/S15327574IJT0403_1]; Campbell J. C., 1997, VIOLENCE AGAINST WOM, V3, P271, DOI DOI 10.1177/1077801297003003004; CAMPBELL JC, 1993, NURSING CARE SURVIVO, P249; Chan K. L., 2005, STUDY CHILD ABUSE SP; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; *Dutton M.A., 1992, EMPOWERING HEALING B; Follingstad D.R., 1990, J FAM VIOLENCE, V5, P107, DOI DOI 10.1007/BF00978514; Furukawa TA, 2010, J PSYCHOSOM RES, V68, P581, DOI 10.1016/j.jpsychores.2009.05.003; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; *GOV HONG KONG SOC, 2009, STAT CHILD AB BATT S; Huang WJ, 2005, FAM PROCESS, V44, P161, DOI 10.1111/j.1545-5300.2005.00051.x; Johnson MP, 2000, J MARRIAGE FAM, V62, P948, DOI 10.1111/j.1741-3737.2000.00948.x; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; McFarlane J, 2000, PUBLIC HEALTH NURS, V17, P443, DOI 10.1046/j.1525-1446.2000.00443.x; McFarlane J, 2002, NURS RES, V51, P347, DOI 10.1097/00006199-200211000-00002; Parker B, 1999, RES NURS HEALTH, V22, P59; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Sackett L A, 1999, Violence Vict, V14, P105; Schreier M., 2012, QUALITATIVE CONTENT; SULLIVAN CM, 1992, AM J COMMUN PSYCHOL, V20, P309, DOI 10.1007/BF00937912; Sullivan CM, 2002, J INTERPERS VIOLENCE, V17, P915, DOI 10.1177/0886260502017009001; Tang CSK, 1999, J FAM VIOLENCE, V14, P173, DOI 10.1023/A:1022028803208; Tiwari A, 2007, BJOG-INT J OBSTET GY, V114, P1065, DOI 10.1111/j.1471-0528.2007.01441.x; Tiwari A, 2008, BJOG-INT J OBSTET GY, V115, P377, DOI 10.1111/j.1471-0528.2007.01593.x; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; Tiwari A., 2005, STUDY PREVALENCE INT; WALTER SD, 1990, J CLIN EPIDEMIOL, V43, P1431, DOI 10.1016/0895-4356(90)90113-4; Ware JE, 1995, SCORE SF 12 PHYS MEN; Weissman MM, 1991, PSYCHIAT DISORDERS A, P53; World Health Organization, 2002, WORLD REPORT VIOLENC	32	80	80	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					536	543		10.1001/jama.2010.1052	http://dx.doi.org/10.1001/jama.2010.1052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682933	Green Submitted, Bronze			2022-12-28	WOS:000280525700021
J	Potrykus, I				Potrykus, Ingo			Regulation must be revolutionized	NATURE			English	Editorial Material											Potrykus, I (corresponding author), Stigler 54, CH-4312 Magden, Switzerland.	ingo@potrykus.ch						POTRYKUS I, TRANSGENIC IN PRESS	1	53	54	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					561	561		10.1038/466561a	http://dx.doi.org/10.1038/466561a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	632HA	20671692	hybrid			2022-12-28	WOS:000280412100018
J	Braunstein, A; Trief, D; Wang, NK; Chang, S; Tsang, SH				Braunstein, Alexandra; Trief, Danielle; Wang, Nan-Kai; Chang, Stanley; Tsang, Stephen H.			Vitamin A deficiency in New York City	LANCET			English	Editorial Material									[Braunstein, Alexandra; Trief, Danielle; Wang, Nan-Kai; Chang, Stanley; Tsang, Stephen H.] Columbia Univ, Edward Harkness Eye Inst, New York, NY 10032 USA; [Wang, Nan-Kai; Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Wang, Nan-Kai] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan	Columbia University; Columbia University; Chang Gung Memorial Hospital	Tsang, SH (corresponding author), Columbia Univ, Edward Harkness Eye Inst, 160 Ft Washington Ave,Room 513, New York, NY 10032 USA.	sht2@columbia.edu	Wang, Nan-Kai/AAO-6559-2020; Wang, Nan-Kai/D-6608-2011; Chang, Stanley/AAL-2741-2021	Wang, Nan-Kai/0000-0002-6277-9879; Wang, Nan-Kai/0000-0002-6277-9879; 	NATIONAL EYE INSTITUTE [R01EY018213] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018213, R01 EY018213-02, R01 EY018213-01A2, R01 EY018213-03, R01 EY018213-05, R01 EY018213-04] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					267	267		10.1016/S0140-6736(09)61874-2	http://dx.doi.org/10.1016/S0140-6736(09)61874-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20663549	Green Accepted			2022-12-28	WOS:000280457200036
J	van Leeuwen, JL				van Leeuwen, Johan L.			Launched at 36,000g	SCIENCE			English	Editorial Material							SPHAGNUM; MECHANISM; SIZE		Wageningen Univ, Expt Zool Grp, Wageningen Inst Anim Sci, NL-6708 PG Wageningen, Netherlands	Wageningen University & Research	van Leeuwen, JL (corresponding author), Wageningen Univ, Expt Zool Grp, Wageningen Inst Anim Sci, NL-6708 PG Wageningen, Netherlands.	johan.vanleeuwen@wur.nl	van Leeuwen, Johan/N-3437-2019; van Leeuwen, Johan L/B-7897-2011	van Leeuwen, Johan/0000-0002-4433-880X; 				Duckett JG, 2009, NEW PHYTOL, V183, P1053, DOI 10.1111/j.1469-8137.2009.02905.x; Edwards J, 2005, NATURE, V435, P164, DOI 10.1038/435164a; Ingold C. T., 1965, SPORE LIBERATION; Nawaschin S., 1897, FLORA, V83, P151; Sundberg S, 1998, J BRYOL, V20, P1; Sundberg S, 2010, NEW PHYTOL, V185, P886, DOI 10.1111/j.1469-8137.2009.03086.x; Sundberg S, 2010, ANN BOT-LONDON, V105, P291, DOI 10.1093/aob/mcp288; Whitaker DL, 2010, SCIENCE, V329, P406, DOI 10.1126/science.1190179	8	3	3	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					395	396		10.1126/science.1193047	http://dx.doi.org/10.1126/science.1193047			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651138				2022-12-28	WOS:000280196500020
J	Boyce, JW; Liu, Y; Rossman, GR; Guan, YB; Eiler, JM; Stolper, EM; Taylor, LA				Boyce, Jeremy W.; Liu, Yang; Rossman, George R.; Guan, Yunbin; Eiler, John M.; Stolper, Edward M.; Taylor, Lawrence A.			Lunar apatite with terrestrial volatile abundances	NATURE			English	Article							MICROPHENOCRYSTIC APATITE; SO3 CONTENTS; BASALT; METALLOGENESIS; PHILIPPINES; EVOLUTION; FLUORINE; INTERIOR; CHLORINE; GLASSES	The Moon is thought to be depleted relative to the Earth in volatile elements such as H, Cl and the alkalis(1-3). Nevertheless, evidence for lunar explosive volcanism(4,5) has been used to infer that some lunar magmas exsolved a CO-rich and CO(2)-rich vapour phase before or during eruption(6-8). Although there is also evidence for other volatile species on glass spherules(9), until recently(10) there had been no unambiguous reports of indigenous H in lunar rocks. Here we report quantitative ion microprobe measurements of late-stage apatite from lunar basalt 14053 that document concentrations of H, Cl and S that are indistinguishable from apatites in common terrestrial igneous rocks. These volatile contents could reflect post-magmatic metamorphic volatile addition or growth from a late-stage, interstitial, sulphide-saturated melt that contained similar to 1,600 parts per million H(2)O and similar to 3,500 parts per million Cl. Both metamorphic and igneous models of apatite formation suggest a volatile inventory for at least some lunar materials that is similar to comparable terrestrial materials. One possible implication is that portions of the lunar mantle or crust are more volatile-rich than previously thought.	[Boyce, Jeremy W.; Rossman, George R.; Guan, Yunbin; Eiler, John M.; Stolper, Edward M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Boyce, Jeremy W.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Liu, Yang; Taylor, Lawrence A.] Univ Tennessee, Dept Earth & Planetary Sci, Planetary Geosci Inst, Knoxville, TN 37996 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of Tennessee System; University of Tennessee Knoxville	Boyce, JW (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	jwboyce@alum.mit.edu	Rossman, George R/D-8894-2013; Boyce, Jeremy W/A-7514-2008; Liu, Yang/F-3775-2017; Liu, Yang/A-4708-2012	Liu, Yang/0000-0003-0308-0942; Rossman, George/0000-0002-4571-6884	NASA Cosmochemistry [NNX08AG54G, NNX09AG40G]; NSF [OCE-0840983]; Moore foundation; Division Of Ocean Sciences [0840983] Funding Source: National Science Foundation	NASA Cosmochemistry(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Moore foundation(Gordon and Betty Moore Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by grants from NASA Cosmochemistry (NNX08AG54G to L.A.T. and NNX09AG40G to E.M.S.), the NSF (OCE-0840983 to J.W.B.) and the Moore foundation for support of the Caltech Microanalysis Center.	Boyce JW, 2008, GEOLOGY, V36, P63, DOI 10.1130/G24184A.1; Boyce JW, 2009, CONTRIB MINERAL PETR, V157, P135, DOI 10.1007/s00410-008-0325-x; BRENAN J, 1993, CHEM GEOL, V110, P195, DOI 10.1016/0009-2541(93)90254-G; Delano J.W., 1986, 16TH P LUN PLAN SCI, pD201; EPSTEIN S, 1973, 4 P LUN SCI C GEO S4, V2, P1559; EPSTEIN S, 1971, P 2 LUN SCI C, V2, P1421; Fleck B, 1998, ASTROPHYS SPACE SCI, V258, P57; FOGEL RA, 1995, GEOCHIM COSMOCHIM AC, V59, P201, DOI 10.1016/0016-7037(94)00377-X; GIBSON EK, 1973, SCIENCE, V179, P69, DOI 10.1126/science.179.4068.69; Greenwood J P, 2010, 41 LUN PLAN SCI C, P2439; Henning PA, 2000, Z KRISTALLOGR, V215, P226, DOI 10.1524/zkri.2000.215.4.226; Imai A, 2004, RESOUR GEOL, V54, P357, DOI 10.1111/j.1751-3928.2004.tb00211.x; Imai A, 2002, RESOUR GEOL, V52, P147, DOI 10.1111/j.1751-3928.2002.tb00127.x; Imai A, 2001, RESOUR GEOL, V51, P71, DOI 10.1111/j.1751-3928.2001.tb00083.x; LIU Y, 2010, 41 LUN PLAN SCI C, P2647; Mathez EA, 2005, GEOCHIM COSMOCHIM AC, V69, P1275, DOI 10.1016/j.gca.2004.08.035; MCCUBBIN FM, 2010, 41 LUN PLAN SCI C, P2468; MCGETCHIN TR, 1973, SCIENCE, V180, P68, DOI 10.1126/science.180.4081.68; Nadeau SL, 1999, GEOCHIM COSMOCHIM AC, V63, P1837, DOI 10.1016/S0016-7037(99)00057-5; PAN YM, 2002, REV MINERAL GEOCHEM, V13, P49; Peng GY, 1997, AM MINERAL, V82, P1210; Rutherford MJ, 2009, GEOLOGY, V37, P219, DOI 10.1130/G25402A.1; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Sarbas B., 2008, GEOINFORMATICS 2008, P42; Sato M., 1979, P LUNAR PLANETARY SC, P311; SCLAR CB, 1975, METEORITICS, V10, P484; Streck MJ, 1998, GEOLOGY, V26, P523, DOI 10.1130/0091-7613(1998)026<0523:SEOOAM>2.3.CO;2; Taylor LA, 2004, AM MINERAL, V89, P1617, DOI 10.2138/am-2004-11-1205; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; WILSON L, 2003, GEOPHYS RES LETT, V30, P71	31	219	231	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2010	466	7305					466	U2		10.1038/nature09274	http://dx.doi.org/10.1038/nature09274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651686				2022-12-28	WOS:000280141200030
J	Spence, D				Spence, Des			From the Frontline Bad medicine: medicated minors	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3907	10.1136/bmj.c3907	http://dx.doi.org/10.1136/bmj.c3907			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GW	20659982				2022-12-28	WOS:000280411700022
J	Segal, S; Gelfand, BJ; Hurwitz, S; Berkowitz, L; Ashley, SW; Nadel, ES; Katz, JT				Segal, Scott; Gelfand, Brian J.; Hurwitz, Shelley; Berkowitz, Lori; Ashley, Stanley W.; Nadel, Eric S.; Katz, Joel T.			Plagiarism in Residency Application Essays	ANNALS OF INTERNAL MEDICINE			English	Article							SUBSEQUENT DISCIPLINARY ACTION; RESEARCH PUBLICATIONS; MISREPRESENTATION	Background: Anecdotal reports suggest that some residency application essays contain plagiarized content. Objective: To determine the prevalence of plagiarism in a large cohort of residency application essays. Design: Retrospective cohort study. Setting: 4975 application essays submitted to residency programs at a single large academic medical center between 1 September 2005 and 22 March 2007. Measurements: Specialized software was used to compare residency application essays with a database of Internet pages, published works, and previously submitted essays and the percentage of the submission matching another source was calculated. A match of more than 10% to an existing work was defined as evidence of plagiarism. Results: Evidence of plagiarism was found in 5.2% (95% CI, 4.6% to 5.9%) of essays. The essays of non-U.S. citizens were more likely to demonstrate evidence of plagiarism. Other characteristics associated with the prevalence of plagiarism included medical school location outside the United States and Canada; previous residency or fellowship; lack of research experience, volunteer experience, or publications; a low United States Medical Licensing Examination Step 1 score; and nonmembership in the Alpha Omega Alpha Honor Medical Society. Limitations: The software database is probably incomplete, the 10%-match threshold for defining plagiarism has not been statistically validated, and the study was confined to applicants to 1 institution. Evidence of matching content in an essay cannot be used to infer the applicant's intent and is not sensitive to variations in the cultural context of copying in some societies. Conclusion: Evidence of plagiarism in residency application essays is more common in international applicants but was found in those by applicants to all specialty programs, from all medical school types, and even among applicants with significant academic honors.	[Segal, Scott] Harvard Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Segal, S (corresponding author), Harvard Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	bsegal@partners.org	Segal, Scott/S-4157-2019	Segal, Scott/0000-0002-7647-6422				*ACCR COUNC GRAD M, GEN COMP; [Anonymous], 2008, RES DAT 2008 MAIN RE; *ASS AM MED COLL, 2009, ERAS 2010 MYERAS US; *ASS AM MED COLL, ERAS INT PROM ED PRO; Baker DR, 2000, ACAD RADIOL, V7, P727, DOI 10.1016/S1076-6332(00)80531-0; Bilic-Zulle L, 2008, SCI ENG ETHICS, V14, P139, DOI 10.1007/s11948-007-9037-2; Braumoeller BF, 2001, PS, V34, P835, DOI 10.1017/S1049096501000786; Cohen-Gadol AA, 2003, SURG NEUROL, V60, P280, DOI 10.1016/S0090-3019(03)00429-4; Cole AF, 2007, FAM MED, V39, P436; Dale JA, 1999, J BONE JOINT SURG AM, V81A, P1679; DeVoss D., 2002, Computer and Composition, V19, P191, DOI 10.1016/S8755-4615(02)00112-3; Errami M, 2008, BIOINFORMATICS, V24, P243, DOI 10.1093/bioinformatics/btm574; Hayes N, 2005, J ACAD ETHICS, V3, P55, DOI 10.1007/s10805-006-9006-4; Hebert RS, 2003, ANN INTERN MED, V138, P390, DOI 10.7326/0003-4819-138-5-200303040-00008; Introna L. D., 2008, STUDENT PLAGIARISM O, P108, DOI 10.4018/978-1-59904-801-7.ch008; Konstantakos EK, 2007, J BONE JOINT SURG AM, V89A, P2084, DOI 10.2106/JBJS.G.00567; *OXF ENGL DICT, PLAG; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Papadakis MA, 2008, ANN INTERN MED, V148, P869, DOI 10.7326/0003-4819-148-11-200806030-00009; Park C., 2003, ASSESS EVAL HIGH EDU, V28, P471, DOI [10.1080/02602930301677, DOI 10.1080/02602930301677]; Patel MV, 2003, SPINE, V28, P632, DOI 10.1097/00007632-200304010-00002; Rimer S., 2003, NY TIMES, pB7; Royce J., 2003, TEACHER LIB, V30, P26; Scanlon P.M., 2003, COLL TEACHING, V51, P161, DOI DOI 10.1080/87567550309596432; Scanlon PM, 2002, J COLL STUDENT DEV, V43, P374; SCHLEIMER S, 2003, P 2003 ACM SIGMOD IN; TAYLOR CA, 1995, OBSTET GYNECOL, V85, P299, DOI 10.1016/0029-7844(94)00388-T; *U COLL ADM SERV, UCAS SIM DET SERV GU; WILHOIT S, 1994, COLL TEACHING, V42, P161, DOI DOI 10.1080/87567555.1994.9926849; Yang Gary Y, 2006, J Am Coll Radiol, V3, P259, DOI 10.1016/j.jacr.2005.12.001	30	40	42	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2					112	W44		10.7326/0003-4819-153-2-201007200-00007	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643991				2022-12-28	WOS:000280095400006
J	Rosenberg, MI; Desplan, C				Rosenberg, Miriam I.; Desplan, Claude			MOLECULAR BIOLOGY Hiding in Plain Sight	SCIENCE			English	Editorial Material							POLYCISTRONIC MESSENGER-RNA; LONG NONCODING RNAS; OPEN READING FRAMES; DROSOPHILA-MELANOGASTER; EVOLUTION; PEPTIDES; GENOME		[Rosenberg, Miriam I.; Desplan, Claude] NYU, Ctr Dev Genet, Dept Biol, New York, NY 10003 USA	New York University	Rosenberg, MI (corresponding author), NYU, Ctr Dev Genet, Dept Biol, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413	NIGMS NIH HHS [R01 GM064864, R01 GM064864-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064864] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909	15	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					284	285		10.1126/science.1192769	http://dx.doi.org/10.1126/science.1192769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647453	Green Accepted			2022-12-28	WOS:000279925900025
J	Utne-Palm, AC; Salvanes, AGV; Currie, B; Kaartvedt, S; Nilsson, GE; Braithwaite, VA; Stecyk, JAW; Hundt, M; van der Bank, M; Flynn, B; Sandvik, GK; Klevjer, TA; Sweetman, AK; Bruchert, V; Pittman, K; Peard, KR; Lunde, IG; Strandabo, RAU; Gibbons, MJ				Utne-Palm, Anne C.; Salvanes, Anne G. V.; Currie, Bronwen; Kaartvedt, Stein; Nilsson, Goran E.; Braithwaite, Victoria A.; Stecyk, Jonathan A. W.; Hundt, Matthias; van der Bank, Megan; Flynn, Bradley; Sandvik, Guro K.; Klevjer, Thor A.; Sweetman, Andrew K.; Bruchert, Volker; Pittman, Karin; Peard, Kathleen R.; Lunde, Ida G.; Strandabo, Ronnaug A. U.; Gibbons, Mark J.			Trophic Structure and Community Stability in an Overfished Ecosystem	SCIENCE			English	Article							COASTAL UPWELLING SYSTEM; HYDROGEN-SULFIDE; BENGUELA ECOSYSTEM; NAMIBIAN SHELF; HYPOXIA; OCEAN; DETOXIFICATION; ASSOCIATION; EMISSIONS; ERUPTIONS	Since the collapse of the pelagic fisheries off southwest Africa in the late 1960s, jellyfish biomass has increased and the structure of the Benguelan fish community has shifted, making the bearded goby (Sufflogobius bibarbatus) the new predominant prey species. Despite increased predation pressure and a harsh environment, the gobies are thriving. Here we show that physiological adaptations and antipredator and foraging behaviors underpin the success of these fish. In particular, body-tissue isotope signatures reveal that gobies consume jellyfish and sulphidic diatomaceous mud, transferring "dead-end" resources back into the food chain.	[Utne-Palm, Anne C.; Salvanes, Anne G. V.; Braithwaite, Victoria A.; Hundt, Matthias; Pittman, Karin] Univ Bergen, Dept Biol, Bergen, Norway; [Currie, Bronwen] Natl Marine Informat & Res Ctr, Swakopmund, Namibia; [Kaartvedt, Stein; Klevjer, Thor A.] Univ Oslo, Dept Biol, Oslo, Norway; [Nilsson, Goran E.; Stecyk, Jonathan A. W.; Sandvik, Guro K.; Lunde, Ida G.; Strandabo, Ronnaug A. U.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Braithwaite, Victoria A.] Penn State Univ, Sch Forest Resources, State Coll, PA USA; [Braithwaite, Victoria A.] Penn State Univ, Dept Biol, State Coll, PA USA; [Peard, Kathleen R.] Minist Fisheries & Marine Resources, Luderitz, Namibia; [van der Bank, Megan; Flynn, Bradley; Gibbons, Mark J.] Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa; [Sweetman, Andrew K.] Norwegian Inst Water Res NIVA, Reg Off Bergen, Bergen, Norway; [Bruchert, Volker] Stockholm Univ, Dept Sci, S-10691 Stockholm, Sweden; [Kaartvedt, Stein] King Abdullah Univ Sci & Technol, Thuwai, Saudi Arabia	University of Bergen; University of Oslo; University of Oslo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of the Western Cape; Norwegian Institute for Water Research (NIVA); Stockholm University; King Abdullah University of Science & Technology	Utne-Palm, AC (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	anne.palm@bio.uib.no	Gibbons, Mark/A-8806-2008; Nilsson, Göran Erik/Q-6129-2019; Nilsson, Goran E/K-7668-2012; Stecyk, Jonathan/B-4530-2013; Lunde, Ida Gjervold/ABN-5567-2022	Gibbons, Mark/0000-0002-8320-8151; Nilsson, Goran E/0000-0002-3195-3053; Stecyk, Jonathan/0000-0002-0973-9472; Bruchert, Volker/0000-0002-8956-3840; Lunde, Ida Gjervold/0000-0001-9502-6841	National Research Foundation of South Africa; Research Council of Norway; Natural Sciences and Engineering Reserach Council of Canada	National Research Foundation of South Africa(National Research Foundation - South Africa); Research Council of Norway(Research Council of Norway); Natural Sciences and Engineering Reserach Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank the crew of the G. O. Sars; F. Midtoy for assistance; and P. Ellitson, M. Hordnes, R. Jones, R. Amundsen and the rest of the scientific crew. We thank the National Research Foundation of South Africa, the Research Council of Norway, and our home institutions for funding and support. We thank BENEFIT (Benguela Environment Fisheries Interaction and Training), S. Sundby, D. C. Boyer, J. Otto Krakstad, and the crew of the research vessel Dr. Fridtjof Nansen for support with earlier goby cruises, laying the basis for the present study. We thank K. Helge Jensen for statistical support. We appreciate the comments on this manuscript by J. Giske, C. Jorgensen, M. P. Heino, and the anonymous reviewers. Care and handling of experimental animals were performed in accordance with institutional guidelines. J. A. W. S. was a postdoctoral researcher funded by the Natural Sciences and Engineering Reserach Council of Canada at the time when the research was conducted.	BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; BAGARINAO T, 1990, J COMP PHYSIOL B, V160, P519; Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Boyer DC, 2001, S AFR J MARINE SCI, V23, P5; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Bruchert V, 2009, PROG OCEANOGR, V83, P169, DOI 10.1016/j.pocean.2009.07.017; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CRAWFORD RJM, 1987, OCEANOGR MAR BIOL, V25, P353; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Domenici P, 2007, PHILOS T R SOC B, V362, P2105, DOI 10.1098/rstb.2007.2103; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Gibbons MJ, 2000, S AFR J MARINE SCI, V22, P1, DOI 10.2989/025776100784125708; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Heymans JJ, 2004, ECOL MODEL, V172, P175, DOI 10.1016/j.ecolmodel.2003.09.006; Kaartvedt S, 2009, MAR ECOL PROG SER, V390, P237, DOI 10.3354/meps08196; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lynam CP, 2006, CURR BIOL, V16, P1976, DOI 10.1016/j.cub.2006.09.012; MATIKAINEN N, 1992, J EXP BIOL, V167, P203; MILLERO FJ, 1988, LIMNOL OCEANOGR, V33, P269, DOI 10.4319/lo.1988.33.2.0269; Monteiro PMS, 2008, DEEP-SEA RES PT I, V55, P435, DOI 10.1016/j.dsr.2007.12.010; Pang HP, 2005, AM J PHYSIOL-CELL PH, V289, pC982, DOI 10.1152/ajpcell.00364.2004; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Prosser C.L., 1961, COMP ANIMAL PHYSL; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; ROGERS J, 1991, OCEANOGR MAR BIOL, V29, P1; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; TODD ES, 1976, COPEIA, P374; van der Lingen D, 2006, LAR MAR ECOSYST, V14, P147; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Yamamoto J, 2008, MAR BIOL, V153, P311, DOI 10.1007/s00227-007-0807-9	34	106	109	2	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					333	336		10.1126/science.1190708	http://dx.doi.org/10.1126/science.1190708			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647468				2022-12-28	WOS:000279925900045
J	Muoio, DM				Muoio, Deborah M.			Metabolism and Vascular Fatty Acid Transport.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VEGF		[Muoio, Deborah M.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Muoio, Deborah M.] Duke Univ, Dept Med & Pharmacol, Durham, NC USA; [Muoio, Deborah M.] Duke Univ, Dept Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University	Muoio, DM (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA.		Muoio, Debbie Marie/E-1147-2012	Muoio, Deborah/0000-0003-3760-9277				Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384	5	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					291	293		10.1056/NEJMcibr1005397	http://dx.doi.org/10.1056/NEJMcibr1005397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647206				2022-12-28	WOS:000279864200016
J	Boal, AK; Cotruvo, JA; Stubbe, J; Rosenzweig, AC				Boal, Amie K.; Cotruvo, Joseph A., Jr.; Stubbe, JoAnne; Rosenzweig, Amy C.			Structural Basis for Activation of Class Ib Ribonucleotide Reductase	SCIENCE			English	Article							SOLUBLE METHANE MONOOXYGENASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RADICAL COFACTOR; ACTIVE FORM; FLAVODOXIN; MANGANESE; SUBUNIT; PROTEIN; IRON	The class Ib ribonucleotide reductase of Escherichia coli can initiate reduction of nucleotides to deoxynucleotides with either a Mn-2(III)-tyrosyl radical (Y center dot) or a Fe-2(III)-Y center dot cofactor in the NrdF subunit. Whereas Fe-2(III)-Y center dot can self-assemble from Fe-2(II)-NrdF and O-2, activation of Mn-2(II)-NrdF requires a reduced flavoprotein, NrdI, proposed to form the oxidant for cofactor assembly by reduction of O-2. The crystal structures reported here of E. coli Mn-2(II)-NrdF and Fe-2(II)-NrdF reveal different coordination environments, suggesting distinct initial binding sites for the oxidants during cofactor activation. In the structures of Mn-2(II)-NrdF in complex with reduced and oxidized NrdI, a continuous channel connects the NrdI flavin cofactor to the NrdF Mn-2(II) active site. Crystallographic detection of a putative peroxide in this channel supports the proposed mechanism of Mn-2(III)-Y center dot cofactor assembly.	[Cotruvo, Joseph A., Jr.; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwestern University; Northwestern University; Massachusetts Institute of Technology (MIT)	Stubbe, J (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	stubbe@mit.edu; amyr@northwestern.edu	Johnson, Michael D. L./B-4352-2012; Cotruvo, Joseph A/C-5700-2019; Cotruvo, Joseph/N-5127-2019	Cotruvo, Joseph A/0000-0003-4243-8257; 	NIH [GM58518, GM81393]; American Cancer Society [PF-10-148-01-DMC]; National Defense Science and Engineering Graduate fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058518, R01GM081393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Defense Science and Engineering Graduate fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM58518 (A. C. R.) and GM81393 (J.S.), American Cancer Society grant PF-10-148-01-DMC (A. K. B.), and a National Defense Science and Engineering Graduate fellowship to J.A.C. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). Some data were collected at General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT), which has been funded in whole or in part with federal funds from the National Cancer Institute (grant Y1-CO-1020) and the National Institute of General Medical Science (grant Y1-GM-1104). We thank Z. Wawrzak for assistance with data processing and S. Lippard for helpful discussions. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3N37 (Mn<INF>2</INF><SUP>II</SUP>-NrdF), 3N38 (Fe<INF>2</INF><SUP>II</SUP>-NrdF), 3N39 (NrdI<INF>ox</INF>-NrdF), 3N3A (NrdI<INF>hq</INF>-NrdF), and 3N3B (NrdI<INF>hq</INF>-NrdF<INF>perox</INF>).	ATKIN CL, 1973, J BIOL CHEM, V248, P7464; ATTA M, 1992, J BIOL CHEM, V267, P20682; Barynin VV, 2001, STRUCTURE, V9, P725, DOI 10.1016/S0969-2126(01)00628-1; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Do LH, 2010, J AM CHEM SOC, V132, P1273, DOI 10.1021/ja909718f; Drennan CL, 1999, J MOL BIOL, V294, P711, DOI 10.1006/jmbi.1999.3151; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; LUDWIG ML, 1992, CHEM BIOCH FLAVOENZY, V3, P427; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2005, J AM CHEM SOC, V127, P5814, DOI 10.1021/ja044099b; Uppsten M, 2004, FEBS LETT, V569, P117, DOI 10.1016/j.febslet.2004.05.059; Uppsten M, 2006, J MOL BIOL, V359, P365, DOI 10.1016/j.jmb.2006.03.035; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; WILLING A, 1988, EUR J BIOCHEM, V170, P603, DOI 10.1111/j.1432-1033.1988.tb13740.x; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; ZHOU ZM, 1995, BIOCHEMISTRY-US, V34, P3183, DOI 10.1021/bi00010a007	30	105	105	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1526	1530		10.1126/science.1190187	http://dx.doi.org/10.1126/science.1190187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20688982	Green Accepted			2022-12-28	WOS:000281869000043
J	Perocchi, F; Gohil, VM; Girgis, HS; Bao, XR; McCombs, JE; Palmer, AE; Mootha, VK				Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; McCombs, Janet E.; Palmer, Amy E.; Mootha, Vamsi K.			MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake	NATURE			English	Article							RAT KIDNEY MITOCHONDRIA; CALCIUM-UPTAKE; YEAST MITOCHONDRIA; INNER MEMBRANE; UNIPORTER; TRANSPORT; CELL; PHOSPHORYLATION; GLYCOPROTEIN; OSCILLATIONS	Mitochondrial calcium uptake has a central role in cell physiology by stimulating ATP production, shaping cytosolic calcium transients and regulating cell death. The biophysical properties of mitochondrial calcium uptake have been studied in detail, but the underlying proteins remain elusive. Here we use an integrative strategy to predict human genes involved in mitochondrial calcium entry based on clues from comparative physiology, evolutionary genomics and organelle proteomics. RNA interference against 13 top candidates highlighted one gene, CBARA1, that we call hereafter mitochondrial calcium uptake 1 (MICU1). Silencing MICU1 does not disrupt mitochondrial respiration or membrane potential but abolishes mitochondrial calcium entry in intact and permeabilized cells, and attenuates the metabolic coupling between cytosolic calcium transients and activation of matrix dehydrogenases. MICU1 is associated with the mitochondrial inner membrane and has two canonical EF hands that are essential for its activity, indicating a role in calcium sensing. MICU1 represents the founding member of a set of proteins required for high-capacity mitochondrial calcium uptake. Its discovery may lead to the complete molecular characterization of mitochondrial calcium uptake pathways, and offers genetic strategies for understanding their contribution to normal physiology and disease.	[Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [McCombs, Janet E.; Palmer, Amy E.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Boulder	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	vamsi@hms.harvard.edu		Gohil, Vishal/0000-0002-9920-2563; perocchi, fabiana/0000-0002-1102-6500; Bao, Xiaoyan/0000-0001-7931-2944; McCombs, Janet/0000-0002-3514-8019	National Institutes of Health [GM084027, TR2 GM08759, GM0077465, DK080261]; HHMI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084027, T32GM008759, R01GM077465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Grabarek, S. Silver and D. Root for advice; S. Calvo and A. Wolf for assistance with bioinformatics; P. Federico for technical assistance; and members of the Mootha Laboratory for valuable feedback. This work was supported by grants from the National Institutes of Health (GM084027) to A.E.P, TR2 GM08759 to J.E.M. and GM0077465, DK080261 awarded to V.K.M., and by an HHMI Early Career Physician Scientist Award to V.K.M.	Aichberger KJ, 2005, J IMMUNOL, V175, P1286, DOI 10.4049/jimmunol.175.2.1286; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; BALCAVAG.WX, 1973, BIOCHIM BIOPHYS ACTA, V305, P41, DOI 10.1016/0005-2728(73)90229-6; Bernardi P., 2007, V45, P481; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; FAVARON M, 1985, FEBS LETT, V183, P260, DOI 10.1016/0014-5793(85)80789-4; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Gaspers LD, 2008, METHODS, V46, P224, DOI 10.1016/j.ymeth.2008.09.012; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; McDonald T, 2006, MOL CELL PROTEOMICS, V5, P2392, DOI 10.1074/mcp.T500036-MCP200; MIRONOVA GD, 1982, J BIOENERG BIOMEMBR, V14, P213, DOI 10.1007/BF00751016; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; PANFILI E, 1976, NATURE, V264, P185, DOI 10.1038/264185a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; VERCESI AE, 1992, BIOCHEM J, V284, P463, DOI 10.1042/bj2840463; Zazueta C, 1998, J BIOENERG BIOMEMBR, V30, P489, DOI 10.1023/A:1020546331217; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	48	618	635	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					291	U67		10.1038/nature09358	http://dx.doi.org/10.1038/nature09358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20693986	Green Accepted			2022-12-28	WOS:000281824900031
J	Wardlaw, D; Van Meirhaeghe, J				Wardlaw, Douglas; Van Meirhaeghe, Jan			Another chapter for vertebral compression fractures	LANCET			English	Editorial Material							QUALITY-OF-LIFE; OSTEOPOROTIC FRACTURES; BALLOON KYPHOPLASTY; RANDOMIZED-TRIAL; VERTEBROPLASTY		[Wardlaw, Douglas] NHS Grampian, Woodend Hosp, Aberdeen AB15 6ZQ, Scotland; [Van Meirhaeghe, Jan] Algemeen Ziekenhuis St Jan, Brugge, Belgium		Wardlaw, D (corresponding author), NHS Grampian, Woodend Hosp, Aberdeen AB15 6ZQ, Scotland.	d.wardlaw@nhs.net	Wardlaw, Douglas/AAF-6460-2020					Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P1781, DOI 10.1007/s00198-006-0193-z; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Eck JC, 2008, SPINE J, V8, P488, DOI 10.1016/j.spinee.2007.04.004; Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; LYLES KW, 1993, AM J MED, V94, P595, DOI 10.1016/0002-9343(93)90210-G; LYRITIS G P, 1989, Clinical Rheumatology, V8, P66; Peterson C, 2010, SKELETAL RADIOL, V39, P5, DOI 10.1007/s00256-009-0783-x; Phillips FM, 2002, SPINE, V27, P2173, DOI 10.1097/00007632-200210010-00018; Rousing R, 2010, SPINE, V35, P478, DOI 10.1097/BRS.0b013e3181b71bd1; Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063; Silverman SL, 2001, ARTHRITIS RHEUM, V44, P2611, DOI 10.1002/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N; Strom O, 2010, OSTEOPOROSIS INT, V21, P1599, DOI 10.1007/s00198-009-1096-6; Taylor RS, 2006, SPINE, V31, P2747, DOI 10.1097/01.brs.0000244639.71656.7d; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6	18	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2010	376	9746					1031	1033		10.1016/S0140-6736(10)61162-2	http://dx.doi.org/10.1016/S0140-6736(10)61162-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	657KM	20701963				2022-12-28	WOS:000282411600006
J	Calo, E; Quintero-Estades, JA; Danielian, PS; Nedelcu, S; Berman, SD; Lees, JA				Calo, Eliezer; Quintero-Estades, Jose A.; Danielian, Paul S.; Nedelcu, Simona; Berman, Seth D.; Lees, Jacqueline A.			Rb regulates fate choice and lineage commitment in vivo	NATURE			English	Article							ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; RETINOBLASTOMA GENE; TUMOR-SUPPRESSOR; OSTEOSARCOMA; TRANSCRIPTION; INACTIVATION; EXPRESSION; WHITE; P53	Mutation of the retinoblastoma gene (RB1) tumour suppressor occurs in one-third of all human tumours and is particularly associated with retinoblastoma and osteosarcoma(1). Numerous functions have been ascribed to the product of the human RB1 gene, the retinoblastoma protein (pRb). The best known is pRb's ability to promote cell-cycle exit through inhibition of the E2F transcription factors and the transcriptional repression of genes encoding cell-cycle regulators(1). In addition, pRb has been shown in vitro to regulate several transcription factors that are master differentiation inducers(2). Depending on the differentiation factor and cellular context, pRb can either suppress or promote their transcriptional activity. For example, pRb binds to Runx2 and potentiates its ability to promote osteogenic differentiation in vitro(3). In contrast, pRb acts with E2F to suppress peroxisome proliferator-activated receptor gamma subunit (PPAR-gamma), the master activator of adipogenesis(4,5). Because osteoblasts and adipocytes can both arise from mesenchymal stem cells, these observations suggest that pRb might play a role in the choice between these two fates. However, so far, there is no evidence for this in vivo. Here we use mouse models to address this hypothesis in mesenchymal tissue development and tumorigenesis. Our data show that Rb status plays a key role in establishing fate choice between bone and brown adipose tissue in vivo.	[Calo, Eliezer; Quintero-Estades, Jose A.; Danielian, Paul S.; Nedelcu, Simona; Berman, Seth D.; Lees, Jacqueline A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lees, JA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jalees@mit.edu		Danielian, Paul/0000-0003-2651-0386	National Cancer Institute/National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA121921, P01CA042063] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Jacks, C. Tabin and A. McMahon for providing key mutant mouse strains, K. Lane for pCW22, M. Hemann for the Rb shRNA, the University of Iowa Gene Transfer Vector Core for the adenoviral Cre and GFP vectors, and G. Karsenty for p6OSE2-Luc and control p4Luc. We also thank members of the Lees laboratory, S. Mukherjee and M. Hemann for input during this study. This work was supported by an National Cancer Institute/National Institutes of Health grant to J.A.L., who is a Ludwig Scholar at MIT.	Barski Artem, 2008, V455, P177, DOI 10.1007/978-1-59745-104-8_14; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	20	232	244	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1110	U126		10.1038/nature09264	http://dx.doi.org/10.1038/nature09264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20686481	Green Accepted, Green Submitted			2022-12-28	WOS:000281203600041
J	Bascompte, J				Bascompte, Jordi			Structure and Dynamics of Ecological Networks	SCIENCE			English	Editorial Material							ARCHITECTURE		CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41092 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Bascompte, J (corresponding author), CSIC, Estn Biol Donana, Integrat Ecol Grp, Amer Vespucio S-N, E-41092 Seville, Spain.	bascompte@ebd.csic.es	Bascompte, Jordi/B-7596-2008	Bascompte, Jordi/0000-0002-0108-6411				Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Joppa LN, 2009, ECOL LETT, V12, P961, DOI 10.1111/j.1461-0248.2009.01341.x; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J.N., 2005, INTERSPEC INTERACT; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1	12	159	170	16	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					765	766		10.1126/science.1194255	http://dx.doi.org/10.1126/science.1194255			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705836				2022-12-28	WOS:000280809900022
J	Kallen, AJ; Mu, Y; Bulens, S; Reingold, A; Petit, S; Gershman, K; Ray, SM; Harrison, LH; Lynfield, R; Dumyati, G; Townes, JM; Schaffner, W; Patel, PR; Fridkin, SK				Kallen, Alexander J.; Mu, Yi; Bulens, Sandra; Reingold, Arthur; Petit, Susan; Gershman, Ken; Ray, Susan M.; Harrison, Lee H.; Lynfield, Ruth; Dumyati, Ghinwa; Townes, John M.; Schaffner, William; Patel, Priti R.; Fridkin, Scott K.		ABCs MRSA Investigators Emerging I	Health Care-Associated Invasive MRSA Infections, 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; SURVEILLANCE CULTURES; DISEASE; IMPACT; COLONIZATION; EMERGENCE; ADMISSION	Context Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen of public health importance; MRSA prevention programs that may affect MRSA transmission and infection are increasingly common in health care settings. Whether there have been changes in MRSA infection incidence as these programs become established is unknown; however, recent data have shown that rates of MRSA bloodstream infections (BSIs) in intensive care units are decreasing. Objective To describe changes in rates of invasive health care associated MRSA infections from 2005 through 2008 among residents of 9 US metropolitan areas. Design, Setting, and Participants Active, population-based surveillance for invasive MRSA in 9 metropolitan areas covering a population of approximately 15 million persons. All reports of laboratory-identified episodes of invasive (from a normally sterile body site) MRSA infections from 2005 through 2008 were evaluated and classified based on the setting of the positive culture and the presence or absence of health care exposures. Health care associated infections (ie, hospital-onset and health care associated community-onset), which made up 82% of the total infections, were included in this analysis. Main Outcome Measures Change in incidence of invasive health care associated MRSA infections and health care associated MRSA BSIs using population of the catchment area as the denominator. Results From 2005 through 2008, there were 21 503 episodes of invasive MRSA infection; 17 508 were health care associated. Of these, 15 458 were MRSA BSIs. The incidence rate of hospital-onset invasive MRSA infections was 1.02 per 10 000 population in 2005 and decreased 9.4% per year (95% confidence interval [Cl], 14.7% to 3.8%; P=.005), and the incidence of health care associated community-onset infections was 2.20 per 10 000 population in 2005 and decreased 5.7% per year (95% Cl, 9.7% to 1.6%; P=.01). The decrease was most prominent for the subset of infections with BSIs (hospital-onset: -11.2%; 95% Cl -15.9% to -6.3%; health care associated community-onset: -6.6%; 95% Cl -9.5% to -3.7%). Conclusion Over the 4-year period from 2005 through 2008 in 9 diverse metropolitan areas, rates of invasive health care associated MRSA infections decreased among patients with health care associated infections that began in the community and also decreased among those with hospital-onset invasive disease. JAMA. 2010;304(6):641-648	[Kallen, Alexander J.; Mu, Yi; Bulens, Sandra; Patel, Priti R.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Bulens, Sandra] Atlanta Res & Educ Fdn, Decatur, GA USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Petit, Susan] Connecticut Dept Publ Hlth & Addict Serv, Hartford, CT 06106 USA; [Gershman, Ken] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Ray, Susan M.] Emory Univ, Sch Med, Atlanta, GA USA; [Harrison, Lee H.] Maryland Emerging Infect Program, Baltimore, MD USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Dumyati, Ghinwa] Univ Rochester, Rochester, NY USA; [Townes, John M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California Berkeley; Colorado Department of Public Health & Environment; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Minnesota Department of Health (MHD); University of Rochester; Oregon Health & Science University; Vanderbilt University	Kallen, AJ (corresponding author), 1600 Clifton Rd NE,MS A-35, Atlanta, GA 30333 USA.	AKallen@cdc.gov		Ray, Susan/0000-0002-6327-088X; Shutt, Kathleen/0000-0003-3376-6152				[Anonymous], 2005, MMWR MORB MORTAL WKL; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Calfee DP, 2008, INFECT CONT HOSP EP, V29, pS62, DOI 10.1086/591061; Carrillo-Marquez MA, 2009, PEDIATR INFECT DIS J, V28, P1076, DOI 10.1097/INF.0b013e3181adbcfe; Centers for Disease Control and Prevention, ACT BACT COR SURV RE; Chaberny IF, 2008, J ANTIMICROB CHEMOTH, V62, P1422, DOI 10.1093/jac/dkn373; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Collins A., 2007, Morbidity and Mortality Weekly Report, V56, P197; DeFrances Carol J, 2007, Vital Health Stat 13, P1; DeFrances CJ, 2008, 5 NAT CTR HLTH STAT; Enayet I, 2006, CLIN INFECT DIS, V42, pE57, DOI 10.1086/501125; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Liebowitz Lynne D, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS11, DOI 10.1016/S0924-8579(09)70551-5; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Pearson A, 2009, J ANTIMICROB CHEMOTH, V64, P11, DOI 10.1093/jac/dkp260; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Ridenour G, 2007, INFECT CONT HOSP EP, V28, P1155, DOI 10.1086/520102; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Siegel JD, 2006, HEALTHCARE INFECT CO; U.S. Department of Health and Human Services Office of the Secretary Office of the Assistant Secretary for Health, HHS ACT PLAN PREV HE	31	325	334	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					641	648		10.1001/jama.2010.1115	http://dx.doi.org/10.1001/jama.2010.1115			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699455	Bronze			2022-12-28	WOS:000280829200019
J	Endo, T; Yamano, K; Yoshihisa, T				Endo, Toshiya; Yamano, Koji; Yoshihisa, Tohru			Mitochondrial Matrix Reloaded with RNA	CELL			English	Editorial Material							POLYNUCLEOTIDE PHOSPHORYLASE; INTERMEMBRANE SPACE; IMPORT; PATHWAYS		[Endo, Toshiya; Yamano, Koji] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yoshihisa, Tohru] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yoshihisa, Tohru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp						Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Lithgow T, 2010, PHILOS T R SOC B, V365, P799, DOI 10.1098/rstb.2009.0167; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010	7	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2010	142	3					362	363		10.1016/j.cell.2010.07.024	http://dx.doi.org/10.1016/j.cell.2010.07.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691896	Bronze			2022-12-28	WOS:000280609100012
J	Sacco, T; Sacchetti, B				Sacco, Tiziana; Sacchetti, Benedetto			Role of Secondary Sensory Cortices in Emotional Memory Storage and Retrieval in Rats	SCIENCE			English	Article							FEAR-POTENTIATED STARTLE; VISUAL CONDITIONED-STIMULUS; ANTERIOR CINGULATE CORTEX; BASOLATERAL AMYGDALA; PERIRHINAL CORTEX; TEMPORAL CORTEX; AUDITORY-CORTEX; INVOLVEMENT; CONSOLIDATION; THALAMUS	Visual, acoustic, and olfactory stimuli associated with a highly charged emotional situation take on the affective qualities of that situation. Where the emotional meaning of a given sensory experience is stored is a matter of debate. We found that excitotoxic lesions of auditory, visual, or olfactory secondary sensory cortices impaired remote, but not recent, fear memories in rats. Amnesia was modality-specific and not due to an interference with sensory or emotional processes. In these sites, memory persistence was dependent on ongoing protein kinase M zeta activity and was associated with an increased activity of layers II-IV, thus suggesting a synaptic strengthening of corticocortical connections. Lesions of the same areas left intact the memory of sensory stimuli not associated with any emotional charge. We propose that secondary sensory cortices support memory storage and retrieval of sensory stimuli that have acquired a behavioral salience with the experience.	[Sacco, Tiziana; Sacchetti, Benedetto] Univ Turin, Dept Neurosci, I-10125 Turin, Italy; [Sacchetti, Benedetto] Natl Inst Neurosci, I-10125 Turin, Italy	University of Turin	Sacchetti, B (corresponding author), Univ Turin, Dept Neurosci, Corso Raffaello 30, I-10125 Turin, Italy.	benedetto.sacchetti@unito.it	Sacchetti, Benedetto/AAG-2916-2022; Sacchetti, Benedetto/AFK-4141-2022	Sacchetti, Benedetto/0000-0002-8695-8310	Italian Ministry of University	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	We thank J. L. McGaugh for critical comments on the manuscript and L. Milano, A. Renna, D. Germano, V. Pastrone, D. Tonello, and G. Benvenuti for technical assistance. Supported by grants from the Italian Ministry of University.	BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; Calu DJ, 2007, CEREB CORTEX, V17, P1342, DOI 10.1093/cercor/bhl045; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; COLEMAN J, 1980, BRAIN RES, V194, P205, DOI 10.1016/0006-8993(80)91329-3; DIAMOND DM, 1984, BEHAV NEUROSCI, V98, P189, DOI 10.1037/0735-7044.98.2.189; FALLS WA, 1993, BEHAV NEURAL BIOL, V60, P259, DOI 10.1016/0163-1047(93)90504-B; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; GONZALEZLIMA F, 1989, BRAIN RES, V489, P67, DOI 10.1016/0006-8993(89)90009-7; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kolb B.E., 1990, CEREBRAL CORTEX RAT; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee YL, 1996, BEHAV NEUROSCI, V110, P836, DOI 10.1037/0735-7044.110.4.836; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Malin EL, 2006, P NATL ACAD SCI USA, V103, P1959, DOI 10.1073/pnas.0510890103; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Poremba A, 1998, EUR J NEUROSCI, V10, P3035, DOI 10.1046/j.1460-9568.1998.00304.x; ROMANSKI LM, 1992, NEUROSCI LETT, V142, P228, DOI 10.1016/0304-3940(92)90379-L; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROSEN JB, 1992, J NEUROSCI, V12, P4624; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sacchetti B, 2007, EUR J NEUROSCI, V25, P2875, DOI 10.1111/j.1460-9568.2007.05508.x; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shi CJ, 2001, J NEUROSCI, V21, P9844, DOI 10.1523/JNEUROSCI.21-24-09844.2001; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; Wan H, 2001, EUR J NEUROSCI, V14, P118, DOI 10.1046/j.0953-816x.2001.01625.x; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; ZHU XO, 1995, NEUROSCIENCE, V69, P821, DOI 10.1016/0306-4522(95)00320-I; Zilles K, 1985, CORTEX RAT	39	189	189	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					649	656		10.1126/science.1183165	http://dx.doi.org/10.1126/science.1183165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689011	Green Submitted			2022-12-28	WOS:000280602700030
J	Cooper, S; Khatib, F; Treuille, A; Barbero, J; Lee, J; Beenen, M; Leaver-Fay, A; Baker, D; Popovic, Z; Players, F				Cooper, Seth; Khatib, Firas; Treuille, Adrien; Barbero, Janos; Lee, Jeehyung; Beenen, Michael; Leaver-Fay, Andrew; Baker, David; Popovic, Zoran; Players, Foldit			Predicting protein structures with a multiplayer online game	NATURE			English	Article								People exert large amounts of problem-solving effort playing computer games. Simple image-and text-recognition tasks have been successfully 'crowd-sourced' through games(1-3), but it is not clear if more complex scientific problems can be solved with human-directed computing. Protein structure prediction is one such problem: locating the biologically relevant native conformation of a protein is a formidable computational challenge given the very large size of the search space. Here we describe Foldit, a multiplayer online game that engages non-scientists in solving hard prediction problems. Foldit players interact with protein structures using direct manipulation tools and user-friendly versions of algorithms from the Rosetta structure prediction methodology(4), while they compete and collaborate to optimize the computed energy. We show that top-ranked Foldit players excel at solving challenging structure refinement problems in which substantial backbone rearrangements are necessary to achieve the burial of hydrophobic residues. Players working collaboratively develop a rich assortment of new strategies and algorithms; unlike computational approaches, they explore not only the conformational space but also the space of possible search strategies. The integration of human visual problem-solving and strategy development capabilities with traditional computational algorithms through interactive multiplayer games is a powerful new approach to solving computationally-limited scientific problems.	[Cooper, Seth; Treuille, Adrien; Barbero, Janos; Beenen, Michael; Popovic, Zoran] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Khatib, Firas; Leaver-Fay, Andrew; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Treuille, Adrien; Lee, Jeehyung] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Carnegie Mellon University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Popovic, Z (corresponding author), Univ Washington, Dept Comp Sci & Engn, Box 352350, Seattle, WA 98195 USA.	dabaker@u.washington.edu; zoran@cs.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Barbero, Janos/0000-0002-8256-7734; Newman, Gregory/0000-0003-0503-5782	NSF [IIS0811902, 0906026]; DARPA [N00173-08-1-G025]; Howard Hughes Medical Institute; Microsoft; NVIDIA Fellowship; Div Of Biological Infrastructure [0906026] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [0953985] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Microsoft(Microsoft); NVIDIA Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank D. Salesin, K. Tuite, J. Snyder, D. Suskin, P. Krahenbuhl, A. C. Snyder, H. Lu, L. S. Tan, A. Chia, M. Yao, E. Butler, C. Carrico, P. Bradley, I. Davis, D. Kim, R. Das, W. Sheffler, J. Thompson, O. Lange, R. Vernon, B. Correia, D. Anderson, Y. Zhao, S. Herin and B. Bethurum for their help. We would like to thank N. Koga, R. Koga and A. Deacon and the JCSG for providing us with protein structures before their public release. We would also like to acknowledge all of the Foldit players who have made this work possible. Usernames of players whose solutions were used in figures can be found in Supplementary Table 4. This work was supported by NSF grants IIS0811902 and 0906026, DARPA grant N00173-08-1-G025, the DARPA PDP program, the Howard Hughes Medical Institute (D. B.), Microsoft, and an NVIDIA Fellowship. This material is based upon work supported by the National Science Foundation under a grant awarded in 2009.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano W.L, PYMOL MOL GRAPHICS S; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rosato A, 2009, NAT METHODS, V6, P625, DOI 10.1038/nmeth0909-625; von Ahn L., 2004, P SIGCHI C HUM FACT, P319, DOI [DOI 10.1145/985692.985733, 10.1145/985692.985733]; von Ahn L., 2006, P SIGCHI C HUMAN FAC, P55, DOI DOI 10.1145/1124772.1124782; Westphal AJ, 2010, AIP CONF PROC, V1221, P131, DOI 10.1063/1.3399239; Yee N, 2006, CYBERPSYCHOL BEHAV, V9, P772, DOI 10.1089/cpb.2006.9.772	11	700	715	5	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					756	760		10.1038/nature09304	http://dx.doi.org/10.1038/nature09304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686574	Green Accepted			2022-12-28	WOS:000280562500039
J	Togan, E; Chu, Y; Trifonov, AS; Jiang, L; Maze, J; Childress, L; Dutt, MVG; Sorensen, AS; Hemmer, PR; Zibrov, AS; Lukin, MD				Togan, E.; Chu, Y.; Trifonov, A. S.; Jiang, L.; Maze, J.; Childress, L.; Dutt, M. V. G.; Sorensen, A. S.; Hemmer, P. R.; Zibrov, A. S.; Lukin, M. D.			Quantum entanglement between an optical photon and a solid-state spin qubit	NATURE			English	Article							SINGLE-PHOTON; ATOMIC ENSEMBLES; DIAMOND; EXCITATION; INTERFACE; VIOLATION; MATTER; LIGHT	Quantum entanglement is among the most fascinating aspects of quantum theory(1). Entangled optical photons are now widely used for fundamental tests of quantum mechanics(2) and applications such as quantum cryptography(1). Several recent experiments demonstrated entanglement of optical photons with trapped ions(3), atoms(4,5) and atomic ensembles(6-8), which are then used to connect remote long-term memory nodes in distributed quantum networks(9-11). Here we realize quantum entanglement between the polarization of a single optical photon and a solid-state qubit associated with the single electronic spin of a nitrogen vacancy centre in diamond. Our experimental entanglement verification uses the quantum eraser technique(5,12), and demonstrates that a high degree of control over interactions between a solid-state qubit and the quantum light field can be achieved. The reported entanglement source can be used in studies of fundamental quantum phenomena and provides a key building block for the solid-state realization of quantum optical networks(13,14).	[Togan, E.; Chu, Y.; Trifonov, A. S.; Jiang, L.; Maze, J.; Childress, L.; Dutt, M. V. G.; Zibrov, A. S.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Jiang, L.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Jiang, L.] CALTECH, Inst Quantum Informat, Pasadena, CA 91125 USA; [Childress, L.] Bates Coll, Dept Phys & Astron, Lewiston, ME 04240 USA; [Dutt, M. V. G.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Sorensen, A. S.] Univ Copenhagen, Niels Bohr Inst, QUANTOP, DK-2100 Copenhagen, Denmark; [Hemmer, P. R.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Harvard University; California Institute of Technology; California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Copenhagen; Niels Bohr Institute; Texas A&M University System; Texas A&M University College Station	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu	Sørensen, Anders Søndberg/L-1868-2013; Zibrov, Alexander S/G-7419-2014; Childress, Lilian/H-1359-2012; Jiang, Liang/A-9847-2008; Dutt, Gurudev/B-2889-2009; Jiang, Liang/GVU-8654-2022; Maze, Jeronimo/E-7422-2013	Sørensen, Anders Søndberg/0000-0003-1337-9163; Childress, Lilian/0000-0002-0507-6392; Jiang, Liang/0000-0002-0000-9342; Jiang, Liang/0000-0002-0000-9342; Maze, Jeronimo/0000-0003-0751-9182; Dutt, Gurudev/0000-0001-7426-9246	Defense Advanced Research Projects Agency; NSF; Harvard-MIT CUA; NDSEG Fellowship; Packard Foundation; Division Of Physics [0855599] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); Harvard-MIT CUA; NDSEG Fellowship; Packard Foundation(The David & Lucile Packard Foundation); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank F. Jelezko, J. Wrachtrup, V. Jacques, N. Manson, J. Taylor and J. MacArthur for discussions and experimental help. This work was supported by the Defense Advanced Research Projects Agency, NSF, Harvard-MIT CUA, the NDSEG Fellowship and the Packard Foundation. The content of the information does not necessarily reflect the position or the policy of the US Government, and no official endorsements should be inferred.	Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Cabrillo C, 1999, PHYS REV A, V59, P1025, DOI 10.1103/PhysRevA.59.1025; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Duan LM, 2008, ADV ATOM MOL OPT PHY, V55, P419, DOI 10.1016/S1049-250X(07)55007-X; Englund D, 2007, NATURE, V450, P857, DOI 10.1038/nature06234; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; KAISER F, 2009, POLARIZATION PROPERT; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Manson NB, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.104303; Matsukevich DN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040405; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Schietinger S, 2008, NANO LETT, V8, P3911, DOI 10.1021/nl8023627; SCULLY MO, 1982, PHYS REV A, V25, P2208, DOI 10.1103/PhysRevA.25.2208; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Tamarat P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045004; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404; Wang CF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2813023; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241	30	826	837	11	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					730	U4		10.1038/nature09256	http://dx.doi.org/10.1038/nature09256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686569				2022-12-28	WOS:000280562500033
J	Buckholtz, JW; Treadway, MT; Cowan, RL; Woodward, ND; Li, R; Ansari, MS; Baldwin, RM; Schwartzman, AN; Shelby, ES; Smith, CE; Kessler, RM; Zald, DH				Buckholtz, Joshua W.; Treadway, Michael T.; Cowan, Ronald L.; Woodward, Neil D.; Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Schwartzman, Ashley N.; Shelby, Evan S.; Smith, Clarence E.; Kessler, Robert M.; Zald, David H.			Dopaminergic Network Differences in Human Impulsivity	SCIENCE			English	Article							COCAINE		[Buckholtz, Joshua W.; Treadway, Michael T.; Schwartzman, Ashley N.; Shelby, Evan S.; Zald, David H.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Buckholtz, Joshua W.] Vanderbilt Univ, Vanderbilt Brain Inst, Grad Program Neurosci, Nashville, TN 37240 USA; [Cowan, Ronald L.; Woodward, Neil D.; Smith, Clarence E.; Zald, David H.] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37240 USA; [Cowan, Ronald L.; Woodward, Neil D.] Vanderbilt Univ, Psychiat Neuroimaging Program, Nashville, TN 37240 USA; [Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.] Vanderbilt Univ, Dept Radiol, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Buckholtz, JW (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	joshua.buckholtz@vanderbilt.edu	Buckholtz, Joshua/E-7299-2010; Woodward, Neil D/N-3365-2017; Zald, David H/A-1448-2011; Woodward, Neil/V-3735-2019; Treadway, Michael/O-9056-2017	Buckholtz, Joshua/0000-0002-9418-8686; 	National Institute on Drug Abuse [R01DA019670-04]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019670] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institute on Drug Abuse (R01DA019670-04).	Barratt ES, 1999, PSYCHIAT RES, V86, P163, DOI 10.1016/S0165-1781(99)00024-4; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Lambert NM, 2006, ADDICTION, V101, P713, DOI 10.1111/j.1360-0443.2006.01408.x; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; SANTIAGO M, 1991, EUR J PHARMACOL, V204, P79, DOI 10.1016/0014-2999(91)90838-H; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Zilberman ML, 2003, BMC PSYCHIATRY, V3, DOI 10.1186/1471-244X-3-1	8	423	431	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					532	532		10.1126/science.1185778	http://dx.doi.org/10.1126/science.1185778			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633EX	20671181	Green Accepted			2022-12-28	WOS:000280483500026
J	Levy, N; Burke, SA; Meaker, KL; Panlasigui, M; Zettl, A; Guinea, F; Neto, AHC; Crommie, MF				Levy, N.; Burke, S. A.; Meaker, K. L.; Panlasigui, M.; Zettl, A.; Guinea, F.; Castro Neto, A. H.; Crommie, M. F.			Strain-Induced Pseudo-Magnetic Fields Greater Than 300 Tesla in Graphene Nanobubbles	SCIENCE			English	Article							SCANNING TUNNELING SPECTROSCOPY; DIRAC-FERMIONS; MEMBRANES; PT(111)	Recent theoretical proposals suggest that strain can be used to engineer graphene electronic states through the creation of a pseudo-magnetic field. This effect is unique to graphene because of its massless Dirac fermion-like band structure and particular lattice symmetry (C-3v). Here, we present experimental spectroscopic measurements by scanning tunneling microscopy of highly strained nanobubbles that form when graphene is grown on a platinum (111) surface. The nanobubbles exhibit Landau levels that form in the presence of strain-induced pseudo-magnetic fields greater than 300 tesla. This demonstration of enormous pseudo-magnetic fields opens the door to both the study of charge carriers in previously inaccessible high magnetic field regimes and deliberate mechanical control over electronic structure in graphene or so-called "strain engineering."	[Levy, N.; Burke, S. A.; Meaker, K. L.; Panlasigui, M.; Zettl, A.; Crommie, M. F.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Levy, N.; Zettl, A.; Crommie, M. F.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Guinea, F.] CSIC, Inst Ciencia Mat Madrid, E-28049 Madrid, Spain; [Castro Neto, A. H.] Boston Univ, Dept Phys, Boston, MA 02215 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Boston University	Crommie, MF (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	crommie@berkeley.edu	Guinea, Francisco/A-7122-2008; Zettl, Alex K/O-4925-2016; Burke, Sarah A/A-2731-2008; Castro Neto, Antonio/C-8363-2014	Guinea, Francisco/0000-0001-5915-5427; Zettl, Alex K/0000-0001-6330-136X; Burke, Sarah A/0000-0002-7337-0569; Castro Neto, Antonio/0000-0003-0613-4010	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; DOE [DE-FG02-08ER46512]; Office of Naval Research Multidisciplinary University Research Initiative (MURI) [N00014-09-1-1066]; MURI [N00014-09-1-1063]; Ministerio de Ciencia e Innovacion (MICINN) (Spain) [FIS2008-00124/CSD2007-00010]; Miller Institute for Basic Research; Natural Sciences and Engineering Research Council (Canada); NSF	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Office of Naval Research Multidisciplinary University Research Initiative (MURI)(MURI); MURI(MURI); Ministerio de Ciencia e Innovacion (MICINN) (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Miller Institute for Basic Research; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF))	Research supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231 (instrumentation development and materials synthesis) and DOE contract no. DE-FG02-08ER46512 (experimental data analysis), by the Office of Naval Research Multidisciplinary University Research Initiative (MURI) award no. N00014-09-1-1066 (experimental STM measurements) and MURI award no. N00014-09-1-1063 (electronic structure calculations), and by Ministerio de Ciencia e Innovacion (MICINN) (Spain), award nos. FIS2008-00124/CSD2007-00010 (continuum elasticity simulations). A.H.C.N. acknowledges the support of the Miller Institute for Basic Research. S.A.B. and K.L.M. acknowledge fellowship support from Natural Sciences and Engineering Research Council (Canada) and NSF, respectively. The authors declare no competing financial interests. Requests for materials should be addressed to M.F.C.	Akola J, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.193410; Bao WZ, 2009, NAT NANOTECHNOL, V4, P562, DOI [10.1038/nnano.2009.191, 10.1038/NNANO.2009.191]; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; Brar VW, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2771084; Brar VW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.036805; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Enachescu M, 1999, PHYS REV B, V60, P16913, DOI 10.1103/PhysRevB.60.16913; Gao M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3309671; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Guinea F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075422; Guinea F, 2010, NAT PHYS, V6, P30, DOI 10.1038/NPHYS1420; Guinea F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035408; LAND TA, 1992, SURF SCI, V264, P261, DOI 10.1016/0039-6028(92)90183-7; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li G, 2007, NAT PHYS, V3, P623, DOI 10.1038/nphys653; Miller DL, 2009, SCIENCE, V324, P924, DOI 10.1126/science.1171810; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pereira VM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.046801; Preobrajenski AB, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.073401; Rutter GM, 2007, SCIENCE, V317, P219, DOI 10.1126/science.1142882; SEUNG HS, 1988, PHYS REV A, V38, P1005, DOI 10.1103/PhysRevA.38.1005; Stroscio J A, 1993, SCANNING TUNNELING M; Sutter P, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245411; WALLACE PR, 1947, PHYS REV, V71, P622, DOI 10.1103/PhysRev.71.622; Wiebe J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.193406; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2008, NAT PHYS, V4, P627, DOI 10.1038/nphys1022	29	1185	1204	9	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					544	547		10.1126/science.1191700	http://dx.doi.org/10.1126/science.1191700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671183				2022-12-28	WOS:000280483500030
J	Donmez, G; Wang, D; Cohen, DE; Guarente, L				Donmez, Gizem; Wang, Diana; Cohen, Dena E.; Guarente, Leonard			RETRACTED: SIRT1 Suppresses beta-Amyloid Production by Activating the alpha-Secretase Gene ADAM10 (Retracted article. See vol. 158, pg. 959, 2014)	CELL			English	Article; Retracted Publication							RETINOIC ACID RECEPTORS; ALZHEIMERS-DISEASE; CALORIC RESTRICTION; TRANSGENIC MICE; MOUSE MODEL; PROTEIN; NOTCH; PATHWAY; NEURODEGENERATION; PHOSPHORYLATION	A hallmark of Alzheimer's disease (AD) is the accumulation of plaques of A beta 1-40 and 1-42 peptides, which result from the sequential cleavage of APP by the beta and gamma-secretases. The production of A beta peptides is avoided by alternate cleavage of APP by the alpha and gamma-secretases. Here we show that production of beta-amyloid and plaques in a mouse model of AD are reduced by overexpressing the NAD-dependent deacetylase SIRT1 in brain, and are increased by knocking out SIRT1 in brain. SIRT1 directly activates the transcription of the gene encoding the alpha-secretase, ADAM10. SIRT1 deacetylates and coactivates the retinoic acid receptor beta, a known regulator of ADAM10 transcription. ADAM10 activation by SIRT1 also induces the Notch pathway, which is known to repair neuronal damage in the brain. Our findings indicate SIRT1 activation is a viable strategy to combat AD and perhaps other neurodegenerative diseases.	[Donmez, Gizem; Wang, Diana; Cohen, Dena E.; Guarente, Leonard] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Donmez, Gizem; Wang, Diana; Cohen, Dena E.; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Paul F Glenn Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu			American Parkinson Disease Association; NIH; NATIONAL INSTITUTE ON AGING [R01AG015339] Funding Source: NIH RePORTER	American Parkinson Disease Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Hyo-Jin Park and Seong Hun Kim for N2A APPswe/PSEN1dE9 cells. We thank Dennis Selkoe for helpful discussions. We also thank Takashi Nakagawa, Hung Chun Chang, and Petra Simic for comments on the manuscript. This work is supported by an American Parkinson Disease Association post-doctoral fellowship to G.D. and grants from the NIH and a gift from the Paul F. Glenn Foundation to L.G.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bryan KJ, 2009, FRONT NEUROSCI, P1; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Costa RM, 2005, TRENDS NEUROSCI, V28, P429, DOI 10.1016/j.tins.2005.05.003; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; DOLLE P, 1990, DEVELOPMENT, V110, P1133; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Fahrenholz F, 2008, ADV BEHAV BIOL, V57, P369, DOI 10.1007/978-0-387-72076-0_38; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Johansson S, 2006, NEUROREPORT, V17, P907, DOI 10.1097/01.wnr.0000221844.35502.29; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1992, RETINOID RECEPTORS T; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; PANTER SS, 1985, NEUROCHEM RES, V10, P1567, DOI 10.1007/BF00988599; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Saftig P, 2005, PROTEAS BIOL DIS, V4, P85; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vieira SI, 2009, MOL CELL BIOCHEM, V328, P145, DOI 10.1007/s11010-009-0084-7; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	49	356	387	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					320	332		10.1016/j.cell.2010.06.020	http://dx.doi.org/10.1016/j.cell.2010.06.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655472	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000280204300022
J	Eastman, Q				Eastman, Quinn			A Grand Experiment in Shovel-Ready Science	CELL			English	Editorial Material																			0	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					181	183		10.1016/j.cell.2010.07.008	http://dx.doi.org/10.1016/j.cell.2010.07.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655458	Bronze			2022-12-28	WOS:000280204300006
J	Donovan, JC; Price, VH				Donovan, Jeff C.; Price, Vera H.			Chloroquine-Induced Hair Hypopigmentation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Donovan, Jeff C.] Univ Toronto, Toronto, ON, Canada; [Price, Vera H.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Toronto; University of California System; University of California San Francisco	Donovan, JC (corresponding author), Univ Toronto, Toronto, ON, Canada.	pricev@derm.ucsf.edu							0	6	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					372	372		10.1056/NEJMicm0912609	http://dx.doi.org/10.1056/NEJMicm0912609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660405				2022-12-28	WOS:000280139300011
J	Delbanco, T; Walker, J; Darer, JD; Elmore, JG; Feldman, HJ; Leveille, SG; Ralston, JD; Ross, SE; Vodicka, E; Weber, VD				Delbanco, Tom; Walker, Jan; Darer, Jonathan D.; Elmore, Joann G.; Feldman, Henry J.; Leveille, Suzanne G.; Ralston, James D.; Ross, Stephen E.; Vodicka, Elisabeth; Weber, Valerie D.			Open Notes: Doctors and Patients Signing On	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONGESTIVE-HEART-FAILURE; MEDICAL-RECORD; CARE RECORD; ACCESS; EXPERIENCES; PHYSICIAN; ATTITUDES; SYSTEM; TRIAL	Few patients read their doctors' notes, despite having the legal right to do so. As information technology makes medical records more accessible and society calls for greater transparency, patients' interest in reading their doctors' notes may increase. Inviting patients to review these notes could improve understanding of their health, foster productive communication, stimulate shared decision making, and ultimately lead to better outcomes. Yet, easy access to doctors' notes could have negative consequences, such as confusing or worrying patients and complicating rather than improving patient-doctor communication. To gain evidence about the feasibility, benefits, and harms of providing patients ready access to electronic doctors' notes, a team of physicians and nurses have embarked on a demonstration and evaluation of a project called OpenNotes. The authors describe the intervention and share what they learned from conversations with doctors and patients during the planning stages. The team anticipates that "open notes" will spread and suggests that over time, if drafted collaboratively and signed by both doctors and patients, they might evolve to become contracts for care.	Beth Israel Deaconess Med Ctr, Brookline, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Geisinger Hlth Syst, Danville, PA USA; Univ Washington, Harborview Med Ctr, Sch Med, Seattle, WA 98104 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; Univ Colorado, Aurora, CO USA; Commonwealth Med Coll, Scranton, PA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Geisinger Health System; Harborview Medical Center; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Colorado System; University of Colorado Anschutz Medical Campus; Geisinger Commonwealth School of Medicine	Delbanco, T (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02115 USA.	tdelbanc@bidmc.harvard.edu	Leveille, Suzanne G/ACS-6588-2022	Leveille, Suzanne G/0000-0003-0427-1580	Robert Wood Johnson Foundation; Drane Family Fund	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Drane Family Fund	Grant Support: By the Robert Wood Johnson Foundation's Pioneer Portfolio and the Drane Family Fund.	BROYARD A, 1992, INTOXICATED MY ILLNE, P49; Chen C, 2009, HEALTH AFFAIR, V28, P323, DOI 10.1377/hlthaff.28.2.323; Christy N. P., 1997, P S J, V17, P1; Cimino JJ, 2001, STUD HEALTH TECHNOL, V84, P1440; Delbanco T, 2004, NEW ENGL J MED, V350, P1705, DOI 10.1056/NEJMp038209; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; Earnest MA, 2004, J AM MED INFORM ASSN, V11, P410, DOI 10.1197/jamia.M1479; *ENC BRIT, CORP HIPP; FISCHBACH RL, 1980, PATIENT COUNS HEALTH, V2, P1, DOI 10.1016/S0738-3991(80)80022-X; Goldberg Harold I, 2003, Jt Comm J Qual Saf, V29, P443; Greenhalgh T, 2008, BMJ-BRIT MED J, V336, P1290, DOI 10.1136/bmj.a114; Hartzband P, 2008, NEW ENGL J MED, V358, P1656, DOI 10.1056/NEJMp0802221; Hassol A, 2004, J AM MED INFORM ASSN, V11, P505, DOI 10.1197/jamia.M1593; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Lin CT, 2005, J MED INTERNET RES, V7, P13, DOI 10.2196/jmir.7.4.e47; Ralston JD, 2007, J AM MED INFORM ASSN, V14, P798, DOI 10.1197/jamia.M2302; Reti SR, 2010, J AM MED INFORM ASSN, V17, P192, DOI 10.1136/jamia.2009.000927; Ross SE, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e12; Ross SE, 2003, J AM MED INFORM ASSN, V10, P129, DOI 10.1197/jamia.M1147; Schiff GD, 2010, NEW ENGL J MED, V362, P1066, DOI 10.1056/NEJMp0911734; SHENKIN BN, 1973, NEW ENGL J MED, V289, P688, DOI 10.1056/NEJM197309272891311; Slack WV, 2004, JAMA-J AM MED ASSOC, V292, P2255, DOI 10.1001/jama.292.18.2255; Walker J, 2009, J GEN INTERN MED, V24, P727, DOI 10.1007/s11606-009-0973-1; WEED LL, 1971, ANN CLIN RES, V3, P131; 2002, FED REG, V67, P53181	25	162	163	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2					121	W45		10.7326/0003-4819-153-2-201007200-00008	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628DU	20643992				2022-12-28	WOS:000280095400007
J	Chalkidou, K; Levine, R; Dillon, A				Chalkidou, Kalipso; Levine, Ruth; Dillon, Andrew			Helping poorer countries make locally informed health decisions	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chalkidou, Kalipso] NICE Int, Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England; [Levine, Ruth] Ctr Global Dev, Washington, DC 20036 USA	National Institute for Health & Care Excellence	Chalkidou, K (corresponding author), NICE Int, Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England.	kalipso.chalkidou@nice.org.uk						Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; [Anonymous], 2005, PARIS DECLARATION AI; Asprey D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1823; BAHREE M, 2009, FORBES MAGAZINE 1228; BOSELEY S, 2009, GUARDIAN        0213; CHATTERJEE S, 2010, BLOOMBERG       0104; CHEN Z, 2009, FINANCIAL TIMES 1208; *INT HLTH POL PROG, 2009, RES DEV OPT POL STRA; Laurell AC, 2007, INT J HEALTH SERV, V37, P515, DOI 10.2190/0133-572V-564N-4831; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; *MIN FIN PLANN REP, 2006, SCAL ACH HLTH MDGS R; Mudur G, 2005, BRIT MED J, V330, P920, DOI 10.1136/bmj.330.7497.920-a; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; *SECR SAL INF RES, 2009, PRIMER SEMESTRE 2009; STEWART H, 2009, GUARDIAN        0803; Teerawattananon Y, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309090709; *US PRES EM PLAN D, 2009, PARTN FIGHT HIV AIDS; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0; World Health Organization, 2007, AID EFF HLTH	19	25	25	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 16	2010	341								c3651	10.1136/bmj.c3651	http://dx.doi.org/10.1136/bmj.c3651			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XF	20639295				2022-12-28	WOS:000280157000003
J	Klazen, CAH; Lohle, PNM; de Vries, J; Jansen, FH; Tielbeek, AV; Blonk, MC; Venmans, A; van Rooij, WJJ; Schoemaker, MC; Juttmann, JR; Lo, TH; Verhaar, HJJ; van der Graaf, Y; van Everdingen, KJ; Muller, AF; Elgersma, OEH; Halkema, DR; Fransen, H; Janssens, X; Buskens, E; Mali, WPTM				Klazen, Caroline A. H.; Lohle, Paul N. M.; de Vries, Jolanda; Jansen, Frits H.; Tielbeek, Alexander V.; Blonk, Marion C.; Venmans, Alexander; van Rooij, Willem Jan J.; Schoemaker, Marinus C.; Juttmann, Job R.; Lo, Tjoen H.; Verhaar, Harald J. J.; van der Graaf, Yolanda; van Everdingen, Kaspar J.; Muller, Alex F.; Elgersma, Otto E. H.; Halkema, Dirk R.; Fransen, Hendrik; Janssens, Xavier; Buskens, Erik; Mali, Willem P. Th M.			Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial	LANCET			English	Article							QUALITY-OF-LIFE; PERCUTANEOUS VERTEBROPLASTY; PAIN RELIEF; FOLLOW-UP; KYPHOPLASTY; IMPROVEMENT	Background Percutaneous vertebroplasty is increasingly used for treatment of pain in patients with osteoporotic vertebral compression fractures, but the efficacy, cost-effectiveness, and safety of the procedure remain uncertain. We aimed to clarify whether vertebroplasty has additional value compared with optimum pain treatment in patients with acute vertebral fractures. Methods Patients were recruited to this open-label prospective randomised trial from the radiology departments of six hospitals in the Netherlands and Belgium. Patients were aged 50 years or older, had vertebral compression fractures on spine radiograph (minimum 15% height loss; level of fracture at Th5 or lower; bone oedema on MRI), with back pain for 6 weeks or less, and a visual analogue scale (VAS) score of 5 or more. Patients were randomly allocated to percutaneous vertebroplasty or conservative treatment by computer-generated randomisation codes with a block size of six. Masking was not possible for participants, physicians, and outcome assessors. The primary outcome was pain relief at 1 month and 1 year as measured by VAS score. Analysis was by intention to treat. This study is registered at ClinicalTrials.gov, number NCT00232466. Findings Between Oct 1,2005, and June 30,2008, we identified 431 patients who were eligible for randomisation. 229 (53%) patients had spontaneous pain relief during assessment, and 202 patients with persistent pain were randomly allocated to treatment (101 vertebroplasty, 101 conservative treatment). Vertebroplasty resulted in greater pain relief than did conservative treatment; difference in mean VAS score between baseline and 1 month was -5.2 (95% CI -5.88 to -4.72) after vertebroplasty and -2.7 (-3.22 to -1.98) after conservative treatment, and between baseline and 1 year was -5.7 (-6.22 to -4.98) after vertebroplasty and -3-7 (-4.35 to -3.05) after conservative treatment. The difference between groups in reduction of mean VAS score from baseline was 2.6 (95% CI 1.74-3.37, p<0.0001) at 1 month and 2.0 (1.13-2.80, p<0.0001) at 1 year. No serious complications or adverse events were reported. Interpretation In a subgroup of patients with acute osteoporotic vertebral compression fractures and persistent pain, percutaneous vertebroplasty is effective and safe. Pain relief after vertebroplasty is immediate, is sustained for at least a year, and is significantly greater than that achieved with conservative treatment, at an acceptable cost.	[Klazen, Caroline A. H.; Lohle, Paul N. M.; de Vries, Jolanda; Venmans, Alexander; van Rooij, Willem Jan J.; Schoemaker, Marinus C.; Juttmann, Job R.] St Elizabeth Hosp, Tilburg, Netherlands; [Jansen, Frits H.; Tielbeek, Alexander V.; Blonk, Marion C.] Catharina Hosp, Eindhoven, Netherlands; [Klazen, Caroline A. H.; Lo, Tjoen H.; Verhaar, Harald J. J.; Mali, Willem P. Th M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van Everdingen, Kaspar J.; Muller, Alex F.] Diakonessenhuis Utrecht, Utrecht, Netherlands; [Elgersma, Otto E. H.; Halkema, Dirk R.] Schweitzer Ziekenhuis, Dordrecht, Netherlands; [Fransen, Hendrik; Janssens, Xavier] AZ St Lucas, Ghent, Belgium; [Buskens, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); Catharina Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; University of Groningen	Klazen, CAH (corresponding author), St Elizabeth Hosp, Hilvarenbeekseweg 60, Tilburg, Netherlands.	cahklazen@hotmail.com	Mali, Willem PThM/I-1123-2014	Mali, Willem PThM/0000-0003-4391-0904; buskens, erik/0000-0002-6463-1106	ZonMw (Dutch organisation for health care research and innovation of care) [945-06-351]; COOK Medical (Bloomington, IN, USA)	ZonMw (Dutch organisation for health care research and innovation of care)(Netherlands Organization for Health Research and Development); COOK Medical (Bloomington, IN, USA)	This study was sponsored by ZonMw (Dutch organisation for health care research and innovation of care), project number 945-06-351 and an unrestricted grant from COOK Medical (Bloomington, IN, USA).	Alvarez L, 2006, SPINE, V31, P1113; Anselmetti GC, 2007, CARDIOVASC INTER RAD, V30, P441, DOI 10.1007/s00270-006-0146-0; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Clark W, 2009, NEW ENGL J MED, V361, P2097, DOI 10.1056/NEJMc096289; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Eck JC, 2008, SPINE J, V8, P488, DOI 10.1016/j.spinee.2007.04.004; Evans AJ, 2003, RADIOLOGY, V226, P366, DOI 10.1148/radiol.2262010906; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Klazen CAH, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-33; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Legroux-Gerot I, 2004, CLIN RHEUMATOL, V23, P310, DOI 10.1007/s10067-004-0914-7; Lips P, 1999, OSTEOPOROSIS INT, V10, P150, DOI 10.1007/s001980050210; Liu JT, 2010, OSTEOPOROSIS INT, V21, P359, DOI 10.1007/s00198-009-0952-8; Mathis JM, 2004, AM J NEURORADIOL, V25, P840; McGraw JK, 2002, J VASC INTERV RADIOL, V13, P883, DOI 10.1016/S1051-0443(07)61770-9; McHugh GA, 2007, RHEUMATOLOGY, V46, P631, DOI 10.1093/rheumatology/kel355; OOSTENBRINK JB, 2004, DUTCH GUIDELINES COS; Perez-Higueras A, 2002, NEURORADIOLOGY, V44, P950, DOI 10.1007/s00234-002-0856-1; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Voormolen MHJ, 2006, J VASC INTERV RADIOL, V17, P1313, DOI 10.1097/01.RVI.0000231952.75209.4A; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Zoarski GH, 2002, J VASC INTERV RADIOL, V13, P139, DOI 10.1016/S1051-0443(07)61930-7	28	570	640	1	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2010	376	9746					1085	1092		10.1016/S0140-6736(10)60954-3	http://dx.doi.org/10.1016/S0140-6736(10)60954-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	657KM	20701962	Green Submitted			2022-12-28	WOS:000282411600035
J	Farias, M; Vargas, G; Tassara, A; Carretier, S; Baize, S; Melnick, D; Bataille, K				Farias, Marcelo; Vargas, Gabriel; Tassara, Andres; Carretier, Sebastien; Baize, Stephane; Melnick, Daniel; Bataille, Klaus			Land-Level Changes Produced by the M-w 8.8 2010 Chilean Earthquake	SCIENCE			English	Article									[Farias, Marcelo; Vargas, Gabriel] Univ Chile, Dept Geol, Santiago, Chile; [Tassara, Andres; Bataille, Klaus] Univ Concepcion, Dept Ciencias Tierra, Concepcion, Chile; [Carretier, Sebastien] Univ Toulouse, Observ Midi Pyrenees, Univ Toulouse 3, Lab Mecanismes & Transferts Geol,IRD, F-31400 Toulouse, France; [Baize, Stephane] IRSN, F-92262 Fontenay Aux Roses, France; [Melnick, Daniel] Univ Potsdam, Inst Erd & Umweltwissensch, D-14476 Golm, Germany	Universidad de Chile; Universidad de Concepcion; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of Potsdam	Farias, M (corresponding author), Univ Chile, Dept Geol, Plaza Ercilla 803, Santiago, Chile.	mfarias@dgf.uchile.cl	Vargas, Gabriel Easton/F-5225-2018; Melnick, Daniel/G-8484-2011; Carretier, Sebastien/D-2960-2009; Farias, Marcelo/K-4588-2014; carretier, sebastien/L-4580-2017; carretier, sebastien/G-9686-2013; Vargas, Victor Gabriel/I-6826-2016; Bataille, Klaus/AAI-4499-2020; Farias, Marcelo/AAY-5938-2020	Vargas, Gabriel Easton/0000-0003-2358-8807; Melnick, Daniel/0000-0001-8397-7391; Carretier, Sebastien/0000-0001-8336-1263; Farias, Marcelo/0000-0002-3264-341X; carretier, sebastien/0000-0002-5527-5146; carretier, sebastien/0000-0001-8336-1263; Vargas, Victor Gabriel/0000-0002-7521-7891; Farias, Marcelo/0000-0002-3264-341X	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11085022, 1070279, 1101034]; Programa Bicentenario de Ciencia y Tecnologia [PDA-07]; Millenium Nucleus on Seismotectonics and Seismic Hazard (CIIT-MB) [P06-064F]; French IRD, Institut National des Sciences de l'Univers-Centre National de la Recherche Scientifique, and IRSN; Deutsche Forschungsgemeinschaft [ME 3157/2-1]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa Bicentenario de Ciencia y Tecnologia; Millenium Nucleus on Seismotectonics and Seismic Hazard (CIIT-MB); French IRD, Institut National des Sciences de l'Univers-Centre National de la Recherche Scientifique, and IRSN; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grants 11085022, 1070279, and 1101034; Programa Bicentenario de Ciencia y Tecnologia PDA-07; Millenium Nucleus on Seismotectonics and Seismic Hazard (CIIT-MB, grant P06-064F); the French IRD, Institut National des Sciences de l'Univers-Centre National de la Recherche Scientifique, and IRSN; and grant ME 3157/2-1 of the Deutsche Forschungsgemeinschaft.	OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Ortlieb L, 1996, QUATERNARY SCI REV, V15, P949, DOI 10.1016/S0277-3791(96)00056-X; Ruegg JC, 2009, PHYS EARTH PLANET IN, V175, P78, DOI 10.1016/j.pepi.2008.02.015; VIGNY C, 2010, AM GEOPH UN AGU CHAP	4	124	125	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					916	916		10.1126/science.1192094	http://dx.doi.org/10.1126/science.1192094			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20671154				2022-12-28	WOS:000281084800026
J	Bhaskaran, K; Hajat, S; Haines, A; Herrett, E; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Hajat, Shakoor; Haines, Andy; Herrett, Emily; Wilkinson, Paul; Smeeth, Liam			Short term effects of temperature on risk of myocardial infarction in England and Wales: time series regression analysis of the Myocardial Ischaemia National Audit Project (MINAP) registry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AIR-POLLUTION; COLD WEATHER; SAO-PAULO; MORTALITY; HEAT; INCREASES; DEATHS; FIBRINOGEN; PLATELET; PRESSURE	Objective To examine the short term relation between ambient temperature and risk of myocardial infarction. Design Daily time series regression analysis. Setting 15 conurbations in England and Wales. Participants 84 010 hospital admissions for myocardial infarction recorded in the Myocardial Ischaemia National Audit Project during 2003-6 (median 57 events a day). Main outcome measures Change in risk of myocardial infarction associated with a 1 degrees C difference in temperature, including effects delayed by up to 28 days. Results Smoothed graphs revealed a broadly linear relation between temperature and myocardial infarction, which was well characterised by log-linear models without a temperature threshold: each 1 degrees C reduction in daily mean temperature was associated with a 2.0% (95% confidence interval 1.1% to 2.9%) cumulative increase in risk of myocardial infarction over the current and following 28 days, the strongest effects being estimated at intermediate lags of 2-7 and 8-14 days: increase per 1 degrees C reduction 0.6% (95% confidence interval 0.2% to 1.1%) and 0.7% (0.3% to 1.1%), respectively. Heat had no detrimental effect. Adults aged 75-84 and those with previous coronary heart disease seemed more vulnerable to the effects of cold than other age groups (P for interaction 0.001 or less in each case), whereas those taking aspirin were less vulnerable (P for interaction 0.007). Conclusions Increases in risk of myocardial infarction at colder ambient temperatures may be one driver of cold related increases in overall mortality, but an increased risk of myocardial infarction at higher temperatures was not detected. The risk of myocardial infarction in vulnerable people might be reduced by the provision of targeted advice or other interventions, triggered by forecasts of lower temperature.	[Bhaskaran, Krishnan; Herrett, Emily; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1F 7HT, England; [Hajat, Shakoor; Wilkinson, Paul] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1F 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Bhaskaran, Krishnan/0000-0001-5364-8757; Haines, Andy/0000-0002-8053-4605; Wilkinson, Paul/0000-0001-7456-259X; Smeeth, Liam/0000-0002-9168-6022	British Heart Foundation [FS/04/045]; Garfield Weston Trust; Wellcome Trust [076583/Z/05/Z]	British Heart Foundation(British Heart Foundation); Garfield Weston Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded through grants from the British Heart Foundation (FS/04/045) and the Garfield Weston Trust. LS is supported by a Wellcome Trust senior research fellowship in clinical science. SH is funded by a Wellcome Trust research career development fellowship (076583/Z/05/Z). The funders had no role in the design or conduct of this review, or in the preparation, review, or approval of the manuscript. All authors carried out this research independently of the funding bodies.	Allender S., 2008, CORONARY HEART DIS S; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Brumback BA, 2000, J AM STAT ASSOC, V95, P16; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; DOMINICI F, 2004, RES REP HLTH EFF I, V3, P27; Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Fenn B, 2008, EPIDEMIOLOGY, V19, pS172; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2007, J EPIDEMIOL COMMUN H, V61, P719, DOI 10.1136/jech.2006.053942; HEPPELL R, 1991, BRIT MED J, V302, P469, DOI 10.1136/bmj.302.6774.469-c; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Mercer JB, 1999, THROMB RES, V95, P93, DOI 10.1016/S0049-3848(99)00028-6; Messner Torbjorn, 2002, Int J Circumpolar Health, V61, P201; Morabito M, 2006, ENVIRON RES, V102, P52, DOI 10.1016/j.envres.2005.12.007; NEILD PJ, 1994, CLIN SCI, V86, P43, DOI 10.1042/cs0860043; OPPER C, 1995, PHARMACOL BIOCHEM BE, V51, P217, DOI 10.1016/0091-3057(94)00432-I; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; RAVEN PB, 1970, J APPL PHYSIOL, V29, P417, DOI 10.1152/jappl.1970.29.4.417; Rossi G, 1999, ARCH ENVIRON HEALTH, V54, P158, DOI 10.1080/00039899909602254; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Sharovsky R, 2004, BRAZ J MED BIOL RES, V37, P1651, DOI 10.1590/S0100-879X2004001100009; *UK MET OFF, COPD HLTH FOR WINT 2; Wang Hongli, 2006, Hiroshima Journal of Medical Sciences, V55, P45	34	130	135	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2010	341								c3823	10.1136/bmj.c3823	http://dx.doi.org/10.1136/bmj.c3823			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DQ	20699305	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000281028800002
J	Daszak, P				Daszak, Peter			Bats, in Black and White	SCIENCE			English	Editorial Material									EcoHlth Alliance, New York, NY 10001 USA	EcoHealth Alliance	Daszak, P (corresponding author), EcoHlth Alliance, 460 W 34th St, New York, NY 10001 USA.	daszak@wildlifetrust.org	daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695				Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Lipkin WI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000002; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; SCHLOEGEL LM, DIS AQUAT ORGAN, DOI DOI 10.3354/DA002140; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; *USAID, 2010, USAID LAUNCH EM PAND	9	5	9	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					634	635		10.1126/science.1194089	http://dx.doi.org/10.1126/science.1194089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689004				2022-12-28	WOS:000280602700022
J	Tronetti, PS				Tronetti, Pamela S.			A Panda Story	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												pam.tronetti@physicianpm.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					384	385		10.1001/jama.2010.975	http://dx.doi.org/10.1001/jama.2010.975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664030				2022-12-28	WOS:000280350100001
J	Wolfe, MS; Selkoe, DJ				Wolfe, Michael S.; Selkoe, Dennis J.			Giving Alzheimer's the Old One-Two	CELL			English	Editorial Material							AMYLOID HYPOTHESIS; DISEASE; PATHWAY		[Wolfe, Michael S.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Wolfe, Michael S.; Selkoe, Dennis J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu; dselkoe@rics.bwh.harvard.edu						Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	9	5	7	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					194	196		10.1016/j.cell.2010.07.006	http://dx.doi.org/10.1016/j.cell.2010.07.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655461	Bronze			2022-12-28	WOS:000280204300009
J	Jin, X; Costa, RM				Jin, Xin; Costa, Rui M.			Start/stop signals emerge in nigrostriatal circuits during sequence learning	NATURE			English	Article							DOPAMINE NEURONS ENCODE; HUNTINGTONS-DISEASE; BASAL GANGLIA; STRIATUM; REPRESENTATION; PATTERN; TIME; POPULATIONS; INITIATION; MOVEMENTS	Learning new action sequences subserves a plethora of different abilities such as escaping a predator, playing the piano, or producing fluent speech. Proper initiation and termination of each action sequence is critical for the organization of behaviour, and is compromised in nigrostriatal disorders like Parkinson's and Huntington's diseases. Using a self-paced operant task in which mice learn to perform a particular sequence of actions to obtain an outcome, we found neural activity in nigrostriatal circuits specifically signalling the initiation or the termination of each action sequence. This start/stop activity emerged during sequence learning, was specific for particular actions, and did not reflect interval timing, movement speed or action value. Furthermore, genetically altering the function of striatal circuits disrupted the development of start/stop activity and selectively impaired sequence learning. These results have important implications for understanding the functional organization of actions and the sequence initiation and termination impairments observed in basal ganglia disorders.	[Jin, Xin; Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Costa, Rui M.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, P-2780156 Oeiras, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Costa, RM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	ruicosta@fchampalimaud.org		Costa, Rui M./0000-0003-0495-8374	NIAAA Division of Intramural Clinical and Biological Research; Institute Gulbenkian de Ciencia; European Research Council [243393]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	NIAAA Division of Intramural Clinical and Biological Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Institute Gulbenkian de Ciencia; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Li for the RGS9-Cre mice, C. Gerfen for the TH-Cre mice, K. Nakazawa for the NMDAR1-loxP mice, F. Tecuapetla and S. Lima for help in the optogenetics experiment, G. Luo for genotyping, and D. Lovinger, G. Cui, C. French, C. Gremel and E. Dias-Ferreira for comments on the manuscript. This research was supported by the NIAAA Division of Intramural Clinical and Biological Research, the Champalimaud Neuroscience Programme at Institute Gulbenkian de Ciencia and European Research Council Grant 243393 to R.M.C.	AGOSTINO R, 1992, BRAIN, V115, P1481, DOI 10.1093/brain/115.5.1481; Aldridge JW, 1998, J NEUROSCI, V18, P2777; Bailey KR, 2006, J NEUROSCI, V26, P1016, DOI 10.1523/JNEUROSCI.3883-05.2006; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; CASTIELLO U, 1993, NEUROPSYCHOLOGIA, V31, P395, DOI 10.1016/0028-3932(93)90162-S; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Gallistel C. R., 1980, ORG ACTION NEW SYNTH; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Hikosaka O, 1998, NEUROBIOL LEARN MEM, V70, P137, DOI 10.1006/nlme.1998.3844; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277, DOI 10.1152/jn.1990.63.6.1277; Lashley K.S., 1951, PROBLEM SERIAL ORDER, V21; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meyer-Luehmann M, 2002, EUR J NEUROSCI, V16, P1599, DOI 10.1046/j.1460-9568.2002.02210.x; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; PHILLIPS JG, 1995, NEUROPSYCHOLOGIA, V33, P365, DOI 10.1016/0028-3932(94)00114-5; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stefanova ED, 2000, MOVEMENT DISORD, V15, P1095, DOI 10.1002/1531-8257(200011)15:6<1095::AID-MDS1006>3.0.CO;2-R; WILLINGHAM DB, 1993, PSYCHOBIOLOGY, V21, P173; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	40	363	364	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					457	462		10.1038/nature09263	http://dx.doi.org/10.1038/nature09263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651684	Green Accepted			2022-12-28	WOS:000280141200028
J	Buscher, AL; Giordano, TP				Buscher, April L.; Giordano, Thomas P.			Gaps in Knowledge in Caring for HIV Survivors Long-term	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; POPULATION		Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Giordano, TP (corresponding author), Michael E DeBakey VA Med Ctr 152, Hlth Serv Res & Dev Ctr Excellence, 2002 Holcombe Blvd, Houston, TX 77030 USA.	tpg@bcm.tmc.edu		Giordano, Thomas/0000-0002-9346-5530				Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Handford C. D., 2006, COCHRANE DB SYST REV, V3; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008; Kirk JB, 2009, J AM GERIATR SOC, V57, P2129, DOI 10.1111/j.1532-5415.2009.02494.x; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	9	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					340	341		10.1001/jama.2010.870	http://dx.doi.org/10.1001/jama.2010.870			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628HV	20639568				2022-12-28	WOS:000280107500024
J	Holmes, CB; Coggin, W; Jamieson, D; Mihm, H; Granich, R; Savio, P; Hope, M; Ryan, C; Moloney-Kitts, M; Goosby, EP; Dybul, M				Holmes, Charles B.; Coggin, William; Jamieson, David; Mihm, Heidi; Granich, Reuben; Savio, Phillip; Hope, Michael; Ryan, Caroline; Moloney-Kitts, Michele; Goosby, Eric P.; Dybul, Mark			Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENOFOVIR	Context One of the biggest hurdles to the rapid scale-up of antiretroviral therapy in the developing world was the price of antiretroviral drugs (ARVs). Modification of an existing US Food and Drug Administration (FDA) process to expedite review and approval of generic ARVs quickly resulted in a large number of FDA-tentatively approved ARVs available for use by the US President's Emergency Plan for AIDS Relief (PEPFAR). Objective To evaluate the uptake of generic ARVs among PEPFAR-supported programs in Guyana, Haiti, Vietnam, and 13 countries in Africa, and changes over time in ARV use and costs. Design, Setting, and Participants An annual survey from 2005 to 2008 of ARVs purchased in 16 countries by PEPFAR implementing and procurement partners (organizations using PEPFAR funding to purchase ARVs). Main Outcome Measures Drug expenditures, ARV types and volumes (assessed per pack, a 1-month supply), proportion of generic procurement across years and countries, and cost savings from generic procurement. Results ARV expenditures increased from $116.8 million (2005) to $202.2 million (2008); and procurement increased from 6.2 million to 22.1 million monthly packs. The proportion spent on generic ARVs increased from 9.17% (95% confidence interval [CI], 9.17%-9.18%) in 2005 to 76.41% (95% CI, 76.41%-76.42%) in 2008 (P<.001), and the proportion of generic packs procured increased from 14.8% (95% CI, 14.79%-14.84%) in 2005 to 89.33% (95% CI, 89.32%-89.34%) in 2008 (P similar to. 001). In 2008, there were 8 PEPFAR programs that procured at least 90.0% of ARV packs in generic form; South Africa had the lowest generic procurement (24.7%; 95% CI, 24.6%-24.8%). Procurement of generic fixed-dose combinations increased from 33.3% (95% CI, 33.24%-33.43%) in 2005 to 42.73% (95% CI, 42.71%-42.75%) in 2008. Estimated yearly savings generated through generic ARV use were $8 108 444 in 2005, $24 940 014 in 2006, $75 645 816 in 2007, and $214 648 982 in 2008, a total estimated savings of $323 343 256. Conclusion Among PEPFAR-supported programs in 16 countries, availability of generic ARVs was associated with increased ARV procurement and substantial estimated cost savings. JAMA. 2010;304(3):313-320 www.jama.com	[Holmes, Charles B.; Coggin, William; Granich, Reuben; Ryan, Caroline; Moloney-Kitts, Michele; Goosby, Eric P.; Dybul, Mark] US Dept State, Off US Global AIDS Coordinator, Washington, DC 20522 USA; [Jamieson, David; Savio, Phillip] Supply Chain Management Syst, Arlington, VA USA; [Mihm, Heidi; Hope, Michael] US Agcy Int Dev, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Holmes, CB (corresponding author), US Dept State, Off US Global AIDS Coordinator, 2100 Penn Ave, Washington, DC 20522 USA.	holmescb@state.gov			US government	US government	This study was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) of the US government.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; El-Khatib Z, 2009, SAMJ S AFR MED J, V99, P412; Ford N, 2008, S AFR J HIV MED, P8; Husain M, 2009, INDIAN J CHEM B, V48, P1174; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; *MIN HLTH ZAMB, ANT THER CHRON HIV I; MSF Campaign for Access to Essential Medicines, UNT WEB ANT PRIC RED; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; *SUPPL CHAIN MAN S, US; US Food and Drug Administration, PRES EM PLAN AIDS RE; *US PRES PLAN AIDS, 2008, REP C US GLOB AIDS C; *US PRES PLAN AIDS, WORLD AIDS DAY 2009; *WHO, WHO HLTH SYST SERV P; World Health Organization, 2009, RAP ADV ANT THER HIV	16	66	66	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					313	320		10.1001/jama.2010.993	http://dx.doi.org/10.1001/jama.2010.993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639565	Bronze			2022-12-28	WOS:000280107500021
J	Lamont, T; Dougall, A; Johnson, S; Mathew, D; Scarpello, J; Morris, E				Lamont, Tara; Dougall, Anita; Johnson, Sara; Mathew, Dinah; Scarpello, John; Morris, Edward			Safety Alerts Reducing the risk of retained swabs after vaginal birth: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							INSTRUMENTS		[Lamont, Tara; Dougall, Anita; Johnson, Sara; Mathew, Dinah; Scarpello, John] Natl Patient Safety Agcy, London, England; [Morris, Edward] Norfolk & Norwich Univ Hosp, Norfolk, VA USA		Lamont, T (corresponding author), Natl Patient Safety Agcy, London, England.	tara.lamont@npsa.nhs.uk						*ASS PRE PRACT, 2007, SWAB INSTR NEEDL COU; Egorova NN, 2008, ANN SURG, V247, P13, DOI 10.1097/SLA.0b013e3180f633be; Gawande AA, 2003, NEW ENGL J MED, V348, P229, DOI 10.1056/NEJMsa021721; *I CLIN SYST IMPR, 2009, PREV UN RET FOR OBJ; National Institute for Health and Clinical Excellence, 2007, INTR CAR CAR HLTH WO	5	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2010	341								c3679	10.1136/bmj.c3679	http://dx.doi.org/10.1136/bmj.c3679			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GU	20643710				2022-12-28	WOS:000280411500001
J	Kondo, T; Plaza, S; Zanet, J; Benrabah, E; Valenti, P; Hashimoto, Y; Kobayashi, S; Payre, F; Kageyama, Y				Kondo, T.; Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Hashimoto, Y.; Kobayashi, S.; Payre, F.; Kageyama, Y.			Small Peptides Switch the Transcriptional Activity of Shavenbaby During Drosophila Embryogenesis	SCIENCE			English	Article							POLYCISTRONIC MESSENGER-RNA; OPEN READING FRAMES; EPIDERMIS DIFFERENTIATION; GENOME; IDENTIFICATION; MORPHOGENESIS; EVOLUTION; GENES	A substantial proportion of eukaryotic transcripts are considered to be noncoding RNAs because they contain only short open reading frames (sORFs). Recent findings suggest, however, that some sORFs encode small bioactive peptides. Here, we show that peptides of 11 to 32 amino acids encoded by the polished rice (pri) sORF gene control epidermal differentiation in Drosophila by modifying the transcription factor Shavenbaby (Svb). Pri peptides trigger the amino-terminal truncation of the Svb protein, which converts Svb from a repressor to an activator. Our results demonstrate that during Drosophila embryogenesis, Pri sORF peptides provide a strict temporal control to the transcriptional program of epidermal morphogenesis.	[Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Payre, F.] Univ Toulouse 3, Univ Toulouse, Ctr Dev Biol, F-31062 Toulouse, France; [Kondo, T.; Hashimoto, Y.; Kobayashi, S.; Kageyama, Y.] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan; [Kondo, T.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Payre, F.] CBD, CNRS, UMR 5547, F-31062 Toulouse, France; [Kobayashi, S.] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Hashimoto, Y.; Kageyama, Y.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Nara Institute of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST)	Payre, F (corresponding author), Univ Toulouse 3, Univ Toulouse, Ctr Dev Biol, Batiment 4R3,118 Route Narbonne, F-31062 Toulouse, France.	payre@cict.fr; kageyama@nibb.ac.jp	plaza, serge/F-5290-2015	Kondo, Takefumi/0000-0001-8127-1141; PAYRE, Francois/0000-0002-8144-6711	Japan Society for the Promotion of Science; JST; Ministry of Education, Culture, Sports, Science and Technology [20370091]; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer [1111]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank the Kyoto Drosophila Genetic Resource Center (DGRC); Bloomington Drosophila Stock Center for fly strains; the Indiana DGRC; G. Patterson, J. Lippincott-Schwartz, and C. Hill for plasmids; S. Takada and T. Okubo (NIBB) for technical advice; Y. Latapie and B. Ronsin (CBD) and J. D'Alayer (Institut Pasteur) for excellent technical assistance; and members of the Kobayashi laboratory for helpful comments and discussion. This work was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science; the JST PRESTO program; the Ministry of Education, Culture, Sports, Science and Technology KAKENHI (20370091); Agence Nationale de la Recherche (Programme Blanc "Netoshape"); Fondation pour la Recherche Medicale (Equipe 2005); and Association pour la Recherche sur le Cancer (1111).	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Andrews J, 2000, DEVELOPMENT, V127, P881; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Hashimoto Y, 2008, DEV GROWTH DIFFER, V50, pS269, DOI 10.1111/j.1440-169X.2008.00994.x; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102	21	238	257	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					336	339		10.1126/science.1188158	http://dx.doi.org/10.1126/science.1188158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647469				2022-12-28	WOS:000279925900046
J	Onose, Y; Ideue, T; Katsura, H; Shiomi, Y; Nagaosa, N; Tokura, Y				Onose, Y.; Ideue, T.; Katsura, H.; Shiomi, Y.; Nagaosa, N.; Tokura, Y.			Observation of the Magnon Hall Effect	SCIENCE			English	Article							LIGHT	The Hall effect usually occurs in conductors when the Lorentz force acts on a charge current in the presence of a perpendicular magnetic field. Neutral quasi-particles such as phonons and spins can, however, carry heat current and potentially exhibit the thermal Hall effect without resorting to the Lorentz force. We report experimental evidence for the anomalous thermal Hall effect caused by spin excitations (magnons) in an insulating ferromagnet with a pyrochlore lattice structure. Our theoretical analysis indicates that the propagation of the spin waves is influenced by the Dzyaloshinskii-Moriya spin-orbit interaction, which plays the role of the vector potential, much as in the intrinsic anomalous Hall effect in metallic ferromagnets.	[Onose, Y.; Ideue, T.; Shiomi, Y.; Nagaosa, N.; Tokura, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Onose, Y.; Tokura, Y.] Univ Tokyo, Multiferro Project, Japan Sci & Technol Agcy, Dept Appl Phys, Tokyo 1138656, Japan; [Katsura, H.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Shiomi, Y.; Nagaosa, N.; Tokura, Y.] RIKEN, Adv Sci Inst, Correlated Elect Res Grp, Wako, Saitama 3510198, Japan; [Shiomi, Y.; Nagaosa, N.; Tokura, Y.] RIKEN, Cross Correlated Mat Res Grp, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of California System; University of California Santa Barbara; RIKEN; RIKEN	Onose, Y (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.	onose@ap.t.u-tokyo.ac.jp	Onose, Yoshinori/F-1977-2010; Katsura, Hosho/G-8186-2017; Shiomi, Yuki/C-3853-2012; Ideue, Toshiya/D-2782-2017; Tokura, Yoshinori/C-7352-2009; Nagaosa, Naoto/G-7057-2012	Onose, Yoshinori/0000-0002-8398-2956; Katsura, Hosho/0000-0003-4887-2134; Ideue, Toshiya/0000-0002-5798-2522; Tokura, Yoshinori/0000-0002-2732-4983; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [17071007, 17071005, 19048008, 19048015, 19684011, 20046004, 20340086, 21244053, 22014003]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), Japan	The authors thank C. Terakura for the design of Fig. 1C and P. A. Lee, S. Fujimoto, and T. Arima for fruitful discussion. This work is supported by a Grant-in-Aid for Scientific Research (nos. 17071007, 17071005, 19048008, 19048015, 19684011, 20046004, 20340086, 21244053, and 22014003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), Japan.	Cheng JG, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087205; Chern GW, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.060405; Fujimoto S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.047203; GUILLOT M, 1985, J PHYS C SOLID STATE, V18, P3547, DOI 10.1088/0022-3719/18/18/018; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Ichikawa H, 2005, J PHYS SOC JPN, V74, P1020, DOI 10.1143/JPSJ.74.1020; Kagan Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.145902; KATO YK, 1910, SCIENCE, V306, P2004; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Katsura H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066403; Maekawa S., 2006, CONCEPTS SPIN ELECT; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Rikken GLJA, 1996, NATURE, V381, P54, DOI 10.1038/381054a0; Sheng L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.155901; Strohm C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155901; Zhou HD, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.020411	17	411	414	11	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					297	299		10.1126/science.1188260	http://dx.doi.org/10.1126/science.1188260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647460	Green Submitted			2022-12-28	WOS:000279925900033
J	Schellart, WP; Stegman, DR; Farrington, RJ; Freeman, J; Moresi, L				Schellart, W. P.; Stegman, D. R.; Farrington, R. J.; Freeman, J.; Moresi, L.			Cenozoic Tectonics of Western North America Controlled by Evolving Width of Farallon Slab	SCIENCE			English	Article							PLATE BOUNDARY; SUBDUCTION; EVOLUTION; MANTLE; CONSTRAINTS; MODELS; BASIN; ZONE; AGE	Subduction of oceanic lithosphere occurs through two modes: subducting plate motion and trench migration. Using a global subduction zone data set and three-dimensional numerical subduction models, we show that slab width (W) controls these modes and the partitioning of subduction between them. Subducting plate velocity scales with W-2/3, whereas trench velocity scales with 1/W. These findings explain the Cenozoic slowdown of the Farallon plate and the decrease in subduction partitioning by its decreasing slab width. The change from Sevier-Laramide orogenesis to Basin and Range extension in North America is also explained by slab width; shortening occurred during wide-slab subduction and overriding-plate-driven trench retreat, whereas extension occurred during intermediate to narrow-slab subduction and slab-driven trench retreat.	[Schellart, W. P.; Moresi, L.] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; [Stegman, D. R.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Stegman, D. R.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Farrington, R. J.; Freeman, J.; Moresi, L.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Freeman, J.] Bur Meteorol, Melbourne, Vic 3001, Australia	Monash University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Melbourne; Monash University; Bureau of Meteorology - Australia	Schellart, WP (corresponding author), Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia.	wouter.schellart@monash.edu	Stegman, Dave/F-5794-2010; Moresi, Louis/H-1390-2011	Stegman, Dave/0000-0001-8012-6145; Moresi, Louis/0000-0003-3685-174X; Farrington, Rebecca/0000-0002-2594-6965; Schellart, Wouter/0000-0002-9802-0143	National Computational Infrastructure National Facility at the Australian National University; Australian Research Council [DP0771823]; Monash University; Australian Academy of Science; University of Melbourne; G. Unger Vetlesen Foundation;  [DP0878501]	National Computational Infrastructure National Facility at the Australian National University; Australian Research Council(Australian Research Council); Monash University(Monash University); Australian Academy of Science; University of Melbourne(University of Melbourne); G. Unger Vetlesen Foundation; 	We appreciate discussions and interactions with R. Kerr, R. Govers, F. Capitanio, S. Zlotnik, M. Sandiford, R. Griffiths, and R. Weinberg. We thank the Victorian Partnership for Advanced Computing, the National Computational Infrastructure, and AuScope for computational resources and technical support. This work was supported by an award under the Merit Allocation Scheme on the National Computational Infrastructure National Facility at the Australian National University. W. P. S. was supported by a QE II Fellowship and Discovery grant DP0771823 from the Australian Research Council, a Monash Fellowship from Monash University, and a J. G. Russell Award from the Australian Academy of Science. D. R. S. was supported in part by a Centenary Research Fellowship from the University of Melbourne and in part by the G. Unger Vetlesen Foundation. L. M. and R. J. F. were supported by Discovery grant DP0878501.	Atwater T., 1970, GEOL SOC AM BULL, V81, P3513, DOI [DOI 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2, 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2]; BUCK WR, 1991, J GEOPHYS RES-SOL EA, V96, P20161, DOI 10.1029/91JB01485; Capitanio FA, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002348; CARLSON RL, 1983, GEOPHYS RES LETT, V10, P297, DOI 10.1029/GL010i004p00297; DeCelles PG, 2004, AM J SCI, V304, P105, DOI 10.2475/ajs.304.2.105; Di Giuseppe E, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001776; DICKINSON WR, 1979, J GEOL, V87, P609, DOI 10.1086/628456; Flesch LM, 2000, SCIENCE, V287, P834, DOI 10.1126/science.287.5454.834; FORSYTH D, 1975, GEOPHYS J ROY ASTR S, V43, P163, DOI 10.1111/j.1365-246X.1975.tb00631.x; Goes S, 2008, NATURE, V451, P981, DOI 10.1038/nature06691; GORDON RG, 1986, J GEOPHYS RES-SOLID, V91, P2389, DOI 10.1029/JB091iB12p12389; JARRARD RD, 1986, REV GEOPHYS, V24, P217, DOI 10.1029/RG024i002p00217; KERR RC, 1991, J GEOL, V99, P457, DOI 10.1086/629506; Kincaid C, 2003, NATURE, V425, P58, DOI 10.1038/nature01923; Kreemer C, 2007, GEOLOGY, V35, P943, DOI 10.1130/G23868A.1; Long MD, 2008, SCIENCE, V319, P315, DOI 10.1126/science.1150809; MOLNAR P, 1978, EARTH PLANET SC LETT, V41, P330, DOI 10.1016/0012-821X(78)90187-5; Moresi L, 1996, EARTH PLANET SC LETT, V138, P15, DOI 10.1016/0012-821X(95)00221-W; Morra G, 2006, GEOLOGY, V34, P877, DOI 10.1130/G22462.1; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Schellart WP, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001656; Schellart WP, 2007, NATURE, V446, P308, DOI 10.1038/nature05615; Schellart WP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB002970; Sonder LJ, 1999, ANNU REV EARTH PL SC, V27, P417, DOI 10.1146/annurev.earth.27.1.417; Stegman DR, 2010, TECTONOPHYSICS, V483, P29, DOI 10.1016/j.tecto.2009.08.041; Stegman DR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001056; Zandt G, 2008, GEOLOGY, V36, P295, DOI 10.1130/G24611A.1	28	66	67	5	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					316	319		10.1126/science.1190366	http://dx.doi.org/10.1126/science.1190366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647465				2022-12-28	WOS:000279925900039
J	Mariotti, P; Nociti, V; Stefanini, MC; Frisullo, G; De Rosa, G; Colosimo, C; Batocchi, AP				Mariotti, Paolo; Nociti, Viviana; Stefanini, Maria Chiara; Frisullo, Giovanni; De Rosa, Gabriella; Colosimo, Cesare; Batocchi, Anna Paola			Pneumonia's link with the head and heart	LANCET			English	Editorial Material							MANIFESTATIONS; PATHOGENESIS		[Nociti, Viviana; Frisullo, Giovanni; Batocchi, Anna Paola] Catholic Univ, Inst Neurol, Dept Neurosci, I-00167 Rome, Italy; [Mariotti, Paolo; Stefanini, Maria Chiara] Catholic Univ, Inst Pediat, Unit Child Neuropsychiat, I-00167 Rome, Italy; [De Rosa, Gabriella] Catholic Univ, Dept Med & Surg Pediat Sci, I-00167 Rome, Italy; [Colosimo, Cesare] Catholic Univ, Inst Radiol, Dept Bioimaging & Radiol Sci, I-00167 Rome, Italy; [Nociti, Viviana; Stefanini, Maria Chiara] Don Carlo Gnocchi Fdn, Milan, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Don Carlo Gnocchi Onlus	Batocchi, AP (corresponding author), Catholic Univ, Inst Neurol, Dept Neurosci, Largo Gemelli 8, I-00167 Rome, Italy.		Nociti, Viviana/T-5022-2019; Nociti, Viviana/Z-2441-2019; Frisullo, Giovanni/ABC-7406-2021	Frisullo, Giovanni/0000-0002-1604-6594; DE ROSA, Gabriella/0000-0002-8780-5105				Dale RC, 2002, DEV MED CHILD NEUROL, V44, P485; Guilherme L, 2007, SCAND J IMMUNOL, V66, P199, DOI 10.1111/j.1365-3083.2007.01974.x; Narita M, 2010, J INFECT CHEMOTHER, V16, P162, DOI 10.1007/s10156-010-0044-x; Narita M, 2009, PEDIATR NEUROL, V41, P159, DOI 10.1016/j.pediatrneurol.2009.04.012; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005	5	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					388	388		10.1016/S0140-6736(10)60711-8	http://dx.doi.org/10.1016/S0140-6736(10)60711-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20674721				2022-12-28	WOS:000280717900036
J	Daniel, JA; Santos, MA; Wang, ZB; Zang, CZ; Schwab, KR; Jankovic, M; Filsuf, D; Chen, HT; Gazumyan, A; Yamane, A; Cho, YW; Sun, HW; Ge, K; Peng, WQ; Nussenzweig, MC; Casellas, R; Dressler, GR; Zhao, KJ; Nussenzweig, A				Daniel, Jeremy A.; Santos, Margarida Almeida; Wang, Zhibin; Zang, Chongzhi; Schwab, Kristopher R.; Jankovic, Mila; Filsuf, Darius; Chen, Hua-Tang; Gazumyan, Anna; Yamane, Arito; Cho, Young-Wook; Sun, Hong-Wei; Ge, Kai; Peng, Weiqun; Nussenzweig, Michel C.; Casellas, Rafael; Dressler, Gregory R.; Zhao, Keji; Nussenzweig, Andre			PTIP Promotes Chromatin Changes Critical for Immunoglobulin Class Switch Recombination	SCIENCE			English	Article							LYSINE-4 METHYLTRANSFERASE COMPLEX; CYTIDINE DEAMINASE AID; RNA-POLYMERASE-II; BRCT-DOMAIN; HISTONE MODIFICATIONS; CHROMOSOME BREAKS; PROTEIN PTIP; DNA-DAMAGE; TRANSCRIPTION; METHYLATION	Programmed genetic rearrangements in lymphocytes require transcription at antigen receptor genes to promote accessibility for initiating double-strand break (DSB) formation critical for DNA recombination and repair. Here, we showed that activated B cells deficient in the PTIP component of the MLL3 (mixed-lineage leukemia 3)-MLL4 complex display impaired trimethylation of histone 3 at lysine 4 (H3K4me3) and transcription initiation of downstream switch regions at the immunoglobulin heavy-chain (Igh) locus, leading to defective immunoglobulin class switching. We also showed that PTIP accumulation at DSBs contributes to class switch recombination (CSR) and genome stability independently of Igh switch transcription. These results demonstrate that PTIP promotes specific chromatin changes that control the accessibility of the Igh locus to CSR and suggest a nonredundant role for the MLL3-MLL4 complex in altering antibody effector function.	[Daniel, Jeremy A.; Santos, Margarida Almeida; Filsuf, Darius; Chen, Hua-Tang; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Wang, Zhibin; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Schwab, Kristopher R.; Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Jankovic, Mila; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Jankovic, Mila; Gazumyan, Anna; Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA; [Yamane, Arito; Casellas, Rafael] NIAMSD NIAMS, Bethesda, MD 20892 USA; [Cho, Young-Wook; Ge, Kai] NIDDKD, Nucl Receptor Biol Sect, CEB, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; University of Michigan System; University of Michigan; Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Zang, Chongzhi/D-1445-2011; Yamane, Arito/A-2959-2013; Ge, Kai/H-2810-2019; Daniel, Jeremy/S-4729-2016; Santos, Margarida/GWR-2285-2022; /AAI-2516-2019; Cho, Young-Wook/F-8269-2011; Nussenzweig, Michel/AAE-7292-2019	Zang, Chongzhi/0000-0003-4812-3627; Ge, Kai/0000-0002-7442-5138; Daniel, Jeremy/0000-0002-1981-5571; Peng, Weiqun/0000-0001-5521-9091; Schwab, Kristopher/0000-0001-8056-1817	NIH, National Cancer Institute, and Center for Cancer Research; National Heart, Lung, and Blood Institute; NIH; NATIONAL CANCER INSTITUTE [ZIABC010959, ZICBC009255, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006030, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041149, ZICAR041181, ZIHAR041173, ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, ZIADK047055] Funding Source: NIH RePORTER	NIH, National Cancer Institute, and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Gutierrez-Cruz, V. Sartorelli, M. Kruhlak, K. Cui, and Q. Tang for technical assistance. This work was supported by funding from the Intramural Research Program of the NIH, National Cancer Institute, and Center for Cancer Research to A.N.; the Division of Intramural Research at the National Heart, Lung, and Blood Institute to K.Z.; and an NIH Director's Challenge Award on "Epigenomic regulation of mammalian development and differentiation" to A.N., K.Z., and R.C. M.C.N. is a Howard Hughes Medical Institute investigator. The authors declare no competing financial interests and apologize for not being able to cite all primary references due to space limitations. All sequence data have been deposited in the Gene Expression Omnibus database (accession number GSE20852) at http://ncbi.nlm.nih.gov/geo/.	Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Fang M, 2009, DEVELOPMENT, V136, P1929, DOI 10.1242/dev.026559; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wang X, 2010, GENES CELLS, V15, P243, DOI 10.1111/j.1365-2443.2009.01379.x; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067	39	104	108	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					917	923		10.1126/science.1187942	http://dx.doi.org/10.1126/science.1187942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20671152	Green Accepted			2022-12-28	WOS:000281084800027
J	Roeb, M; Muller-Steinhagen, H				Roeb, Martin; Mueller-Steinhagen, Hans			Concentrating on Solar Electricity and Fuels	SCIENCE			English	Editorial Material							HYDROGEN-PRODUCTION; THERMOCHEMICAL CYCLES		[Roeb, Martin; Mueller-Steinhagen, Hans] Deutsch Zentrum Luft & Raumfahrt, Inst Tech Thermodynam, D-51147 Cologne, Germany	Helmholtz Association; German Aerospace Centre (DLR)	Roeb, M (corresponding author), Deutsch Zentrum Luft & Raumfahrt, Inst Tech Thermodynam, D-51147 Cologne, Germany.	Martin.Roeb@dlr.de; Hans.Mueller-Steinhagen@dlr.de		Roeb, Martin/0000-0002-9813-5135				DESERTEC Foundation, 2009, CLEAN POW DES; Diver RB, 2008, J SOL ENERG-T ASME, V130, DOI 10.1115/1.2969781; *DTSCH ZENTR LUFT, TRANSM INT CONC SOL; *DTSCH ZENTR LUFT, CONC SOL POW MED REG; FORNASIERO P, 1995, J CATAL, V151, P168, DOI 10.1006/jcat.1995.1019; Fresno F, 2009, INT J HYDROGEN ENERG, V34, P2918, DOI 10.1016/j.ijhydene.2009.02.020; Kaneko H, 2007, ENERG FUEL, V21, P2287, DOI 10.1021/ef060581z; Kodama T, 2008, SOL ENERGY, V82, P73, DOI 10.1016/j.solener.2007.03.005; Kodama T, 2007, CHEM REV, V107, P4048, DOI 10.1021/cr050188a; Lorentzou S, 2009, J ALLOY COMPD, V483, P302, DOI 10.1016/j.jallcom.2008.08.131; Miller JE, 2008, J MATER SCI, V43, P4714, DOI 10.1007/s10853-007-2354-7; ROEB M, 2010, SOL ENERGY; Solar Millenium, 2008, PAR TROUGH POW PLANT; [No title captured]; [No title captured]	15	47	53	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					773	774		10.1126/science.1191137	http://dx.doi.org/10.1126/science.1191137			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705841				2022-12-28	WOS:000280809900027
J	Jackson, MG; Carlson, RW; Kurz, MD; Kempton, PD; Francis, D; Blusztajn, J				Jackson, Matthew G.; Carlson, Richard W.; Kurz, Mark D.; Kempton, Pamela D.; Francis, Don; Blusztajn, Jerzy			Evidence for the survival of the oldest terrestrial mantle reservoir	NATURE			English	Article							HIGH HE-3/HE-4; GEOCHEMICAL EVOLUTION; OCEANIC BASALTS; HELIUM; ND; PICRITES; ICELAND; OLIVINE; ISLAND; PB	Helium is a powerful tracer of primitive material in Earth's mantle. Extremely high He-3/He-4 ratios in some ocean-island basalts suggest the presence of relatively undegassed and undifferentiated material preserved in Earth's mantle. However, terrestrial lavas with high He-3/He-4 ratios have never been observed to host the primitive lead-isotopic compositions that are required for an early (roughly 4.5 Gyr ago) formation age(1,2). Here we show that Cenozoic-era Baffin Island and West Greenland lavas, previously found to host the highest terrestrial-mantle He-3/He-4 ratios(3-5), exhibit primitive lead-isotope ratios that are consistent with an ancient mantle source age of 4.55-4.45 Gyr. The Baffin Island and West Greenland lavas also exhibit Nd-143/Nd-144 ratios similar to values recently proposed for an early-formed (roughly 4.5 Gyr ago) terrestrial mantle reservoir(6,7). The combined helium-, lead- and Nd-isotopic compositions in Baffin Island and West Greenland lavas therefore suggest that their source is the most ancient accessible reservoir in the Earth's mantle, and it may be parental to all mantle reservoirs that give rise to modern volcanism.	[Jackson, Matthew G.] Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; [Jackson, Matthew G.; Carlson, Richard W.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Kurz, Mark D.] Woods Hole Oceanog Inst, Dept Marine Chem, Woods Hole, MA 02543 USA; [Kempton, Pamela D.] NERC, Swindon SN2 1EU, Wilts, England; [Francis, Don] McGill Univ, Montreal, PQ H3A 2A7, Canada; [Blusztajn, Jerzy] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Boston University; Carnegie Institution for Science; Woods Hole Oceanographic Institution; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); McGill University; Woods Hole Oceanographic Institution	Jackson, MG (corresponding author), Boston Univ, Dept Earth Sci, 675 Commonwealth Ave, Boston, MA 02215 USA.	jacksonm@bu.edu		Kurz, Mark/0000-0003-1745-2356	Carnegie postdoctoral fellowship	Carnegie postdoctoral fellowship	M.G.J. acknowledges his Carnegie postdoctoral fellowship. We also thank J. P. Brandenburg, J. Day, D. Graham, S. Hart, E. Hauri, C. Herzberg, L. Larsen, N. Shimizu, S. Shirey and P. Van Keken for discussions. We thank J. Curtice for assistance in the laboratory. Reviews from Al Hofmann improved the manuscript. The Ocean Sciences Section of the National Science Foundation partially supported the helium measurements at the Woods Hole Oceanographic Institution.	Albarede F, 2008, SCIENCE, V319, P943, DOI 10.1126/science.1150060; Andreasen R, 2008, EARTH PLANET SC LETT, V266, P14, DOI 10.1016/j.epsl.2007.10.009; Arevalo R, 2009, EARTH PLANET SC LETT, V278, P361, DOI 10.1016/j.epsl.2008.12.023; Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2010, EARTH PLANET SC LETT, V291, P172, DOI 10.1016/j.epsl.2010.01.010; Brandenburg JP, 2008, EARTH PLANET SC LETT, V276, P1, DOI 10.1016/j.epsl.2008.08.027; Carlson RW, 2008, PHILOS T R SOC A, V366, P4077, DOI 10.1098/rsta.2008.0166; Caro G, 2010, GEOCHIM COSMOCHIM AC, V74, P3333, DOI 10.1016/j.gca.2010.02.025; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Dale CW, 2009, EARTH PLANET SC LETT, V278, P267, DOI 10.1016/j.epsl.2008.12.014; DELEEUW GAM, 2010, GEOPH RES ABSTR, V12; FARLEY KA, 1992, EARTH PLANET SC LETT, V111, P183, DOI 10.1016/0012-821X(92)90178-X; FRANCIS D, 1985, CONTRIB MINERAL PETR, V89, P144, DOI 10.1007/BF00379449; Geiss J, 2004, SPACE SCI REV, V110, P307, DOI 10.1023/B:SPAC.0000023409.54469.40; Gonnermann HM, 2009, NATURE, V459, P560, DOI 10.1038/nature08018; Graham DW, 1998, EARTH PLANET SC LETT, V160, P241, DOI 10.1016/S0012-821X(98)00083-1; Hanan BB, 1996, SCIENCE, V272, P991, DOI 10.1126/science.272.5264.991; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; Herzberg C, 2009, NATURE, V458, P619, DOI 10.1038/nature07857; Hilton DR, 1999, EARTH PLANET SC LETT, V173, P53, DOI 10.1016/S0012-821X(99)00215-0; HOFMANN AW, 1986, EARTH PLANET SC LETT, V79, P33, DOI 10.1016/0012-821X(86)90038-5; HOFMANN AW, 1983, Z NATURFORSCH A, V38, P256; Jackson MG, 2007, EARTH PLANET SC LETT, V264, P360, DOI 10.1016/j.epsl.2007.09.023; KELEMEN PB, 2004, MONOGR AM GEOPHYS UN, V138, P223; Kempton PD, 2000, EARTH PLANET SC LETT, V177, P255, DOI 10.1016/S0012-821X(00)00047-9; Kent AJR, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000743; Kurz MD, 2009, EARTH PLANET SC LETT, V286, P23, DOI 10.1016/j.epsl.2009.06.008; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Larsen LM, 2000, J PETROL, V41, P1071, DOI 10.1093/petrology/41.7.1071; LARSEN LM, 2009, J PETROL, V1667, P1711; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Nowell GM, 1998, CHEM GEOL, V149, P211, DOI 10.1016/S0009-2541(98)00036-9; Parman SW, 2005, NATURE, V437, P1140, DOI 10.1038/nature04215; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Saal AE, 2007, EARTH PLANET SC LETT, V257, P391, DOI 10.1016/j.epsl.2007.02.040; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Starkey NA, 2009, EARTH PLANET SC LETT, V277, P91, DOI 10.1016/j.epsl.2008.10.007; Stuart FM, 2003, NATURE, V424, P57, DOI 10.1038/nature01711; Taylor S.R., 1985, GEOL, V94, P57, DOI DOI 10.1002/GJ.3350210116; Todt W., 1996, GEOPHYS MONOGR SER, V95, P429; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011	46	125	129	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					853	U84		10.1038/nature09287	http://dx.doi.org/10.1038/nature09287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703304				2022-12-28	WOS:000280766100033
J	Macilwain, C				Macilwain, Colin			Stitching Together Cross-border Research	CELL			English	Editorial Material																			0	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2010	142	3					347	349		10.1016/j.cell.2010.07.031	http://dx.doi.org/10.1016/j.cell.2010.07.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691889	Bronze			2022-12-28	WOS:000280609100005
J	Monti, MM; Laureys, S; Owen, AM				Monti, Martin M.; Laureys, Steven; Owen, Adrian M.			The vegetative state	BRITISH MEDICAL JOURNAL			English	Review							MINIMALLY CONSCIOUS STATE; SENSORY MODALITY ASSESSMENT; REHABILITATION TECHNIQUE; MEDICAL ASPECTS; BRAIN; DISORDERS; NEUROPATHOLOGY; MISDIAGNOSIS; DIAGNOSIS; ACCURACY		[Monti, Martin M.; Owen, Adrian M.] MRC Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium; [Laureys, Steven] Univ Liege, Dept Neurol, B-4000 Liege, Belgium	University of Liege; University of Liege	Monti, MM (corresponding author), MRC Cognit & Brain Sci Unit, Cambridge CB2 7EF, England.	martin.monti@mrc-cbu.cam.ac.uk	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Owen, Adrian M/B-4997-2015; Monti, Martin/G-8352-2011	Laureys, Steven/0000-0002-3096-3807; Monti, Martin/0000-0001-5511-3780	Medical Research Council [U.1055.01.002.00001.01, U.1055.01.002.00007.01]; European Commission; James S McDonnell Foundation; MRC [MC_U105559847, MC_EX_G0800771] Funding Source: UKRI; Medical Research Council [MC_EX_G0800771, MC_U105559847] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); James S McDonnell Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MMM had support from the Medical Research Council (U.1055.01.002.00001.01) and the European Commission (Deployment of Brain-Computer Interfaces for the Detection of Consciousness in Non-Responsive Patients) for the submitted work. AMO had support from the Medical Research Council (U.1055.01.002.00007.01 and U.1055.01.002.00001.01), the James S McDonnell Foundation and the European Commission (Deployment of Brain-Computer Interfaces for the Detection of Consciousness in Non-Responsive Patients) for the submitted work. SL had support from the James S McDonnell Foundation, the European Commission (Deployment of Brain-Computer Interfaces for the Detection of Consciousness in Non-Responsive Patients, Disorders and Coherence of the Embodied Self, Mindbridge, and Consciousness: A Transdisciplinary, Integrated Approach), Fonds de la Recherche Scientifique, the Mind Science Foundation, the Reine Elisabeth Medical Foundation, the Belgian French-Speaking Community Concerted Research Action, University Hospital of Liege, the University of Liege, and the National Institute for Health Research Biomedical research Centre (Neuroscience Theme); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2005, NAT REV NEUROSCI, V6, P899, DOI 10.1038/nrn1789; Laureys S, 2008, NAT CLIN PRACT NEURO, V4, P544, DOI 10.1038/ncpneuro0887; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Monti MM, 2009, ANN NY ACAD SCI, V1157, P81, DOI 10.1111/j.1749-6632.2008.04121.x; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Posner J.B., 2007, PLUM POSNERS DIAGNOS, V4th ed.; QIN P, HUMAN BRAIN IN PRESS; Royal College of Physicians, 2003, PERM VEG STAT GUID D; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35	30	137	142	2	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2010	341								c3765	10.1136/bmj.c3765	http://dx.doi.org/10.1136/bmj.c3765			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636WD	20679291	Green Submitted			2022-12-28	WOS:000280773500004
J	Milazzo, L; Antinori, S				Milazzo, Laura; Antinori, Spinello			STAT-C: a full revolution or just a step forward?	LANCET			English	Editorial Material							CHRONIC HEPATITIS-C; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; TELAPREVIR; INTERFERON-ALPHA-2B; VX-950		[Milazzo, Laura; Antinori, Spinello] Univ Milan, Dept Clin Sci L Sacco, Sect Infect Dis & Immunopathol, I-20157 Milan, Italy	University of Milan	Milazzo, L (corresponding author), Univ Milan, Dept Clin Sci L Sacco, Sect Infect Dis & Immunopathol, I-20157 Milan, Italy.		Antinori, Spinello/E-7936-2017	Antinori, Spinello/0000-0003-0569-9407				Forestier N, 2007, HEPATOLOGY, V46, P640, DOI 10.1002/hep.21774; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; KWO PY, 2010, LANCET, DOI DOI 10.1016/S1040-6736(10)60934-8; Lange CM, 2010, ALIMENT PHARM THER, V32, P14, DOI 10.1111/j.1365-2036.2010.04317.x; Lawitz E, 2008, J HEPATOL, V49, P163, DOI 10.1016/j.jhep.2008.03.027; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Schiff E, 2008, J HEPATOL, V48, pS46, DOI 10.1016/S0168-8278(08)60106-3; ZEUZEM S, 2008, HEPATOLOGY, V42, pS46	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2010	376	9742					662	663		10.1016/S0140-6736(10)61056-2	http://dx.doi.org/10.1016/S0140-6736(10)61056-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20692692				2022-12-28	WOS:000281582900006
J	Strathdee, SA; Hallett, TB; Bobrova, N; Rhodes, T; Booth, R; Abdool, R; Hankins, CA				Strathdee, Steffanie A.; Hallett, Timothy B.; Bobrova, Natalia; Rhodes, Tim; Booth, Robert; Abdool, Reychad; Hankins, Catherine A.			HIV in people who use drugs 1 HIV and risk environment for injecting drug users: the past, present, and future	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HARM REDUCTION PROGRAMS; HEPATITIS-C; SYRINGE EXCHANGE; SOCIAL EPIDEMIOLOGY; GENDER-DIFFERENCES; HIV/AIDS EPIDEMIC; SAN-FRANCISCO; VACCINE TRIAL; PUBLIC-HEALTH	We systematically reviewed reports about determinants of HIV infection in injecting drug users from 2000 to 2009, classifying findings by type of environmental influence. We then modelled changes in risk environments in regions with severe HIV epidemics associated with injecting drug use. Of 94 studies identified, 25 intentionally examined risk environments. Modelling of HIV epidemics showed substantial heterogeneity in the number of HIV infections that are attributed to injecting drug use and unprotected sex. We estimate that, during 2010-15, HIV prevalence could be reduced by 41% in Odessa (Ukraine), 43% in Karachi (Pakistan), and 30% in Nairobi (Kenya) through a 60% reduction of the unmet need of programmes for opioid substitution, needle exchange, and antiretroviral therapy. Mitigation of patient transition to injecting drugs from non-injecting forms could avert a 98% increase in HIV infections in Karachi; whereas elimination of laws prohibiting opioid substitution with concomitant scale-up could prevent 14% of HIV infections in Nairobi. Optimisation of effectiveness and coverage of interventions is crucial for regions with rapidly growing epidemics. Delineation of environmental risk factors provides a crucial insight into HIV prevention. Evidence-informed, rights-based, combination interventions protecting IDUs' access to HIV prevention and treatment could substantially curtail HIV epidemics.	[Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, London, England; [Bobrova, Natalia] UCL, London WC1E 6BT, England; [Rhodes, Tim] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England; [Booth, Robert] Univ Colorado Denver, Denver, CO USA; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS, Geneva, Switzerland	University of California System; University of California San Diego; Imperial College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Cuscó, Xavier Garcia/S-7576-2019; Hallett, Timothy/A-2390-2011; Strathdee, Steffanie A/B-9042-2009; Rhodes, Tim/DNJ-9679-2022	Cuscó, Xavier Garcia/0000-0001-7199-6931; Rhodes, Tim/0000-0003-2400-9838; Hallett, Timothy/0000-0002-9681-0424; Hankins, Catherine/0000-0002-1642-8592; Strathdee, Steffanie/0000-0002-7724-691X	US National Institute on Drug Abuse [DA027772-S1]; US Office of AIDS Research; The Wellcome Trust (UK); US NIH [RO1DA17620]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027772, R01DA017620] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US Office of AIDS Research; The Wellcome Trust (UK)(Wellcome Trust); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This report was funded by the US National Institute on Drug Abuse grant DA027772-S1, the US Office of AIDS Research, and The Wellcome Trust (UK). RB was supported by a US NIH grant (RO1DA17620). We thank Christy Anderson, Richard Armenta, Annick Borquez, Philippe Bourgois, David Celentano, Jessica Cubeta, Penny Coppernoll-Blach, Anna Dovbah, Faran Emmanuel, Samuel R Friedman, Micah Gell-Redman, Eleanor Gouws, Mauro Guarinieri, Peter Hartsock, Brian Houle, Francisco I Bastos, Natalia Kitsenko, Robert Malow, Bradley Mathers, Lisovska Oksana, Jane Marie Ongo'lo, Samiran Panda, Natalia Rehtina, Diana Rossi, Richard Rothenberg, Tatyana Saliuk, Oleg Semeryk, Ani Shakarishvili, Alexandra Thomas, Emily To, Lucas Wiessing, Daniel Wolfe, and Carl Latkin.	Agha A, 2006, J Pak Med Assoc, V56, pS55; Altaf Arshad, 2007, Harm Reduct J, V4, P7, DOI 10.1186/1477-7517-4-7; [Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2000, ACH BAL NAT OP CONTR; Azim T, 2008, SUBST USE MISUSE, V43, P2124, DOI 10.1080/10826080802344583; BALAKIREVA O, 2005, BEHAV MONITORING YOU; BALAKIREVA O, 2006, SITUATIONAL ANAL HIV; BALAKIREVA O, 2007, BEHAV MONITORING INJ; BALAKIREVA O, 2005, BEHAV MONITORING INJ; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; Barrio G, 2007, EPIDEMIOL INFECT, V135, P592, DOI 10.1017/S0950268806007266; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; Beyrer C, 2009, AIDS RES HUM RETROV, V25, P853, DOI 10.1089/aid.2008.0206; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Boileau C, 2005, JAIDS-J ACQ IMM DEF, V39, P489, DOI 10.1097/01.qai.0000153424.56379.61; Bokhari A, 2007, INT J STD AIDS, V18, P486, DOI 10.1258/095646207781147201; Booth RE, 2004, JAIDS-J ACQ IMM DEF, V35, P82, DOI 10.1097/00126334-200401010-00012; BOOTH RE, 2010, 16 C INT AIDS SOC VI; Booth RE, 2006, AIDS, V20, P2217, DOI 10.1097/QAD.0b013e328010e019; Booth RE, 2009, ADDICTION, V104, P1864, DOI 10.1111/j.1360-0443.2009.02660.x; Buavirat A, 2003, BRIT MED J, V326, P308, DOI 10.1136/bmj.326.7384.308; Burris S, 2006, AIDS, V20, P117, DOI 10.1097/01.aids.0000194806.81917.19; BURRIS S, 2009, BLUEPRINT REFORMING; March JC, 2007, ENFERM INFEC MICR CL, V25, P91, DOI 10.1157/13098569; Chitwood DD, 2003, J PSYCHOACTIVE DRUGS, V35, P445, DOI 10.1080/02791072.2003.10400491; Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012; de la Fuente L, 2006, J EPIDEMIOL COMMUN H, V60, P537, DOI 10.1136/jech.2005.037333; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Des Jarlais DC, 2007, AIDS, V21, P231, DOI 10.1097/QAD.0b013e3280114a15; Dewing S, 2006, DRUG-EDUC PREV POLIC, V13, P121, DOI 10.1080/09687630500480228; Diaz T, 2001, J WOMEN HEALTH GEN-B, V10, P371, DOI 10.1089/152460901750269698; Doherty MC, 2000, AIDS, V14, P717, DOI 10.1097/00002030-200004140-00011; *EHRN, 2009, YOUNG PEOPL INJ DRUG; Emmanuel F, 2008, INT J DRUG POLICY, V19, pS59, DOI 10.1016/j.drugpo.2007.12.012; Emmanuel F, 2009, JAIDS-J ACQ IMM DEF, V51, P85, DOI 10.1097/QAI.0b013e31819906f3; Estebanez P, 2001, EUR J EPIDEMIOL, V17, P573, DOI 10.1023/A:1014563303831; Estebanez PE, 2000, INT J EPIDEMIOL, V29, P734, DOI 10.1093/ije/29.4.734; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; GELMON L, 2009, UNAIDS KENYA HIV PRE; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Grassly N. C., 2003, International Journal of Drug Policy, V14, P25, DOI 10.1016/S0955-3959(02)00224-4; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hacker MA, 2005, SUBST USE MISUSE, V40, P99, DOI 10.1081/JA-200030511; Hankins C, 2002, J ACQ IMMUN DEF SYND, V30, P514, DOI 10.1097/00126334-200208150-00007; HARDING R, 2007, PAIN RELIEVING DRUGS; Hien NT, 2001, J SUBST ABUSE, V13, P45, DOI 10.1016/S0899-3289(01)00059-1; Hu DJ, 2002, J ACQ IMMUN DEF SYND, V30, P240, DOI [10.1097/00042560-200206010-00013, 10.1097/01.QAI.0000014770.35851.44]; ISRAILOV B, 2008, EPIDEMIOL INFECT DIS, V4, P8; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Jarlais DCD, 2009, AM J PUBLIC HEALTH, V99, pS445, DOI 10.2105/AJPH.2008.159327; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; KHEIRANDISH P, 2009, J ACQ IMMUN DEF SYND, V53, P273; Khuwaja A. K., 2007, SMJ Singapore Medical Journal, V48, P509; KOSHKINA EA, 2005, NARCOLOGIJA, V5, P16; Kral AH, 2003, AM J EPIDEMIOL, V157, P915, DOI 10.1093/aje/kwg070; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Latkin CA, 2003, SOC SCI MED, V56, P465, DOI 10.1016/S0277-9536(02)00047-3; Liu W, 2006, ADDICTION, V101, P1493, DOI 10.1111/j.1360-0443.2006.01557.x; Lopez-Zetina J, 2001, ADDICTION, V96, P589, DOI 10.1080/09652140020031638; Maas B, 2007, HEALTH PLACE, V13, P432, DOI 10.1016/j.healthplace.2006.05.005; Maslow CB, 2002, AM J PUBLIC HEALTH, V92, P382, DOI 10.2105/AJPH.92.3.382; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mayhew S, 2009, SEX TRANSM INFECT, V85, P31, DOI 10.1136/sti.2008.033670; Mehrabadi A, 2008, WOMEN HEALTH, V48, P235, DOI 10.1080/03630240802463186; Mesquita F, 2001, J ACQ IMMUN DEF SYND, V28, P298, DOI 10.1097/00042560-200111010-00016; Miller CL, 2006, SUBST USE MISUSE, V41, P199, DOI 10.1080/10826080500391795; *MIN HLTH UKR, 2008, NAT REP MON PROGR UN; National AIDS Control Program, 2008, HIV 2 GEN SURV PAK N; Neaigus A, 2008, J URBAN HEALTH, V85, P309, DOI 10.1007/s11524-008-9271-1; Niccolai LM, 2010, AIDS BEHAV, V14, P932, DOI 10.1007/s10461-008-9469-y; O'Connell JM, 2005, JAIDS-J ACQ IMM DEF, V40, P83, DOI 10.1097/01.qai.0000157006.28535.mL; ODEKOGUNDE M, 2003, P 14 INT C RED DRUG; Oelrichs RB, 2000, J VIROL, V74, P1149, DOI 10.1128/JVI.74.3.1149-1157.2000; Ouellet LJ, 2000, J ACQ IMMUN DEF SYND, V25, P443, DOI 10.1097/00126334-200012150-00010; *PAIN POL STUD GRO, 2007, INT NARC CONTR BOARD; Panda S, 2005, JAIDS-J ACQ IMM DEF, V39, P9, DOI 10.1097/01.qai.0000160713.94203.9b; Panda S, 2000, INT J STD AIDS, V11, P468, DOI 10.1258/0956462001916137; Parviz S, 2006, INT J INFECT DIS, V10, P364, DOI 10.1016/j.ijid.2005.07.010; Platt L, 2008, JAIDS-J ACQ IMM DEF, V47, P623, DOI 10.1097/QAI.0b013e318165dbf7; Platt L, 2006, AIDS, V20, P2120, DOI 10.1097/01.aids.0000247586.23696.20; POHORILA NB, 2008, ANAL REPORT BASED 20; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Reyes JC, 2005, J URBAN HEALTH, V82, P446, DOI 10.1093/jurban/jti073; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Rhodes T, 2006, ADDICTION, V101, P252, DOI 10.1111/j.1360-0443.2006.01317.x; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2002, AIDS, V16, pF25, DOI 10.1097/00002030-200209060-00002; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Rothenberg R, 2001, J URBAN HEALTH, V78, P419, DOI 10.1093/jurban/78.3.419; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Salmon AM, 2009, AUST NZ J PUBL HEAL, V33, P280, DOI 10.1111/j.1753-6405.2009.00389.x; Sanchez JL, 2006, DRUG ALCOHOL DEPEN, V82, pS15, DOI 10.1016/S0376-8716(06)80003-7; Santibanez SS, 2006, J URBAN HEALTH, V83, P86, DOI 10.1007/s11524-005-9009-2; Shafer KP, 2002, JAIDS-J ACQ IMM DEF, V31, P422, DOI 10.1097/00126334-200212010-00009; Spittal PM, 2007, INT J CIRCUMPOL HEAL, V66, P226, DOI 10.3402/ijch.v66i3.18259; Spittal PM, 2003, AIDS CARE, V15, P187, DOI 10.1080/0954012031000068335; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Stachowiak JA, 2006, DRUG ALCOHOL DEPEN, V82, pS7, DOI 10.1016/S0376-8716(06)80002-5; Stark K, 2006, EPIDEMIOL INFECT, V134, P814, DOI 10.1017/S0950268805005613; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690; Suntharasamai P, 2009, ADDICTION, V104, P235, DOI 10.1111/j.1360-0443.2008.02436.x; Tariq Zafar, 2002, International Journal of Drug Policy, V13, P121, DOI 10.1016/S0955-3959(02)00011-7; Tran TMT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-248; Tuan NA, 2007, B WORLD HEALTH ORGAN, V85, P35, DOI 10.2471/BLT.05.026153; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; *UN DRUG CONTR PRO, 2002, PROGR DRUG AB REP PA; *UNODC, 2004, STUD LINK DRUG AB IN; *UNODC, 2009, NAIR OUTR SERV TRUST; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vertefeuille J, 2002, J DRUG ISSUES, V32, P1125, DOI 10.1177/002204260203200408; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Vorobjov S, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-3; Welp EAE, 2002, AIDS, V16, P1279, DOI 10.1097/00002030-200206140-00011; *WHO REG OFF EUR, 2006, SEX TRANSM INF HIV A; *WHO UNAIDS UNICEF, 2009, SCAL PRIOR HIV AIDS; Williams ML, 2009, AIDS EDUC PREV, V21, P474, DOI 10.1521/aeap.2009.21.5.474; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2007, AM J MED, V120, P172, DOI 10.1016/j.amjmed.2006.02.030; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649; *WORLD BANK, 2006, INT HIV AIDS ALL UKR; World Health Organization, 2009, RAP ADV ANT THER HIV; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Zamani S, 2005, AIDS, V19, P709, DOI 10.1097/01.aids.0000166094.24069.72; Zamani S, 2006, JAIDS-J ACQ IMM DEF, V42, P342, DOI 10.1097/01.qai.0000219785.81163.67; Zhang L, 2008, TROP MED INT HEALTH, V13, P814, DOI 10.1111/j.1365-3156.2008.02071.x; Zhang YZ, 2007, INT J INFECT DIS, V11, P318, DOI 10.1016/j.ijid.2006.09.001; Zhang Y, 2007, J INFECTION, V54, P285, DOI 10.1016/j.jinf.2006.06.001; 2009, PREVENTION HIV AIDS	140	391	394	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					268	284		10.1016/S0140-6736(10)60743-X	http://dx.doi.org/10.1016/S0140-6736(10)60743-X			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650523	Green Accepted			2022-12-28	WOS:000280457200037
J	Shintani, F; Izumi, M				Shintani, Futoshi; Izumi, Masaki			Picture quiz Black legs	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEMORY DISORDER; CONFABULATION		[Shintani, Futoshi] Tokyo Musashino Hosp, Dept Neuropsychiat, Tokyo 170037, Japan; [Izumi, Masaki] Tokyo Musashino Hosp, Dept Internal Med, Tokyo 170037, Japan		Shintani, F (corresponding author), Tokyo Musashino Hosp, Dept Neuropsychiat, Tokyo 170037, Japan.	shintani@cmdlab.co.jp	Hug, Balthasar L./G-1568-2010					BERLYNE N, 1972, BRIT J PSYCHIAT, V120, P31, DOI 10.1192/bjp.120.554.31; Dab S, 1999, COGN NEUROPSYCHOL, V16, P215, DOI 10.1080/026432999380771; DANFORD DE, 1982, ANNU REV NUTR, V2, P303, DOI 10.1146/annurev.nu.02.070182.001511; ELLINGER P, 1947, NATURE, V160, P675, DOI 10.1038/160675b0; Gundogar D, 2007, TURK PSIKIYATR DERG, V18, P172; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; Koehn CJ, 1937, J BIOL CHEM, V118, P693; KOPELMAN MD, 1987, J NEUROL NEUROSUR PS, V50, P1482, DOI 10.1136/jnnp.50.11.1482; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Korsakoff SS, 1996, CONSCIOUS COGN, V5, P2, DOI 10.1006/ccog.1996.0002; Latham M.C., 1997, FOOD AGR ORG, V45, P123; MAIR WGP, 1979, BRAIN, V102, P749, DOI 10.1093/brain/102.4.749; Pitche Palokinam T, 2005, Sante, V15, P205; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; VICTOR M, 1971, WERNICKEKORSAKOFF SY; Zuccoli G, 2009, AM J ROENTGENOL, V192, P500, DOI 10.2214/AJR.07.3959	16	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3511	10.1136/bmj.c3511	http://dx.doi.org/10.1136/bmj.c3511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GW	20660006				2022-12-28	WOS:000280411700002
J	Dillner, J; Kjaer, SK; Wheeler, CM; Sigurdsson, K; Iversen, OE; Hernandez-Avila, M; Perez, G; Brown, DR; Koutsky, LA; Tay, EH; Garcia, P; Ault, KA; Garland, SM; Leodolter, S; Olsson, SE; Tang, GWK; Ferris, DG; Paavonen, J; Lehtinen, M; Steben, M; Bosch, FX; Joura, EA; Majewski, S; Munoz, N; Myers, ER; Villa, LL; Taddeo, FJ; Roberts, C; Tadesse, A; Bryan, JT; Maansson, R; Lu, SA; Vuocolo, S; Hesley, TM; Barr, E; Haupt, R				Dillner, Joakim; Kjaer, Susanne K.; Wheeler, Cosette M.; Sigurdsson, Kristjan; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Perez, Gonzalo; Brown, Darron R.; Koutsky, Laura A.; Tay, Eng Hseon; Garcia, Patricia; Ault, Kevin A.; Garland, Suzanne M.; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W. K.; Ferris, Daron G.; Paavonen, Jorma; Lehtinen, Matti; Steben, Marc; Bosch, F. Xavier; Joura, Elmar A.; Majewski, Slawomir; Munoz, Nubia; Myers, Evan R.; Villa, Luisa L.; Taddeo, Frank J.; Roberts, Christine; Tadesse, Amha; Bryan, Janine T.; Maansson, Roger; Lu, Shuang; Vuocolo, Scott; Hesley, Teresa M.; Barr, Eliav; Haupt, Richard		Future I II Study Grp	Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							EXTERNAL GENITAL WARTS; PARTICLE VACCINE; CLINICAL-TRIALS; INFECTION; LESIONS; HEALTH; CANCER; TERMINOLOGY; PREVENTION; MANAGEMENT	Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial neoplasias and anogenital warts (condyloma acuminata). Design Data from two international, double blind, placebo controlled, randomised efficacy trials of quadrivalent HPV vaccine (protocol 013 (FUTURE I) and protocol 015 (FUTURE II)). The trials were to be 4 years in length, and the results reported are from final study data of 42 months' follow-up. Setting Primary care centres and university or hospital associated health centres in 24 countries and territories around the world. Participants 17 622 women aged 16-26 years enrolled between December 2001 and May 2003. Major exclusion criteria were lifetime number of sexual partners (>4), history of abnormal cervical smear test results, and pregnancy. Intervention Three doses of quadrivalent HPV vaccine (for serotypes 6, 11, 16, and 18) or placebo at day 1, month 2, and month 6. Main outcome measures Vaccine efficacy against cervical, vulvar, and vaginal intraepithelial neoplasia grade I and condyloma in a per protocol susceptible population that included subjects who received all three vaccine doses, tested negative for the relevant vaccine HPV types at day 1 and remained negative through month 7, and had no major protocol violations. Intention to treat, generally HPV naive, and unrestricted susceptible populations were also studied. Results In the per protocol susceptible population, vaccine efficacy against lesions related to the HPV types in the vaccine was 96% for cervical intraepithelial neoplasia grade I (95% confidence interval 91% to 98%), 100% for both vulvar and vaginal intraepithelial neoplasia grade I (95% CIs 74% to 100%, 64% to 100% respectively), and 99% for condyloma (96% to 100%). Vaccine efficacy against any lesion (regardless of HPV type) in the generally naive population was 30% (17% to 41%), 75% (22% to 94%), and 48% (10% to 71%) for cervical, vulvar, and vaginal intraepithelial neoplasia grade I, respectively, and 83% (74% to 89%) for condyloma. Conclusions Quadrivalent HPV vaccine provided sustained protection against low grade lesions attributable to vaccine HPV types (6, 11, 16, and 18) and a substantial reduction in the burden of these diseases through 42 months of follow-up.	[Dillner, Joakim] Lund Univ, Dept Lab Med, SE-20502 Malmo, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Biostat, Stockholm, Sweden; [Kjaer, Susanne K.] Rigshosp, Danish Canc Soc, Inst Canc Epidemiol, Dept Virus Hormones & Canc, DK-2100 Copenhagen, Denmark; [Wheeler, Cosette M.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Wheeler, Cosette M.] Univ New Mexico, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; [Sigurdsson, Kristjan] Natl Canc Detect Clin, Reykjavik, Iceland; [Iversen, Ole-Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Iversen, Ole-Erik] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Hernandez-Avila, Mauricio] Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Perez, Gonzalo] Univ Rosario, Bogota, Colombia; [Brown, Darron R.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Koutsky, Laura A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Tay, Eng Hseon] KK Womens & Childrens Hosp, Singapore, Singapore; [Garcia, Patricia] Univ Peruana Cayetano Heredia, Epidemiol HIV & STD Unit, Lima, Peru; [Ault, Kevin A.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA; [Garland, Suzanne M.] Univ Melbourne, Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Leodolter, Sepp; Joura, Elmar A.] Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria; [Olsson, Sven-Eric] Danderyd Hosp, Karolinska Inst, Stockholm, Sweden; [Tang, Grace W. K.] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Ferris, Daron G.] Med Coll Georgia, Dept Family Med & Obstet & Gynecol, Augusta, GA 30912 USA; [Paavonen, Jorma] Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Lehtinen, Matti] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; [Steben, Marc] Inst Natl Sante Publ Quebec, Direct Risques Biol Environm & Occupat, Montreal, PQ, Canada; [Bosch, F. Xavier] IDIBELL, Inst Catala Oncol, Barcelona, Spain; [Majewski, Slawomir] Warsaw Med Univ, Ctr Diagnost & Treatment Sexually Transmitted Dis, Dept Dermatol & Venerol, Warsaw, Poland; [Munoz, Nubia] Natl Canc Inst, Bogota, Colombia; [Myers, Evan R.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Villa, Luisa L.] Ludwig Inst Canc Res, Dept Virol, Sao Paulo, Brazil; [Taddeo, Frank J.; Roberts, Christine; Tadesse, Amha; Bryan, Janine T.; Maansson, Roger; Lu, Shuang; Vuocolo, Scott; Hesley, Teresa M.; Barr, Eliav; Haupt, Richard] Merck Res Labs, West Point, PA USA	Lund University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danish Cancer Society; Rigshospitalet; University of Copenhagen; University of New Mexico; University of New Mexico; University of Bergen; University of Bergen; Haukeland University Hospital; Universidad del Rosario; Indiana University System; Indiana University-Purdue University Indianapolis; University of Washington; University of Washington Seattle; KK Women's & Children's Hospital; Universidad Peruana Cayetano Heredia; Emory University; University of Melbourne; University of Melbourne; Medical University of Vienna; Danderyds Hospital; Karolinska Institutet; University of Hong Kong; University System of Georgia; Augusta University; University of Helsinki; Helsinki University Central Hospital; Tampere University; Institut national de sante publique du Quebec (INSPQ); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Medical University of Warsaw; Duke University; Ludwig Institute for Cancer Research; Merck & Company	Dillner, J (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, SE-20502 Malmo, Sweden.	joakim.dillner@med.lu.se	VILLA, LUISA/AAH-4761-2019; Harper, Diane M./I-2180-2014; BOSCH JOSE, FRANCESC XAVIER/J-6339-2012	VILLA, LUISA/0000-0003-4074-2335; Harper, Diane M./0000-0001-7648-883X; BOSCH JOSE, FRANCESC XAVIER/0000-0002-7172-3412; Kjaer, Susanne/0000-0002-8347-1398; Bryan, Janine/0000-0002-4923-6247; Roberts, Christine/0000-0003-4359-7946; lehtinen, matti/0000-0002-9481-0535; Paavonen, Jorma/0000-0003-4775-606X; Steben, Marc/0000-0002-1136-3208	Merck Research Laboratories, a division of Merck Company; Merck Company; Sanofi Pasteur MSD; Commonwealth Serum Laboratories; GlaxoSmithKline	Merck Research Laboratories, a division of Merck Company(Merck & Company); Merck Company(Merck & Company); Sanofi Pasteur MSD; Commonwealth Serum Laboratories; GlaxoSmithKline(GlaxoSmithKline)	Merck Research Laboratories, a division of Merck & Company, funded these studies.; Role of the funding source: The studies were designed by the sponsor (Merck & Company) in collaboration with external investigators and an external data and safety monitoring board. The sponsor collated the data, monitored the conduct of the study, performed the statistical analysis, and coordinated the writing of the manuscript with all authors. The authors were actively involved in the collection, analysis, or interpretation of the data, the revising of the manuscript for intellectual content, and approved the final manuscript.; JD has received consultancy fees, lecture fees, and research grants from Merck & Company and Sanofi Pasteur MSD. SKK has received consultancy fees and has received funding through her institution to conduct HPV vaccine studies for Sanofi Pasteur MSD and Digene. SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, lecture fees from Merck & Company, and funding through her institution to conduct HPV vaccine studies for GlaxoSmithKline. CMW has received funding through her institution to conduct HPV vaccine studies for GlaxoSmithKline, and has received reagents and equipment from Roche Molecular Systems for HPV genotyping studies. KS has received consultancy fees from Merck & Company. O-EI has received lecture fees from Merck & Company and GlaxoSmithKline. LLV has received lecture fees, advisory board fees, and consultancy fees from Merck & Company and Sanofi Pasteur MSD. KAA has received consultancy and advisory board fees. MH-A has received lecture fees and grant support from Merck & Company. GP has received lecture fees and consultancy fees from Merck & Company and Sanofi Pasteur MSD. DRB has received lecture fees, advisory board fees, and intellectual property fees. SLe has received lecture fees from Merck & Company and Sanofi Pasteur MSD. S-EO has received lecture fees from Merck & Company. DGF has received consultancy fees and funding through his institution to conduct HPV vaccine studies for GlaxoSmithKline, and lecture fees and consultancy fees from Merck & Company. JP has received consultancy fees, advisory board fees, and lecture fees from Merck & Company. MS has received lecture fees and grant support from Merck & Company. FXB has received lecture fees from Merck & Company and GlaxoSmithKline, and has received funding through his institution to conduct HPV vaccine studies for GlaxoSmithKline. EAJ has received lecture fees from Merck & Company, Sanofi Pasteur MSD, and GlaxoSmithKline. SM has received lecture fees, advisory board fees, and consultancy fees from Merck & Company and Sanofi Pasteur MSD. NM has received lecture fees, advisory board fees, and consultancy fees from Merck & Company and Sanofi Pasteur MSD. Additionally, S-EO, CMW, MH-A, LLV, O-EI, GWKT, FXB, JP, JD, EHT, SLe, EAJ, SKK, GP, DGF, KS, MS, LAK, and DRB have received funding through their institutions to conduct HPV vaccine studies for Merck & Company. FJT, CR, AT, JTB, RM, SV, TMH, RH, and EB are employees of Merck & Company and potentially own stock or stock options in the company.	Bergeron C, 2006, Gynecol Obstet Fertil, V34, P1036, DOI 10.1016/j.gyobfe.2006.09.005; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Clarke P, 1996, INT J STD AIDS, V7, P197, DOI 10.1258/0956462961917618; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; GREER CE, 1995, J CLIN MICROBIOL, V33, P2058, DOI 10.1128/JCM.33.8.2058-2063.1995; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P114, DOI 10.1016/j.ajog.2004.01.042; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Jansen KU, 2004, ANNU REV MED, V55, P319, DOI 10.1146/annurev.med.55.091902.103520; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kodner CM, 2004, AM FAM PHYSICIAN, V70, P2335; Lacey CJN, 2005, J CLIN VIROL, V32, pS82, DOI 10.1016/j.jcv.2004.10.020; Langley PC, 2004, INT J STD AIDS, V15, P501, DOI 10.1258/0956462041558168; Maw RD, 1998, INT J STD AIDS, V9, P571, DOI 10.1258/0956462981921143; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Sideri M, 2005, J REPROD MED, V50, P807; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, J INFECT DIS, V196, P1438, DOI 10.1086/522864; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109; World Health Organization, 2004, HUM PAP INF CERV CAN	28	268	274	2	38	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2010	341								c3493	10.1136/bmj.c3493	http://dx.doi.org/10.1136/bmj.c3493			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GV	20647284	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000280411600005
J	Foster, E				Foster, Elyse			Mitral Regurgitation Due to Degenerative Mitral-Valve Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; SURGICAL-CORRECTION; NATRIURETIC PEPTIDE; NATURAL-HISTORY; FLAIL LEAFLETS; PROLAPSE; REPAIR; OUTCOMES; SURVIVAL; COMPLICATIONS	A 44-year-old man presents with dyspnea and new atrial fibrillation. He received a diagnosis of mitral regurgitation at 28 years of age, after physical examination revealed a midsystolic click and late-systolic murmur; echocardiography performed at that time showed mitral-valve prolapse with mild late-systolic mitral regurgitation and normal left ventricular size and function. He has not seen a physician in many years. Physical examination reveals a holosystolic murmur and a soft S-3 sound. Repeat echocardiography shows a flail posterior leaflet and moderately severe mitral regurgitation. How should this case be managed?	Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Foster, E (corresponding author), Univ Calif San Francisco, Div Cardiol, Parnassus Ave,M314A, San Francisco, CA 94143 USA.	foster@medicine.ucsf.edu			Boston Scientific, Evalve	Boston Scientific, Evalve(Boston Scientific)	Dr. Foster reports that the University of California at San Francisco has received grant support from Boston Scientific, Evalve, and EBR Systems for her research. No other potential conflict of interest relevant to this article was reported.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Avierinos JF, 2008, ANN INTERN MED, V149, P787, DOI 10.7326/0003-4819-149-11-200812020-00003; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; Braunberger E, 2001, CIRCULATION, V104, pI8; CLEMENS JD, 1982, NEW ENGL J MED, V307, P776, DOI 10.1056/NEJM198209233071302; David TE, 2003, J THORAC CARDIOV SUR, V125, P1143, DOI 10.1067/mtc.2003.406; DEVEREUX R B, 1986, Journal of the American College of Cardiology, V8, P763; Devereux RB, 2001, AM J MED, V111, P679, DOI 10.1016/S0002-9343(01)00981-0; DEVEREUX RB, 1986, AM J MED, V81, P751, DOI 10.1016/0002-9343(86)90339-6; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; Enriquez-Sarano M, 1999, J AM COLL CARDIOL, V34, P1137, DOI 10.1016/S0735-1097(99)00313-7; ENRIQUEZSARANO M, 1994, CIRCULATION, V90, P830, DOI 10.1161/01.CIR.90.2.830; Flameng W, 2003, CIRCULATION, V107, P1609, DOI 10.1161/01.CIR.0000058703.26715.9D; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Grigioni F, 1999, J AM COLL CARDIOL, V34, P2078, DOI 10.1016/S0735-1097(99)00474-X; Grigioni F, 2002, J AM COLL CARDIOL, V40, P84, DOI 10.1016/S0735-1097(02)01922-8; Grigioni F, 2008, JACC-CARDIOVASC IMAG, V1, P133, DOI 10.1016/j.jcmg.2007.12.005; Kang DH, 2009, CIRCULATION, V119, P797, DOI 10.1161/CIRCULATIONAHA.108.802314; Leung DY, 1996, J AM COLL CARDIOL, V28, P1198, DOI 10.1016/S0735-1097(96)00281-1; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; MARKS AR, 1989, NEW ENGL J MED, V320, P1031, DOI 10.1056/NEJM198904203201602; MOHTY D, 2001, CIRCULATION S1, V104, P1, DOI 10.1161/hc37t1.094903; Mohty Dania, 2002, Curr Cardiol Rep, V4, P104, DOI 10.1007/s11886-002-0021-9; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; NISHIMURA RA, 1985, NEW ENGL J MED, V313, P1305, DOI 10.1056/NEJM198511213132101; Nishimura Rick A, 2008, Catheter Cardiovasc Interv, V72, pE1, DOI 10.1002/ccd.21751; O'Gara P, 2008, JACC-CARDIOVASC IMAG, V1, P221, DOI 10.1016/j.jcmg.2008.01.011; Pizarro R, 2009, J AM COLL CARDIOL, V54, P1099, DOI 10.1016/j.jacc.2009.06.013; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175; Russo A, 2008, J AM COLL CARDIOL, V51, P1203, DOI 10.1016/j.jacc.2007.10.058; Shuhaiber J, 2007, EUR J CARDIO-THORAC, V31, P267, DOI 10.1016/j.ejcts.2006.11.014; *SOC THOR SURG, 2004, NAT CARD SURG DAT EX; Sutton TM, 2003, J AM COLL CARDIOL, V41, P2280, DOI 10.1016/S0735-1097(03)00486-8; Tischler MD, 1996, AM J CARDIOL, V77, P397, DOI 10.1016/S0002-9149(97)89371-X; Tribouilloy C, 2009, J AM COLL CARDIOL, V54, P1961, DOI 10.1016/j.jacc.2009.06.047; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; WINKLE RA, 1976, AM J MED, V60, P961, DOI 10.1016/0002-9343(76)90567-2; Yacoub MH, 2004, CIRCULATION, V109, P1064, DOI 10.1161/01.CIR.0000115634.66549.4D; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; ZUPPIROLI A, 1995, AM J CARDIOL, V75, P1028, DOI 10.1016/S0002-9149(99)80718-8	44	23	23	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					156	165		10.1056/NEJMcp0906782	http://dx.doi.org/10.1056/NEJMcp0906782			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20647211				2022-12-28	WOS:000279574100008
J	Kelly, AE; Ghenoiu, C; Xue, JZ; Zierhut, C; Kimura, H; Funabiki, H				Kelly, Alexander E.; Ghenoiu, Cristina; Xue, John Z.; Zierhut, Christian; Kimura, Hiroshi; Funabiki, Hironori			Survivin Reads Phosphorylated Histone H3 Threonine 3 to Activate the Mitotic Kinase Aurora B	SCIENCE			English	Article							CHROMOSOMAL PASSENGERS; STRUCTURAL BASIS; SMAC/DIABLO; CHROMATIN; SPINDLE; INCENP; INHIBITION; MECHANISM; BINDING; COMPLEX	A hallmark of mitosis is the appearance of high levels of histone phosphorylation, yet the roles of these modifications remain largely unknown. Here, we demonstrate that histone H3 phosphorylated at threonine 3 is directly recognized by an evolutionarily conserved binding pocket in the BIR domain of Survivin, which is a member of the chromosomal passenger complex (CPC). This binding mediates recruitment of the CPC to chromosomes and the resulting activation of its kinase subunit Aurora B. Consistently, modulation of the kinase activity of Haspin, which phosphorylates H3T3, leads to defects in the Aurora B-dependent processes of spindle assembly and inhibition of nuclear reformation. These findings establish a direct cellular role for mitotic histone H3T3 phosphorylation, which is read and translated by the CPC to ensure accurate cell division.	[Kelly, Alexander E.; Ghenoiu, Cristina; Xue, John Z.; Zierhut, Christian; Funabiki, Hironori] Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA; [Ghenoiu, Cristina] Cornell Med Sch, Dept Mol Biol, Weill Cornell Grad Sch Biomed Sci, New York, NY 10021 USA; [Kimura, Hiroshi] Osaka Univ, Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Rockefeller University; Cornell University; Osaka University	Kelly, AE (corresponding author), Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA.	akelly@rockefeller.edu; funabih@rockefeller.edu	Kelly, Alexander/AAZ-8425-2021; Kimura, Hiroshi/B-9524-2015	Kimura, Hiroshi/0000-0003-0854-083X; KELLY, ALEXANDER/0000-0002-3395-6012; Funabiki, Hironori/0000-0003-4831-4087; Zierhut, Christian/0000-0003-3501-603X; Xue, John/0000-0002-7334-0589	Charles H. Revson Biomedical Fellowship; Marie-Josee and Henry Kravis postdoctoral fellowship; Erwin Schrodinger postdoctoral fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH [GM075249]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075249] Funding Source: NIH RePORTER	Charles H. Revson Biomedical Fellowship; Marie-Josee and Henry Kravis postdoctoral fellowship; Erwin Schrodinger postdoctoral fellowship(Austrian Science Fund (FWF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The GenBank accession number for X. laevis Haspin is HM559585. We thank M. Dasso, J. Higgins, and S. Mochida for reagents; T. Maniar and K. Yap for technical assistance; J. Higgins for sharing results; and the Rockefeller University Bio-Imaging Resource Center. This work was supported by a Charles H. Revson Biomedical Fellowship (A. E. K), Marie-Josee and Henry Kravis and Erwin Schrodinger postdoctoral fellowships (C.Z.), grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H. K.) and NIH (GM075249, H.F.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Cao LH, 2006, BIOCHEM BIOPH RES CO, V346, P400, DOI 10.1016/j.bbrc.2006.05.131; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118	20	352	364	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					235	239		10.1126/science.1189505	http://dx.doi.org/10.1126/science.1189505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20705815	Green Accepted			2022-12-28	WOS:000282644600046
J	Rosen, CJ				Rosen, Clifford J.			Revisiting the Rosiglitazone Story - Lessons Learned	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Maine Med Ctr, Res Inst, Scarborough, ME USA	Maine Medical Center	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME USA.							GRAHAM DJ, 2010, JAMA            0628; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2010, ARCH INTERN MED 0628; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167	4	99	101	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					803	806		10.1056/NEJMp1008233	http://dx.doi.org/10.1056/NEJMp1008233			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20660395	Bronze			2022-12-28	WOS:000281196600002
J	Muller, MP; Peters, H; Blumer, J; Blankenfeldt, W; Goody, RS; Itzen, A				Mueller, Matthias P.; Peters, Heide; Bluemer, Julia; Blankenfeldt, Wulf; Goody, Roger S.; Itzen, Aymelt			The Legionella Effector Protein DrrA AMPylates the Membrane Traffic Regulator Rab1b	SCIENCE			English	Article							GLUTAMINE-SYNTHETASE; STRUCTURAL BASIS; GTP HYDROLYSIS; ACTIVATION; GTPASES	In the course of Legionnaires' disease, the bacterium Legionella pneumophila affects the intracellular vesicular trafficking of infected eukaryotic cells by recruiting the small guanosine triphosphatase (GTPase) Rab1 to the cytosolic face of the Legionella-containing vacuole. In order to accomplish this, the Legionella protein DrrA contains a specific guanine nucleotide exchange activity for Rab1 activation that exchanges guanosine triphosphate (GTP) for guanosine diphosphate on Rab1. We found that the amino-terminal domain of DrrA possesses adenosine monophosphorylation (AMPylation) activity toward the switch II region of Rab1b, leading to posttranslational covalent modification of tyrosine 77. AMPylation of switch II by DrrA restricts the access of GTPase activating proteins, thereby rendering Rab1b constitutively active.	[Mueller, Matthias P.; Peters, Heide; Bluemer, Julia; Blankenfeldt, Wulf; Goody, Roger S.; Itzen, Aymelt] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, NRW, Germany	Max Planck Society	Blankenfeldt, W (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, NRW, Germany.	wulf.blankenfeldt@mpi-dortmund.mpg.de; roger.goody@mpi-dortmund.mpg.de; aymelt.itzen@mpi-dortmund.mpg.de	Blankenfeldt, Wulf/F-8877-2010; Goody, Roger S/J-8845-2014; Itzen, Aymelt/F-5157-2014	Blankenfeldt, Wulf/0000-0001-9886-9668; Goody, Roger S/0000-0002-0772-0444; Itzen, Aymelt/0000-0002-4249-5617; Muller, Matthias/0000-0002-1529-8933; Behrmann, Heide/0000-0002-1769-7049	German research foundation [SFB 642]; International Max Planck Research School in Chemical Biology (Dortmund)	German research foundation(German Research Foundation (DFG)); International Max Planck Research School in Chemical Biology (Dortmund)	We thank P. Janning for guidance in tandem mass spectrometry, N. Bleimling for invaluable technical assistance, M. Sulc for help in flow cytometry, the staff of Beamline X10SA at the Paul Scherrer Institute (Villingen, Switzerland), the x-ray communities at the Max Planck Institute (MPI) Dortmund and the MPI Heidelberg (Germany), and M. Machner and A. Barnekow for LidA and MICAL-3 plasmids, respectively. R.S.G. thanks the German research foundation (SFB 642). M.P.M. is grateful to the International Max Planck Research School in Chemical Biology (Dortmund) for financial support. Coordinates of DrrA<INF>9-218</INF> and Rab1b-AMP have been deposited in the Protein Data Bank (Brookhaven National Laboratory) with accession numbers 3NKU and 3NKV, respectively.	Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; DATE T, 1991, BIOCHEMISTRY-US, V30, P5286, DOI 10.1021/bi00235a023; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu YB, 2010, J MOL BIOL, V396, P773, DOI 10.1016/j.jmb.2009.12.011; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	252	260	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2010	329	5994					946	949		10.1126/science.1192276	http://dx.doi.org/10.1126/science.1192276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20651120				2022-12-28	WOS:000281084800035
J	Montaner, JSG; Lima, VD; Barrios, R; Yip, B; Wood, E; Kerr, T; Shannon, K; Harrigan, PR; Hogg, RS; Daly, P; Kendall, P				Montaner, Julio S. G.; Lima, Viviane D.; Barrios, Rolando; Yip, Benita; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard; Hogg, Robert S.; Daly, Patricia; Kendall, Peny			Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study	LANCET			English	Article							SEXUAL TRANSMISSION; PREVENTION; RNA; ACCESS; CURB; AIDS; GROWTH; POLICY	Background Results of cohort studies and mathematical models have suggested that increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV transmission. We aimed to estimate the association between plasma HIV-1 viral load, HAART coverage, and number of new cases of HIV in the population of a Canadian province. Methods We undertook a population-based study of HAART coverage and HIV transmission in British Columbia, Canada. Data for number of HIV tests done and new HIV diagnoses were obtained from the British Columbia Centre for Disease Control. Data for viral load, CD4 cell count, and HAART use were extracted from the British Columbia Centre for Excellence in HIV/AIDS population-based registries. We modelled trends of new HIV-positive tests and number of individuals on HAART using generalised additive models. Poisson log-linear regression models were used to estimate the association between new HIV diagnoses and viral load, year, and number of individuals on HAART. Findings Between 1996 and 2009, the number of individuals actively receiving HAART increased from 837 to 5413 (547% increase; p=0.002), and the number of new HIV diagnoses fell from 702 to 338 per year (52% decrease; p=0.001). The overall correlation between number of individuals on HAART and number of individuals newly testing positive for HIV per year was 0.89 (p<0.0001). For every 100 additional individuals on HAART, the number of new HIV cases decreased by a factor of 0.97 (95% CI 0.96-0.98), and per 1 log,o decrease in viral load, the number of new HIV cases decreased by a factor of 0.86 (0.75-0.98). Interpretation We have shown a strong population-level association between increasing HAART coverage, decreased viral load, and decreased number of new HIV diagnoses per year. Our results support the proposed secondary benefit of HAART used within existing medical guidelines to reduce HIV transmission.	[Montaner, Julio S. G.; Lima, Viviane D.; Barrios, Rolando; Yip, Benita; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard; Hogg, Robert S.] Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Montaner, Julio S. G.; Lima, Viviane D.; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard] Univ British Columbia, Div Aids, Vancouver, BC V5Z 1M9, Canada; [Montaner, Julio S. G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Daly, Patricia] Vancouver Coastal Hlth Author, Vancouver, BC, Canada; [Kendall, Peny] Govt British Columbia, Minist Healthy Living & Sport, Off Prov Hlth Officer, Victoria, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Diego; Simon Fraser University; Vancouver Coastal Health Research Institute	Montaner, JSG (corresponding author), Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, 1081 Burrard St,Room 667, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@cfenet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012; Kendall, Carl/F-9002-2012	Hogg, Robert S/0000-0003-3463-5488; Kendall, Carl/0000-0002-0794-4333	Merck; Gilead and ViiV Healthcare; GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology; GlaxoSmithKline; Abbott; Viiv; Pfizer; Ministry of Health Services; Ministry of Healthy Living and Sport, Province of British Columbia through Canadian Institutes of Health Research (CIHR); National Institute on Drug Abuse at the US National Institutes of Health [1DP1DA026182-01]; CIHR [MOP-79297, RAA-79918]; Michael Smith Foundation for Health Research; US National Institutes of Health [R01DA021525]; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182, R01DA021525] Funding Source: NIH RePORTER	Merck(Merck & Company); Gilead and ViiV Healthcare; GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR)GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Viiv; Pfizer(Pfizer); Ministry of Health Services; Ministry of Healthy Living and Sport, Province of British Columbia through Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JSGM has received funding from Merck, Gilead and ViiV Healthcare to support research into Treatment as Prevention, consultancy fees from Merck, and speakers' fees from Clinical Care Options. PRH holds the GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology. RSH has received a research grant from Merck and a conference travel grant from GlaxoSmithKline. PRH has received honoraria from Viiv, Virco, Quest, and Merck, travel grants to attend conferences from Viiv and Quest, research grants from Abbott, Viiv, Pfizer, and Merck, and speakers' fees from Viiv. VDL, TK, EW, KS, RB, PD, PK, and BY declare that they have no conflicts of interest.; JSGM is supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No 1DP1DA026182-01) from the National Institute on Drug Abuse, at the US National Institutes of Health. TK is supported by CIHR and the Michael Smith Foundation for Health Research. VDL is supported through Fellowship Awards by CIHR and Michael Smith Foundation for Health Research. The study was further supported by the US National Institutes of Health (R01DA021525) and CIHR (MOP-79297, RAA-79918). Merck, Gilead and ViiV Healthcare support research into Treatment as Prevention. We thank Kelly Hsu for her assistance with preparation of the report, and Tom Patterson and Steffanie Strathdee for their helpful comments and advice.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; *BC CTR DIS CONTR, 2008, ANN SUMM REP DIS; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Breslow NE, 1987, IARC SCI PUBL, V82, P82; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Kerr T, 2009, J ADOLESCENT HEALTH, V45, P300, DOI 10.1016/j.jadohealth.2009.03.007; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lloyd-Smith E, 2009, ANN EPIDEMIOL, V19, P404, DOI 10.1016/j.annepidem.2009.03.007; Lorello G, 2009, HIV MED, V10, P548, DOI 10.1111/j.1468-1293.2009.00725.x; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; SHANNON K, 2009, BMJ-BRIT MED J, V11, pB2939; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; SIDIBE M, 2010, COMMUNICATION; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; *US CDCP, QUEST ANSW 15 INCR H; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279	41	589	604	3	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					532	539		10.1016/S0140-6736(10)60936-1	http://dx.doi.org/10.1016/S0140-6736(10)60936-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20638713	Green Accepted			2022-12-28	WOS:000281266800032
J	Chu, JH; Analytis, JG; De Greve, K; McMahon, PL; Islam, Z; Yamamoto, Y; Fisher, IR				Chu, Jiun-Haw; Analytis, James G.; De Greve, Kristiaan; McMahon, Peter L.; Islam, Zahirul; Yamamoto, Yoshihisa; Fisher, Ian R.			In-Plane Resistivity Anisotropy in an Underdoped Iron Arsenide Superconductor	SCIENCE			English	Article							STATE	High-temperature superconductivity often emerges in the proximity of a symmetry-breaking ground state. For superconducting iron arsenides, in addition to the antiferromagnetic ground state, a small structural distortion breaks the crystal's C-4 rotational symmetry in the underdoped part of the phase diagram. We reveal that the representative iron arsenide Ba(Fe1-xCox)(2)As-2 develops a large electronic anisotropy at this transition via measurements of the in-plane resistivity of detwinned single crystals, with the resistivity along the shorter b axis rho(b) being greater than rho(a). The anisotropy reaches a maximum value of similar to 2 for compositions in the neighborhood of the beginning of the superconducting dome. For temperatures well above the structural transition, uniaxial stress induces a resistivity anisotropy, indicating a substantial nematic susceptibility.	[Chu, Jiun-Haw; Analytis, James G.; Fisher, Ian R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chu, Jiun-Haw; Analytis, James G.; Fisher, Ian R.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Chu, Jiun-Haw; Analytis, James G.; Fisher, Ian R.] SLAC Natl Accelerator Lab, Stanford Inst Energy & Mat Sci, Menlo Pk, CA 94025 USA; [De Greve, Kristiaan; McMahon, Peter L.; Yamamoto, Yoshihisa] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Islam, Zahirul] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Yamamoto, Yoshihisa] Natl Inst Informat, Chiyoda Ku, Tokyo 1018403, Japan	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); Argonne National Laboratory; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Fisher, IR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	irfisher@stanford.edu	Yamamoto, Yoshihisa/A-2811-2012; De Greve, Kristiaan/N-1489-2013; analytis, james/ABE-6100-2020; McMahon, Peter/ABI-1817-2020; Chu, Jiun-Haw/B-1613-2012	Yamamoto, Yoshihisa/0000-0002-4150-6804; analytis, james/0000-0002-7657-7688; McMahon, Peter/0000-0002-1177-9887; Fisher, Ian/0000-0002-1278-7862; De Greve, Kristiaan/0000-0002-1314-9715; Chu, Jiun-Haw/0000-0001-6222-1210	U.S. Department of Energy (DOE), Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE, Office of Science [DE-AC02-06CH11357]	U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE, Office of Science(United States Department of Energy (DOE))	The authors thank C. D. Batista, C.-C. Chen, T. P. Devereaux, S. A. Kivelson, A. P. Mackenzie, R. D. McDonald, S. C. Riggs, D. J. Scalapino, and Z.-X. Shen for helpful discussions. This work is supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, under contract DE-AC02-76SF00515. Use of the APS is supported by the DOE, Office of Science, under contract DE-AC02-06CH11357.	Analytis JG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064507; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Chen CC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.180418; Chu JH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214502; Chu JH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014506; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Fang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224509; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Lester C, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144523; Li S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.201204; Lilly MP, 1999, PHYS REV LETT, V82, P394, DOI 10.1103/PhysRevLett.82.394; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; Pratt DK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.087001; Prozorov R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174517; Ren ZA, 2008, CHINESE PHYS LETT, V25, P2215, DOI 10.1088/0256-307X/25/6/080; Rotter M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020503; Sebastian SE, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/42/422203; Tanatar MA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.180508; Xu C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020501; Yildirim T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037003	28	629	634	9	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					824	826		10.1126/science.1190482	http://dx.doi.org/10.1126/science.1190482			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705856	Green Submitted			2022-12-28	WOS:000280809900046
J	Manicassamy, S; Reizis, B; Ravindran, R; Nakaya, H; Salazar-Gonzalez, RM; Wang, YC; Pulendran, B				Manicassamy, Santhakumar; Reizis, Boris; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali			Activation of beta-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; T-HELPER-CELLS; RETINOIC-ACID; INNATE IMMUNITY; RESPONSES; DIFFERENTIATION; MACROPHAGES; DISEASE; EXPRESSION; INDUCTION	Dendritic cells (DCs) play a vital role in initiating robust immunity against pathogens as well as maintaining immunological tolerance to self antigens. However, the intracellular signaling networks that program DCs to become tolerogenic remain unknown. We report here that the Wnt-beta-catenin signaling in intestinal dendritic cells regulates the balance between inflammatory versus regulatory responses in the gut. beta-catenin in intestinal dendritic cells was required for the expression of anti-inflammatory mediators such as retinoic acid-metabolizing enzymes, interleukin-10, and transforming growth factor-beta, and the stimulation of regulatory T cell induction while suppressing inflammatory effector T cells. Furthermore, ablation of beta-catenin expression in DCs enhanced inflammatory responses and disease in a mouse model of inflammatory bowel disease. Thus, beta-catenin signaling programs DCs to a tolerogenic state, limiting the inflammatory response.	[Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Salazar-Gonzalez, Rosa Maria] Cincinnati Childrens Hosp, Med Ctr, Mol Immunol Div, Cincinnati, OH 45229 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Columbia University; Cincinnati Children's Hospital Medical Center; Emory University	Pulendran, B (corresponding author), Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu	Nakaya, Helder/AAF-1738-2020; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010	Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Pulendran, Bali/0000-0001-6517-4333; Reizis, Boris/0000-0003-1140-7853	National Institutes of Health [U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019, NO1 AI50025]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050025, R01AI048638, R37AI048638, U54AI057157, R01AI056499, U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. A. Mertens and L. Bronner for assistance with cell sorting and D. Levesque (Emory Vaccine Center) and D. Bonenberger for assistance with maintenance of mice strains at the Emory Vaccine Center vivarium. The work in the laboratory of BP was supported by grants U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019, and NO1 AI50025 from the National Institutes of Health and a grant from the Bill & Melinda Gates Foundation. Microarray accession number is GSE2213 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22136).	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Brault V, 2001, DEVELOPMENT, V128, P1253; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	34	385	397	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					849	853		10.1126/science.1188510	http://dx.doi.org/10.1126/science.1188510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705860	Green Accepted			2022-12-28	WOS:000280809900053
J	Kraemer, HC; Frank, E				Kraemer, Helena Chmura; Frank, Ellen			Evaluation of Comparative Treatment Trials Assessing Clinical Benefits and Risks for Patients, Rather Than Statistical Effects on Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SIZE; STATEMENT		[Kraemer, Helena Chmura] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94301 USA; [Kraemer, Helena Chmura; Frank, Ellen] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kraemer, HC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, 1116 Forest Ave, Palo Alto, CA 94301 USA.	hckhome@pacbell.net						De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; Garber AM, 2009, NEW ENGL J MED, V360, P1925, DOI 10.1056/NEJMp0901355; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Hsu LA, 2004, PSYCHOL METHODS, V9, P183, DOI 10.1037/1082-989X.9.2.183; Kraemer HC, 2006, JAMA-J AM MED ASSOC, V296, P1286, DOI 10.1001/jama.296.10.1286; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Newcombe RG, 2006, STAT MED, V25, P543, DOI 10.1002/sim.2323; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Rennie D, 1996, JAMA-J AM MED ASSOC, V276, P649, DOI 10.1001/jama.276.8.649	9	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					683	684		10.1001/jama.2010.1133	http://dx.doi.org/10.1001/jama.2010.1133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	637PA	20699462				2022-12-28	WOS:000280829200026
J	O'Connor, PM; Sertich, JJW; Stevens, NJ; Roberts, EM; Gottfried, MD; Hieronymus, TL; Jinnah, ZA; Ridgely, R; Ngasala, SE; Temba, J				O'Connor, Patrick M.; Sertich, Joseph J. W.; Stevens, Nancy J.; Roberts, Eric M.; Gottfried, Michael D.; Hieronymus, Tobin L.; Jinnah, Zubair A.; Ridgely, Ryan; Ngasala, Sifa E.; Temba, Jesuit			The evolution of mammal-like crocodyliforms in the Cretaceous Period of Gondwana	NATURE			English	Article							RED SANDSTONE GROUP; RUKWA RIFT BASIN; MESOEUCROCODYLIA; CROCODYLOMORPHA; REMAINS	Fossil crocodyliforms discovered in recent years(1-5) have revealed a level of morphological and ecological diversity not exhibited by extant members of the group. This diversity is particularly notable among taxa of the Cretaceous Period (144-65 million years ago) recovered from former Gondwanan landmasses. Here we report the discovery of a new species of Cretaceous notosuchian crocodyliform from the Rukwa Rift Basin(6) of southwestern Tanzania. This small-bodied form deviates significantly from more typical crocodyliform craniodental morphologies, having a short, broad skull, robust lower jaw, and a dentition with relatively few teeth that nonetheless show marked heterodonty. The presence of morphologically complex, complementary upper and lower molariform teeth suggests a degree of crown-crown contact during jaw adduction that is unmatched among known crocodyliforms, paralleling the level of occlusal complexity seen in mammals and their extinct relatives(7-12). The presence of another small-bodied mammal-like crocodyliform in the Cretaceous of Gondwana indicates that notosuchians probably filled niches and inhabited ecomorphospace that were otherwise occupied by mammals on northern continents.	[O'Connor, Patrick M.; Stevens, Nancy J.; Ridgely, Ryan] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [O'Connor, Patrick M.; Stevens, Nancy J.] Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Sertich, Joseph J. W.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Roberts, Eric M.] So Utah Univ, Dept Phys Sci, Cedar City, UT 84720 USA; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Gottfried, Michael D.; Ngasala, Sifa E.] Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; [Hieronymus, Tobin L.] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Hieronymus, Tobin L.] Northeastern Ohio Univ Coll Med & Pharm, Coll Pharm, Rootstown, OH 44272 USA; [Jinnah, Zubair A.] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa; [Ngasala, Sifa E.] Univ Dar Es Salaam, Dept Geol, Dar Es Salaam, Tanzania; [Temba, Jesuit] Tanzania Antiqu Unit, Dar Es Salaam, Tanzania	University System of Ohio; Ohio University; University System of Ohio; Ohio University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Utah System of Higher Education; Southern Utah University; James Cook University; Michigan State University; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); University of Witwatersrand; University of Dar es Salaam	O'Connor, PM (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, 228 Irvine Hall, Athens, OH 45701 USA.	oconnorp@ohio.edu	Stevens, Nancy J/E-6928-2013; Roberts, Eric/J-1836-2014; OConnor, Patrick M/I-9383-2012	Roberts, Eric/0000-0002-8583-7437; OConnor, Patrick M/0000-0002-6762-3806; Hieronymus, Tobin/0000-0002-0483-5350; Jinnah, Zubair/0000-0002-1317-7361	Tanzania Antiquities Unit; Tanzania Museum of House of Culture; University of Dar es Salaam; Tanzania Commission for Science and Technology; US National Science Foundation (NSF) [EAR-0617561, EAR-0854218]; National Geographic Society (CRE); University of the Witwatersrand; Michigan State University Office of Research and Graduate Studies; Ohio University College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Directorate For Geosciences [0933619] Funding Source: National Science Foundation	Tanzania Antiquities Unit; Tanzania Museum of House of Culture; University of Dar es Salaam; Tanzania Commission for Science and Technology; US National Science Foundation (NSF)(National Science Foundation (NSF)); National Geographic Society (CRE)(National Geographic Society); University of the Witwatersrand; Michigan State University Office of Research and Graduate Studies; Ohio University College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank: D. Kamamba, F. Ndunguru (Tanzania Antiquities Unit), P. Msemwa (Tanzania Museum of House of Culture), I. Marobhe (University of Dar es Salaam), and the Tanzania Commission for Science and Technology for support; J.P. Cavigelli and V. Heisey for specimen preparation; M. Getty, E. Lund, S. Burch, V. Simons, E. Simons, J. Garcia-Massini, G. Masai, and A. Mussa for field assistance; P. Sereno, E. Gomani, and C. Chiumia for specimen access; J. Sidote for digital processing assistance. This research was supported by the US National Science Foundation (NSF EAR-0617561, EAR-0854218), the National Geographic Society (CRE), the University of the Witwatersrand, the Michigan State University Office of Research and Graduate Studies, and the Ohio University College of Osteopathic Medicine and Ohio University Office of Research and Sponsored Programs.	Angielczyk KD, 2004, PALEOBIOLOGY, V30, P268, DOI 10.1666/0094-8373(2004)030<0268:PEFAIO>2.0.CO;2; Bonaparte J.F., 1986, Journal of Vertebrate Paleontology, V6, P264; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Carvalho Ismar De Souza, 1994, Anais da Academia Brasileira de Ciencias, V66, P331; CROMPTON AW, 1968, BIOL REV, V43, P427, DOI 10.1111/j.1469-185X.1968.tb00966.x; De Andrade Marco Brandalise, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P7; Fiorelli Lucas, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P83; Gomani EM, 1997, J VERTEBR PALEONTOL, V17, P280, DOI 10.1080/02724634.1997.10010975; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Krause DW, 2003, ACTA PALAEONTOL POL, V48, P321; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Lecuona A, 2008, CR PALEVOL, V7, P407, DOI 10.1016/j.crpv.2008.07.001; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Nobre PH, 2008, GONDWANA RES, V13, P139, DOI 10.1016/j.gr.2007.08.002; Nobre PH, 2006, GONDWANA RES, V10, P370, DOI 10.1016/j.gr.2006.05.008; Novas FE, 2009, J VERTEBR PALEONTOL, V29, P1316, DOI 10.1671/039.029.0409; O'Connor PM, 2006, J AFR EARTH SCI, V44, P277, DOI 10.1016/j.jafrearsci.2005.11.022; Osborn JW, 1998, J DENT RES, V77, P1730, DOI 10.1177/00220345980770090901; Pletsch T, 2001, J S AM EARTH SCI, V14, P147, DOI 10.1016/S0895-9811(01)00020-7; Pol D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)490[0001:NARFTE]2.0.CO;2; Pol D, 2003, J VERTEBR PALEONTOL, V23, P817, DOI 10.1671/A1015-7; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Turner AH., 2006, HIST BIOL, V18, P255, DOI [10.1080/08912960500516112, DOI 10.1080/08912960500516112]; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2; ZHAO Z, 2007, DEV FUNCTION EVOLUTI, P152	30	103	105	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					748	751		10.1038/nature09061	http://dx.doi.org/10.1038/nature09061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686573				2022-12-28	WOS:000280562500037
J	Kwo, PY; Lawitz, EJ; McCone, J; Schiff, ER; Vierling, JM; Pound, D; Davis, MN; Galati, JS; Gordon, SC; Ravendhran, N; Rossaro, L; Anderson, FH; Jacobson, IM; Rubin, R; Koury, K; Pedicone, LD; Brass, CA; Chaudhri, E; Albrecht, JK				Kwo, Paul Y.; Lawitz, Eric J.; McCone, Jonathan; Schiff, Eugene R.; Vierling, John M.; Pound, David; Davis, Mitchell N.; Galati, Joseph S.; Gordon, Stuart C.; Ravendhran, Natarajan; Rossaro, Lorenzo; Anderson, Frank H.; Jacobson, Ira M.; Rubin, Raymond; Koury, Kenneth; Pedicone, Lisa D.; Brass, Clifford A.; Chaudhri, Eirum; Albrecht, Janice K.			Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial	LANCET			English	Article							PLUS RIBAVIRIN; RESISTANCE MUTATIONS; PEGYLATED INTERFERON-ALPHA-2B; VIROLOGICAL RESPONSE; (40 KD)/RIBAVIRIN; VIRUS-INFECTION; HCV; THERAPY; TELAPREVIR; SCH-503034	Background Peginterferon plus ribavirin achieves sustained virological response (SVR) in fewer than half of patients with genotype 1 chronic hepatitis C virus infection treated for 48 weeks. We tested the efficacy of boceprevir, an NS3 hepatitis C virus oral protease inhibitor, when added to peginterferon alfa-2b and ribavirin. Methods In part 1 of this trial, undertaken in 67 sites in the USA, Qmada, and Europe, 520 treatment-naive patients with genotype 1 hepatitis C virus infection were randomly assigned to receive peginterferon alfa-2b 1.5 mu g/kg plus ribavirin 800-1400 mg daily for 48 weeks (PR48; n=104); pegmterferon alfa-2b and ribavirin daily for 4 weeks, followed by peginterferon alfa-2b, ribavirin, and boceprevir 800 mg three times a day for 24 weeks (PR4/PR824; 11=103) or 44 weeks (PR4/PRB44; n=103), or peginterferon alfa-2b, ribavirin, and boceprevir three times a day for 28 weeks (PRB28; n=107) or 43 weeks (PRB48; n=103). In part 2,75 patients were randomly assigned to receive either PRB48 (n=16) or low-dose ribavirin (400-1000 mg) plus peginterferon alfa-2b and boceprevir three times a day for 48 weeks (low-dose PRB48; n=59) Randomisation was by computer-generated code, and study personnel and patients were not masked to group assignment. The primary endpoint was SVR 24 weeks after treatment. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00423670. Findings Patients in all four boceprevir groups had higher rates of SVR than did the control group (58/107 [54%, 95% CI 44-64], p=0.013 for PRB28; 58/103 [56%, 44-66], p=0.005 for PR4/PR824; 69/103 [67%, 57-761, p<0.0001 for PRB48; and 77/103 [75%, 65-83], p<0.0001 for PR4/PRB44; vs 39/104 [38%, 28-48] for PR48 control). Low-dose ribavirin was associated with a high rate of viral breakthrough (16/59 [27%]), and a rate of relapse (six of 27 [22%]) similar to control (12/51 124%]). Boceprevir-based groups had higher rates of anaemia (227/416 [55%] vs 35/104 [34%]) and dysgeusia (111/416 [27%] vs nine of 104 [9%]) than did the control group. Interpretation In patients with untreated genotype 1 chronic hepatitis C infection, the addition of the direct-acting antiviral agent boceprevir to standard treatment with peginterferon and ribavirin after a 4-week lead-in seems to have the potential to double the sustained response rate compared with that recorded with standard treatment alone.	[Kwo, Paul Y.] Indiana Univ Sch Med, Dept Med, Div Gastroenterol Hepatol, Indianapolis, IN 46202 USA; [Lawitz, Eric J.] Alamo Med Res, San Antonio, TX USA; [McCone, Jonathan] Mt Vernon Endoscopy Ctr, Alexandria, VA USA; [Schiff, Eugene R.] Univ Miami, Div Hepatol, Miami, FL USA; [Vierling, John M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Vierling, John M.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Pound, David] Indianapolis Gastroenterol Res Fdn, Indianapolis, IN USA; [Davis, Mitchell N.] Digest CARE S Florida Ctr Gastroenterol, Wellington, FL USA; [Galati, Joseph S.] Liver Specialists Texas, Houston, TX USA; [Gordon, Stuart C.] Henry Ford Hosp, Detroit, MI 48202 USA; [Ravendhran, Natarajan] St Agnes Hosp, Dept Gastroenterol & Liver Dis, Baltimore, MD USA; [Rossaro, Lorenzo] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA; [Anderson, Frank H.] Liver & Intestinal Res Ctr, Vancouver, BC, Canada; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Rubin, Raymond] Liver Ctr Atlanta, Atlanta, GA USA; [Koury, Kenneth; Pedicone, Lisa D.; Brass, Clifford A.; Chaudhri, Eirum; Albrecht, Janice K.] Merck, Kenilworth, NJ USA	Indiana University System; Indiana University Bloomington; University of Miami; Baylor College of Medicine; Baylor College of Medicine; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California Davis; Cornell University; Merck & Company	Kwo, PY (corresponding author), Indiana Univ Sch Med, Dept Med, Div Gastroenterol Hepatol, 975 W Walnut St, Indianapolis, IN 46202 USA.		Hezode, Christophe/U-4659-2018; Rubin, Raymond/AAI-2579-2021	Davis, Mitchell/0000-0002-0526-5564	Schering, a Division of Merck	Schering, a Division of Merck	We thank the patients for their participation and support during this trial, and David McNeel and Holh Brousseau (medical writers, Sin Genens Health New York, NY, USA) fra their assistance with report preparation (funded by Schering, a Division of Merck)	Berman K, 2009, CLIN LIVER DIS, V13, P429, DOI 10.1016/j.cld.2009.05.008; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Curry S, 2008, J VIROL METHODS, V153, P156, DOI 10.1016/j.jviromet.2008.07.020; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Ferenci P, 2005, J HEPATOL, V43, P425, DOI 10.1016/j.jhep.2005.04.009; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kwo PY, 2009, HEPATOLOGY, V50, p1035A; Kwo PY, 2009, HEPATOLOGY, V50, p331A; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McGovern BH, 2008, HEPATOLOGY, V48, P1700, DOI 10.1002/hep.22563; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; SCHIFF E, 2008, J HEPATOL, V48; Sulkowski M, 2009, J HEPATOL, V50, pS51, DOI 10.1016/S0168-8278(09)60128-8; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003	28	532	567	0	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2010	376	9742					705	716		10.1016/S0140-6736(10)60934-8	http://dx.doi.org/10.1016/S0140-6736(10)60934-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20692693	Green Submitted			2022-12-28	WOS:000281582900030
J	Gehrke, S; Imai, Y; Sokol, N; Lu, BW				Gehrke, Stephan; Imai, Yuzuru; Sokol, Nicholas; Lu, Bingwei			Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression	NATURE			English	Article							LET-7 MICRORNA; DISTINCT ROLES; CELL-DEATH; DROSOPHILA; MUTATIONS; 4E-BP; GENE; IDENTIFICATION; GROWTH	Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease characterized by age-dependent degeneration of dopaminergic neurons(1,2). The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. Drosophila e2f1 and dp messenger RNAs are translationally repressed by let-7 and miR-184*, respectively. Pathogenic LRRK2 antagonizes these miRNAs, leading to the overproduction of E2F1/DP, previously implicated in cell cycle and survival control 3 and shown here to be critical for LRRK2 pathogenesis. Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic LRRK2. Conversely, increasing the level of let-7 or miR-184* attenuated pathogenic LRRK2 effects. LRRK2 associated with Drosophila Argonaute-1 (dAgo1) or human Argonaute-2 (hAgo2) of the RNA-induced silencing complex (RISC). In aged fly brain, dAgo1 protein level was negatively regulated by LRRK2. Further, pathogenic LRRK2 promoted the association of phospho-4E-BP1 with hAgo2. Our results implicate deregulated synthesis of E2F1/DP caused by the miRNA pathway impairment as a key event in LRRK2 pathogenesis and suggest novel miRNA-based therapeutic strategies.	[Gehrke, Stephan; Lu, Bingwei] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Imai, Yuzuru] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Sokol, Nicholas] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Stanford University; Tohoku University; Indiana University System; Indiana University Bloomington	Gehrke, S (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgehrke@stanford.edu; bingwei@stanford.edu	Sokol, Nicholas N/K-2761-2012; Imai, Yuzuru/AAA-6472-2019	Imai, Yuzuru/0000-0003-2924-5231; Lu, Bingwei/0000-0002-5807-7014; Sokol, Nicholas/0000-0002-2768-4102	National Institutes of Health [R01AR054926, R01MH080378, R21NS056878]; McKnight Foundation; Beckman Foundation; Sloan Foundation; MEXT in Japan; Asahi Glass Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Beckman Foundation; Sloan Foundation(Alfred P. Sloan Foundation); MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. W. Carthew, B. Dickson, B. Edgar, D. St Johnston, N. Sonenberg, W. Smith, Z. Zhang, H. Siomi, B. Hay, S. Cohen, the Vienna Drosophila RNAi Center and the Bloomington Drosophila Stock Center for fly stocks and cell line, and Bestgene Inc. for help with making gDPwt and gDPmut transgenics; N.J. Dyson, R. P. Wharton, C. Zeng, G. Meister and Y. Liu for antibodies; T. Tuschl, P. A. Sharp and Y. Tomari for plasmids; P. Sarnow and R. Cevallos for advice on polysome preparation; S. Guo and A. Fire for reading the manuscript; W. Lee and G. Silverio for technical support; and members of the Lu laboratory for discussions. This work was supported by the National Institutes of Health (R01AR054926, R01MH080378 and R21NS056878), the McKnight, Beckman and Sloan Foundations (B. L.), and the Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by MEXT in Japan and an Asahi Glass Foundation Research Grant (Y.I).	Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan SP, 2008, RNA, V14, P2104, DOI 10.1261/rna.551208; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	30	301	312	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					637	U9		10.1038/nature09191	http://dx.doi.org/10.1038/nature09191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671708	Green Accepted			2022-12-28	WOS:000280412100056
J	Wu, H; Coskun, V; Tao, JF; Xie, W; Ge, WH; Yoshikawa, K; Li, E; Zhang, Y; Sun, YE				Wu, Hao; Coskun, Volkan; Tao, Jifang; Xie, Wei; Ge, Weihong; Yoshikawa, Kazuaki; Li, En; Zhang, Yi; Sun, Yi Eve			Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes	SCIENCE			English	Article							DE-NOVO METHYLATION; METHYLTRANSFERASES DNMT3A; NERVOUS-SYSTEM; HUMAN GENOME; HISTONE H3; HYPERMETHYLATION; EXPRESSION; DOMAIN; CELLS	DNA methylation at proximal promoters facilitates lineage restriction by silencing cell type-specific genes. However, euchromatic DNA methylation frequently occurs in regions outside promoters. The functions of such nonproximal promoter DNA methylation are unclear. Here we show that the de novo DNA methyltransferase Dnmt3a is expressed in postnatal neural stem cells (NSCs) and is required for neurogenesis. Genome-wide analysis of postnatal NSCs indicates that Dnmt3a occupies and methylates intergenic regions and gene bodies flanking proximal promoters of a large cohort of transcriptionally permissive genes, many of which encode regulators of neurogenesis. Surprisingly, Dnmt3a-dependent nonproximal promoter methylation promotes expression of these neurogenic genes by functionally antagonizing Polycomb repression. Thus, nonpromoter DNA methylation by Dnmt3a may be used for maintaining active chromatin states of genes critical for development.	[Wu, Hao; Ge, Weihong; Sun, Yi Eve] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Coskun, Volkan; Tao, Jifang; Sun, Yi Eve] Univ Calif Los Angeles, Semel Inst Neurosci, Intellectual Dev & Disabil Res Ctr, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Xie, Wei] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 5650871, Japan; [Li, En] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Osaka University; Novartis; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Wu, H (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	haowu7@gmail.com; ysun@mednet.ucla.edu	feng, jian/G-9313-2011; Xie, Wei/J-1380-2017; Wu, Hao/G-4145-2013	Xie, Wei/0000-0003-2126-3849; Wu, Hao/0000-0002-1256-6891; Zhang, Yi/0000-0002-2789-0811; Wu, Hao/0000-0003-4395-6929	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Carey (UCLA) for technical assistance on in vitro chromatin recruitment assays and J. Rubenstein (University of California San Francisco) for providing the pCAG-Dlx2 expression plasmid. This work was supported by NIH RO1 grants to Y.E.S. All microarray data are deposited in Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE22476.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rush Margaret, 2009, Epigenetics, V4, P404; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	26	441	454	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					444	448		10.1126/science.1190485	http://dx.doi.org/10.1126/science.1190485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651149	Green Accepted, Green Published			2022-12-28	WOS:000280196500038
J	Chiao, EY; Dezube, BJ; Krown, SE; Wachsman, W; Brock, MV; Giordano, TP; Mitsuyasu, R; Pantanowitz, L				Chiao, Elizabeth Y.; Dezube, Bruce J.; Krown, Susan E.; Wachsman, William; Brock, Malcolm V.; Giordano, Thomas P.; Mitsuyasu, Ronald; Pantanowitz, Liron			Time for Oncologists to Opt In for Routine Opt-Out HIV Testing?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-RELATED MALIGNANCIES; SQUAMOUS-CELL CARCINOMA; HEALTH-CARE SETTINGS; LUNG-CANCER; INFECTED PATIENTS; UNITED-STATES; ANAL CANCER; DEFINING CANCERS	Human immunodeficiency virus (HIV)-infected individuals are at high risk of malignancies. However, it is not currently the standard of care to routinely test cancer patients for HIV. In 2006, the Centers for Disease Control and Prevention recommended HIV testing in all health care settings, calling for standard nontargeted "opt-out" HIV screening. For a variety of reasons, routine opt-out HIV testing is still not widely used in the United States. Although many barriers to routine opt-out HIV testing have been addressed, such opt-out HIV testing continues to be conducted primarily in venues that target specific patient populations such as pregnant women. Although opt-out testing has been piloted in emergency departments, less emphasis has been placed on opt-out HIV testing in other clinical settings. In this article, the background, rationale, and evidence for supporting opt-out HIV testing as routine care for cancer patients are presented. In addition, evidence is discussed for the potential of opt-out HIV testing to improve clinical outcomes by facilitating appropriate HIV management during cancer treatment for individuals who are found to be HIV positive. JAMA. 2010;304(3):334-339 www.jama.com	[Chiao, Elizabeth Y.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Chiao, Elizabeth Y.; Giordano, Thomas P.] Dept Vet Affairs Med Ctr, Houston, TX USA; [Dezube, Bruce J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA; [Krown, Susan E.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Wachsman, William] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Brock, Malcolm V.] Johns Hopkins Med Ctr, Baltimore, MD USA; [Mitsuyasu, Ronald] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles Ctr Clin AIDS Res & Educ, Los Angeles, CA 90095 USA; [Pantanowitz, Liron] Tufts Univ, Sch Med, Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baystate Medical Center; Tufts University	Chiao, EY (corresponding author), Michael E DeBakey VA Med Ctr 152, Houston VA Hlth Serv Res & Dev, 2002 Holcombe Blvd, Houston, TX 77030 USA.	echiao@bcm.edu	Pantanowitz, Liron/AFP-8163-2022	Chiao, Elizabeth/0000-0001-5752-2916; Giordano, Thomas/0000-0002-9346-5530	National Cancer Institute [UO1 CA 121947]; Houston VA Health Services Research and Development Center of Excellence [HFP90-020]; National Cancer Institute, National Institutes of Health [K23CA124318]; NATIONAL CANCER INSTITUTE [U01CA121947, K23CA124318] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Houston VA Health Services Research and Development Center of Excellence; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This material is based on work supported by National Cancer Institute grant UO1 CA 121947 to the AIDS Malignancy Consortium. This work was also supported in part by the Houston VA Health Services Research and Development Center of Excellence (grant HFP90-020). Dr Chiao received support from the National Cancer Institute, National Institutes of Health, grant K23CA124318.	Abramowitz L, 2009, ALIMENT PHARM THER, V30, P414, DOI 10.1111/j.1365-2036.2009.04026.x; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Berenguer J, 2008, JAIDS-J ACQ IMM DEF, V47, P422, DOI 10.1097/QAI.0b013e31815e722b; Besson C, 2001, BLOOD, V98, P2339, DOI 10.1182/blood.V98.8.2339; Bower M, 2004, JAIDS-J ACQ IMM DEF, V37, P1563, DOI 10.1097/00126334-200412150-00004; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; Bower M, 2009, AIDS, V23, P1701, DOI 10.1097/QAD.0b013e32832d080d; Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brock MV, 2006, JAIDS-J ACQ IMM DEF, V43, P47, DOI 10.1097/01.qai.0000232260.95288.93; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Cave J, 2009, CLIN MED, V9, P320, DOI 10.7861/clinmedicine.9-4-320; *CDCP, 2005, HIV AIDS SURV REP CA, V16; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Clarke CA, 2004, JAIDS-J ACQ IMM DEF, V36, P1083, DOI 10.1097/00126334-200408150-00012; Cunningham CO, 2009, AIDS PATIENT CARE ST, V23, P619, DOI 10.1089/apc.2009.0005; Deeken JF, 2009, CURR OPIN ONCOL, V21, P445, DOI 10.1097/CCO.0b013e32832f3e04; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hakimian R, 2007, J THORAC ONCOL, V2, P268, DOI 10.1097/01.JTO.0000263707.31202.d7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hoffmann C, 2004, BRIT J HAEMATOL, V125, P455, DOI 10.1111/j.1365-2141.2004.04934.x; Hogg ME, 2009, DIS COLON RECTUM, V52, P891, DOI 10.1007/DCR.0b013e31819eefa6; KAPLAN L D, 1989, Journal of the American Medical Association, V261, P719, DOI 10.1001/jama.261.5.719; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; KNOWLES DM, 1988, ANN INTERN MED, V108, P744, DOI 10.7326/0003-4819-108-5-744; Lavole A, 2009, LUNG CANCER, V65, P345, DOI 10.1016/j.lungcan.2008.11.018; Levine AM, 2008, CURR OPIN ONCOL, V20, P522, DOI 10.1097/CCO.0b013e3283094ec7; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309; Oehler-Jaenne C, 2008, J CLIN ONCOL, V26, P2550, DOI 10.1200/JCO.2007.15.2348; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Powles T, 2003, BRIT J CANCER, V89, P457, DOI 10.1038/sj.bjc.6601111; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Remick SC, 1996, HEMATOL ONCOL CLIN N, V10, P1203, DOI 10.1016/S0889-8588(05)70394-4; Seo Y, 2009, INT J RADIAT ONCOL, V75, P143, DOI 10.1016/j.ijrobp.2008.10.046; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Spano JP, 2008, J CLIN ONCOL, V26, P4834, DOI 10.1200/JCO.2008.16.8252; SRIDHAR KS, 1992, CHEST, V102, P1704, DOI 10.1378/chest.102.6.1704; Stadler RF, 2004, DIS COLON RECTUM, V47, P1305, DOI 10.1007/s10350-004-0584-1; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sturtevant D, 2009, CAN J PUBLIC HEALTH, V100, P116, DOI 10.1007/BF03405519; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Tirelli U, 2000, CANCER-AM CANCER SOC, V88, P563, DOI 10.1002/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D; *US DEP HHS, 2009, MED EXP LIST COV PRE	50	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					334	339		10.1001/jama.2010.752	http://dx.doi.org/10.1001/jama.2010.752			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639567	Green Submitted, Green Accepted			2022-12-28	WOS:000280107500023
J	Sabin, M; Lo, YR				Sabin, Miriam; Lo, Ying-Ru			Progress in Providing HIV Testing and Counseling in Health Facilities WHO/UNAIDS Guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sabin, Miriam; Lo, Ying-Ru] WHO, HIV Dept, CH-1211 Geneva, Switzerland	World Health Organization	Sabin, M (corresponding author), WHO, HIV Dept, 20 Ave Apia, CH-1211 Geneva, Switzerland.	sabinm@unaids.org		Sabin, Miriam/0000-0002-7758-8338				Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Leon N, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-8; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; *WHO, 2009, PREV MOTH TO CHILD T; WHO, 2011, DEL HIV TEST RES MES; WHO, UN ACC; *WHO, HIV TEST COUNS PRIS; WHO, GUID PROV IN HIV TES	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					342	343		10.1001/jama.2010.995	http://dx.doi.org/10.1001/jama.2010.995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639569				2022-12-28	WOS:000280107500025
J	Davies, P				Davies, Peter			Private Finance Initiative Hard times: is this the end of the road for the private finance initiative?	BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com						Edwards C, 2009, PRIVATE GAIN PUBLIC; HELLOWELL M, 2008, IS PFI CRITICAL LIST; HELM T, 2009, OBSERVER        1115; MCKINSEY, 2009, 200910201314 NHS; National Audit Office, 2010, PERF MAN HOSP PFI CO; ODOWD A, 2005, BRIT MED J, V331, P1042; [No title captured]	7	4	4	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2010	341								c3828	10.1136/bmj.c3828	http://dx.doi.org/10.1136/bmj.c3828			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GV	20647288				2022-12-28	WOS:000280411600007
J	Elley, CR; Selak, V				Elley, C. Raina; Selak, Vanessa			Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Elley, C. Raina; Selak, Vanessa] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Elley, CR (corresponding author), Univ Auckland, Auckland 1, New Zealand.							Calonge N, 2009, ANN INTERN MED, V150, P396; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Saha SA, 2007, AM HEART J, V154, P943, DOI 10.1016/j.ahj.2007.07.011	6	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-4	10.7326/0003-4819-153-2-201007200-02004	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643982				2022-12-28	WOS:000280095400022
J	Smith, SA				Smith, Steven A.			Higher "normal" glycated hemoglobin levels were associated with increased risk for diabetes, CVD, stroke, and mortality in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mayo Clin Rochester, Rochester, MN 55905 USA	Mayo Clinic	Smith, SA (corresponding author), Mayo Clin Rochester, Rochester, MN 55905 USA.		Smith, Steven/HDM-9496-2022					Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe64, DOI 10.2337/dc09-zb06; Fonseca V, 2009, DIABETES CARE, V32, P1344, DOI 10.2337/dc09-9034; Holmes EW, 2008, AM J CLIN PATHOL, V129, P540, DOI 10.1309/U3GPPTCBP1VLL8AW; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Selvin E, 2009, DIABETES CARE, V32, P828, DOI 10.2337/dc08-1699	5	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-13	10.7326/0003-4819-153-2-201007200-02013	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643979				2022-12-28	WOS:000280095400031
J	Gavidia, T; Brune, MN; McCarty, KM; Pronczuk, J; Etzel, R; Neira, M; Carpenter, DO; Suk, WA; Arnold, RG; Ha, EH; Sly, PD				Gavidia, Tania; Brune, Marie-Noel; McCarty, Kathleen M.; Pronczuk, Jenny; Etzel, Ruth; Neira, Maria; Carpenter, David O.; Suk, William A.; Arnold, Robert G.; Ha, Eun Hee; Sly, Peter D.			Children's environmental health-from knowledge to action	LANCET			English	Editorial Material									[Gavidia, Tania; Sly, Peter D.] WHO Collaborating Ctr Res Childrens Environm Hlth, Perth, WA, Australia; [Brune, Marie-Noel; Pronczuk, Jenny; Etzel, Ruth; Neira, Maria] WHO, Dept Publ Hlth & Environm, CH-1211 Geneva, Switzerland; [McCarty, Kathleen M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Environm Hlth Sci, New Haven, CT 06510 USA; [Pronczuk, Jenny] Univ Republica, Dept Toxicol, Montevideo, Uruguay; [Carpenter, David O.] SUNY Albany, Inst Hlth & Environm, Rensselaer, NY USA; [Suk, William A.] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Arnold, Robert G.] Univ Arizona, Chem & Environm Engn Dept, Tucson, AZ USA; [Ha, Eun Hee] Ewha Womans Univ, Dept Prevent Med, Seoul, South Korea; [Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia	World Health Organization; Yale University; Universidad de la Republica, Uruguay; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Arizona; Ewha Womans University; University of Queensland	Sly, PD (corresponding author), WHO Collaborating Ctr Res Childrens Environm Hlth, Perth, WA, Australia.	p.sly@uq.edu.au	Etzel, Ruth A./N-5700-2019; Sly, Peter D/F-1486-2010	Etzel, Ruth A./0000-0002-5236-3976; Sly, Peter D/0000-0001-6305-2201				*PAC BAS CONS, 2009, PERTH DECL GLOB RED; Suk WA, 2003, ENVIRON HEALTH PERSP, V111, P1340, DOI 10.1289/ehp.6059; WHO, 2009, 3 WHO INT C CHILDR H; 2009, 3 INT C CHILDR HLTH; 2009, PAC BAS CONS C 2009	5	13	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1134	1136		10.1016/S0140-6736(10)60929-4	http://dx.doi.org/10.1016/S0140-6736(10)60929-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	20667587				2022-12-28	WOS:000289539300009
J	Qu, DX; Hor, YS; Xiong, J; Cava, RJ; Ong, NP				Qu, Dong-Xia; Hor, Y. S.; Xiong, Jun; Cava, R. J.; Ong, N. P.			Quantum Oscillations and Hall Anomaly of Surface States in the Topological Insulator Bi2Te3	SCIENCE			English	Article							PHASE	Topological insulators are insulating materials that display massless, Dirac-like surface states in which the electrons have only one spin degree of freedom on each surface. These states have been imaged by photoemission, but little information on their transport parameters, for example, mobility, is available. We report the observation of Shubnikov-de Haas oscillations arising from the surface states in nonmetallic crystals of Bi2Te3. In addition, we uncovered a Hall anomaly in weak fields, which enables the surface current to be seen directly. Both experiments yield a surface mobility (9000 to 10,000 centimeter(2) per volt-second) that is substantially higher than in the bulk. The Fermi velocity of 4 x 10(5) meters per second obtained from these transport experiments agrees with angle-resolved photoemission experiments.	[Qu, Dong-Xia; Xiong, Jun; Ong, N. P.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Hor, Y. S.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Qu, DX (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	dqu@princeton.edu; npo@princeton.edu	Ong, N. Phuan/Z-1626-2019; li, yuan/B-4627-2011; San Hor, Yew/S-1429-2017	San Hor, Yew/0000-0002-1417-4357; Ong, N. Phuan/0000-0001-7166-1058; Qu, Dong-Xia/0000-0001-7623-4207	NSF under Materials Research Science and Engineering Centers [DMR-0819860]; NSF [DMR-0084173]; state of Florida; U.S. Department of Energy	NSF under Materials Research Science and Engineering Centers; NSF(National Science Foundation (NSF)); state of Florida; U.S. Department of Energy(United States Department of Energy (DOE))	The research is supported by NSF under Materials Research Science and Engineering Centers grant DMR-0819860. We acknowledge valuable comments by J. G. Checkelsky, M. Z. Hasan, A. Yazdani, A. Bernevig, and F. D. M. Haldane. High-field measurements were carried out at the National High Magnetic Field Laboratory, Tallahassee, which is supported by NSF cooperative agreement no. DMR-0084173, by the state of Florida, and by the U.S. Department of Energy.	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Checkelsky JG, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246601; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Gusynin VP, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.125124; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Taskin AA, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085303; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274	15	705	715	10	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					821	824		10.1126/science.1189792	http://dx.doi.org/10.1126/science.1189792			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20671155				2022-12-28	WOS:000280809900045
J	Reich, PB				Reich, Peter B.			The Carbon Dioxide Exchange	SCIENCE			English	Editorial Material							SOIL RESPIRATION; TEMPERATURE SENSITIVITY; THERMAL-ACCLIMATION; VEGETATION; Q(10); MODEL		Univ Minnesota, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Reich, PB (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	preich@umn.edu		Reich, Peter/0000-0003-4424-662X				Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Atkin OK, 2008, GLOBAL CHANGE BIOL, V14, P2709, DOI 10.1111/j.1365-2486.2008.01664.x; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bolstad PV, 2003, TREE PHYSIOL, V23, P969, DOI 10.1093/treephys/23.14.969; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; Gu LH, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003164; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Malcolm GM, 2008, GLOBAL CHANGE BIOL, V14, P1169, DOI 10.1111/j.1365-2486.2008.01555.x; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Tjoelker MG, 2008, GLOBAL CHANGE BIOL, V14, P782, DOI 10.1111/j.1365-2486.2008.01548.x; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Wythers KR, 2005, GLOBAL CHANGE BIOL, V11, P435, DOI 10.1111/j.1365-2486.2005.00922.x	16	35	37	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					774	775		10.1126/science.1194353	http://dx.doi.org/10.1126/science.1194353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705842	Green Submitted			2022-12-28	WOS:000280809900028
J	Zhang, APP; Pigli, YZ; Rice, PA				Zhang, Adrianna P. P.; Pigli, Ying Z.; Rice, Phoebe A.			Structure of the LexA-DNA complex and implications for SOS box measurement	NATURE			English	Article							NONCONTACTED BASES; CRYSTAL-STRUCTURE; OPERATOR COMPLEX; BINDING DOMAIN; REPRESSOR; PROTEIN; AFFINITY; IDENTIFICATION; ROTATION; CONTACTS	The eubacterial SOS system is a paradigm of cellular DNA damage and repair, and its activation can contribute to antibiotic resistance(1-3). Under normal conditions, LexA represses the transcription of many DNA repair proteins by binding to SOS 'boxes' in their operators. Under genotoxic stress, accumulating complexes of RecA, ATP and single-stranded DNA (ssDNA) activate LexA for autocleavage. To address how LexA recognizes its binding sites, we determined three crystal structures of Escherichia coli LexA in complex with SOS boxes. Here we report the structure of these LexA-DNA complexes. The DNA-binding domains of the LexA dimer interact with the DNA in the classical fashion of a winged helix-turn-helix motif. However, the wings of these two DNA-binding domains bind to the same minor groove of the DNA. These wing-wing contacts may explain why the spacing between the two half-sites of E. coli SOS boxes is invariant.	[Pigli, Ying Z.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Zhang, Adrianna P. P.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	price@uchicago.edu			National Institutes of Health [GM058827]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Harris and O. Adekeye for help with crystal growth and optimization; Y.-L.C. Leung for advice on DNA-binding assays; S. Montano and other members of the Rice laboratory for help and discussions; the staffs at beamlines BioCARS 14, SBC 19-ID and 19-BM, and LS-CAT 21-ID-F at the Advanced Photon Source, Argonne National Laboratory, for helping with the synchrotron X-ray data collection. The research is supported in part by National Institutes of Health grant GM058827.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Butala M, 2007, FEBS LETT, V581, P4816, DOI 10.1016/j.febslet.2007.09.006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DUMOULIN P, 1993, P NATL ACAD SCI USA, V90, P2030, DOI 10.1073/pnas.90.5.2030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Garnett JA, 2008, J MOL BIOL, V379, P284, DOI 10.1016/j.jmb.2008.03.007; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; HURSTEL S, 1988, EMBO J, V7, P269, DOI 10.1002/j.1460-2075.1988.tb02809.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KNEGTEL RMA, 1995, PROTEINS, V21, P226, DOI 10.1002/prot.340210305; KOUDELKA GB, 1992, NATURE, V355, P89, DOI 10.1038/355089a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; OERTELBUCHHEIT P, 1990, MOL GEN GENET, V223, P40, DOI 10.1007/BF00315795; OERTELBUCHHEIT P, 1992, J MOL BIOL, V225, P609, DOI 10.1016/0022-2836(92)90389-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Shinagawa H, 1996, EXS, V77, P221; THLIVERIS AT, 1992, P NATL ACAD SCI USA, V89, P4500, DOI 10.1073/pnas.89.10.4500; THLIVERIS AT, 1991, BIOCHIMIE, V73, P449, DOI 10.1016/0300-9084(91)90112-E; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; WALKER GC, 1985, ANNU REV BIOCHEM, V54, P425, DOI 10.1146/annurev.bi.54.070185.002233; WU L, 1992, J BIOL CHEM, V267, P9134	39	70	76	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					883	U119		10.1038/nature09200	http://dx.doi.org/10.1038/nature09200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703307	Green Accepted			2022-12-28	WOS:000280766100040
J	Autier, P; Boniol, M; LaVecchia, C; Vatten, L; Gavin, A; Hery, C; Heanue, M				Autier, Philippe; Boniol, Mathieu; LaVecchia, Carlo; Vatten, Lars; Gavin, Anna; Hery, Clarisse; Heanue, Mary			Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CALMAN-HINE REPORT; RISK-FACTORS; TUMOR CHARACTERISTICS; SCREENING-PROGRAMS; TIME TRENDS; SURVIVAL; IMPACT; WOMEN; RATES; STAGE	Objective To examine changes in temporal trends in breast cancer mortality in women living in 30 European countries. Design Retrospective trend analysis. Data source WHO mortality database on causes of deaths Subjects reviewed Female deaths from breast cancer from 1989 to 2006 Main outcome measures Changes in breast cancer mortality for all women and by age group (<50, 50-69, and >= 70 years) calculated from linear regressions of log transformed, age adjusted death rates. Joinpoint analysis was used to identify the year when trends in all age mortality began to change. Results From 1989 to 2006, there was a median reduction in breast cancer mortality of 19%, ranging from a 45% reduction in Iceland to a 17% increase in Romania. Breast cancer mortality decreased by >= 20% in 15 countries, and the reduction tended to be greater in countries with higher mortality in 1987-9. England and Wales, Northern Ireland, and Scotland had the second, third, and fourth largest decreases of 35%, 29%, and 30%, respectively. In France, Finland, and Sweden, mortality decreased by 11%, 12%, and 16%, respectively. In central European countries mortality did not decline or even increased during the period. Downward mortality trends usually started between 1988 and 1996, and the persistent reduction from 1999 to 2006 indicates that these trends may continue. The median changes in the age groups were -37% (range -76% to -14%) in women aged <50, -21% (-40% to 14%) in 50-69 year olds, and -2% (-42% to 80%) in >= 70 year olds. Conclusions Changes in breast cancer mortality after 1988 varied widely between European countries, and the UK is among the countries with the largest reductions. Women aged <50 years showed the greatest reductions in mortality, also in countries where screening at that age is uncommon. The increasing mortality in some central European countries reflects avoidable mortality.	[Autier, Philippe; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France; [Autier, Philippe; Boniol, Mathieu; Hery, Clarisse; Heanue, Mary] Int Agcy Res Canc, F-69372 Lyon, France; [LaVecchia, Carlo] Univ Milan, Mario Negri Inst, Milan, Italy; [LaVecchia, Carlo] Univ Milan, Sch Med, Milan, Italy; [Vatten, Lars] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Gavin, Anna] Queens Univ, No Ireland Canc Registry, Belfast, Antrim, North Ireland	World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Milan; Norwegian University of Science & Technology (NTNU); Queens University Belfast	Autier, P (corresponding author), Int Prevent Res Inst, 95 Cours Lafayette, F-69006 Lyon, France.	philippe.autier@i-pri.org	Vatten, Lars/AAF-9380-2022; Autier, Philippe/A-4402-2014; Vatten, Lars/AFK-2073-2022; Boniol, Mathieu/F-9623-2011	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; La Vecchia, Carlo/0000-0003-1441-897X	Public Health Agency for Northern Ireland	Public Health Agency for Northern Ireland	Institutions in which authors work had no influence in the conduct of the research or in the writing of the paper. The work of the Northern Ireland Cancer Registry is funded by the Public Health Agency for Northern Ireland	ABADIE C, 2002, REV MED ASS MALADIE, V33, P267; [Anonymous], 2007, LANCET, V369, P1665, DOI 10.1093/annonc/mdm096; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; AUGUST DA, 1994, ANN SURG ONCOL, V1, P45, DOI 10.1007/BF02303540; Autier P, 2008, BRIT J CANCER, V99, P1185, DOI 10.1038/sj.bjc.6604657; Autier P, 2007, LANCET ONCOL, V8, P1050, DOI 10.1016/S1470-2045(07)70354-6; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Bernardi D, 2008, ACTA ONCOL, V47, P187, DOI 10.1080/02841860701630234; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bradburn MJ, 1998, BRIT J CANCER, V77, P1944, DOI 10.1038/bjc.1998.322; Burke JP, 2008, EJSO-EUR J SURG ONC, V34, P149, DOI 10.1016/j.ejso.2007.03.025; Chiu C, 2006, CANCER CAUSE CONTROL, V17, P153, DOI 10.1007/s10552-005-2368-x; Coebergh JW, 2008, EUR J CANCER, V44, P1341, DOI 10.1016/j.ejca.2008.04.010; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Doll R, 1981, CAUSES CANC; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P52, DOI 10.1158/1055-9965.EPI-05-0953; Eaker S, 2006, PLOS MED, V3, P321, DOI 10.1371/journal.pmed.0030025; *EUR COMM, 2008, CANC SCREEN EUR UN E; Fracheboud J, 2004, BRIT J CANCER, V91, P861, DOI 10.1038/sj.bjc.6602075; Fritsch B, 2007, PRESSE MED, V36, P1712, DOI 10.1016/j.lpm.2007.03.046; Hermon C, 1996, BRIT J CANCER, V73, P955, DOI 10.1038/bjc.1996.171; Hery C, 2008, ANN ONCOL, V19, P1009, DOI 10.1093/annonc/mdm593; Hery C, 2008, ANN ONCOL, V19, P1187, DOI 10.1093/annonc/mdn025; Hofvind S, 2008, ACTA ONCOL, V47, P225, DOI 10.1080/02841860701518041; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jonsson B, 2007, ANN ONCOL, V18, P1, DOI 10.1093/annonc/mdm095; Jonsson B, 2009, EUR J CANCER, V45, P1100, DOI 10.1016/j.ejca.2009.01.035; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Klug SJ, 2005, EUR J PUBLIC HEALTH, V15, P70, DOI 10.1093/eurpub/cki118; Kumle M, 2008, LANCET, V372, P608, DOI 10.1016/S0140-6736(08)61255-6; Levi F, 2005, EUR J CANCER PREV, V14, P497, DOI 10.1097/00008469-200512000-00002; Lutz JM, 2004, EUR J CANCER PREV, V13, P77, DOI 10.1097/00008469-200402000-00012; Madhavan KS, 2002, BREAST, V11, P265, DOI 10.1054/brst.2001.0410; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McCann J, 1998, J MED SCREEN, V5, P42, DOI 10.1136/jms.5.1.42; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Micheli A, 2003, ANN ONCOL, V14, pV41, DOI 10.1093/annonc/mdg753; Monaghan P, 2005, J PUBLIC HEALTH, V27, P171, DOI 10.1093/pubmed/fdi003; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Morris E, 2008, ANN ONCOL, V19, P284, DOI 10.1093/annonc/mdm432; Morris E, 2007, EUR J CANCER CARE, V16, P150, DOI 10.1111/j.1365-2354.2006.00723.x; *NAT CANC I, 2009, JOIPOINT REGR PROGR; *NAT EV TEAM BREAS, 2005, NAT EV BREAST CANC S; NYSTROM L, 1995, ACTA ONCOL, V34, P145, DOI 10.3109/02841869509093948; Pisani P, 2004, BRIT J CANCER, V90, P652, DOI 10.1038/sj.bjc.6601614; Ray-Coquard I, 2005, J CLIN ONCOL, V23, P4414, DOI 10.1200/JCO.2005.01.040; Siebel Marisa F, 2005, Curr Oncol Rep, V7, P23, DOI 10.1007/s11912-005-0022-0; Sobotka T, 2003, POPULATION, V58, P511, DOI 10.2307/3271307; Spyckerelle Y, 2002, B CANCER, V89, P957; Sukel MPP, 2008, EUR J CANCER, V44, P1846, DOI 10.1016/j.ejca.2008.06.001; Valentini M, 1999, ANN ONCOL, V10, P789, DOI 10.1023/A:1008355014886; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Vervoort MM, 2004, BRIT J CANCER, V91, P242, DOI 10.1038/sj.bjc.6601969; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; *WOM HLTH COUNC, 2008, BREAT CANC TREATM RE; World Health Organization, 2009, MORT DAT; World Health Organization, 2009, WHO STAT INF SYST; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; 2007, LANCET ONCOL, V8, P747	62	245	251	2	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2010	341								c3620	10.1136/bmj.c3620	http://dx.doi.org/10.1136/bmj.c3620			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DR	20702548	Green Published, hybrid			2022-12-28	WOS:000281028900002
J	Conacci-Sorrell, M; Ngouenet, C; Eisenman, RN				Conacci-Sorrell, Maralice; Ngouenet, Celine; Eisenman, Robert N.			Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes alpha-Tubulin Acetylation and Cell Differentiation	CELL			English	Article							C-MYC; IN-VIVO; CYTOSKELETAL ORGANIZATION; ESSENTIAL COFACTOR; SELF-RENEWAL; STEM-CELLS; PROTEIN; CALPAIN; TRANSCRIPTION; INVOLVEMENT	The Myc oncoprotein family comprises transcription factors that control multiple cellular functions and are widely involved in oncogenesis. Here we report the identification of Myc-nick, a cytoplasmic form of Myc generated by calpain-dependent proteolysis at lysine 298 of full-length Myc. Myc-nick retains conserved Myc box regions but lacks nuclear localization signals and the bHLHZ domain essential for heterodimerization with Max and DNA binding. Myc-nick induces alpha-tubulin acetylation and altered cell morphology by recruiting histone acetyltransferase GCN5 to microtubules. During muscle differentiation, while the levels of full-length Myc diminish, Myc-nick and acetylated alpha-tubulin levels are increased. Ectopic expression of Myc-nick accelerates myoblast fusion, triggers the expression of myogenic markers, and permits Myc-deficient fibroblasts to transdifferentiate in response to MyoD. We propose that the cleavage of Myc by calpain abrogates the transcriptional inhibition of differentiation by fulllength Myc and generates Myc-nick, a driver of cytoplasmic reorganization and differentiation.	[Conacci-Sorrell, Maralice; Ngouenet, Celine; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	eisenman@fhcrc.org	Sorrell, Maralice/ABD-6764-2021		EMBO; NIH/NCI [CA20525]; NATIONAL CANCER INSTITUTE [R37CA020525, R01CA020525] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Nao Ikegaki, William Tansey, John Sedivy, and Peter Hurlin for reagents essential for this work. We also thank Stephen Tapscott, Maura Parker, Hector Rincon, Bill Carter, Linda Wordeman, and members of the Eisenman lab for advice and discussion. M.C.-S. was a recipient of an EMBO Long-Term Fellowship. This work was supported by NIH/NCI grant CA20525 (R.N.E.).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BAI MK, 1994, ONCOLOGY, V51, P314; Calcagno DQ, 2009, ANTICANCER RES, V29, P2479; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gonen H, 1997, FEBS LETT, V406, P17, DOI 10.1016/S0014-5793(97)00225-1; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; KUMAR A, 1992, CELL MOL BIOL, V38, P477; Mailhes John B, 2002, Cell Chromosome, V1, P2, DOI 10.1186/1475-9268-1-2; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Moyen C, 2004, INT J BIOCHEM CELL B, V36, P728, DOI 10.1016/S1357-2725(03)00265-6; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okano HJ, 1999, GENE DEV, V13, P2087, DOI 10.1101/gad.13.16.2087; PIETILAINEN T, 1995, ANTICANCER RES, V15, P959; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taira T, 1998, GENES CELLS, V3, P549, DOI 10.1046/j.1365-2443.1998.00206.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tworkowski KA, 2002, ONCOGENE, V21, P8515, DOI 10.1038/sj.onc.1205976; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; WAKAMATSU Y, 1993, NEURON, V10, P1, DOI 10.1016/0896-6273(93)90236-K; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	51	159	163	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					480	493		10.1016/j.cell.2010.06.037	http://dx.doi.org/10.1016/j.cell.2010.06.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691906	Bronze, Green Accepted			2022-12-28	WOS:000280609100024
J	Kaya, D; Green, NL; Maloney, CE; Islam, MF				Kaya, D.; Green, N. L.; Maloney, C. E.; Islam, M. F.			Normal Modes and Density of States of Disordered Colloidal Solids	SCIENCE			English	Article							BOSON PEAK; VIBRATIONAL EXCITATIONS; GLASS; CRYSTALS; PHONONS; SYSTEMS	The normal modes and the density of states (DOS) of any material provide a basis for understanding its thermal and mechanical transport properties. In perfect crystals, normal modes are plane waves, but they can be complex in disordered systems. We have experimentally measured normal modes and the DOS in a disordered colloidal crystal. The DOS shows Debye-like behavior at low energies and an excess of modes, or Boson peak, at higher energies. The normal modes take the form of plane waves hybridized with localized short wavelength features in the Debye regime but lose both longitudinal and transverse plane-wave character at a common energy near the Boson peak.	[Kaya, D.; Islam, M. F.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA; [Green, N. L.; Islam, M. F.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Maloney, C. E.] Carnegie Mellon Univ, Dept Civil & Environm Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Islam, MF (corresponding author), Carnegie Mellon Univ, Dept Mat Sci & Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	mohammad@cmu.edu	Kaya, Defne/AAE-8707-2019; Kaya, Deniz/A-2832-2016; Islam, Mohammad/B-7211-2011; Maloney, Craig/A-1923-2012	Kaya, Deniz/0000-0002-1951-2466; Islam, Mohammad/0000-0001-9253-3709; 	NSF [DMR-0645596, DMR-0619424]; Sloan Foundation; American Chemical Society	NSF(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); American Chemical Society(American Chemical Society)	We acknowledge M. Widom, A. D. Dinsmore, and J. C. Crocker for valuable discussions. This work was supported by NSF through grants DMR-0645596 and DMR-0619424 (M. F. I.), the Sloan Foundation (M. F. I.), and American Chemical Society Petroleum Research Fund (M.F.I.).	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; Ashcroft N.W., 1976, SOLID STATE PHYS; Baumgartl J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.205503; Chaikin P. M., 2000, PRINCIPLES CONDENSED; Cheng ZD, 2000, PHYS REV LETT, V85, P1460, DOI 10.1103/PhysRevLett.85.1460; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X; ELLIOTT RJ, 1974, REV MOD PHYS, V46, P465, DOI 10.1103/RevModPhys.46.465; Elliott S.R., 1990, PHYS AMORPHOUS MAT; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Ghosh A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.248305; Ghosh A, 2010, SOFT MATTER, V6, P3082, DOI 10.1039/c0sm00265h; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; Keim P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.215504; LAIRD BB, 1991, PHYS REV LETT, V66, P636, DOI 10.1103/PhysRevLett.66.636; Mattsson J, 2009, NATURE, V462, P83, DOI 10.1038/nature08457; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Reinke D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038301; Schirmacher W, 1998, PHYS REV LETT, V81, P136, DOI 10.1103/PhysRevLett.81.136; Schober HR, 2004, J PHYS-CONDENS MAT, V16, pS2659, DOI 10.1088/0953-8984/16/27/005; Schober HR, 1996, PHYS REV B, V53, P11469, DOI 10.1103/PhysRevB.53.11469; Shintani H, 2008, NAT MATER, V7, P870, DOI 10.1038/nmat2293; Simdyankin SI, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104302; Souslov A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.205503; Strachan A, 2004, J CHEM PHYS, V120, P1, DOI 10.1063/1.1635364; Taraskin SN, 1997, PHYS REV B, V56, P8605, DOI 10.1103/PhysRevB.56.8605; Taraskin SN, 2001, PHYS REV LETT, V86, P1255, DOI 10.1103/PhysRevLett.86.1255; von Grunberg HH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255703; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	30	86	86	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					656	658		10.1126/science.1187988	http://dx.doi.org/10.1126/science.1187988			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689012				2022-12-28	WOS:000280602700031
J	Briggs, DEG				Briggs, Derek E. G.			OBITUARY Harry Whittington (1916-2010)	NATURE			English	Biographical-Item									[Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA	Yale University; Yale University	Briggs, DEG (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	derek.briggs@yale.edu							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					706	706		10.1038/466706a	http://dx.doi.org/10.1038/466706a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686564	Bronze			2022-12-28	WOS:000280562500028
J	Cobbold, JFL; Anstee, QM; Thomas, HC				Cobbold, Jeremy F. L.; Anstee, Quentin M.; Thomas, Howard C.			Rational Testing Investigating mildly abnormal serum aminotransferase values	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIVER FIBROSIS		[Cobbold, Jeremy F. L.; Anstee, Quentin M.; Thomas, Howard C.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Endocrinol Diabet & Metab, Hepatol & Gastroenterol Sect, London W2 1NY, England	Imperial College London	Anstee, QM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Endocrinol Diabet & Metab, Hepatol & Gastroenterol Sect, London W2 1NY, England.	q.anstee@imperial.ac.uk	Anstee, Quentin M./L-2981-2013	Anstee, Quentin M./0000-0002-9518-0088	Medical Research Council [G0200250, G84/6233] Funding Source: Medline; MRC [G84/6233] Funding Source: UKRI; National Institute for Health Research [CL-2007-21-007] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Uddin G, 2010, J VIRAL HEPATITIS, V17, P327, DOI 10.1111/j.1365-2893.2009.01240.x	9	21	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2010	341								c4039	10.1136/bmj.c4039	http://dx.doi.org/10.1136/bmj.c4039			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634HB	20675393				2022-12-28	WOS:000280570300002
J	Tyagi, S				Tyagi, Sanjay			GENOMICS E. coli, What a Noisy Bug	SCIENCE			English	Editorial Material							STOCHASTIC GENE-EXPRESSION; SINGLE-CELL		Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Tyagi, S (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.	tyagisa@umdnj.edu	Tyagi, Sanjay/F-1109-2010	Tyagi, Sanjay/0000-0001-7303-5827	NIMH NIH HHS [MH079197] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079197] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308	12	17	18	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					518	519		10.1126/science.1194036	http://dx.doi.org/10.1126/science.1194036			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671174				2022-12-28	WOS:000280483500019
J	Aaron, HJ				Aaron, Henry J.			The SGR for Physician Payment -- An Indispensable Abomination.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							Vladeck BC, 2010, NEW ENGL J MED, V362, P1955, DOI 10.1056/NEJMp1004709; 2008, BUDGET OPTIONS, V1, P112	2	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2010	363	5					403	405		10.1056/NEJMp1007200	http://dx.doi.org/10.1056/NEJMp1007200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GS	20647187				2022-12-28	WOS:000280411300002
J	Franson, JD				Franson, James D.			Pairs Rule Quantum Interference	SCIENCE			English	Editorial Material									Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Franson, JD (corresponding author), Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA.	jfranson@umbc.edu						Feynman R.P., 1964, FEYNMAN LECT PHYS; FRANSON JD, 1989, PHYS REV LETT, V62, P2205, DOI 10.1103/PhysRevLett.62.2205; HORNE MA, 1989, PHYS REV LETT, V62, P2209, DOI 10.1103/PhysRevLett.62.2209; Salart D, 2008, NATURE, V454, P861, DOI 10.1038/nature07121	5	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					396	397		10.1126/science.1192624	http://dx.doi.org/10.1126/science.1192624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651139				2022-12-28	WOS:000280196500021
J	Oh, DY; Olefsky, JM				Oh, Da Young; Olefsky, Jerrold M.			Wnt Fans the Flames in Obesity	SCIENCE			English	Editorial Material							INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATION		[Oh, Da Young; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Oh, DY (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	OH, DA YOUNG/B-2369-2008		NIDDK NIH HHS [DK074868, DK063491, DK033651] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, P01DK074868, R01DK033651, P30DK063491] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	9	22	25	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					397	398		10.1126/science.1193404	http://dx.doi.org/10.1126/science.1193404			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651140				2022-12-28	WOS:000280196500022
J	Dong, AG; Chen, J; Vora, PM; Kikkawa, JM; Murray, CB				Dong, Angang; Chen, Jun; Vora, Patrick M.; Kikkawa, James M.; Murray, Christopher B.			Binary nanocrystal superlattice membranes self-assembled at the liquid-air interface	NATURE			English	Article							NANOPARTICLE SUPERLATTICES; STRUCTURAL-CHARACTERIZATION; MONODISPERSE NANOCRYSTALS; ELECTRON TOMOGRAPHY; ARRAYS; CRYSTALS; PHASE; CDSE; DNA	The spontaneous organization of multicomponent micrometresized colloids(1) or nanocrystals(2) into superlattices is of scientific importance for understanding the assembly process on the nanometre scale and is of great interest for bottom-up fabrication of functional devices. In particular, co-assembly of two types of nanocrystal into binary nanocrystal superlattices (BNSLs) has recently attracted significant attention(2-8), as this provides a lowcost, programmable way to design metamaterials(4) with precisely controlled properties that arise from the organization and interactions of the constituent nanocrystal components(9). Although challenging, the ability to grow and manipulate large-scale BNSLs is critical for extensive exploration of this new class of material. Here we report a general method of growing centimetre-scale, uniform membranes of BNSLs that can readily be transferred to arbitrary substrates. Our method is based on the liquid-air interfacial assembly of multicomponent nanocrystals and circumvents the limitations associated with the current assembly strategies, allowing integration of BNSLs on any substrate for the fabrication of nanocrystal-based devices(10). We demonstrate the construction of magnetoresistive devices by incorporating large-area (1.5 mm x 32.5 mm) BNSL membranes; their magnetotransport measurements clearly show that device magnetoresistance is dependent onthe structure (stoichiometry) of the BNSLs. The ability to transfer BNSLs also allows the construction of free-standing membranes and other complex architectures that have not been accessible previously.	[Dong, Angang; Murray, Christopher B.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Chen, Jun; Murray, Christopher B.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Vora, Patrick M.; Kikkawa, James M.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Dong, AG (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	angang@sas.upenn.edu; cbmurray@sas.upenn.edu	Liu, Xin/I-7709-2015; Dong, Angang/C-5308-2014; Chen, Jun/F-7103-2014; Vora, Patrick/U-3106-2019	Dong, Angang/0000-0002-9677-8778; Vora, Patrick/0000-0003-3967-8137	US Army Research Office (ARO) [MURI W911NF-08-1-0364]; NSF [DMR-0520020]	US Army Research Office (ARO); NSF(National Science Foundation (NSF))	A.D. and C.B.M. acknowledge the financial support from the US Army Research Office (ARO) under award number MURI W911NF-08-1-0364. J.C., P.M.V. and J.M.K. are grateful for support from the NSF MRSEC programme under award number DMR-0520020. We thank C. Kagan for access to the thermal evaporator.	Aleksandrovic V, 2008, ACS NANO, V2, P1123, DOI 10.1021/nn800147a; Chen ZY, 2007, J AM CHEM SOC, V129, P15702, DOI 10.1021/ja076698z; Cheng WL, 2009, NAT MATER, V8, P519, DOI [10.1038/nmat2440, 10.1038/NMAT2440]; Cheon J, 2006, P NATL ACAD SCI USA, V103, P3023, DOI 10.1073/pnas.0508877103; Evers WH, 2009, ANGEW CHEM INT EDIT, V48, P9655, DOI 10.1002/anie.200904821; Friedrich H, 2009, NANO LETT, V9, P2719, DOI 10.1021/nl901212m; Jang SJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.212403; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Mueggenburg KE, 2007, NAT MATER, V6, P656, DOI 10.1038/nmat1965; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Overgaag K, 2008, J AM CHEM SOC, V130, P7833, DOI 10.1021/ja802932m; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Ramos AV, 2006, J APPL PHYS, V100, DOI 10.1063/1.2386927; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; Sachan M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2168438; Saunders AE, 2005, CHEMPHYSCHEM, V6, P61, DOI 10.1002/cphc.200400382; Shevchenko EV, 2006, J AM CHEM SOC, V128, P3620, DOI 10.1021/ja0564261; Shevchenko EV, 2002, J AM CHEM SOC, V124, P11480, DOI 10.1021/ja025976l; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Smith DK, 2009, J AM CHEM SOC, V131, P3281, DOI 10.1021/ja8085438; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Talapin DV, 2008, ACS NANO, V2, P1097, DOI 10.1021/nn8003179; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Taub N, 2009, J MAGN MAGN MATER, V321, P1933, DOI 10.1016/j.jmmm.2008.12.012; Tran TB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.076806; Urban JJ, 2007, NAT MATER, V6, P115, DOI 10.1038/nmat1826; Viau G, 2003, CHEM MATER, V15, P486, DOI 10.1021/cm0212109; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	30	654	658	32	869	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2010	466	7305					474	477		10.1038/nature09188	http://dx.doi.org/10.1038/nature09188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651688				2022-12-28	WOS:000280141200032
J	Frobell, RB; Roos, EM; Roos, HP; Ranstam, J; Lohmander, LS				Frobell, Richard B.; Roos, Ewa M.; Roos, Harald P.; Ranstam, Jonas; Lohmander, L. Stefan			A Randomized Trial of Treatment for Acute Anterior Cruciate Ligament Tears	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATELLAR TENDON-BONE; OUTCOME SCORE KOOS; 2-YEAR FOLLOW-UP; OPERATIVE TREATMENT; KNEE INJURY; RECONSTRUCTION; SEMITENDINOSUS; AUTOGRAFTS; GRAFTS; REHABILITATION	BACKGROUND The optimal management of a torn anterior cruciate ligament (ACL) of the knee is unknown. METHODS We conducted a randomized, controlled trial involving 121 young, active adults with acute ACL injury in which we compared two strategies: structured rehabilitation plus early ACL reconstruction and structured rehabilitation with the option of later ACL reconstruction if needed. The primary outcome was the change from baseline to 2 years in the average score on four subscales of the Knee Injury and Osteoarthritis Outcome Score (KOOS) - pain, symptoms, function in sports and recreation, and knee-related quality of life (KOOS4; range of scores, 0 [worst] to 100 [best]). Secondary outcomes included results on all five KOOS subscales, the Medical Outcomes Study 36-Item Short-Form Health Survey, and the score on the Tegner Activity Scale. RESULTS Of 62 subjects assigned to rehabilitation plus early ACL reconstruction, 1 did not undergo surgery. Of 59 assigned to rehabilitation plus optional delayed ACL reconstruction, 23 underwent delayed ACL reconstruction; the other 36 underwent rehabilitation alone. The absolute change in the mean KOOS4 score from baseline to 2 years was 39.2 points for those assigned to rehabilitation plus early ACL reconstruction and 39.4 for those assigned to rehabilitation plus optional delayed reconstruction (absolute between-group difference, 0.2 points; 95% confidence interval, -6.5 to 6.8; P=0.96 after adjustment for the baseline score). There were no significant differences between the two treatment groups with respect to secondary outcomes. Adverse events were common in both groups. The results were similar when the data were analyzed according to the treatment actually received. CONCLUSIONS In young, active adults with acute ACL tears, a strategy of rehabilitation plus early ACL reconstruction was not superior to a strategy of rehabilitation plus optional delayed ACL reconstruction. The latter strategy substantially reduced the frequency of surgical reconstructions. (Funded by the Swedish Research Council and the Medical Faculty of Lund University and others; Current Controlled Trials number, ISRCTN84752559.)	[Frobell, Richard B.; Roos, Harald P.; Ranstam, Jonas; Lohmander, L. Stefan] Lund Univ, Dept Orthoped, SE-22185 Lund, Sweden; [Roos, Ewa M.] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark	Lund University; University of Southern Denmark	Frobell, RB (corresponding author), Lund Univ, Dept Orthoped, SE-22185 Lund, Sweden.	richard.frobell@med.lu.se	Ranstam, Jonas/A-4386-2009; Roos, Ewa M/A-5416-2012; Lohmander, Stefan/I-8326-2012; Lohmander, Stefan/AAL-8314-2021	Ranstam, Jonas/0000-0002-8287-7273; Roos, Ewa M/0000-0001-5425-2199; Lohmander, Stefan/0000-0002-5424-9448	Swedish Research Council; Medical Faculty of Lund University; Skane Regional Council; Thelma Zoegas Fund; Stig and Ragna Gorthon Research Foundation; Swedish National Center for Research in Sports; Pfizer Global Research; Pfizer	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty of Lund University; Skane Regional Council; Thelma Zoegas Fund; Stig and Ragna Gorthon Research Foundation; Swedish National Center for Research in Sports; Pfizer Global Research(Pfizer); Pfizer(Pfizer)	Supported by grants from the Swedish Research Council and the Medical Faculty of Lund University (to Drs. Lohmander and E. M. Roos), the Skane Regional Council (to Drs. Lohmander, Frobell, and E. M. Roos), the Thelma Zoegas Fund (to Drs. Frobell and H. P. Roos), the Stig and Ragna Gorthon Research Foundation (to Dr. Frobell), the Swedish National Center for Research in Sports (to Drs. Lohmander and Frobell), and Pfizer Global Research (to Dr. Lohmander).; Dr. Lohmander reports receiving lecture fees from Pfizer. No other potential conflict of interest relevant to this article was reported.	AGEBERG E, 2010, AM J SPORTS MED 0421; Aglietti P, 2004, J BONE JOINT SURG AM, V86A, P2143, DOI 10.2106/00004623-200410000-00004; Aglietti P, 1996, AM J SPORT MED, V24, P726, DOI 10.1177/036354659602400605; ANDERSSON C, 1989, J BONE JOINT SURG AM, V71A, P965, DOI 10.2106/00004623-198971070-00002; Beynnon BD, 2005, AM J SPORT MED, V33, P347, DOI 10.1177/0363546504268406; Biau DJ, 2007, CLIN ORTHOP RELAT R, P180, DOI 10.1097/BLO.0b013e31803dcd6b; Biau DJ, 2006, BRIT MED J, V332, P995, DOI 10.1136/bmj.38784.384109.2F; Brophy RH, 2009, AM J SPORT MED, V37, P683, DOI 10.1177/0363546508328121; Ejerhed L, 2003, AM J SPORT MED, V31, P19, DOI 10.1177/03635465030310011401; Eriksson K, 2001, J BONE JOINT SURG BR, V83B, P348, DOI 10.1302/0301-620X.83B3.11685; Frobell RB, 2007, CONTEMP CLIN TRIALS, V28, P295, DOI 10.1016/j.cct.2006.10.002; Goldhahn S, 2009, J BONE JOINT SURG AM, V91A, P1847, DOI 10.2106/JBJS.H.01455; Granan LP, 2008, AM J SPORT MED, V36, P308, DOI 10.1177/0363546507308939; Jansson KA, 2003, AM J SPORT MED, V31, P12, DOI 10.1177/03635465030310010501; JONES KG, 1970, J BONE JOINT SURG AM, VA 52, P838; Kapoor B, 2004, BRIT J SPORT MED, V38, P542, DOI 10.1136/bjsm.2002.002568; Khanna AJ, 2001, J BONE JOINT SURG AM, V83A, P128, DOI 10.2106/00004623-200100022-00011; Laxdal G, 2005, ARTHROSCOPY, V21, P34, DOI 10.1016/j.arthro.2004.09.014; Lind M, 2009, KNEE SURG SPORT TR A, V17, P117, DOI 10.1007/s00167-008-0654-3; Linko E, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001356.pub4, 10.1002/14651858.CD001356.pub3]; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Maffulli N, 2009, NEW ENGL J MED, V360, P1463, DOI 10.1056/NEJMc082471; Meuffels DE, 2009, BRIT J SPORT MED, V43, P347, DOI 10.1136/bjsm.2008.049403; Moksnes H, 2009, SCAND J MED SCI SPOR, V19, P345, DOI 10.1111/j.1600-0838.2008.00816.x; Morshed S, 2009, J BONE JOINT SURG AM, V91A, P3, DOI 10.2106/JBJS.H.00338; Nau T, 2002, J BONE JOINT SURG BR, V84B, P356, DOI 10.1302/0301-620X.84B3.12400; Risberg MA, 2004, PHYS THER SPORT, V5, P125, DOI 10.1016/j.ptsp.2004.02.003; Risberg MA, 2007, PHYS THER, V87, P737, DOI 10.2522/ptj.20060041; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos EM, 1998, SCAND J MED SCI SPOR, V8, P439, DOI 10.1111/j.1600-0838.1998.tb00465.x; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; SANDBERG R, 1987, J BONE JOINT SURG AM, V69A, P1120, DOI 10.2106/00004623-198769080-00002; Spindler KP, 2005, J BONE JOINT SURG AM, V87A, P1673, DOI 10.2106/JBJS.D.01842; Spindler KR, 2004, AM J SPORT MED, V32, P1986, DOI 10.1177/0363546504271211; Spindler KP, 2008, NEW ENGL J MED, V359, P2135, DOI 10.1056/NEJMcp0804745; Swirtun LR, 2006, SCAND J MED SCI SPOR, V16, P441, DOI 10.1111/j.1600-0838.2005.00505.x; TEGNER Y, 1985, CLIN ORTHOP RELAT R, V198, P43; Thorstensson CA, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-100; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	498	512	2	116	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					331	342		10.1056/NEJMoa0907797	http://dx.doi.org/10.1056/NEJMoa0907797			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660401				2022-12-28	WOS:000280139300006
J	Kumar, R; Seibold, MA; Aldrich, MC; Williams, LK; Reiner, AP; Colangelo, L; Galanter, J; Gignoux, C; Hu, DL; Sen, S; Choudhry, S; Peterson, EL; Rodriguez-Santana, J; Rodriguez-Cintron, W; Nalls, MA; Leak, TS; O'Meara, E; Meibohm, B; Kritchevsky, SB; Li, RL; Harris, TB; Nickerson, DA; Fornage, M; Enright, P; Ziv, E; Smith, LJ; Liu, KA; Gonzalez-Burchard, E				Kumar, Rajesh; Seibold, Max A.; Aldrich, Melinda C.; Williams, L. Keoki; Reiner, Alex P.; Colangelo, Laura; Galanter, Joshua; Gignoux, Christopher; Hu, Donglei; Sen, Saunak; Choudhry, Shweta; Peterson, Edward L.; Rodriguez-Santana, Jose; Rodriguez-Cintron, William; Nalls, Michael A.; Leak, Tennille S.; O'Meara, Ellen; Meibohm, Bernd; Kritchevsky, Stephen B.; Li, Rongling; Harris, Tamara B.; Nickerson, Deborah A.; Fornage, Myriam; Enright, Paul; Ziv, Elad; Smith, Lewis J.; Liu, Kiang; Gonzalez-Burchard, Esteban			Genetic Ancestry in Lung-Function Predictions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AFRICAN-AMERICANS; POPULATION-STRUCTURE; PULMONARY-FUNCTION; NATURAL-HISTORY; ADMIXTURE; RACE; ASTHMA; DISEASE; PREVALENCE; INFERENCE	BACKGROUND Self-identified race or ethnic group is used to determine normal reference standards in the prediction of pulmonary function. We conducted a study to determine whether the genetically determined percentage of African ancestry is associated with lung function and whether its use could improve predictions of lung function among persons who identified themselves as African American. METHODS We assessed the ancestry of 777 participants self-identified as African American in the Coronary Artery Risk Development in Young Adults (CARDIA) study and evaluated the relation between pulmonary function and ancestry by means of linear regression. We performed similar analyses of data for two independent cohorts of subjects identifying themselves as African American: 813 participants in the Health, Aging, and Body Composition (HABC) study and 579 participants in the Cardiovascular Health Study (CHS). We compared the fit of two types of models to lung-function measurements: models based on the covariates used in standard prediction equations and models incorporating ancestry. We also evaluated the effect of the ancestry-based models on the classification of disease severity in two asthma-study populations. RESULTS African ancestry was inversely related to forced expiratory volume in 1 second (FEV1) and forced vital capacity in the CARDIA cohort. These relations were also seen in the HABC and CHS cohorts. In predicting lung function, the ancestry-based model fit the data better than standard models. Ancestry-based models resulted in the reclassification of asthma severity (based on the percentage of the predicted FEV1) in 4 to 5% of participants. CONCLUSIONS Current predictive equations, which rely on self-identified race alone, may misestimate lung function among subjects who identify themselves as African American. Incorporating ancestry into normative equations may improve lung-function estimates and more accurately categorize disease severity.	[Kumar, Rajesh] Childrens Mem Hosp, Div Allergy & Immunol, Chicago, IL 60614 USA; [Colangelo, Laura; Smith, Lewis J.; Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Seibold, Max A.] Natl Jewish Hlth, Denver, CO USA; [Aldrich, Melinda C.; Galanter, Joshua; Gignoux, Christopher; Hu, Donglei; Sen, Saunak; Choudhry, Shweta; Ziv, Elad; Gonzalez-Burchard, Esteban] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Williams, L. Keoki; Peterson, Edward L.] Henry Ford Hlth Syst, Detroit, MI USA; [Reiner, Alex P.; O'Meara, Ellen; Nickerson, Deborah A.] Univ Washington, Seattle, WA 98195 USA; [Rodriguez-Santana, Jose] Pediat Pulm Program San Juan, San Juan, PR USA; [Rodriguez-Cintron, William] Univ Puerto Rico, Sch Med, San Juan Vet Affairs Med Ctr, San Juan, PR 00936 USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Leak, Tennille S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Meibohm, Bernd] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Memphis, TN USA; [Li, Rongling] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN USA; [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA; [Enright, Paul] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; National Jewish Health; University of California System; University of California San Francisco; Henry Ford Health System; Henry Ford Hospital; University of Washington; University of Washington Seattle; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Arizona	Kumar, R (corresponding author), Childrens Mem Hosp, Div Allergy & Immunol, 2300 Childrens Plaza,Box 60, Chicago, IL 60614 USA.	rkumar@childrensmemorial.org	Ziv, Elad/L-5396-2014; Aldrich, Melinda/C-7783-2013	Smith, Lewis J/0000-0002-4728-1562; Kumar, Rajesh/0000-0002-1962-7108; Meibohm, Bernd/0000-0003-3923-3648; Kritchevsky, Stephen/0000-0003-3336-6781; Galanter, Joshua/0000-0002-2561-6384	National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) [N01-HC-48047, N01-HC-48050, N01-HC-95095]; NIH [HL078885, HL088133, AI077439, ES015794, K23HL093023-01, R01 HL71862, R01 HL71017, R01 AG032136, R01 AI79139, R01 AI61774, R01 HL79055]; Robert Wood Johnson Foundation Amos Medical Faculty; Flight Attendant Medical Research Institute; American Asthma Foundation; Tobacco-Related Disease Research Program [15KT-0008]; NHLBI [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; National Institute of Neurological Disorders and Stroke; National Institute on Aging (NIA), Longevity Consortium [U19 AG023122, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Center for Research Resources [U54-RR020278]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC048049, N01HC045133, N01HC035129, N01HC048050, N01HC095095, N01HC085083, N01HC085082, N01HC055222, N01HC085085, N01HC075150, N01HC048048, N01HC085086, N01HC085079, N01HC015103, N01HC085084, N01HC048047, N01HC085081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL071017, K23HL093023, R01HL078885, R01HL071862, R01HL079055, R01HL088133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079139, R01AI061774, U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032136, ZIAAG007390, U19AG023122, P30AG021332, ZIAAG006000, N01AG062103, N01AG062101, N01AG062106] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation Amos Medical Faculty(Robert Wood Johnson Foundation (RWJF)); Flight Attendant Medical Research Institute; American Asthma Foundation; Tobacco-Related Disease Research Program(University of California System); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA), Longevity Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by contracts (N01-HC-48047 through 48050 and N01-HC-95095) from the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), as well as grants from the NIH (HL078885, HL088133, AI077439, and ES015794, to Dr. Burchard; K23HL093023-01, to Dr. Kumar; R01 HL71862, R01 HL71017, and R01 AG032136, to Dr. Reiner; and R01 AI79139, R01 AI61774, and R01 HL79055, to Dr. Williams), the Robert Wood Johnson Foundation Amos Medical Faculty Development Program and the Flight Attendant Medical Research Institute (to Dr. Burchard), the American Asthma Foundation (to Dr. Williams), and the Tobacco-Related Disease Research Program (New Investigator Award 15KT-0008, to Dr. Choudhry). The CHS was supported by NHLBI grants (N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and U01 HL080295), with additional funding from the National Institute of Neurological Disorders and Stroke and a grant from the National Institute on Aging (NIA) (U19 AG023122 from the Longevity Consortium). The CARe Consortium was supported in part by a grant from the NHLBI (with a full description of the funding available at http://public.nhlbi.nih.gov/GeneticsGenomics/home/care.aspx). Health ABC was supported in part by the Intramural Research Program of the NIH and by the NIA, through contracts (N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106), and by a grant from the National Center for Research Resources (U54-RR020278) for the genotyping.	Aldrich MC, 2008, AM J EPIDEMIOL, V168, P1035, DOI 10.1093/aje/kwn224; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; American Medical Association, 2008, GUID EV PERM IMP; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Arif AA, 2003, EUR RESPIR J, V21, P827, DOI 10.1183/09031936.03.00054103a; Berg K, 2005, AM J HUM GENET, V77, P519; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Celli BR, 2006, EUR RESPIR J, V27, P242, DOI 10.1183/09031936.06.00129305; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Divers J, 2008, ETHNIC DIS, V18, P384; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Goldstein DB, 2004, NAT GENET, V36, P1243, DOI 10.1038/ng1204-1243; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; HUBERT HB, 1982, AM REV RESPIR DIS, V125, P409; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193; MCCLEARN GE, 1994, J GERONTOL, V49, pM264, DOI 10.1093/geronj/49.6.M264; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Phimister EG, 2003, NEW ENGL J MED, V348, P1081, DOI 10.1056/NEJMp030028; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raby BA, 2004, PEDIATRICS, V114, pE327, DOI 10.1542/peds.2003-0838-L; REDLINE S, 1989, AM J EPIDEMIOL, V129, P827, DOI 10.1093/oxfordjournals.aje.a115197; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; RONA RJ, 1993, BMJ-BRIT MED J, V306, P817, DOI 10.1136/bmj.306.6881.817; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; TAGER IB, 1988, AM REV RESPIR DIS, V138, P837, DOI 10.1164/ajrccm/138.4.837; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Tsai HJ, 2006, HUM GENET, V119, P547, DOI 10.1007/s00439-006-0169-2; U.S. Census Bureau Population Division, ANN EST RES POP SEX; Visser M, 2000, ANN NY ACAD SCI, V904, P456, DOI 10.1111/j.1749-6632.2000.tb06500.x; Wu BL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-317; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Yang JJ, 2008, J ALLERGY CLIN IMMUN, V122, P820, DOI 10.1016/j.jaci.2008.07.044	47	179	180	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					321	330		10.1056/NEJMoa0907897	http://dx.doi.org/10.1056/NEJMoa0907897			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20647190	Green Accepted			2022-12-28	WOS:000280139300005
J	Jaffer, AK; Campo, RE; Gaski, G; Reyes, M; Gebhard, R; Ginzburg, E; Kolber, MA; Macdonald, J; Falcone, S; Green, BA; Barreras-Pagan, L; O'Neill, WW				Jaffer, Amir K.; Campo, Rafael E.; Gaski, Greg; Reyes, Mario; Gebhard, Ralf; Ginzburg, Enrique; Kolber, Michael A.; Macdonald, John; Falcone, Steven; Green, Barth A.; Barreras-Pagan, Lazara; O'Neill, William W.			An Academic Center's Delivery of Care After the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Article								The Miller School of Medicine of the University of Miami and Project Medishare, an affiliated not-for-profit organization, provided a large-scale relief effort in Haiti after the earthquake of 12 January 2010. Their experience demonstrates that academic medical centers in proximity to natural disasters can help deliver effective medical care through a coordinated process involving mobilization of their own resources, establishment of focused management teams at home and on the ground with formal organizational oversight, and partnership with governmental and nongovernmental relief agencies. Proximity to the disaster area allows for prompt arrival of medical personnel and equipment. The recruitment and organized deployment of large numbers of local and national volunteers are indispensable parts of this effort. Multidisciplinary teams on short rotations can form the core of the medical response.	[O'Neill, William W.] Univ Miami Hlth Syst, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Miami Childrens Hosp, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami	O'Neill, WW (corresponding author), Univ Miami Hlth Syst, 1600 NW 10th Ave,RMSB 1122A, Miami, FL 33136 USA.	WONeill@med.miami.edu						Ginzburg E, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1002026; Mulvey JM, 2008, INJURY, V39, P554, DOI 10.1016/j.injury.2007.07.025; Yang C, 2009, INJURY, V40, P488, DOI 10.1016/j.injury.2009.01.102	3	16	16	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2010	153	4					262	265		10.7326/0003-4819-153-4-201008170-00266	http://dx.doi.org/10.7326/0003-4819-153-4-201008170-00266			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639KF	20643974				2022-12-28	WOS:000280973000007
J	Genovese, G; Friedman, DJ; Ross, MD; Lecordier, L; Uzureau, P; Freedman, BI; Bowden, DW; Langefeld, CD; Oleksyk, TK; Knob, ALU; Bernhardy, AJ; Hicks, PJ; Nelson, GW; Vanhollebeke, B; Winkler, CA; Kopp, JB; Pays, E; Pollak, MR				Genovese, Giulio; Friedman, David J.; Ross, Michael D.; Lecordier, Laurence; Uzureau, Pierrick; Freedman, Barry I.; Bowden, Donald W.; Langefeld, Carl D.; Oleksyk, Taras K.; Knob, Andrea L. Uscinski; Bernhardy, Andrea J.; Hicks, Pamela J.; Nelson, George W.; Vanhollebeke, Benoit; Winkler, Cheryl A.; Kopp, Jeffrey B.; Pays, Etienne; Pollak, Martin R.			Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans	SCIENCE			English	Article							STAGE RENAL-DISEASE; 9 GENE MYH9; POSITIVE SELECTION; NATURAL-SELECTION; HUMAN SERUM; POLYMORPHISMS; RHODESIENSE; GENOME	African Americans have higher rates of kidney disease than European Americans. Here, we show that, in African Americans, focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22 {FSGS odds ratio = 10.5 [95% confidence interval (CI) 6.0 to 18.4]; H-ESKD odds ratio = 7.3 (95% CI 5.6 to 9.5)}. The two APOL1 variants are common in African chromosomes but absent from European chromosomes, and both reside within haplotypes that harbor signatures of positive selection. ApoL1 (apolipoprotein L-1) is a serum factor that lyses trypanosomes. In vitro assays revealed that only the kidney disease-associated ApoL1 variants lysed Trypanosoma brucei rhodesiense. We speculate that evolution of a critical survival factor in Africa may have contributed to the high rates of renal disease in African Americans.	[Genovese, Giulio; Friedman, David J.; Bernhardy, Andrea J.; Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Genovese, Giulio; Friedman, David J.; Bernhardy, Andrea J.; Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Genovese, Giulio] Dartmouth Coll, Dept Math, Hanover, NH 03755 USA; [Friedman, David J.] Beth Israel Deaconess Med Ctr, Dept Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Ross, Michael D.; Knob, Andrea L. Uscinski] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02215 USA; [Lecordier, Laurence; Uzureau, Pierrick; Vanhollebeke, Benoit; Pays, Etienne] Univ Libre Bruxelles, Inst Biol & Med Mol, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Freedman, Barry I.] Wake Forest Univ, Sch Med, Nephrol Sect, Dept Internal Med, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Ctr Diabet Res, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Langefeld, Carl D.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Langefeld, Carl D.] Wake Forest Univ, Sch Med, Ctr Publ Hlth Genom, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Langefeld, Carl D.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00681 USA; [Nelson, George W.; Kopp, Jeffrey B.] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Winkler, Cheryl A.] NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21702 USA; [Pollak, Martin R.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Dartmouth College; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Universite Libre de Bruxelles; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; University of Puerto Rico; University of Puerto Rico Mayaguez; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pollak, MR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA.	epays@ulb.ac.be; mpollak@bidmc.harvard.edu	Rinaldi2, Carlos/D-4479-2011; Taras, Oleksyk/J-8805-2013; Kopp, Jeffrey B/O-2681-2015	Taras, Oleksyk/0000-0002-8148-3918; Kopp, Jeffrey B/0000-0001-9052-186X; Friedman, David/0000-0002-0301-9298; Vanhollebeke, Benoit/0000-0002-0353-365X; Genovese, Giulio/0000-0003-3066-5575	Walloon Region; Fonds National de la Recherche Scientifique; Belgian Science Policy; NIH [R01 DK54931, K08-DK076868, R01 DK066358, R01 DK053591, R01 HL56266, R01 DK 070941, R01 DK 084149]; National Institute of Diabetes, Digestive, and Kidney Disease [Z01 DK043308]; NCI, Center for Cancer Research [ZIA BC 010022]; NephCure Foundation; NCI, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010022, ZIABC010297] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070941, ZIADK043308, R01DK084149, R01DK054931, K08DK076868, R01DK066358, R01DK053591, Z01DK043308] Funding Source: NIH RePORTER	Walloon Region; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy(Belgian Federal Science Policy Office); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive, and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NephCure Foundation; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Broad Institute Medical and Population Genetics Program for helpful advice and review of the manuscript. We thank the study participants for their participation and J. Robinson for the help provided accessing the 1000 Genomes project data. We thank X. C. Zhou [National Cancer Institute (NCI)] and E. Binns-Roemer (NCI), P. Poelvoorde [Universite Libre de Bruxelles (ULB)], P. Tebabi (ULB) and A. Pays (ULB) for excellent technical assistance. We thank the investigators in the BWH and NIH FSGS genetic studies: W. Briggs, R. Dart, S. Korbet, M. Mokrzycki, P. Kimmel, T. Ahuja, J. Berns, E. Simon, M. Smith, H. Trachtman, M. Michel, J. R. Schelling, G. Appel, and A. Katz. The work at the University of Brussels was supported by the "CIBLES" program of the Walloon Region, the Fonds National de la Recherche Scientifique, and the Interuniversity Attraction Poles program of the Belgian Science Policy. This work was also supported by grants from the NIH (R01 DK54931 to M.R.P; K08-DK076868 to D.J.F.; R01 DK066358 and R01 DK053591 to D. W. B.; and R01 HL56266, R01 DK 070941, and R01 DK 084149 to B.I.F.), the National Institute of Diabetes, Digestive, and Kidney Disease Intramural research program (Z01 DK043308 to J.B.K.), the Intramural Research Program of NCI, Center for Cancer Research (Project ZIA BC 010022; C.A.W. and G.W.N.), and the NephCure Foundation (to M.R.P). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The publisher or recipient acknowledges right of the U.S. Government to retain a nonexclusive, royalty-free license in and to any copyright covering the article. This project has been funded in part with federal funds from the NCI, NIH, under contract HHSN261200800001E. All participants gave informed consent for genetic studies, and research was conducted under protocols approved by the appropriate institutional review boards. J.B.K., G.W.N., C.A.W., and the NCI have a patent application pending for chromosome 22 polymorphisms and haplotypes for genetic screening and clinical applications. M.R.P., G.G., the Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center have been added as coinventors to an amendment to this application naming the specific ApoL1 SNPs described in this manuscript. E.P., L.L., P.U., and ULB have applied for a patent related to the use of plasma from ESKD patients to treat human sleeping sickness by plasma transfer.	Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; BYRNE C, 1994, AM J KIDNEY DIS, V23, P16, DOI 10.1016/S0272-6386(12)80806-7; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Gibson W, 2002, TRENDS PARASITOL, V18, P486, DOI 10.1016/S1471-4922(02)02390-5; GIBSON W C, 1986, Parasitology Today, V2, P255, DOI 10.1016/0169-4758(86)90011-6; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; Oleksyk TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011474; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Satko SG, 2005, KIDNEY INT, V67, pS46, DOI 10.1111/j.1523-1755.2005.09411.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	23	1299	1340	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					841	845		10.1126/science.1193032	http://dx.doi.org/10.1126/science.1193032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20647424	Green Accepted			2022-12-28	WOS:000280809900051
J	Feingold, G; Koren, I; Wang, HL; Xue, HW; Brewer, WA				Feingold, Graham; Koren, Ilan; Wang, Hailong; Xue, Huiwen; Brewer, Wm. Alan			Precipitation-generated oscillations in open cellular cloud fields	NATURE			English	Article							CONVECTION; ORGANIZATION; DRIZZLE; MICROPHYSICS; PATTERNS; AEROSOL; CELLS; MODEL	Cloud fields adopt many different patterns that can have a profound effect on the amount of sunlight reflected back to space, with important implications for the Earth's climate. These cloud patterns can be observed in satellite images of the Earth and often exhibit distinct cell-like structures associated with organized convection at scales of tens of kilometres(1-3). Recent evidence has shown that atmospheric aerosol particles-through their influence on precipitation formation-help to determine whether cloud fields take on closed (more reflective) or open (less reflective) cellular patterns(4,5). The physical mechanisms controlling the formation and evolution of these cells, however, are still poorly understood(6), limiting our ability to simulate realistically the effects of clouds on global reflectance. Here we use satellite imagery and numerical models to show how precipitating clouds produce an open cellular cloud pattern that oscillates between different, weakly stable states. The oscillations are a result of precipitation causing downward motion and outflow from clouds that were previously positively buoyant. The evaporating precipitation drives air down to the Earth's surface, where it diverges and collides with the outflows of neighbouring precipitating cells. These colliding outflows form surface convergence zones and new cloud formation. In turn, the newly formed clouds produce precipitation and new colliding outflow patterns that are displaced from the previous ones. As successive cycles of this kind unfold, convergence zones alternate with divergence zones and new cloud patterns emerge to replace old ones. The result is an oscillating, self-organized system with a characteristic cell size and precipitation frequency.	[Feingold, Graham; Brewer, Wm. Alan] NOAA Earth Syst Res Lab, Div Chem Sci, Boulder, CO 80305 USA; [Koren, Ilan] Weizmann Inst Sci, Dept Environm Sci, IL-76100 Rehovot, Israel; [Wang, Hailong] Pacific NW Natl Lab, Richland, WA 99352 USA; [Xue, Huiwen] Peking Univ, Sch Phys, Dept Atmospher Sci, Beijing 100871, Peoples R China	National Oceanic Atmospheric Admin (NOAA) - USA; Weizmann Institute of Science; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Peking University	Feingold, G (corresponding author), NOAA Earth Syst Res Lab, Div Chem Sci, Boulder, CO 80305 USA.	graham.feingold@noaa.gov	Wang, Hailong/B-8061-2010; Brewer, Wm Alan/I-3920-2013; feingold, graham/B-6152-2009; Koren, Ilan/K-1417-2012; feingold, graham/AAQ-2010-2020; Wang, Hailong/AAM-1464-2021	Wang, Hailong/0000-0002-1994-4402; feingold, graham/0000-0002-0774-2926; Koren, Ilan/0000-0001-6759-6265; feingold, graham/0000-0002-0774-2926; Wang, Hailong/0000-0002-1994-4402	NOAA; CIRES; Pacific Northwest National Laboratory	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); CIRES; Pacific Northwest National Laboratory(United States Department of Energy (DOE))	We thank NOAA's Climate Goal Program, a CIRES Visiting Fellowship (I. K.) and the Pacific Northwest National Laboratory (H. W.) for supporting this work. We acknowledge the www.LBMethod.org project for sharing the Lattice Boltzmann Method theory and code, and S. C. Tucker and S. E. Yuter for their support in acquiring the lidar and radar data during the VOCALS-REx field experiment. C. A. Ennis provided editorial assistance and D. Fisher helped with the figures.	AGEE EM, 1984, B AM METEOROL SOC, V65, P938, DOI 10.1175/1520-0477(1984)065<0938:OFSATC>2.0.CO;2; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Atkinson BW, 1996, REV GEOPHYS, V34, P403, DOI 10.1029/96RG02623; BAKER MB, 1990, NATURE, V345, P142, DOI 10.1038/345142a0; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Garay MJ, 2004, B AM METEOROL SOC, V85, P1585, DOI 10.1175/BAMS-85-10-1585; GETLING AV, 2001, ADV SERIES NONLINEAR, V11; Graham A, 1934, PHILOS T R SOC LOND, V232, P285, DOI 10.1098/rsta.1934.0008; Guo ZL, 2002, INT J NUMER METH FL, V39, P325, DOI 10.1002/fld.337; HELFAND HM, 1983, J ATMOS SCI, V40, P631, DOI 10.1175/1520-0469(1983)040<0631:AMTDOO>2.0.CO;2; Heylighen F., 2001, ENCY LIFE SUPPORT SY; KRISHNAMURTI R, 1975, J ATMOS SCI, V32, P1353, DOI 10.1175/1520-0469(1975)032<1353:OCCPPM>2.0.CO;2; KRUEGER AF, 1961, TELLUS, V13, P1, DOI 10.1111/j.2153-3490.1961.tb00061.x; Parodi A, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/106; Rayleigh L, 1916, PHILOS MAG, V32, P529, DOI 10.1080/14786441608635602; Rosenfeld D, 2006, ATMOS CHEM PHYS, V6, P2503, DOI 10.5194/acp-6-2503-2006; Savic-Jovcic V, 2008, J ATMOS SCI, V65, P1587, DOI 10.1175/2007JAS2456.1; Sharon TM, 2006, J ATMOS SCI, V63, P983, DOI 10.1175/JAS3667.1; Stevens B, 2005, B AM METEOROL SOC, V86, P51, DOI 10.1175/BAMS-86-1-51; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; Wang HL, 2009, J ATMOS SCI, V66, P3257, DOI 10.1175/2009JAS3120.1; WILLIS GE, 1979, J GEOPHYS RES-OCEANS, V84, P295, DOI 10.1029/JC084iC01p00295; Wood R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009371; WOOD R, 2009, CLIVAR, V7, P5; Xue HW, 2008, J ATMOS SCI, V65, P392, DOI 10.1175/2007JAS2428.1; Yair YY, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010738	30	135	136	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					849	852		10.1038/nature09314	http://dx.doi.org/10.1038/nature09314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703303				2022-12-28	WOS:000280766100032
J	Thirugnanasothy, S				Thirugnanasothy, Subashini			Managing urinary incontinence in older people	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE FACTORS; OVERACTIVE BLADDER; STRESS-INCONTINENCE; RISK-FACTORS; RADICAL PROSTATECTOMY; WOMEN; TOLTERODINE; PREVALENCE; MANAGEMENT		Freeman Rd Hosp, Dept Care Elderly, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	Thirugnanasothy, S (corresponding author), Freeman Rd Hosp, Dept Care Elderly, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	subathiru@yahoo.co.uk						Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Bo K, 1999, BMJ-BRIT MED J, V318, P487, DOI 10.1136/bmj.318.7182.487; Bracewell C., 2005, ESSENTIAL FACTS GERI; Chapple CR, 2004, BJU INT, V93, P303, DOI 10.1111/j.1464-410X.2004.04606.x; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Dallosso HM, 2003, BJU INT, V92, P69, DOI 10.1046/j.1464-410X.2003.04271.x; Department of Health, 2001, NAT SERV FRAM OLD PE; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; Gordon D, 2005, UROLOGY, V65, P479, DOI 10.1016/j.urology.2004.09.059; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Hay-Smith EJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005654; Homma Y, 2003, BJU INT, V92, P741, DOI 10.1046/j.1464-410X.2003.04468.x; Malone-Lee JG, 2001, J AM GERIATR SOC, V49, P700, DOI 10.1046/j.1532-5415.2001.49144.x; MARIAPPAN P, 2005, COCHRANE DB SYST REV, V3; *NAT I HLTH CLIN E, 2008, SUB SYNTH SLING INS; *NAT I HLTH CLIN E, 2003, SYST REV EFF SAF SAC; National Institute for Health and Clinical Excellence, 2010, MAN LOW UR TRACT SYM; National Institute for Health & Clinical Excellence, 2006, UR INC MAN UR INC WO; NORTON PA, 1988, BRIT MED J, V297, P1187, DOI 10.1136/bmj.297.6657.1187; Parazzini F, 2003, BJOG-INT J OBSTET GY, V110, P927, DOI 10.1111/j.1471-0528.2003.02343.x; Perry S, 2000, J PUBLIC HEALTH MED, V22, P427, DOI 10.1093/pubmed/22.3.427; Peyrat L, 2002, BJU INT, V89, P61, DOI 10.1046/j.1464-4096.2001.01813.x; Rudy D, 2006, UROLOGY, V67, P275, DOI 10.1016/j.urology.2005.08.017; Sacco E, 2006, BJU INT, V97, P1234, DOI 10.1111/j.1464-410X.2006.06185.x; Shaw C, 2001, FAM PRACT, V18, P48, DOI 10.1093/fampra/18.1.48; Shekelle P G, 1999, J Spinal Cord Med, V22, P258; SPENCEJONES C, 1994, BRIT J OBSTET GYNAEC, V101, P147, DOI 10.1111/j.1471-0528.1994.tb13081.x; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Van Kampen M, 2000, LANCET, V355, P98, DOI 10.1016/S0140-6736(99)03473-X; Wagg A, 2008, AGE AGEING, V37, P39, DOI 10.1093/ageing/afm163	30	13	13	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2010	341								c3835	10.1136/bmj.c3835	http://dx.doi.org/10.1136/bmj.c3835			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DO	20696747				2022-12-28	WOS:000281028500002
J	Juliano, C; Wessel, G				Juliano, Celina; Wessel, Gary			Versatile Germline Genes	SCIENCE			English	Editorial Material							SOMATIC STEM-CELLS; SMALL MICROMERE LINEAGE; SEA-URCHIN; EXPRESSION; NANOS; POSTERIOR; EMBRYO; ORIGIN; HYDRA		[Juliano, Celina] Yale Univ, Dept Cell Biol, Stem Cell Ctr, New Haven, CT 06520 USA; [Wessel, Gary] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Yale University; Brown University	Juliano, C (corresponding author), Yale Univ, Dept Cell Biol, Stem Cell Ctr, New Haven, CT 06520 USA.	gary_wessel@brown.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD028152, R01 HD028152-17] Funding Source: Medline; NIGMS NIH HHS [T32 GM007601] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Juliano CE, 2006, DEV BIOL, V300, P406, DOI 10.1016/j.ydbio.2006.07.035; Juliano CE, 2010, DEV BIOL, V337, P220, DOI 10.1016/j.ydbio.2009.10.030; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; TANAKA S, 1990, DEV GROWTH DIFFER, V32, P145; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039	13	71	71	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					640	641		10.1126/science.1194037	http://dx.doi.org/10.1126/science.1194037			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689009	Green Accepted			2022-12-28	WOS:000280602700027
J	Lieber, MR; Wilson, TE				Lieber, Michael R.; Wilson, Thomas E.			SnapShot: Nonhomologous DNA End Joining (NHEJ)	CELL			English	Editorial Material							REPAIR		[Lieber, Michael R.] Univ So Calif, Los Angeles, CA 90089 USA; [Wilson, Thomas E.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Southern California; University of Michigan System; University of Michigan	Lieber, MR (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.			Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	NCI NIH HHS [R01 CA102563, R37 CA051105, R01 CA100504] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100504, R37CA051105, R01CA102563] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009	5	41	43	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2010	142	3					496	U174	496.e1	10.1016/j.cell.2010.07.035	http://dx.doi.org/10.1016/j.cell.2010.07.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691907	Bronze			2022-12-28	WOS:000280609100026
J	You, YZ				You, Yuzhu			Harnessing telecoms cables for science	NATURE			English	Editorial Material									Univ Sydney, Inst Marine Sci, Sydney, NSW 2006, Australia	University of Sydney	You, YZ (corresponding author), Univ Sydney, Inst Marine Sci, Sydney, NSW 2006, Australia.	yuzhu.you@sydney.edu.au						[Anonymous], 2000, AGU, DOI [DOI 10.1029/00EO00105, 10.1029/00EO00105]; Butler R, 2003, 3RD INTERNATIONAL WORKSHOP ON SCIENTIFIC USE OF SUBMARINE CABLES AND RELATED TECHNOLOGY, PROCEEDINGS, P248; Duennebier F, 2008, SEA TECHNOL, V49, P51; YOU Y, 2009, CLIVAR EXCHANGES 51, V14, P11; YOU Y, 2010, EOS T AM GEOPHYS UN, V91, P13; 2003, DEOS CABLE REUSE COM	6	14	15	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					690	691		10.1038/466690a	http://dx.doi.org/10.1038/466690a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	634EN	20686551				2022-12-28	WOS:000280562500015
J	Ramnarayan, P; Thiru, K; Parslow, RC; Harrison, DA; Draper, ES; Rowan, KM				Ramnarayan, Padmanabhan; Thiru, Krish; Parslow, Roger C.; Harrison, David A.; Draper, Elizabeth S.; Rowan, Kathy M.			Effect of specialist retrieval teams on outcomes in children admitted to paediatric intensive care units in England and Wales: a retrospective cohort study	LANCET			English	Article							CRITICALLY-ILL; HOSPITAL VOLUME; HEALTH-CARE; MORTALITY; REDUCTION; TRANSPORT; IMPLEMENTATION; ADMISSION; DELIVERY; SURGERY	Background Intensive care services for children have undergone substantial centralisation in the UK. Along with the establishment of regional paediatric intensive care units (PICUs), specialist retrieval teams were set up to transport critically ill children from other hospitals. We studied the outcome of children transferred from local hospitals to PICUs. Methods We analysed data that were gathered for a cohort of children (<= 16 years) admitted consecutively to 29 PICUs in England and Wales during 4 years (Jan 1, 2005, to Dec 31, 2008). We compared unplanned admissions from wards within the same hospital as the PICU and from other hospitals; interhospital transfers by non-specialist and specialist retrieval teams; and patients transferred to their nearest PICU and those who were not. Primary outcome measures were mortality rate in PICU and length of stay in P ICU. We analysed data by use of logistic regression analysis. Findings There were 57997 admissions to PICUs during the study. Nearly half of unplanned admissions (17 649 [53%] of 33 492) were from other hospitals. Although children admitted from other hospitals were younger (median 10 months [IQR 1-55] vs 18 months [3-85]), sicker at admission (median predicted risk of mortality 6% [4-10] vs 4% [2-7]), stayed longer in PICUs (75 h [33-153] vs 43 h [18-116]), and had higher crude mortality rates (1384 [8%] of 17 649 vs 996 [6%] of 15843; odds ratio 1.27, 95% CI 1.16-1.38), the risk-adjusted mortality rate in PICUs was lower than among children admitted from within the same hospital (0.65, 0.53-0.80). In a multivariable analysis, use of a specialist retrieval team for transfer was associated with improved survival (0 58, 0.39-0.87). Interpretation These findings support the policy of combining centralisation of intensive care services for children with transfer by specialist retrieval teams.	[Ramnarayan, Padmanabhan] Great Ormond St Hosp Sick Children, Childrens Acute Transport Serv, London, England; [Thiru, Krish] City Univ London, Sch Informat, Ctr Hlth Informat, London EC1V 0HB, England; [Parslow, Roger C.] Leeds Inst Genet Hlth & Therapeut, Ctr Biostat & Epidemiol, Paediat Epidemiol Grp, Leeds, W Yorkshire, England; [Harrison, David A.; Draper, Elizabeth S.] Intens Care Natl Audit & Res Ctr, London, England; [Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; City University London; University of Leeds; Intensive Care National Audit & Research Centre; University of Leicester	Ramnarayan, P (corresponding author), Great Ormond St Hosp NHS Trust, Childrens Acute Transport Serv, 44-B Bedford Row, London WC1R 4LL, England.		Harrison, David A/O-4355-2018; Draper, Elizabeth/S-6874-2019; Draper, Elizabeth S/I-6304-2018; Parslow, Roger/AAV-1477-2020; Ramnarayan, Padmanabhan/AAI-6783-2020	Harrison, David A/0000-0002-9002-9098; Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Ramnarayan, Padmanabhan/0000-0003-0784-8154; Rowan, Kathryn/0000-0001-8217-5602; Parslow, Roger/0000-0002-3945-5294	National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership; Health Commission Wales Specialised Services	National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership; Health Commission Wales Specialised Services	PICANet is funded by the National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership, Health Commission Wales Specialised Services. National Health Service (NHS) Lothian and National Service Division NHS Scotland. the Royal Belfast Hospital for Sick Children, and the Pan Thames PICU Commissioning Consortium We thank all the staff in participating hospitals who gathered data for PICANet A full list of participating PICUs and steering group and clinical advisory group membership is available on the latest PICANet Annual Report We thank Steve Harris for commenting on an early draft of this report and contributing to discussions about the sensitivity analyses, and Philip McShane for extracting the study data from the PICANet database	Bazzani LG, 2007, CIRCULATION, V115, P2652, DOI 10.1161/CIRCULATIONAHA.106.678904; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bellingan G, 2000, INTENS CARE MED, V26, P740; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; BRITTO J, 1995, BRIT MED J, V311, P836, DOI 10.1136/bmj.311.7009.836; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; CHAN PS, ARCH INTERN MED, V170, P18; Combes A, 2005, CRIT CARE MED, V33, P705, DOI 10.1097/01.CCM.0000158518.32730.C5; Department of Health, 1997, PAED INT CAR FRAM FU; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; FIELD D, 1991, ARCH DIS CHILD-FETAL, V66, P408, DOI 10.1136/adc.66.4_Spec_No.408; Gregory CJ, 2008, PEDIATRICS, V121, pE906, DOI 10.1542/peds.2007-2089; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hanson CC, 2009, QUAL SAF HEALTH CARE, V18, P500, DOI 10.1136/qshc.2007.026054; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maybloom B, 1997, LANCET, V350, P65, DOI 10.1016/S0140-6736(97)26027-7; McDonnell A, 2007, J CRIT CARE, V22, P212, DOI 10.1016/j.jcrc.2007.02.002; Odetola FO, 2008, PEDIATR CRIT CARE ME, V9, P20, DOI 10.1097/01.PCC.0000298642.11872.29; Orr RA, 2009, PEDIATRICS, V124, P40, DOI 10.1542/peds.2008-0515; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; *PICA NET, 2006, NAT REP PAED INT CAR; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Stevenson A, 2005, EMERG MED J, V22, P795, DOI 10.1136/emj.2004.017822; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; *U YORK, 1996, EFF HLTH CAR HOSP VO; Vos GD, 2004, INTENS CARE MED, V30, P302, DOI 10.1007/s00134-003-2066-7	29	96	99	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					698	704		10.1016/S0140-6736(10)61113-0	http://dx.doi.org/10.1016/S0140-6736(10)61113-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20708255				2022-12-28	WOS:000281582900029
J	Cai, WJ; Chen, LQ; Chen, BS; Gao, ZY; Lee, SH; Chen, JF; Pierrot, D; Sullivan, K; Wang, YC; Hu, XP; Huang, WJ; Zhang, YH; Xu, SQ; Murata, A; Grebmeier, JM; Jones, EP; Zhang, HS				Cai, Wei-Jun; Chen, Liqi; Chen, Baoshan; Gao, Zhongyong; Lee, Sang H.; Chen, Jianfang; Pierrot, Denis; Sullivan, Kevin; Wang, Yongchen; Hu, Xinping; Huang, Wei-Jen; Zhang, Yuanhui; Xu, Suqing; Murata, Akihiko; Grebmeier, Jacqueline M.; Jones, E. Peter; Zhang, Haisheng			Decrease in the CO2 Uptake Capacity in an Ice-Free Arctic Ocean Basin	SCIENCE			English	Article							SPATIAL VARIABILITY; CARBON-DIOXIDE; ACIDIFICATION; SHELF; PHYTOPLANKTON	It has been predicted that the Arctic Ocean will sequester much greater amounts of carbon dioxide (CO2) from the atmosphere as a result of sea ice melt and increasing primary productivity. However, this prediction was made on the basis of observations from either highly productive ocean margins or ice-covered basins before the recent major ice retreat. We report here a high-resolution survey of sea-surface CO2 concentration across the Canada Basin, showing a great increase relative to earlier observations. Rapid CO2 invasion from the atmosphere and low biological CO2 drawdown are the main causes for the higher CO2, which also acts as a barrier to further CO2 invasion. Contrary to the current view, we predict that the Arctic Ocean basin will not become a large atmospheric CO2 sink under ice-free conditions.	[Cai, Wei-Jun; Chen, Baoshan; Wang, Yongchen; Hu, Xinping; Huang, Wei-Jen] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Chen, Liqi; Gao, Zhongyong; Zhang, Yuanhui; Xu, Suqing] SOA, Inst Oceanog 3, Key Lab Global Change & Marine Atmospher Chem, Xiamen 361005, Peoples R China; [Lee, Sang H.] Korea Polar Res Inst, Inchon 406840, South Korea; [Chen, Jianfang; Zhang, Haisheng] SOA, Inst Oceanog 2, Lab Marine Ecosyst & Biogeochem, Hangzhou 310012, Zhejiang, Peoples R China; [Pierrot, Denis; Sullivan, Kevin] NOAA, Atlantic Oceanog & Meteorol Lab, Ocean Chem Div, Miami, FL 33149 USA; [Pierrot, Denis; Sullivan, Kevin] Univ Miami, Cooperat Inst Marine & Atmospher Sci, Miami, FL 33149 USA; [Murata, Akihiko] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan; [Grebmeier, Jacqueline M.] Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA; [Jones, E. Peter] Bedford Inst Oceanog, Ocean Sci Div, Dept Fisheries & Oceans, Dartmouth, NS B2Y 4A2, Canada	University System of Georgia; University of Georgia; State Oceanic Administration; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); State Oceanic Administration; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University System of Maryland; University of Maryland Center for Environmental Science; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Cai, WJ (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	wcai@uga.edu	Cai, Wei-Jun/C-1361-2013; Hu, Xinping/F-6282-2011; Pierrot, Denis/A-7459-2014; Grebmeier, Jacqueline/L-9805-2013; Pierrot, Denis/AAH-7687-2020	Cai, Wei-Jun/0000-0003-3606-8325; Hu, Xinping/0000-0002-0613-6545; Pierrot, Denis/0000-0002-0374-3825; Grebmeier, Jacqueline/0000-0001-7624-3568; Huang, Wei-Jen/0000-0002-1713-2515	Ministry of Science and Technology of China [2009DFA22920]; Natural Science Foundation of China [40531007]; U.S. National Oceanic and Atmospheric Administration [NA05OAR4311161, NA09OAR4310078]; NSF [ARC-0909330]; Korean Arctic Research project [PM09020]; Chinese Arctic and Antarctic Administration; Polar Research Institute of China; Division Of Polar Programs [0909330] Funding Source: National Science Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Korean Arctic Research project; Chinese Arctic and Antarctic Administration; Polar Research Institute of China; Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank R. Wanninkhof, P. Yager, and N. Bates for discussions; J. Zhao for the salinity and temperature data; and H. Li and S. Gao for sample collection. Funding for the CHINARE CO<INF>2</INF> survey and subsequent synthesis was provided by the Ministry of Science and Technology of China (2009DFA22920), the Natural Science Foundation of China (40531007), and the U.S. National Oceanic and Atmospheric Administration (NA05OAR4311161 and NA09OAR4310078) and NSF (ARC-0909330). The measurements for primary production of phytoplankton were funded by a Korean Arctic Research project (PM09020). We also thank the Chinese Arctic and Antarctic Administration and the Polar Research Institute of China for their support. We are grateful to the captain and crew of icebreaker Xuelong.	Anderson LG, 1998, GLOBAL BIOGEOCHEM CY, V12, P455, DOI 10.1029/98GB01372; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bates NR, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003083; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Codispoti LA, 2009, DEEP-SEA RES PT II, V56, P1144, DOI 10.1016/j.dsr2.2008.10.013; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Fransson A, 2009, CONT SHELF RES, V29, P1317, DOI 10.1016/j.csr.2009.03.008; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; GREBMEIER JM, 2010, EOS, V91, P161, DOI DOI 10.1029/2010EO180001; Guo LD, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002593; Hansell DA, 2004, SCIENCE, V304, P858, DOI 10.1126/science.1096175; Kaltin S, 2005, MAR CHEM, V94, P67, DOI 10.1016/j.marchem.2004.07.010; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Chen LQ, 2007, DEEP-SEA RES PT II, V54, P2619, DOI 10.1016/j.dsr2.2007.08.010; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murata A, 2003, CONT SHELF RES, V23, P753, DOI 10.1016/S0278-4343(03)00046-3; Pabi S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004578; Rysgaard S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003572; Solomon S., 2007, PHYS SCI BASIS WORKI; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Yager PL, 1999, LIMNOL OCEANOGR, V44, P1882, DOI 10.4319/lo.1999.44.8.1882; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190	25	169	200	6	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					556	559		10.1126/science.1189338	http://dx.doi.org/10.1126/science.1189338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20651119				2022-12-28	WOS:000280483500034
J	Khmelinskii, A; Keller, PJ; Lorenz, H; Schiebel, E; Knop, M				Khmelinskii, Anton; Keller, Philipp J.; Lorenz, Holger; Schiebel, Elmar; Knop, Michael			Segregation of yeast nuclear pores	NATURE			English	Letter									[Khmelinskii, Anton; Keller, Philipp J.; Knop, Michael] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Khmelinskii, Anton; Lorenz, Holger; Schiebel, Elmar] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Khmelinskii, A (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de; knop@embl.de	Keller, Philipp J/F-2343-2010; Khmelinskii, Anton/B-2830-2008	Keller, Philipp/0000-0003-2896-4920; Khmelinskii, Anton/0000-0002-0256-5190				Barral Y, 2008, CURR OPIN CELL BIOL, V20, P647, DOI 10.1016/j.ceb.2008.10.007; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Chudakov DM, 2007, BIOTECHNIQUES, V42, P553, DOI 10.2144/000112470; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Henderson KA, 2008, CURR OPIN CELL BIOL, V20, P723, DOI 10.1016/j.ceb.2008.09.004; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119	10	35	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2010	466	7305								10.1038/nature09255	http://dx.doi.org/10.1038/nature09255			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651645	Bronze			2022-12-28	WOS:000280141200043
J	Scurlock, D				Scurlock, Donna			Vaccine, Please	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dscurlockmd@comcast.net						*KEN MOD HIV TRANS, 2009, KEN HIV PREV RESP MO; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					250	251		10.1001/jama.2010.751	http://dx.doi.org/10.1001/jama.2010.751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639552				2022-12-28	WOS:000280107500001
J	Altice, FL; Kamarulzaman, A; Soriano, VV; Schechter, M; Friedland, GH				Altice, Frederick L.; Kamarulzaman, Adeeba; Soriano, Vincent V.; Schechter, Mauro; Friedland, Gerald H.			Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs	LANCET			English	Article							ADMINISTERED ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CLINICAL-TRIAL; OPIOID SUBSTITUTION TREATMENT; SOFT-TISSUE INFECTIONS; HEPATITIS-C; METHADONE-MAINTENANCE; TREATMENT OUTCOMES; BEHAVIORAL INTERVENTION; BUPRENORPHINE TREATMENT	HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs. Substance-use disorders negatively affect the health of HIV-infected drug users, who also have frequent medical and psychiatric comorbidities that complicate HIV treatment and prevention. Evidence-based treatments are available for the management of substance-use disorders, mental illness, HIV and other infectious complications such as viral hepatitis and tuberculosis, and many non-HIV-associated comorbidities. Tuberculosis co-infection in HIV-infected drug users, including disease caused by drug-resistant strains, is acquired and transmitted as a consequence of inadequate prescription of antiretroviral therapy, poor adherence, and repeated interfaces with congregate settings such as prisons. Medication-assisted therapies provide the strongest evidence for HIV treatment and prevention efforts, yet are often not available where they are needed most. Antiretroviral therapy, when prescribed and adherence is at an optimum, improves health-related outcomes for HIV infection and many of its comorbidities, including tuberculosis, viral hepatitis, and renal and cardiovascular disease. Simultaneous clinical management of multiple comorbidities in HIV-infected drug users might result in complex pharmacokinetic drug interactions that must be adequately addressed Moreover, interventions to improve adherence to treatment, including integration of health services delivery, are needed. Multifaceted, interdisciplinary approaches are urgently needed to achieve parity in health outcomes in HIV-infected drug users	[Altice, Frederick L.; Friedland, Gerald H.] Yale Univ, Dept Med, Infect Dis Sect, New Haven, CT 06510 USA; [Altice, Frederick L.; Kamarulzaman, Adeeba] Univ Malaya, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia; [Soriano, Vincent V.] Hosp Carlos III, Dept Infect Dis, Madrid, Spain; [Schechter, Mauro] Univ Fed Rio de Janeiro, Hosp Escola Sao Francisco de Assis, Projeto Praca Onze, Rio De Janeiro, Brazil	Yale University; Universiti Malaya; Hospital Carlos III; Universidade Federal do Rio de Janeiro	Altice, FL (corresponding author), Yale Univ, Dept Med, Infect Dis Sect, 135 Coll St,Suite 323, New Haven, CT 06510 USA.		KAMARULZAMAN, ADEEBA/B-5216-2010; Schechter, Mauro/AAG-7445-2020; Soriano, Vicente/O-5730-2018	Soriano, Vicente/0000-0002-4624-5199	National Institutes on Drug Abuse [K24 DA017072, R01 DA013805, R01 DA017059, R01 DA025943, R01 DA025932]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013805, R01DA017059, R01DA025943, R01DA025932, K24DA017072] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge funding from the National Institutes on Drug Abuse for career development (K24 DA017072, FLA) and research support for FLA (R01 DA013805, R01 DA017059, and R01 DA025943) and G H (R01 DA025932) that contributed substantially to the creation of this report	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Altice FL, 2004, CLIN INFECT DIS, V38, pS376, DOI 10.1086/421400; Altice FL, 2003, J URBAN HEALTH, V80, P416, DOI 10.1093/jurban/jtg053; Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; Altice FL, 2006, CLIN INFECT DIS, V43, pS178, DOI 10.1086/508181; Altice FL, 2010, ARCH INTERN MED, V170, P109, DOI 10.1001/archinternmed.2009.459; Amato L, 2005, J SUBST ABUSE TREAT, V28, P321, DOI 10.1016/j.jsat.2005.02.007; Anand P, 2010, AIDS BEHAV, V14, P1213, DOI 10.1007/s10461-010-9684-1; [Anonymous], 2009, GUID SURV DRUG RES T; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; ARNATO L, 2008, COCHRANE DB SYST REV, V4; ARNSTEN J, 2009, 4 INT C HIV TREATM A; Ashton H, 2005, CURR OPIN PSYCHIATR, V18, P249, DOI 10.1097/01.yco.0000165594.60434.84; Avants SK, 2004, J SUBST ABUSE TREAT, V26, P67, DOI 10.1016/S0740-5472(03)00159-4; Babudieri S, 2000, JAMA-J AM MED ASSOC, V284, P179, DOI 10.1001/jama.284.2.179; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Barry J, 2009, EUROSURVEILLANCE, V14; Basu S, 2006, CLIN INFECT DIS, V42, P716, DOI 10.1086/500200; Batki SL, 2002, DRUG ALCOHOL DEPEN, V66, P283, DOI 10.1016/S0376-8716(01)00208-3; Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x; Behforouz HL, 2004, JAIDS-J ACQ IMM DEF, V36, P642, DOI 10.1097/00126334-200405010-00016; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Binswanger IA, 2008, J STUD ALCOHOL DRUGS, V69, P924, DOI 10.15288/jsad.2008.69.924; Blanco JMS, 2005, INT J STD AIDS, V16, P133, DOI 10.1258/0956462053057503; Brands B, 2008, J ADDICT DIS, V27, P37, DOI 10.1080/10550880802122620; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; Broadhead RS, 2002, J DRUG ISSUES, V32, P329, DOI 10.1177/002204260203200113; Bruce RD, 2007, INFECT DIS CLIN N AM, V21, P149, DOI 10.1016/j.idc.2007.03.009; Bruce RD, 2010, AIDS, V24, P331, DOI 10.1097/QAD.0b013e32833407d3; Bruce RD, 2006, JAIDS-J ACQ IMM DEF, V41, P563, DOI 10.1097/01.qai.0000219769.89679.ec; Burkey MD, 2008, HIV MED, V9, P858, DOI 10.1111/j.1468-1293.2008.00629.x; Carrieri MP, 2006, JAIDS-J ACQ IMM DEF, V41, P477, DOI 10.1097/01.qai.0000186364.27587.0e; Chaisson RE, 2001, AM J MED, V110, P610, DOI 10.1016/S0002-9343(01)00695-7; CHANDLER C, 1999, BERKELEY WOMENS LAW, V14, P66; Chaulk CP, 1998, JAMA-J AM MED ASSOC, V279, P943, DOI 10.1001/jama.279.12.943; Cho SH, 2009, ALCOHOL CLIN EXP RES, V33, P1305, DOI 10.1111/j.1530-0277.2009.00959.x; Conway B, 2004, CLIN INFECT DIS, V38, pS402, DOI 10.1086/421404; Crum-Cianflone N, 2009, AIDS PATIENT CARE ST, V23, P499, DOI 10.1089/apc.2008.0240; Curtis SJ, 2007, J INFECTION, V54, P422, DOI 10.1016/j.jinf.2006.10.004; De P, 2008, J VIRAL HEPATITIS, V15, P279, DOI 10.1111/j.1365-2893.2007.00942.x; Drucker E, 2002, J URBAN HEALTH, V79, P434, DOI 10.1093/jurban/79.3.434; Durand E, 2001, ANN MED INTERNE, V152, pS9; Fernandez Guerrero ML, 2009, MEDICINE, V88, P1, DOI 10.1097/MD.0b013e318194da65; Ferreros I, 2008, ADDICTION, V103, P651, DOI 10.1111/j.1360-0443.2008.02135.x; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Frazee BW, 2008, J EMERG MED, V34, P139, DOI 10.1016/j.jemermed.2007.03.041; Frederick T, 2009, AIDS PATIENT CARE ST, V23, P915, DOI 10.1089/apc.2009.0111; Garbutt JC, 2009, J SUBST ABUSE TREAT, V36, pS15, DOI 10.1016/j.jsat.2008.08.008; Golub JE, 2008, JAIDS-J ACQ IMM DEF, V49, P532, DOI 10.1097/QAI.0b013e31818d5c1c; Goujard C, 2003, JAIDS-J ACQ IMM DEF, V34, P191, DOI 10.1097/00126334-200310010-00009; Gourevitch MN, 2007, J SUBST ABUSE TREAT, V32, P143, DOI 10.1016/j.jsat.2006.07.008; Grebely J, 2010, DRUG ALCOHOL DEPEN, V107, P244, DOI 10.1016/j.drugalcdep.2009.09.015; GREENSTEIN RA, 1983, DRUG ALCOHOL DEPEN, V12, P173, DOI 10.1016/0376-8716(83)90042-X; Hammett TM, 2006, AM J PUBLIC HEALTH, V96, P974, DOI 10.2105/AJPH.2005.066993; HARNSON LD, 2001, CRIME DELINQUENCY, V47, P462; Hart JE, 2010, JAIDS-J ACQ IMM DEF, V54, P167, DOI 10.1097/QAI.0b013e3181d9a330; Hope V, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-120; Hsieh YH, 2008, JAIDS-J ACQ IMM DEF, V49, P398, DOI 10.1097/QAI.0b013e318183ac84; Izenberg JM, 2010, ADDICTION, V105, P569, DOI 10.1111/j.1360-0443.2009.02881.x; Izzedine H, 2009, AIDS, V23, P1219, DOI 10.1097/QAD.0b013e32832ac36a; Kalichman SC, 2005, J ASSOC NURSE AIDS C, V16, P3, DOI 10.1016/j.jana.2005.07.001; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P59, DOI 10.1136/sti.79.1.59; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Kerr T, 2005, AIDS CARE, V17, P539, DOI 10.1080/09540120412331319778; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Kidder DP, 2007, AIDS BEHAV, V11, pS149, DOI 10.1007/s10461-007-9249-0; Kim TW, 2007, AIDS CARE, V19, P1039, DOI 10.1080/09540120701294245; KIM TW, 2006, BMC HEALTH SERV RES, P6; Kinlock TW, 2009, J SUBST ABUSE TREAT, V37, P277, DOI 10.1016/j.jsat.2009.03.002; Kohli R, 2005, CLIN INFECT DIS, V41, P864, DOI 10.1086/432883; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Kushel MB, 2006, CLIN INFECT DIS, V43, P234, DOI 10.1086/505212; Larney S, 2009, EUR ADDICT RES, V15, P107, DOI 10.1159/000199046; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lertmaharit Somrat, 2005, J Med Assoc Thai, V88 Suppl 4, pS149; LEWDEN C, 2010, 17 C RETR OPP INF SA; Lintzeris N, 2004, AM J ADDICTION, V13, pS29, DOI 10.1080/10550490490440799; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Lobmaier P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006140.pub2; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Lucas GM, 2004, CLIN INFECT DIS, V38, pS409, DOI 10.1086/421405; Lucas GM, 2002, AIDS, V16, P767, DOI 10.1097/00002030-200203290-00012; Lucas GM, 2002, AIDS PATIENT CARE ST, V16, P527, DOI 10.1089/108729102761041083; Lucas GM, 2010, ANN INTERN MED, V152, P704, DOI 10.7326/0003-4819-152-11-201006010-00003; Macalino GE, 2007, AIDS, V21, P1473, DOI 10.1097/QAD.0b013e32811ebf68; Macias J, 2006, ANTIVIR THER, V11, P839; Mann K, 2008, ALCOHOL CLIN EXP RES, V32, P1105, DOI 10.1111/j.1530-0277.2008.00690.x; Margolin A, 2003, HEALTH PSYCHOL, V22, P223, DOI 10.1037/0278-6133.22.2.223; Maru DSR, 2008, CLIN INFECT DIS, V47, P952, DOI 10.1086/591707; Maru DSR, 2007, LANCET INFECT DIS, V7, P568, DOI 10.1016/S1473-3099(07)70190-1; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; MARUSCHAK LM, 2009, 228307 NCJ; Mason B J, 2000, CNS Spectr, V5, P58; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2001, ALCOHOL ALCOHOLISM, V36, P109, DOI 10.1093/alcalc/36.2.109; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; McVay D., 2004, TREATMENT INCARCERAT; Mitchell CG, 2007, AIDS CARE, V19, P561, DOI 10.1080/09540120601040813; Mitty JA, 2005, JAIDS-J ACQ IMM DEF, V39, P545; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; Murray JB, 1998, PSYCHOL REP, V83, P295, DOI 10.2466/PR0.83.5.295-302; Murray-Lillibridge K, 2006, EPIDEMIOL INFECT, V134, P894, DOI 10.1017/S0950268805005418; NGUYEN ML, 2009, CURRENT INFECT DIS R, V12, P46; Palepu A, 2004, ANTIVIR THER, V9, P713; Palepu A, 2005, J SUBST ABUSE TREAT, V28, P3, DOI 10.1016/j.jsat.2004.09.002; Palepu A, 2003, J URBAN HEALTH, V80, P667, DOI 10.1093/jurban/jtg073; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Parsons JT, 2007, JAIDS-J ACQ IMM DEF, V46, P443, DOI 10.1097/QAI.0b013e318158a461; Parsons JT, 2007, J HEALTH PSYCHOL, V12, P357, DOI 10.1177/1359105307074298; Partanen TA, 2009, EUR J VASC ENDOVASC, V37, P704, DOI 10.1016/j.ejvs.2009.01.016; Peixoto B, 2008, ADV CLIN EXP MED, V17, P53; Petersen ML, 2007, CLIN INFECT DIS, V45, P908, DOI 10.1086/521250; Piper ME, 2009, ARCH GEN PSYCHIAT, V66, P1253, DOI 10.1001/archgenpsychiatry.2009.142; Podlekareva DN, 2009, AIDS, V23, P2485, DOI 10.1097/QAD.0b013e3283326879; Purcell DW, 2007, JAIDS-J ACQ IMM DEF, V46, pS35, DOI 10.1097/QAI.0b013e31815767c4; Rawlings MK, 2003, JAIDS-J ACQ IMM DEF, V34, P174, DOI 10.1097/00126334-200310010-00007; Reyes MP, 2009, MEDICINE, V88, P294, DOI 10.1097/MD.0b013e3181b8bedc; Rodrigo T, 2002, INT J TUBERC LUNG D, V6, P1091; Rogers RE, 2008, PSYCHOL ADDICT BEHAV, V22, P544, DOI 10.1037/0893-164X.22.4.544; Roth A, 1997, J SUBST ABUSE TREAT, V14, P19, DOI 10.1016/S0740-5472(96)00164-X; Roux P, 2009, CLIN INFECT DIS, V49, P1433, DOI 10.1086/630209; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sadaphal P, 2001, CLIN INFECT DIS, V33, P1687, DOI 10.1086/323896; SAMANDARI T, 2010, 17 C RETR OPP INF SA; Samet JH, 2007, PANMINERVA MED, V49, P67; Schiavini M, 2006, HIV MED, V7, P331, DOI 10.1111/j.1468-1293.2006.00384.x; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Serfaty L, 2009, LIVER INT, V29, P13, DOI 10.1111/j.1478-3231.2008.01952.x; Sierra JM, 2006, MEDICINE, V85, P139, DOI 10.1097/01.md.0000224707.24392.52; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Sindelar JL, 2007, ADDICTION, V102, P1463, DOI 10.1111/j.1360-0443.2007.01913.x; Smith SS, 2009, ARCH INTERN MED, V169, P2148, DOI 10.1001/archinternmed.2009.426; Smith-Rohrberg D, 2004, J DRUG ISSUES, V34, P451, DOI 10.1177/002204260403400210; Smith-Rohrberg D, 2006, JAIDS-J ACQ IMM DEF, V43, pS48, DOI 10.1097/01.qai.0000248338.74943.85; Smith-Rohrberg D, 2006, CLIN INFECT DIS, V43, P1221, DOI 10.1086/508357; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Spire B, 2007, INT J DRUG POLICY, V18, P262, DOI 10.1016/j.drugpo.2006.12.014; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer Sandra A, 2005, Curr HIV/AIDS Rep, V2, P165, DOI 10.1007/s11904-005-0011-9; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; SRISURAPANONT M, 2005, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001867.PUB2; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Sylla L, 2007, INT J DRUG POLICY, V18, P306, DOI 10.1016/j.drugpo.2007.03.001; Takahashi TA, 2010, J BEHAV HEALTH SER R, V37, P508, DOI 10.1007/s11414-009-9177-z; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thirthalli J, 2009, CURR OPIN PSYCHIATR, V22, P274, DOI 10.1097/YCO.0b013e32832a1dc0; Thomas JC, 2006, SEX TRANSM DIS, V33, pS6, DOI 10.1097/01.olq.0000221025.17158.26; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; WALLACE R, 1993, SOC SCI MED, V37, P887, DOI 10.1016/0277-9536(93)90143-R; Weaver MR, 2009, J MENT HEALTH POLICY, V12, P33; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; WHO, 2008, ANT DRUG RES WORLD W; *WHO, 2007, TUB INF CONTR ER EXP; *WHO, 2004, UNAIDS SUBST MAINT T; Wohl AR, 2006, CLIN INFECT DIS, V42, P1619, DOI 10.1086/503906; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2008, POL GUID COLL TB HIV; World Health Organization, 2009, RAP ADV ANT THER HIV; Zahari MM, 2010, AM J DRUG ALCOHOL AB, V36, P31, DOI 10.3109/00952990903544828	164	345	350	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					367	387		10.1016/S0140-6736(10)60829-X	http://dx.doi.org/10.1016/S0140-6736(10)60829-X			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20650518	Green Accepted			2022-12-28	WOS:000280717900035
J	Saugstad, OD				Saugstad, Ola Didrik			Resuscitation of newborn infants: from oxygen to room air	LANCET			English	Editorial Material							100-PERCENT OXYGEN; NEONATAL RESUSCITATION; HYPOXANTHINE; METAANALYSIS; 21-PERCENT; INCREASES; HYPOXIA; PIGLETS; INJURY; TRIAL		Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Paediat Res, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Saugstad, OD (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Paediat Res, N-0027 Oslo, Norway.	odsaugstad@rr-research.no	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254				[Anonymous], 2006, PEDIATRICS, V117, pe978; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Hansmann G, 2004, LANCET, V364, P1293, DOI 10.1016/S0140-6736(04)17203-6; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lakshminrusimha S, 2006, PEDIATR RES, V59, P137, DOI 10.1203/01.pdr.0000191136.69142.8c; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; Naumburg E, 2002, ACTA PAEDIATR, V91, P1328, DOI 10.1080/08035250216105; Paneth N, 2005, J PEDIATR-US, V147, P4, DOI 10.1016/j.jpeds.2005.04.058; RAMJI S, 1993, PEDIATR RES, V34, P809, DOI 10.1203/00006450-199312000-00023; ROOTWELT T, 1992, PEDIATR RES, V32, P107, DOI 10.1203/00006450-199207000-00021; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; SAUGSTAD OD, 1980, EUR SURG RES, V12, P123, DOI 10.1159/000128117; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Sejersted Y, 2009, PEDIATR RES, V66, P533, DOI 10.1203/PDR.0b013e3181ba1a42; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; Spector LG, 2005, J PEDIATR-US, V147, P27, DOI 10.1016/j.jpeds.2005.03.008; Tarnow-Mordi WO, 1998, LANCET, V352, P341, DOI 10.1016/S0140-6736(05)60464-3; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; *WHO, 1997, BAS NEWB RES PRACT G	23	60	61	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 11	2010	376	9757					1970	1971		10.1016/S0140-6736(10)60543-0	http://dx.doi.org/10.1016/S0140-6736(10)60543-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	20663546				2022-12-28	WOS:000285807700008
J	Greenway, FL; Fujioka, K; Plodkowski, RA; Mudaliar, S; Guttadauria, M; Erickson, J; Kim, DD; Dunayevich, E				Greenway, Frank L.; Fujioka, Ken; Plodkowski, Raymond A.; Mudaliar, Sunder; Guttadauria, Maria; Erickson, Janelle; Kim, Dennis D.; Dunayevich, Eduardo		COR-I Study Grp	Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article								Background Despite increasing public health concerns regarding obesity, few safe and effective drug treatments are available. Combination treatment with sustained-release naltrexone and bupropion was developed to produce complementary actions in CNS pathways regulating bodyweight. The Contrave Obesity Research I (COR-I) study assessed the effect of such treatment on bodyweight in overweight and obese participants. Methods Men and women aged 18-65 years who had a body-mass index (BMI) of 30-45 kg/m(2) and uncomplicated obesity or BMI 27-45 kg/m(2) with dyslipidaemia or hypertension were eligible for enrolment in this randomised, double-blind, placebo-controlled, phase 3 trial undertaken at 34 sites in the USA. Participants were prescribed mild hypocaloric diet and exercise and were randomly assigned in a 1:1:1 ratio to receive sustained-release naltrexone 32 mg per day plus sustained-release bupropion 360 mg per day combined in fixed-dose tablets (also known as NB32), sustained-release naltrexone 16 mg per day plus sustained-release bupropion 360 mg per day combined in fixed-dose tablets (also known as NB16), or matching placebo twice a day, given orally for 56 weeks. The trial included a 3-week dose escalation. Randomisation was done by use of a centralised, computer-generated, web-based system and was stratified by study centre. Co-primary efficacy endpoints at 56 weeks were percentage change in bodyweight and proportion of participants who achieved a decrease in bodyweight of 5% or more. The primary analysis included all randomised participants with a baseline weight measurement and a post-baseline weight measurement while on study drug (last observation carried forward). This study is registered with ClinicalTrials.gov, number NCT00532779. Findings 1742 participants were enrolled and randomised to double-blind treatment (naltrexone 32 mg plus bupropion, n=583; naltrexone 16 mg plus bupropion, n=578; placebo, n=581). 870 (50%) participants completed 56 weeks of treatment (n=296; n=284; n=290, respectively) and 1453 (83%) were included in the primary analysis (n=471; n=471; n=511). Mean change in bodyweight was -1.3% (SE 0.3) in the placebo group, -6.1% (0.3) in the naltrexone 32 mg plus bupropion group (p<0.0001 vs placebo) and -5.0% (0.3) in the naltrexone 16 mg plus bupropion group (p<0.0001 vs placebo). 84 (16%) participants assigned to placebo had a decrease in bodyweight of 5% or more compared with 226 (48%) assigned to naltrexone 32 mg plus bupropion (p<0.0001 vs placebo) and 186 (39%) assigned to naltrexone 16 mg plus bupropion (p<0.0001 vs placebo). The most frequent adverse event in participants assigned to combination treatment was nausea (naltrexone 32 mg plus bupropion, 171 participants [29.8%]; naltrexone 16 mg plus bupropion, 155 [27.2%]; placebo, 30 [5.3%]). Headache, constipation, dizziness, vomiting, and dry mouth were also more frequent in the naltrexone plus bupropion groups than in the placebo group. A transient increase of around 1.5 mm Hg in mean systolic and diastolic blood pressure was followed by a reduction of around 1 mm Hg below baseline in the naltrexone plus bupropion groups. Combination treatment was not associated with increased depression or suicidality events compared with placebo. Interpretation A sustained-release combination of naltrexone plus bupropion could be a useful therapeutic option for treatment of obesity.	[Greenway, Frank L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Fujioka, Ken] Scripps Clin, La Jolla, CA 92037 USA; [Plodkowski, Raymond A.] Univ Nevada, Sch Med, Reno, NV 89557 USA; [Plodkowski, Raymond A.] Sierra Nevada Hlth Care Syst, Reno Vet Affairs Med Ctr, Reno, NV USA; [Mudaliar, Sunder] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Mudaliar, Sunder] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Guttadauria, Maria] MG Consulting, New York, NY USA; [Erickson, Janelle] inVentiv Clin Solut, Baltimore, MD USA; [Kim, Dennis D.; Dunayevich, Eduardo] Orexigen Therapeut, La Jolla, CA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Scripps Research Institute; Nevada System of Higher Education (NSHE); University of Nevada Reno; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Greenway, FL (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	frank.greenway@pbrc.edu	Mudaliar, Sunder/N-5813-2019; Greenway, Frank/N-1966-2017; Mudaliar, Sunder/R-2781-2019	Greenway, Frank/0000-0002-1766-6111; Loper, Joyce/0000-0003-3501-5969	Orexigen; Amylin; Lilly; Merck; Sanofi-Aventis; Arena Pfizer; Bristol-Myers Squibb; Nastech; Schering Plough; GlaxoSmithKline; Hollis-Eden; Orexigen Therapeutics	Orexigen; Amylin; Lilly(Eli Lilly); Merck(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Arena Pfizer; Bristol-Myers Squibb(Bristol-Myers Squibb); Nastech; Schering Plough(Merck & CompanySchering Plough Corporation); GlaxoSmithKline(GlaxoSmithKline); Hollis-Eden; Orexigen Therapeutics	FLG has received consulting fees and travel support from Orexigen, is a member of advisory boards for Orexigen, Baronova, Biologene, Catalyst Pharmaceutical Partners, GlaxoSmithKline, Jenny Craig, Leptos Biomedical, Novo Nordisk, Obecure, Schering-Plough Research Institute, NuMe, and Origin Biomed, is a consultant for Basic Research, Dow Chemical, General Nutrition, Lithera, Otsuka Pharmaceutical Development and Commercialization, and Third Rock Ventures, and has received research grants or has grants pending from Amylin, Lilly, Orexigen, Merck, Sanofi-Aventis, Arena Pfizer, Bristol-Myers Squibb, Nastech, Schering Plough, GlaxoSmithKline, and Hollis-Eden. FLG holds three patents related to obesity treatment. KF is a member of the advisory board and has received consulting fees and research grant support from Orexigen. RAP has received a research grant and travel support from Orexigen. SM has received research grant support from Orexigen. MG has received consulting fees and travel support from Orexigen. JE is a former employee at Orexigen. DDK and ED are employees at and hold stock in Orexigen.; This study was sponsored by Orexigen Therapeutics. Metropolitan Research Associates (New York, NY, USA) was responsible for study conduct and monitoring, and inVentiv Clinical Solutions (Hunt Valley, MD, USA) was responsible for data management and statistical analyses. We thank Georgia Tsaroucha, Terry Rees, and Colleen Burns (Orexigen) for statistical programming support, as well as all clinical research staff and participants for their patience and dedication. Sonja K Billes, a medical writer employed by Orexigen, provided assistance in writing and preparation of the report.	Anderson JW, 2002, OBES RES, V10, P633, DOI 10.1038/oby.2002.86; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Crosby RD, 2004, J CLIN EPIDEMIOL, V57, P1153, DOI 10.1016/j.jclinepi.2004.04.004; Dhillon S, 2008, DRUGS, V68, P653, DOI 10.2165/00003495-200868050-00011; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Gradman AH, 2002, CURR HYPERTENS REP, V4, P343, DOI 10.1007/s11906-002-0062-x; Greenway FL, 2009, J CLIN ENDOCR METAB, V94, P4898, DOI 10.1210/jc.2009-1350; Greenway FL, 2009, OBESITY, V17, P30, DOI 10.1038/oby.2008.461; Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007; Grodstein F, 1996, ARCH INTERN MED, V156, P1302, DOI 10.1001/archinte.156.12.1302; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; *IMS HLTH, 2004, NAT DIS THER IND; Jain AK, 2002, OBES RES, V10, P1049, DOI 10.1038/oby.2002.142; Krishna R, 2009, CLIN PHARMACOL THER, V86, P659, DOI 10.1038/clpt.2009.167; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; *NHLBI NIDDK, 1998, CLIN GUID ID EV TREA; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pelchat ML, 1997, APPETITE, V28, P103, DOI 10.1006/appe.1996.0063; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; RIDDLE M, 2000, AM J MED, V108, P15; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Rush A.J., 2000, INT J METH PSYCH RES, V9, P45, DOI [DOI 10.1002/MPR.79, 10.1002/mpr.79]; Sinnayah P, 2007, N AM ASS STUD OB ANN; *TABL BARR LAB, 2007, PACK INS NALTR HYDR, P1; Thase ME, 2008, J CLIN PSYCHOPHARM, V28, P302, DOI 10.1097/JCP.0b013e318172424e; VanGaal LF, 1997, INT J OBESITY, V21, pS5; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wadden TA, 2011, OBESITY, V19, P110, DOI 10.1038/oby.2010.147; White MA, 2002, OBES RES, V10, P107, DOI 10.1038/oby.2002.17; Wilcox CS, 2010, ADDICT BEHAV, V35, P229, DOI 10.1016/j.addbeh.2009.10.017; World Medical Association, 2004, DECL HELS ETH PRINC	33	504	530	2	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					595	605		10.1016/S0140-6736(10)60888-4	http://dx.doi.org/10.1016/S0140-6736(10)60888-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20673995				2022-12-28	WOS:000281309100030
J	Muller, RD				Mueller, R. Dietmar			Sedimentary Basins Feeling the Heat from Below	SCIENCE			English	Editorial Material							SEA-LEVEL; CONVECTION; FLUCTUATIONS; MANTLE		Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia	University of Sydney	Muller, RD (corresponding author), Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia.	dietmar.muller@usyd.edu.au	Müller, Dietmar/L-1200-2019	Müller, Dietmar/0000-0002-3334-5764				Ballmer MD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031636; Boutilier RR, 1999, J GEOPHYS RES-SOL EA, V104, P7389, DOI 10.1029/1998JB900076; CLOETINGH S, 1986, GEOLOGY, V14, P617, DOI 10.1130/0091-7613(1986)14<617:ISANTM>2.0.CO;2; Expedition 317 Scientists, 2010, 317 IODP; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; *IODP, 2010, 313 IODP; Kominz MA, 2001, GEOL SOC AM BULL, V113, P291, DOI 10.1130/0016-7606(2001)113<0291:OEFTDS>2.0.CO;2; MIALL AD, 1992, GEOLOGY, V20, P787, DOI 10.1130/0091-7613(1992)020<0787:EGCCAE>2.3.CO;2; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; PARSONS B, 1978, J GEOPHYS RES, V83, P4485, DOI 10.1029/JB083iB09p04485; Pay- ton C.E., 1977, AAPG BULL, V26, P83, DOI DOI 10.1306/M26490C6; Petersen KD, 2010, SCIENCE, V329, P827, DOI 10.1126/science.1190115; RICHTER FM, 1973, J GEOPHYS RES, V78, P8735, DOI 10.1029/JB078i035p08735	14	1	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					769	770		10.1126/science.1194560	http://dx.doi.org/10.1126/science.1194560			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705839				2022-12-28	WOS:000280809900025
J	Guo, HL; Ingolia, NT; Weissman, JS; Bartel, DP				Guo, Huili; Ingolia, Nicholas T.; Weissman, Jonathan S.; Bartel, David P.			Mammalian microRNAs predominantly act to decrease target mRNA levels	NATURE			English	Article							GENOME-WIDE ANALYSIS; POSTTRANSCRIPTIONAL REGULATION; PROTEIN-SYNTHESIS; IN-VIVO; TRANSLATION; INITIATION; DEADENYLATION; DEGRADATION; ELEGANS; MIRNAS	MicroRNAs (miRNAs) are endogenous similar to 22-nucleotide RNAs that mediate important gene-regulatory events by pairing to the mRNAs of protein-coding genes to direct their repression. Repression of these regulatory targets leads to decreased translational efficiency and/or decreased mRNA levels, but the relative contributions of these two outcomes have been largely unknown, particularly for endogenous targets expressed at low-to-moderate levels. Here, we use ribosome profiling to measure the overall effects on protein production and compare these to simultaneously measured effects on mRNA levels. For both ectopic and endogenous miRNA regulatory interactions, lowered mRNA levels account for most (>= 84%) of the decreased protein production. These results show that changes in mRNA levels closely reflect the impact of miRNAs on gene expression and indicate that destabilization of target mRNAs is the predominant reason for reduced protein output.	[Guo, Huili; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Guo, Huili; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Guo, Huili; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Weissman, Jonathan/0000-0003-2445-670X; Guo, Huili/0000-0002-2294-5684	NIH; Agency for Science, Technology and Research, Singapore; Ruth L. Kirschstein National Research Service Award [GM080853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031, F32GM080853] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Camargo, C. Jan, J. Kim and C. Petersen for advice and discussions, R. Green and O. Rissland for comments on the manuscript, and the Whitehead Institute's Genome Technology Core for sequencing and microarray profiling. This work was supported by grants from the NIH (D. P. B. and J. S. W.). H. G. was supported by the Agency for Science, Technology and Research, Singapore. N.T.I. was supported by a Ruth L. Kirschstein National Research Service Award (GM080853). D. P. B and J. S. W. are investigators of the Howard Hughes Medical Institute.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103	34	2936	3049	4	337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					835	U66		10.1038/nature09267	http://dx.doi.org/10.1038/nature09267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703300	Green Submitted, Green Accepted			2022-12-28	WOS:000280766100029
J	Schirmer, A; Rude, MA; Li, XZ; Popova, E; del Cardayre, SB				Schirmer, Andreas; Rude, Mathew A.; Li, Xuezhi; Popova, Emanuela; del Cardayre, Stephen B.			Microbial Biosynthesis of Alkanes	SCIENCE			English	Article							RIBONUCLEOTIDE REDUCTASE; HYDROCARBONS; ALGAE; ACID; GENE	Alkanes, the major constituents of gasoline, diesel, and jet fuel, are naturally produced by diverse species; however, the genetics and biochemistry behind this biology have remained elusive. Here we describe the discovery of an alkane biosynthesis pathway from cyanobacteria. The pathway consists of an acyl-acyl carrier protein reductase and an aldehyde decarbonylase, which together convert intermediates of fatty acid metabolism to alkanes and alkenes. The aldehyde decarbonylase is related to the broadly functional nonheme diiron enzymes. Heterologous expression of the alkane operon in Escherichia coli leads to the production and secretion of C13 to C17 mixtures of alkanes and alkenes. These genes and enzymes can now be leveraged for the simple and direct conversion of renewable raw materials to fungible hydrocarbon fuels.	[Schirmer, Andreas; Rude, Mathew A.; Li, Xuezhi; Popova, Emanuela; del Cardayre, Stephen B.] LS9 Inc, San Francisco, CA 94080 USA		Schirmer, A (corresponding author), LS9 Inc, 600 Gateway Blvd, San Francisco, CA 94080 USA.	aschirmer@ls9.com			LS9, Inc.	LS9, Inc.	We thank M. Alibhai for homology modeling, S. Brubaker for bioinformatics work, T. Baron for technical assistance, and C. Chang for help with preparing Fig. 3. The patent applications WO 2009/140695 and WO 2009/140696 are relevant to this paper. All authors have a financial interest in LS9, Inc. We would like to dedicate this paper to the memory of C. Richard Hutchinson, who died on 5 January 2010. "Hutch" was an important mentor for A.S. and S.B.d.C. He will be missed.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Dembitsky VM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1276, DOI 10.1023/A:1021309623541; DENNIS M, 1992, P NATL ACAD SCI USA, V89, P5306, DOI 10.1073/pnas.89.12.5306; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; FEHLER SWG, 1970, BIOCHEMISTRY-US, V9, P418, DOI 10.1021/bi00804a032; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Ladygina N, 2006, PROCESS BIOCHEM, V41, P1001, DOI 10.1016/j.procbio.2005.12.007; MCINNES AG, 1980, LIPIDS, V15, P609, DOI 10.1007/BF02534009; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Muller J, 2002, BIOCHEMISTRY-US, V41, P42, DOI 10.1021/bi015668k; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Regalbuto JR, 2009, SCIENCE, V325, P822, DOI 10.1126/science.1174581; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; SHIEA J, 1990, ORG GEOCHEM, V15, P223, DOI 10.1016/0146-6380(90)90001-G; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; TORNABENE TG, 1982, EXPERIENTIA, V38, P43, DOI 10.1007/BF01944525; Wackett LP, 2007, APPL ENVIRON MICROB, V73, P7192, DOI 10.1128/AEM.01785-07; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454	25	719	804	10	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					559	562		10.1126/science.1187936	http://dx.doi.org/10.1126/science.1187936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671186				2022-12-28	WOS:000280483500035
J	Kapranov, P; Ozsolak, F; Kim, SW; Foissac, S; Lipson, D; Hart, C; Roels, S; Borel, C; Antonarakis, SE; Monaghan, AP; John, B; Milos, PM				Kapranov, Philipp; Ozsolak, Fatih; Kim, Sang Woo; Foissac, Sylvain; Lipson, Doron; Hart, Chris; Roels, Steve; Borel, Christelle; Antonarakis, Stylianos E.; Monaghan, A. Paula; John, Bino; Milos, Patrice M.			New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanism	NATURE			English	Article							POLYMERASE-II; TRANSCRIPTION	Small (<200 nucleotide) RNA (sRNA) profiling of human cells using various technologies demonstrates unexpected complexity of sRNAs with hundreds of thousands of sRNA species present(1-4). Genetic and in vitro studies show that these RNAs are not merely degradation products of longer transcripts but could indeed have a function(1,2,5). Furthermore, profiling of RNAs, including the sRNAs, can reveal not only novel transcripts, but also make clear predictions about the existence and properties of novel biochemical pathways operating in a cell. For example, sRNA profiling in human cells indicated the existence of an unknown capping mechanism operating on cleaved RNA(2), a biochemical component of which was later identified(6). Here we show that human cells contain a novel type of sRNA that has non-genomically encoded 5' poly(U) tails. The presence of these RNAs at the termini of genes, specifically at the very 3' ends of known mRNAs, strongly argues for the presence of a yet uncharacterized endogenous biochemical pathway in cells that can copy RNA. We show that this pathway can operate on multiple genes, with specific enrichment towards transcript-encoding components of the translational machinery. Finally, we show that genes are also flanked by sense, 3' polyadenylated sRNAs that are likely to be capped.	[Kapranov, Philipp; Ozsolak, Fatih; Lipson, Doron; Hart, Chris; Roels, Steve; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA; [Kim, Sang Woo; John, Bino] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Foissac, Sylvain] Integromics SL, Madrid 28760, Spain; [Borel, Christelle; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Geneva; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kapranov, P (corresponding author), Helicos BioSci Corp, 1 Kendall Sq,Ste B7301, Cambridge, MA 02139 USA.	philippk08@gmail.com; pmilos@helicosbio.com	borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Kapranov, Philipp/0000-0003-2647-4856; Foissac, Sylvain/0000-0002-2631-5356; Kim, Sang Woo/0000-0002-3144-4822	Swiss National Science Foundation; NIH [GM079756, MH60774]; American Cancer Society [RSG0905401]; Comunidad de Madrid; European Union [Exp. 11/2009]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank A. Willingham, J. Thompson and Z. Li for discussions and help in the preparation of the manuscript. S. E. A. is supported by the Swiss National Science Foundation, B. J. by the NIH (GM079756) and American Cancer Society (RSG0905401), and A. P. M. by the NIH (MH60774). S. F. acknowledges support by a grant from the Comunidad de Madrid and European Union (Exp. 11/2009).	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Aspegren A, 2004, NUCLEIC ACIDS RES, V32, P4646, DOI 10.1093/nar/gkh804; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fodor E, 2000, EMBO REP, V1, P513; GILADI E, J COMPUT BI IN PRESS; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Volloch V, 1996, P NATL ACAD SCI USA, V93, P2476, DOI 10.1073/pnas.93.6.2476	19	61	69	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					642	646		10.1038/nature09190	http://dx.doi.org/10.1038/nature09190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671709	Green Accepted			2022-12-28	WOS:000280412100057
J	Witlox, J; Eurelings, LSM; de Jonghe, JFM; Kalisvaart, KJ; Eikelenboom, P; van Gool, WA				Witlox, Joost; Eurelings, Lisa S. M.; de Jonghe, Jos F. M.; Kalisvaart, Kees J.; Eikelenboom, Piet; van Gool, Willem A.			Delirium in Elderly Patients and the Risk of Postdischarge Mortality, Institutionalization, and Dementia A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HIP FRACTURE PATIENTS; POSTOPERATIVE DELIRIUM; OLDER PATIENTS; PROGNOSTIC-SIGNIFICANCE; PUBLICATION BIAS; OUTCOMES; REHABILITATION; PREDICTORS; PEOPLE; DEATH	Context Delirium is a common and serious complication in elderly patients. Evidence suggests that delirium is associated with long-term poor outcome but delirium often occurs in individuals with more severe underlying disease. Objective To assess the association between delirium in elderly patients and long-term poor outcome, defined as mortality, institutionalization, or dementia, while controlling for important confounders. Data Sources Asystematic search of studies published between January 1981 and April 2010 was conducted using the databases of MEDLINE, EMBASE, PsycINFO, and CINAHL. Study Selection Observational studies of elderly patients with delirium as a study variable and data on mortality, institutionalization, or dementia after a minimum follow-up of 3 months, and published in the English or Dutch language. Titles, abstracts, and articles were reviewed independently by 2 of the authors. Of 2939 references in the original search, 51 relevant articles were identified. Data Extraction Information on study design, characteristics of the study population, and outcome were extracted. Quality of studies was assessed based on elements of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for cohort studies. Data Synthesis The primary analyses included only high-quality studies with statistical control for age, sex, comorbid illness or illness severity, and baseline dementia. Pooled-effect estimates were calculated with random-effects models. The primary analysis with adjusted hazard ratios (HRs) showed that delirium is associated with an increased risk of death compared with controls after an average follow-up of 22.7 months (7 studies; 271/714 patients [38.0%] with delirium, 616/2243 controls [27.5%]; HR, 1.95 [95% confidence interval {CI}, 1.51-2.52]; I-2, 44.0%). Moreover, patients who had experienced delirium were also at increased risk of institutionalization (7 studies; average follow-up, 14.6 months; 176/527 patients [33.4%] with delirium and 219/2052 controls [10.7%]; odds ratio [OR], 2.41 [95% CI, 1.77-3.29]; I-2, 0%) and dementia (2 studies; average follow-up, 4.1 years; 35/56 patients [62.5%] with delirium and 15/185 controls [8.1%]; OR, 12.52 [95% CI, 1.86-84.21]; I-2, 52.4%). The sensitivity, trim-and-fill, and secondary analyses with unadjusted high-quality risk estimates stratified according to the study characteristics confirmed the robustness of these results. Conclusion This meta-analysis provides evidence that delirium in elderly patients is associated with poor outcome independent of important confounders, such as age, sex, comorbid illness or illness severity, and baseline dementia. JAMA. 2010; 304(4): 443-451	[Eurelings, Lisa S. M.; Eikelenboom, Piet; van Gool, Willem A.] Acad Med Ctr, Dept Neurol, NL-1100 DE Amsterdam, Netherlands; [Witlox, Joost; de Jonghe, Jos F. M.] Med Ctr Alkmaar, Dept Geriatr Med, Alkmaar, Netherlands; [Kalisvaart, Kees J.] Kennemer Gasthuis, Dept Geriatr Med, Haarlem, Netherlands; [Eikelenboom, Piet] GGZinGeest, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Medical Center Of Alkmaar; Spaarne Hospital	van Gool, WA (corresponding author), Acad Med Ctr, Dept Neurol, POB 22700, NL-1100 DE Amsterdam, Netherlands.	w.a.vangool@amc.uva.nl	Van Gool, Willem A/G-5985-2012; Eikelenboom, Piet/AAF-6359-2020	Kalisvaart, Kees/0000-0002-7027-490X; Van Gool, Willem/0000-0003-3174-8233				Adamis D, 2007, AGE AGEING, V36, P644, DOI 10.1093/ageing/afm094; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.5771/0943-7444-2017-8-668]; Bellelli G, 2008, AGE AGEING, V37, P353, DOI 10.1093/ageing/afn056; Bellelli G, 2007, J GERONTOL A-BIOL, V62, P1306, DOI 10.1093/gerona/62.11.1306; Bellelli G, 2008, J AM MED DIR ASSOC, V9, P55, DOI 10.1016/j.jamda.2007.09.009; BERGGREN D, 1987, ANESTH ANALG, V66, P497; Bickel H, 2008, DEMENT GERIATR COGN, V26, P26, DOI 10.1159/000140804; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Borenstein M., 2009, INTRO META ANAL, P59, DOI [10.1002/9780470743386.ch13, DOI 10.1002/9780470743386.CH13]; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; Brannstrom B, 1989, Scand J Caring Sci, V3, P27; Cole MG, 2009, AGE AGEING, V38, P19, DOI 10.1093/ageing/afn253; Curyto KJ, 2001, AM J GERIAT PSYCHIAT, V9, P141, DOI 10.1176/appi.ajgp.9.2.141; Dasgupta M, 2006, J AM GERIATR SOC, V54, P1578, DOI 10.1111/j.1532-5415.2006.00893.x; de Rooij S E, 2007, Ned Tijdschr Geneeskd, V151, P1987; Dolan MM, 2000, J GERONTOL A-BIOL, V55, pM527, DOI 10.1093/gerona/55.9.M527; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edelstein DM, 2004, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000128649.59959.0c; Edlund A, 2001, J AM GERIATR SOC, V49, P1335, DOI 10.1046/j.1532-5415.2001.49261.x; Edlund A, 1999, DEMENT GERIATR COGN, V10, P325, DOI 10.1159/000017163; Edlund A, 2006, J GERIATR PSYCH NEUR, V19, P83, DOI 10.1177/0891988706286509; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; Furlaneto ME, 2007, CLINICS, V62, P545, DOI 10.1590/S1807-59322007000500003; George J, 1997, AGE AGEING, V26, P423, DOI 10.1093/ageing/26.6.423; Giusti A, 2006, ARCH PHYS MED REHAB, V87, P826, DOI 10.1016/j.apmr.2006.02.018; Gonzalez M, 2005, EUR J PSYCHIAT, V19, P165, DOI 10.4321/s0213-61632005000300005; Gonzalez M, 2009, PSYCHOSOMATICS, V50, P234, DOI 10.1176/appi.psy.50.3.234; GUSTAFSON Y, 1988, J AM GERIATR SOC, V36, P525, DOI 10.1111/j.1532-5415.1988.tb04023.x; Harjola VP, 2010, EUR J HEART FAIL, V12, P239, DOI 10.1093/eurjhf/hfq002; Heijmeriks JA, 2000, CLIN CARDIOL, V23, P540, DOI 10.1002/clc.4960230714; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holroyd-Leduc JM, 2010, CAN MED ASSOC J, V182, P465, DOI 10.1503/cmaj.080519; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Isaia G, 2009, AGE, V31, P109, DOI 10.1007/s11357-009-9086-3; Iwata M, 2006, GERONTOLOGY, V52, P92, DOI 10.1159/000090954; Juliebo V, 2009, J AM GERIATR SOC, V57, P1354, DOI 10.1111/j.1532-5415.2009.02377.x; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kakuma R, 2003, J AM GERIATR SOC, V51, P443, DOI 10.1046/j.1532-5415.2003.51151.x; Kat MG, 2008, DEMENT GERIATR COGN, V26, P1, DOI 10.1159/000140611; Koster S, 2009, ANN THORAC SURG, V87, P1469, DOI 10.1016/j.athoracsur.2009.02.080; Leslie DL, 2005, ARCH INTERN MED, V165, P1657, DOI 10.1001/archinte.165.14.1657; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; LEWIS LM, 1995, AM J EMERG MED, V13, P142, DOI 10.1016/0735-6757(95)90080-2; Loponen P, 2008, SCAND CARDIOVASC J, V42, P337, DOI 10.1080/14017430801939217; Lundstrom M, 2003, J AM GERIATR SOC, V51, P1002, DOI 10.1046/j.1365-2389.2003.51315.x; MacLullich AMJ, 2008, J PSYCHOSOM RES, V65, P229, DOI 10.1016/j.jpsychores.2008.05.019; Marcantonio ER, 2005, J AM GERIATR SOC, V53, P963, DOI 10.1111/j.1532-5415.2005.53305.x; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; McAvay GJ, 2006, J AM GERIATR SOC, V54, P1245, DOI 10.1111/j.1532-5415.2006.00815.x; McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; Minden SL, 2005, GEN HOSP PSYCHIAT, V27, P209, DOI 10.1016/j.genhosppsych.2004.12.004; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Morandi A, 2009, INT REV PSYCHIATR, V21, P43, DOI 10.1080/09540260802675296; Nightingale S, 2001, LANCET, V357, P1264, DOI 10.1016/S0140-6736(00)04421-4; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; Olofsson B, 2005, SCAND J CARING SCI, V19, P119, DOI 10.1111/j.1471-6712.2005.00324.x; Pitkala KH, 2006, J GERONTOL A-BIOL, V61, P176, DOI 10.1093/gerona/61.2.176; Pitkala KH, 2005, DEMENT GERIATR COGN, V19, P158, DOI 10.1159/000082888; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; POOR G, 1995, CLIN ORTHOP RELAT R, P260; Rockwood K, 1999, AGE AGEING, V28, P551, DOI 10.1093/ageing/28.6.551; Rudolph JL, 2008, ANAESTHESIA, V63, P941, DOI 10.1111/j.1365-2044.2008.05523.x; Satish S, 1996, J AM GERIATR SOC, V44, P914, DOI 10.1111/j.1532-5415.1996.tb01860.x; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wacker P, 2006, DEMENT GERIATR COGN, V21, P221, DOI 10.1159/000091022; Young J, 2007, BMJ-BRIT MED J, V334, P842, DOI 10.1136/bmj.39169.706574.AD; Zakriya K, 2004, ANESTH ANALG, V98, P1798, DOI 10.1213/01.ANE.0000117145.50236.90	76	1103	1144	1	126	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					443	451		10.1001/jama.2010.1013	http://dx.doi.org/10.1001/jama.2010.1013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	631MA	20664045				2022-12-28	WOS:000280350100028
J	Haukoos, JS; Hopkins, E; Conroy, AA; Silverman, M; Byyny, RL; Eisert, S; Thrun, MW; Wilson, ML; Hutchinson, AB; Forsyth, J; Johnson, SC; Heffelfinger, JD				Haukoos, Jason S.; Hopkins, Emily; Conroy, Amy A.; Silverman, Morgan; Byyny, Richard L.; Eisert, Sheri; Thrun, Mark W.; Wilson, Michael L.; Hutchinson, Angela B.; Forsyth, Jessica; Johnson, Steven C.; Heffelfinger, James D.		Denver Emergency Dept HIV Opt-Out	Routine Opt-Out Rapid HIV Screening and Detection of HIV Infection in Emergency Department Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOR-DISEASE-CONTROL; CARE; PROGRAM; HEALTH; RECOMMENDATIONS; IMPLEMENTATION; EXPERIENCE; TESTS; MODEL	Context The Centers for Disease Control and Prevention (CDC) recommends routine (nontargeted) opt-out HIV screening in health care settings, including emergency departments (EDs), where the prevalence of undiagnosed infection is 0.1% or greater. The utility of this approach in EDs remains unknown. Objective To determine whether nontargeted opt-out rapid HIV screening in the ED was associated with identification of more patients with newly diagnosed HIV infection than physician-directed diagnostic rapid HIV testing. Design, Setting, and Patients Quasi-experimental equivalent time-samples design in an urban public safety-net hospital with an approximate annual ED census of 55 000 patient visits. Patients were 16 years or older and capable of providing consent for rapid HIV testing. Interventions Nontargeted opt-out rapid HIV screening and physician-directed diagnostic rapid HIV testing alternated in sequential 4-month time intervals between April 15, 2007, and April 15, 2009. Main Outcome Measures Number of patients with newly identified HIV infection and the association between nontargeted opt-out rapid HIV screening and identification of HIV infection. Results In the opt-out phase, of 28 043 eligible ED patients, 6933 patients (25%) completed HIV testing (6702 patients were screened; 231 patients were diagnostically tested). Ten of 6702 patients (0.15%; 95% CI, 0.07%-0.27%) who did not decline HIV screening in the opt-out phase had new HIV diagnoses, and 5 of 231 patients (2.2%; 95% CI, 0.7%-5.0%) who were diagnostically tested during the opt-out phase had new HIV diagnoses. In the diagnostic phase, of 29 925 eligible patients, 243 (0.8%) completed HIV testing. Of these, 4 patients (1.6%; 95% CI, 0.5%-4.2%) had new diagnoses. The prevalence of new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 15 in 28 043 (0.05%; 95% CI, 0.03%-0.09%) and 4 in 29 925 (0.01%; 95% CI, 0.004%-0.03%), respectively. Nontargeted opt-out HIV screening was independently associated with new HIV diagnoses (risk ratio, 3.6; 95% CI, 1.2-10.8) when adjusting for patient demographics, insurance status, and whether diagnostic testing was performed in the opt-out phase. The median CD4 cell count for those with new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 69/mu L (IQR, 17-430) and 13/mu L (IQR, 11-15), respectively (P=.02). Conclusion Nontargeted opt-out rapid HIV screening in the ED, vs diagnostic testing, was associated with identification of a modestly increased number of patients with new HIV diagnoses, most of whom were identified late in the course of disease. JAMA. 2010;304(3):284-292 www.jama.com	[Haukoos, Jason S.; Hopkins, Emily; Byyny, Richard L.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; [Silverman, Morgan] Denver Hlth Med Ctr, Dept Clin Social Work, Denver, CO 80204 USA; [Eisert, Sheri] Denver Hlth Med Ctr, Dept Hlth Serv Res, Denver, CO 80204 USA; [Wilson, Michael L.] Denver Hlth Med Ctr, Dept Pathol, Denver, CO 80204 USA; [Haukoos, Jason S.; Byyny, Richard L.; Thrun, Mark W.; Wilson, Michael L.; Johnson, Steven C.] Univ Colorado, Sch Med, Aurora, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Eisert, Sheri] Colorado Sch Publ Hlth, Dept Hlth Syst Management & Policy, Aurora, CO USA; [Conroy, Amy A.] Univ Colorado Denver, Dept Hlth & Behav Sci, Denver, CO USA; [Thrun, Mark W.] Denver Publ Hlth, Denver, CO USA; [Hutchinson, Angela B.; Heffelfinger, James D.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Forsyth, Jessica] Childrens Hosp, Childrens Immunodeficiency Program, Aurora, CO USA; [Johnson, Steven C.] Univ Colorado, Univ Colorado Hosp, HIV AIDS Clin Program, Aurora, CO USA	Denver Health Medical Center; Denver Health Medical Center; Denver Health Medical Center; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Colorado School of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centers for Disease Control & Prevention - USA; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Hospital	Haukoos, JS (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St,Mail Code 0108, Denver, CO 80204 USA.	jason.haukoos@dhha.org		Byyny, Richard/0000-0002-9145-7457	Abbott Laboratories; Centers for Disease Control and Prevention (CDC) [U18 PS000314]; Agency for Healthcare Research and Quality (AHRQ) [K02 HS017526]; Colorado Department of Public Health and Environment (CDPHE); Colorado Center for AIDS Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017526] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U18PS000314] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Colorado Department of Public Health and Environment (CDPHE); Colorado Center for AIDS Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Dr Haukoos reported receiving unrestricted research support from Abbott Laboratories and being supported in part by the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ). Ms Hopkins reported being supported previously by an unrestricted research grant from Abbott Laboratories and supported in full during the course of this project by the CDC. Dr Thrun reported receiving support from the Colorado Department of Public Health and Environment (CDPHE) and the CDC and having been a paid consultant for the CDC on issues related to HIV prevention. Dr Johnson reported participating in advisory boards and serving as a consultant for both ViiV Healthcare and Gilead Sciences Inc. No other disclosures were reported.; This study was funded by a cooperative agreement (U18 PS000314) with the CDC (J.S.H.) and supported in part by an Independent Scientist Award (K02 HS017526) from the AHRQ (J.S.H.) and a Career Development Award from the Colorado Center for AIDS Research (R.L.B.).	Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bernstein SL, 2003, ACAD EMERG MED, V10, P938, DOI 10.1197/S1069-6563(03)00311-7; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; *CDCP, 2006, NEW EST US HIV PREV; Chou R, 2007, SCREENING HUMAN IMMU; Ehrenkranz PD, 2008, ACAD EMERG MED, V15, P144, DOI 10.1111/j.1553-2712.2008.00028.x; Gabow P, 2003, ANN INTERN MED, V138, P143, DOI 10.7326/0003-4819-138-2-200301210-00016; Glick NR, 2004, AIDS EDUC PREV, V16, P126, DOI 10.1521/aeap.16.2.126.29391; Goggin MA, 2000, J EMERG MED, V19, P13, DOI 10.1016/S0736-4679(00)00175-X; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI 10.1111/j.1553-2712.2007.tb02335.x; Haukoos JS, 2009, ACAD EMERG MED, V16, P1044, DOI 10.1111/j.1553-2712.2009.00556.x; Haukoos JS, 2009, ACAD EMERG MED, V16, P800, DOI 10.1111/j.1553-2712.2009.00477.x; Hsieh YH, 2008, AIDS, V22, P2127, DOI 10.1097/QAD.0b013e328310e066; Irvin CB, 2007, ANN EMERG MED, V49, P722, DOI 10.1016/j.annemergmed.2007.03.011; Kelen GD, 2009, ANN EMERG MED, V54, P65, DOI 10.1016/j.annemergmed.2009.03.027; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Kelen GD, 1996, ANN EMERG MED, V27, P687, DOI 10.1016/S0196-0644(96)70184-1; KELEN GD, 1991, AM J EMERG MED, V9, P416, DOI 10.1016/0735-6757(91)90205-X; Lyons MS, 2009, J MED SCREEN, V16, P29, DOI 10.1258/jms.2009.008086; Lyons MS, 2005, ANN EMERG MED, V46, P22, DOI 10.1016/j.annemergmed.2004.12.022; Lyss S, 2004, ANN EMERG MED, V44, pS56, DOI 10.1016/j.annemergmed.2004.07.184; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Mollen C, 2008, AIDS PATIENT CARE ST, V22, P505, DOI 10.1089/apc.2007.0098; Owens SD, 2008, VET CLIN PATH, V37, P49, DOI 10.1111/j.1939-165X.2008.00003.x; Rothman RE, 2007, ACAD EMERG MED, V14, P653, DOI 10.1197/j.aem.2007.04.004; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Torres GW, 2009, PUBLIC HEALTH REP, V124, P400, DOI 10.1177/003335490912400309; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027	34	138	139	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					284	292		10.1001/jama.2010.953	http://dx.doi.org/10.1001/jama.2010.953			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639562	Bronze			2022-12-28	WOS:000280107500018
J	Stanbrook, MB				Stanbrook, Matthew B.			Review: Tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							[Anonymous], 2009, GLOB STRAT DIAGN MAN; Lee TA, 2008, ANN INTERN MED, V149, P380, DOI 10.7326/0003-4819-149-6-200809160-00004; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-2	10.7326/0003-4819-153-2-201007200-02002	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643980				2022-12-28	WOS:000280095400020
J	Coeytaux, RR; Williams, JW; Gray, RN; Wang, A				Coeytaux, Remy R.; Williams, John W., Jr.; Gray, Rebecca N.; Wang, Andrew			Percutaneous Heart Valve Replacement for Aortic Stenosis: State of the Evidence	ANNALS OF INTERNAL MEDICINE			English	Review							HIGH-RISK PATIENTS; EDWARDS-SAPIEN VALVE; IN-VALVE; TRANSCATHETER IMPLANTATION; HEMODYNAMIC PERFORMANCE; CORONARY INTERVENTION; TRANSAPICAL APPROACH; CLINICAL-OUTCOMES; EARLY EXPERIENCE; EUROPEAN SYSTEM	Surgical aortic valve replacement (SAVR) is the only treatment known to improve symptoms and survival in patients with severe, symptomatic aortic stenosis. Perioperative mortality, however, is high among many patients for whom SAVR may be indicated. Percutaneous heart valve replacement (PHVR) is an emerging, catheter-based technology that allows for implantation of a prosthetic valve without open heart surgery. This review describes the available literature on PHVR for aortic stenosis, which comprised 84 published reports representing 76 distinct studies and 2375 unique patients. Successful implantation was achieved in 94% of patients; 30-day survival was 89%. Differences between patients undergoing PHVR and those typically selected for SAVR make full interpretation of these results difficult. A large, multicenter, randomized, controlled trial comparing PHVR with SAVR or medical management was recently completed, with initial results expected in September 2010. Pending publication of findings from that trial, the available evidence is inadequate to determine the most appropriate clinical role of PHVR or the specific patient populations for whom it might eventually be indicated.	[Coeytaux, Remy R.] Duke Evidence Based Practice Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; Duke Univ, Med Ctr, Durham, NC USA	Duke University; Duke University	Coeytaux, RR (corresponding author), Duke Evidence Based Practice Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	remy.coeytaux@duke.edu	Williams, John/AAM-4572-2020	Williams, John/0000-0002-5267-5558; Wang, Andrew/0000-0001-8729-0933	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-02-0025]	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract 290-02-0025).	Al-Attar N, 2009, J THORAC CARDIOV SUR, V137, pE21, DOI 10.1016/j.jtcvs.2008.07.018; Ambler G, 2005, CIRCULATION, V112, P224, DOI 10.1161/CIRCULATIONAHA.104.515049; Asgar AW, 2009, J THORAC CARDIOV SUR, V137, P773, DOI 10.1016/j.jtcvs.2007.12.084; Avanzas P, 2010, REV ESP CARDIOL, V63, P141, DOI 10.1016/S0300-8932(10)70031-2; Bagur R, 2010, JACC-CARDIOVASC INTE, V3, P253, DOI 10.1016/j.jcin.2009.11.016; Bagur RH, 2009, CIRCULATION, V120, pE140, DOI 10.1161/CIRCULATIONAHA.109.850651; Bartorelli AL, 2010, ANN THORAC SURG, V89, P953, DOI 10.1016/j.athoracsur.2009.08.024; Bauer F, 2004, CIRCULATION, V110, P1473, DOI 10.1161/01.CIR.0000134961.36773.D6; Bauernschmitt R, 2009, HEART SURG FORUM, V12, pE63, DOI 10.1532/HSF98.20081112; Berry C, 2007, CATHETER CARDIO INTE, V70, P610, DOI 10.1002/ccd.21282; Berry C, 2007, CATHETER CARDIO INTE, V69, P56, DOI 10.1002/ccd.20958; Bleiziffer S, 2009, DTSCH ARZTEBL INT, V106, P235, DOI 10.3238/arztebl.2009.0235; Bojara W, 2009, CLIN RES CARDIOL, V98, P201, DOI 10.1007/s00392-009-0750-5; Bollati M, 2009, Minerva Cardioangiol, V57, P131; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Bruschi G, 2010, J CARDIOVASC MED, V11, P182, DOI 10.2459/JCM.0b013e32832ffcb4; Bruschi G, 2009, ANN THORAC SURG, V88, pE50, DOI 10.1016/j.athoracsur.2009.07.028; Buellesfeld L, 2008, CATHETER CARDIO INTE, V71, P579, DOI 10.1002/ccd.21470; Casserly IP, 2005, EXPERT REV CARDIOVAS, V3, P143, DOI 10.1586/14779072.3.1.143; Chandavimol M, 2006, CAN J CARDIOL, V22, P1159, DOI 10.1016/S0828-282X(06)70954-0; Chiam PTL, 2009, SINGAP MED J, V50, P534; Clavel MA, 2009, ANN THORAC SURG, V87, P618, DOI 10.1016/j.athoracsur.2008.06.059; Clavel MA, 2009, J AM COLL CARDIOL, V53, P1883, DOI 10.1016/j.jacc.2009.01.060; *CLINICALTRIALS GO, NCT00986193 CLINICAL; *CLINICALTRIALS GO, NCT01057173 CLINICAL; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049; Dumonteil N, 2009, JACC-CARDIOVASC INTE, V2, P897, DOI 10.1016/j.jcin.2009.05.023; Dvir Danny, 2009, J Invasive Cardiol, V21, pE237; Dvir D, 2009, ISR MED ASSOC J, V11, P244; Eltchaninoff Helene, 2003, J Interv Cardiol, V16, P515, DOI 10.1046/j.1540-8183.2003.01051.x; Falk V, 2009, ANN THORAC SURG, V87, P925, DOI 10.1016/j.athoracsur.2008.12.026; Geist V, 2009, CATHETER CARDIO INTE, V73, P61, DOI 10.1002/ccd.21744; Grube E, 2005, CATHETER CARDIO INTE, V66, P465, DOI 10.1002/ccd.20544; GRUBE E, 2007, J AM COLL CARDIOL, V30, P50; Grube E, 2006, CIRCULATION, V114, P1616, DOI 10.1161/CIRCULATIONAHA.106.639450; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; Gutierrez M, 2009, AM HEART J, V158, P302, DOI 10.1016/j.ahj.2009.05.029; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; Hanzel GS, 2005, CATHETER CARDIO INTE, V64, P322, DOI 10.1002/ccd.20299; Himbert D, 2009, J AM COLL CARDIOL, V54, P303, DOI 10.1016/j.jacc.2009.04.032; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Kapadia SR, 2009, CATHETER CARDIO INTE, V73, P966, DOI 10.1002/ccd.21867; Khawaja MZ, 2010, J AM COLL CARDIOL, V55, P97, DOI 10.1016/j.jacc.2009.06.060; Klaaborg KE, 2009, ANN THORAC SURG, V87, P1943, DOI 10.1016/j.athoracsur.2008.11.034; Kolettis TN, 2009, HELL J CARDIOL, V50, P79; Lamarche Y, 2007, ANN THORAC SURG, V83, P284, DOI 10.1016/j.athoracsur.2006.05.121; Lange R, 2007, HEART SURG FORUM, V10, pE478, DOI 10.1532/HSF98.20071140; Lichtenstein SV, 2006, CIRCULATION, V114, P591, DOI 10.1161/CIRCULATIONAHA.106.632927; Marcheix B, 2007, J THORAC CARDIOV SUR, V134, P1150, DOI 10.1016/j.jtcvs.2007.07.031; Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063; Moreno R, 2009, CIRCULATION, V120, pE29, DOI 10.1161/CIRCULATIONAHA.109.849281; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Ng ACT, 2009, JACC-CARDIOVASC IMAG, V2, P522, DOI 10.1016/j.jcmg.2009.01.006; Olsen Lene Kjaer, 2009, Interact Cardiovasc Thorac Surg, V9, P837, DOI 10.1510/icvts.2009.211144; Paniagua D, 2005, TEX HEART I J, V32, P393; *PARTNER TRIAL, NCT00530894 PARTNER; Piazza N, 2009, EUROINTERVENTION, V5, P580, DOI 10.4244/EIJV5I5A94; Piazza N, 2009, CATHETER CARDIO INTE, V73, P161, DOI 10.1002/ccd.21843; Piazza N, 2009, CATHETER CARDIO INTE, V73, P530, DOI 10.1002/ccd.21822; Piazza Nicolo, 2008, EuroIntervention, V4, P242, DOI 10.4244/EIJV4I2A43; Pilgrim Thomas, 2010, J Invasive Cardiol, V22, pE30; Rodes-Cabau J, 2008, AM J CARDIOL, V102, P1240, DOI 10.1016/j.amjcard.2008.06.061; Rodes-Cabau J, 2008, ANN THORAC SURG, V85, P1787, DOI 10.1016/j.athoracsur.2007.11.007; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Rodes-Cabau J, 2009, CATHETER CARDIO INTE, V74, P1116, DOI 10.1002/ccd.22168; Ross J Jr, 1968, Circulation, V38, P61; Ruiz CE, 2008, CATHETER CARDIO INTE, V72, P143, DOI 10.1002/ccd.21597; Ruiz-Salmeron RJ, 2010, CIRCULATION, V121, P1542, DOI 10.1161/CIR.0b013e3181d9b96e; Scherner M, 2009, ANN THORAC SURG, V88, P1662, DOI 10.1016/j.athoracsur.2009.04.078; Schofer J, 2008, CIRC-CARDIOVASC INTE, V1, P126, DOI 10.1161/CIRCINTERVENTIONS.108.800607; Sheiban I, 2009, CATHETER CARDIO INTE, V74, P805, DOI 10.1002/ccd.22118; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Stabile E, 2010, ANN THORAC SURG, V89, pE19, DOI 10.1016/j.athoracsur.2009.12.076; Svensson LG, 2008, ANN THORAC SURG, V86, P46, DOI 10.1016/j.athoracsur.2008.04.049; Tamburino C, 2009, J INVASIVE CARDIOL, V21, P93; Taramasso M, 2010, CATHETER CARDIO INTE, V75, P51, DOI 10.1002/ccd.22199; Taramasso M, 2009, J CARDIOVASC MED, V10, P936, DOI 10.2459/JCM.0b013e32832fd3ea; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Ussia Gian Paolo, 2009, J Invasive Cardiol, V21, pE51; Ussia GP, 2009, CATHETER CARDIO INTE, V73, P713, DOI 10.1002/ccd.21896; Walther T, 2008, EUR J CARDIO-THORAC, V33, P983, DOI 10.1016/j.ejcts.2008.01.046; Walther T, 2007, CIRCULATION, V116, pI240, DOI 10.1161/CIRCULATIONAHA.106.677237; Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Webb JG, 2010, CIRCULATION, V121, P1848, DOI 10.1161/CIRCULATIONAHA.109.924613; Webb JG, 2009, J AM COLL CARDIOL, V53, P1855, DOI 10.1016/j.jacc.2008.07.075; Wenaweser P, 2007, CATHETER CARDIO INTE, V70, P760, DOI 10.1002/ccd.21300; Wendt Daniel, 2009, Interact Cardiovasc Thorac Surg, V8, P684, DOI 10.1510/icvts.2008.201798; Wong DR, 2009, J THORAC CARDIOV SUR, V137, P1547, DOI 10.1016/j.jtcvs.2008.06.018; Ye J, 2007, EUR J CARDIO-THORAC, V31, P16, DOI 10.1016/j.ejcts.2006.10.023; Ye J, 2009, ANN THORAC SURG, V88, P1322, DOI 10.1016/j.athoracsur.2009.02.053; Zahn R, 2010, CLIN RES CARDIOL, V99, P193, DOI 10.1007/s00392-009-0102-5; Zierer A, 2008, J THORAC CARDIOV SUR, V136, P948, DOI 10.1016/j.jtcvs.2008.06.028	97	39	45	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2010	153	5					314	324		10.7326/0003-4819-153-5-201009070-00267	http://dx.doi.org/10.7326/0003-4819-153-5-201009070-00267			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647GF	20679543				2022-12-28	WOS:000281605500005
J	Bungard, D; Fuerth, BJ; Zeng, PY; Faubert, B; Maas, NL; Viollet, B; Carling, D; Thompson, CB; Jones, RG; Berger, SL				Bungard, David; Fuerth, Benjamin J.; Zeng, Ping-Yao; Faubert, Brandon; Maas, Nancy L.; Viollet, Benoit; Carling, David; Thompson, Craig B.; Jones, Russell G.; Berger, Shelley L.			Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation	SCIENCE			English	Article							PROTEIN-KINASE; METABOLIC CHECKPOINT; METHYLATION; COMPLEX; ENERGY; LKB1	The mammalian adenosine monophosphate-activated protein kinase (AMPK) is a serine-threonine kinase protein complex that is a central regulator of cellular energy homeostasis. However, the mechanisms by which AMPK mediates cellular responses to metabolic stress remain unclear. We found that AMPK activates transcription through direct association with chromatin and phosphorylation of histone H2B at serine 36. AMPK recruitment and H2B Ser(36) phosphorylation colocalized within genes activated by AMPK-dependent pathways, both in promoters and in transcribed regions. Ectopic expression of H2B in which Ser(36) was substituted by alanine reduced transcription and RNA polymerase II association to AMPK-dependent genes, and lowered cell survival in response to stress. Our results place AMPK-dependent H2B Ser(36) phosphorylation in a direct transcriptional and chromatin regulatory pathway leading to cellular adaptation to stress.	[Bungard, David; Zeng, Ping-Yao; Maas, Nancy L.; Berger, Shelley L.] Univ Penn, Sch Med, Dept Cellular & Dev Biol, Philadelphia, PA 19104 USA; [Fuerth, Benjamin J.; Faubert, Brandon; Jones, Russell G.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Fuerth, Benjamin J.; Faubert, Brandon; Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Zeng, Ping-Yao] Fudan Univ, Inst Biomed Sci Epigenet Program, Shanghai 200032, Peoples R China; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, F-75014 Paris, France; [Viollet, Benoit] INSERM, U1016, F-75014 Paris, France; [Carling, David] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, MRC,Cellular Stress Grp, London W12 0NN, England; [Thompson, Craig B.; Jones, Russell G.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Thompson, Craig B.; Jones, Russell G.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; McGill University; McGill University; Fudan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Jones, RG (corresponding author), Univ Penn, Sch Med, Dept Cellular & Dev Biol, Philadelphia, PA 19104 USA.	russell.jones@mcgill.ca; bergers@mail.med.upenn.edu	Jones, Russell/AAC-2861-2022; Viollet, Benoit/O-6927-2017; Carling, David/F-1943-2014; Viollet, Benoit/N-2397-2019; Jones, Russell Graham/ABD-5261-2021	Viollet, Benoit/0000-0002-0121-0224; Carling, David/0000-0002-2316-1830; Viollet, Benoit/0000-0002-0121-0224; Jones, Russell Graham/0000-0003-2250-4675; Faubert, Brandon/0000-0002-2886-886X; Berger, Shelley/0000-0001-5398-4400	NIH [CA078831, CA105463, CA09171]; Canadian Institutes of Health Research [MOP-93799]; McGill Integrated Cancer Research Training Program; Leukemia and Lymphoma Society, NIH, National Cancer Institute; American Association for Cancer Research (AACR); Medical Research Council [MC_U120027537] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA104838, R01CA105463, R55CA078831, T32CA009171, R01CA078831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Integrated Cancer Research Training Program; Leukemia and Lymphoma Society, NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Leukemia and Lymphoma Society); American Association for Cancer Research (AACR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by NIH grants CA078831 (S. L. B.) and CA105463 (C. B. T.), NIH Training Program in Basic Cancer Research grant CA09171 (D. B.), Canadian Institutes of Health Research grant MOP-93799 (R.G.J.), the McGill Integrated Cancer Research Training Program (B. F.), and the Leukemia and Lymphoma Society, NIH, National Cancer Institute, and American Association for Cancer Research (AACR)/Stand Up to Cancer (C. B. T.). C. B. T. reports the filing of patent applications exploiting the use of AMPK activators in cancer therapy. He is also a member of the board of directors of Merck, the scientific advisory board of Agios Pharmaceuticals, and the medical advisory board of the Howard Hughes Medical Institute.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hardie DG, 2000, METH MOL B, V99, P63; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999	19	267	295	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1201	1205		10.1126/science.1191241	http://dx.doi.org/10.1126/science.1191241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20647423	Green Accepted			2022-12-28	WOS:000281485600035
J	Mills, A; Engelhard, CL; Tereskerz, PM				Mills, Ann; Engelhard, Carolyn L.; Tereskerz, Patricia M.			Truth and Consequences - Insurance-Premium Rate Regulation and the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mills, Ann; Tereskerz, Patricia M.] Univ Virginia, Sch Med, Program Eth & Policy Healthcare Syst, Ctr Biomed Eth & Humanities, Charlottesville, VA 22908 USA; [Engelhard, Carolyn L.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Mills, A (corresponding author), Univ Virginia, Sch Med, Program Eth & Policy Healthcare Syst, Ctr Biomed Eth & Humanities, Charlottesville, VA 22908 USA.							Cutler D., 2010, IMPACT HLTH REFORM H; *DEP HLTH HUM SERV, 2010, INS CO PROSP FAM SUF; *NAT ASS INS COMM, 2010, NAIC RESP HHS QUEST; PEAR R, 2010, NY TIMES        0308; 2010, FED REG, V75, P19335	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2010	363	10					899	901		10.1056/NEJMp1006344	http://dx.doi.org/10.1056/NEJMp1006344			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645GW	20660397				2022-12-28	WOS:000281441500002
J	Benjamin, R				Benjamin, Regina			Finding My Way to Electronic Health Records	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US PHS, Washington, DC USA	United States Public Health Service	Benjamin, R (corresponding author), US PHS, Washington, DC USA.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					505	506		10.1056/NEJMp1007785	http://dx.doi.org/10.1056/NEJMp1007785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634BB	20647182				2022-12-28	WOS:000280552700002
J	Al-Jabri, S; Malus, M; Tulandi, T				Al-Jabri, Sheikha; Malus, Michael; Tulandi, Togas			Easily Missed? Ectopic pregnancy	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-EXAMINATION; DIAGNOSIS; EMERGENCY; HISTORY; RISK		[Al-Jabri, Sheikha; Malus, Michael] McGill Univ, Dept Family Med, Montreal, PQ H3A 1A1, Canada	McGill University	Al-Jabri, S (corresponding author), McGill Univ, Dept Family Med, Montreal, PQ H3A 1A1, Canada.	s_umreem@hotmail.com						Buckley RG, 1999, ANN EMERG MED, V34, P589, DOI 10.1016/S0196-0644(99)70160-5; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Job-Spira N, 1999, AM J OBSTET GYNECOL, V180, P938, DOI 10.1016/S0002-9378(99)70665-4; Lewis G, 2007, 7 CEMACH, P92; Lipscomb GH, 1999, NEW ENGL J MED, V341, P1974, DOI 10.1056/NEJM199912233412604; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Robson SJ, 1996, AUST NZ J OBSTET GYN, V36, P182, DOI 10.1111/j.1479-828X.1996.tb03282.x; STOVALL TG, 1990, ANN EMERG MED, V19, P1098, DOI 10.1016/S0196-0644(05)81511-2; Wong TW, 1998, J ACCID EMERG MED, V15, P155	9	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 30	2010	341								c3770	10.1136/bmj.c3770	http://dx.doi.org/10.1136/bmj.c3770			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634HB	20675392				2022-12-28	WOS:000280570300001
J	Sinha, U; Couteau, C; Jennewein, T; Laflamme, R; Weihs, G				Sinha, Urbasi; Couteau, Christophe; Jennewein, Thomas; Laflamme, Raymond; Weihs, Gregor			Ruling Out Multi-Order Interference in Quantum Mechanics	SCIENCE			English	Article							NONLINEAR-WAVE MECHANICS; LINEARITY; TESTS; LIGHT	Quantum mechanics and gravitation are two pillars of modern physics. Despite their success in describing the physical world around us, they seem to be incompatible theories. There are suggestions that one of these theories must be generalized to achieve unification. For example, Born's rule-one of the axioms of quantum mechanics-could be violated. Born's rule predicts that quantum interference, as shown by a double-slit diffraction experiment, occurs from pairs of paths. A generalized version of quantum mechanics might allow multipath (i.e., higher-order) interference, thus leading to a deviation from the theory. We performed a three-slit experiment with photons and bounded the magnitude of three-path interference to less than 10(-2) of the expected two-path interference, thus ruling out third-and higher-order interference and providing a bound on the accuracy of Born's rule. Our experiment is consistent with the postulate both in semiclassical and quantum regimes.	[Sinha, Urbasi; Couteau, Christophe; Jennewein, Thomas; Laflamme, Raymond; Weihs, Gregor] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Sinha, Urbasi; Couteau, Christophe; Jennewein, Thomas; Laflamme, Raymond; Weihs, Gregor] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Couteau, Christophe] Univ Technol Troyes, Lab Nanotechnol & Instrumentat Opt, F-10000 Troyes, France; [Laflamme, Raymond] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Weihs, Gregor] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria	University of Waterloo; University of Waterloo; Universite de Technologie de Troyes; Perimeter Institute for Theoretical Physics; University of Innsbruck	Sinha, U (corresponding author), Univ Waterloo, Inst Quantum Comp, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	usinha@iqc.ca; gregor.weihs@uibk.ac.at	Sinha, Urbasi/E-6900-2012; Couteau, Christophe/A-2201-2015; Weihs, Gregor/G-2564-2013	Weihs, Gregor/0000-0003-2260-3008; Couteau, Christophe/0000-0001-7676-3205	Natural Science and Engineering Research Council; Canada Foundation for Innovation; European Research Area; Quantum Works; Ontario Centres of Excellence; Canadian Institute for Advanced Research	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); European Research Area; Quantum Works; Ontario Centres of Excellence; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	U. S., C. C., and T.J. performed the experiments; C. C., R. L., and G. W. conceived of and supervised the experiment and developed the theoretical aspects; G. W. and U. S. performed the modeling and the data and error analysis; and all authors contributed to the writing of the paper. We thank H. Hubel, R. Kaltenback, A. J. Leggett, A. Sinha, R. D. Sorkin, and A. Zeilinger for valuable discussions, and Z. Medendorp and I. Sollner for technical assistance earlier in the experiments. Supported by The Natural Science and Engineering Research Council, Canada Foundation for Innovation, European Research Area, Quantum Works, Ontario Centres of Excellence, and Canadian Institute for Advanced Research.	Aaronson S, 2005, P ROY SOC A-MATH PHY, V461, P3473, DOI 10.1098/rspa.2005.1546; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Arndt M, 1999, NATURE, V401, P680, DOI 10.1038/44348; BIALYNICKIBIRULA I, 1976, ANN PHYS-NEW YORK, V100, P62, DOI 10.1016/0003-4916(76)90057-9; BOLLINGER JJ, 1985, PHYS REV LETT, V54, P1000, DOI 10.1103/PhysRevLett.54.1000; Born M, 1926, Z PHYS, V37, P863, DOI 10.1007/BF01397477; GAHLER R, 1981, PHYS REV A, V23, P1611, DOI 10.1103/PhysRevA.23.1611; Gaudreau L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036807; GRANGIER P, 1986, EUROPHYS LETT, V1, P173, DOI 10.1209/0295-5075/1/4/004; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; Jacques V, 2005, EUR PHYS J D, V35, P561, DOI 10.1140/epjd/e2005-00201-y; MAJUMDER PK, 1990, PHYS REV LETT, V65, P2931, DOI 10.1103/PhysRevLett.65.2931; OHSHITA A, 1982, J ELECTRON MICROSC, V34, P357; Simon C, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.170405; SUMMHAMMER J, 1987, PHYS REV A, V36, P4447, DOI 10.1103/PhysRevA.36.4447; UDUDEC C, 2010, FOUND PHYS; WALSWORTH RL, 1990, PHYS REV LETT, V64, P2599, DOI 10.1103/PhysRevLett.64.2599; WEINBERG S, 1989, PHYS REV LETT, V62, P485, DOI 10.1103/PhysRevLett.62.485; ZEILINGER A, 1988, REV MOD PHYS, V60, P1067, DOI 10.1103/RevModPhys.60.1067; Zurek WH, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.120404	21	128	131	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					418	421		10.1126/science.1190545	http://dx.doi.org/10.1126/science.1190545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651147	Green Submitted			2022-12-28	WOS:000280196500031
J	Stringer, EM; Ekouevi, DK; Coetzee, D; Tih, PM; Creek, TL; Stinson, K; Giganti, MJ; Welty, TK; Chintu, N; Chi, BH; Wilfert, CM; Shaffer, N; Dabis, F; Stringer, JSA				Stringer, Elizabeth M.; Ekouevi, Didier K.; Coetzee, David; Tih, Pius M.; Creek, Tracy L.; Stinson, Kathryn; Giganti, Mark J.; Welty, Thomas K.; Chintu, Namwinga; Chi, Benjamin H.; Wilfert, Catherine M.; Shaffer, Nathan; Dabis, Francois; Stringer, Jeffrey S. A.		PEARL Study Team	Coverage of Nevirapine-Based Services to Prevent Mother-to-Child HIV Transmission in 4 African Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-DOSE NEVIRAPINE; RANDOMIZED-TRIAL; MASS-SPECTROMETRY; PROGRAMS; UGANDA; WOMEN; QUANTIFICATION; SURVEILLANCE; PERFORMANCE	Context Few studies have objectively evaluated the coverage of services to prevent transmission of human immunodeficiency virus (HIV) from mother to child. Objective To measure the coverage of services to prevent mother-to-child HIV transmission in 4 African countries. Design, Setting, and Patients Cross-sectional surveillance study of mother-infant pairs using umbilical cord blood samples collected between June 10, 2007, and October 30, 2008, from 43 randomly selected facilities (grouped as 25 service clusters) providing delivery services in Cameroon, Cote d'Ivoire, South Africa, and Zambia. All sites used at least single-dose nevirapine to prevent mother-to-child HIV transmission and some sites used additional prophylaxis drugs. Main Outcome Measure Population nevirapine coverage, defined as the proportion of HIV-exposed infants in the sample with both maternal nevirapine ingestion (confirmed by cord blood chromatography) and infant nevirapine ingestion (confirmed by direct observation). Results A total of 27 893 cord blood specimens were tested, of which 3324 were HIV seropositive (12%). Complete data for cord blood nevirapine results were available on 3196 HIV-seropositive mother-infant pairs. Nevirapine coverage varied significantly by site (range: 0%-82%). Adjusted for country, the overall coverage estimate was 51% (95% confidence interval [CI], 49%-53%). In multivariable analysis, failed coverage of nevirapine-based services was significantly associated with maternal age younger than 20 years (adjusted odds ratio [AOR], 1.44; 95% CI, 1.18-1.76) and maternal age between 20 and 25 years (AOR, 1.28; 95% CI, 1.07-1.54) vs maternal age of older than 30 years; 1 or fewer antenatal care visits (AOR, 2.91; 95% CI, 2.40-3.54), 2 or 3 antenatal care visits (AOR, 1.93; 95% CI, 1.60-2.33), and 4 or 5 antenatal care visits (AOR, 1.56; 95% CI, 1.34-1.80) vs 6 or more antenatal care visits; vaginal delivery (AOR, 1.22; 95% CI, 1.03-1.44) vs cesarean delivery; and infant birth weight of less than 2500 g (AOR, 1.34; 95% CI, 1.11-1.62) vs birth weight of 3500 g or greater. Conclusion In this random sampling of sites with services to prevent mother-to-child HIV transmission, only 51% of HIV-exposed infants received the minimal regimen of single-dose nevirapine. JAMA. 2010;304(3):293-302 www.jama.com	[Stringer, Elizabeth M.; Giganti, Mark J.; Chintu, Namwinga; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Ekouevi, Didier K.] Programme PAC CI, Abidjan, Cote Ivoire; [Coetzee, David; Stinson, Kathryn] Univ Cape Town, Sch Publ Hlth & Community Med, Infect Dis & Epidemiol Unit, ZA-7925 Cape Town, South Africa; [Tih, Pius M.; Welty, Thomas K.] Cameroon Baptist Hlth Convent Hlth Board, Bamenda, Cameroon; [Creek, Tracy L.] Ctr Dis Control & Prevent, Ctr HIV AIDS Viral Hepatitis STD & TB Prevent, Global AIDS Program, Atlanta, GA USA; [Wilfert, Catherine M.] Elizabeth Glaser Pediat AIDS Fdn, Santa Monica, CA USA; [Shaffer, Nathan] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Dabis, Francois] Univ Bordeaux 2, Inst Sante Publ Epidemiol & Dev, F-33076 Bordeaux, France	University of Cape Town; Centers for Disease Control & Prevention - USA; World Health Organization; UDICE-French Research Universities; Universite de Bordeaux	Stringer, JSA (corresponding author), Ctr Infect Dis Res Zambia, Plot 1275,Lubutu Rd,POB 34681, Lusaka, Zambia.	stringer@cidrz.org	DABIS, FRANCOIS/S-9298-2019; EKOUEVI, Didier K/E-7960-2014; Stringer, Jeffrey S. A./AAU-2342-2021	DABIS, FRANCOIS/0000-0002-1614-8857; Stringer, Jeffrey/0000-0002-9590-7216	US Centers for Disease Control and Prevention [T0906150021]; Bill and Melinda Gates Foundation [351-07]; Elizabeth Glaser Pediatric AIDS Foundation	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Elizabeth Glaser Pediatric AIDS Foundation	The Zambia, South Africa, and Cote d'Ivoire work was supported by contract T0906150021 from the US Centers for Disease Control and Prevention Global AIDS Program. The Cameroon work was supported by the Bill and Melinda Gates Foundation grant 351-07, which was awarded to the Elizabeth Glaser Pediatric AIDS Foundation.	Chi BH, 2006, HIV CLIN TRIALS, V7, P263, DOI 10.1310/hct0705-263; Cressey TR, 2007, ANTIMICROB AGENTS CH, V51, P3361, DOI 10.1128/AAC.00445-07; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/00002030-200403050-00018; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, REP GLOB HIV AIDS EP; Kagaayi J, 2005, JAIDS-J ACQ IMM DEF, V39, P121, DOI 10.1097/01.qai.0000148530.66587.7c; Koal T, 2005, RAPID COMMUN MASS SP, V19, P2995, DOI 10.1002/rcm.2158; Laurito TL, 2002, J MASS SPECTROM, V37, P434, DOI 10.1002/jms.300; Mate KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005483; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Megazzini KM, 2010, AIDS, V24, P447, DOI 10.1097/QAD.0b013e328334b285; Mirochnick M, 2000, CLIN PHARMACOKINET, V39, P281, DOI 10.2165/00003088-200039040-00004; *OFF US GLOB AIDS, CEL LIF; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Painter TM, 2004, BMJ-BRIT MED J, V329, P543, DOI 10.1136/bmj.329.7465.543; Plipat T, 2007, AIDS, V21, P145, DOI 10.1097/QAD.0b013e328010e02d; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Songok EM, 2003, AM J TROP MED HYG, V69, P8, DOI 10.4269/ajtmh.2003.69.8; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Stringer JSA, 2004, AIDS, V18, P939, DOI 10.1097/00002030-200404090-00012; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; *UNAIDS, 2001, UN GEN ASS SPEC SESS; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; WEERAHANDI S, 2006, WILEY SERIES PROBABI; *WHO, 2006, ANT DRUGS TREAT WOM; WHO, RAP ADV US ANT DRUGS; WHO, UN ACC	30	113	114	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					293	302		10.1001/jama.2010.990	http://dx.doi.org/10.1001/jama.2010.990			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639563				2022-12-28	WOS:000280107500019
J	Schectman, J				Schectman, Joel			Influenza vaccination of children and adolescents decreased influenza infection in nonvaccinated community members	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia Hlth Syst, Charlottesville, VA USA	University of Virginia	Schectman, J (corresponding author), Univ Virginia Hlth Syst, Charlottesville, VA USA.				Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		*CDCP, 2010, MMWR, V58	1	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-10	10.7326/0003-4819-153-2-201007200-02010	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643976				2022-12-28	WOS:000280095400028
J	Weiner, SJ; Schwartz, A; Weaver, F; Goldberg, J; Yudkowsky, R; Sharma, G; Binns-Calvey, A; Preyss, B; Schapira, MM; Persell, SD; Jacobs, E; Abrams, RI				Weiner, Saul J.; Schwartz, Alan; Weaver, Frances; Goldberg, Julie; Yudkowsky, Rachel; Sharma, Gunjan; Binns-Calvey, Amy; Preyss, Ben; Schapira, Marilyn M.; Persell, Stephen D.; Jacobs, Elizabeth; Abrams, Richard I.			Contextual Errors and Failures in Individualizing Patient Care A Multicenter Study	ANNALS OF INTERNAL MEDICINE			English	Article							PREVALENCE	Background: A contextual error occurs when a physician overlooks elements of a patient's environment or behavior that are essential to planning appropriate care. In contrast to biomedical errors, which are not patient-specific, contextual errors represent a failure to individualize care. Objective: To explore the frequency and circumstances under which physicians probe contextual and biomedical red flags and avoid treatment error by incorporating what they learn from these probes. Design: An incomplete randomized block design in which unannounced, standardized patients visited 111 internal medicine attending physicians between April 2007 and April 2009 and presented variants of 4 scenarios. In all scenarios, patients presented both a contextual and a biomedical red flag. Responses to probing about flags varied in whether they revealed an underlying complicating biomedical or contextual factor (or both) that would lead to errors in management if overlooked. Setting: 14 practices, including 2 academic clinics, 2 community-based primary care networks with multiple sites, a core safety net provider, and 3 U. S. Department of Veterans Affairs facilities. Measurements: Primary outcomes were the proportion of visits in which physicians probed for contextual and biomedical factors in response to hints or red flags and the proportion of visits that resulted in error-free treatment plans. Results: Physicians probed fewer contextual red flags (51%) than biomedical red flags (63%). Probing for contextual or biomedical information in response to red flags was usually necessary but not sufficient for an error-free plan of care. Physicians provided error-free care in 73% of the uncomplicated encounters, 38% of the biomedically complicated encounters, 22% of the contextually complicated encounters, and 9% of the combined biomedically and contextually complicated encounters. Limitations: Only 4 case scenarios were used. The study assessed physicians' propensity to make errors when every encounter provided an opportunity to do so and did not measure actual error rates that occur in primary care settings because of inattention to context. Conclusion: Inattention to contextual information, such as a patient's transportation needs, economic situation, or caretaker responsibilities, can lead to contextual error, which is not currently measured in assessments of physician performance.	[Weiner, Saul J.] Univ Illinois, Coll Med, Vet Affairs Ctr Management Complex Chron Care, Chicago, IL 60612 USA; Northwestern Univ, Jesse Brown Vet Affairs Med Ctr, Feinberg Sch Med, John H Stroger Jr Hosp, Chicago, IL 60611 USA; [Jacobs, Elizabeth] Rush Univ, Med Ctr, Chicago, IL 60612 USA; Edward Hines Vet Affairs Med Ctr, Hines, IL USA; Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; John H Stroger Junior Hospital Cook County; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Rush University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Medical College of Wisconsin	Weiner, SJ (corresponding author), Univ Illinois, Coll Med, Vet Affairs Ctr Management Complex Chron Care, 1853 W Polk St,CMW 105, Chicago, IL 60612 USA.	sweiner@uic.edu	Yudkowsky, Rachel/AAP-8240-2020; Weaver, Frances/S-1540-2019; Binns, Colin W/A-6012-2008; Schwartz, Alan/G-2814-2010	Yudkowsky, Rachel/0000-0002-2145-7582; Binns, Colin W/0000-0002-6220-3933; Schwartz, Alan/0000-0003-3809-6637	Department of Veterans Affairs Health Services Research and Development Service [IIR 04-107]	Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Grant Support: By the Department of Veterans Affairs Health Services Research and Development Service (grant IIR 04-107).	Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Breslin M, 2008, PATIENT EDUC COUNS, V73, P465, DOI 10.1016/j.pec.2008.07.024; Brown H., 1999, APPL MIXED MODELS ME; CUNNINGHAM PJ, 2002, PRESCRIPTION DRUG AC; Falzer PR, 2010, ACAD MED, V85, P548, DOI 10.1097/ACM.0b013e3181ccd83c; Falzer PR, 2009, J EVAL CLIN PRACT, V15, P1142, DOI 10.1111/j.1365-2753.2009.01315.x; Franz CE, 2006, HEALTH SERV RES, V41, P2290, DOI 10.1111/j.1475-6773.2006.00560.x; Howell D. C., 2007, SAGE HDB SOCIAL SCI, P208; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Kim TW, 2007, HEALTH SERV RES, V42, P755, DOI 10.1111/j.1475-6773.2006.00630.x; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Nelson K, 1998, JAMA-J AM MED ASSOC, V279, P1211, DOI 10.1001/jama.279.15.1211; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Stange KC, 2009, ANN FAM MED, V7, P387, DOI 10.1370/afm.990; Weiner SJ, 2007, MED DECIS MAKING, V27, P726, DOI 10.1177/0272989X07306113; Weiner Saul J, 2004, ACP J Club, V141, pA11; Weiner SJ, 2004, J GEN INTERN MED, V19, P281, DOI 10.1111/j.1525-1497.2004.30261.x; WEINER SJ, 2008, ENCY MED DECISION MA, P198	19	138	138	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2					69	W29		10.7326/0003-4819-153-2-201007200-00002	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628DU	20643988				2022-12-28	WOS:000280095400001
J	Hu, J; Yu, MF				Hu, Jie; Yu, Min-Feng			Meniscus-Confined Three-Dimensional Electrodeposition for Direct Writing of Wire Bonds	SCIENCE			English	Article							FABRICATION; DEPOSITION	Continued progress in the electronics industry depends on downsizing, to a few micrometers, the wire bonds required for wiring integrated chips into circuit boards. We developed an electrodeposition method that exploits the thermodynamic stability of a microscale or nanoscale liquid meniscus to "write" pure copper and platinum three-dimensional structures of designed shapes and sizes in an ambient air environment. We demonstrated an automated wire-bonding process that enabled wire diameters of less than 1 micrometer and bond sizes of less than 3 micrometers, with a breakdown current density of more than 10(11) amperes per square meter for the wire bonds. The technology was used to fabricate high-density and high-quality interconnects, as well as complex three-dimensional microscale and even nanoscale metallic structures.	[Hu, Jie; Yu, Min-Feng] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Yu, MF (corresponding author), Univ Illinois, Dept Mech Sci & Engn, 1206 W Green St, Urbana, IL 61801 USA.	mfyu@illinois.edu	Yu, Min-Feng/C-2809-2012		Grainger Foundation	Grainger Foundation	Supported by the Grainger Foundation. We acknowledge the use of microscopy facilities in the Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign. A U.S. patent application based on this work was filed by the University of Illinois on 7 June 2010.	Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Defay R., 1966, SURFACE TENSION ADSO; Ghasemi H, 2010, J PHYS CHEM C, V114, P5088, DOI 10.1021/jp911259n; Harman G., 2009, WIRE BONDING MICROEL; Harper C. A., 2005, ELECT PACKAGING INTE; Huang QJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/7/075706; Huang QJ, 2008, J APPL PHYS, V104, DOI 10.1063/1.2956703; Jang J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.156104; Jang JY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.085504; Karim S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/18/185403; Lanyon YH, 2007, ANAL CHEM, V79, P3048, DOI 10.1021/ac061878x; Li Y, 2001, J AM CHEM SOC, V123, P2105, DOI 10.1021/ja005654m; Madden JD, 1996, J MICROELECTROMECH S, V5, P24, DOI 10.1109/84.485212; Major RC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177803; Morita T, 2003, J VAC SCI TECHNOL B, V21, P2737, DOI 10.1116/1.1630329; RAMM P, 2008, 3 D IC INTEGRATION T, P289; Suryavanshi AP, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105305; Suryavanshi AP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177538; Tatarchenko Y., 1993, SHAPED CRYSTAL GROWT; Toimil-Molares ME, 2003, APPL PHYS LETT, V82, P2139, DOI 10.1063/1.1563741	20	217	237	18	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					313	316		10.1126/science.1190496	http://dx.doi.org/10.1126/science.1190496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647464				2022-12-28	WOS:000279925900038
J	Jones, RB; Tervaert, JWC; Hauser, T; Luqmani, R; Morgan, MD; Peh, CA; Savage, CO; Segelmark, M; Tesar, V; van Paassen, P; Walsh, D; Walsh, M; Westman, K; Jayne, DRW				Jones, Rachel B.; Tervaert, Jan Willem Cohen; Hauser, Thomas; Luqmani, Raashid; Morgan, Matthew D.; Peh, Chen Au; Savage, Caroline O.; Segelmark, Marten; Tesar, Vladimir; van Paassen, Pieter; Walsh, Dorothy; Walsh, Michael; Westman, Kerstin; Jayne, David R. W.		European Vasculitis Study Grp	Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVE RHEUMATOID-ARTHRITIS; WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; DOUBLE-BLIND; THERAPY; REMISSION; EFFICACY; MULTICENTER	Background: Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are effective in 70 to 90% of patients, but they are associated with high rates of death and adverse events. Treatment with rituximab has led to remission rates of 80 to 90% among patients with refractory ANCA-associated vasculitis and may be safer than cyclophosphamide regimens. Methods: We compared rituximab with cyclophosphamide as induction therapy in ANCA-associated vasculitis. We randomly assigned, in a 3:1 ratio, 44 patients with newly diagnosed ANCA-associated vasculitis and renal involvement to a standard glucocorticoid regimen plus either rituximab at a dose of 375 mg per square meter of body-surface area per week for 4 weeks, with two intravenous cyclophosphamide pulses (33 patients, the rituximab group), or intravenous cyclophosphamide for 3 to 6 months followed by azathioprine (11 patients, the control group). Primary end points were sustained remission rates at 12 months and severe adverse events. Results: The median age was 68 years, and the glomerular filtration rate (GFR) was 18 ml per minute per 1.73 m(sup 2) of body-surface area. A total of 25 patients in the rituximab group (76%) and 9 patients in the control group (82%) had a sustained remission (P=0.68). Severe adverse events occurred in 14 patients in the rituximab group (42%) and 4 patients in the control group (36%) (P=0.77). Six of the 33 patients in the rituximab group (18%) and 2 of the 11 patients in the control group (18%) died (P=1.00). The median increase in the GFR between 0 and 12 months was 19 ml per minute in the rituximab group and 15 ml per minute in the control group (P=0.14). Conclusions: A rituximab-based regimen was not superior to standard intravenous cyclophosphamide for severe ANCA-associated vasculitis. Sustained-remission rates were high in both groups, and the rituximab-based regimen was not associated with reductions in early severe adverse events. (Funded by Cambridge University Hospitals National Health Service Foundation Trust and F. Hoffmann-La Roche; Current Controlled Trials number, ISRCTN28528813.) N Engl J Med 2010;363:211-20.	[Jones, Rachel B.; Walsh, Dorothy; Walsh, Michael; Jayne, David R. W.] Addenbrookes Hosp, Vasculitis & Lupus Clin, Renal Unit, Cambridge CB2 0QQ, England; [Luqmani, Raashid] Nuffield Orthopaed Ctr, Dept Rheumatol, Oxford OX3 7LD, England; [Morgan, Matthew D.; Savage, Caroline O.] Univ Birmingham, Dept Renal Immunobiol, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Tervaert, Jan Willem Cohen; van Paassen, Pieter] Maastricht Univ, Med Ctr, Div Clin & Expt Immunol, Dept Internal Med, Maastricht, Netherlands; [Hauser, Thomas] Immunol Zentrum Zurich, Zurich, Switzerland; [Hauser, Thomas] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Peh, Chen Au] Royal Adelaide Hosp, Renal Unit, Adelaide, SA 5000, Australia; [Segelmark, Marten] Univ Hosp Skane, Dept Nephrol Lund, Lund, Sweden; [Segelmark, Marten] Lund Univ, Lund, Sweden; [Westman, Kerstin] Univ Hosp Skane, Dept Nephrol & Transplantat Malmo, Malmo, Sweden; [Westman, Kerstin] Lund Univ, Malmo, Sweden; [Tesar, Vladimir] Charles Univ Prague, Fac Med 1, Prague, Czech Republic	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Nuffield Orthopaedic Centre; University of Birmingham; Maastricht University; University of Zurich; University Zurich Hospital; Royal Adelaide Hospital; Lund University; Lund University; Charles University Prague	Jones, RB (corresponding author), Addenbrookes Hosp, Vasculitis & Lupus Clin, Renal Unit, Box 57,Hills Rd, Cambridge CB2 0QQ, England.	rbjones@doctors.org.uk	Morgan, Matthew David/K-2240-2019; Walsh, Michael/ABE-1278-2021; tervaert, jan willem cohen/AAB-1111-2019; Tesar, Vladimir/O-2312-2017	Morgan, Matthew David/0000-0002-7831-2245; Walsh, Michael/0000-0001-8292-2014; Tesar, Vladimir/0000-0001-6982-0689; Luqmani, Raashid/0000-0002-4446-5841; Westman, Kerstin/0000-0002-2930-998X; Jones, Rachel/0000-0003-4790-283X; Peh, Chen Au/0000-0002-9712-0396; Jayne, David/0000-0002-1712-0637; Segelmark, Marten/0000-0002-1221-0772	Cambridge University Hospitals National Health Service Foundation Trust; Canadian Institute of Health Research; Kidney Foundation of Canada; Canadian Society of Nephrology; Alberta Heritage Foundation for Medical Research; Biogen Idec; GlaxoSmithKline; Biovitrum and Talecris; Medical Research Council [G9818340B] Funding Source: researchfish	Cambridge University Hospitals National Health Service Foundation Trust; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Canadian Society of Nephrology; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Biogen Idec(Biogen); GlaxoSmithKline(GlaxoSmithKline); Biovitrum and Talecris; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Cambridge University Hospitals National Health Service Foundation Trust, a research grant from F. Hoffmann-La Roche, which also provided rituximab for the study, a Kidney Research Scientist Core Education and National Training Program award from the Canadian Institute of Health Research, grants from the Kidney Foundation of Canada and the Canadian Society of Nephrology, and a Clinical Fellowship Award from the Alberta Heritage Foundation for Medical Research (all to Dr. M. Walsh).; Dr. Jones reports receiving lecture fees from F. Hoffmann-La Roche; Dr. Jayne, consulting and lecture fees from F. Hoffmann-La Roche; Dr. Cohen Tervaert, lecture fees and book royalties from F. Hoffmann-La Roche; Dr. Tesar, travel support from F. Hoffmann-La Roche; Dr. Luqmani, consulting fees from Schering-Plough and F. Hoffmann-La Roche and travel support from Wyeth, F. Hoffmann-La Roche, and Abbott; and Dr. Savage, consulting fees from Biogen Idec and GlaxoSmithKline and a paid sabbatical at GlaxoSmithKline after the completion of this study. Addenbrooke's Hospital has received grant support and lecture fees from F. Hoffmann-La Roche for services provided by Dr. Jayne. The University of Birmingham has received grant support from Biovitrum and Talecris for services provided by Dr. Savage. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2002, Med Etika Bioet, V9, P12; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; CUPPS TR, 1982, J IMMUNOL, V128, P2453; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Exley AR, 1997, ARTHRITIS RHEUM, V40, P371, DOI 10.1002/art.1780400222; FAUCI AS, 1979, NEW ENGL J MED, V301, P235, DOI 10.1056/NEJM197908023010503; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jayne D, 2010, J AM SOC NEPHROL, V21, P14, DOI 10.1681/ASN.2008070786; Jayne DRW, 2007, J AM SOC NEPHROL, V18, P2180, DOI 10.1681/ASN.2007010090; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Jennette JC, 2006, J AM SOC NEPHROL, V17, P1235, DOI 10.1681/ASN.2005101048; Jones RB, 2009, ARTHRITIS RHEUM, V60, P2156, DOI 10.1002/art.24637; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Krumbholz M, 2005, J AUTOIMMUN, V25, P298, DOI 10.1016/j.jaut.2005.08.004; Lapraik C, 2007, RHEUMATOLOGY, V46, P1615, DOI 10.1093/rheumatology/kem146a; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MCHORNEY CA, 1992, MED CARE S, V30, P253; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mease PJ, 2008, J RHEUMATOL, V35, P20; Mukhtyar C, 2008, ANN RHEUM DIS, V67, P1004, DOI 10.1136/ard.2007.071936; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P310, DOI 10.1136/ard.2008.088096; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Rafailidis PI, 2007, CANCER, V109, P2182, DOI 10.1002/cncr.22666; Sanders JSF, 2006, RHEUMATOLOGY, V45, P724, DOI 10.1093/rheumatology/kei272; Smith KGC, 2006, ARTHRITIS RHEUM-US, V54, P2970, DOI 10.1002/art.22046; Stasi R, 2006, RHEUMATOLOGY, V45, P1432, DOI 10.1093/rheumatology/kel098; STEINBERG AD, 1991, ARTHRITIS RHEUM-US, V34, P945, DOI 10.1002/art.1780340803; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Voswinkel J, 2006, ANN RHEUM DIS, V65, P859, DOI 10.1136/ard.2005.044909; Voswinkel J, 2005, ANN NY ACAD SCI, V1051, P12, DOI 10.1196/annals.1361.042; Walsh M, 2007, KIDNEY INT, V72, P676, DOI 10.1038/sj.ki.5002395	38	1031	1100	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					211	220		10.1056/NEJMoa0909169	http://dx.doi.org/10.1056/NEJMoa0909169			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647198				2022-12-28	WOS:000279864200004
J	Oler, JA; Fox, AS; Shelton, SE; Rogers, J; Dyer, TD; Davidson, RJ; Shelledy, W; Oakes, TR; Blangero, J; Kalin, NH				Oler, Jonathan A.; Fox, Andrew S.; Shelton, Steven E.; Rogers, Jeffrey; Dyer, Thomas D.; Davidson, Richard J.; Shelledy, Wendy; Oakes, Terrence R.; Blangero, John; Kalin, Ned H.			Amygdalar and hippocampal substrates of anxious temperament differ in their heritability	NATURE			English	Article							BEHAVIORAL-INHIBITION; GENETIC-VARIATION; ANXIETY; EMOTION; DISORDERS; BRAIN; FEAR; MECHANISMS; EXPRESSION; CHILDHOOD	Anxious temperament (AT) in human and non-human primates is a trait-like phenotype evident early in life that is characterized by increased behavioural and physiological reactivity to mildly threatening stimuli(1-4). Studies in children demonstrate that AT is an important risk factor for the later development of anxiety disorders, depression and comorbid substance abuse(5). Despite its importance as an early predictor of psychopathology, little is known about the factors that predispose vulnerable children to develop AT and the brain systems that underlie its expression. To characterize the neural circuitry associated with AT and the extent to which the function of this circuit is heritable, we studied a large sample of rhesus monkeys phenotyped for AT. Using 238 young monkeys from a multigenerational single-family pedigree, we simultaneously assessed brain metabolic activity and AT while monkeys were exposed to the relevant ethological condition that elicits the phenotype. High-resolution (18)F-labelled deoxyglucose positron-emission tomography (FDG-PET) was selected as the imaging modality because it provides semi-quantitative indices of absolute glucose metabolic rate, allows for simultaneous measurement of behaviour and brain activity, and has a time course suited for assessing temperament-associated sustained brain responses. Here we demonstrate that the central nucleus region of the amygdala and the anterior hippocampus are key components of the neural circuit predictive of AT. We also show significant heritability of the AT phenotype by using quantitative genetic analysis. Additionally, using voxelwise analyses, we reveal significant heritability of metabolic activity in AT-associated hippocampal regions. However, activity in the amygdala region predictive of AT is not significantly heritable. Furthermore, the heritabilities of the hippocampal and amygdala regions significantly differ from each other. Even though these structures are closely linked, the results suggest differential influences of genes and environment on how these brain regions mediate AT and the ongoing risk of developing anxiety and depression.	[Oler, Jonathan A.; Shelton, Steven E.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Fox, Andrew S.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Oler, Jonathan A.; Shelton, Steven E.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin, HealthEmot Res Inst, Madison, WI 53719 USA; [Fox, Andrew S.; Davidson, Richard J.; Oakes, Terrence R.; Kalin, Ned H.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53705 USA; [Rogers, Jeffrey] Baylor Coll Med, Houston, TX 77030 USA; [Rogers, Jeffrey; Dyer, Thomas D.; Shelledy, Wendy; Blangero, John] SW Fdn Biomed Res, San Antonio, TX 78227 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine; Texas Biomedical Research Institute	Kalin, NH (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	nkalin@wisc.edu	Blangero, John/ABA-7175-2021	Kalin, Ned/0000-0003-1184-0868; Davidson, Richard/0000-0002-8506-4964	National Institutes of Health [MH046729, MH081884, MH084051, MH018931, MH059490]; HealthEmotions Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081884, R01MH059490, R01MH046729, T32MH018931, R37MH059490, P50MH084051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HealthEmotions Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported by National Institutes of Health grants MH046729 (to N.H.K.), MH081884 (to N.H.K. and J.R.), MH084051 (to R.J.D. and N.H.K.), MH018931 (to J.A.O., A. S. F. and R.J.D.) and the HealthEmotions Research Institute. The SOLAR statistical genetics computer package is supported by National Institutes of Health grant MH059490 (to J.B.). The supercomputing facilities used for this work were supported in part by a gift from the AT&T Foundation. We thank the staff at the Wisconsin National Primate Center, the Harlow Center for Biological Psychology, the HealthEmotions Research Institute, the Waisman Laboratory for Brain Imaging and Behavior, B. Christian, P. Roseboom, H. Van Valkenberg, K. Myer, E. Larson, I. Monosov, F. Spector and R. Stone. We also thank R. Garcia for assistance in genotyping the 5HTTLPR polymorphism.	Biederman J, 2001, AM J PSYCHIAT, V158, P1673, DOI 10.1176/appi.ajp.158.10.1673; Chudasama Y, 2009, EUR J NEUROSCI, V30, P2327, DOI 10.1111/j.1460-9568.2009.07012.x; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Davis OSP, 2009, PSYCHOL SCI, V20, P1301, DOI 10.1111/j.1467-9280.2009.02433.x; Fox AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002570; Fox NA, 2005, ANNU REV PSYCHOL, V56, P235, DOI 10.1146/annurev.psych.55.090902.141532; Fudge JL, 2004, J COMP NEUROL, V476, P330, DOI 10.1002/cne.20228; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kalin NH, 2008, MOL PSYCHIATR, V13, P1021, DOI 10.1038/mp.2008.37; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lyons DM, 2001, ARCH GEN PSYCHIAT, V58, P1145, DOI 10.1001/archpsyc.58.12.1145; Machado CJ, 2008, PSYCHONEUROENDOCRINO, V33, P926, DOI 10.1016/j.psyneuen.2008.04.012; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; O'Rourke H, 2006, BIOL PSYCHIAT, V60, P479, DOI 10.1016/j.biopsych.2005.09.020; Paxinos G., 2009, RHESUS MONKEY BRAIN; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rogers J, 2008, GENES BRAIN BEHAV, V7, P463, DOI 10.1111/j.1601-183X.2007.00381.x; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Viviani R, 2010, BIOL PSYCHIAT, V67, P317, DOI 10.1016/j.biopsych.2009.08.035; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	31	151	156	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					864	868		10.1038/nature09282	http://dx.doi.org/10.1038/nature09282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703306	Green Accepted			2022-12-28	WOS:000280766100036
J	Watson, AJA; Williams, JMJ				Watson, Andrew J. A.; Williams, Jonathan M. J.			The Give and Take of Alcohol Activation	SCIENCE			English	Editorial Material							CATALYZED N-ALKYLATION; BORROWING HYDROGEN METHODOLOGY; AMINES; SULFONAMIDES		[Watson, Andrew J. A.; Williams, Jonathan M. J.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England	University of Bath	Watson, AJA (corresponding author), Univ Bath, Dept Chem, Claverton Down, Bath BA2 7AY, Avon, England.	ajaw20@bath.ac.uk; chsjmjw@bath.ac.uk		Watson, Andrew/0000-0002-7203-9129				Blank B, 2009, CHEM-EUR J, V15, P3790, DOI 10.1002/chem.200802318; Bower JF, 2008, ORG LETT, V10, P1033, DOI 10.1021/ol800159w; Edwards MG, 2004, CHEM COMMUN, P90, DOI 10.1039/b312162c; Edwards MG, 2002, ANGEW CHEM INT EDIT, V41, P4740, DOI 10.1002/anie.200290034; Fujita K, 2005, SYNLETT, P560, DOI 10.1055/s-2005-862381; GRIGG R, 1981, J CHEM SOC CHEM COMM, P611, DOI 10.1039/c39810000611; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Gunanathan C, 2008, ANGEW CHEM INT EDIT, V47, P8661, DOI 10.1002/anie.200803229; Hamid MHSA, 2009, J AM CHEM SOC, V131, P1766, DOI 10.1021/ja807323a; Hamid MHSA, 2007, CHEM COMMUN, P725, DOI 10.1039/b616859k; Hollmann D, 2007, CHEM-ASIAN J, V2, P403, DOI 10.1002/asia.200600391; Martinez R, 2006, TETRAHEDRON, V62, P8988, DOI 10.1016/j.tet.2006.07.013; Martinez-Asencio A, 2010, TETRAHEDRON LETT, V51, P325, DOI 10.1016/j.tetlet.2009.11.009; Nixon TD, 2009, DALTON T, P753, DOI 10.1039/b813383b; Patman RL, 2008, ANGEW CHEM INT EDIT, V47, P5220, DOI 10.1002/anie.200801359; Prades A, 2008, CHEM-EUR J, V14, P11474, DOI 10.1002/chem.200801580; Saidi O, 2010, CHEM COMMUN, V46, P1541, DOI 10.1039/b923083a; Salvatore RN, 2001, TETRAHEDRON, V57, P7785, DOI 10.1016/S0040-4020(01)00722-0; Shi F, 2009, ANGEW CHEM INT EDIT, V48, P5912, DOI 10.1002/anie.200901510; WATANABE Y, 1981, TETRAHEDRON LETT, V22, P2667, DOI 10.1016/S0040-4039(01)92965-X	20	508	516	2	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					635	636		10.1126/science.1191843	http://dx.doi.org/10.1126/science.1191843			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689005				2022-12-28	WOS:000280602700023
J	Jouvet, P; Lacroix, J				Jouvet, Philippe; Lacroix, Jacques			Improving interhospital paediatric transport	LANCET			English	Editorial Material							INTENSIVE-CARE; CRITICALLY-ILL; RETRIEVAL TEAM; REDUCTION; CHILDREN; MORBIDITY; SEVERITY; OUTCOMES; ILLNESS; SYSTEM		[Jouvet, Philippe; Lacroix, Jacques] Univ Montreal, St Justine Hosp, Dept Paediat, Div Paediat Crit Care Med, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Lacroix, J (corresponding author), Univ Montreal, St Justine Hosp, Dept Paediat, Div Paediat Crit Care Med, Montreal, PQ H3T 1C5, Canada.		Jouvet, Philippe A/H-3293-2018	Jouvet, Philippe A/0000-0001-5684-3398				BRITTO J, 1995, BRIT MED J, V311, P836, DOI 10.1136/bmj.311.7009.836; Duncan H, 2006, J CRIT CARE, V21, P271, DOI 10.1016/j.jcrc.2006.06.007; EDGE WE, 1994, CRIT CARE MED, V22, P1186, DOI 10.1097/00003246-199407000-00023; Gregory CJ, 2008, PEDIATRICS, V121, pE906, DOI 10.1542/peds.2007-2089; Hanson CC, 2009, QUAL SAF HEALTH CARE, V18, P500, DOI 10.1136/qshc.2007.026054; Odetola FO, 2008, PEDIATR CRIT CARE ME, V9, P20, DOI 10.1097/01.PCC.0000298642.11872.29; Orr RA, 2009, PEDIATRICS, V124, P40, DOI 10.1542/peds.2008-0515; Ramnarayan P, 2010, LANCET, V376, P698, DOI 10.1016/S0140-6736(10)61113-0; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; Vos GD, 2004, INTENS CARE MED, V30, P302, DOI 10.1007/s00134-003-2066-7; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A	12	3	4	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					660	661		10.1016/S0140-6736(10)61110-5	http://dx.doi.org/10.1016/S0140-6736(10)61110-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20708257				2022-12-28	WOS:000281582900005
J	Goldstein, AS; Huang, JT; Guo, CY; Garraway, IP; Witte, ON				Goldstein, Andrew S.; Huang, Jiaoti; Guo, Changyong; Garraway, Isla P.; Witte, Owen N.			Identification of a Cell of Origin for Human Prostate Cancer	SCIENCE			English	Article							STEM-CELLS; EPITHELIAL-CELLS; INTRAEPITHELIAL NEOPLASIA; BASAL; PTEN; EXPRESSION; CARCINOMA; LEADS; SUBPOPULATION; PROGENITORS	Luminal cells are believed to be the cells of origin for human prostate cancer, because the disease is characterized by luminal cell expansion and the absence of basal cells. Yet functional studies addressing the origin of human prostate cancer have not previously been reported because of a lack of relevant in vivo human models. Here we show that basal cells from primary benign human prostate tissue can initiate prostate cancer in immunodeficient mice. The cooperative effects of AKT, ERG, and androgen receptor in basal cells recapitulated the histological and molecular features of human prostate cancer, with loss of basal cells and expansion of luminal cells expressing prostate-specific antigen and alpha-methylacyl-CoA racemase. Our results demonstrate that histological characterization of cancers does not necessarily correlate with the cellular origins of the disease.	[Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med,Dept Mol & Med Pharmacol, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Goldstein, Andrew S.; Witte, Owen N.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Guo, Changyong; Garraway, Isla P.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Guo, Changyong; Garraway, Isla P.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Witte, ON (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med,Dept Mol & Med Pharmacol, Dept Microbiol Mol Genet & Immunol, 675 Charles E Young Dr S,5-748 MRL, Los Angeles, CA 90095 USA.	owenwitte@mednet.ucla.edu		Huang, Jiaoti/0000-0003-1195-1998; Goldstein, Andrew/0000-0003-0434-9149	Ruth L. Kirschstein National Research Service [GM07185]; American Cancer Society; Department of Defense (DOD); UCLA SPORE in Prostate Cancer; Jean Perkins Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense (DOD)(United States Department of Defense); UCLA SPORE in Prostate Cancer; Jean Perkins Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Anderson for manuscript preparation; D. Cheng for cell sorting; Y. Zong for vectors; H. Zhang for tissue preparation; and A. Chhabra, B. Van Handel, D. Mulholland, C. Soroudi, and T. Stoyanova for discussion and technical help. A.S.G. is supported by an institutional Ruth L. Kirschstein National Research Service Award (GM07185). J.H. is supported by the American Cancer Society, the Department of Defense (DOD) Prostate Cancer Research Program, and the UCLA SPORE in Prostate Cancer (principal investigator, R. Reiter). I.P.G is supported by the DOD and the Jean Perkins Foundation. O.N.W. is an Investigator of the Howard Hughes Medical Institute. J.H., I.P.G., and O.N.W. are supported by a Challenge Award from the Prostate Cancer Foundation.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; MCNEAL JE, 1986, HUM PATHOL, V17, P64, DOI 10.1016/S0046-8177(86)80156-3; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ruijter ET, 1996, J PATHOL, V180, P295; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; WOJNO KJ, 1995, AM J SURG PATHOL, V19, P251, DOI 10.1097/00000478-199503000-00002; Wu CL, 2004, HUM PATHOL, V35, P1008, DOI 10.1016/j.humpath.2004.03.019; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	31	395	409	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					568	571		10.1126/science.1189992	http://dx.doi.org/10.1126/science.1189992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671189	Green Accepted			2022-12-28	WOS:000280483500038
J	Harries, MJ; Sun, J; Paus, R; King, LE				Harries, M. J.; Sun, J.; Paus, R.; King, L. E., Jr.			Management of alopecia areata	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLOBETASOL PROPIONATE 0.05-PERCENT; TRIAMCINOLONE ACETONIDE; DOUBLE-BLIND; TOPICAL MINOXIDIL; PULSE THERAPY; EFFICACY; GUIDELINES; ANTHRALIN; TRIAL; FOAM		[Harries, M. J.] Univ Manchester, Salford Royal NHS Fdn Trust, Sch Translat Med, Manchester M6 8HD, Lancs, England; [Sun, J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Sun, J.] Jilin Univ, China Japan Union Hosp, Dept Dermatol, Changchun, Peoples R China; [Paus, R.] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [King, L. E., Jr.] Vanderbilt Univ Sch Med, Div Dermatol, Skin Dis Res Ctr, Nashville, TN USA	Salford Royal NHS Foundation Trust; University of Manchester; Jackson Laboratory; Jilin University; University of Lubeck; Vanderbilt University	Harries, MJ (corresponding author), Univ Manchester, Salford Royal NHS Fdn Trust, Sch Translat Med, Manchester M6 8HD, Lancs, England.	mjharries@doctors.org.uk	Harries, Matthew J/I-4687-2015; Paus, Ralf/B-5279-2015	Harries, Matthew J/0000-0002-0563-8690; Paus, Ralf/0000-0002-3492-9358	University of Manchester, UK; British Association of Dermatologists; University of Lubeck; National Alopecia Areata Foundation; National Institute of Health [5P30AR041943]; British Skin Foundation; Cicatricial Alopecia Research Foundation; MSD, Germany; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041943] Funding Source: NIH RePORTER	University of Manchester, UK; British Association of Dermatologists; University of Lubeck; National Alopecia Areata Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Skin Foundation; Cicatricial Alopecia Research Foundation; MSD, Germany; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Professor C Griffiths (University of Manchester, UK) for support and advice and Professor R Happle (University of Marburg, Germany) for generously supplying clinical images.; Writing of this review was made possible in part by the Geoffrey-Dowling Fellowship from the British Association of Dermatologists (MJH), a grant from the University of Lubeck Research Focus Programme on Autoimmunity (RP), a grant from the National Alopecia Areata Foundation and National Institute of Health 5P30AR041943 (LEK), and a research grant from the British Skin Foundation (MJH, RP).; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MH and RP have received research grants from the British Skin Foundation and Cicatricial Alopecia Research Foundation; RP has received research grants from the University of Lubeck, has been paid for developing and delivering educational presentations for MSD, Germany, and does consultancy for Hankel (Duesseldorf, Germany) and Dr Wolff (Bielefeld, Germany); LK has received research grants from the NIH and National Alopecia Areata Foundation; no other relationships or activities that could appear to have influenced the submitted work.	ABELL E, 1973, BRIT J DERMATOL, V88, P55; Agarwal A, 2006, J EUR ACAD DERMATOL, V20, P1375, DOI 10.1111/j.1468-3083.2006.01727.x; Chang KH, 2009, J DRUGS DERMATOL, V8, P909; Charuwichitratana S, 2000, ARCH DERMATOL, V136, P1276, DOI 10.1001/archderm.136.10.1276; Delamere FM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004413.pub2; FENTON DA, 1983, BRIT MED J, V287, P1015, DOI 10.1136/bmj.287.6398.1015; FIEDLER VC, 1990, ARCH DERMATOL, V126, P756, DOI 10.1001/archderm.126.6.756; FIEDLERWEISS VC, 1987, ARCH DERMATOL, V123, P1491, DOI 10.1001/archderm.123.11.1491; Georgala S, 2006, ACTA DERM-VENEREOL, V86, P422, DOI 10.2340/00015555-0138; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; GIP L, 1969, ACTA DERM-VENEREOL, V49, P180; Hay IC, 1998, ARCH DERMATOL, V134, P1349, DOI 10.1001/archderm.134.11.1349; Hull SPM, 2003, BRIT J DERMATOL, V149, P692, DOI 10.1046/j.1365-2133.2003.05535.x; Kar BR, 2005, J AM ACAD DERMATOL, V52, P287, DOI 10.1016/j.jaad.2004.10.873; KUBEYINJE EP, 1994, E AFR MED J, V71, P674; Luggen P, 2008, J DTSCH DERMATOL GES, V6, P375, DOI 10.1111/j.1610-0387.2007.06608.x; Mancuso G, 2003, INT J DERMATOL, V42, P572, DOI 10.1046/j.1365-4362.2003.01862.x; Olsen EA, 2004, J AM ACAD DERMATOL, V51, P440, DOI 10.1016/j.jaad.2003.09.032; PASCHER F, 1970, DERMATOLOGICA, V141, P193, DOI 10.1159/000252466; PORTER D, 1971, BRIT J DERMATOL, V85, P272, DOI 10.1111/j.1365-2133.1971.tb07230.x; PRICE VH, 1987, J AM ACAD DERMATOL, V16, P730, DOI 10.1016/S0190-9622(87)70095-4; Rokhsar CK, 1998, J AM ACAD DERMATOL, V39, P751, DOI 10.1016/S0190-9622(98)70048-9; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; SCHMOECKEL C, 1979, ARCH DERMATOL, V115, P1254, DOI 10.1001/archderm.115.10.1254; Sharma Vinod Kumar, 1999, Journal of Dermatology (Tokyo), V26, P562; Talpur R, 2009, J AM ACAD DERMATOL, V61, P592, DOI 10.1016/j.jaad.2009.02.037; Tosti A, 2003, J AM ACAD DERMATOL, V49, P96, DOI 10.1067/mjd.2003.423; Tosti A, 2006, J EUR ACAD DERMATOL, V20, P1243, DOI 10.1111/j.1468-3083.2006.01781.x; WALKER SA, 1950, J INVEST DERMATOL, V14, P403, DOI 10.1038/jid.1950.52; Wiseman MC, 2001, ARCH DERMATOL, V137, P1063	30	63	64	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2010	341								c3671	10.1136/bmj.c3671	http://dx.doi.org/10.1136/bmj.c3671			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GY	20656774	Green Published			2022-12-28	WOS:000280411900001
J	Mueller, M; Ban, N				Mueller, Marcus; Ban, Nenad			SnapShot: Pore-Forming Toxins	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; HEMOLYSIN; MECHANISM; ATTACK		[Mueller, Marcus; Ban, Nenad] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Mueller, Marcus] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Mueller, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.							CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Lukoyanova N, 2008, TRENDS IMMUNOL, V29, P51, DOI 10.1016/j.it.2007.11.003; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, BACTERIAL PROTEIN TO, V24, P302; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0	10	8	8	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					334	U169		10.1016/j.cell.2010.07.010	http://dx.doi.org/10.1016/j.cell.2010.07.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655473	Bronze			2022-12-28	WOS:000280204300023
J	Heath, I				Heath, Iona			Life and Death What do we want to die from?	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk							0	10	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3883	10.1136/bmj.c3883	http://dx.doi.org/10.1136/bmj.c3883			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GW	20659979				2022-12-28	WOS:000280411700017
J	Vijeyarasa, R; Stein, RA				Vijeyarasa, Ramona; Stein, Richard A.			HIV and Human Trafficking-Related Stigma Health Interventions for Trafficked Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stein, Richard A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Vijeyarasa, Ramona] Univ New S Wales, Sch Social Sci & Int Studies, Sydney, NSW, Australia	Princeton University; University of New South Wales Sydney	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, 1 Washington Rd,LTL320, Princeton, NJ 08544 USA.	ras2@princeton.edu	Vijeyarasa, Ramona/HHZ-6618-2022	Vijeyarasa, Dr Ramona/0000-0003-4581-4924				Dharmadhikari AS, 2009, INT J INFECT DIS, V13, P543, DOI 10.1016/j.ijid.2008.11.010; Gupta J, 2009, INT J GYNECOL OBSTET, V107, P30, DOI 10.1016/j.ijgo.2009.06.009; *HIV MED ASS INF D, 2007, HIV TB COINF BAS FAC; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Tachover D, 2011, WORLD MED HEALTH POL, V3, DOI 10.2202/1948-4682.1135; UN, 2000, PROT PREV SUPPR PUN; Vijeyarasa R, 2010, CULT HEALTH SEX, V12, pS89, DOI 10.1080/13691050903359257; Zimmerman C., 2003, HLTH RISKS CONSEQUEN	10	7	7	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					344	345		10.1001/jama.2010.964	http://dx.doi.org/10.1001/jama.2010.964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639570				2022-12-28	WOS:000280107500026
J	Greer, DM; Styer, AK; Toth, TL; Kindregan, CP; Romero, JM				Greer, David M.; Styer, Aaron K.; Toth, Thomas L.; Kindregan, Charles P.; Romero, Javier M.			Case 21-2010: A Request for Retrieval of Oocytes from a 36-Year-Old Woman with Anoxic Brain Injury.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPERM RETRIEVAL; CRYOPRESERVATION; DEATH; REPRODUCTION; PRESERVATION; TECHNOLOGY; FERTILITY; TISSUE; STATE; IVF		[Greer, David M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Styer, Aaron K.; Toth, Thomas L.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Romero, Javier M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Greer, David M.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Styer, Aaron K.; Toth, Thomas L.] Harvard Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Romero, Javier M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kindregan, Charles P.] Suffolk Univ, Sch Law, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Suffolk University	Greer, DM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Greer, David/0000-0002-2026-8333; Romero, Javier/0000-0001-5749-3000				Annas GJ, 2000, NEW ENGL J MED, V343, P373, DOI 10.1056/NEJM200008033430519; Applbaum AI, 2008, JAMA-J AM MED ASSOC, V299, P2188, DOI 10.1001/jama.299.18.2188; Bankowski BJ, 2005, FERTIL STERIL, V84, P823, DOI 10.1016/j.fertnstert.2005.02.057; Batzer FR, 2003, FERTIL STERIL, V79, P1263, DOI 10.1016/S0015-0282(03)00384-4; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Chian RC, 2004, CURR OPIN OBSTET GYN, V16, P211, DOI 10.1097/00001703-200406000-00003; *CTR DIS CONTR PRE, 2006, ASS REPR TECHN SUCC; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Ethics Committee of the American Society for Reproductive Medicine, 2004, Fertil Steril, V82 Suppl 1, pS260; Greer DM, 2004, NEUROCRIT CARE, V1, P213, DOI 10.1385/NCC:1:2:213; HEIKKINEN JE, 1985, BRIT MED J, V290, P1237, DOI 10.1136/bmj.290.6477.1237; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; KAZEM R, 1995, HUM REPROD, V10, P2650, DOI 10.1093/oxfordjournals.humrep.a135761; Kindregan CP, 2008, FAM LAW QUART, V42, P203; Landau R, 2004, HUM REPROD, V19, P1952, DOI 10.1093/humrep/deh360; Lobo RA, 2005, NEW ENGL J MED, V353, P64, DOI 10.1056/NEJMra043475; Mejia R, 2008, MEDICINA-BUENOS AIRE, V68, P447; Noyes N, 2009, REPROD BIOMED ONLINE, V18, P769, DOI 10.1016/S1472-6483(10)60025-9; Ohl DA, 1996, FERTIL STERIL, V66, P889, DOI 10.1016/S0015-0282(16)58680-4; Parkin L, 2006, THROMB HAEMOSTASIS, V95, P807, DOI 10.1160/TH05-12-0813; Ragni G, 2005, HUM REPROD, V20, P2224, DOI 10.1093/humrep/dei011; Soules MR, 1999, J LAW MED ETHICS, V27, P362, DOI 10.1111/j.1748-720X.1999.tb01472.x; Strong C, 2000, HUM REPROD, V15, P739, DOI 10.1093/humrep/15.4.739; Styer AK, 2003, FERTIL STERIL, V80, P584, DOI 10.1016/S0015-0282(03)00976-2; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; WIJDICKS EFM, NEUROLOGY IN PRESS; RESUSCITATI IN PRESS	28	9	9	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					276	283		10.1056/NEJMcpc1004360	http://dx.doi.org/10.1056/NEJMcpc1004360			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647203				2022-12-28	WOS:000279864200012
J	Wei, CJ; Boyington, JC; McTamney, PM; Kong, WP; Pearce, MB; Xu, L; Andersen, H; Rao, S; Tumpey, TM; Yang, ZY; Nabel, GJ				Wei, Chih-Jen; Boyington, Jeffrey C.; McTamney, Patrick M.; Kong, Wing-Pui; Pearce, Melissa B.; Xu, Ling; Andersen, Hanne; Rao, Srinivas; Tumpey, Terrence M.; Yang, Zhi-Yong; Nabel, Gary J.			Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination	SCIENCE			English	Article							RECOMBINANT ADENOVIRAL VECTORS; VIRUS; IMMUNIZATION; IMMUNOGENICITY; IMMUNITY; HIV-1	The rapid dissemination of the 2009 pandemic influenza virus underscores the need for universal influenza vaccines that elicit protective immunity to diverse viral strains. Here, we show that vaccination with plasmid DNA encoding H1N1 influenza hemagglutinin (HA) and boosting with seasonal vaccine or replication-defective adenovirus 5 vector encoding HA stimulated the production of broadly neutralizing influenza antibodies. This prime/boost combination increased the neutralization of diverse H1N1 strains dating from 1934 to 2007 as compared to either component alone and conferred protection against divergent H1N1 viruses in mice and ferrets. These antibodies were directed to the conserved stem region of HA and were also elicited in nonhuman primates. Cross-neutralization of H1N1 subtypes elicited by this approach provides a basis for the development of a universal influenza vaccine for humans.	[Wei, Chih-Jen; Boyington, Jeffrey C.; McTamney, Patrick M.; Kong, Wing-Pui; Xu, Ling; Rao, Srinivas; Yang, Zhi-Yong; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Pearce, Melissa B.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; [Andersen, Hanne] BIOQUAL, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; BIOQUAL Inc.	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022	Elyard, Hanne/0000-0003-1103-9608	Vaccine Research Center, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Ault, J.-P. Todd, A. Zajac, and C. Chiedi for help with the animal studies; K. Dai, W. Shi, and S. Y. Ko for technical support; M. Lewis (BIOQUAL), B. Sanders (BIOQUAL), and members of the Nabel lab for helpful discussions; A. Tislerics and B. Hartman for manuscript preparation; and Y. Okuno for providing the C179 mAb. NIH has filed a patent application (U.S. patent E-341-2008l; international patent WO 2010/036958 A2) on this work (authors: C-J.W., Z-y.Y, and G.J.N.), related to gene-and protein-based approaches to influenza vaccination. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Mascola JR, 2005, J VIROL, V79, P771, DOI 10.1128/JVI.79.2.771-779.2005; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; *WHO, 2010, WHO GLOB INFL PROGR; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004	18	284	330	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1060	1064		10.1126/science.1192517	http://dx.doi.org/10.1126/science.1192517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20647428				2022-12-28	WOS:000281253500036
J	Topol, EJ; Bousser, MG; Fox, KAA; Creager, MA; Despres, JP; Easton, JD; Hamm, CW; Montalescot, G; Steg, PG; Pearson, TA; Cohen, E; Gaudin, C; Job, B; Murphy, JH; Bhatt, DL				Topol, Eric J.; Bousser, Marie-Germaine; Fox, Keith A. A.; Creager, Mark A.; Despres, Jean-Pierre; Easton, J. Donald; Hamm, Christian W.; Montalescot, Gilles; Steg, P. Gabriel; Pearson, Thomas A.; Cohen, Eric; Gaudin, Christophe; Job, Bernard; Murphy, Judith H.; Bhatt, Deepak L.		CRESCENDO Investigators	Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial	LANCET			English	Article							CANNABINOID-1 RECEPTOR BLOCKER; RISK-FACTORS; OVERWEIGHT PATIENTS; ASSOCIATION; CLOPIDOGREL; VARIANTS; WEIGHT	Background Blockade of the endocannabinoid receptor reduces obesity and improves metabolic abnormalities such as triglycerides, HDL cholesterol, and fasting blood glucose. We assessed whether rimonabant would improve major vascular event-free survival. Methods This double-blind, placebo-controlled trial was undertaken in 974 hospitals in 42 countries. 18 695 patients with previously manifest or increased risk of vascular disease were randomly assigned to receive either rimonabant 20 mg (n=9381) or matching placebo (n=9314). Randomisation was stratified by centre, implemented with an independent interactive voice response system, and all study personnel and participants were masked to group assignment. The primary endpoint was the composite of cardiovascular death, myocardial infarction, or stroke, as determined via central adjudication. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00263042. Findings At a mean follow-up of 13.8, months (95% CI 13.6-14.0), the trial was prematurely discontinued because of concerns by health regulatory authorities in three countries about suicide in individuals receiving rimonabant. All randomised participants were analysed. At the close of the trial (Nov 6, 2008), the composite primary endpoint of cardiovascular death, myocardial infarction, or stroke occurred in 364 (3.9%) patients assigned to rimonabant and 375 (4.0%) assigned to placebo (hazard ratio 0.97, 95% CI 0.84-1.12, p=0.68). With rimonabant, gastrointestinal (3038 [33%] vs 2084 [22%]), neuropsychiatric (3028 [32%] vs 1989 [21%]), and serious psychiatric side-effects (232 [2.5%] vs 120 [1.3%]) were significantly increased compared with placebo. Four patients in the rimonabant group and one in the placebo group committed suicide. Interpretation The premature termination of this trial has important lessons for drug development. A drug that was being marketed for weight loss, but being tested for improving cardiovascular outcomes, induced a level of serious neuropsychiatric effects that was deemed unacceptable by regulatory authorities, and both the drug and the trial were abruptly terminated.	[Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Bousser, Marie-Germaine] Hop Lariboisiere, F-75475 Paris, France; [Fox, Keith A. A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Creager, Mark A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Creager, Mark A.] Harvard Univ, Boston, MA 02115 USA; [Despres, Jean-Pierre] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Easton, J. Donald] Rhode Isl Hosp, Providence, RI USA; [Easton, J. Donald] Brown Univ, Providence, RI 02912 USA; [Hamm, Christian W.] Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, D-6350 Bad Nauheim, Germany; [Montalescot, Gilles] CHU Pitie Salpetriere, Paris, France; [Steg, P. Gabriel] Univ Paris 07, INSERM, U698, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Pearson, Thomas A.] Univ Rochester, Rochester, NY USA; [Cohen, Eric] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Gaudin, Christophe; Job, Bernard; Murphy, Judith H.] Sanofi Aventis, Paris, France; [Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA USA	Scripps Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Laval University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Kerckhoff Clinic; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Rochester; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Sanofi-Aventis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Court, La Jolla, CA 92037 USA.	etopol@scripps.edu	Berge, David/P-2179-2017; Viana-Baptista, Miguel/AAW-6791-2020; Urina-Triana, Miguel A/H-2605-2016; Chazova, Irina/B-8688-2017; Zateyshchikov, Dmitry A/D-6575-2012; Chen, Christopher/E-7023-2013; STEG, Philippe Gabriel/Z-1567-2019; Fox, keith A A/I-3742-2013; Tütüncü, Neslihan Başçıl/ABG-5027-2020; Orlova, Iana/Y-2619-2019; Hamm, Christian W./I-3155-2017; MHIRI, Chokri/O-8801-2014	Berge, David/0000-0002-2918-1824; Viana-Baptista, Miguel/0000-0001-6166-2073; Urina-Triana, Miguel A/0000-0001-6003-4622; Chazova, Irina/0000-0002-9822-4357; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Chen, Christopher/0000-0002-1047-9225; Tütüncü, Neslihan Başçıl/0000-0002-1816-3903; Orlova, Iana/0000-0002-8160-5612; Hamm, Christian W./0000-0001-6763-4161; Waldenstrom, Anders/0000-0002-5304-0802; Fox, Keith/0000-0002-0140-2752; Cunha, Luis/0000-0002-0828-3485; VAN BELLE, ERIC/0000-0001-6509-443X; MHIRI, Chokri/0000-0001-7591-6994; Touze, Emmanuel/0000-0002-7254-2162; STEG, Philippe Gabriel/0000-0001-6896-2941; Gupta, Milan/0000-0002-7385-9006; Held, Claes/0000-0001-9402-7404	Sanofi-Aventis; Servier; AstraZeneca; Boehringer-Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Menarini; Medtronic; Nycomed; Pierre Fabre; Medicines Company; Astellas; Bayer; Daiichi-Sankyo; MSD; Otsuka; Eisai; Ethicon; Heartscape; Eli Lilly Canada; Torrent Pharmaceuticals; Teratechnologies; Abbott Laboratories; Merck; Pfizer; Solvay Pharma; Novartis; Guerbet Medical; Boston Scientific; Cordis; Sago; Centocor; Fondation de France; INSERM; Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; ITC Edison; Schering-Plough; Portola; Merck Sharpe St Dohme; Accumetrics; Scripps Translational Science institute [NIH UL1 RR025774]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER	Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Menarini(Menarini Group); Medtronic(Medtronic); Nycomed; Pierre Fabre; Medicines Company; Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Daiichi-Sankyo(Daiichi Sankyo Company Limited); MSD; Otsuka(Otsuka Pharmaceutical); Eisai(Eisai Co Ltd); Ethicon; Heartscape; Eli Lilly Canada(Eli Lilly); Torrent Pharmaceuticals; Teratechnologies; Abbott Laboratories(Abbott Laboratories); Merck(Merck & Company); Pfizer(Pfizer); Solvay Pharma(Solvay SA); Novartis(Novartis); Guerbet Medical; Boston Scientific(Boston Scientific); Cordis; Sago; Centocor; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; ITC Edison; Schering-Plough(Merck & CompanySchering Plough Corporation); Portola; Merck Sharpe St Dohme; Accumetrics; Scripps Translational Science institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	All authors disclose relationships with the sponsor of the study, Sanofi-Aventis, such that all authors have received research finding support and either consulting or honoraria fees with the exception of CG, BJ, and JHM who are employees of Sanofi-Aventis. PGS reports receiving research grants from Sanofi-Avenfis and Servier, speaking fees for AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Menarini, Medtronic, Nycomed, Pierre Fabre, Sanofi-Aventis, Service and The Medicines Company; consulting fees from Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Medtronic, MSD, Otsuka, Sanofi-Aventis, Servier, and The Medicines Company; and being a stockholder with Aterovax. DLB specifically reports receiving research grants from AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Heartscape, Sanofi-Aventis, and The Medicines Company. J-PD reports receiving research funding from Eli Lilly Canada and Sanofi-Aventis; consulting fees from Torrent Pharmaceuticals and Teratechnologies; and speaker fees from Abbott Laboratories, AstraZereca, Merck, Pfizer, Solvay Pharma, GlaxoSmithKline, and Novartis. GM reports receiving research grants from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Sago, Centocor, Fondation de France, INSERM, Federation Francaise de Cardiologie, Societe Francaise de Cardiologie. ITC Edison, and Pfizer; consulting fees from Sanofi-Aventis, Eli Lilly, Bristol-Myers Squibb, The Medicines Company, Schering-Plough, Portola, Novartis, Menarini, Eisai, Daiichi, Bayer, and Boehringer Ingelheim; and lecture fees from Sanofi-Aventis, Eli Lilly, Bristol-Myers Squibb, Merck Sharpe St Dohme, Cordis, GlaxoSinithKline, Schering-Plough, Accumetrics, AstraZeneca, Daiichi, and Menarini. TAP reports receiving speaking fees for Bayer and consulting fees for Bayer and Sanofi-Aventis. MG reports receiving grants from Sanofi-Aventis and Service CH reports receiving speaking and advisory fees from Sanofi-Aventis. Bristol-Myers Squibb, AstraZeneca, The Medicines Company, GlaxoSmithKline, Daiichi-Sankyo, Irak, and MSD.; This trial was funded by Sanofi-Aventis. EJT is supported in part by the Scripps Translational Science institute Clinical Translational Science Award (NIH UL1 RR025774). The authors thank all the patients who participated in the CRESCENDO trial and the study site research coordinators.	Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hill MN, 2009, JAMA-J AM MED ASSOC, V301, P1165, DOI 10.1001/jama.2009.369; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; PEDERSEN TR, 1994, LANCET, V344, P1383; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; RACKOFF JD, 2010, WALL STREET J   0405; Rumsfeld JS, 2008, JAMA-J AM MED ASSOC, V299, P1601, DOI 10.1001/jama.299.13.1601; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X	15	168	172	0	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					517	523		10.1016/S0140-6736(10)60935-X	http://dx.doi.org/10.1016/S0140-6736(10)60935-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20709233				2022-12-28	WOS:000281266800030
J	Tian, BZ; Cohen-Karni, T; Qing, Q; Duan, XJ; Xie, P; Lieber, CM				Tian, Bozhi; Cohen-Karni, Tzahi; Qing, Quan; Duan, Xiaojie; Xie, Ping; Lieber, Charles M.			Three-Dimensional, Flexible Nanoscale Field-Effect Transistors as Localized Bioprobes	SCIENCE			English	Article							CELLS; ELECTROPHYSIOLOGY; CHEMISTRY; DYNAMICS; ARRAYS; FUSION	Nanoelectronic devices offer substantial potential for interrogating biological systems, although nearly all work has focused on planar device designs. We have overcome this limitation through synthetic integration of a nanoscale field-effect transistor (nanoFET) device at the tip of an acute-angle kinked silicon nanowire, where nanoscale connections are made by the arms of the kinked nanostructure, and remote multilayer interconnects allow three-dimensional (3D) probe presentation. The acute-angle probe geometry was designed and synthesized by controlling cis versus trans crystal conformations between adjacent kinks, and the nanoFET was localized through modulation doping. 3D nanoFET probes exhibited conductance and sensitivity in aqueous solution, independent of large mechanical deflections, and demonstrated high pH sensitivity. Additionally, 3D nanoprobes modified with phospholipid bilayers can enter single cells to allow robust recording of intracellular potentials.	[Tian, Bozhi; Qing, Quan; Duan, Xiaojie; Xie, Ping; Lieber, Charles M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Cohen-Karni, Tzahi; Lieber, Charles M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Cohen-Karni, Tzahi/CAG-1520-2022; Duan, Xiaojie/N-7667-2013; Qing, Quan/R-8411-2017	Cohen-Karni, Tzahi/0000-0001-5742-1007; Qing, Quan/0000-0002-4230-8244; Duan, xiaojie/0000-0001-7799-3897	NIH [5DP1OD003900]; National Security Science and Engineering Faculty Fellow (NSSEFF) [N00244-09-1-0078]; McKnight Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Security Science and Engineering Faculty Fellow (NSSEFF); McKnight Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Yellen, W. C. Claycomb, B. P. Bean, P. T. Ellinor, G. H. Yu, D. Casanova, B. P. Timko, and T. Dvir for help with experiments and data analysis. C. M. L. acknowledges support from a NIH Director's Pioneer Award (5DP1OD003900), a National Security Science and Engineering Faculty Fellow (NSSEFF) award (N00244-09-1-0078), and the McKnight Foundation Neuroscience award.	Almquist BD, 2010, P NATL ACAD SCI USA, V107, P5815, DOI 10.1073/pnas.0909250107; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Eschermann JF, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194138; EWING AG, 1992, ACCOUNTS CHEM RES, V25, P440, DOI 10.1021/ar00022a002; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Heller I, 2009, SMALL, V5, P2528, DOI 10.1002/smll.200900823; Ieong Meikei, 2004, Science, V306, P2057, DOI 10.1126/science.1100731; Leong TG, 2009, P NATL ACAD SCI USA, V106, P703, DOI 10.1073/pnas.0807698106; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Misra N, 2009, P NATL ACAD SCI USA, V106, P13780, DOI 10.1073/pnas.0904850106; Molleman A., 2003, PATCH CLAMPING INTRO; PURVES RD, 1981, MICROELECTRODE METHO; Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; Tian BZ, 2009, NAT NANOTECHNOL, V4, P824, DOI [10.1038/nnano.2009.304, 10.1038/NNANO.2009.304]; Wightman RM, 2006, SCIENCE, V311, P1570, DOI 10.1126/science.1120027; Zhou XJ, 2007, NAT NANOTECHNOL, V2, P185, DOI 10.1038/nnano.2007.34; Zipes DP., 2018, CARDIAC ELECTROPHYSI, V7	27	619	653	6	427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					830	834		10.1126/science.1192033	http://dx.doi.org/10.1126/science.1192033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705858	Green Accepted			2022-12-28	WOS:000280809900048
J	Barry, MA				Barry, M. Anita			A 29-Year-Old Woman With Flu-like Symptoms Review of Influenza Diagnosis and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							A H1N1 VIRUS; GUILLAIN-BARRE-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; HEALTH-CARE WORKERS; NEW-YORK-CITY; PANDEMIC INFLUENZA; UNITED-STATES; OSELTAMIVIR TREATMENT; WORKING ADULTS	countries, resulting in significant morbidity and mortality. Using the case of Ms R, a 29-year-old woman who presented with acute onset of respiratory symptoms and was evaluated for influenza, considerations regarding symptoms and signs, evaluation, treatment, and prevention of influenza are discussed. Symptoms of influenza can be similar to those of other respiratory viruses, making diagnosis challenging. Laboratory testing should be reserved for patients who are seriously ill or for whom test results may affect management or have public health implications. For most cases of influenza, treatment is supportive and specific antiviral medication is not needed. Annual vaccination is the most effective way to prevent infection. Educating patients on practical steps to reduce the spread of influenza in the community is critical. JAMA 2010;304(6) 671-678	Boston Publ Hlth Commiss, Infect Dis Bur, Boston, MA 02118 USA		Barry, MA (corresponding author), Boston Publ Hlth Commiss, Infect Dis Bur, 1010 Massachusetts Ave, Boston, MA 02118 USA.	abarry@bphc.org		Barry, M./0000-0002-2795-4467				*ADV COMM IMM PRAC, ACIP PROV REC US INF; ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; [Anonymous], 2005, PRINCIPLES PRACTICE; AOKI FY, 2010, PRINCIPLES PRACTICE, P573; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, FLU ACT SURV REP SUR; Centers for Disease Control and Prevention, RAP DIAGN TEST INFL; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chien YW, 2009, NEW ENGL J MED, V361, P2582, DOI 10.1056/NEJMc0908216; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Cruz AT, 2008, J CLIN VIROL, V41, P143, DOI 10.1016/j.jcv.2007.11.006; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P1, DOI 10.3122/jabfm.17.1.1; Eurosurveillance editorial team, 2009, Euro Surveill, V14, P19237; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraund S, 1999, J HEART LUNG TRANSPL, V18, P220, DOI 10.1016/S1053-2498(98)00013-8; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Gooskens J, 2009, JAMA-J AM MED ASSOC, V301, P1042, DOI 10.1001/jama.2009.297; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Hak E, 2005, ARCH INTERN MED, V165, P274, DOI 10.1001/archinte.165.3.274; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; Kilbourne ED, 2006, J INFECT DIS, V193, P7, DOI 10.1086/498984; Kroon FP, 2000, VACCINE, V18, P3040, DOI 10.1016/S0264-410X(00)00079-7; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Madan RP, 2008, CLIN INFECT DIS, V46, P712, DOI 10.1086/527391; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; McGeer AJ, 2009, CLIN INFECT DIS, V48, pS14, DOI 10.1086/591852; MCLEAN DM, 1961, CAN MED ASSOC J, V85, P290; *MEDL, FLUMIST PRESCR INF; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; MONTO A S, 1971, American Journal of Epidemiology, V94, P269; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Moscona A, 2007, JAMA-J AM MED ASSOC, V297, P1492, DOI 10.1001/jama.297.13.1492; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Nichol KL, 1996, ARCH INTERN MED, V156, P1546, DOI 10.1001/archinte.156.14.1546; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Ong AK, 2007, J INFECT DIS, V196, P181, DOI 10.1086/518939; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Pearson Michele L., 2006, Morbidity and Mortality Weekly Report, V55, P1; Perez-Ruiz M, 2007, J CLIN MICROBIOL, V45, P3109, DOI 10.1128/JCM.00697-07; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043; *ROCH LAB, 2008, TAM OS PHOSPH CAPS O; Schiller J.S., 2009, VACCINATION COVERAGE; Schonberger L B, 1977, Dev Biol Stand, V39, P295; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Vera D. M., 2010, Morbidity and Mortality Weekly Report, V59, P162; Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P590, DOI 10.1097/01.inf.0000220229.51531.47; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Weiss Martin Meyer, 2007, Am J Public Health, V97 Suppl 1, pS32, DOI 10.2105/AJPH.2006.096214; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Wong JP, 2007, VACCINE, V25, P3175, DOI 10.1016/j.vaccine.2007.01.051; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; 2009, CLIN INFECT DIS S1, V48, pS1; 2007, MMWR MORB MORTAL WKL, V56, P325	119	5	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					671	678		10.1001/jama.2010.907	http://dx.doi.org/10.1001/jama.2010.907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699459				2022-12-28	WOS:000280829200023
J	Cardwell, CR; Abnet, CC; Cantwell, MM; Murray, LJ				Cardwell, Chris R.; Abnet, Christian C.; Cantwell, Marie M.; Murray, Liam J.			Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROESOPHAGEAL-REFLUX; VALIDATION; APOPTOSIS; THERAPY	Context Use of oral bisphosphonates has increased dramatically in the United States and elsewhere. Esophagitis is a known adverse effect of bisphosphonate use; and recent reports suggest a link between bisphosphonate use and esophageal cancer, but this has not been robustly investigated. Objective To investigate the association between bisphosphonate use and esophageal cancer. Design, Setting, and Participants Data were extracted from the UK General Practice Research Database to compare the incidence of esophageal and gastric cancer in a cohort of patients treated with oral bisphosphonates between January 1996 and December 2006 with incidence in a control cohort. Cancers were identified from relevant Read/Oxford Medical Information System codes in the patient's clinical files. Cox proportional hazards modeling was used to calculate hazard ratios and 95% confidence intervals for risk of esophageal and gastric cancer in bisphosphonate users compared with nonusers, with adjustment for potential confounders. Main Outcome Measure Hazard ratio for the risk of esophageal and gastric cancer in the bisphosphonate users compared with the bisphosphonate nonusers. Results Mean follow-up time was 4.5 and 4.4 years in the bisphosphonate and control cohorts, respectively. Excluding patients with less than 6 months' follow-up, there were 41 826 members in each cohort (81% women; mean age, 70.0 (SD, 11.4) years). One hundred sixteen esophageal or gastric cancers (79 esophageal) occurred in the bisphosphonate cohort and 115 (72 esophageal) in the control cohort. The incidence of esophageal and gastric cancer combined was 0.7 per 1000 person-years of risk in both the bisphosphonate and control cohorts; the incidence of esophageal cancer alone in the bisphosphonate and control cohorts was 0.48 and 0.44 per 1000 person-years of risk, respectively. There was no difference in risk of esophageal and gastric cancer combined between the cohorts for any bisphosphonate use (adjusted hazard ratio, 0.96 [95% confidence interval, 0.74-1.25]) or risk of esophageal cancer only (adjusted hazard ratio, 1.07 [95% confidence interval, 0.77-1.49]). There also was no difference in risk of esophageal or gastric cancer by duration of bisphosphonate intake. Conclusion Among patients in the UK General Practice Research Database, the use of oral bisphosphonates was not significantly associated with incident esophageal or gastric cancer. JAMA. 2010;304(6):657-663	[Cardwell, Chris R.; Cantwell, Marie M.; Murray, Liam J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland; [Abnet, Christian C.] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA	Queens University Belfast; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cardwell, CR (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland.	c.cardwell@qub.ac.uk	Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843; Cardwell, Chris/0000-0002-2689-4335	Medical Research Council; UK Medicines and Healthcare Products Regulatory Agency; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medicines and Healthcare Products Regulatory Agency; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Access to the GPRD database was funded through the Medical Research Council's license agreement with the UK Medicines and Healthcare Products Regulatory Agency. However, the interpretation and conclusions contained in this study are those of the authors alone.	Abrahamsen B, 2009, NEW ENGL J MED, V360, P1789, DOI 10.1056/NEJMc096026; Breslow NE., 1987, STAT METHODS CANC RE, P81; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Coxon JP, 2004, BJU INT, V94, P164, DOI 10.1111/j.1464-4096.2004.04831.x; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hollowell J, 1997, Popul Trends, P36; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; KINN S, 1995, BRIT MED J, V311, P739, DOI 10.1136/bmj.311.7007.739; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Ribeiro A, 1998, GASTROINTEST ENDOSC, V47, P525, DOI 10.1016/S0016-5107(98)70256-1; Ryan JM, 1998, RADIOLOGY, V206, P389, DOI 10.1148/radiology.206.2.9457190; Shipman CM, 1997, BRIT J HAEMATOL, V98, P665, DOI 10.1046/j.1365-2141.1997.2713086.x; Solomon DH, 2009, NEW ENGL J MED, V360, P1789; Udell JA, 2006, J BONE MINER RES, V21, P765, DOI 10.1359/JBMR.060119; Usher C, 2006, EUR J CLIN PHARMACOL, V62, P307, DOI 10.1007/s00228-005-0083-x; Watson J, 2007, EUR J CLIN PHARMACOL, V63, P843, DOI 10.1007/s00228-007-0320-6; WHO, AN THER CHEM CLASS S; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738	24	146	152	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					657	663		10.1001/jama.2010.1098	http://dx.doi.org/10.1001/jama.2010.1098			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699457	Green Accepted, Bronze			2022-12-28	WOS:000280829200021
J	Profumo, D; Dinneen, M				Profumo, David; Dinneen, Michael			A Patient's Journey At sixes and sevens: prostate cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dinneen, Michael] Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London		david.profumo@virgin.net							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2010	341								c3834	10.1136/bmj.c3834	http://dx.doi.org/10.1136/bmj.c3834			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DO	20696746				2022-12-28	WOS:000281028500001
J	Garcia-Perez, JL; Morell, M; Scheys, JO; Kulpa, DA; Morell, S; Carter, CC; Hammer, GD; Collins, KL; O'Shea, KS; Menendez, P; Moran, JV				Garcia-Perez, Jose L.; Morell, Maria; Scheys, Joshua O.; Kulpa, Deanna A.; Morell, Santiago; Carter, Christoph C.; Hammer, Gary D.; Collins, Kathleen L.; O'Shea, K. Sue; Menendez, Pablo; Moran, John V.			Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells	NATURE			English	Article							STEM-CELLS; LINE-1 RETROTRANSPOSITION; SOMATIC MOSAICISM; PROTEIN; MOUSE; EXPRESSION; PATTERNS; VIRUS	Long interspersed element-1 (LINE-1 or L1) retrotransposition continues to affect human genome evolution(1,2). L1s can retrotranspose in the germline, during early development and in select somatic cells(3-8); however, the host response to L1 retrotransposition remains largely unexplored. Here we show that reporter genes introduced into the genome of various human embryonic carcinoma-derived cell lines (ECs) by L1 retrotransposition are rapidly and efficiently silenced either during or immediately after their integration. Treating ECs with histone deacetylase inhibitors rapidly reverses this silencing, and chromatin immunoprecipitation experiments revealed that reactivation of the reporter gene was correlated with changes in chromatin status at the L1 integration site. Under our assay conditions, rapid silencing was also observed when reporter genes were delivered into ECs by mouse L1s and a zebrafish LINE-2 element, but not when similar reporter genes were delivered into ECs by Moloney murine leukaemia virus or human immunodeficiency virus, suggesting that these integration events are silenced by distinct mechanisms. Finally, we demonstrate that subjecting ECs to culture conditions that promote differentiation attenuates the silencing of reporter genes delivered by L1 retrotransposition, but that differentiation, in itself, is not sufficient to reactivate previously silenced reporter genes. Thus, our data indicate that ECs differ from many differentiated cells in their ability to silence reporter genes delivered by L1 retrotransposition.	[Garcia-Perez, Jose L.; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.; Morell, Maria; Morell, Santiago; Menendez, Pablo] Univ Granada, Ctr Biomed Res, Consejeria Salud Junta Andalucia, Andalusian Stem Cell Bank, Granada 18100, Spain; [Morell, Maria; Hammer, Gary D.; O'Shea, K. Sue] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Scheys, Joshua O.; Carter, Christoph C.; Hammer, Gary D.; Collins, Kathleen L.; Moran, John V.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Kulpa, Deanna A.; Hammer, Gary D.; Collins, Kathleen L.; Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hammer, Gary D.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Collins, Kathleen L.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Moran, John V.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Michigan System; University of Michigan; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48109 USA.	josel.garcia.perez@juntadeandalucia.es; moranj@umich.edu	Morell, Maria/ABF-8213-2020; Kulpa, Deanna A/O-5016-2019; Morell, Maria/C-4606-2017; Kulpa, Deanna/ABE-2035-2020; Bujan, Pablo Menendez/W-3736-2017	Morell, Maria/0000-0001-9613-9741; Kulpa, Deanna A/0000-0002-0411-7295; Morell, Maria/0000-0002-3692-1333; Bujan, Pablo Menendez/0000-0001-9372-1007; Garcia-Perez, Jose Luis/0000-0002-8132-9849	National Institutes of Health (NIH) [GM060518, GM082970, NS-048187, GM-069985, AI051198]; Howard Hughes Medical Institute; Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA) [EMER07/056]; Marie Curie International Reintegration Grant action [FP7-PEOPLE-2007-4-3-IRG]; Junta de Andalucia (Spain) [P09-CTS-4980, PI0002/2009, P08-CTS-3678]; Spanish Ministry of Health [FIS PI08171, CP07/00065, FIS PI070026]; Spanish Ministry of Science and Innovation MICINN-PLANE [PLE-2009-0111]; Burroughs Wellcome Foundation; National Institute of Diabetes and Digestive and Kidney Diseases NIH [R01 (DK62027)]; Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant [T32-GM08322]; Cancer Research Institute; University of Michigan; University of Michigan's Cancer Center [NIH 5 P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069985, R01GM060518, R01GM082970, T32GM008322, T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048187] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA); Marie Curie International Reintegration Grant action; Junta de Andalucia (Spain)(Junta de Andalucia); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation MICINN-PLANE(Ministry of Science and Innovation, Spain (MICINN)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive and Kidney Diseases NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant; Cancer Research Institute; University of Michigan(University of Michigan System); University of Michigan's Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. W. Andrews for providing human EC lines, discussing unpublished data from his laboratory and giving advice during the course of this study. We thank A. Macia and M. Munoz-Lopez (Andalusian Stem Cell Bank) for sharing unpublished data; A. V. Furano, H. Kazazian, J. K. Kim, H. Kopera, A. Muotri, and members of the Moran and Garcia-Perez laboratories for critical reading of the manuscript; and G. Smith and L. Villa for help in creating the time-lapsed movie. We thank M. Velkey for providing plasmid pBSSK-pgk; H. Kazazian for providing plasmid pJCC5/LRE3; J. Boeke for providing synthetic mouse LINE-1 constructs; M. Kajikawa and N. Okada for providing the zebrafish LINE-2 expression plasmids; T. Fanning for providing the polyclonal ORF1 antibody; I. Damjanov for comments on the teratoma characterization; T. Lanigan for preparing Moloney murine leukaemia virus retroviral supernatants; C. Pigott for EC culture advice; and T. de la Cueva, P. Catalina and A. Nieto (Andalusian Stem Cell Bank) for their help with mouse experimentation, SKY-FISH and pathology analyses, respectively. J. V. M. is supported by the National Institutes of Health (NIH) (GM060518 and GM082970) and the Howard Hughes Medical Institute. J. L. G.-P. is supported by the Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA) (EMER07/056), by a Marie Curie International Reintegration Grant action (FP7-PEOPLE-2007-4-3-IRG), by CICE (P09-CTS-4980) and Proyectos en Salud (PI0002/2009) from Junta de Andalucia (Spain) and through the Spanish Ministry of Health (FIS PI08171 and Miguel Servet CP07/00065). M. M. is supported by the ISCIII-CSJA (EMER07/056). P. M. is supported by the Spanish Ministry of Science and Innovation MICINN-PLANE (PLE-2009-0111), by CICE (P08-CTS-3678) from Junta de Andalucia (Spain) and by the Spanish Ministry of Health (FIS PI070026). K.S.O'S. is supported by the NIH (NS-048187 and GM-069985). K. L. C. is supported by the Burroughs Wellcome Foundation and by an NIH Research Project Grant (R01) (AI051198). G. D. H is supported by a National Institute of Diabetes and Digestive and Kidney Diseases NIH R01 (DK62027). J.O.S. is supported by a Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant (T32-GM08322). D. A. K. is supported by The Irvington Institute Fellowship Program of the Cancer Research Institute. S. M. is supported by a CICE (P08-CTS-3678) scholarship from Junta de Andalucia, Spain. C. C. C. is supported by a Rackham Predoctoral Fellowship from the University of Michigan. We defrayed the costs of DNA sequencing in part with the University of Michigan's Cancer Center Support Grant (NIH 5 P30 CA46592).	Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Gummow BM, 2006, MOL ENDOCRINOL, V20, P2711, DOI 10.1210/me.2005-0461; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; LOH TP, 1987, MOL CELL BIOL, V7, P3775, DOI 10.1128/MCB.7.10.3775; MATTHAEI KI, 1983, EXP CELL RES, V143, P471, DOI 10.1016/0014-4827(83)90076-9; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sugano T, 2006, GENE, V365, P74, DOI 10.1016/j.gene.2005.09.037; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844	30	114	114	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					769	773		10.1038/nature09209	http://dx.doi.org/10.1038/nature09209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686575	Green Accepted			2022-12-28	WOS:000280562500042
J	Sarewitz, D				Sarewitz, Daniel			Not by experts alone	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	14	14	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					688	688		10.1038/466688a	http://dx.doi.org/10.1038/466688a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	634EN	20686548	Bronze			2022-12-28	WOS:000280562500012
J	Spiegel, PB; Robinson, C				Spiegel, Paul B.; Robinson, Courtland			Large-Scale "Expert" Mortality Surveys in Conflicts-Concerns and Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIOLENCE; DARFUR		[Spiegel, Paul B.] United Nations High Commissioner Refugees, CH-1211 Geneva, Switzerland; [Robinson, Courtland] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Spiegel, PB (corresponding author), United Nations High Commissioner Refugees, 94 Rue Montbrillant, CH-1211 Geneva, Switzerland.	spiegel@unhcr.org	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; *GEN ACC OFF, DARF CRIS DEATH EST; *HUM SEC REP PROJ, SHRINK COSTS WAR 200; *INT RES COMM, MORT DEM REP CONG ON; *INT RES COMM, MOR E DRC RES 5 MORT; *MIN HLTH UG WHO U, HLTH MORT SURV INT D	10	7	7	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					567	568		10.1001/jama.2010.1094	http://dx.doi.org/10.1001/jama.2010.1094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633SQ	20682938				2022-12-28	WOS:000280525700026
J	Strachan, NJC; Forbes, KJ				Strachan, Norval J. C.; Forbes, Ken J.			The growing UK epidemic of human campylobacteriosis	LANCET			English	Editorial Material							GENERAL-PRACTICE; INFECTION		[Strachan, Norval J. C.] Univ Aberdeen, Sch Biol Sci, Inst Environm & Biol Sci, Aberdeen AB24 3UU, Scotland; [Forbes, Ken J.] Univ Aberdeen, Sch Med, Sect Immunol & Infect, Aberdeen AB24 3UU, Scotland	University of Aberdeen; University of Aberdeen	Strachan, NJC (corresponding author), Univ Aberdeen, Sch Biol Sci, Inst Environm & Biol Sci, Aberdeen AB24 3UU, Scotland.		Strachan, Norval J/D-4744-2009					Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Ethelberg S, 2005, AM J EPIDEMIOL, V162, P1008, DOI 10.1093/aje/kwi316; *FOOD STAND AG, 2009, Q PUBL ATT TRACK DEC; Food Standards Agency (FSA), 2009, FSA REP UK SURV CAMP; *FSA, 2010, CAMP EV PROGR; Gormley FJ, 2008, APPL ENVIRON MICROB, V74, P383, DOI 10.1128/AEM.01455-07; LOWMAN R, 2009, 15 INT C CAMP HEL RE; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; POLLOCK K, 2010, HPS WKLY REP, V44, P38; *POP ENV HLTH GROU, 2009, NOT OTH DIS NZ 2008; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Zia S, 2003, RHEUMATOLOGY, V42, P1083, DOI 10.1093/rheumatology/keg303; 2006, DOMINION POST   0710, pA5; 2005, EFSA J, V297, P1; 2010, HLTH PROTECTION REP, V4, P5	19	24	24	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					665	667		10.1016/S0140-6736(10)60708-8	http://dx.doi.org/10.1016/S0140-6736(10)60708-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20663545				2022-12-28	WOS:000281582900008
J	Al-Khalisi, N				Al-Khalisi, Nabil			Personal View The perils of being a doctor in Baghdad	BRITISH MEDICAL JOURNAL			English	Editorial Material									Al Furat Gen Hosp, Baghdad, Iraq		Al-Khalisi, N (corresponding author), Al Furat Gen Hosp, Baghdad, Iraq.	nabeelraad@yahoo.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2010	341								c4043	10.1136/bmj.c4043	http://dx.doi.org/10.1136/bmj.c4043			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634GZ	20667953				2022-12-28	WOS:000280570100008
J	Neugut, AI; Lebwohl, B				Neugut, Alfred I.; Lebwohl, Benjamin			Colonoscopy vs Sigmoidoscopy Screening Getting It Right	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER		[Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Med, New York, NY 10032 USA; [Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Neugut, Alfred I.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Neugut, AI (corresponding author), Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Med, 722 W 168th St,Room 725, New York, NY 10032 USA.	ain1@columbia.edu			NATIONAL CANCER INSTITUTE [R43CA095929, T32CA009529] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA095929] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; NEUGUT AI, 1988, AM J GASTROENTEROL, V83, P295; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh H, 2010, AM J GASTROENTEROL, V105, P663, DOI 10.1038/ajg.2009.650	10	56	57	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					461	462		10.1001/jama.2010.1001	http://dx.doi.org/10.1001/jama.2010.1001			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664047				2022-12-28	WOS:000280350100030
J	Cardenas, C; Miller, RA; Smith, I; Bui, T; Molgo, J; Muller, M; Vais, H; Cheung, KH; Yang, J; Parker, I; Thompson, CB; Birnbaum, MJ; Hallows, KR; Foskett, JK				Cardenas, Cesar; Miller, Russell A.; Smith, Ian; Bui, Thi; Molgo, Jordi; Mueller, Marioly; Vais, Horia; Cheung, King-Ho; Yang, Jun; Parker, Ian; Thompson, Craig B.; Birnbaum, Morris J.; Hallows, Kenneth R.; Foskett, J. Kevin			Essential Regulation of Cell Bioenergetics by Constitutive InsP(3) Receptor Ca2+ Transfer to Mitochondria	CELL			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; CALCIUM SIGNALS; ATP SYNTHESIS; AUTOPHAGY; CHANNEL; APOPTOSIS; MTOR	Mechanisms that regulate cellular metabolism are a fundamental requirement of all cells. Most eukaryotic cells rely on aerobic mitochondrial metabolism to generate ATP. Nevertheless, regulation of mitochondrial activity is incompletely understood. Here we identified an unexpected and essential role for constitutive InsP(3)R-mediated Ca2+ release in maintaining cellular bioenergetics. Macroautophagy provides eukaryotes with an adaptive response to nutrient deprivation that prolongs survival. Constitutive InsP(3)R Ca2+ signaling is required for macroautophagy suppression in cells in nutrient-replete media. In its absence, cells become metabolically compromised due to diminished mitochondrial Ca2+ uptake. Mitochondrial uptake of InsP(3)R-released Ca2+ is fundamentally required to provide optimal bioenergetics by providing sufficient reducing equivalents to support oxidative phosphorylation. Absence of this Ca2+ transfer results in enhanced phosphorylation of pyruvate dehydrogenase and activation of AMPK, which activates prosurvival macroautophagy. Thus, constitutive InsP(3)R Ca2+ release to mitochondria is an essential cellular process that is required for efficient mitochondrial respiration and maintenance of normal cell bioenergetics.	[Cardenas, Cesar; Mueller, Marioly; Vais, Horia; Cheung, King-Ho; Yang, Jun; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Miller, Russell A.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Bui, Thi; Thompson, Craig B.] Univ Penn, Abramson Canc Inst, Philadelphia, PA 19104 USA; [Bui, Thi; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Smith, Ian; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Dev,UPR 3294, F-91198 Gif Sur Yvette, France; [Hallows, Kenneth R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; smith, ian/E-7528-2011; Muller, Marioly/J-5420-2014; Hallows, Kenneth/A-8477-2013; Cardenas, Julio C/I-3221-2013; /B-3424-2011	Hallows, Kenneth/0000-0002-2964-2440; /0000-0001-8683-1654; Birnbaum, Morris/0000-0001-9972-8680; Foskett, J. Kevin/0000-0002-8854-0268	NIH [GM/DK56328, MH059937, DK075048, CA099179, CA092660, GM48071, GM065830]; American Heart Association;  [DK079572]; NATIONAL CANCER INSTITUTE [R01CA099179, R01CA092660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, F32DK079572, R01DK056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R01GM048071, R37GM048071, R01GM065830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Robert Balaban for helpful discussions. This work was supported by NIH grants GM/DK56328 and MH059937 (J.K.F.), DK075048 (K. R. H.), CA099179 and CA092660 (C. T.), GM48071 (I. P.), and GM065830 (J.K.F. and I. P.). We thank the University of Pennsylvania Institute for Diabetes, Obesity and Metabolism (P30-DK19535) for assistance. C. C. was supported by an award from the American Heart Association. R. A. M. was supported by DK079572.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BROWN GC, 1992, BIOCHEM J, V284, P1; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Demuro A, 2006, CELL CALCIUM, V40, P413, DOI 10.1016/j.ceca.2006.08.006; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kimball SR, 2006, MED SCI SPORT EXER, V38, P1958, DOI 10.1249/01.mss.0000233796.16411.13; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MAK DOD, 1994, J BIOL CHEM, V269, P29375; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Meijer Alfred J., 2008, V445, P89, DOI 10.1007/978-1-59745-157-4_5; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656	48	723	742	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					270	283		10.1016/j.cell.2010.06.007	http://dx.doi.org/10.1016/j.cell.2010.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655468	Green Accepted, Bronze			2022-12-28	WOS:000280204300018
J	Stiles, AR; Russell, DW				Stiles, Ashlee R.; Russell, David W.			SRD5A3: A Surprising Role in Glycosylation	CELL			English	Editorial Material							REDUCTASES		[Stiles, Ashlee R.; Russell, David W.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Russell, DW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	david.russell@utsouthwestern.edu		Russell, David/0000-0002-0277-403X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083831] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM083831, T32 GM083831-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Langlois VS, 2010, GEN COMP ENDOCR, V166, P489, DOI 10.1016/j.ygcen.2009.08.004; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; WILSON JD, 1978, ANNU REV PHYSIOL, V40, P279, DOI 10.1146/annurev.ph.40.030178.001431	6	33	34	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					196	198		10.1016/j.cell.2010.07.003	http://dx.doi.org/10.1016/j.cell.2010.07.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655462	Bronze, Green Accepted			2022-12-28	WOS:000280204300010
J	Thomas, B; Dorling, D; Smith, GD				Thomas, Bethan; Dorling, Danny; Smith, George Davey			Inequalities in premature mortality in Britain: observational study from 1921 to 2007	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To report on the extent of inequality in premature mortality as measured between geographical areas in Britain. Design Observational study of routinely collected mortality data and public records. Population subdivided by age, sex, and geographical area (parliamentary constituencies from 1991 to 2007, pre-1974 local authorities over a longer time span). Setting Great Britain. Participants Entire population aged under 75 from 1990 to 2007, and entire population aged under 65 in the periods 1921-39, 1950-3, 1959-63, 1969-73, and 1981-2007. Main outcome measure Relative index of inequality (RII) and ratios of inequality in age-sex standardised mortality ratios under ages 75 and 65. The relative index of inequality is the relative rate of mortality for the hypothetically worst-off compared with the hypothetically best-off person in the population, assuming a linear association between socioeconomic position and risk of mortality. The ratio of inequality is the ratio of the standardised mortality ratio of the most deprived 10% to the least deprived 10%. Results When measured by the relative index of inequality, geographical inequalities in age-sex standardised rates of mortality below age 75 have increased every two years from 1990-1 to 2006-7 without exception. Over this period the relative index of inequality increased from 1.61 (95% confidence interval 1.52 to 1.69) in 1990-1 to 2.14 (2.02 to 2.27) in 2006-7. Simple ratios indicated a brief period around 2001 when a small reduction in inequality was recorded, but this was quickly reversed and inequalities up to the age of 75 have now reached the highest levels reported since at least 1990. Similarly, inequalities in mortality ratios under the age of 65 improved slightly in the early years of this century but the latest figures surpass the most extreme previously reported. Comparison of crudely age-sex standardised rates for those below age 65 from historical records showed that geographical inequalities in mortality are higher in the most recent decade than in any similar time period for which records are available since at least 1921. Conclusions Inequalities in premature mortality between areas of Britain continued to rise steadily during the first decade of the 21st century. The last time in the long economic record that inequalities were almost as high was in the lead up to the economic crash of 1929 and the economic depression of the 1930s. The economic crash of 2008 might precede even greater inequalities in mortality between areas in Britain.	[Thomas, Bethan; Dorling, Danny] Univ Sheffield, Dept Geog, Social & Spatial Inequal Grp, Sheffield S10 2TN, S Yorkshire, England; [Smith, George Davey] Univ Bristol, Dept Social Med, Bristol BS8 2BN, Avon, England	University of Sheffield; University of Bristol	Thomas, B (corresponding author), Univ Sheffield, Dept Geog, Social & Spatial Inequal Grp, Sheffield S10 2TN, S Yorkshire, England.	B.S.Thomas@sheffield.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475				Barnard A, 2009, EC LABOUR MARKET REV, V3, P56; Breslow NE, 1980, ANAL CASE CONTROL ST; Brewer M., 2009, POVERTY INEQUALITY U; DAVEYSMITH G, 1998, BRIT MED J, V317, P1465; *DEP HLTH, 1998, IND INQ IN HLTH; Department of Health, 2009, TACKL HLTH IN 10 YEA; DORLING D, 2009, SOCIALIST REV    APR; Dorling D., 2009, UNDERSTANDING HLTH I; Dorling D., 2007, POVERTY WEALTH PLACE; ELLIOT L, 2009, GUARDIAN        0508; *GLOB HLTH EQ GROU, 2010, DOC; Goldthorpe JH, 2010, EUR SOCIOL REV, V26, P731, DOI 10.1093/esr/jcp046; Hills J., 2009, MORE EQUAL SOC; *I FISC STUD, 2010, FISC FACTS; Marmot M, 2010, FAIR SOC HLTH LIVES; Norman P, 2008, POPUL SPACE PLACE, V14, P449, DOI 10.1002/psp.492; *OFF NAT STAT, 2009, CORR NOT LIF EXP BIR; PEARCE JR, 2010, ANN ASSOC AM GEOGR, P1; Shaw M, 1998, SOCIOL HEALTH ILL, V20, P694, DOI 10.1111/1467-9566.00125; Shaw M, 2008, GRIM REAPERS ROAD MA; Smith GD, 1998, LANCET, V352, P1439, DOI 10.1016/S0140-6736(05)61261-5; Smith GD, 2002, J EPIDEMIOL COMMUN H, V56, P434; Smith GD, 2007, P NUTR SOC, V66, P216, DOI 10.1017/S0029665107005460; Tunstall HVZ, 2004, J EPIDEMIOL COMMUN H, V58, P6, DOI 10.1136/jech.58.1.6	24	98	98	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2010	341								c3639	10.1136/bmj.c3639	http://dx.doi.org/10.1136/bmj.c3639			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GX	20650979	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000280411800001
J	DellaVigna, S				DellaVigna, Stefano			ECONOMICS Consumers Who Care	SCIENCE			English	Editorial Material							FIELD		Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	DellaVigna, S (corresponding author), Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA.	sdellavi@econ.berkeley.edu						DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Dellavigna Stefano, 2009, W15629 NBER; ELFENBEIN D, 2009, W15614 NBER; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gneezy A, 2010, SCIENCE, V329, P325, DOI 10.1126/science.1186744; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577	7	1	1	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					287	288		10.1126/science.1193044	http://dx.doi.org/10.1126/science.1193044			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625VW	20647455				2022-12-28	WOS:000279925900027
J	Legrand, YM; van der Lee, A; Barboiu, M				Legrand, Yves-Marie; van der Lee, Arie; Barboiu, Mihail			Single-Crystal X-ray Structure of 1,3-Dimethylcyclobutadiene by Confinement in a Crystalline Matrix	SCIENCE			English	Article							ALPHA-PYRONE; CYCLOBUTADIENE; COMPLEXES; CAPSULES	Cyclobutadiene (CBD), the smallest cyclic hydrocarbon bearing conjugated double bonds, has long intrigued chemists on account of its strained geometry and electronic instability, but the parent compound and its unperturbed derivatives have thus far eluded crystallographic characterization. In this work, we immobilize a precursor, 4,6-dimethyl-alpha-pyrone, in a guanidinium-sulfonate-calixarene (G(4)C) crystalline network that confines the guest through a combination of CH-pi and hydrogen-bond interactions. Ultraviolet irradiation of the crystals transforms the entrapped 4,6-dimethyl-alpha-pyrone into a 4,6-dimethyl-beta-lactone Dewar intermediate that is sufficiently stable under the confined conditions at 175 kelvin to allow a conventional structure determination by x-ray diffraction. Further irradiation pushes the reaction to completion, enabling the structure determination of 1,3-dimethylcyclobutadiene Me2CBD. Our data support experimental observation of square-planar (Me2CBDS) and rectangular-bent (Me2CBDR) geometries in the G(4)C host matrix. The hydrogen-bonded, dissociated carbon dioxide coproduct interacts more strongly with Me2CBDS than with Me2CBDR.	[Legrand, Yves-Marie; van der Lee, Arie; Barboiu, Mihail] Univ Montpellier 2, Adapt Supramol Nanosyst Grp, Inst Europeen Membranes,II UMR CNRS 5635, Ecole Natl Super Chim Montpellier, F-34095 Montpellier 5, France	Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Barboiu, M (corresponding author), Univ Montpellier 2, Adapt Supramol Nanosyst Grp, Inst Europeen Membranes,II UMR CNRS 5635, Ecole Natl Super Chim Montpellier, Pl Eugene Bataillon CC047, F-34095 Montpellier 5, France.	mihai.barboiu@iemm.univ-montp2.fr	Legrand, Yves-Marie/AAY-1638-2021; Barboiu, Mihail/AAH-1165-2020; Legrand, Yves-marie/AAP-4521-2021; Barboiu, Mihail/R-1984-2016; Legrand, Yves-Marie PJ/A-2798-2015	Legrand, Yves-Marie/0000-0002-0334-1666; Barboiu, Mihail/0000-0003-0042-9483; Barboiu, Mihail/0000-0003-0042-9483; 	European Heads of Research Councils; European Science Foundation; European Comission	European Heads of Research Councils; European Science Foundation(European Science Foundation (ESF)European Commission); European Comission(European CommissionEuropean Commission Joint Research Centre)	This work-conducted as part of the award "Dynamic adaptive materials for separation and sensing Microsystems" (M. B.) made under the European Heads of Research Councils and European Science Foundation European Young Investigator (EURYI) Awards scheme in 2004-was supported by funds from the Participating Organizations of EURYI and the European Comission Sixth Framework Program (see www.esf.org/euryi). The x-ray crystallographic coordinates for structures reported in this paper have been deposited at the Cambridge Crystallographic Data Centre (CCDC) under deposition numbers CCDC 764864 to 764868. These data can be obtained free of charge from the CCDC (www.ccdc.cam.ac.uk/data_request/cif).	Atwood JL, 2001, COORDIN CHEM REV, V222, P3, DOI 10.1016/S0010-8545(01)00345-9; AVRAM M, 1963, TETRAHEDRON, V19, P187, DOI 10.1016/0040-4020(63)80021-6; AVRAM M, 1961, TETRAHEDRON LETT, P21; BLAKE AJ, 1994, ACTA CRYSTALLOGR C, V50, P1938, DOI 10.1107/S0108270194007225; Breda S, 2004, J PHOTOCH PHOTOBIO A, V162, P139, DOI 10.1016/S1010-6030(03)00339-3; Cazacu A, 2009, P NATL ACAD SCI USA, V106, P8117, DOI 10.1073/pnas.0813257106; CHAPMAN OL, 1973, J AM CHEM SOC, V95, P244, DOI 10.1021/ja00782a047; CRAM DJ, 1988, ANGEW CHEM INT EDIT, V27, P1009, DOI 10.1002/anie.198810093; CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; CRAM DJ, 1991, J AM CHEM SOC, V113, P7717, DOI 10.1021/ja00020a039; DELBAERE LTJ, 1975, J AM CHEM SOC, V97, P1973, DOI 10.1021/ja00840a072; DINULESCU IG, 1992, REV CHIM-BUCHAREST, V43, P502; Dumitru F, 2009, CHEM COMMUN, P2667, DOI 10.1039/b822619a; Eckert-Maksic M, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2222366; HELGESON RC, 1995, CHEM COMMUN, V3, P307; Holman KT, 2001, SCIENCE, V294, P1907, DOI 10.1126/science.1064432; Huckel E., 1938, GRUNDZUGE THEORIE UN, P77; Kawamichi T, 2008, ANGEW CHEM INT EDIT, V47, P8030, DOI 10.1002/anie.200802545; Kawamichi T, 2009, NATURE, V461, P633, DOI 10.1038/nature08326; Limanto J, 2000, J AM CHEM SOC, V122, P8071, DOI 10.1021/ja001946b; MAIER G, 1974, ANGEW CHEM INT EDIT, V13, P425, DOI 10.1002/anie.197404251; Mitra T, 2009, CHEM-EUR J, V15, P1844, DOI 10.1002/chem.200801602; NEUMANN F, 1994, J ORG CHEM, V59, P6437, DOI 10.1021/jo00100a055; TANNER ME, 1990, J AM CHEM SOC, V112, P1659, DOI 10.1021/ja00160a072; Warmuth R, 2000, J INCL PHENOM MACRO, V37, P1, DOI 10.1023/A:1008082732631; Zheng SL, 2008, CHEM-EUR J, V14, P706, DOI 10.1002/chem.200701037	26	77	78	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					299	302		10.1126/science.1188002	http://dx.doi.org/10.1126/science.1188002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647461				2022-12-28	WOS:000279925900034
J	Kim, SK; Shindo, A; Park, TJ; Oh, EC; Ghosh, S; Gray, RS; Lewis, RA; Johnson, CA; Attie-Bittach, T; Katsanis, N; Wallingford, JB				Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Oh, Edwin C.; Ghosh, Srimoyee; Gray, Ryan S.; Lewis, Richard A.; Johnson, Colin A.; Attie-Bittach, Tania; Katsanis, Nicholas; Wallingford, John B.			Planar Cell Polarity Acts Through Septins to Control Collective Cell Movement and Ciliogenesis	SCIENCE			English	Article							CILIATED EPITHELIAL-CELLS; BARDET-BIEDL-SYNDROME; CONVERGENT EXTENSION; EMBRYONIC-DEVELOPMENT; XENOPUS GASTRULATION; ZEBRAFISH; FORCHLORFENURON; POLARIZATION; ORGANIZATION; DISRUPTION	The planar cell polarity (PCP) signaling pathway governs collective cell movements during vertebrate embryogenesis, and certain PCP proteins are also implicated in the assembly of cilia. The septins are cytoskeletal proteins controlling behaviors such as cell division and migration. Here, we identified control of septin localization by the PCP protein Fritz as a crucial control point for both collective cell movement and ciliogenesis in Xenopus embryos. We also linked mutations in human Fritz to Bardet-Biedl and Meckel-Gruber syndromes, a notable link given that other genes mutated in these syndromes also influence collective cell movement and ciliogenesis. These findings shed light on the mechanisms by which fundamental cellular machinery, such as the cytoskeleton, is regulated during embryonic development and human disease.	[Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Ghosh, Srimoyee; Gray, Ryan S.; Wallingford, John B.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Ghosh, Srimoyee; Gray, Ryan S.; Wallingford, John B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Cell Biol, Durham, NC 27710 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Pediat, Durham, NC 27710 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol, Leeds LS9 7TF, W Yorkshire, England; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Attie-Bittach, Tania] Univ Paris 05, Hop Necker Enfants Malad, INSERM, Dept Genet,U781, Paris, France; [Wallingford, John B.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Duke University; Duke University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin	Wallingford, JB (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu	Gray, Ryan/G-2187-2010; Katsanis, Nicholas/E-1837-2012; Park, Tae Joo/G-1460-2011; ATTIE-BITACH, Tania/K-1453-2017; Gray, Ryan/L-3923-2019; Gray, Ryan/W-8366-2019	Gray, Ryan/0000-0001-9668-6497; Park, Tae Joo/0000-0003-3176-177X; ATTIE-BITACH, Tania/0000-0002-1155-3626; Gray, Ryan/0000-0001-9668-6497; Shindo, Asako/0000-0002-3314-7151; Katsanis, Nicholas/0000-0002-2480-0171; Johnson, Colin/0000-0002-2979-8234	Uehara Memorial Foundation; National Institute of General Medcial Science (NIH); March of Dimes; Burroughs Wellcome Fund; Sandler Program for Asthma Research; Texas Advanced Research Program; National Institute of Child Health and Human Development; National Institute of Digestive Diseases and Kidney Disease (NIH); MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); National Institute of General Medcial Science (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sandler Program for Asthma Research; Texas Advanced Research Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Digestive Diseases and Kidney Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Abitua for technical assistance; E. Spiliotis for the antibodies; and A. Ewald, B. Mitchell, E. Brooks, and K. Smith for critical discussions and reading. This work was supported by grants from the Uehara Memorial Foundation (A.S.); National Institute of General Medcial Science (NIH), March of Dimes, Burroughs Wellcome Fund, the Sandler Program for Asthma Research, and the Texas Advanced Research Program (J.B.W.); National Institute of Child Health and Human Development and National Institute of Digestive Diseases and Kidney Disease (NIH) (N.K.). N.K. is the George W. Brumley Professor. J.B.W. is an Early Career Scientist of the Howard Hughes Medical Institute.	Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; SHIH J, 1992, DEVELOPMENT, V116, P901; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; TRINKAUS JP, 1969, CELL ORGANS FORCES S; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zeng HQ, 2010, DEV BIOL, V339, P418, DOI 10.1016/j.ydbio.2010.01.003	33	245	259	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1337	1340		10.1126/science.1191184	http://dx.doi.org/10.1126/science.1191184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20671153	Green Accepted			2022-12-28	WOS:000281657300037
J	Jennings, CC; Hayes, KJ				Jennings, Christopher C.; Hayes, Katherine J.			Walking the Tightrope of Health Insurance Reform between 2010 and 2014	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jennings, Christopher C.; Hayes, Katherine J.] Jennings Policy Strategies, Hlth Policy, Washington, DC USA; [Hayes, Katherine J.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC USA	George Washington University	Jennings, CC (corresponding author), Jennings Policy Strategies, Hlth Policy, Washington, DC USA.							*AM AC ACT, 2010, CRIT ISS HLTH REF MI; *HJ KAIS FAM FDN H, 2009, EMPL HLTH BEN 2009 A	2	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2010	363	10					897	899		10.1056/NEJMp1007991	http://dx.doi.org/10.1056/NEJMp1007991			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645GW	20660396	Bronze			2022-12-28	WOS:000281441500001
J	Ito, S; D'Alessio, AC; Taranova, OV; Hong, K; Sowers, LC; Zhang, Y				Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Sowers, Lawrence C.; Zhang, Yi			Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification	NATURE			English	Article							ZYGOTIC PATERNAL GENOME; EMBRYONIC STEM-CELLS; DNA METHYLATION; DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; PLURIPOTENCY; PATTERNS; GENE	DNA methylation is one of the best-characterized epigenetic modifications(1-4). Although the enzymes that catalyse DNA methylation have been characterized, enzymes responsible for demethylation have been elusive(5). A recent study indicates that the human TET1 protein could catalyse the conversion of 5-methylcytosine (5mC) of DNA to 5-hydroxymethylcytosine (5hmC), raising the possibility that DNA demethylation may be a Tet1-mediated process(6). Here we extend this study by demonstrating that all three mouse Tet proteins (Tet1, Tet2 and Tet3) can also catalyse a similar reaction. Tet1 has an important role in mouse embryonic stem (ES) cell maintenance through maintaining the expression of Nanog in ES cells. Downregulation of Nanog via Tet1 knockdown correlates with methylation of the Nanog promoter, supporting a role for Tet1 in regulating DNA methylation status. Furthermore, knockdown of Tet1 in pre-implantation embryos results in a bias towards trophectoderm differentiation. Thus, our studies not only uncover the enzymatic activity of the Tet proteins, but also demonstrate a role for Tet1 in ES cell maintenance and inner cell mass cell specification.	[Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sowers, Lawrence C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Loma Linda University	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	jia, xu/A-8386-2016	Hong, Kwonho/0000-0001-7479-4091; Zhang, Yi/0000-0002-2789-0811	NIH [GM68804, CA084487]; NATIONAL CANCER INSTITUTE [R01CA084487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Okano for the J1 and DNMT triple knockout ES cells; J. He and A. Nguyen for help in FACS sorting; and S. Wu for critical reading of the manuscript. This work was supported by NIH grants GM68804 (to Y.Z.) and CA084487 (to L.C.S.). S.I. is a research fellow of the Japan Society for the Promotion of Science. O.T. is a postdoctoral fellow of Juvenile Diabetes Research Foundation International. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x	19	1813	1927	1	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1129	U151		10.1038/nature09303	http://dx.doi.org/10.1038/nature09303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20639862	Green Submitted, Green Accepted			2022-12-28	WOS:000281203600045
J	Xu, YP; Ramu, Y; Lu, Z				Xu, Yanping; Ramu, Yajamana; Lu, Zhe			A Shaker K+ Channel with a Miniature Engineered Voltage Sensor	CELL			English	Article							POTASSIUM-CHANNEL; GATING-CHARGE; SODIUM-CHANNELS; SENSING RESIDUES; ACTIVATION GATE; MOLECULAR-BASIS; MOVEMENT; S4; PORE; CURRENTS	Voltage-gated ion channels sense transmembrane voltage changes via a paddle-shaped motif that includes the C-terminal part of the third transmembrane segment (S3b) and the N-terminal part of the fourth segment ((NT)S4) that harbors voltage-sensing arginines. Here, we find that residue triplets in S3b and (NT)S4 can be deleted individually, or even in some combinations, without compromising the channels' basic voltage-gating capability. Thus, a high degree of complementarity between these S3b and (NT)S4 regions is not required for basic voltage gating per se. Remarkably, the voltage-gated Shaker K+ channel remains voltage gated after a 43 residue paddle sequence is replaced by a glycine triplet. Therefore, the paddle motif comprises a minimal core that suffices to confer voltage gating in the physiological voltage range, and a larger, modulatory part. Our study also shows that the hydrophobic residues between the voltage-sensing arginines help set the sensor's characteristic chemical equilibrium between activated and deactivated states.	[Xu, Yanping; Ramu, Yajamana; Lu, Zhe] Univ Penn, Howard Hughes Med Inst, Dept Physiol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Physiol, Philadelphia, PA 19104 USA.	zhelu@mail.med.upenn.edu			National Institutes of Health [GM55560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. De Weer for critical review and discussion of our manuscript and K. Baek for help with figure preparation. Molecular models were prepared with PyMOL 1.0 (DeLano Scientific). This study was supported by grant GM55560 from the National Institutes of Health to Z.L. Z. L. is an investigator of the Howard Hughes Medical Institute.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Broomand A, 2008, NEURON, V59, P770, DOI 10.1016/j.neuron.2008.07.008; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tang CY, 1997, J GEN PHYSIOL, V109, P301, DOI 10.1085/jgp.109.3.301; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	64	37	37	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 20	2010	142	4					580	589		10.1016/j.cell.2010.07.013	http://dx.doi.org/10.1016/j.cell.2010.07.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20691466	Green Accepted, Bronze			2022-12-28	WOS:000281115900012
J	Campbell, EG; Zinner, DE				Campbell, Eric G.; Zinner, Darren E.			Disclosing Industry Relationships - Toward an Improved Federal Research Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Campbell, Eric G.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Zinner, Darren E.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA	Harvard University; Massachusetts General Hospital; Brandeis University	Campbell, EG (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA.							*DEP HLTH HUM SERV, 2009, GRANT MAN FIN CONFL; Institute of Medicine, 2009, CONFL INT MED RES ED; Rockey SJ, 2010, JAMA-J AM MED ASSOC, V303, P2400, DOI 10.1001/jama.2010.774; Zinner DE, 2009, HEALTH AFFAIR, V28, P1814, DOI 10.1377/hlthaff.28.6.1814	4	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					604	606		10.1056/NEJMp1006973	http://dx.doi.org/10.1056/NEJMp1006973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TN	20647185	Bronze			2022-12-28	WOS:000280764600002
J	Maczyczka, A; Squire, IB				Maczyczka, Annette; Squire, Ian B.			Cough syncope-a diagnosis under pressure	LANCET			English	Editorial Material									[Maczyczka, Annette; Squire, Ian B.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England	University of Leicester	Squire, IB (corresponding author), Univ Leicester, Dept Med & Therapeut, Leicester Royal Infirm, Robert Kilpatrick Clin Sci Bldg, Leicester LE2 7LX, Leics, England.	is11@le.ac.uk						Chen-Scarabelli C, 2005, LANCET ONCOL, V6, P347, DOI 10.1016/S1470-2045(05)70172-8; MATTLE HP, 1995, NEUROLOGY, V45, P498, DOI 10.1212/WNL.45.3.498; OGANE K, SHINKEI GEKA, V18, P457	3	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					486	486		10.1016/S0140-6736(10)60754-4	http://dx.doi.org/10.1016/S0140-6736(10)60754-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20692531				2022-12-28	WOS:000281012900033
J	Prockter, LM; Ernst, CM; Denevi, BW; Chapman, CR; Head, JW; Fassett, CI; Merline, WJ; Solomon, SC; Watters, TR; Strom, RG; Cremonese, G; Marchi, S; Massironi, M				Prockter, Louise M.; Ernst, Carolyn M.; Denevi, Brett W.; Chapman, Clark R.; Head, James W., III; Fassett, Caleb I.; Merline, William J.; Solomon, Sean C.; Watters, Thomas R.; Strom, Robert G.; Cremonese, Gabriele; Marchi, Simone; Massironi, Matteo			Evidence for Young Volcanism on Mercury from the Third MESSENGER Flyby	SCIENCE			English	Article							CRATERING RECORD; SMOOTH PLAINS; IMPACT BASINS; CALORIS BASIN; EVOLUTION; MISSION; GEOLOGY; VIEW	During its first two flybys of Mercury, the MESSENGER spacecraft acquired images confirming that pervasive volcanism occurred early in the planet's history. MESSENGER's third Mercury flyby revealed a 290-kilometer-diameter peak-ring impact basin, among the youngest basins yet seen, having an inner floor filled with spectrally distinct smooth plains. These plains are sparsely cratered, postdate the formation of the basin, apparently formed from material that once flowed across the surface, and are therefore interpreted to be volcanic in origin. An irregular depression surrounded by a halo of bright deposits northeast of the basin marks a candidate explosive volcanic vent larger than any previously identified on Mercury. Volcanism on the planet thus spanned a considerable duration, perhaps extending well into the second half of solar system history.	[Prockter, Louise M.; Ernst, Carolyn M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Denevi, Brett W.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85251 USA; [Chapman, Clark R.; Merline, William J.] SW Res Inst, Boulder, CO 80302 USA; [Head, James W., III; Fassett, Caleb I.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20013 USA; [Strom, Robert G.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Cremonese, Gabriele] Astron Observ Padova, Inst Nazl Astrofis, I-35122 Padua, Italy; [Marchi, Simone] Univ Padua, Dept Astron, I-35137 Padua, Italy; [Massironi, Matteo] Univ Padua, Dept Geosci, I-35137 Padua, Italy	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Arizona State University; Arizona State University-Tempe; Brown University; Carnegie Institution for Science; Smithsonian Institution; University of Arizona; Istituto Nazionale Astrofisica (INAF); University of Padua; University of Padua; University of Padua	Prockter, LM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	Louise.Prockter@jhuapl.edu	Massironi, Matteo/F-8860-2012; Ernst, Carolyn M/I-4902-2012; Denevi, Brett W./I-6502-2012	Ernst, Carolyn M/0000-0002-9434-7886; Denevi, Brett W./0000-0001-7837-6663; Massironi, Matteo/0000-0002-7757-8818; Cremonese, Gabriele/0000-0001-9021-1140; Fassett, Caleb/0000-0001-9155-3804	NASA [NASW-00002, NAS5-97271]	NASA(National Aeronautics & Space Administration (NASA))	We are grateful to N. Chabot, N. Laslo, and H. Kang, who designed the imaging sequences that made this contribution possible, and to the tireless efforts of the engineers and technical support personnel on the MESSENGER team. The MESSENGER project is supported by the NASA Discovery Program under contracts NASW-00002 to the Carnegie Institution of Washington and NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory.	BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P2415, DOI 10.1029/JB090iB14p12415; Chapman C. R., 1988, MERCURY, P1; Cintala MJ, 1998, METEORIT PLANET SCI, V33, P889, DOI 10.1111/j.1945-5100.1998.tb01695.x; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; Fassett CI, 2009, EARTH PLANET SC LETT, V285, P297, DOI 10.1016/j.epsl.2009.05.022; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; Head JW, 2007, SPACE SCI REV, V131, P41, DOI 10.1007/s11214-007-9263-6; Head JW, 2009, EARTH PLANET SC LETT, V285, P227, DOI 10.1016/j.epsl.2009.03.007; HEAD JW, 1993, J GEOPHYS RES-PLANET, V98, P17149, DOI 10.1029/93JE01278; Kerber L, 2009, EARTH PLANET SC LETT, V285, P263, DOI 10.1016/j.epsl.2009.04.037; Marchi S, 2009, ASTRON J, V137, P4936, DOI 10.1088/0004-6256/137/6/4936; Massironi M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040353; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; PIKE RJ, 1988, MERCURY, P165; Prockter L.M., 2009, LUNAR PLANET SCI, V40; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; SOLOMON SC, 1980, REV GEOPHYS, V18, P107, DOI 10.1029/RG018i001p00107; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Spudis, 1993, GEOLOGY MULTIRING BA; Spudis P.D., 1988, MERCURY, P118; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; Watters TR, 2009, EARTH PLANET SC LETT, V285, P309, DOI 10.1016/j.epsl.2009.03.040; Watters TR, 2009, SCIENCE, V324, P618, DOI 10.1126/science.1172109; Wood C.A., 1976, P LUNAR PLANET SCI C, P3629	25	84	86	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					668	671		10.1126/science.1188186	http://dx.doi.org/10.1126/science.1188186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20647421				2022-12-28	WOS:000280602700035
J	Subramanian, R; Wilson-Kubalek, EM; Arthur, CP; Bick, MJ; Campbell, EA; Darst, SA; Milligan, RA; Kapoor, TM				Subramanian, Radhika; Wilson-Kubalek, Elizabeth M.; Arthur, Christopher P.; Bick, Matthew J.; Campbell, Elizabeth A.; Darst, Seth A.; Milligan, Ronald A.; Kapoor, Tarun M.			Insights into Antiparallel Microtubule Crosslinking by PRC1, a Conserved Nonmotor Microtubule Binding Protein	CELL			English	Article							FISSION YEAST; NDC80 COMPLEX; MOTORS; CYTOKINESIS; ATTACHMENT; ASE1P; VISUALIZATION; MOVEMENTS; KINESIN-5; TRACKING	Formation of microtubule architectures, required for cell shape maintenance in yeast, directional cell expansion in plants and cytokinesis in eukaryotes, depends on antiparallel microtubule crosslinking by the conserved MAP65 protein family. Here, we combine structural and single molecule fluorescence methods to examine how PRC1, the human MAP65, crosslinks antiparallel microtubules. We find that PRC1's microtubule binding is mediated by a structured domain with a spectrin-fold and an unstructured Lys/Arg-rich domain. These two domains, at each end of a homodimer, are connected by a linkage that is flexible on single microtubules, but forms well-defined crossbridges between antiparallel filaments. Further, we show that PRC1 crosslinks are compliant and do not substantially resist filament sliding by motor proteins in vitro. Together, our data show how MAP65s, by combining structural flexibility and rigidity, tune microtubule associations to establish crosslinks that selectively "mark'' antiparallel overlap in dynamic cytoskeletal networks.	[Subramanian, Radhika; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Wilson-Kubalek, Elizabeth M.; Arthur, Christopher P.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Bick, Matthew J.; Campbell, Elizabeth A.; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA	Rockefeller University; Scripps Research Institute; Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA.	kapoor@mail.rockefeller.edu		Bick, Matthew/0000-0002-9585-859X; Campbell, Elizabeth/0000-0002-1332-128X	NIH [GM65933, GM65933-S1, GM52468]; Rockefeller Women and Science postdoctoral fellowship; National Resource for Automated Molecular Microscopy (NIH) [RR17573]; SBRC (NIH) [1S10RR022321-01]; Keck Facility at Yale University (NIH) [1S10RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748, S10RR022321, P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052468, R01GM065933, R01GM052468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller Women and Science postdoctoral fellowship; National Resource for Automated Molecular Microscopy (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBRC (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Facility at Yale University (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rajashankar (Argonne Advanced Photon Source) and Deena Oren (Rockefeller University Structural Biology Resource Center (SBRC)) for technical assistance. T.M.K. is grateful to the NIH (GM65933 and GM65933-S1) for support. R.S. is a recipient of the Rockefeller Women and Science postdoctoral fellowship. R.A.M. acknowledges support from the NIH (GM52468). We also acknowledge the National Resource for Automated Molecular Microscopy (NIH RR17573), the SBRC (NIH 1S10RR022321-01), and the Keck Facility at Yale University (NIH 1S10RR023748-01) for instrument use.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Gaillard J, 2008, MOL BIOL CELL, V19, P4534, DOI 10.1091/mbc.E08-04-0341; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Korneev MJ, 2007, EUR BIOPHYS J BIOPHY, V36, P675, DOI 10.1007/s00249-007-0134-6; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Millman BM, 1998, PHYSIOL REV, V78, P359, DOI 10.1152/physrev.1998.78.2.359; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Sasabe M, 2006, CURR OPIN PLANT BIOL, V9, P563, DOI 10.1016/j.pbi.2006.09.010; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Thadani R, 2009, CURR BIOL, V19, P1861, DOI 10.1016/j.cub.2009.09.063; Valentine MT, 2009, BIOPHYS J, V97, P1671, DOI 10.1016/j.bpj.2009.07.013; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; WHITTAKER M, 1995, ULTRAMICROSCOPY, V58, P245, DOI 10.1016/0304-3991(95)00057-8; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zeng CQ, 2000, MICROSC RES TECHNIQ, V49, P467, DOI 10.1002/(SICI)1097-0029(20000601)49:5<467::AID-JEMT9>3.3.CO;2-M; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	40	199	202	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					433	443		10.1016/j.cell.2010.07.012	http://dx.doi.org/10.1016/j.cell.2010.07.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691902	Green Accepted, Bronze			2022-12-28	WOS:000280609100020
J	Hart, M; Milton, NM; Baranec, C; Powell, K; Stalcup, T; McCarthy, D; Kulesa, C; Bendek, E				Hart, M.; Milton, N. M.; Baranec, C.; Powell, K.; Stalcup, T.; McCarthy, D.; Kulesa, C.; Bendek, E.			A ground-layer adaptive optics system with multiple laser guide stars	NATURE			English	Article							WIDE-FIELD; ARCHES CLUSTER; MASS FUNCTION; MOTIONS; TESTS; MMT	To determine the influence of the environment on star formation, we need to study the process in the extreme conditions of massive young star clusters (similar to 10(4) solar masses) near the centre of our own Galaxy(1,2). Observations must be carried out in the near infrared because of very high extinction in visible light within the Galactic plane. We need high resolution to identify cluster members from their peculiar motions 3, and because most such clusters span more than 1', efficient observation demands a wide field of view. There is at present no space-based facility that meets all these criteria. Ground-based telescopes can in principle make such observations when fitted with ground-layer adaptive optics (GLAO)(4-6), which removes the optical aberration caused by atmospheric turbulence up to an altitude of similar to 500 m (refs 7-10). A GLAO system that uses multiple laser guide stars(11-13) has been developed at the 6.5-m MMT telescope, in Arizona. In previous tests(13), the system improved the resolution of the telescope by 30-50%, limited by wavefront error in the optics, but that was insufficient to allow rapid determination of cluster membership. Here we report observations of the core of the globular cluster M3 made after commissioning a sensor to monitor and remove slowly varying aberration in the optics. In natural seeing of 0.7 '', the point spread function at 2.2-mu m wavelength was sharpened uniformly to 0.3 '' over a field of at least 2'. The wide-field resolution was enhanced by a factor of two to three over previous work(13), with better uniformity, and extends to a wavelength of 1.2 mu m. Entire stellar clusters may be examined in a single pointing, and cluster membership can be determined from two such observations separated by just one year(14-17).	[Hart, M.; Milton, N. M.; Powell, K.; McCarthy, D.; Kulesa, C.; Bendek, E.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Baranec, C.] CALTECH, Caltech Opt Observ, Pasadena, CA 91125 USA; [Stalcup, T.] WM Keck Observ, Kamuela, HI 96743 USA	University of Arizona; California Institute of Technology	Hart, M (corresponding author), Univ Arizona, Steward Observ, Tucson, AZ 85721 USA.	mhart@as.arizona.edu		Baranec, Christoph/0000-0002-1917-9157	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	We thank the staff of the Steward Observatory Engineering and Technical Services division and the staff of the MMT Observatory for their support in the development and deployment of the MMT adaptive optics system. We are grateful to P. Strittmatter and R. Angel for reading the manuscript. The observations reported here were made at the MMT Observatory, a joint facility of The University of Arizona and the Smithsonian Institution. The work has been supported by the National Science Foundation.	Andersen DR, 2006, PUBL ASTRON SOC PAC, V118, P1574, DOI 10.1086/509266; Angel R, 2000, P SOC PHOTO-OPT INS, V4007, P270, DOI 10.1117/12.390330; Baranec C, 2009, ASTROPHYS J, V693, P1814, DOI 10.1088/0004-637X/693/2/1814; Cameron PB, 2009, ASTRON J, V137, P83, DOI 10.1088/0004-6256/137/1/83; Hussmann B, 2010, IAU SYMP P SERIES, P422, DOI 10.1017/S174392130999158X; Le Louarn M, 2006, MON NOT R ASTRON SOC, V365, P1324, DOI 10.1111/j.1365-2966.2005.09823.x; Lloyd-Hart M, 2000, PUBL ASTRON SOC PAC, V112, P264, DOI 10.1086/316503; Lloyd-Hart M, 2005, ASTROPHYS J, V634, P679, DOI 10.1086/496960; Lloyd-Hart M, 2006, OPT EXPRESS, V14, P7541, DOI 10.1364/OE.14.007541; Mandel H., 2007, ASTRON NACHR, V328, P626; Marchetti E., 2007, MESSENGER, V129, P8; MARTIN O, 2008, P SPIE, V7015; McCarthy DW, 2001, PUBL ASTRON SOC PAC, V113, P353, DOI 10.1086/319328; McCrady N, 2005, ASTROPHYS J, V621, P278, DOI 10.1086/427487; RABIEN S, 2008, P SPIE, V7015; Reid MJ, 2009, ASTROPHYS J, V700, P137, DOI 10.1088/0004-637X/700/1/137; Rigaut F., 2002, EUROPEAN SO OBSERVAT, V58, P11; SASIELA RJ, 1994, ELECTROMAGNETIC WAVE, P164; Schodel R, 2009, ASTRON ASTROPHYS, V502, P91, DOI 10.1051/0004-6361/200810922; Stalcup TE, 2004, P SOC PHOTO-OPT INS, V5490, P1021, DOI 10.1117/12.551952; Stolte A, 2008, ASTROPHYS J, V675, P1278, DOI 10.1086/527027; Stolte A, 2005, ASTROPHYS J, V628, pL113, DOI 10.1086/432909; Tokovinin A, 2004, PUBL ASTRON SOC PAC, V116, P941, DOI 10.1086/424805; TOKOVININ A, 2008, P SPIE, V7015; Wildi F, 2003, P SOC PHOTO-OPT INS, V5169, P17, DOI 10.1117/12.507687	25	33	37	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					727	729		10.1038/nature09311	http://dx.doi.org/10.1038/nature09311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686568				2022-12-28	WOS:000280562500032
J	Musunuru, K; Strong, A; Frank-Kamenetsky, M; Lee, NE; Ahfeldt, T; Sachs, KV; Li, XY; Li, H; Kuperwasser, N; Ruda, VM; Pirruccello, JP; Muchmore, B; Prokunina-Olsson, L; Hall, JL; Schadt, EE; Morales, CR; Lund-Katz, S; Phillips, MC; Wong, J; Cantley, W; Racie, T; Ejebe, KG; Orho-Melander, M; Melander, O; Koteliansky, V; Fitzgerald, K; Krauss, RM; Cowan, CA; Kathiresan, S; Rader, DJ				Musunuru, Kiran; Strong, Alanna; Frank-Kamenetsky, Maria; Lee, Noemi E.; Ahfeldt, Tim; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Muchmore, Brian; Prokunina-Olsson, Ludmila; Hall, Jennifer L.; Schadt, Eric E.; Morales, Carlos R.; Lund-Katz, Sissel; Phillips, Michael C.; Wong, Jamie; Cantley, William; Racie, Timothy; Ejebe, Kenechi G.; Orho-Melander, Marju; Melander, Olle; Koteliansky, Victor; Fitzgerald, Kevin; Krauss, Ronald M.; Cowan, Chad A.; Kathiresan, Sekar; Rader, Daniel J.			From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus	NATURE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; PROTEIN; GENE; SORTILIN; TRANSCRIPTION; DISEASE; DESIGN; RISK; MICE	Recent genome-wide association studies (GWASs) have identified a locus on chromosome 1p13 strongly associated with both plasma low-density lipoprotein cholesterol (LDL-C) and myocardial infarction (MI) in humans. Here we show through a series of studies in human cohorts and human-derived hepatocytes that a common noncoding polymorphism at the 1p13 locus, rs12740374, creates a C/EBP (CCAAT/enhancer binding protein) transcription factor binding site and alters the hepatic expression of the SORT1 gene. With small interfering RNA (siRNA) knockdown and viral overexpression in mouse liver, we demonstrate that Sort1 alters plasma LDL-C and very low-density lipoprotein (VLDL) particle levels by modulating hepatic VLDL secretion. Thus, we provide functional evidence for a novel regulatory pathway for lipoprotein metabolism and suggest that modulation of this pathway may alter risk for MI in humans. We also demonstrate that common noncoding DNA variants identified by GWASs can directly contribute to clinical phenotypes.	[Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Musunuru, Kiran; Lee, Noemi E.; Ahfeldt, Tim; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Musunuru, Kiran; Lee, Noemi E.; Ahfeldt, Tim; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran; Lee, Noemi E.; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Musunuru, Kiran; Pirruccello, James P.; Hall, Jennifer L.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Broad Inst, Cambridge, MA 02142 USA; [Musunuru, Kiran] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21287 USA; [Frank-Kamenetsky, Maria; Wong, Jamie; Cantley, William; Racie, Timothy; Koteliansky, Victor; Fitzgerald, Kevin] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Muchmore, Brian; Prokunina-Olsson, Ludmila] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Hall, Jennifer L.] Univ Minnesota, Program Cardiovasc Translat Genom, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA 98109 USA; [Morales, Carlos R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Lund-Katz, Sissel; Phillips, Michael C.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Orho-Melander, Marju; Melander, Olle] Lund Univ, Skania Univ Hosp, Dept Clin Sci, SE-20502 Malmo, Sweden; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Rader, DJ (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	skathiresan@partners.org; rader@mail.med.upenn.edu	Morales, Carlos R./H-1055-2011; Prokunina-Olsson, Ludmila/A-8240-2019; Ahfeldt, Tim/E-2935-2017; Prokunina-Olsson, Ludmila/V-7960-2019; Ejebe, Kenechi/I-9238-2016	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Ejebe, Kenechi/0000-0002-6090-8657; Ahfeldt, Tim/0000-0001-6377-7376; Pirruccello, James/0000-0001-6088-4037; Melander, Olle/0000-0002-2581-484X; Phillips, Michael/0000-0002-7147-8007	United States National Institutes of Health (NIH); NIH [K99-HL098364, U01-HL069757, RC2-HL101864, P01-HL059407]; Harvard Stem Cell Institute; Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH; Swedish Medical Research Council; Heart-Lung Foundation; Pahlsson Foundation; Quest Diagnostics, Inc.; Bristol-Myers Squibb; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL098364, RC2HL101864, P01HL059407, U01HL069757, T32HL007954] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Pahlsson Foundation; Quest Diagnostics, Inc.; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Altshuler, E. Fisher and J. Maraganore for advice and guidance, and A. Akinc, J. Billheimer, R. Brown, R. Camahort, D. Cromley, E. Eduoard, I. Fuki, C. Geaney, G. Hinkle, I. Kohaar, S. Kuchimanchi, W. Lagor, F. Lau, D. Lum, M. Maier, D. Marchadier, R. Meyers, J. Millar, S. Milstein, D. Nguyen, D. Perez, D. Peters, V. Redon, A. Rigamonti, R. Schinzel, M.-S. Sun, S.-A. Toh, A. Wilson and K. Wojnoonski for assistance and suggestions. We acknowledge the National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Resource Program for providing support for viral vector production as well as the Vector Core laboratory of the University of Pennsylvania for producing the vectors. We acknowledge the members of the NHLBI Candidate Gene Association Resource (CARe) lipids working group for the contribution of association data in African Americans. This work was supported in part by a T32 grant in Cell and Molecular Training for Cardiovascular Biology from the United States National Institutes of Health (NIH), K99-HL098364 from the NIH, and the Clinician Scientist Program of the Harvard Stem Cell Institute (K. M.); a Medical Scientist Training Program grant from the NIH (A. S.); the intramural research program of the Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH (L.P.-O.); the Swedish Medical Research Council, Heart-Lung Foundation, and Pahlsson Foundation (M.O.-M., O.M.); U01-HL069757 from the NIH and research support from Quest Diagnostics, Inc. (R. M. K.); RC2-HL101864 from the NIH (S. K.); and P01-HL059407 and RC2-HL101864 from the NIH and a "Freedom to Discover'' Unrestricted Cardiovascular Research Grant from Bristol-Myers Squibb (D.J.R.).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Brown MS, 1996, SCIENCE, V272, P629, DOI 10.1126/science.272.5262.629; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Keebler ME, 2009, CIRC-CARDIOVASC GENE, V2, P238, DOI 10.1161/CIRCGENETICS.108.829473; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Osada S, 1996, J BIOL CHEM, V271, P3891; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Siri-Tarino PW, 2009, OBESITY, V17, P1768, DOI 10.1038/oby.2009.146; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016	35	772	806	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					714	U2		10.1038/nature09266	http://dx.doi.org/10.1038/nature09266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686566	Green Accepted			2022-12-28	WOS:000280562500030
J	Cheung, J; Sharrard, M; Clements, H				Cheung, J.; Sharrard, M.; Clements, H.			Case Report Recurrent vomiting and lethargy in an infant-just another viral illness?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORNITHINE TRANSCARBAMYLASE DEFICIENCY; LONG-TERM CORRECTION; INBORN-ERRORS; HYPERAMMONEMIA; TRANSPLANTATION; METABOLISM; MUTATIONS; SURVIVAL; AMMONIA; NEWBORN		[Cheung, J.; Clements, H.] Kings Mill Hosp, Sutton In Ashfield NG17 4JL, England; [Sharrard, M.] Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Cheung, J (corresponding author), Kings Mill Hosp, Sutton In Ashfield NG17 4JL, England.	op_joy@yahoo.co.uk						Barsotti RJ, 2001, J PEDIATR-US, V138, pS11, DOI 10.1067/mpd.2001.111832; BATSHAW ML, 1986, J PEDIATR-US, V108, P236, DOI 10.1016/S0022-3476(86)80989-1; Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836; Becroft D M, 1986, Adv Exp Med Biol, V195 Pt A, P67; BECROFT DMO, 1984, J INHERIT METAB DIS, V7, P157, DOI 10.1007/BF01805599; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; BRUSILOW SW, 1984, J CLIN INVEST, V74, P2144, DOI 10.1172/JCI111640; Butterworth RF, 1998, J INHERIT METAB DIS, V21, P6, DOI 10.1023/A:1005393104494; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; DIXON MA, 1992, ARCH DIS CHILD, V67, P1387, DOI 10.1136/adc.67.11.1387; Enns GM, 2007, NEW ENGL J MED, V356, P2282, DOI 10.1056/NEJMoa066596; Fitzpatrick D, 2006, J ROY COLL PHYS EDIN, V36, P147; Gordon N, 2003, EUR J PAEDIATR NEURO, V7, P115, DOI 10.1016/S1090-3798(03)00040-0; HUDAK ML, 1985, J PEDIATR-US, V107, P712, DOI 10.1016/S0022-3476(85)80398-X; Kurihara A, 2003, BRAIN DEV-JPN, V25, P40, DOI 10.1016/S0387-7604(02)00153-5; Lee B, 2001, J PEDIATR-US, V138, pS62, DOI 10.1067/mpd.2001.111838; Leonard JV, 2001, J PEDIATR-US, V138, pS40, DOI 10.1067/mpd.2001.111835; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; Maestri NE, 1999, J PEDIATR-US, V134, P268, DOI 10.1016/S0022-3476(99)70448-8; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; Moscioni D, 2006, MOL THER, V14, P25, DOI 10.1016/j.ymthe.2006.03.009; Potter M, 2001, J INHERIT METAB DIS, V24, P5, DOI 10.1023/A:1005682017337; Puppi J, 2008, AM J TRANSPLANT, V8, P452, DOI 10.1111/j.1600-6143.2007.02058.x; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Steiner RD, 2001, J PEDIATR-US, V138, pS21, DOI 10.1067/mpd.2001.111833; Stephenne X, 2005, AM J TRANSPLANT, V5, P2058, DOI 10.1111/j.1600-6143.2005.00935.x; Summar M, 2001, J PEDIATR-US, V138, pS6, DOI 10.1067/mpd.2001.111831; SUMMAR M, 2001, J PEDIAT, V138, P6; *UK NAT MET BIOCH, 2004, GUID INV HYP INH MET; Wraith JE, 2001, ARCH DIS CHILD, V84, P84, DOI 10.1136/adc.84.1.84; Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339; 2005, UREA CYCLE DISORDERS	32	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2010	341								c1037	10.1136/bmj.c1037	http://dx.doi.org/10.1136/bmj.c1037			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636WI	20685779				2022-12-28	WOS:000280774000015
J	Bozell, JJ				Bozell, Joseph J.			CHEMISTRY Connecting Biomass and Petroleum Processing with a Chemical Bridge	SCIENCE			English	Editorial Material							GAMMA-VALEROLACTONE; CONVERSION		Univ Tennessee, Biomass Chem Labs, Forest Prod Ctr, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Bozell, JJ (corresponding author), Univ Tennessee, Biomass Chem Labs, Forest Prod Ctr, Knoxville, TN 37996 USA.	jbozell@utk.edu						Bond JQ, 2010, SCIENCE, V327, P1110, DOI 10.1126/science.1184362; Bozell JJ, 2008, CLEAN-SOIL AIR WATER, V36, P641, DOI 10.1002/clen.200800100; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Chheda JN, 2007, ANGEW CHEM INT EDIT, V46, P7164, DOI 10.1002/anie.200604274; de Jong E, 2006, BIOREFINERIES - INDUSTRIAL PROCESSES AND PRODUCTS: STATUS QUO AND FUTURE DIRECTIONS, VOL 1, P85; Fitzpatrick SW, 2006, ACS SYM SER, V921, P271; Green M. M., 2003, ORGANIC CHEM PRINCIP; Heeres H, 2009, GREEN CHEM, V11, P1247, DOI 10.1039/b904693c; Lange JP, 2010, ANGEW CHEM INT EDIT, V49, P4479, DOI 10.1002/anie.201000655; Mehdi H, 2008, TOP CATAL, V48, P49, DOI 10.1007/s11244-008-9047-6; Perlack R.D., 2005, DOEGO1029952135; Weissermel K., 2003, IND ORGANIC CHEM, V4th	12	240	263	4	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					522	523		10.1126/science.1191662	http://dx.doi.org/10.1126/science.1191662			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671177				2022-12-28	WOS:000280483500022
J	Ramos-Casals, M; Tzioufas, AG; Stone, JH; Siso, A; Bosch, X				Ramos-Casals, Manuel; Tzioufas, Athanasios G.; Stone, John H.; Siso, Antoni; Bosch, Xavier			Treatment of Primary Sjogren Syndrome A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NONPRESERVED METHYLPREDNISOLONE THERAPY; DRY EYE SYMPTOMS; DOUBLE-BLIND; KERATOCONJUNCTIVITIS SICCA; OPHTHALMIC EMULSION; RITUXIMAB TREATMENT; CONTROLLED-TRIAL; DEHYDROEPIANDROSTERONE DHEA; TOPICAL CYCLOSPORINE; ORAL PILOCARPINE	Context A variety of topical and systemic drugs are available to treat primary Sjogren syndrome, although no evidence-based therapeutic guidelines are currently available. Objective To summarize evidence on primary Sjogren syndrome drug therapy from randomized controlled trials. Data Sources We searched MEDLINE and EMBASE for articles on drug therapy for primary Sjogren syndrome published between January 1, 1986, and April 30, 2010. Study Selection Controlled trials of topical and systemic drugs including adult patients with primary Sjogren syndrome were selected as the primary information source. Results The search strategy yielded 37 trials. A placebo-controlled trial found significant improvement in the Schirmer and corneal staining scores, blurred vision, and artificial tear use in patients treated with topical ocular 0.05% cyclosporine. Three placebo-controlled trials found that pilocarpine was associated with improvements in dry mouth (61%-70% vs 24%-31% in the placebo group) and dry eye (42%-53% vs 26%). Two placebo-controlled trials found that cevimeline was associated with improvement in dry mouth (66%-76% vs 35%-37% in the placebo group) and dry eye (39%-72% vs 24%-30%). Small trials (<20 patients) found no significant improvement in sicca outcomes for oral prednisone or hydroxychloroquine and limited benefits for immunosuppressive agents (azathioprine and cyclosporine). A large trial found limited benefits for oral interferon alfa-2a. Two placebo-controlled trials of infliximab and etanercept did not achieve the primary outcome (a composite visual analog scale measuring joint pain, fatigue, and dryness); neither did 2 small trials (<30 patients) testing rituximab, although significant results were observed in some secondary outcomes and improvement compared with baseline. Conclusions In primary Sjogren syndrome, evidence from controlled trials suggests benefits for pilocarpine and cevimeline for sicca features and topical cyclosporine for moderate or severe dry eye. Anti-tumor necrosis factor agents have not shown clinical efficacy, and larger controlled trials are needed to establish the efficacy of rituximab. JAMA. 2010; 304(4): 452-460	[Ramos-Casals, Manuel] Hosp Clin Barcelona, Dept Autoimmune Dis, Josep Font Lab Autoimmune Dis,IDIBAPS, Sjogren Syndrome Res Grp AGAUR, E-08036 Barcelona, Spain; [Bosch, Xavier] Hosp Clin Barcelona, Dept Internal Med, Inst Clin Med & Dermatol, E-08036 Barcelona, Spain; [Tzioufas, Athanasios G.] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [Stone, John H.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Siso, Antoni] GESCLINIC, Primary Care Ctr Les Corts, IDIBAPS, Primary Care Res Grp, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Massachusetts General Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Ramos-Casals, M (corresponding author), Hosp Clin Barcelona, Dept Autoimmune Dis, Josep Font Lab Autoimmune Dis,IDIBAPS, Sjogren Syndrome Res Grp AGAUR, C Villarroel 170, E-08036 Barcelona, Spain.	mramos@clinic.ub.es	TZIOUFAS, ATHANASIOS G/A-1690-2008	Ramos-Casals, Manuel/0000-0001-5709-6734; Siso Almirall, Antoni/0000-0001-9832-2689	La Marato de TV3 [071810]; Fondo de Investigaciones Sanitarias [080103]	La Marato de TV3; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This study was supported by grants from La Marato de TV3 (071810) and Fondo de Investigaciones Sanitarias (080103).	Aragona P, 2005, EYE, V19, P535, DOI 10.1038/sj.eye.6701537; Avunduk AM, 2003, AM J OPHTHALMOL, V136, P593, DOI 10.1016/S0002-9394(03)00326-X; Barber LD, 2005, OPHTHALMOLOGY, V112, P1790, DOI 10.1016/j.ophtha.2005.05.013; Cummins MJ, 2003, ARTHRIT RHEUM-ARTHR, V49, P585, DOI 10.1002/art.11199; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Devauchelle-Pensec V, 2007, ARTHRIT RHEUM-ARTHR, V57, P310, DOI 10.1002/art.22536; DROSOS AA, 1986, SCAND J RHEUMATOL, P246; Fife RS, 2002, ARCH INTERN MED, V162, P1293, DOI 10.1001/archinte.162.11.1293; Forsblad-d'Elia H, 2009, J CLIN ENDOCR METAB, V94, P2044, DOI 10.1210/jc.2009-0106; FOX PC, 1993, CLIN EXP RHEUMATOL, V11, P149; Fox RI, 1996, LUPUS, V5, pS31, DOI 10.1177/096120339600500108; Gescuk B, 2005, ANN RHEUM DIS, V64, P1326, DOI 10.1136/ard.2004.031393; Gottenberg JE, 2005, ANN RHEUM DIS, V64, P913, DOI 10.1136/ard.2004.029694; Hartkamp A, 2008, ANN RHEUM DIS, V67, P91, DOI 10.1136/ard.2007.071563; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hong S, 2007, J OCUL PHARMACOL TH, V23, P78, DOI 10.1089/jop.2006.0091; Jousse-Joulin S, 2007, BIOL-TARGETS THER, V1, P311; Kasama T, 2008, MOD RHEUMATOL, V18, P455, DOI 10.1007/s10165-008-0078-4; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Khurshudian AV, 2003, ORAL SURG ORAL MED O, V95, P38, DOI 10.1067/moe.2003.30; Kim EC, 2009, AM J OPHTHALMOL, V147, P206, DOI 10.1016/j.ajo.2008.08.015; KRUIZE AA, 1993, ANN RHEUM DIS, V52, P360, DOI 10.1136/ard.52.5.360; Leung KCM, 2008, CLIN RHEUMATOL, V27, P429, DOI 10.1007/s10067-007-0723-x; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Marsh P, 1999, OPHTHALMOLOGY, V106, P811, DOI 10.1016/S0161-6420(99)90171-9; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Miyawaki S, 1999, INTERNAL MED, V38, P938, DOI 10.2169/internalmedicine.38.938; Nakayamada Shingo, 2007, Mod Rheumatol, V17, P464; Ono M, 2004, AM J OPHTHALMOL, V138, P6, DOI 10.1016/j.ajo.2004.02.010; Papas AS, 2004, JCR-J CLIN RHEUMATOL, V10, P169, DOI 10.1097/01.rhu.0000135553.08057.21; Pers JO, 2007, ARTHRITIS RHEUM, V56, P1464, DOI 10.1002/art.22603; Petrone D, 2002, ARTHRITIS RHEUM, V46, P748, DOI 10.1002/art.510; Pflugfelder SC, 2004, AM J OPHTHALMOL, V138, P444, DOI 10.1016/j.ajo.2004.04.052; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Pijpe J, 2007, ANN RHEUM DIS, V66, P107, DOI 10.1136/ard.2006.052647; Pijpe J, 2009, ARTHRITIS RHEUM-US, V60, P3251, DOI 10.1002/art.24903; Pillemer SR, 2004, ARTHRIT RHEUM-ARTHR, V51, P601, DOI 10.1002/art.20540; Pillemer SR, 2004, ARTHRIT RHEUM-ARTHR, V51, P505, DOI 10.1002/art.20416; Price EJ, 1998, J RHEUMATOL, V25, P896; Ramos-Casals M, 2005, ANN RHEUM DIS, V64, P347, DOI 10.1136/ard.2004.025676; Ramos-Casals M., 2007, CURRENT DIAGNOSIS TR, P237; Ramos-Casals M, 2008, MEDICINE, V87, P345, DOI 10.1097/MD.0b013e318190f170; Ramos-Casals M, 2008, MEDICINE, V87, P210, DOI 10.1097/MD.0b013e318181e6af; RAMOSCASALS M, 2010, CLIN EXP RHEUMATOL; Rihl M, 2009, RHEUMATOLOGY, V48, P796, DOI 10.1093/rheumatology/kep104; Roberts CW, 2007, CORNEA, V26, P805, DOI 10.1097/ICO.0b013e318074e460; Sall K, 2000, OPHTHALMOLOGY, V107, P631, DOI 10.1016/S0161-6420(99)00176-1; Sall Ken N, 2006, Eye Contact Lens, V32, P21, DOI 10.1097/01.icl.0000170599.57728.29; Sankar V, 2004, ARTHRITIS RHEUM-US, V50, P2240, DOI 10.1002/art.20299; Seitsalo H, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-11; Seror R, 2007, ANN RHEUM DIS, V66, P351, DOI 10.1136/ard.2006.057919; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shiozawa S, 1998, J INTERF CYTOK RES, V18, P255, DOI 10.1089/jir.1998.18.255; Sjogren H., 1933, ACTA OPHTHALMOL    S, V11, P1, DOI DOI 10.1111/J.1755-3768.1935.TB04186.X; Skopouli FN, 1996, CLIN EXP RHEUMATOL, V14, P555; Steinfeld SD, 1999, RHEUMATOLOGY, V38, P814, DOI 10.1093/rheumatology/38.9.814; Steinfeld SD, 2001, ARTHRITIS RHEUM, V44, P2371, DOI 10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W; Steinfeld SD, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2018; Stevenson D, 2000, OPHTHALMOLOGY, V107, P967, DOI 10.1016/S0161-6420(00)00035-X; Sugai S, 2009, MOD RHEUMATOL, V19, P114, DOI 10.1007/s10165-008-0141-1; Tauber J, 2004, CORNEA, V23, P784, DOI 10.1097/01.ico.0000133993.14768.a9; ter Borg EJ, 2002, NETH J MED, V60, P402; TETZLAFF JM, COCHRANE BIAS METHOD; Tishler M, 1999, ANN RHEUM DIS, V58, P253, DOI 10.1136/ard.58.4.253; Toker E, 2010, CORNEA, V29, P133, DOI 10.1097/ICO.0b013e3181acf68d; Tsifetaki N, 2003, ANN RHEUM DIS, V62, P1204, DOI 10.1136/ard.2002.003889; Van Woerkom JM, 2007, ANN RHEUM DIS, V66, P1026, DOI 10.1136/ard.2006.060905; Virkki LM, 2010, ARTHRIT CARE RES, V62, P118, DOI 10.1002/acr.20022; Vivino FB, 1999, ARCH INTERN MED, V159, P174, DOI 10.1001/archinte.159.2.174; WALTERS MT, 1986, SCAND J RHEUMATOL, P253; Willeke P, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2322; Wu CH, 2006, J FORMOS MED ASSOC, V105, P796, DOI 10.1016/S0929-6646(09)60266-7; Yamada H, 2007, CLIN RHEUMATOL, V26, P1320, DOI 10.1007/s10067-006-0507-8; Zandbelt MM, 2004, J RHEUMATOL, V31, P96	74	229	240	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					452	460		10.1001/jama.2010.1014	http://dx.doi.org/10.1001/jama.2010.1014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664046	Bronze			2022-12-28	WOS:000280350100029
J	Shawcross, DL; O'Grady, JG				Shawcross, Debbie L.; O'Grady, John G.			The 6-month abstinence rule in liver transplantation	LANCET			English	Editorial Material							ALCOHOLIC HEPATITIS; DISEASE; SURVIVAL; STEROIDS; RELAPSE		[Shawcross, Debbie L.; O'Grady, John G.] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	O'Grady, JG (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	john.o'grady@kcl.ac.uk	Shawcross, Debbie Lindsay/H-9669-2012	Shawcross, Debbie Lindsay/0000-0001-6133-4619				Beresford TP, 2000, LIVER TRANSPLANT, V6, P777, DOI 10.1053/jlts.2000.19027; BIRD GLA, 1990, BRIT MED J, V301, P15, DOI 10.1136/bmj.301.6742.15; Castel H, 2009, HEPATOLOGY, V50, p307A; Dureja P, 2010, J HEPATOL, V52, P759, DOI 10.1016/j.jhep.2009.12.021; KUMAR S, 1990, HEPATOLOGY, V11, P159, DOI 10.1002/hep.1840110202; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Neuberger J, 2002, J HEPATOL, V36, P130, DOI 10.1016/S0168-8278(01)00278-1; O'Grady JG, 2006, GUT, V55, P1529, DOI 10.1136/gut.2005.090506; OSORIO RW, 1994, HEPATOLOGY, V20, P105, DOI 10.1016/0270-9139(94)90141-4; SHAWCROSS D, 2009, BRIT MED J, V338, P1081; Tandon P, 2009, AM J GASTROENTEROL, V104, P1700, DOI 10.1038/ajg.2009.226	12	40	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					216	217		10.1016/S0140-6736(10)60487-4	http://dx.doi.org/10.1016/S0140-6736(10)60487-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20656110				2022-12-28	WOS:000280457200009
J	Brashares, JS				Brashares, Justin S.			Filtering Wildlife	SCIENCE			English	Editorial Material							EXTINCTION; MAMMALS; DECLINE		Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Brashares, JS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	brashares@berkeley.edu						Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Hebblewhite M, 2010, CONSERV BIOL, V24, P341, DOI 10.1111/j.1523-1739.2009.01343.x; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Marton-Lefevre J, 2010, SCIENCE, V327, P1179, DOI 10.1126/science.1188424; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rodrigues ASL, 2006, SCIENCE, V313, P1051, DOI 10.1126/science.1131302; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; White J, 2003, MATER WORLD, V11, P2; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; WRIGHT GM, 1934, US DEP INT WILD DIV, V2	16	17	20	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					402	403		10.1126/science.1190095	http://dx.doi.org/10.1126/science.1190095			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651143				2022-12-28	WOS:000280196500025
J	Kale, SD; Gu, BA; Capelluto, DGS; Dou, DL; Feldman, E; Rumore, A; Arredondo, FD; Hanlon, R; Fudal, I; Rouxel, T; Lawrence, CB; Shan, WX; Tyler, BM				Kale, Shiv D.; Gu, Biao; Capelluto, Daniel G. S.; Dou, Daolong; Feldman, Emily; Rumore, Amanda; Arredondo, Felipe D.; Hanlon, Regina; Fudal, Isabelle; Rouxel, Thierry; Lawrence, Christopher B.; Shan, Weixing; Tyler, Brett M.			External Lipid PI3P Mediates Entry of Eukaryotic Pathogen Effectors into Plant and Animal Host Cells	CELL			English	Article							PHYTOPHTHORA-SOJAE; PLASMODIUM-FALCIPARUM; MOLECULAR-BASIS; PROTEINS; AVIRULENCE; GENE; RESISTANCE; VIRULENCE; RECOGNITION; DYNAMICS	Pathogens of plants and animals produce effector proteins that are transferred into the cytoplasm of host cells to suppress host defenses. One type of plant pathogens, oomycetes, produces effector proteins with N-terminal RXLR and dEER motifs that enable entry into host cells. We show here that effectors of another pathogen type, fungi, contain functional variants of the RXLR motif, and that the oomycete and fungal RXLR motifs enable binding to the phospholipid, phosphatidylinositol-3-phosphate (PI3P). We find that PI3P is abundant on the outer surface of plant cell plasma membranes and, furthermore, on some animal cells. All effectors could also enter human cells, suggesting that PI3P-mediated effector entry may be very widespread in plant, animal and human pathogenesis. Entry into both plant and animal cells involves lipid raft-mediated endocytosis. Blocking PI3P binding inhibited effector entry, suggesting new therapeutic avenues.	[Gu, Biao; Shan, Weixing] NW A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China; [Gu, Biao; Shan, Weixing] NW A&F Univ, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China; [Kale, Shiv D.; Gu, Biao; Dou, Daolong; Feldman, Emily; Rumore, Amanda; Arredondo, Felipe D.; Hanlon, Regina; Lawrence, Christopher B.; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Capelluto, Daniel G. S.; Rumore, Amanda; Lawrence, Christopher B.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Fudal, Isabelle; Rouxel, Thierry] INRA Bioger, F-78850 Thiverval Grignon, France	Northwest A&F University - China; Northwest A&F University - China; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Shan, WX (corresponding author), NW A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China.	wxshan@nwsuaf.edu.cn; bmtyler@vt.edu	Gu, Biao/AAT-8220-2021; Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642; Shan, Weixing/0000-0001-7286-4041; Fudal, Isabelle/0000-0002-9105-9432	National Research Initiative of the USDA National Institute of Food and Agriculture [2007-35319-18100]; U.S. National Science Foundation [IOS-0924861]; Ministry of Science and Technology of China [2006CB101901]; Earmarked Fund for Modern Agro-industry Technology Research System of China; China Scholarship Council via NW A F University [2007U27066]; Direct For Biological Sciences [0924861] Funding Source: National Science Foundation	National Research Initiative of the USDA National Institute of Food and Agriculture; U.S. National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Earmarked Fund for Modern Agro-industry Technology Research System of China; China Scholarship Council via NW A F University(China Scholarship Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The project was conceived by B. M. T, W. S., and D. D., and the experiments were planned by all authors. S. D. K. and B. G. conducted most of the experiments with contributions from D. G. S. C., D. D., E. F., A. C., R. H., and F. A. S. D. K and B. M. T wrote the paper with input from all authors. We thank Furong Sun and Vincenzo Antignani for technical assistance; Rays Jiang (Broad Institute) for bioinformatics assistance; John McDowell, Ryan Anderson (Virginia Tech), and Frank Takken (University of Amsterdam) for useful discussions; Joop Vermeer and Teun Munnik (University of Amsterdam) for the Hrs-2xFYVE biosensor gene; Michael Klemba (Virginia Tech) for human erythrocytes, Saghai Maroof (Virginia Tech) for soybean seed and Maureen Lawrence, Lisa Gunderman and Emily Alberts for manuscript preparation. This work was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture, grant number #2007-35319-18100 (to B. M. T), by the U.S. National Science Foundation, grant number IOS-0924861 (to B. M. T), in part by the 973 program of the Ministry of Science and Technology of China, grant #2006CB101901 and by grant 15 from the Earmarked Fund for Modern Agro-industry Technology Research System of China (to W. S.). S. D. K. was supported in part by a U.S. National Science Foundation predoctoral fellowship and B. G. was supported by a China Scholarship Council fellowship, #2007U27066, via NW A & F University.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Boon JM, 2002, MED RES REV, V22, P251, DOI 10.1002/med.10009; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Fudal I, 2007, MOL PLANT MICROBE IN, V20, P459, DOI 10.1094/MPMI-20-4-0459; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KALE SD, 2009, METHODS MOL BIOL PLA; KHANG CH, 2010, PLANT CELL, V22, DOI DOI 10.1105/TPC.1109.069666; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Langel U., 2006, HDB CELL PENETRATING; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lord JM, 1999, CELL MICROBIOL, V1, P85, DOI 10.1046/j.1462-5822.1999.00015.x; Lou Y, 2006, PLANT MOL BIOL, V60, P729, DOI 10.1007/s11103-005-5548-x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; QUINN PJ, 2002, SUBCELLULAR BIOCH, P39; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Sarma GN, 2005, PLANT CELL, V17, P3190, DOI 10.1105/tpc.105.034918; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Vermeer JEM, 2006, PLANT J, V47, P687, DOI 10.1111/j.1365-313X.2006.02830.x; Vermeer JEM, 2009, PLANT J, V57, P356, DOI 10.1111/j.1365-313X.2008.03679.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	44	286	309	6	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					284	295		10.1016/j.cell.2010.06.008	http://dx.doi.org/10.1016/j.cell.2010.06.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655469	Bronze			2022-12-28	WOS:000280204300019
J	Choi, JH; Banks, AS; Estall, JL; Kajimura, S; Bostrom, P; Laznik, D; Ruas, JL; Chalmers, MJ; Kamenecka, TM; Bluher, M; Griffin, PR; Spiegelman, BM				Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Chalmers, Michael J.; Kamenecka, Theodore M.; Blueher, Matthias; Griffin, Patrick R.; Spiegelman, Bruce M.			Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR gamma by Cdk5	NATURE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; LIGAND-BINDING; ADIPOSE-TISSUE; OLIGONUCLEOTIDE ARRAYS; EXPRESSION; ADIPOGENESIS; HORMONE; THIAZOLIDINEDIONES; STIMULATION	Obesity induced in mice by high-fat feeding activates the protein kinase Cdk5 (cyclin-dependent kinase 5) in adipose tissues. This results in phosphorylation of the nuclear receptor PPAR gamma (peroxisome proliferator-activated receptor c), a dominant regulator of adipogenesis and fat cell gene expression, at serine 273. This modification of PPAR gamma does not alter its adipogenic capacity, but leads to dysregulation of a large number of genes whose expression is altered in obesity, including a reduction in the expression of the insulin-sensitizing adipokine, adiponectin. The phosphorylation of PPAR gamma by Cdk5 is blocked by anti-diabetic PPAR gamma ligands, such as rosiglitazone and MRL24. This inhibition works both in vivo and in vitro, and is completely independent of classical receptor transcriptional agonism. Similarly, inhibition of PPAR gamma phosphorylation in obese patients by rosiglitazone is very tightly associated with the anti-diabetic effects of this drug. All these findings strongly suggest that Cdk5-mediated phosphorylation of PPAR gamma may be involved in the pathogenesis of insulin-resistance, and present an opportunity for development of an improved generation of anti-diabetic drugs through PPAR gamma.	[Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Metab & Chron Dis, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Chalmers, Michael J.; Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Scripps Research Institute; Leipzig University	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019; Banks, Alexander/B-4832-2012; Ruas, Jorge/AAE-6094-2019; Choi, Jang Hyun/B-3055-2012	Kajimura, Shingo/0000-0003-0672-5910; Banks, Alexander/0000-0003-1787-6925; Ruas, Jorge/0000-0002-1110-2606; Chalmers, Michael/0000-0002-2139-6089; Estall, Jennifer/0000-0002-9838-1440	NIH [DK31405, DK087853]; Deutsche Forschungsgemeinschaft (DFG); N National Institute of Mental Health [U54-MH084512]; NIH National Institute of General Medical Sciences [R01-GM084041]; Clinical Research group [KFO 152, BL 833/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, R01DK031405, R00DK087853, K99DK087853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); N National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clinical Research group; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Mootha for help with the analysis of microarray data and for critical comments. We thank M. Kirschner for a critical reading of the manuscript and for comments. We are grateful to R. Gupta and P. Cohen for critical comments on the manuscript. J.H.C., A.S.B., J.L.E., P.B., D.L., J.L.R. and B.M.S are supported by NIH DK31405. S.K. is supported by NIH grant DK087853. M.B. is supported by a grant from Deutsche Forschungsgemeinschaft (DFG) and the Clinical Research group 'Atherobesity' KFO 152 (project BL 833/1-1). P.R.G., M.J.C. and T.M.K. are supported in part by the by the Intramural Research Program of the N National Institute of Mental Health (P.R.G., M.J.C., T.M.K., U54-MH084512; H. Rosen Principal Investigator) and by the NIH National Institute of General Medical Sciences (P.R.G. and M.J.C., R01-GM084041).	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Musa FRM, 2000, J ANDROL, V21, P392; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ostberg T, 2004, J BIOL CHEM, V279, P41124, DOI 10.1074/jbc.M401552200; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Salim C, 2009, GLIA, V57, P535, DOI 10.1002/glia.20782; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	46	631	660	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					451	U1		10.1038/nature09291	http://dx.doi.org/10.1038/nature09291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651683	Green Accepted			2022-12-28	WOS:000280141200027
J	Coppell, KJ; Kataoka, M; Williams, SM; Chisholm, AW; Vorgers, SM; Mann, JI				Coppell, Kirsten J.; Kataoka, Minako; Williams, Sheila M.; Chisholm, Alex W.; Vorgers, Sue M.; Mann, Jim I.			Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment-Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; SELF-MANAGEMENT; INSULIN; MELLITUS; AGENTS; REGIMENS; REGISTER; IMPROVES; ADULTS	Objective To determine the extent to which intensive dietary intervention can influence glycaemic control and risk factors for cardiovascular disease in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment. Design Randomised controlled trial. Setting Dunedin, New Zealand. Participants 93 participants aged less than 70 years with type 2 diabetes and a glycated haemoglobin (HbA(1c)) of more than 7% despite optimised drug treatments plus at least two of overweight or obesity, hypertension, and dyslipidaemia. Intervention Intensive individualised dietary advice (according to the nutritional recommendations of the European Association for the Study of Diabetes) for six months; both the intervention and control participants continued with their usual medical surveillance. Main outcome measures HbA(1c) was the primary outcome. Secondary outcomes included measures of adiposity, blood pressure, and lipid profile. Results After adjustment for age, sex, and baseline measurements, the difference in HbA(1c) between the intervention and control groups at six months (-0.4%, 95% confidence interval -0.7% to -0.1%) was highly statistically significant (P=0.007), as were the decreases in weight (-1.3 kg, -2.4 to -0.1 kg; P=0.032), body mass index (-0.5, -0.9 to -0.1; P=0.026), and waist circumference (-1.6 cm, -2.7 to -0.5 cm; P=0.005). A decrease in saturated fat (-1.9% total energy, -3.3% to -0.6%; P=0.006) and an increase in protein (1.6% total energy, 0.04% to 3.1%; P=0.045) in the intervention group were the most striking differences in nutritional intake between the two groups. Conclusions Intensive dietary advice has the potential to appreciably improve glycaemic control and anthropometric measures in patients with type 2 diabetes and unsatisfactory HbA(1c) despite optimised hypoglycaemic drug treatment.	[Coppell, Kirsten J.; Mann, Jim I.] Univ Otago, Dept Med & Surg Sci, Edgar Natl Ctr Diabet & Obes Res, Dunedin 9054, New Zealand; [Kataoka, Minako; Chisholm, Alex W.; Vorgers, Sue M.] Univ Otago, Dept Human Nutr, Dunedin 9054, New Zealand; [Williams, Sheila M.] Univ Otago, Dept Prevent & Social Med, Dunedin 9054, New Zealand	University of Otago; University of Otago; University of Otago	Coppell, KJ (corresponding author), Univ Otago, Dept Med & Surg Sci, Edgar Natl Ctr Diabet & Obes Res, POB 913, Dunedin 9054, New Zealand.	kirsten.coppell@otago.ac.nz	Williams, Sheila/L-4028-2019		Health Research Council of New Zealand [06/352]; Southern Trust, New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); Southern Trust, New Zealand	This study was supported by grants from the Health Research Council of New Zealand (06/352) and the Southern Trust, New Zealand. The funders had no role in any aspect of the study.	Aas AM, 2005, DIABETIC MED, V22, P316, DOI 10.1111/j.1464-5491.2005.01421.x; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; ARY DV, 1986, DIABETES CARE, V9, P168, DOI 10.2337/diacare.9.2.168; Bauman Adrian, 2003, N Z Med J, V116, pU535; Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903; Clar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006112; Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB, P56; Coppell Kirsten, 2002, N Z Med J, V115, pU146; Coppell KJ, 2006, DIABETES RES CLIN PR, V71, P345, DOI 10.1016/j.diabres.2005.08.006; Ellasson B, 2007, DIABETES METAB, V33, P269, DOI 10.1016/j.diabet.2007.02.003; Espeland M, 2007, DIABETES CARE, V30, P1374; Fonseca V, 2007, DIABETOLOGIA, V50, P1148, DOI 10.1007/s00125-007-0633-0; FUNNELL MM, 2002, AMJ PREV MED S4, V22, pS3; Gallwitz B, 2010, DIABETES OBES METAB, V12, P1, DOI 10.1111/j.1463-1326.2009.01095.x; Goudswaard AN, 2004, DIABETIC MED, V21, P491, DOI 10.1111/j.1464-5491.2004.01153.x; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; Hollander P, 2007, ARCH INTERN MED, V167, P1284, DOI 10.1001/archinte.167.12.1284; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Mann DM, 2009, ARCH INTERN MED, V169, P1718, DOI 10.1001/archinternmed.2009.296; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Ministry of Health, 2008, PORTR HLTH KEY RES 2; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; New Zealand Guidelines Group, 2003, MAN TYP 2 DIAB; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Perry TL, 1997, EUR J CLIN NUTR, V51, P757, DOI 10.1038/sj.ejcn.1600478; Rivellese AA, 2008, EUR J CLIN NUTR, V62, P660, DOI 10.1038/sj.ejcn.1602755; Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SIMPSON HCR, 1981, LANCET, V1, P1; Snoek FJ, 2000, INT J OBESITY, V24, pS12, DOI 10.1038/sj.ijo.0801421; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TRUSWELL AS, 1975, BRIT MED J, V4, P7, DOI 10.1136/bmj.4.5987.7; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wolf AM, 2004, DIABETES CARE, V27, P1570, DOI 10.2337/diacare.27.7.1570; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	37	110	116	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2010	341								c3337	10.1136/bmj.c3337	http://dx.doi.org/10.1136/bmj.c3337			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GV	20647285	Green Published, hybrid			2022-12-28	WOS:000280411600001
J	Tsapas, A				Tsapas, Apostolos			Review: Metformin does not increase risk for lactic acidosis in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki	Tsapas, A (corresponding author), Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece.		Tsapas, Apostolos/P-5593-2019	Tsapas, Apostolos/0000-0003-0221-4072				Bodmer M, 2008, DIABETES CARE, V31, P2086, DOI 10.2337/dc08-1171; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holstein A, 2005, DIABETOLOGIA, V48, P2454, DOI 10.1007/s00125-005-0026-1; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y	4	4	4	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-9	10.7326/0003-4819-153-2-201007200-02009	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643987				2022-12-28	WOS:000280095400027
J	Lutz, S				Lutz, Stefan			BIOCHEMISTRY Reengineering Enzymes	SCIENCE			English	Editorial Material							DIELS-ALDER REACTION; CATALYSIS; DESIGN		Emory Univ, Dept Chem, Atlanta, GA 30322 USA	Emory University	Lutz, S (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	sal2@emory.edu	Lutz, Stefan/H-7853-2013		NIGMS NIH HHS [GM69958, R01 GM069958] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069958] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; HILVERT D, 1989, J AM CHEM SOC, V111, P9261, DOI 10.1021/ja00208a037; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kazlauskas RJ, 2009, NAT CHEM BIOL, V5, P526, DOI 10.1038/nchembio0809-526; Koszelewski D, 2008, ADV SYNTH CATAL, V350, P2761, DOI 10.1002/adsc.200800496; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Tarasow TM, 1997, NATURE, V389, P54, DOI 10.1038/37950; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203	16	18	20	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					285	287		10.1126/science.1192224	http://dx.doi.org/10.1126/science.1192224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647454	Green Accepted			2022-12-28	WOS:000279925900026
J	Nelson, EAS; Glass, RI				Nelson, E. Anthony S.; Glass, Roger I.			Rotavirus: realising the potential of a promising vaccine	LANCET			English	Editorial Material							EFFICACY; GASTROENTERITIS; DIARRHEA; SAFETY		[Nelson, E. Anthony S.] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Nelson, EAS (corresponding author), Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	tony-nelson@cuhk.edu.hk	Nelson, E Anthony S/ABF-4238-2020	Nelson, E Anthony S/0000-0002-2521-3403				Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Butcher J, 2007, LANCET, V369, P91, DOI 10.1016/S0140-6736(07)60049-X; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3513; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Phua KB, 2009, VACCINE, V27, P5936, DOI 10.1016/j.vaccine.2009.07.098; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; United Nations Development Programme, HUM DEV REP 2009; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2007, INT J INFECT DIS, V11, pS29, DOI 10.1016/S1201-9712(07)60019-8; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; *WHO, 2009, MMWR WKLY EPIDEMIOL, V84, P533; *WHO, 2009, MMWR WKLY EPIDEMIOL, V84, P220; *WHO, 2007, MMWR WKLY EPIDEMIOL, V82, P285; Widdowson MA, 2009, J INFECT DIS, V200, pS1, DOI 10.1086/605061; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	19	39	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					568	570		10.1016/S0140-6736(10)60896-3	http://dx.doi.org/10.1016/S0140-6736(10)60896-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20692032				2022-12-28	WOS:000281309100005
J	Warnke, PH				Warnke, Patrick H.			In-vivo tissue engineering of biological joint replacements	LANCET			English	Editorial Material							BONE; DISEASE; DECADE		Bond Univ, Fac Med & Hlth Sci, Gold Coast, Qld 4229, Australia	Bond University	Warnke, PH (corresponding author), Bond Univ, Fac Med & Hlth Sci, Gold Coast, Qld 4229, Australia.	pwarnke@bond.edu.au						Brooks PM, 2006, CLIN RHEUMATOL, V25, P778, DOI 10.1007/s10067-006-0240-3; Brooks PM, 2000, MED J AUSTRALIA, V172, P307, DOI 10.5694/j.1326-5377.2000.tb123972.x; Cullinane DM, 2003, J EXP BIOL, V206, P2459, DOI 10.1242/jeb.00453; Karrholm J, SWEDISH HIP ARTHROPL; LEE CH, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60668-X; *MYJOINT, BIOL JOINT REPL PROJ; Soderman P, 2001, ACTA ORTHOP SCAND, V72, P113, DOI 10.1080/000164701317323345; Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050; Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3; Weinstein SL, 2000, J BONE JOINT SURG AM, V82A, P1	10	12	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 7	2010	376	9739					394	396		10.1016/S0140-6736(10)60931-2	http://dx.doi.org/10.1016/S0140-6736(10)60931-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20692514				2022-12-28	WOS:000281012900006
J	Barsotti, AM; Prives, C				Barsotti, Anthony M.; Prives, Carol			Noncoding RNAs: The Missing "Linc" in p53-Mediated Repression	CELL			English	Editorial Material							ONE PROTEIN; HNRNP-K; P53; TARGET		[Barsotti, Anthony M.; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	clp3@columbia.edu						Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Shi M, 2010, BBA-REV CANCER, V1805, P218, DOI 10.1016/j.bbcan.2009.12.001	9	16	17	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					358	360		10.1016/j.cell.2010.07.029	http://dx.doi.org/10.1016/j.cell.2010.07.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691894	Bronze			2022-12-28	WOS:000280609100010
J	Lee, CC; Hu, YL; Ribbe, MW				Lee, Chi Chung; Hu, Yilin; Ribbe, Markus W.			Vanadium Nitrogenase Reduces CO	SCIENCE			English	Article							CHEMISTRY; MECHANISM		[Lee, Chi Chung; Hu, Yilin; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			Herman Frasch Foundation [617-HF07]; NIH [GM-67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	Herman Frasch Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees of Caltech (Pasadena) for help on the GC-MS analysis. This work was supported by Herman Frasch Foundation grant 617-HF07 (M. W. R.) and NIH grant GM-67626 (M.W.R.).	Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Hill HGM, 2003, ASTROBIOLOGY, V3, P291, DOI 10.1089/153110703769016389; ROBSON RL, 1986, NATURE, V322, P388, DOI 10.1038/322388a0; ROFERDEPOORTER CK, 1981, CHEM REV, V81, P447, DOI 10.1021/cr00045a002; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553	6	188	189	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					642	642		10.1126/science.1191455	http://dx.doi.org/10.1126/science.1191455			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689010	Green Accepted			2022-12-28	WOS:000280602700028
J	Moore, W				Moore, Wendy			Past Caring Ye olde Tudor health market	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						CLOWES W, 1948, SELECTED WRITINGS; Pelling Margaret, 1979, HLTH MED MORTALITY 1	2	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2010	341								c4125	10.1136/bmj.c4125	http://dx.doi.org/10.1136/bmj.c4125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636WI	20685774				2022-12-28	WOS:000280774000023
J	Krumholz, HM; Hayward, RA				Krumholz, Harlan M.; Hayward, Rodney A.			Shifting views on lipid lowering therapy	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; STATIN THERAPY; HEART-FAILURE; CANCER-RISK; METAANALYSIS; DISEASE; CHOLESTEROL; PREVENTION; EZETIMIBE; HYPERCHOLESTEROLEMIA		[Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Hayward, Rodney A.] VA Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA	Yale University; Yale University; Yale University; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020					Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bonovas S, 2006, J CLIN ONCOL, V24, P4808, DOI 10.1200/JCO.2006.06.3560; *BRIDG EXC, COR ART DIS CAR LINK; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Cannon CP, 2010, LANCET, V375, P700, DOI 10.1016/S0140-6736(10)60234-6; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Hayward RA, 2006, ANN INTERN MED, V145, P520, DOI 10.7326/0003-4819-145-7-200610030-00010; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee TH, 2000, JAMA-J AM MED ASSOC, V283, P94, DOI 10.1001/jama.283.1.94; *NAT HEART LUNG BL, 2001, DET EV TREATM HIGH B; PETTYPIECE S, 2008, BLOOMBERG       0116; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Steinberg D, 2008, CIRCULATION, V118, P672, DOI 10.1161/CIRCULATIONAHA.107.753152; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x; 1988, ARCH INTERN MED, V148, P36	25	12	12	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2010	341								c3531	10.1136/bmj.c3531	http://dx.doi.org/10.1136/bmj.c3531			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634GZ	20667950				2022-12-28	WOS:000280570100001
J	Holzel, M; Huang, SD; Koster, J; Ora, I; Lakeman, A; Caron, H; Nijkamp, W; Xie, J; Callens, T; Asgharzadeh, S; Seeger, RC; Messiaen, L; Versteeg, R; Bernards, R				Holzel, Michael; Huang, Sidong; Koster, Jan; Ora, Ingrid; Lakeman, Arjan; Caron, Huib; Nijkamp, Wouter; Xie, Jing; Callens, Tom; Asgharzadeh, Shahab; Seeger, Robert C.; Messiaen, Ludwine; Versteeg, Rogier; Bernards, Rene			NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome	CELL			English	Article							HIGH-RISK NEUROBLASTOMA; NEUROFIBROMATOSIS TYPE-1; NOONAN-SYNDROME; INDUCED DIFFERENTIATION; 13-CIS-RETINOIC ACID; GENE-MUTATIONS; CHROMOSOME 1P; NIH3T3 CELLS; RAR-ALPHA; EXPRESSION	Retinoic acid (RA) induces differentiation of neuroblastoma cells in vitro and is used with variable success to treat aggressive forms of this disease. This variability in clinical response to RA is enigmatic, as no mutations in components of the RA signaling cascade have been found. Using a large-scale RNAi genetic screen, we identify crosstalk between the tumor suppressor NF1 and retinoic acid-induced differentiation in neuroblastoma. Loss of NF1 activates RAS-MEK signaling, which in turn represses ZNF423, a critical transcriptional coactivator of the retinoic acid receptors. Neuroblastomas with low levels of both NF1 and ZNF423 have extremely poor outcome. We find NF1 mutations in neuroblastoma cell lines and in primary tumors. Inhibition of MEK signaling downstream of NF1 restores responsiveness to RA, suggesting a therapeutic strategy to overcome RA resistance in NF1-deficient neuroblastomas.	[Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [Koster, Jan; Ora, Ingrid; Lakeman, Arjan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands; [Caron, Huib] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, NL-1100 DE Amsterdam, Netherlands; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Childrens Hosp Los Angeles, Div Hematol Oncol, Dept Pediat, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Xie, Jing; Callens, Tom; Messiaen, Ludwine] Univ Alabama, Med Genom Lab, Dept Genet, Birmingham, AL 35294 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Alabama System; University of Alabama Birmingham	Bernards, R (corresponding author), Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Versteeg, Rogier/AAQ-1765-2020; Øra, Ingrid/J-2596-2013; Koster, Jan/C-5934-2008	Øra, Ingrid/0000-0002-3931-4125; Koster, Jan/0000-0002-0890-7585; Huang, Sidong/0000-0002-2838-4726; Asgharzadeh, Shahab/0000-0002-0510-3848; Versteeg, Rogier/0000-0001-7172-0388; Bernards, Rene/0000-0001-8677-3423	Netherlands Genomics Initiative (NGI); US National Institutes of Health [R01-CA60104, K12-CA60104]; Dutch Cancer Society; NATIONAL CANCER INSTITUTE [R01CA060104] Funding Source: NIH RePORTER	Netherlands Genomics Initiative (NGI); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Hauptmann for statistical advice, the NKI microarray facility for supporting gene expression studies, and C. Sun for assistance. This work was supported by The Netherlands Genomics Initiative (NGI), grants from the US National Institutes of Health R01-CA60104 (R.C.S.) and K12-CA60104 (S.A.), and a grant from the Dutch Cancer Society (KWF).	Antonyak MA, 2003, J BIOL CHEM, V278, P15859, DOI 10.1074/jbc.M300037200; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; BUNONE G, 1995, EXP CELL RES, V217, P92, DOI 10.1006/excr.1995.1067; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; COTTON JL, 1995, ARCH PEDIAT ADOL MED, V149, P1280, DOI 10.1001/archpedi.1995.02170240098019; Delaune A, 2008, J NEUROCHEM, V104, P89, DOI 10.1111/j.1471-4159.2007.05019.x; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Griffiths S, 2007, FAM CANCER, V6, P21, DOI 10.1007/s10689-006-9001-3; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; KOSA K, 1995, CANCER RES, V55, P4850; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Martinsson T, 1997, CANCER GENET CYTOGEN, V95, P183, DOI 10.1016/S0165-4608(96)00259-2; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; MOLEY JF, 1991, CANCER RES, V51, P1596; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Origone P, 2003, AM J MED GENET A, V118A, P309, DOI 10.1002/ajmg.a.10167; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Verheijen MHG, 1999, J BIOL CHEM, V274, P1487, DOI 10.1074/jbc.274.3.1487; Wimmer K, 2006, GENE CHROMOSOME CANC, V45, P265, DOI 10.1002/gcc.20289; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103	45	130	137	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					218	229		10.1016/j.cell.2010.06.004	http://dx.doi.org/10.1016/j.cell.2010.06.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655465	Green Accepted, Bronze			2022-12-28	WOS:000280204300014
J	Power, M; Wigglesworth, N; Donaldson, E; Chadwick, P; Gillibrand, S; Goldmann, D				Power, Maxine; Wigglesworth, Neil; Donaldson, Emma; Chadwick, Paul; Gillibrand, Stephen; Goldmann, Donald			Quality Improvement Report Reducing Clostridium difficile infection in acute care by using an improvement collaborative	BRITISH MEDICAL JOURNAL			English	Article							DIARRHEA	Problem In 2006, despite a focus on infection control, Salford Royal had the fourth highest rate of Clostridium difficile infection in north west England. Design Interrupted time series in five collaborative wards ( intervention group) and 35 non-collaborative wards ( control group). Setting University teaching hospital with 850 acute beds. Key measures for improvement Number of cases of C difficile infection per 1000 occupied bed days. Strategies for change In February 2007, a newly formed antimicrobial team led the implementation of revised guidelines in all wards and departments. From March to December 2007, five wards participated in an improvement collaborative. Since December 2007, the changes from the collaborative have been collated and implemented throughout the organisation. Effects of change At baseline the non-collaborative wards had 1.15 (95% CI 1.03 to 1.29) cases per 1000 occupied bed days. In August 2007 cases reduced 56% from baseline (0.51, 0.44 to 0.60), which has been maintained since that time. In the collaborative wards, there were 2.60 (2.11 to 3.17) cases per 1000 occupied bed days at baseline. A shift occurred in April 2007 representing a reduction of 73% (0.69, 0.50 to 0.91) from baseline, which has been maintained. Lessons learnt Careful use of antimicrobial drugs is important in reducing the number of cases of C difficile infection. A collaborative learning model can enable teams to test and implement changes that can accelerate, amplify, and sustain control of C difficile.	[Power, Maxine] Dept Hlth, London SE1 6LH, England; [Wigglesworth, Neil] NHS E Lancashire, Nelson BB9 8AS, Lancs, England; [Donaldson, Emma; Chadwick, Paul; Gillibrand, Stephen] Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England; [Goldmann, Donald] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Goldmann, Donald] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Salford Royal NHS Foundation Trust; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement	Power, M (corresponding author), Dept Hlth, London SE1 6LH, England.	maxine.power@dh.gsi.gov.uk	Donaldson, Emma/AAT-4254-2021	Donaldson, Emma/0000-0002-8052-6744				[Anonymous], 2003, BREAKTHR SER IHIS CO; *DEP HLTH, 1994, CLOSTR DIFF INF PREV; *DEP HLTH HLTH PRO, 2009, CLOSTR DIFF INF DEAL; Health Protection Agency, RES MAND CLOSTR DIFF; *HLTH PROT AG, 2009, C DIFF MAND SURV N W; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525	9	14	14	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3359	10.1136/bmj.c3359	http://dx.doi.org/10.1136/bmj.c3359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GW	20659985				2022-12-28	WOS:000280411700001
J	Sawhney, V; Ezzat, VA; Sharp, ASP; Schilling, RJ				Sawhney, Vinit; Ezzat, Vivienne A.; Sharp, Andrew S. P.; Schilling, Richard J.			latrogenic asystole on the ITU	LANCET			English	Editorial Material							CAROTID-SINUS HYPERSENSITIVITY; DIAGNOSIS; SYNCOPE; GUIDELINES; MANAGEMENT; TRIAL		[Sawhney, Vinit; Ezzat, Vivienne A.; Schilling, Richard J.] St Bartholomews Hosp, Barts & London NHS Trust, Dept Cardiol, London EC1A 7BE, England; [Sharp, Andrew S. P.] Imperial Coll Hlth Care NHS Trust, Dept Cardiol, London, England	Barts Health NHS Trust; University of London; Queen Mary University London	Ezzat, VA (corresponding author), St Bartholomews Hosp, Barts & London NHS Trust, Dept Cardiol, Dominion House, London EC1A 7BE, England.	vaezzat@doctors.org.uk						Brignole M, 2004, EUR HEART J, V25, P2054, DOI 10.1016/j.ehj.2004.09.004; Kerr SRJ, 2006, ARCH INTERN MED, V166, P515, DOI 10.1001/archinte.166.5.515; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Parry SW, 2009, HEART, V95, P405, DOI 10.1136/hrt.2008.153189; Ryan DJ, 2010, HEART, V96, P347, DOI 10.1136/hrt.2009.176206	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					204	204		10.1016/S0140-6736(10)60702-7	http://dx.doi.org/10.1016/S0140-6736(10)60702-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20638566				2022-12-28	WOS:000280313100029
J	Wang, J; Chen, PJ; Wang, GJ; Keller, L				Wang, John; Chen, Pei-Jiun; Wang, George J.; Keller, Laurent			Chromosome Size Differences May Affect Meiosis and Genome Size	SCIENCE			English	Article									[Wang, John; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Chen, Pei-Jiun] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Wang, George J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wang, George J.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Lausanne; University of Lausanne; Howard Hughes Medical Institute; Stanford University; Stanford University	Wang, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	John.Wang@unil.ch; Laurent.Keller@unil.ch	keller, laurent/AAI-7175-2020; Wang, John/C-3690-2012	Wang, John/0000-0002-6179-775X; keller, laurent/0000-0002-5046-9953	NIH National Center for Research Resources; University of Lausanne Cellular Imaging Facility; Vital-IT Center for high-performance computing; Swiss National Science Foundation	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Lausanne Cellular Imaging Facility; Vital-IT Center for high-performance computing; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank W. Herr, P. Gonczy, A. W. Murray, and A. M. Villeneuve for comments on the manuscript; S. K. Kim and R. E. Ellis for discussions; W. Herr, in whose laboratory the experiments were performed; the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains; the University of Lausanne Cellular Imaging Facility; and the Vital-IT Center for high-performance computing. Supported by grants from the Swiss National Science Foundation to L.K. and W. Herr. L.K. thanks S. Leibler for hosting him during his sabbatical at Rockefeller University.	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Haag ES, 2007, TRENDS GENET, V23, P101, DOI 10.1016/j.tig.2007.01.002; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045	6	27	30	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					293	293		10.1126/science.1190130	http://dx.doi.org/10.1126/science.1190130			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647459	Green Published			2022-12-28	WOS:000279925900031
J	Halfon, N; Lu, MC				Halfon, Neal; Lu, Michael C.			Gestational weight gain and birthweight	LANCET			English	Editorial Material							MACROSOMIA		[Halfon, Neal; Lu, Michael C.] Univ Calif Los Angeles, Ctr Healthier Children Families & Commun, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Halfon, N (corresponding author), Univ Calif Los Angeles, Ctr Healthier Children Families & Commun, Los Angeles, CA 90024 USA.	nhalfon@ucla.edu						Ferber A, 2000, CLIN OBSTET GYNECOL, V43, P335, DOI 10.1097/00003081-200006000-00011; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Grassi AE, 2000, CLIN OBSTET GYNECOL, V43, P340, DOI 10.1097/00003081-200006000-00012; Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; RONNBERG A, 2010, BJOG, DOI DOI 10.1111/0.471-0528.2010.02619; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; 2009, NATL CHILDRENS STUDY	10	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2010	376	9745					937	938		10.1016/S0140-6736(10)61024-0	http://dx.doi.org/10.1016/S0140-6736(10)61024-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JZ	20691468				2022-12-28	WOS:000282247600007
J	Ferrante, G; Pugliese, F; Di Mario, C				Ferrante, Giuseppe; Pugliese, Francesca; Di Mario, Carlo			Jugular venous pressure: a cardinal sign	LANCET			English	Editorial Material									[Ferrante, Giuseppe] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00168 Rome, Italy; [Ferrante, Giuseppe; Di Mario, Carlo] Royal Brompton Hosp, Cardiovasc Dept, London SW3 6LY, England; [Pugliese, Francesca] Royal Brompton Hosp, Dept Radiol, London SW3 6LY, England; [Di Mario, Carlo] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London	Ferrante, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Cardiol, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	giu.ferrante@hotmail.it	Ferrante, Giuseppe/AAN-7122-2020; Ferrante, Giuseppe/K-5384-2016; Di Mario, Carlo/K-5185-2018	Ferrante, Giuseppe/0000-0001-9175-1464; Ferrante, Giuseppe/0000-0001-9175-1464; Di Mario, Carlo/0000-0002-4461-2055					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 4	2010	376	9743					802	802		10.1016/S0140-6736(09)61502-6	http://dx.doi.org/10.1016/S0140-6736(09)61502-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20708789				2022-12-28	WOS:000281831000031
J	Sharp, ZD; Shearer, CK; McKeegan, KD; Barnes, JD; Wang, YQ				Sharp, Z. D.; Shearer, C. K.; McKeegan, K. D.; Barnes, J. D.; Wang, Y. Q.			The Chlorine Isotope Composition of the Moon and Implications for an Anhydrous Mantle	SCIENCE			English	Article							EARTHS; IMPACT; ORIGIN; WATER	Arguably, the most striking geochemical distinction between Earth and the Moon has been the virtual lack of water (hydrogen) in the latter. This conclusion was recently challenged on the basis of geochemical data from lunar materials that suggest that the Moon's water content might be far higher than previously believed. We measured the chlorine isotope composition of Apollo basalts and glasses and found that the range of isotopic values [from -1 to +24 per mil (parts per thousand) versus standard mean ocean chloride] is 25 times the range for Earth. The huge isotopic spread is explained by volatilization of metal halides during basalt eruption-a process that could only occur if the Moon had hydrogen concentrations lower than those of Earth by a factor of similar to 10(4) to 10(5), implying that the lunar interior is essentially anhydrous.	[Sharp, Z. D.; Shearer, C. K.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87122 USA; [Shearer, C. K.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87122 USA; [McKeegan, K. D.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Barnes, J. D.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Wang, Y. Q.] Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA	University of New Mexico; University of New Mexico; University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Los Alamos National Laboratory	Sharp, ZD (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87122 USA.	zsharp@unm.edu	Barnes, Jaime D/B-5454-2011; McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X	NASA [07-SSO07-0077, NNX08AY786]; NSF; DOE Office of Basic Energy Sciences	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	Supported by NASA Origins grant 07-SSO07-0077 (Z.D.S.), NASA LASER grant NNX08AY786 (C.K.S.), and a NASA Cosmochemistry grant (K.D.M.). The UCLA ion microprobe facility is partially supported by a grant from the NSF Instrumentation and Facilities Program. We thank lunar curator G. Lofgren and staff of the Johnson Space Center, Houston. P. Burger provided imaging and quantitative elemental analyses of apatite. The Ion Beam Materials Laboratory at Los Alamos is partially supported by DOE Office of Basic Energy Sciences programs.	Abe Y., 2000, ORIGIN EARTH MOON, P413; Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Barnes JD, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002587; Barnes JD, 2008, GEOLOGY, V36, P883, DOI 10.1130/G25182A.1; Bonifacie M, 2008, SCIENCE, V319, P1518, DOI 10.1126/science.1150988; Cameron AGW, 1997, ICARUS, V126, P126, DOI 10.1006/icar.1996.5642; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CARLSON RW, 2000, ORIGIN EARTH MOON, P25; CHOU CL, 1975, P LUNAR PLANET SCI C, V2, P1701; COLSON RO, 1992, P LUNAR PLANET SCI, V22, P427; ESAT TM, 1988, GEOCHIM COSMOCHIM AC, V52, P1409, DOI 10.1016/0016-7037(88)90211-6; FEGLEY B, 1991, GEOPHYS RES LETT, V18, P2073, DOI 10.1029/91GL02624; Fegley B.J., 1993, RES NEAR EARTH SPACE, P367; GREENWOOD JP, 2010, LUNAR PLANET SCI C, V41; HUMAYUN M, 1995, GEOCHIM COSMOCHIM AC, V59, P2131, DOI 10.1016/0016-7037(95)00132-8; LIU Y, 2010, LUNAR PLANET SCI C, V41; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; McKay D. S., 1993, LUNAR PLANET SCI, V24, P961; Morris R.V., 1978, LUNAR PLANETARY SCI, V2, P2287; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Richter FM, 2007, GEOCHIM COSMOCHIM AC, V71, P5544, DOI 10.1016/j.gca.2007.09.005; RINGWOOD AE, 1979, ORIGIN EARTH MOON; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Schauble EA, 2003, GEOCHIM COSMOCHIM AC, V67, P3267, DOI 10.1016/S0016-7037(02)01375-3; Sharp ZD, 2007, NATURE, V446, P1062, DOI 10.1038/nature05748; Sharp ZD, 2010, GEOCHIM COSMOCHIM AC, V74, P264, DOI 10.1016/j.gca.2009.09.032; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; Shearer CK, 1999, AM MINERAL, V84, P1469; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037	32	163	169	5	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1050	1053		10.1126/science.1192606	http://dx.doi.org/10.1126/science.1192606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20688980				2022-12-28	WOS:000281253500033
J	Hotez, PJ; Engels, D; Fenwick, A; Savioli, L				Hotez, Peter J.; Engels, Dirk; Fenwick, Alan; Savioli, Lorenzo			Africa is desperate for praziquantel	LANCET			English	Editorial Material							SCHISTOSOMIASIS; MORBIDITY; INFECTION; IMPACT		[Hotez, Peter J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC 20037 USA; [Engels, Dirk; Savioli, Lorenzo] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Fenwick, Alan] Univ London Imperial Coll Sci Technol & Med, Schistosomiasis Control Initiat, London, England	George Washington University; World Health Organization; Imperial College London	Hotez, PJ (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	photez@gwu.edu		Hotez, Peter/0000-0001-8770-1042				Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Fenwick A, 2006, ADV PARASIT, V61, P567, DOI 10.1016/S0065-308X(05)61013-5; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; Koukounari A, 2006, AM J TROP MED HYG, V75, P278, DOI 10.4269/ajtmh.2006.75.278; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Zhang Y, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-27; 2006, HIST PRAZIQUANTEL	12	49	50	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					496	498		10.1016/S0140-6736(10)60879-3	http://dx.doi.org/10.1016/S0140-6736(10)60879-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20709217				2022-12-28	WOS:000281266800009
J	Thebault, E; Fontaine, C				Thebault, Elisa; Fontaine, Colin			Stability of Ecological Communities and the Architecture of Mutualistic and Trophic Networks	SCIENCE			English	Article							FOOD-WEB STRUCTURE; BIODIVERSITY; POLLINATION; COMPETITION; MODULARITY; DIVERSITY	Research on the relationship between the architecture of ecological networks and community stability has mainly focused on one type of interaction at a time, making difficult any comparison between different network types. We used a theoretical approach to show that the network architecture favoring stability fundamentally differs between trophic and mutualistic networks. A highly connected and nested architecture promotes community stability in mutualistic networks, whereas the stability of trophic networks is enhanced in compartmented and weakly connected architectures. These theoretical predictions are supported by a meta-analysis on the architecture of a large series of real pollination (mutualistic) and herbivory (trophic) networks. We conclude that strong variations in the stability of architectural patterns constrain ecological networks toward different architectures, depending on the type of interaction.	[Thebault, Elisa; Fontaine, Colin] Univ London Imperial Coll Sci Technol & Med, Div Biol, Nat Environm Res Council, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Thebault, Elisa] Wageningen Univ, NL-6708 PB Wageningen, Netherlands; [Fontaine, Colin] Museum Natl Hist Nat, CNRS, Lab Conservat Especes Restaurat & Suivides Popula, UMR 7204, F-75005 Paris, France	Imperial College London; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Thebault, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Nat Environm Res Council, Ctr Populat Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.		Fontaine, Colin/N-6469-2015	Fontaine, Colin/0000-0001-5367-5675; Thebault, Elisa/0000-0002-9669-5227	UK Natural Environment Research Council; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Bascompte, T. Barraclough, C. Devaux, P. de Ruiter, V. Savolainen, and F. van Veen for comments on the manuscript, and F. Ory for the art work. E.T. and C.F. were funded by the UK Natural Environment Research Council.	Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Fontaine C, 2009, P R SOC B, V276, P3027, DOI 10.1098/rspb.2009.0635; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Rezende EL, 2007, OIKOS, V116, P1919, DOI 10.1111/j.2007.0030-1299.16029.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Thebault E, 2008, OIKOS, V117, P555, DOI 10.1111/j.0030-1299.2008.16485.x; THOMPSON JN, 2005, GEOGRAPHIC MOSAIC CO, V2; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120	23	935	960	28	637	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					853	856		10.1126/science.1188321	http://dx.doi.org/10.1126/science.1188321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705861				2022-12-28	WOS:000280809900054
J	Ittner, LM; Ke, YD; Delerue, F; Bi, MA; Gladbach, A; van Eersel, J; Wolfing, H; Chieng, BC; Christie, MJ; Napier, IA; Eckert, A; Staufenbiel, M; Hardeman, E; Gotz, J				Ittner, Lars M.; Ke, Yazi D.; Delerue, Fabien; Bi, Mian; Gladbach, Amadeus; van Eersel, Janet; Woelfing, Heidrun; Chieng, Billy C.; Christie, MacDonald J.; Napier, Ian A.; Eckert, Anne; Staufenbiel, Matthias; Hardeman, Edna; Goetz, Juergen			Dendritic Function of Tau Mediates Amyloid-beta Toxicity in Alzheimer's Disease Mouse Models	CELL			English	Article							PAIRED HELICAL FILAMENT; APP23 TRANSGENIC MICE; TYROSINE PHOSPHORYLATION; COGNITIVE IMPAIRMENTS; PROTEIN; FYN; DEFICITS; KINASE; SUBUNIT; NEURODEGENERATION	Alzheimer's disease (AD) is characterized by amyloid-beta (A beta) and tau deposition in brain. It has emerged that A beta toxicity is tau dependent, although mechanistically this link remains unclear. Here, we show that tau, known as axonal protein, has a dendritic function in postsynaptic targeting of the Src kinase Fyn, a substrate of which is the NMDA receptor (NR). Missorting of tau in transgenic mice expressing truncated tau (Delta tau) and absence of tau in tau(-/-) mice both disrupt postsynaptic targeting of Fyn. This uncouples NR-mediated excitotoxicity and hence mitigates A beta toxicity. Delta tau expression and tau deficiency prevent memory deficits and improve survival in A beta-forming APP23 mice, a model of AD. These deficits are also fully rescued with a peptide that uncouples the Fyn-mediated interaction of NR and PSD-95 in vivo. Our findings suggest that this dendritic role of tau confers A beta toxicity at the postsynapse with direct implications for patho-genesis and treatment of AD.	[Ittner, Lars M.; Ke, Yazi D.; Delerue, Fabien; Bi, Mian; Gladbach, Amadeus; van Eersel, Janet; Woelfing, Heidrun; Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2050, Australia; [Chieng, Billy C.; Christie, MacDonald J.; Napier, Ian A.] Univ Sydney, Brain & Mind Res Inst, Neuropharmacol Lab, Sydney, NSW 2050, Australia; [Eckert, Anne] Univ Basel, Psychiat Univ Clin, Neurobiol Res Lab, CH-4025 Basel, Switzerland; [Staufenbiel, Matthias] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Hardeman, Edna] Univ New S Wales, Neuromuscular & Regenerat Med Unit, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; University of Basel; Novartis; University of New South Wales Sydney	Ittner, LM (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2050, Australia.	littner@med.usyd.edu.au; jgoetz@med.usyd.edu.au	Ke, Yazi/ABC-3052-2020; Götz, Jürgen/C-2448-2014; Christie, MacDonald J/F-4724-2013; Hardeman, Edna C/F-8872-2012; van Eersel, Janet/AAZ-4197-2020	Ke, Yazi/0000-0002-1423-0451; Götz, Jürgen/0000-0001-8501-7896; Christie, MacDonald J/0000-0002-0622-609X; van Eersel, Janet/0000-0002-1354-6171; Eckert, Anne/0000-0002-9341-3669; Bi, Mian/0000-0002-4383-3606; Hardeman, Edna/0000-0003-1649-7712; Ittner, Lars/0000-0001-6738-3825; Delerue, Fabien/0000-0001-7944-2108; Chieng, Billy/0000-0003-0222-8001	University of Sydney; National Health and Medical Research Council; Australian Research Council; Deutsche Forschungsgemeinschaft	University of Sydney(University of Sydney); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Yves-Alain Barde for providing tau<SUP>-/-</SUP> mice and him as well as Hanns Mohler and Nikolas Haass for helpful comments. This research was supported by grants from the University of Sydney, National Health and Medical Research Council, Australian Research Council, and Deutsche Forschungsgemeinschaft. J.G. is a Medical Foundation Fellow.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ashe KH, 2007, NEW ENGL J MED, V357, P933, DOI 10.1056/NEJMcibr073552; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CROWTHER T, 1989, ANN MED, V21, P127, DOI 10.3109/07853898909149199; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kelly PH, 2003, NEUROBIOL AGING, V24, P365, DOI 10.1016/S0197-4580(02)00098-2; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kojima N, 1998, LEARN MEMORY, V5, P429; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Lee G, 1998, J CELL SCI, V111, P3167; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Roskam S, 2010, NEUROSCI BIOBEHAV R, V34, P487, DOI 10.1016/j.neubiorev.2009.10.006; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	54	1266	1322	3	248	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					387	397		10.1016/j.cell.2010.06.036	http://dx.doi.org/10.1016/j.cell.2010.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20655099	Bronze			2022-12-28	WOS:000280609100016
J	Iglehart, JK				Iglehart, John K.			Health Reform, Primary Care, and Graduate Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Aizenman N.C., 2010, WASH POST       0829, pA4; *AM COLL PHYS, 2010, RES MATCH RES NOT EN; BAUCUS M, 2009, CALL ACTION HLTH REF; BEIN B, 2010, MATCH RESULTS 2010 F; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Congressional Budget Office, 2008, BUDG OPT, V1; CORDASCO K, 2009, WR686 RAND MED PAYM; *COUNC GRAD MED ED, 2010, 20 DEP HLTH HUM SERV; Cronenwett L, 2010, WHO WILL PROVIDE PRI; Dentzer S, 2010, HEALTH AFFAIR, V29, P757, DOI 10.1377/hlthaff.2010.0410; Department of Health and Human Services, 2009, FISC YEAR 2010 BUDG; Freed GL, 2009, PEDIATRICS, V123, pS26, DOI 10.1542/peds.2008-1578H; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Grundy P, 2010, HEALTH AFFAIR, V29, P791, DOI 10.1377/hlthaff.2010.0084; Henderson TM., 2010, MEDICAID DIRECT INDI; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; *MED PAYM ADV COMM, 2009, REP C AL INC MED; Medicare Payment Advisory Commission, 2010, REP C AL INC MED; *NAT RES MATCH PRO, 2010, ADV DAT TABL 2010 MA; Newhouse JP, 2001, HEALTH AFFAIR, V20, P136, DOI 10.1377/hlthaff.20.2.136; SEBELIUS K, 2010, COMMUNICATION   0510; Whitcomb M, 2009, NEW DEV MED SCH MOTI; Whitcomb ME, 2007, ACAD MED, V82, P825, DOI 10.1097/ACM.0b013e318132f0c5; Whitcomb ME, 2010, NEW ENGL J MED, V362, P1255, DOI 10.1056/NEJMp0912179	24	48	48	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					584	590		10.1056/NEJMhpr1006115	http://dx.doi.org/10.1056/NEJMhpr1006115			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634BB	20660398				2022-12-28	WOS:000280552700015
J	Coulehan, J				Coulehan, Jack			On Humility	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The new professionalism movement in medical education takes seriously the old medical virtues. Perhaps the most difficult virtue to understand and practice is humility, which seems out of place in a medical culture characterized by arrogance, assertiveness, and a sense of entitlement. Countercultural though it is, humility need not suggest weakness or lack of self-confidence. On the contrary, humility requires toughness and emotional resilience. Humility in medicine manifests itself as unflinching self-awareness; empathic openness to others; and a keen appreciation of, and gratitude for, the privilege of caring for sick persons. Justified pride in medicine's accomplishments should neither rule out nor diminish our humility as healers.	SUNY Stony Brook, Ctr Med Humanities Compassionate Care & Bioeth, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Coulehan, J (corresponding author), SUNY Stony Brook, Ctr Med Humanities Compassionate Care & Bioeth, Stony Brook, NY 11794 USA.	jcoulehan@notes.cc.sunysb.edu						INGELFINGER FJ, 1980, NEW ENGL J MED, V303, P1507, DOI 10.1056/NEJM198012253032604	1	28	28	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					200	201		10.7326/0003-4819-153-3-201008030-00011	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679563				2022-12-28	WOS:000280557600009
J	Haller, E; Hart, R; Mark, MJ; Danzl, JG; Reichsollner, L; Gustavsson, M; Dalmonte, M; Pupillo, G; Nagerl, HC				Haller, Elmar; Hart, Russell; Mark, Manfred J.; Danzl, Johann G.; Reichsoellner, Lukas; Gustavsson, Mattias; Dalmonte, Marcello; Pupillo, Guido; Naegerl, Hanns-Christoph			Pinning quantum phase transition for a Luttinger liquid of strongly interacting bosons	NATURE			English	Article							ATOMS; GAS; INSULATOR; FERMIONS	Quantum many-body systems can have phase transitions(1) even at zero temperature; fluctuations arising from Heisenberg's uncertainty principle, as opposed to thermal effects, drive the system from one phase to another. Typically, during the transition the relative strength of two competing terms in the system's Hamiltonian changes across a finite critical value. A well-known example is the Mott-Hubbard quantum phase transition from a superfluid to an insulating phase(2,3), which has been observed for weakly interacting bosonic atomic gases. However, for strongly interacting quantum systems confined to lower-dimensional geometry, a novel type(4,5) of quantum phase transition may be induced and driven by an arbitrarily weak perturbation to the Hamiltonian. Here we observe such an effect-the sine-Gordon quantum phase transition from a superfluid Luttinger liquid to a Mott insulator(6,7)-in a one-dimensional quantum gas of bosonic caesium atoms with tunable interactions. For sufficiently strong interactions, the transition is induced by adding an arbitrarily weak optical lattice commensurate with the atomic granularity, which leads to immediate pinning of the atoms. We map out the phase diagram and find that our measurements in the strongly interacting regime agree well with a quantum field description based on the exactly solvable sine-Gordon model(8). We trace the phase boundary all the way to the weakly interacting regime, where we find good agreement with the predictions of the one-dimensional Bose-Hubbard model. Our results open up the experimental study of quantum phase transitions, criticality and transport phenomena beyond Hubbard-type models in the context of ultracold gases.	[Haller, Elmar; Hart, Russell; Mark, Manfred J.; Danzl, Johann G.; Reichsoellner, Lukas; Gustavsson, Mattias; Naegerl, Hanns-Christoph] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Haller, Elmar; Hart, Russell; Mark, Manfred J.; Danzl, Johann G.; Reichsoellner, Lukas; Gustavsson, Mattias; Naegerl, Hanns-Christoph] Univ Innsbruck, Zentrum Quantenphys, A-6020 Innsbruck, Austria; [Dalmonte, Marcello; Pupillo, Guido] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Dalmonte, Marcello; Pupillo, Guido] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Dalmonte, Marcello] Univ Bologna, Dipartimento Fis, I-40127 Bologna, Italy; [Dalmonte, Marcello] Ist Nazl Fis Nucl, I-40127 Bologna, Italy	University of Innsbruck; University of Innsbruck; University of Innsbruck; Austrian Academy of Sciences; University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN)	Nagerl, HC (corresponding author), Univ Innsbruck, Inst Expt Phys, Tech Str 25, A-6020 Innsbruck, Austria.	christoph.naegerl@uibk.ac.at	Danzl, Johann Georg/AGX-2475-2022; Gustavsson, Mattias/A-3397-2009; Haller, Elmar/E-8916-2010; Danzl, Johann/N-9987-2015; Mark, Manfred J/E-4286-2010; Naegerl, Hanns-Christoph/E-7329-2010	Danzl, Johann Georg/0000-0001-8559-3973; Haller, Elmar/0000-0002-7951-1721; Danzl, Johann/0000-0001-8559-3973; Mark, Manfred J/0000-0001-8157-4716; Naegerl, Hanns-Christoph/0000-0002-7789-4431; Reichsollner, Lukas/0000-0002-9986-2334; Pupillo, Guido/0000-0002-1549-0386; dalmonte, marcello/0000-0001-5338-4181	Austrian Ministry of Science and Research (Bundesministerium fur Wissenschaft und Forschung); Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung); European Union [FP7-ICT-2007-C]; Marie Curie International Incoming Fellowship	Austrian Ministry of Science and Research (Bundesministerium fur Wissenschaft und Forschung); Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); European Union(European Commission); Marie Curie International Incoming Fellowship(European Commission)	We thank W. Zwerger for discussions. We are indebted to R. Grimm for generous support. We gratefully acknowledge funding by the Austrian Ministry of Science and Research (Bundesministerium fur Wissenschaft und Forschung) and the Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) in the form of a START prize grant, and by the European Union through the STREP FP7-ICT-2007-C project NAME-QUAM (Nanodesigning of Atomic and Molecular Quantum Matter) and within the framework of the EuroQUASAR collective research project QuDeGPM. R. H. is supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme.	Altman E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.020402; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Buchler HP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.130401; Cazalilla MA, 2004, J PHYS B-AT MOL OPT, V37, pS1, DOI 10.1088/0953-4075/37/7/051; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Clark SR, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/160; Fertig CD, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.120403; Giamarchi T., 2003, QUANTUM PHYS ONE DIM, V121; GIRARDEAU M, 1960, J MATH PHYS, V1, P516, DOI 10.1063/1.1703687; Gogolin AO., 1998, BOSONIZATION STRONGL; GOULD PL, 1986, PHYS REV LETT, V56, P827, DOI 10.1103/PhysRevLett.56.827; GREINER M, 2002, NATURE, V39, P415; Haller E, 2009, SCIENCE, V325, P1224, DOI [10.1126/science.11758510, 10.1126/science.1175850]; Iucci A, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041608; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Kraemer T, 2004, APPL PHYS B-LASERS O, V79, P1013, DOI 10.1007/s00340-004-1657-5; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; Mun J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150604; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; POKROVSKY VL, 1979, PHYS REV LETT, V42, P65, DOI 10.1103/PhysRevLett.42.65; Rapsch S, 1999, EUROPHYS LETT, V46, P559, DOI 10.1209/epl/i1999-00302-7; Sachdev S., 2000, QUANTUM PHASE TRANSI; Schachenmayer J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/2/025014; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; ZAMOLODCHIKOV AB, 1979, ANN PHYS-NEW YORK, V120, P253, DOI 10.1016/0003-4916(79)90391-9; ZAMOLODCHIKOV AB, 1995, INT J MOD PHYS A, V10, P1125, DOI 10.1142/S0217751X9500053X	30	162	163	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					597	U1		10.1038/nature09259	http://dx.doi.org/10.1038/nature09259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671704	Green Submitted			2022-12-28	WOS:000280412100047
J	Sachs, J; Remans, R; Smukler, S; Winowiecki, L; Andelman, SJ; Cassman, KG; Castle, D; DeFries, R; Denning, G; Fanzo, J; Jackson, LE; Leemans, R; Lehmann, J; Milder, JC; Naeem, S; Nziguheba, G; Palm, CA; Pingali, PL; Reganold, JP; Richter, DD; Scherr, SJ; Sircely, J; Sullivan, C; Tomich, TP; Sanchez, PA				Sachs, Jeffrey; Remans, Roseline; Smukler, Sean; Winowiecki, Leigh; Andelman, Sandy J.; Cassman, Kenneth G.; Castle, David; DeFries, Ruth; Denning, Glenn; Fanzo, Jessica; Jackson, Louise E.; Leemans, Rik; Lehmann, Johannes; Milder, Jeffrey C.; Naeem, Shahid; Nziguheba, Generose; Palm, Cheryl A.; Pingali, Prabhu L.; Reganold, John P.; Richter, Daniel D.; Scherr, Sara J.; Sircely, Jason; Sullivan, Clare; Tomich, Thomas P.; Sanchez, Pedro A.			Monitoring the world's agriculture	NATURE			English	Editorial Material							GENETICALLY-ENGINEERED PLANTS; SCIENTISTS ANALYSIS; FOODS		[Sachs, Jeffrey; Remans, Roseline; Smukler, Sean; Winowiecki, Leigh; Nziguheba, Generose; Palm, Cheryl A.; Sullivan, Clare; Sanchez, Pedro A.] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Remans, Roseline] Katholieke Univ Leuven, Louvain, Belgium; [Cassman, Kenneth G.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Castle, David] Univ Ottawa, Fac Arts, Ottawa, ON K1N 6N5, Canada; [Castle, David] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [DeFries, Ruth; Naeem, Shahid; Sircely, Jason] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Denning, Glenn] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Fanzo, Jessica] Biovers Int, Rome, Italy; [Jackson, Louise E.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Leemans, Rik] Wageningen Univ, Environm Syst Anal Grp, Wageningen, Netherlands; [Lehmann, Johannes] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Milder, Jeffrey C.; Scherr, Sara J.] EcoAgr Partners, Washington, DC USA; [Pingali, Prabhu L.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Reganold, John P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Richter, Daniel D.] Duke Univ, Nicholas Sch Environm, Environm Sci & Policy Div, Durham, NC 27706 USA; [Tomich, Thomas P.] Univ Calif Davis, Agr Sustainabil Inst, Davis, CA 95616 USA	Columbia University; KU Leuven; University of Nebraska System; University of Nebraska Lincoln; University of Ottawa; University of Ottawa; Columbia University; Columbia University; Alliance; Bioversity International; University of California System; University of California Davis; Wageningen University & Research; Cornell University; Bill & Melinda Gates Foundation; Washington State University; Duke University; University of California System; University of California Davis	Sachs, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.		Leemans, Rik/A-1548-2009; Richter, D.D./AAN-4583-2021; Jackson, Louise E/A-3562-2010; Cassman, Kenneth G/C-3646-2019; Fanzo, Jessica/HCH-3533-2022; Lehmann, Johannes/H-2682-2014	Leemans, Rik/0000-0002-4001-6301; Lehmann, Johannes/0000-0002-4701-2936; Castle, David/0000-0002-6884-0001; Fanzo, Jessica/0000-0002-6760-1359; Nziguheba, Generose/0000-0003-4227-2242				[Anonymous], 2005, EC HUM WELL BEING SY; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007; Jackson L.E., 2005, AGROBIODIVERSITY NEW; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Lemaux PG, 2009, ANNU REV PLANT BIOL, V60, P511, DOI 10.1146/annurev.arplant.043008.092013; McIntyre BD, 2009, AGR CROSSR GLOB REP; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970	10	111	118	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					558	560		10.1038/466558a	http://dx.doi.org/10.1038/466558a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	632HA	20671691				2022-12-28	WOS:000280412100017
J	Horton, R; Das, P				Horton, Richard; Das, Pam			Rescuing people with HIV who use drugs	LANCET			English	Editorial Material									[Horton, Richard; Das, Pam] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Colfax G, 2010, LANCET, V376, P458, DOI 10.1016/S0140-6736(10)60753-2; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; *HUM RIGHTS WATCH, 2009, CAMB STOP FORC PART; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	9	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					207	208		10.1016/S0140-6736(10)61025-2	http://dx.doi.org/10.1016/S0140-6736(10)61025-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650525				2022-12-28	WOS:000280457200004
J	Sultan, S; Forsmark, CE				Sultan, Shahnaz; Forsmark, Chris E.			Review: Enteral nutrition reduces mortality, multiple organ failure, and systemic infection more than TPN in acute pancreatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sultan, Shahnaz; Forsmark, Chris E.] Univ Florida, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Sultan, S (corresponding author), Univ Florida, Gainesville, FL 32611 USA.			Sultan, Shahnaz/0000-0002-5867-8741				Forsmark CE, 2007, GASTROENTEROLOGY, V132, P2022, DOI 10.1053/j.gastro.2007.03.065; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117	2	4	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2							JC1-6	10.7326/0003-4819-153-2-201007200-02006	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20643984				2022-12-28	WOS:000280095400024
J	Wolfe, D; Carrieri, MP; Shepard, D				Wolfe, Daniel; Carrieri, M. Patrizia; Shepard, Donald			Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward	LANCET			English	Review							ACTIVE ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; SUBSTANCE-ABUSE; ST-PETERSBURG; VIROLOGICAL RESPONSE; ONGOING INJECTION; TREATMENT PROGRAM; HAART ACCESS; SEXUAL RISK; ADHERENCE	We review evidence for effectiveness, cost-effectiveness, and coverage of antiretroviral therapy (ART) for injecting drug users (IDUs) infected with HIV, with particular attention to low-income and middle-income countries. In these countries, nearly half (47%) of all IDUs infected with HIV are in five nations-China, Vietnam, Russia, Ukraine, and Malaysia. In all five countries, IDU access to ART is disproportionately low, and systemic and structural obstacles restrict treatment access. IDUs are 67% of cumulative HIV cases in these countries, but only 25% of those receiving ART Integration of ART with opioid substitution and tuberculosis treatment, increased peer engagement in treatment delivery, and reform of harmful policies-including police use of drug-user registries, detention of drug users in centres offering no evidence-based treatment, and imprisonment for possession of drugs for personal use-are needed to improve ART coverage of IDUs.	[Wolfe, Daniel] Open Soc Inst, Int Harm Reduct Dev Program, New York, NY 10019 USA; [Carrieri, M. Patrizia] INSERM, U912, SE4S, F-13258 Marseille, France; [Carrieri, M. Patrizia] Univ Aix Marseille, IRD, UMR S912, Marseille, France; [Shepard, Donald] Brandeis Univ, Waltham, MA USA; [Carrieri, M. Patrizia] Observ Reg Sante Provence Alpes Cote Azur, ORS PACA, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Brandeis University; UDICE-French Research Universities; Aix-Marseille Universite	Wolfe, D (corresponding author), Open Soc Inst, Int Harm Reduct Dev Program, New York, NY 10019 USA.			Carrieri, Patrizia/0000-0002-6794-4837	French National Agency of AIDS and Hepatitis Research; Brandeis University, USA; Civilian Research and Defense Foundation	French National Agency of AIDS and Hepatitis Research; Brandeis University, USA; Civilian Research and Defense Foundation	The authors thank Darman Walker for research on cost and access to medicines us all countries considered In addition DW is supported by die Open Society Institute, USA MPC is supported by the French National Agency of AIDS and Hepatitis Research DS is supported by Brandeis University, USA. and a grant from the Civilian Research and Defense Foundation to Brandeis University We thank Azizbek Boltaev, Jolsna Hoey, Robin Lee. Oleksandr Pokanevych, Roxanne Saucier, and Anna Shubashvili for assistance with research, Anya Sarang. Adeeba Kamarulzaman. Volodymir Kurpita. Olena Kucheruk, and Konstantin Lezhentsev for information about ART in their countries. and Sarang for permission to excerpt her interview Chris Beyrer, Adeeba Kamarulzman. Kasia Malinowska Sempruch and Evan Wood offered valuable comments and insights on eat her drafts, as did anonymous peer reviewers The Open Medical Institute at the American-Austrian Foundation provided a forum for several authors to confer and finalise the paper	Abdala N, 2008, EUR ADDICT RES, V14, P19, DOI 10.1159/000110407; Aceijas C, 2006, ADDICTION, V101, P1246, DOI 10.1111/j.1360-0443.2006.01509.x; Altice FL, 2004, CLIN INFECT DIS, V38, pS376, DOI 10.1086/421400; Altice FL, 2003, J URBAN HEALTH, V80, P416, DOI 10.1093/jurban/jtg053; Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; ANDERSON A, 2009, CLOSING GAP CASE STU; *APN, KNOWL ACC I IN PRESS; ARCHER J, 2007, E ASIA PACIFIC REGIO; Atun R, 2010, INT J DRUG POLICY, V21, P103, DOI 10.1016/j.drugpo.2010.01.002; Barfod TS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-154; Barnett PG, 2009, DRUG ALCOHOL DEPEN, V100, P115, DOI 10.1016/j.drugalcdep.2008.09.017; Basu A, 2008, HEALTH ECON, V17, P927, DOI 10.1002/hec.1305; Bergenstrom A, 2008, SUBST USE MISUSE, V43, P73, DOI 10.1080/10826080701205109; BEZZICHERI S, 2009, 9 INT C AIDS AS PAC; BOBRIK A, 2006, DELIVERING CARE TREA; Bobrova N, 2007, INT J DRUG POLICY, V18, P313, DOI 10.1016/j.drugpo.2007.01.015; Bobrova N, 2006, DRUG ALCOHOL DEPEN, V82, pS57, DOI 10.1016/S0376-8716(06)80010-4; Bouhnik AD, 2004, ADDICT BEHAV, V29, P1189, DOI 10.1016/j.addbeh.2004.01.006; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; Carrieri MP, 2003, INT J BEHAV MED, V10, P1, DOI 10.1207/S15327558IJBM1001_01; Carrieri MP, 1999, J EPIDEMIOL COMMUN H, V53, P4, DOI 10.1136/jech.53.1.4; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; *CHIN COUNTR COORD, 2005, RED HIV TRANS VULN G; Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487; CHOO M, 2009, 9 INT C AIDS AS PAC; COFFIN P, 2008, OVERDOSE LEADING CAU; Cohen Patricia Cline, 1982, CALCULATING PEOPLE S; Conway B, 2004, CLIN INFECT DIS, V38, pS402, DOI 10.1086/421404; DAVIS SL, 2009, HARM REDUCT J, P6; *DEP SOC EV, 2009, ASS EFF TREATM DRUG; Dhingra V K, 2008, Indian J Tuberc, V55, P122; DOBKIN JF, 2004, BREAKING DOWN BARRIE, P60; Donoghoe MC, 2007, INT J DRUG POLICY, V18, P271, DOI 10.1016/j.drugpo.2007.02.010; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Escaffre N, 2000, AIDS CARE, V12, P723, DOI 10.1080/09540120020014264; Ettner SL, 2006, HEALTH SERV RES, V41, P192, DOI 10.1111/j.1475-6773.2005.00466.x; *FED AIDS CTR, 2008, ANN FORM FED STAT ST; *GLOB FUND FIGHT A, 2006, TUB MAL E EUR CENTR; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Green TC, 2009, INT J DRUG POLICY, V20, P270, DOI 10.1016/j.drugpo.2008.07.002; Grigoryan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004445; Hall W, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P907; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Heimer R, 2008, AIDS, V22, P123, DOI 10.1097/QAD.0b013e3282f244ef; HOANG TV, 2009, LUNCHT SEM ART IDU H; *HUM RIGHTS WATCH, 2010, DARKN KNOWS NO LIM; Human Rights Watch, 2003, FANN FLAM HUM RIGHTS; Human Rights Watch, 2009, PLEAS NOT MAK US SUF; Human Rights Watch and Thai AIDS Treatment Action Group, 2007, DEADL DEN BARR HIV A; *INCB, 1996, AV OP MED NEEDS REP; *INT HARM RED DEV, 2010, WOM HARM RED HIV KEY; *INT HARM RED DEV, 2008, BARR ACC MED ASS TRE; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP; Kamarulzaman Adeeba, 2009, HIV Therapy, V3, P573, DOI 10.2217/HIV.09.41; KANIARUTLZAMAN A, 2009, J ACQUIR IMMUNE D S1, V52, pS17; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Kerr T, 2005, AIDS CARE, V17, P539, DOI 10.1080/09540120412331319778; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Kumar MS, 2008, SUBST USE MISUSE, V43, P1062, DOI 10.1080/10826080801918189; KURPITA V, 2009, UKR EXP IMPL M WINDH; KUZNETSOVA A, 2009, INT C 2009 PRIS HLTH; LEVINSON I, 2008, HARM REDUCT J, P5; LI J, 2008, SALZB SEM EFF DRUG T; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Lucas GM, 2006, AM J EPIDEMIOL, V163, P412, DOI 10.1093/aje/kwj059; Lucas GM, 2004, CLIN INFECT DIS, V38, pS409, DOI 10.1086/421405; MAKSYMENKO K, 2010, J SOC COMMENTARY; Malotte CK, 2001, AM J PREV MED, V20, P103, DOI 10.1016/S0749-3797(00)00283-X; Malta M, 2003, CLIN INFECT DIS, V37, pS386, DOI 10.1086/377546; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Malta M, 2009, JAIDS-J ACQ IMM DEF, V52, P629, DOI 10.1097/QAI.0b013e3181b31b8a; MAMEDOVA E, 2009, AIDS 5 IAS C HIV PAT; MARON E, ASSESSMENT IN PRESS; Mathers B, 2010, INT J DRUG POLICY, V21, P100, DOI 10.1016/j.drugpo.2009.12.007; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mazlan M, 2006, DRUG ALCOHOL REV, V25, P473, DOI 10.1080/09595230600883354; McCance-Katz EF, 2002, AM J ADDICTION, V11, P271, DOI 10.1080/10550490290088072; *MED MOND, 2008, LIV NOT WELL HLTH SO; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; *MIN HLTH VIETN, 2008, SOC REP VIETN 3 COUN; *MIN PUBL SEC PEOP, 2008, NARC CONTR REP; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; *MOSC HEL GROUP, 2004, SIT PRIS CONT RUSS; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; NEEDLE R, 2010, CLOSING COVERAGE GAP; NOWAK M, 2009, AHRC1044 UN HIGH COM; OHARA M, 2009, OBSERVER LONDON 0419; Orsi F, 2010, LANCET, V375, P1693, DOI 10.1016/S0140-6736(10)60737-4; Palepu A, 2003, JAIDS-J ACQ IMM DEF, V32, P522, DOI 10.1097/00126334-200304150-00009; Parfitt T, 2006, LANCET, V368, P279, DOI 10.1016/S0140-6736(06)69060-0; Pradier C, 2003, HIV CLIN TRIALS, V4, P121; Rawson RA, 2006, ADDICTION, V101, P267, DOI 10.1111/j.1360-0443.2006.01312.x; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; Roux P, 2009, CLIN INFECT DIS, V49, P1433, DOI 10.1086/630209; Sabin LL, 2008, AIDS CARE, V20, P1242, DOI 10.1080/09540120801918651; SCHLEIFER R, 2006, RHETORIC RISK HUMAN; Seal KH, 2003, DRUG ALCOHOL DEPEN, V71, P127, DOI 10.1016/S0376-8716(03)00074-7; Sergeev B, 2003, J URBAN HEALTH, V80, P212, DOI 10.1093/jurban/jtg024; Sharma M, 2007, INT J DRUG POLICY, V18, P319, DOI 10.1016/j.drugpo.2007.04.001; Sharma M, 2009, AIDS, V23, P1405, DOI 10.1097/QAD.0b013e32832bd7c9; Sherer R, 2002, AIDS CARE, V14, pS31, DOI 10.1080/09540120220149975; SHIELDS A, 2009, EFFECTS DRUG USER RE; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; SIDIBE M, 2009, BANGKOK POST BA 0420; Smit C, 2006, ADDICTION, V101, P433, DOI 10.1111/j.1360-0443.2006.01339.x; *SOC REP VIETN, 2006, SCAL UN ACC HIV AIDS; STRATHDEE SA, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)60743-X; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; TAKENOVA M, 2009, RESULTS PILOT PROJEC; Tang YL, 2005, J SUBST ABUSE TREAT, V29, P215, DOI 10.1016/j.jsat.2005.06.006; Thomson N., 2010, DETENTION TREATMENT; Toussova O, 2009, J URBAN HEALTH, V86, pS121, DOI 10.1007/s11524-009-9364-5; TRAN D, 2009, INT HARM RED ASS C A; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; UMAR S, 2009, 20 C RED DRUG REL HA; UNAIDS, 2009, 2009 AIDS EP UPD; VYCHAVKA O, 2010, PROBLEM PROPHYLAXINS; Wakeman SE, 2009, J ADDICT DIS, V28, P124, DOI 10.1080/10550880902772423; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; Warren E, 2006, DRUG ALCOHOL DEPEN, V84, P160, DOI 10.1016/j.drugalcdep.2006.01.010; Weber R, 2009, HIV MED, V10, P407, DOI 10.1111/j.1468-1293.2009.00701.x; Werb D, 2010, LANCET INFECT DIS, V10, P464, DOI 10.1016/S1473-3099(10)70097-9; *WHO, 2005, GEORG SUMM COUNTR PR; WHO, 2006, HIV AIDS TREATM CAR; WOLFE D, 2009, WHAT COST HIV HUMAN; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; Wolfe D, 2010, INT J DRUG POLICY, V21, P145, DOI 10.1016/j.drugpo.2010.01.008; Wood E, 2004, ANTIVIR THER, V9, P229; Wood E, 2005, AIDS, V19, P1189, DOI 10.1097/01.aids.0000176219.48484.f1; Wood E, 2005, AIDS, V19, P837, DOI 10.1097/01.aids.0000168982.20456.eb; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649; Wood Evan, 2007, Harm Reduct J, V4, P2, DOI 10.1186/1477-7517-4-2; World Health Organization, 2009, ASS COMP TREATM PEOP; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4; Yin L, 2007, AM J DRUG ALCOHOL AB, V33, P505, DOI 10.1080/00952990701407223; YUSWAN F, 2009, M DEV REG STRAT HARM; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	144	341	347	0	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					355	366		10.1016/S0140-6736(10)60832-X	http://dx.doi.org/10.1016/S0140-6736(10)60832-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20650513				2022-12-28	WOS:000280717900034
J	Tong, C; Li, P; Wu, NL; Yan, YZ; Ying, QL				Tong, Chang; Li, Ping; Wu, Nancy L.; Yan, Youzhen; Ying, Qi-Long			Production of p53 gene knockout rats by homologous recombination in embryonic stem cells	NATURE			English	Article							MUTAGENESIS; MICE; GENERATION; SELECTION	The use of homologous recombination to modify genes in embryonic stem (ES) cells provides a powerful means to elucidate gene function and create disease models(1). Application of this technology to engineer genes in rats has not previously been possible because of the absence of germline-competent ES cells in this species. We have recently established authentic rat ES cells(2,3). Here we report the generation of gene knockout rats using the ES-cell-based gene targeting technology. We designed a targeting vector to disrupt the tumour suppressor gene p53 (also known as Tp53) in rat ES cells by means of homologous recombination. p53 gene-targeted rat ES cells can be routinely generated. Furthermore, the p53 gene-targeted mutation in the rat ES-cell genome can transmit through the germ line via ES-cell rat chimaeras to create p53 gene knockout rats. The rat is the most widely used animal model in biological research(4-7). The establishment of gene targeting technology in rat ES cells, in combination with advances in genomics and the vast amount of research data on physiology and pharmacology in this species, now provide a powerful new platform for the study of human disease.	[Tong, Chang; Li, Ping; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Wu, Nancy L.; Yan, Youzhen] Univ So Calif, Keck Sch Med, Norris Canc Ctr Transgen, Knockout Core Facil, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Ying, QL (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	qying@usc.edu			NIH/NCRR [1R01 RR025881]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025881] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010926] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a NIH/NCRR grant to Q.-L.Y. (1R01 RR025881). We thank members of the Ying laboratory and the USC Stem Cell Core for technical assistance; G. Chester for ordering rats; R. Montano and colleagues for rat husbandry; T. Saunders, E. Bryda and M. Pera for critical reading of the manuscript; E. Kho for financial support. We are also grateful to M. Pera and R. Maxson for their support and encouragement.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cozzi Jean, 2009, Methods Mol Biol, V561, P73, DOI 10.1007/978-1-60327-019-9_5; Feil R, 2007, Handb Exp Pharmacol, P3; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liu X, 1997, DEV DYNAM, V209, P85; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; MCCARRICK JW, 1993, TRANSGENIC RES, V2, P183, DOI 10.1007/BF01977348; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Sambrook J., 2001, MOL CLONING LAB MANU; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830	29	208	284	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					211	U98		10.1038/nature09368	http://dx.doi.org/10.1038/nature09368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20703227	Green Accepted			2022-12-28	WOS:000281616300035
J	Iglehart, JK				Iglehart, John K.			Facing the Wild West of Health Care Reform - Donald Berwick, Pioneer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Berwick DM, 2006, JT COMM J QUAL PATIE, V32, P628, DOI 10.1016/S1553-7250(06)32081-8; LANGEL S, 2010, HLTH AFFAIRS BLOG; PECQUET J, 2010, HEALTHWATCH HILLS HE; Wachter RM, 2006, JT COMM J QUAL PATIE, V32, P621, DOI 10.1016/S1553-7250(06)32080-6	4	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2010	363	8					707	709		10.1056/NEJMp1007682	http://dx.doi.org/10.1056/NEJMp1007682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639TE	20647184				2022-12-28	WOS:000280996600003
J	Javitt, G				Javitt, Gail			Assign regulation appropriate to the level of risk	NATURE			English	Editorial Material							GENOMIC PROFILES		[Javitt, Gail] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA	Johns Hopkins University	Javitt, G (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA.	gjavitt1@jhu.edu						Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Javitt Gail H, 2004, Oklahoma Law Rev, V57, P251; Lachance CR, 2010, GENET MED, V12, P304, DOI 10.1097/GIM.0b013e3181dbd8b2; Mihaescu R, 2009, GENET MED, V11, P588, DOI 10.1097/GIM.0b013e3181b13a4f; Offit K, 2008, JAMA-J AM MED ASSOC, V299, P1353, DOI 10.1001/jama.299.11.1353	5	22	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					817	818		10.1038/466817a	http://dx.doi.org/10.1038/466817a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20703288				2022-12-28	WOS:000280766100017
J	Li, J; Liu, ZY; Tan, C; Guo, XM; Wang, LJ; Sancar, A; Zhong, DP				Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Sancar, Aziz; Zhong, Dongping			Dynamics and mechanism of repair of ultraviolet-induced (6-4) photoproduct by photolyase	NATURE			English	Article							DNA PHOTOLYASE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; COFACTOR; ENZYME; CRYPTOCHROME; HISTIDINES; BINDING	One of the detrimental effects of ultraviolet radiation on DNA is the formation of the (6-4) photoproduct, 6-4PP, between two adjacent pyrimidine rings(1). This lesion interferes with replication and transcription, and may result in mutation and cell death(2). In many organisms, a flavoenzyme called photolyase uses blue light energy to repair the 6-4PP (ref. 3). The molecular mechanism of the repair reaction is poorly understood. Here, we use ultrafast spectroscopy to show that the key step in the repair photocycle is a cyclic proton transfer between the enzyme and the substrate. By femtosecond synchronization of the enzymatic dynamics with the repair function, we followed the function evolution and observed direct electron transfer from the excited flavin cofactor to the 6-4PP in 225 picoseconds, but surprisingly fast back electron transfer in 50 picoseconds without repair. We found that the catalytic proton transfer between a histidine residue in the active site and the 6-4PP, induced by the initial photoinduced electron transfer from the excited flavin cofactor to 6-4PP, occurs in 425 picoseconds and leads to 6-4PP repair in tens of nanoseconds. These key dynamics define the repair photocycle and explain the underlying molecular mechanism of the enzyme's modest efficiency.	[Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Biochem, Program Biophys, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Chem Phys Program, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Program Biochem, Columbus, OH 43210 USA; [Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhong, DP (corresponding author), Ohio State Univ, Dept Phys, 191 W Woodruff Ave, Columbus, OH 43210 USA.	dongping@mps.ohio-state.edu	Liu, Zheyun/N-4054-2013; Zhong, Dongping/I-2444-2013; Guo, Xunmin/E-7908-2013	Zhong, Dongping/0000-0001-9381-8992; 	National Institutes of Health [GM074813]; Packard fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074813] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard fellowship(The David & Lucile Packard Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank T. Todo and T. Kitagawa for the generous gift of Arabidopsis thaliana (6-4) photolyase plasmid; C. Forsyth for discussions; and Y.-T. Kao and C.-W. Chang for help during the experiments. This work is supported in part by the National Institutes of Health (research grant GM074813) and the Packard fellowship.	Borg OA, 2007, J PHYS CHEM A, V111, P2351, DOI 10.1021/jp0676383; Chang CW, 2010, P NATL ACAD SCI USA, V107, P2914, DOI 10.1073/pnas.1000001107; Domratcheva T, 2009, J AM CHEM SOC, V131, P17793, DOI 10.1021/ja904550d; Glas AF, 2009, CHEM-EUR J, V15, P10387, DOI 10.1002/chem.200901004; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Joseph A, 2000, J AM CHEM SOC, V122, P11219, DOI 10.1021/ja002541u; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kao YT, 2007, CELL BIOCHEM BIOPHYS, V48, P32, DOI 10.1007/s12013-007-0034-5; Kao YT, 2005, P NATL ACAD SCI USA, V102, P16128, DOI 10.1073/pnas.0506586102; LECLERC JE, 1991, P NATL ACAD SCI USA, V88, P9685, DOI 10.1073/pnas.88.21.9685; Li J, 2006, J PHYS CHEM B, V110, P16724, DOI 10.1021/jp062998b; Marcus RA, 2006, PHILOS T R SOC B, V361, P1445, DOI 10.1098/rstb.2006.1873; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Saxena C, 2004, J PHYS CHEM B, V108, P18026, DOI 10.1021/jp048376c; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; TAYLOR JS, 1994, ACCOUNTS CHEM RES, V27, P76, DOI 10.1021/ar00039a003; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; Wang HY, 2007, SCIENCE, V316, P747, DOI 10.1126/science.1140030; Yamamoto J, 2009, ORG BIOMOL CHEM, V7, P161, DOI 10.1039/b815458a; Yamamoto J, 2009, BIOCHEMISTRY-US, V48, P9306, DOI 10.1021/bi900956p; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580; Zhong DP, 2007, CURR OPIN CHEM BIOL, V11, P174, DOI 10.1016/j.cbpa.2007.02.034	26	161	161	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					887	U124		10.1038/nature09192	http://dx.doi.org/10.1038/nature09192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20657578	Green Submitted, Green Accepted			2022-12-28	WOS:000280766100041
J	Ritchie, K; Carriere, I; Ritchie, CW; Berr, C; Artero, S; Ancelin, ML				Ritchie, K.; Carriere, I.; Ritchie, C. W.; Berr, C.; Artero, S.; Ancelin, M-L			Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors	BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; ELDERLY-PEOPLE; HEAD-INJURY; OLDEST-OLD; METAANALYSIS; POPULATION; CONSUMPTION; ALCOHOL	Objective To estimate the percentage reduction in incidence of dementia that would be obtained if specific risk factors were eliminated. Design Prospective seven year cohort study. Setting General population, Montpellier, France. Participants 1433 people aged over 65 with a mean baseline age of 72.5 (SD 5.1) years. Main outcome measures Diagnosis of mild cognitive impairment or dementia established by a standardised neurological examination. Results Cox models were constructed to derive hazard ratios and determine confounding and interaction effects for potentially modifiable risk factors for dementia. Mean percentage population attributable fractions were calculated with 95% confidence intervals derived from bootstrapping for seven year incidence of mild cognitive impairment or dementia. The final model retained crystallised intelligence (population attributable fraction 18.11%, 95% confidence interval 10.91% to 25.42%), depression (10.31%, 3.66% to 17.17%), fruit and vegetable consumption (6.46%, 0.15% to 13.06%), diabetes (4.88%, 1.87% to 7.98%), and apolipoprotein E epsilon 4 allele (7.11%, 2.44% to 11.98%). Conclusions Increasing crystallised intelligence and fruit and vegetable consumption and eliminating depression and diabetes are likely to have the biggest impact on reducing the incidence of dementia, outweighing even the effect of removing the principal known genetic risk factor. Although causal relations cannot be concluded with certainty, the study suggests priorities that may inform public health programmes.	[Ritchie, K.; Carriere, I.; Berr, C.; Artero, S.; Ancelin, M-L] Colombiere Hosp, INSERM, Nervous Syst Pathol Epidemiol & Clin Res U888, F-34093 Montpellier 5, France; [Ritchie, K.; Carriere, I.; Berr, C.; Artero, S.; Ancelin, M-L] Univ Montpellier 1, F-34000 Montpellier, France; [Ritchie, K.; Ritchie, C. W.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Fac Med, London SW7 2AZ, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Imperial College London	Ritchie, K (corresponding author), Colombiere Hosp, INSERM, Nervous Syst Pathol Epidemiol & Clin Res U888, F-34093 Montpellier 5, France.	karen.ritchie@inserm.fr	Artero, Sylvaine/AAE-6059-2020; Carrière, Isabelle/W-8728-2019; Ritchie, Karen/G-3571-2013; Ancelin, Marie-Laure/F-3079-2013; Ancelin, Marie-Laure/L-1198-2019; berr, Claudine/D-5238-2014	Ritchie, Karen/0000-0002-0688-8982; Ancelin, Marie-Laure/0000-0002-1149-4320; Ancelin, Marie-Laure/0000-0002-1149-4320; berr, Claudine/0000-0001-5254-7655; Carriere, Isabelle/0000-0002-3617-0752; Artero, Sylvaine/0000-0002-1671-226X	Novartis; National Research Agency [07 LVIE004]	Novartis(Novartis); National Research Agency(French National Research Agency (ANR))	The Esprit Study was funded by an unconditional grant from Novartis and from the National Research Agency (ANR Project 07 LVIE004). Funding from Novartis was used to purchase equipment and pay for secretarial assistance. ANR funding provided salaries for the interviewers and the costs of clinical and biological examinations. Neither body was involved in the statistical analyses or preparation of the manuscript.	Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Ancelin ML, 2005, CURR PHARM DESIGN, V11, P4229, DOI 10.2174/138161205774913228; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Eriksson UK, 2008, DEMENT GERIATR COGN, V25, P148, DOI 10.1159/000112729; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Farooki A, 2009, NEUROLOGY, V72, P1030; FERRI C, 2005, LANCET, V17, P2112; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; GAMMANPILA UP, 2007, BMC GERIATR, V6, P7; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gharibzadeh S, 2007, MED HYPOTHESES, V68, P718, DOI 10.1016/j.mehy.2006.08.019; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Harwood DG, 2010, INT J GERIATR PSYCH, V25, P511, DOI 10.1002/gps.2372; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; LECRUBIER Y, 1997, EUROPEAN PSYCHIAT, V12, P232; LEE Y, 2009, INT PSYCHOGERIATR, V9, P1; LIN C, 2010, BRIT MED J, V340, pB5465; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Peila R, 2001, STROKE, V32, P2882, DOI 10.1161/hs1201.100392; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Razay G, 2009, DEMENT GERIATR COGN, V28, P70, DOI 10.1159/000230877; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; Ritchie K, 1999, AGE AGEING, V28, P385, DOI 10.1093/ageing/28.4.385; Ritchie K, 2010, J ALZHEIMERS DIS, V20, pS161, DOI 10.3233/JAD-2010-1387; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Ryan J, 2009, NEUROLOGY, V73, P1729, DOI 10.1212/WNL.0b013e3181c34b0c; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Seripa D, 2009, AGEING RES REV, V8, P214, DOI 10.1016/j.arr.2008.12.003; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stewart R, 2002, J AM GERIATR SOC, V50, P1227, DOI 10.1046/j.1532-5415.2002.50309.x; Stewart R, 2007, ARCH NEUROL-CHICAGO, V64, P103, DOI 10.1001/archneur.64.1.103; VANDUIJN CM, 1991, BRIT MED J, V302, P1491, DOI 10.1136/bmj.302.6791.1491; WHITE L, 2006, ALZ DIS ASSOC DIS, V20, P79	52	142	148	2	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 5	2010	341								c3885	10.1136/bmj.c3885	http://dx.doi.org/10.1136/bmj.c3885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636WK	20688841	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000280774200004
J	Bell, CC; McBride, DF				Bell, Carl C.; McBride, Dominica F.			Affect Regulation and Prevention of Risky Behaviors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADULT PSYCHIATRIC-DISORDERS; CHILDHOOD ADVERSITIES; PROGRAMS; CHILDREN		[Bell, Carl C.] Community Mental Hlth Council Inc, Chicago, IL 60617 USA; [Bell, Carl C.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60680 USA; [McBride, Dominica F.] HELP Inst, Huntsville, AL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bell, CC (corresponding author), Community Mental Hlth Council Inc, 8704 S Constance, Chicago, IL 60617 USA.	carlcbell@pol.net						Bell CC, 2001, SCH VIOLENCE CONTRIB, P251; Fein Rashi, 2005, HLTH CARE MESS WE GO; Flay BR, 2004, ARCH PEDIAT ADOL MED, V158, P377, DOI 10.1001/archpedi.158.4.377; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; McLaughlin KA, 2010, ARCH GEN PSYCHIAT, V67, P124, DOI 10.1001/archgenpsychiatry.2009.187; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; Olds DL, 2007, J CHILD PSYCHOL PSYC, V48, P355, DOI 10.1111/j.1469-7610.2006.01702.x; Sanders MR, 2008, J PRIM PREV, V29, P197, DOI 10.1007/s10935-008-0139-7; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Webster-Stratton C, 2004, J CLIN CHILD ADOLESC, V33, P105, DOI 10.1207/S15374424JCCP3301_11	10	47	47	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					565	566		10.1001/jama.2010.1058	http://dx.doi.org/10.1001/jama.2010.1058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682937				2022-12-28	WOS:000280525700025
J	Sokol, DK				Sokol, Daniel K.			Ethics Man When is restraint appropriate?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						GILLON R, 1985, PHILOS MED ETHICS, P61; TOWNSEND M, 2010, OBSERVER        0718	2	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2010	341								c4147	10.1136/bmj.c4147	http://dx.doi.org/10.1136/bmj.c4147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636WI	20685776				2022-12-28	WOS:000280774000022
J	Beyrer, C; Malinowska-Sempruch, K; Kamarulzaman, A; Strathdee, SA				Beyrer, Chris; Malinowska-Sempruch, Kasia; Kamarulzaman, Adeeba; Strathdee, Steffanie A.			12 myths about HIV/AIDS and people who use drugs	LANCET			English	Editorial Material							INJECTION; EFFICACY		[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Malinowska-Sempruch, Kasia] Open Soc Inst, Drug Policy Program, Warsaw, Poland; [Kamarulzaman, Adeeba] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Epidemiol, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; University of California System; University of California San Diego	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhsph.edu	KAMARULZAMAN, ADEEBA/B-5216-2010; Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X				Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Fisher DG, 2003, JAIDS-J ACQ IMM DEF, V33, P199, DOI 10.1097/00126334-200306010-00014; Grigoryan A., 2009, Morbidity and Mortality Weekly Report, V58, P1291; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Institute of Medicine, 2006, PREV HIV INF INJ DRU; Kerr T., 2007, PUBLIC HLTH HUMAN RI, P11; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; Mauer M., 2007, UNEVEN JUSTICE STATE; Mausbach BT, 2007, ANN BEHAV MED, V34, P263, DOI 10.1007/BF02874551; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; *OFF NAT DRUG CONT, MIN DRUGS FACTS FIG; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Stoltz JA, 2007, J PUBLIC HEALTH, V29, P35, DOI 10.1093/pubmed/fdl090; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; VLAHOV D, 2009, CLIN INFECT DIS, V104, P796; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550	18	19	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					208	211		10.1016/S0140-6736(10)61005-7	http://dx.doi.org/10.1016/S0140-6736(10)61005-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650524				2022-12-28	WOS:000280457200005
J	Erba, E; Bottini, C; Weissert, HJ; Keller, CE				Erba, Elisabetta; Bottini, Cinzia; Weissert, Helmut J.; Keller, Christina E.			Calcareous Nannoplankton Response to Surface-Water Acidification Around Oceanic Anoxic Event 1a	SCIENCE			English	Article							PLANKTON EVOLUTION; CALCIFICATION; NANNOFOSSILS; CARBON; STRATIGRAPHY; EXTINCTION; GREENHOUSE; SEDIMENTS; PULSE; EARTH	Ocean acidification induced by atmospheric CO2 may be a major threat to marine ecosystems, particularly to calcareous nannoplankton. We show that, during the Aptian (similar to 120 million years ago) Oceanic Anoxic Event 1a, which resulted from a massive addition of volcanic CO2, the morphological features of calcareous nannofossils traced the biological response to acidified surface waters. We observe the demise of heavily calcified nannoconids and reduced calcite paleofluxes at the beginning of a pre-anoxia calcification crisis. Ephemeral coccolith dwarfism and malformation represent species-specific adjustments to survive lower pH, whereas later, abundance peaks indicate intermittent alkalinity recovery. Deepwater acidification occurred with a delay of 25,000 to 30,000 years. After the dissolution climax, nannoplankton and carbonate recovery developed over similar to 160,000 years under persisting global dysoxia-anoxia.	[Erba, Elisabetta; Bottini, Cinzia] Univ Milan, Dipartimento Sci Terra Ardito Desio, I-20133 Milan, Italy; [Weissert, Helmut J.; Keller, Christina E.] ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland	University of Milan; Swiss Federal Institutes of Technology Domain; ETH Zurich	Erba, E (corresponding author), Univ Milan, Dipartimento Sci Terra Ardito Desio, Via Mangiagalli 34, I-20133 Milan, Italy.	elisabetta.erba@unimi.it	bottini, cinzia/T-1478-2017	bottini, cinzia/0000-0003-1287-5579; Allam, Sherif/0000-0002-5555-7928	MIUR (Italian Ministry of University and Research) [2007-2007W9B2WE 001]; Swiss Science Foundation [200021-113687]; ETH Zurich	MIUR (Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	E.E. and C.B. were funded through MIUR (Italian Ministry of University and Research), Research Programs of National Interest (PRIN) grant 2007-2007W9B2WE 001. H.J.W. and C. E. K. were funded by the Swiss Science Foundation (project 200021-113687) and by ETH Zurich. E. E. and C. B. investigated calcareous nannofossil assemblages, H.J.W. and C. E. K. analyzed C and O isotopes. All authors contributed to the synthesis and paleoceanographic model. Samples from DSDP site 463 were supplied by the Integrated Ocean Drilling Program.	Ando A, 2008, PALAEOGEOGR PALAEOCL, V260, P463, DOI 10.1016/j.palaeo.2007.12.007; Ramos JBE, 2010, BIOGEOSCIENCES, V7, P177, DOI 10.5194/bg-7-177-2010; Bernoulli D, 2009, SEDIMENTOLOGY, V56, P149, DOI 10.1111/j.1365-3091.2008.01017.x; Bown P, 2009, MAR MICROPALEONTOL, V71, P60, DOI 10.1016/j.marmicro.2009.01.005; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Erba E, 2004, MAR MICROPALEONTOL, V52, P85, DOI 10.1016/j.marmicro.2004.04.007; Erba E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000884; ERBA E, 1994, PALEOCEANOGRAPHY, V9, P483, DOI 10.1029/94PA00258; Erba E, 1999, J FORAMIN RES, V29, P371; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; Larson RL, 1999, PALEOCEANOGRAPHY, V14, P663, DOI 10.1029/1999PA900040; Leckie RM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000623; Malinverno A, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001769; Mehay S, 2009, GEOLOGY, V37, P819, DOI 10.1130/G30100A.1; Menegatti AP, 1998, PALEOCEANOGRAPHY, V13, P530, DOI 10.1029/98PA01793; Millan MI, 2009, EARTH PLANET SC LETT, V287, P392, DOI 10.1016/j.epsl.2009.08.023; Raffi I, 2008, MAR MICROPALEONTOL, V69, P119, DOI 10.1016/j.marmicro.2008.07.002; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Tejada MLG, 2009, GEOLOGY, V37, P855, DOI 10.1130/G25763A.1; Weissert H, 2004, J GEOL SOC LONDON, V161, P695, DOI 10.1144/0016-764903-087; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	29	173	178	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					428	432		10.1126/science.1188886	http://dx.doi.org/10.1126/science.1188886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651148				2022-12-28	WOS:000280196500034
J	van Boxel, GI; Goodman, AJ; Green, J; Orme, RM				van Boxel, G. I.; Goodman, A. J.; Green, J.; Orme, R. M.			Picture Quiz Loss of consciousness on turning the patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							VENOUS AIR-EMBOLISM; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; PATENT FORAMEN OVALE; GAS EMBOLISM; DOGS; RESUSCITATION; RETRIEVAL; LIDOCAINE; ERCP		[van Boxel, G. I.; Orme, R. M.] Cheltenham Gen Hosp, Dept Crit Care, Cheltenham GL53 7AN, Glos, England; [Goodman, A. J.] Cheltenham Gen Hosp, Dept Gastrointestinal Surg, Cheltenham GL53 7AN, Glos, England; [Green, J.] Cheltenham Gen Hosp, Dept Radiol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	van Boxel, GI (corresponding author), Cheltenham Gen Hosp, Dept Crit Care, Cheltenham GL53 7AN, Glos, England.	gijs.vanboxel@glos.nhs.uk						Blanc P, 2002, INTENS CARE MED, V28, P559, DOI 10.1007/s00134-002-1255-0; BOWDLE TA, 1988, ANESTHESIOLOGY, V68, P107, DOI 10.1097/00000542-198801000-00017; BUTLER BD, 1985, J APPL PHYSIOL, V59, P543, DOI 10.1152/jappl.1985.59.2.543; COLLEY PS, 1989, ANESTH ANALG, V68, P298; COLLEY PS, 1987, ANESTH ANALG, V66, P991; Dexter F, 1997, ANESTH ANALG, V84, P1203, DOI 10.1097/00000539-199706000-00006; EVANS DE, 1984, J NEUROSURG, V60, P257, DOI 10.3171/jns.1984.60.2.0257; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; MASSEY EW, 1990, J HYPERBARIC MED, V5, P12; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Mitchell SJ, 1999, ANN THORAC SURG, V67, P1117, DOI 10.1016/S0003-4975(99)00057-0; Moon R.E., 1996, HDB HYPERBARIC MED, P229; Muth CM, 2000, NEW ENGL J MED, V342, P476, DOI 10.1056/NEJM200002173420706; Nayagam J, 2004, ANAESTH INTENS CARE, V32, P260, DOI 10.1177/0310057X0403200217; OREBAUGH SL, 1992, CRIT CARE MED, V20, P1169, DOI 10.1097/00003246-199208000-00017; Palmon SC, 1997, J CLIN ANESTH, V9, P251, DOI 10.1016/S0952-8180(97)00024-X; Pinto FJ, 2005, HEART, V91, P438, DOI 10.1136/hrt.2004.052233; Romberg C, 2009, GASTROINTEST ENDOSC, V70, P1043, DOI 10.1016/j.gie.2009.03.028; Siddiqui J, 2005, GASTROINTEST ENDOSC, V61, P153, DOI 10.1016/S0016-5107(04)02448-4; Stabile L, 2006, ACTA ANAESTH SCAND, V50, P648, DOI 10.1111/j.1399-6576.2006.00978.x; Trytko BE, 2008, ANAESTH INTENS CARE, V36, P60, DOI 10.1177/0310057X0803600110; van Boxel GI, 2010, ENDOSCOPY, V42, pE80, DOI 10.1055/s-0029-1243826; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P237; Vesely TM, 2001, J VASC INTERV RADIOL, V12, P1291, DOI 10.1016/S1051-0443(07)61554-1	24	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2010	341								c3542	10.1136/bmj.c3542	http://dx.doi.org/10.1136/bmj.c3542			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DR	20702547				2022-12-28	WOS:000281028900001
J	Bieling, P; Telley, IA; Surrey, T				Bieling, Peter; Telley, Ivo A.; Surrey, Thomas			A Minimal Midzone Protein Module Controls Formation and Length of Antiparallel Microtubule Overlaps	CELL			English	Article							EGG EXTRACT SPINDLES; MITOTIC SPINDLE; FISSION YEAST; DYNAMIC INSTABILITY; ANAPHASE-B; PRC1; CYTOKINESIS; MOTORS; FORCE; ASE1P	During cell division, microtubules are arranged in a large bipolar structure, the mitotic spindle, to segregate the duplicated chromosomes. Antiparallel microtubule overlaps in the spindle center are essential for establishing bipolarity and maintaining spindle stability throughout mitosis. In anaphase, this antiparallel microtubule array is tightly bundled forming the midzone, which serves as a hub for the recruitment of proteins essential for late mitotic events. The molecular mechanism of midzone formation and the control of its size are not understood. Using an in vitro reconstitution approach, we show here that PRC1 autonomously bundles antiparallel microtubules and recruits Xklp1, a kinesin-4, selectively to overlapping antiparallel microtubules. The processive motor Xklp1 controls overlap size by overlap length-dependent microtubule growth inhibition. Our results mechanistically explain how the two conserved, essential midzone proteins PRC1 and Xklp1 cooperate to constitute a minimal protein module capable of dynamically organizing the core structure of the central anaphase spindle.	[Bieling, Peter; Telley, Ivo A.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	surrey@embl.de	Surrey, Thomas/AAC-4608-2021; Telley, Ivo Andreas/D-2063-2011	Telley, Ivo Andreas/0000-0003-4444-1046; Bieling, Peter/0000-0002-7458-4358; Surrey, Thomas/0000-0001-9082-1870	DFG; HFSPO; European Commission; Swiss National Science Foundation	DFG(German Research Foundation (DFG)); HFSPO(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Vladimir Rybin for analytical ultracentrifugation, Jan Ellenberg, Elmar Schiebel, Johanna Roostalu, and Scott Hansen for critically reading the manuscript, and the DFG, HFSPO, the European Commission (STREP "Active Biomics''), and the Swiss National Science Foundation for financial support.	Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Bieling P, 2010, CURR BIOL, V20, P763, DOI 10.1016/j.cub.2010.02.067; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cheerambathur DK, 2007, J CELL BIOL, V177, P995, DOI 10.1083/jcb.200611113; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lee YM, 2004, EXP MOL MED, V36, P93, DOI 10.1038/emm.2004.13; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Muller S, 2004, CURR BIOL, V14, P412, DOI 10.1016/j.cub.2004.02.032; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; Powers J, 2004, J CELL BIOL, V166, P991, DOI 10.1083/jcb.200403036; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; TRANQUILLO RT, 1987, J MATH BIOL, V25, P229, DOI 10.1007/BF00276435; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	57	207	209	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					420	432		10.1016/j.cell.2010.06.033	http://dx.doi.org/10.1016/j.cell.2010.06.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691901	Bronze			2022-12-28	WOS:000280609100019
J	Haass, C; Mandelkow, E				Haass, Christian; Mandelkow, Eckhard			Fyn-Tau-Amyloid: A Toxic Triad	CELL			English	Editorial Material							ALZHEIMERS-DISEASE; PROTEIN-TAU; NEURODEGENERATION		[Haass, Christian] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Mandelkow, Eckhard] Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, D-23175 Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Haass, C (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de; mand@mpasmb.desy.de						Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Lee G, 1998, J CELL SCI, V111, P3167; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736	9	73	78	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2010	142	3					356	358		10.1016/j.cell.2010.07.032	http://dx.doi.org/10.1016/j.cell.2010.07.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691893	Bronze			2022-12-28	WOS:000280609100009
J	Kim, Y; Holland, AJ; Lan, W; Cleveland, DW				Kim, Yumi; Holland, Andrew J.; Lan, Weijie; Cleveland, Don W.			Aurora Kinases and Protein Phosphatase 1 Mediate Chromosome Congression through Regulation of CENP-E	CELL			English	Article							SMALL-MOLECULE INHIBITOR; MITOTIC CHECKPOINT; OUTER KINETOCHORE; KINESIN MOTOR; CELL-DIVISION; SPINDLE POLE; B KINASE; A KINASE; MICROTUBULE; ANEUPLOIDY	Opposing roles of Aurora kinases and protein phosphatase 1 (PP1) during mitosis have long been suggested. Here, we demonstrate that Aurora kinases A and B phosphorylate a conserved residue on the kinetochore motor CENP-E. PP1 binds CENP-E via a motif overlapping this phosphorylation site and binding is disrupted by Aurora phosphorylation. Phosphorylation of CENP-E by the Auroras is enriched at spindle poles, disrupting binding of PP1 and reducing CENP-E's affinity for individual microtubules. This phosphorylation is required for CENP-E-mediated towing of initially polar chromosomes toward the cell center. Kinetochores on such chromosomes cannot make subsequent stable attachment to spindle microtubules when dephosphorylation of CENP-E or rebinding of PP1 to CENP-E is blocked. Thus, an Aurora/PP1 phosphorylation switch modulates CENP-E motor activity as an essential feature of chromosome congression from poles and localized PP1 delivery by CENP-E to the outer kinetochore is necessary for stable microtubule capture by those chromosomes.	[Kim, Yumi; Holland, Andrew J.; Lan, Weijie; Cleveland, Don W.] Univ Calif Berkeley, Ludwig Inst Canc Res, Berkeley, CA 94720 USA; [Kim, Yumi] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif Berkeley, Ludwig Inst Canc Res, Berkeley, CA 94720 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	National Institutes of Health [GM29513]; Ludwig Institute for Cancer Research; European Molecular Biology Organization (EMBO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029513, R37GM029513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Stephen Taylor, Patrick Eyers, Todd Stukenberg, and Arshad Desai for providing reagents. This work was supported by a grant (GM29513) from the National Institutes of Health to D. W.C., who receives salary support from the Ludwig Institute for Cancer Research. A.J.H. is supported by a European Molecular Biology Organization (EMBO) Long-Term Fellowship.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	52	175	177	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					444	455		10.1016/j.cell.2010.06.039	http://dx.doi.org/10.1016/j.cell.2010.06.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691903	Green Accepted, Bronze			2022-12-28	WOS:000280609100021
J	Ito, T; Kwon, HY; Zimdahl, B; Congdon, KL; Blum, J; Lento, WE; Zhao, C; Lagoo, A; Gerrard, G; Foroni, L; Goldman, J; Goh, H; Kim, SH; Kim, DW; Chuah, C; Oehler, VG; Radich, JP; Jordan, CT; Reya, T				Ito, Takahiro; Kwon, Hyog Young; Zimdahl, Bryan; Congdon, Kendra L.; Blum, Jordan; Lento, William E.; Zhao, Chen; Lagoo, Anand; Gerrard, Gareth; Foroni, Letizia; Goldman, John; Goh, Harriet; Kim, Soo-Hyun; Kim, Dong-Wook; Chuah, Charles; Oehler, Vivian G.; Radich, Jerald P.; Jordan, Craig T.; Reya, Tannishtha			Regulation of myeloid leukaemia by the cell-fate determinant Musashi	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BINDING PROTEIN MUSASHI-1; CML BLAST CRISIS; STEM-CELLS; BCR-ABL; GENE-EXPRESSION; TRANSLATIONAL REPRESSION; MURINE MODEL; NUMB; RNA	Chronic myelogenous leukaemia (CML) can progress from a slow growing chronic phase to an aggressive blast crisis phase(1), but the molecular basis of this transition remains poorly understood. Here we have used mouse models of CML(2,3) to show that disease progression is regulated by the Musashi-Numb signalling axis(4,5). Specifically, we find that the chronic phase is marked by high levels of Numb expression whereas the blast crisis phase has low levels of Numb expression, and that ectopic expression of Numb promotes differentiation and impairs advanced-phase disease in vivo. As a possible explanation for the decreased levels of Numb in the blast crisis phase, we show that NUP98-HOXA9, an oncogene associated with blast crisis CML(6,7), can trigger expression of the RNA-binding protein Musashi2 (Msi2), which in turn represses Numb. Notably, loss of Msi2 restores Numb expression and significantly impairs the development and propagation of blast crisis CML in vitro and in vivo. Finally we show that Msi2 expression is not only highly upregulated during human CML progression but is also an early indicator of poorer prognosis. These data show that the Musashi-Numb pathway can control the differentiation of CML cells, and raise the possibility that targeting this pathway may provide a new strategy for the therapy of aggressive leukaemias.	[Ito, Takahiro; Kwon, Hyog Young; Zimdahl, Bryan; Congdon, Kendra L.; Blum, Jordan; Lento, William E.; Zhao, Chen; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lagoo, Anand] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gerrard, Gareth; Foroni, Letizia; Goldman, John] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London W12 0NN, England; [Goh, Harriet; Kim, Soo-Hyun; Kim, Dong-Wook] Catholic Univ Korea, Seoul St Marys Hosp, Div Hematol, Seoul, South Korea; [Chuah, Charles] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Oehler, Vivian G.; Radich, Jerald P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Jordan, Craig T.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	Duke University; Duke University; Imperial College London; Catholic University of Korea; Seoul St. Mary's Hospital; National University of Singapore; Singapore General Hospital; Fred Hutchinson Cancer Center; University of Rochester	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu	Ito, Takahiro/F-5006-2011; Gerrard, Gareth/B-4375-2009; Kwon, Hyog/T-7915-2019; jordan, craig/D-7666-2014	Ito, Takahiro/0000-0001-7165-0412; Gerrard, Gareth/0000-0002-4614-227X; Kwon, Hyog/0000-0003-1663-5118; jordan, craig/0000-0003-0869-3465	Astellas Foundation for Research on Metabolic Disorders; American Heart Association; Leukemia and Lymphoma Society; ASH; NIH [CA18029, CA140371, CA122206, DK63031, DK072234, AI067798, HL097767, DP1OD006430]; Alexander and Margaret Stewart Fund; Lisa Stafford Research Prize;  [T32 GM007184-33]; NATIONAL CANCER INSTITUTE [R01CA122206, DP1CA174422, R01CA140371, P01CA018029] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072234, R01DK063031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006430] Funding Source: NIH RePORTER	Astellas Foundation for Research on Metabolic Disorders; American Heart Association(American Heart Association); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ASH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Fund; Lisa Stafford Research Prize; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. M. Pendergast, J. Chute, K. Itahana, L. Penalva and L. Grimes for advice and reagents; K.-i. Yamamura for the Msi2 gene-trap mice; T. Honjo for the Rbpj conditional mice; N. Gaiano for the TNR mice; D. Baltimore for the lentiviral shRNA constructs; and A. Means and B. Hogan for comments on the manuscript. We also thank M. Cook, B. Harvat and L. Martinek for cell sorting; M. Fereshteh for advice on analysis of patient samples; D. McDonnell and H. Wade for advice on ChIP experiments; S. W. Tian for help in collecting patient samples and A. Chen and S. Honeycutt for technical help. The BCR-ABL construct was a gift from W. Pear and the NUP98-HOXA9 construct a gift from G. Gilliland. T. I. is the recipient of a postdoctoral fellowship from the Astellas Foundation for Research on Metabolic Disorders, K. L. C. is the recipient of an American Heart Association predoctoral award, B.Z. received support from T32 GM007184-33 and T. R. is the recipient of a Leukemia and Lymphoma Society Scholar Award. This work was also supported by an LLS Translational Research grant and an ASH Junior Faculty Award to V.G.O., as well as NIH grants CA18029 to J. P. R., CA140371 to V.G.O., CA122206 to C. T. J. and DK63031, DK072234, AI067798, HL097767, DP1OD006430 and an Alexander and Margaret Stewart Fund grant to T. R. We are grateful for the support received from the Lisa Stafford Research Prize.	Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Goldman JM, 2008, ACTA HAEMATOL-BASEL, V119, P212, DOI 10.1159/000140633; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Jegga AG, 2002, GENOME RES, V12, P1408, DOI 10.1101/gr.255002; Justice N, 2003, CURR BIOL, V13, P778, DOI 10.1016/S0960-9822(03)00288-4; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Shen Q, 2002, DEVELOPMENT, V129, P4843; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Witte O, 2001, SEMIN HEMATOL, V38, P3, DOI 10.1053/shem.2001.27077; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198	35	260	276	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					765	U13		10.1038/nature09171	http://dx.doi.org/10.1038/nature09171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20639863	Green Accepted			2022-12-28	WOS:000280562500041
J	Volavka, J; Swanson, J				Volavka, Jan; Swanson, Jeffrey			Violent Behavior in Mental Illness: The Role of Substance Abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCHIZOPHRENIA; DISORDER; CRIME		[Volavka, Jan] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Swanson, Jeffrey] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA	New York University; Duke University	Volavka, J (corresponding author), POB 160663, Big Sky, MT 59716 USA.	janvolavka@gmail.com	Volavka, Jan/E-9529-2019	Volavka, Jan/0000-0002-4178-8207	NIMH NIH HHS [KO2-MH67864, K02 MH067864] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH067864] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Krakowski MI, 2006, ARCH GEN PSYCHIAT, V63, P622, DOI 10.1001/archpsyc.63.6.622; Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012; Swanson JW, 2008, LAW HUMAN BEHAV, V32, P228, DOI 10.1007/s10979-007-9095-7; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Volavka J, 2008, INT J CLIN PRACT, V62, P1237, DOI 10.1111/j.1742-1241.2008.01797.x; Yates KF, 2010, J FORENSIC PSYCHI PS, V21, P167, DOI 10.1080/14789940903174238	10	41	41	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					563	564		10.1001/jama.2010.1097	http://dx.doi.org/10.1001/jama.2010.1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682936	Green Accepted			2022-12-28	WOS:000280525700024
J	d'Oliveira, C; Carson, S; James, K; Lazarus, J				d'Oliveira, Cecilia; Carson, Stephen; James, Kate; Lazarus, Jeff			SERIES WINNER MIT OpenCourseWare: Unlocking Knowledge, Empowering Minds	SCIENCE			English	Editorial Material									[d'Oliveira, Cecilia; Carson, Stephen; James, Kate; Lazarus, Jeff] MIT, MIT OpenCourseWare, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	d'Oliveira, C (corresponding author), MIT, MIT OpenCourseWare, Cambridge, MA 02142 USA.	cec@mit.edu							0	14	15	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					525	526		10.1126/science.11826962	http://dx.doi.org/10.1126/science.11826962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633EX	20671179				2022-12-28	WOS:000280483500024
J	Contreras, JL				Contreras, Jorge L.			Prepublication Data Release, Latency, and Genome Commons	SCIENCE			English	Editorial Material							GENETICS; PROJECT		Washington Univ, Sch Law, St Louis, MO 63130 USA	Washington University (WUSTL)	Contreras, JL (corresponding author), Washington Univ, Sch Law, St Louis, MO 63130 USA.	jlcontreras@wulaw.wustl.edu		Contreras, Jorge/0000-0002-7899-3060				[Anonymous], 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Brumfiel G, 2008, NATURE, V453, P139, DOI 10.1038/453139a; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Collins F., 2010, LANGUAGE LIFE; DOE, 1993, HUMAN GENOME NEW JAN, P4; *GAIN, DAT US CERT AGR VERS; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HEFFERNAN O, NATURE; HESS C., 2007, UNDERSTANDING KNOWLE; Hess C, 2006, INT SOC SCI J, V58, P335, DOI 10.1111/j.1468-2451.2006.00622.x; HOLDEN AL, 2002, BIOTECHNIQUES, V32, pS22; *INT HAPMAP PROJ, DAT REL POL; *ISAEC, INT PROP PROGR; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Madison MJ, 2010, CORNELL LAW REV, V95, P657; Merrill Stephen A., 2006, REAP BEN GEN PROT RE; National Academy of Sciences National Academy of Engineering & Institute of Medicine, 2009, ENS INT ACC STEW RES; National Research Council, 1997, BITS POW ISS GLOB AC; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; *NHGRI, 2008, ENCODE CONS DAT REL; *NHGRI, 2000, POL REL DAT DEP SEQ; *NIH, 2008, NOTOD08033 NIH; Rai Arti K., 2003, LAW CONTEMP PROBL, V66, P289; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; 2007, FED REG, V72, P49290; 2003, WELLC TRUST SHAR DAT; 1996, SUMM PRINC AGR INT S; ENCODE PROJECT DATA	31	19	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					393	394		10.1126/science.1189253	http://dx.doi.org/10.1126/science.1189253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KJ	20651137				2022-12-28	WOS:000280196500019
J	Ferron, M; Wei, JW; Yoshizawa, T; Del Fattore, A; DePinho, RA; Teti, A; Ducy, P; Karsenty, G				Ferron, Mathieu; Wei, Jianwen; Yoshizawa, Tatsuya; Del Fattore, Andrea; DePinho, Ronald A.; Teti, Anna; Ducy, Patricia; Karsenty, Gerard			Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; OSTEOCLAST FORMATION; GLUCOSE-TOLERANCE; BETA-CELL; OSTEOCALCIN; RECEPTOR; MICE; EXPRESSION; KNOCKOUT; DELETION	The broad expression of the insulin receptor suggests that the spectrum of insulin function has not been fully described. A cell type expressing this receptor is the osteoblast, a bone-specific cell favoring glucose metabolism through a hormone, osteocalcin, that becomes active once uncarboxylated. We show here that insulin signaling in osteoblasts is necessary for whole-body glucose homeostasis because it increases osteocalcin activity. To achieve this function insulin signaling in osteoblasts takes advantage of the regulation of osteoclastic bone resorption exerted by osteoblasts. Indeed, since bone resorption occurs at a pH acidic enough to decarboxylate proteins, osteoclasts determine the carboxylation status and function of osteocalcin. Accordingly, increasing or decreasing insulin signaling in osteoblasts promotes or hampers glucose metabolism in a bone resorption-dependent manner in mice and humans. Hence, in a feed-forward loop, insulin signals in osteoblasts activate a hormone, osteocalcin, that promotes glucose metabolism.	[Ferron, Mathieu; Wei, Jianwen; Yoshizawa, Tatsuya; Karsenty, Gerard] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Ducy, Patricia] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Del Fattore, Andrea; Teti, Anna] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA	Columbia University; Columbia University; University of L'Aquila; Harvard University; Harvard Medical School	Karsenty, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Del Fattore, Andrea/H-4409-2015; Del Fattore, Andrea/AAP-2045-2020; Ferron, Mathieu/M-7794-2013	Del Fattore, Andrea/0000-0003-3848-412X; Del Fattore, Andrea/0000-0003-3848-412X; DePinho, Ronald/0000-0002-5625-577X; Teti, Anna Maria/0000-0002-5887-4419; Yoshizawa, Tatsuya/0000-0002-5728-1996	Fond de la recherche en sante du Quebec; National Institutes of Health; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078042] Funding Source: NIH RePORTER	Fond de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Kousteni, T. Zee, R. L. Levine, M. Tremblay, and J. Vacher for reagents; Dr. J. Lacombe for help with transplantations; Drs. K. Henriksen and J. Bollerslev for generously sharing patient serum samples; Dr. T. Lam at the W. M. Keck Foundation Biotechnology Resource Laboratory, Yale University, for FT-ICR mass spectral analyses; and Drs. J. K. Kim and F. Mauvais-Jarvis for critical reading of the manuscript. This work was supported by a fellowship from the Fond de la recherche en sante du Quebec (M. F.), grants from the National Institutes of Health (G. K.), and the Juvenile Diabetes Research Foundation (P. D.). G. K. is a founder and member of the scientific advisory board of Escoublac Inc. P. D. is a founder and consultant of Escoublac Inc.	Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chengalvala MV, 2001, BIOCHEMISTRY-US, V40, P814, DOI 10.1021/bi0019996; Cousin W, 2004, BIOCHEM BIOPH RES CO, V321, P259, DOI 10.1016/j.bbrc.2004.06.137; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; ENGELKE JA, 1991, BIOCHIM BIOPHYS ACTA, V1078, P31, DOI 10.1016/0167-4838(91)90088-H; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Kaji H, 2009, J BONE MINER METAB, V27, P76, DOI 10.1007/s00774-008-0005-y; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; KASUGA M, 1983, J BIOL CHEM, V258, P973; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Sadler JE, 2004, NATURE, V427, P493, DOI 10.1038/427493a; Schaller S, 2005, DRUG NEWS PERSPECT, V18, P489, DOI 10.1358/dnp.2005.18.8.944546; Scheen AJ, 2005, DRUG SAFETY, V28, P601, DOI 10.2165/00002018-200528070-00004; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Yamauchi M, 2010, CLIN NUTR, V29, P761, DOI 10.1016/j.clnu.2010.02.010; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366	37	783	839	4	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					296	308		10.1016/j.cell.2010.06.003	http://dx.doi.org/10.1016/j.cell.2010.06.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655470	Green Accepted, Bronze			2022-12-28	WOS:000280204300020
J	Smith, SR; Weissman, NJ; Anderson, CM; Sanchez, M; Chuang, E; Stubbe, S; Bays, H; Shanahan, WR				Smith, Steven R.; Weissman, Neil J.; Anderson, Christen M.; Sanchez, Matilde; Chuang, Emil; Stubbe, Scott; Bays, Harold; Shanahan, William R.		Behav Modification & Lorcaserin O	Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CARDIAC-VALVE REGURGITATION; 5-HT2C RECEPTOR AGONIST; VALVULAR HEART-DISEASE; PARKINSONS-DISEASE; DOPAMINE AGONISTS; OBESE-PATIENTS; FENFLURAMINE; OVERWEIGHT; RISK	Background: Lorcaserin is a selective serotonin 2C receptor agonist that could be useful in reducing body weight. Methods: In this double-blind clinical trial, we randomly assigned 3182 obese or overweight adults (mean body-mass index [the weight in kilograms divided by the square of the height in meters] of 36.2) to receive lorcaserin at a dose of 10 mg, or placebo, twice daily for 52 weeks. All patients also underwent diet and exercise counseling. At week 52, patients in the placebo group continued to receive placebo but patients in the lorcaserin group were randomly reassigned to receive either placebo or lorcaserin. Primary outcomes were weight loss at 1 year and maintenance of weight loss at 2 years. Serial echocardiography was used to identify patients in whom valvulopathy (as defined by the Food and Drug Administration) developed. Results: At 1 year, 55.4% of patients (883 of 1595) receiving lorcaserin and 45.1% of patients (716 of 1587) receiving placebo remained in the trial; 1553 patients continued into year 2. At 1 year, 47.5% of patients in the lorcaserin group and 20.3% in the placebo group had lost 5% or more of their body weight (P<0.001), corresponding to an average loss of 5.8+/-0.2 kg with lorcaserin and 2.2+/-0.1 kg with placebo during year 1 (P<0.001). Among the patients who received lorcaserin during year 1 and who had lost 5% or more of their baseline weight at 1 year, the loss was maintained in more patients who continued to receive lorcaserin during year 2 (67.9%) than in patients who received placebo during year 2 (50.3%, P<0.001). Among 2472 patients evaluated at 1 year and 1127 evaluated at 2 years, the rate of cardiac valvulopathy was not increased with the use of lorcaserin. Among the most frequent adverse events reported with lorcaserin were headache, dizziness, and nausea. The rates of serious adverse events in the two groups were similar. Conclusions: In conjunction with behavioral modification, lorcaserin was associated with significant weight loss and improved maintenance of weight loss, as compared with placebo. (Funded by Arena Pharmaceuticals; ClinicalTrials.gov number, NCT00395135.) N Engl J Med 2010;363:245-56.	[Smith, Steven R.] Florida Hosp, Translat Res Inst Metab & Diabet, Winter Pk, FL 32789 USA; [Smith, Steven R.] Sanford Burnham Inst, Winter Pk, FL USA; [Weissman, Neil J.] Washington Hosp Ctr, MedStar Hlth Res Inst, Washington, DC 20010 USA; [Weissman, Neil J.] Georgetown Univ, Washington, DC USA; [Anderson, Christen M.; Sanchez, Matilde; Chuang, Emil; Stubbe, Scott; Shanahan, William R.] Arena Pharmaceut, San Diego, CA USA; [Bays, Harold] Louisville Metab & Atherosclerosis Res Ctr, Louisville, KY USA	Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Winter Park; Sanford Burnham Prebys Medical Discovery Institute; MedStar Health Research Institute; MedStar Washington Hospital Center; Georgetown University; L-MARC Research Center	Smith, SR (corresponding author), Florida Hosp, Translat Res Inst Metab & Diabet, 2566 Lee Rd, Winter Pk, FL 32789 USA.	steven.r.smith.MD@flhosp.org	Smith, Steven/HDM-9496-2022	Smith, Steven/0000-0002-5098-8147	Arena Pharmaceuticals	Arena Pharmaceuticals	Supported by Arena Pharmaceuticals.	[Anonymous], 1997, MMWR MORB MORTAL WKL, V46, P1061; Antonini A, 2007, LANCET NEUROL, V6, P826, DOI 10.1016/S1474-4422(07)70218-1; Casey PR, 2006, BRIT J PSYCHIAT, V189, P410, DOI 10.1192/bjp.bp.105.017368; Connolly HM, 1997, NEW ENGL J MED, V337, P1783; Dewey RB, 2007, ARCH NEUROL-CHICAGO, V64, P377, DOI 10.1001/archneur.64.3.377; Ditschuneit HH, 2002, EUR J CLIN NUTR, V56, P264, DOI 10.1038/sj.ejcn.1601375; Fabricatore AN, 2009, OBES REV, V10, P333, DOI 10.1111/j.1467-789X.2009.00567.x; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Gottdiener JS, 2002, AM HEART J, V144, P115, DOI 10.1067/mhj.2002.123139; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hofmann C, 2006, CLIN NEUROPHARMACOL, V29, P80, DOI 10.1097/00002826-200603000-00005; Karason K, 2000, ARCH INTERN MED, V160, P1797, DOI 10.1001/archinte.160.12.1797; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Mertens IL, 2000, OBES RES, V8, P270, DOI 10.1038/oby.2000.32; *NAT CHOL ED PROGR, RISK ASS TOOL EST 10; National Heart Lung and Blood Institute, 3 EXP PAN DET EV TRE; Padwal R, 2003, INT J OBESITY, V27, P1437, DOI 10.1038/sj.ijo.0802475; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; PISUNYER FX, 2006, JAMA-J AM MED ASSOC, V295, P1252; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2002, PHARMACOL THERAPEUT, V95, P73, DOI 10.1016/S0163-7258(02)00234-6; Rothman RB, 2000, CIRCULATION, V102, P2836; Sachdev M, 2002, AM HEART J, V144, P1065, DOI 10.1067/mhj.2002.126733; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Smith BM, 2008, J MED CHEM, V51, P305, DOI 10.1021/jm0709034; Smith S. R., 2008, OBESITY, V17, P494; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; WHO, 1985, WHO TECHN REP SER, V724, P71; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830	32	629	647	1	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					245	256		10.1056/NEJMoa0909809	http://dx.doi.org/10.1056/NEJMoa0909809			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647200	Bronze			2022-12-28	WOS:000279864200007
